PLoS Biol	26668765	2008-01-23	PMC1054884	15737066	viral recombin dramat impact evolut epidemiolog virus recombin rate depend frequenc genet exchang viral genom infect host cell frequenc coinfect occur recombin rate evalu experiment coinfect cell cultur virus direct quantif biolog level host infect lack studi fill gap cauliflow mosaic viru model distribut neutral marker viral genom coinocul host plant markercontain wildtyp virus frequenc recombin genom evalu postinocul averag viral genom recov singl host infect recombin clearli indic recombin frequent viru estim recombin rate region genom equal process assum ten viral replic cycl occur experimentbas data time coat protein detectionth base replic cycl recombin rate order determin viru recombin rate singl multicellular host infect indic recombin frequent everydai life viru
Crit Care	18216103	2010-05-01	PMC1065064	15566586	introduct critic care physician benefit access medic refer materi evalu feasibl potenti benefit handheld comput base knowledg access system link central academ intens care unit icu multipl communitybas icu method commun hospit icu physician particip prospect intervent studi train internetlink updat handheld comput knowledg access system physician handheld devic clinic environ month intervent period feasibl system evalu track handheld comput conduct survei focu group discuss intervent period particip underw simul patient care scenario design evalu sourc access speed qualiti decis make particip gener admiss order scenario score blind evalu ten physician system regularli nonmed applic median month interquartil rang iqr medic softwar access median month iqr physician complet final scenario chose handheld comput access median time access handheld handheld comput iqr group exhibit improv admiss order score compar resourc benefit barrier technolog identifi conclus updat handheld comput system feasibl pointofcar access medic refer materi improv clinic decis make studi accept system variabl improv train technolog overcom barrier identifi
PLoS Biol	20035236	2015-01-23	PMC1084330	15884975	infect human cell polioviru induc prolifer doublemembran cytoplasm vesicl surfac site viral rna replic origin unknown hallmark cellular autophagosom identifi poliovirusinduc vesicl includ coloc lamp lc human homolog saccharomyc cerevisia atgp stain fluorophor monodansylcadaverin fixat coloc lc lamp observ earli polioviru replic cycl cell infect rhinovirus and cell express polioviru protein bc suffici induc doublemembran vesicl stimul autophagi increas polioviru yield inhibit autophagosom pathwai methyladenin rna interfer mrna encod protein requir autophagi decreas polioviru yield propos polioviru rhinoviru compon cellular machineri autophagosom format subvert promot viral replic autophagi serv innat immun respons microorgan find inconsist role induc autophagosomelik structur clearanc polioviru argu doublemembran structur provid membran support viral rna replic complex enabl nonlyt releas cytoplasm content includ progeni virion infect cell
BMC Public Health	25634147	2011-12-01	PMC1084353	15804368	background emerg infecti diseas sever acut respiratori syndrom sar strike suddenli wonder public overwhelm fear sar deter patient seek routin care hospit andor interrupt patient continu care studi sought estim influenc pregnant women fear sever acut respiratori syndrom sar choic provid mode childbirth length stai lo deliveri sar epidem taiwan method nation health insur data januari decemb populationbas descript analysi conduct assess chang volum market share cesarean rate averag lo provid level sar epidem compar presar period medic center region hospit drop market share childbirth servic peak sar period district hospit clinic increas chang cesarean rate larger increas observ medic center peak sar period term lo reduct averag lo observ hospit level clinic averag lo shorten dai medic center dai region hospit dai district hospit conclus larg amount patient shift matern ward advanc hospit advanc hospit coupl substanti reduct length matern stai fear sar lead seriou concern qualiti care patient access qualiti provid continu care
Virol J	22105176	2014-02-05	PMC1087510	15833113	in aftermath sar epidem progress understand molecular cell biologi sarscov mileston avail viral genom sequenc identif viral receptor develop infecti cdna clone identif viral antigen elicit neutral antibodi larg gap understand sarscov interact host cell rapidli chang viral genom add variabl equat sarscov stori enter phase search prevent strategi cure diseas review highlight progress identifi molecular aspect sarscov biologi relev develop diseas prevent strategi author conclud develop success sarscov vaccin antivir depend progress area futur
BMC Bioinformatics	24501403	2005-01-28	PMC1090557	15817134	background current dna diagnost test identifi organ specif oligonucleotid probe complementari sequenc hybridis dna target speci contrast tradit taxonomi specimen identifi dichotom kei combin charact share member target set specif charact target effici strategi identif combin share bisectionallydistribut charact effici strategi effici separ target progress binari develop practic method find minim set subsequ identifi individu sequenc target combin probe effici strategi tradit taxonom identif dna diagnosi size minim subsequ set depend sequenc divers subsequ length interact paramet distinct cytochrom oxidas subunit gene moth lepidoptera distinguish subsequ nucleotid long subsequ nucleotid long requir distinguish gene speci largest order insect conclus presenceabs subsequ set gene sequenc question tradit dichotom taxonom kei hybridis probe complementari subsequ provid effici identifi individu speci subtyp genotyp sequenc divers subsequ length major factor determin number distinguish subsequ set sequenc
BMC Infect Dis	15681456	2010-08-04	PMC1090578	15819995	background postul genet predisposit influenc suscept sarscoronaviru infect diseas outcom studi suggest delet allel allel angiotensin convert enzym ac gene associ hypoxemia sar patient ac allel preval patient suffer adult respiratori distress syndrom ard previou studi investig associ ac insertiondelet polymorph progress ard requir intens care sar patient method forti genet unrel chines sar patient healthi volunt recruit ac genotyp determin polymeras chain reaction agaros gel electrophoresi differ genotyp distribut allel frequenc ac polymorph sar patient healthi control subject evid ac polymorph associ progress ard requir intens care sar patient multivari logist analysi ag factor associ develop ard ag male sex independ factor associ requir intens care conclus ac polymorph directli increas suscept sarscoronaviru infect associ poor outcom sarscoronaviru infect
PLoS Biol	20686038	2019-10-01	PMC1110908	15884978	a wide rang rna virus program ribosom frameshift product viral fusion protein inspect overlap region orfa orfb sarscov genom reveal coronavirus program ribosom frameshift viru produc fusion protein comput analys frameshift signal predict presenc mrna pseudoknot three doublestrand rna stem structur phylogenet analys conserv potenti threestem pseudoknot frameshift signal coronavirus genbank databas presenc threestem structur support nucleas map twodimension nuclear magnet reson studi find interact stem structur result local distort aform rna distort evid vicin predict abulg stem vitro vivo frameshift assai sarscov frameshift signal function viral frameshift signal promot effici frameshift standard assai system sensit drug genet mutat affect frameshift effici yeast viru mutagenesi studi reveal specif sequenc structur stem effici frameshift identifi rna structur motif capabl promot effici program ribosom frameshift high degre conserv threestem mrna pseudoknot structur coronavirus suggest present novel target antivir therapeut
PLoS Biol	30944180	2003-10-13	PMC1149493	15941360	just protein form distinct structur motif structur commonli adopt rna molecul preval rna pseudoknot
BMC Genomics	14557669	2012-02-01	PMC1156889	15904493	background microbi forens track sourc pathogen diseas natur occur outbreak crimin investig method spr opt snp pcrrflp optim softwar perform comprehens wholegenom analysi forens discrimin multipl sequenc present tool optim forens type singl nucleotid polymorph snp pcrrestrict fragment length polymorph pcrrflp analys multipl isol sequenc speci describ pcrrflp analysi includ predict select optim primer restrict enzym enabl maximum isol discrimin base sequenc spr opt calcul snp pcrrflp variat sequenc group haplotyp cosegreg sequenc perform combinator analys determin set haplotyp provid maxim discrimin input sequenc set combin requir membership fewest haplotyp queri fewest assai perform analys highlight variabl region base exist sequenc data marker heterogen unsequenc isol character relationship unsequenc sequenc isol predict multilocu analys mump sar virus summar phylogenet tree creat base snp pcrrflp full genom compar sar viru illustr purport phylogeni base snp pcrrflp variat match base multipl sequenc align full genom conclus softwar optim select forens marker maxim gain fewest assai accept partial genom sequenc data input sequenc data multipl strain isol speci autom comput approach describ will essenti sens larg amount guid optim effort laboratori softwar sourc code spr opt publicli free nonprofit 
J Inflamm (Lond)	22301138	2016-09-29	PMC1156932	15921526	background respiratori viral infect character infiltr leukocyt includ activ neutrophil lung lead sustain lung injuri contribut chronic lung diseas specif mechan recruit neutrophil lung virusinduc lung inflamm injuri fulli elucid cxcl cxcl act cxcr potent neutrophil chemoattract investig role dsrnainduc lung injuri dsrna poli ic welldescrib synthet agent mimick acut viral infect method week femal balbc mice intratrach inject singlestrand ssrna doublestrand rna dsrna airwai lung harvest design timepoint character elicit chemokin respons result lung injuri dsrna exposur demonstr qualitit histopatholog analysi quantit fac protein mrna analysi bal fluid tissu sampl repeat experi pretreat mice antipmn correspond control antibodi subsequ pretreat separ cohort mice anticxcr correspond control antibodi prior dsrna exposur intratrach dsrna led increas neutrophil infiltr lung injuri balbc mice dsrna respons ssrna poli control treatment express cxcr ligand cxcr parallel neutrophil recruit lung neutrophil deplet studi reduc neutrophil infiltr lung injuri respons dsrna mice pretreat antipmn monoclon ab inhibit cxcr ligandscxcr interact pretreat dsrnaexpos mice anticxcr neutral ab attenu neutrophil sequestr lung injuri conclus find demonstr cxc chemokin ligandcxcr biolog axi critic pathogenesi dsrnainduc lung injuri relev acut viral infect
Respir Res	27578435	2015-02-01	PMC1156954	15888207	background acut phase sever acut respiratori syndrom sar mononuclear cell infiltr alveolar cell desquam hyalin membran format describ dysregul plasma cytokin level persist highresolut comput tomographi hrct abnorm occur sar patient dai recoveri method determin time cours recoveri lung inflamm investig hrct inflammatori profil coronaviru persist bronchoalveolar lavag fluid balf patient recoveri dai dai compar normal control sar patient increas cellular balf increas alveolar macrophag cd cell hrct score increas correl tcell number subpopul invers cdcd ratio tnf il il rant mcp level increas viral particl detect electron microscopi sar patient high hrct score dai hrct score improv patient normal balf cell count patient repeat bronchoscopi puls steroid therapi prolong fever independ factor associ delai resolut pneumon nonrandom retrospect analysi conclus resolut pneumon delai patient sar recoveri associ delai clearanc coronaviru complet resolut occur dai later
BMC Med Inform Decis Mak	25381058	2013-06-19	PMC1166558	15967040	background object studi explor percept local sever acut respiratori syndrom sar extranet potenti support futur commun applic sar extranet singl manag electron limit access system manag local provinci sar control method juli webbas paperbas survei conduct sar steer committe member hamilton assess percept extranet built support committe sar outbreak distribut survei usertest base thinkaloud protocol revis quantit qualit question ask frequenc extranet perceiv resourc rational potenti barrier strength limit potenti futur extranet respons rate respond report visit site rate highli low high site rate compar commun strategi outbreak half respond visit site dai common reason respond visit extranet access sar steer committe minut access hamilton medic advisori commonli cite potenti futur extranet send privat email public health expert surveil encount person barrier site mention time duplic email challeng conclus despit higher rank commun strategi sar outbreak email meet teleconfer web site user gener perceiv local extranet support dissemin local public health emerg
Virol J	23785216	2005-07-13	PMC1177995	15927084	viral fusion protein mediat cell entri undergo seri conform chang result viriontarget cell membran fusion class viral fusion protein encod influenza viru human immunodefici viru hiv promin alpha helic peptid mimic portion alpha helic inhibit structur rearrang fusion protein prevent viral infect envelop glycoprotein flavivirus west nile viru wnv dengu viru denv class ii viral fusion protein compris beta sheet physiochem algorithm wimleywhit interfaci hydrophob scale wwih combin structur data identifi potenti peptid inhibitor wnv denv infect target viral protein viral inhibit assai confirm peptid interfer target viru entri inhibitori concentr ic rang inhibitori peptid sequenc domain wwih score includ domain ii iib stem domain detect dn peptid correspond stem domain denv inhibit infect denv inhibit plaqu format concentr crossinhibit wnv fusioninfect inhibit demonstr dn potent wnv inhibitori peptid wn correspond wnv domain iib inhibit infect denv addit inhibitori peptid noncytotox sequenc specif manner inhibitori peptid identifi serv lead compound develop peptid drug flaviviru infect
PLoS Med	16014947	2016-07-24	PMC1181873	16013892	background mathemat model invalu manag tool epidemiologist shed light mechan underli observ dynam make quantit predict effect control measur explain substanti bias introduc ignor assumpt core vast major model method find analyt method ignor latent period ii make common assumpt exponenti distribut latent infecti period includ latent period underestim basic reproduct ratio infect outbreak data proce illustr point fit epidem model data influenza outbreak final document unrealist priori assumpt concern model structur rise systemat overoptimist predict outcom potenti manag option conclus work aim highlight develop model public health pai care attent intrins assumpt embed classic framework
BMC Bioinformatics	27449759	2007-01-24	PMC1183192	16042814	background algorithm assess similar primer templat develop base hypothesi anneal primer templat transfer process primer sequenc convert vector full potenti hydrogen number or templat sequenc convert vector actual hydrogen bond number form primer anneal consid sourc destin inform coeffici calcul measur fidel transfer process measur similar primer potenti anneal site templat conclus success predict pcr product genom sequenc comput program base algorithm demonstr potenti algorithm area silico pcr gene find
Virol J	17251282	2007-01-01	PMC1183252	15963240	a seri frameshift mutat gene observ culturederiv sever acut respiratori syndrom coronaviru sarscov report viral rna clinic sampl sarscov infect patient heterogen popul wildtyp mutant transcript
BMC Evol Biol	17038051	2014-06-11	PMC1185527	15987510	background rodent primat pregnancyspecif glycoprotein psg gene famili expand independ common ancestor express virtual exclus placent trophoblast speci unknown multipl paralog select diversif function increas dosag monofunct psg analys evolut mous psg sequenc compar rat human baboon psg attempt understand evolut complex gene famili phylogenet tree analys indic primat domain rodent domain exhibit higher degre conserv observ comparison mous n domain mous n domain compar human baboon psg domain exon mous rat psg domain exon undergon sequenc homogenis high nonsynonym substitut rate observ cfg face mous domain context conserv suggest diverg function mous psg rat psg famili appear undergon expans mous exhibit lower diverg rate increas sequenc homogenis cfg face domain contrast primat psg domain rodent psg domain rgd tripeptid motif rgdlike sequenc conserv rodent n domain conclus rel conserv primat domain rodent domain suggest despit independ gene famili expans structur diversif mous human psg retain conserv function human psg gene famili expans homogenis suggest evolut occur concert manner maintain function psg whilst increas gene dosag famili mous gene famili expans coupl local diversif cfg face suggest select increas gene dosag diversif function partial conserv rgd rgdlike tripeptid primat rodent n domain support role motif psg function
PLoS Med	24920815	2013-08-28	PMC1188248	16104827	background clinic relev infect novel human coronaviru nl hcovnl investig systemat determin associ diseas young children lower respiratori tract infect lrti method find fortynin sampl nasopharyng secret children ag lrti analys quantit hcovnlspecif realtim pcr sampl collect hospitalis patient outpati decemb octob region germani prospect populationbas pride studi analys rna respiratori virus fortynin sampl deriv winter season posit hcovnl rna viral rna preval sampl outpati hospitalis patient coinfect respiratori syncyti viru parainfluenza viru observ frequent sampl hcovnl rna detect higher viral load sampl addit respiratori virus median versu copiesml strong associ croup appar hcovnlposit patient high hcovnl load absenc coinfect suffer croup compar hcovnlneg group higher fraction sampl croup patient noncroup patient contain hcovnl rna conclus hcovnl infect occur frequent young children lrti strong associ croup suggest causal relationship
Virol J	22466658	2012-09-26	PMC1190220	16107218	sever acut respiratori syndrom coronaviru sarscov lifethreaten atyp pneumonia infect organ lung liver immun organ induc parenchyma cell apoptosi necrosi genom sarscov close character coronaviru encod replicas major structur protein number nonstructur protein publish studi nonstructur protein plai role replic virul pathogenesi virus potenti sarscov nonstructur protein protein orf predict encod amino acid lack similar protein till report function protein studi gene link egfp tag terminu cell cycl analysi overexpress begfp protein vero co cell induc cell cycl arrest gg phase co cell express begfp induc increas subg phase transfect obviou apoptosi induct fusion protein co cell confirm doubl cell label aad annexin function protein induc cell gg arrest apoptosi provid insight studi mechan sar pathogenesi
Retrovirology	15956573	2007-10-23	PMC1201173	16091143	background major determin retroviru host rang presenc absenc appropri cellsurfac receptor requir viru entri ortholog function receptor wide rang speci amino acid differ render receptor nonfunct case amino acid differ result addit nlink glycosyl block viru infect block retroviru infect overcom treatment cell compound tunicamycin prevent addit nlink oligosaccharid discov treatment cell liposom compos phosphatidylserin ps overcom block infect mediat nlink glycosyl importantli occur appar chang glycosyl state receptor virus occur delai kinet compar previou show enhanc viru infect ps treatment cell express function viru receptor conclus demonstr ps treatment reliev block retroviru infect cell express retrovir receptor render nonfunct glycosyl find implic current model describ inhibit viru entri receptor glycosyl
BMC Pulm Med	17954898	2006-09-13	PMC1208914	16138926	background infecti respiratori diseas transmit noninfect subject infect person expel pathogen microorgan surround environ cough sneez airwai mucu layer interact highspe airflow droplet expel aerosol concentr size distribut plai role diseas transmiss goal reduc aerosoliz respiratori secret interf minim normal mucu clearanc agent capabl increas crosslink mucin glycoprotein network method expos mucu simul ms airflow simul cough machin scm ms rang nonvisc nonelast substanc water ms vari degre viscos elast mucociliari clearanc ms assess frog palat elast filancemet aerosol pattern bullsey target sampl load weigh cough maneuv test mucomodul sodium tetrabor xlb calcium chlorid xl mucociliari transport close normal speed viscoelast sampl compar nonelast nonvisc viscousonli sampl spinnabl rang cm amount ms expel scm increas ad xl concurr particl invers reduc disappear aerosol pattern conclus aerosoliz ms modifi increas cohes reduc number particl expel scm interf minim clearanc frog palat unexpect find ms crosslink increas expector
Global Health	16971444	2013-05-01	PMC1208931	16078989	thi paper describ conceptu framework health implic globalis framework develop identifi main determin popul health main featur globalis process conceptu model explicitli visualis globalis institut econom socialcultur ecolog determin popul health globalis process oper contextu level influenc health distal proxim determin develop framework valuabl insight organis complex involv studi health effect globalis meaning contribut empir serv thinkmodel basi develop futur scenario health
Hum Resour Health	23778667	2010-07-07	PMC1215505	16092972	background influenza pandem inevit estim potenti impact primari care medic workforc zealand plan mitig disrupt pandem challeng method model fluaid softwar center diseas control prevent cdc atlanta appli zealand primari care medic workforc gener practition peak week pandem lead to loss medic work time conserv baselin assumpt workdai lost ill hospitalis prematur death input sever scenario includ greater health effect time spent care sick rel scenario medic workdai lost peak week compress sixweek period pandem wave base case lost workdai ill care hospitalis prematur death conclus prepared plan futur influenza pandem consid impact medic workforc incorpor strategi minimis impact includ infect control measur welldesign protocol improv health sector surg capac
Virol J	20610721	2014-11-25	PMC1215526	16076403	herp simplex viru hsv type virus histori evolut share human gener welladapt virus infect harm capac hide neuron life rare situat primari infect gener involv brain primari hsv infect asymptomat crucial element earli restrict viru replic avoid symptom infect concert action arm innat immun respons earli light struggl inhibit hsv replic will spare host real war huge amount viru infect war will jeopard life host will interest includ viru settl conflict amic weapon unspecif defenc earli strike battl dai hsv infect discuss review gener macrophag orchestr multitud antiherpet action hour attack wave respons cytokin type interferon ifn tumour necrosi factor produc exert direct antivir activ macrophag wave interleukin il cytokin induc product ifn nk cell posit feedback mechan synergist interact intensifi system rise heavi antivir weapon reactiv oxygen speci nitric oxid gener allianc viral enemi heavi weapon control avoid harm host il reaction hamper allow foci hsv replic focus activ relev site hero allianc cytokin macrophag cell plai central role implic futur treatment modal shortli consid
BMC Public Health	25425699	2002-08-01	PMC1232855	16120225	background assess pattern inject drug hiv preval inject drug user idu intern border area major heroin transship rout method crosssect survei idu site lang son provinc vietnam site ning ming counti guangxi provinc china respond recruit peer referr snowbal method countri offici record list idu vietnam risk behavior questionnair administ hiv counsel test conduct particip countri male unmarri major subject countri member ethnic minor group strong geograph gradient length drug inject hiv seropreval year inject hiv seropreval declin vietnames site farthest border chines site farthest border particip china particip vietnam report cross intern border month prior interview cross border idu associ distanc border member ethnic minor group hiv seroposit chines particip conclus reduc intern spread hiv idu will requir program global region nation local cross border level local cross border level program coordin side border suffici scale idu will clean inject equip side border countri resid
Virol J	12097550	2013-08-02	PMC1232869	16115318	background sever acut respiratori syndrom sar caus newli discov coronaviru sarscov effect prophylact postexposur therapi current report chloroquin strong antivir effect sarscov infect primat cell inhibitori effect observ cell treat drug exposur viru suggest prophylact therapeut advantag addit wellknown function chloroquin elev endosom ph drug appear interfer termin glycosyl cellular receptor angiotensinconvert enzym neg influenc virusreceptor bind abrog infect ramif elev vesicular ph inhibit infect spread sar cov clinic admiss concentr conclus chloroquin effect prevent spread sar cov cell cultur favor inhibit viru spread observ cell treat chloroquin prior sar cov infect addit indirect immunofluoresc assai describ repres simpl rapid method screen sarscov antivir compound
Virol J	23913960	2006-09-18	PMC1236967	16122388	the entri sar coronaviru scv cell initi bind spike envelop glycoprotein receptor ac identifi receptorbind domain rbd fragment length includ amino acid residu potenti glycosyl site character role glycosyl identifi residu function interact partner ac clone express character solubl fragment rbd mutat potenti glycosyl site residu shortest fragment bind receptor ac includ residu potenti glycosyl site start residu potenti glycosyl site residu mutat of site alanin glutamin mutat residu alanin longer fragment decreas molecular weight kda suggest glycosyl site function simultan mutat glycosyl site lack express suggest glycosyl site three requir express glycosyl affect bind ac alanin scan mutagenesi fragment identif ten residu reduc bind ac residu appear increas bind mutat residu reduc bind fold mutat residu fold analysi data map mutat determin crystal structur fragment rbd complex ac li li farzan harrison submit suggest exist hot spot rbd surfac contribut portion bind energi find mutat includ glycosyl site affect rbd bind function indic mechan evas immun respons
Genome Biol	16982825	2013-07-23	PMC1242213	16168085	dna microarrai identifi microbi speci environment clinic sampl autom tool reliabl speci identif base observ microarrai hybrid pattern lack algorithm epredict microarraybas speci identif epredict compar observ hybrid pattern theoret energi profil repres speci demonstr applic algorithm viral detect set clinic sampl discuss relev metagenom applic
Int J Health Geogr	26835306	2007-05-23	PMC1242244	16176577	thi eyeopen articl aim introduc health gi commun emerg onlin consum geoinformat servic googl microsoft msn potenti util creat custom onlin interact health map programm interfac provid googl msn creat three interact demonstr map england strateg health author brows onlin googl map api applic program interfac version googl earth kml keyhol markup languag version msn virtual earth map control version googl msn worldwid distribut free geospati tool imageri map commend step ultim wikif map gi discuss provid emerg onlin map trend expect futur implic develop direct associ individu privaci nation secur copyright issu esri announc plan respons googl msn remain envisag plan will materi compar offer googl msn googl msn map tool will evolv futur
Environ Health Perspect	21194389	2009-02-01	PMC1247620	15531441	we appli cartograph geostatist method analyz pattern diseas spread sever acut respiratori syndrom sar outbreak hong kong geograph system gi technolog analyz integr databas contain clinic person detail patient confirm sar februari june elementari map diseas occurr space time simultan reveal geograph extent spread territori statist surfac creat kernel method confirm sar case highli cluster identifi distinct diseas hot spot contextu analysi standard deviat densiti class indic period dai februari dai march prodrom epidem dai june mark declin phase outbreak originanddestin plot direct bia radiu spread superspread event integr gi technolog routin field epidemiolog surveil offer realtim quantit method identifi track geospati spread infecti diseas experi sar demonstr
Genet Vaccines Ther	31355825	2007-06-23	PMC1249587	16115319	sever studi cellmedi immun respons plai crucial role control viral replic candid sar vaccin elicit broad cd tcell immun respons group mice immun combin sarsnucleocapsid immunogen high level specif sarscd tcell respons demonstr mice receiv dna encod sarsnucleocapsid protein xiap adjuv observ coadministr plasmid express nucleocapsid recombin protein montanidecpg induc high antibodi titer immun mice vaccin approach merit investig potenti candid vaccin sar
Environ Health Perspect	17639238	2014-07-09	PMC1257548	15866764	state local health depart continu face unpreced challeng prepar recogn respond threat public health attack septemb ensu anthrax mail highlight public health readi respons hurdl pose intention caus injuri ill time natur disast highlight compar public health readi respons capabl public health readi respons activ conceptu intent attack natur disast humancaus accid consist view feder govern adopt allhazard respons model fundament paradigm adopt paradigm power improv effici efficaci reduc creat complex famili situationspecif prepared respons activ practic public health prepared requir addit model tool provid framework better understand priorit emerg readi respons facilit solut true local health depart level propos extend haddon matrixa conceptu model decad injuri prevent respons strategiesfor purpos
Virol J	25008936	2017-11-06	PMC1260030	16115320	much world popul activ immin danger establish infecti pathogen sporad pandem infect emerg agent threaten rna polymeras rnapol gener enorm genet consequ antigen heterogen permit virus cellular pathogen evad host defenc rnapol morbid prematur mortal molecul extraordinari genet heterogen defin viral quasispeci rnapol infidel caus rapid cumul genom rna mutat process uncontrol catastroph loss sequenc integr inexor quasispeci extinct select replic replic homeostasi epicycl regulatori mechan dynam link rnapol fidel process quasispeci phenotyp divers modul polymeras fidel control quasispeci behaviour prevent happen mediat immun escap importantli ineluct gener broad phenotyp divers viral rna translat protein quasispeci suggest mechan diseas target function disrupt host cell surfac molecul includ hormon lipid cell signal neurotransmitt receptor virus coopt cell entri mechan viral receptor diseas vrd explain socal viral autoimmun classic autoimmun disord diseas includ type ii diabet mellitu form obes viral receptor diseas unifi hypothesi explain diseas wellestablish multifactori unrel aetiolog coronari arteri vascular diseas addit diseas schizophrenia understood lack plausibl coher pathogen explan
BMC Infect Dis	29105570	2007-05-23	PMC1261265	16171519	background sever acut respiratori syndrom sarscov newli emerg viru sar high mortal rate infect peopl success control global sar epidem will requir rapid sensit diagnost test monitor spread develop vaccin antivir compound includ neutral antibodi effect prevent treat diseas method human synthet singlechain fragment variabl scfv eth phage antibodi librari isol scfv nucleocapsid protein sarscov bio panningbas strategi select scfv character geneticsmolecular aspect sarscov protein detect elisa western blot immunocytochemistri human scfv antibodi protein sarscov easili isol select eth phage librari immunotub coat antigen vitro select human scfv recogn elisa western blot studi distinct epitop protein domain detect immunohistochemistri investig sarscov particl infect vero cell conclus human scfv antibodi isol describ studi repres reagent rapid detect sarscov protein sar viru particl infect target cell
BMC Genomics	17522233	2005-06-14	PMC1262710	16174304	background sever acut respiratori syndrom sar epidem human diseas caus novel coronaviru sarscov report asia sar spread worldwid intern travel juli health organ report total peopl afflict sar mortal rate immunopatholog damag account sever respiratori distress genomewid gene express host chang attack sarscov base chang gene express peripher blood identifi signatur gene accur discrimin acut sar patient nonsar control gener suppress gene express predomin sarsinfect blood gene includ involv innat immun defensin eosinophilderiv neurotoxin upregul emploi cluster method rank sever recov sar patient gener associ plot gap express profil signatur gene method discov smooth transit pattern sever normal control acut sar patient rank sar sever correl recoveri period dai clinic pulmonari infect score conclus gap approach prove analyz complex continu biolog system sever rank deriv global express profil regul gene patient elucid pathophysiolog diseas
Environ Health	15956182	2012-01-20	PMC1262740	16219096	background incid needlestick injuri farmer veterinari surgeon consequ inject seriou case present report accident inject bovin vaccin base finger increas pressur flexor sheath caus sign symptom ischemia amput digit requir despit repeat surgic debrid decompress conclus previou report inject oilbas vaccin human hand granulomat inflamm steril abscess caus morbid tissu loss selfinject veterinari vaccin occup hazard farmer veterinari surgeon inject vaccin close compart human finger seriou sequela includ loss inject digit injuri underestim earli debrid irrig inject area decompress best outcom frequent review procedur repeat oper requir
Crit Care	22264283	2014-05-28	PMC1269458	16137358	introduct pneumothorax complic manag mechan ventil sever acut respiratori syndrom sar patient isol intens care unit icu sought determin pneumothorac induc high ventilatori pressur volum associ mortal mechan ventil sar patient method conduct prospect clinic studi fortyon mechan ventil sar patient includ studi sar patient sedat receiv mechan ventil isol icu mechan ventil sar patient divid group pneumothorax demograph data clinic characterist ventilatori variabl posit endexpiratori pressur peak inspiratori pressur airwai pressur tidal volum tidal volum kilogram respiratori rate minut ventil accumul mortal rate dai mechan ventil analyz statist differ pressur volum group mortal group patient develop pneumothorax mechan ventil frequent express higher respiratori rate admiss lower paofio ratio higher paco level hospit compar pneumothorax conclus studi sar patient suffer pneumothorax present tachypn admiss pronounc hypoxem hypercapn hospit variabl signal deterior respiratori function indic develop pneumothorax mechan ventil sar patient meticul respiratori therapi monitor mandatori patient
BMC Health Serv Res	24872583	2013-04-01	PMC1274243	15885149	background main object studi appli autoregress integr move averag arima model realtim predict number bed occupi tan tock seng hospit sar outbreak method retrospect studi design hospit admiss occup data isol bed collect tan tock seng hospit period march st main outcom measur daili number isol bed occupi sar patient covari consid daili number peopl screen daili number peopl admit includ observ suspect probabl case dai event discoveri util strategi analysi firstli split outbreak data data march st april model develop structur arima model attempt model number bed occupi estim maximum likelihood method kalman filter arima model paramet consid simplest parsimoni lowest order model arima model describ predict number bed occupi sar outbreak absolut percentag error mape train set valid set reason hospit set model provid threedai forecast number bed requir total number admiss probabl case admit previou dai independ prognost factor bed occup conclus arima model provid tool administr clinician plan realtim bed capac outbreak infecti diseas sar model plan bedcapac outbreak infecti diseas well
BMC Infect Dis	23288419	2009-05-26	PMC1276795	16229749	background sever acut respiratori syndrom sar newli emerg infecti diseas caus global epidem sequenc analysi sarscoronaviru isol reveal specif genotyp predomin period epidem footprint trace epidemiolog infect monitor viral evolut direct sequenc analysi larg number clinic sampl cumbersom time consum simpl rapid assai screen sarscoronaviru genotyp base fluorogen oligonucleotid probe allel discrimin method thirti sar patient recruit allel discrimin assai develop base fluorogen oligonucleotid probe taqman genotyp sarscoronaviru isol patient carri allel discrimin assai confirm direct sequenc genotyp base allel discrimin assai fulli concord direct sequenc sarscoronaviru genotyp studi characterist genotyp document associ the epidem isol contain report major delet patient epidemiolog studi cohort conclus develop simpl accur method character screen sarscoronaviru genotyp promis tool studi epidemiolog relationship document case outbreak
BMC Health Serv Res	14728778	2011-06-01	PMC1298296	16259634	background commun affect percept fair process intens care unit bed alloc decis impact public condit account reason method perform qualit case studi describ particip percept commun bed alloc decis bed univers affili medicalsurg critic care unit sunnybrook women colleg health scienc centr interview particip critic care physician clinic fellow critic care resourc nurs endus physician commonli refer patient unit member administr staff median bed occup studi period janapril daili admiss discharg median evalu descript ethic framework account reason ar identifi opportun improv critic care physician resourc nurs critic care fellow endus trauma team leader surgeon neurosurgeon anesthesiologist function independ unoffici parallel track bed alloc decisionmak conflict offici design critic care physician sole author commun kei decisionmak indirect exclud decis notabl famili member particip perceiv lack public bed alloc rational conclus public condit improv critic care bed alloc decis decisionmak parallel track describ unavoid usual constraint time urgenc demand formal guidelin direct commun kei particip circumst help improv fair decis
PLoS Pathog	21632762	2020-03-17	PMC1298938	16341254	the coronaviru replicasetranscriptas complex assembl viral cellular protein mediat synthesi genom subgenomes mrna virusinfect cell report genet function analysi temperaturesensit mutant murin hepat viru mhva unabl synthes viral rna infect initi maintain nonpermiss temperatur classic biochem complement analysi lead predict major mhva orfa replicas gene product nonstructur protein nspnsp form singl complement group cistron replicas gene product encod orfb nonstructur protein nspnsp function tran compris three complement group cistron iivi identifi mutat nonstructur protein nsp nsp nsp nsp nsp nsp respons phenotyp mhva mutant allow conclud protein essenti assembl function replicasetranscriptas complex final analysi viral rna synthesi mutant virusinfect cell allow discrimin three phenotyp regard inabl specif mutant synthes viral rna nonpermiss temperatur mutant la appear defect continu negativestrand synthesi mutant alb appear form neg strand util positivestrand rna synthesi mutant alb defect elong posit negativestrand rna basi propos model describ pathwai viral rna synthesi mhvainfect cell biochem analysi mutant allow identifi intermedi pathwai elucid precis function viral replicas protein involv
PLoS Biol	32184199	2009-04-22	PMC1310650	16336043	the human gut reservoir wide varieti microb includ virus rna virus associ gastroenter enter rna viral commun healthi human describ compar metagenom analysi rna virus three fecal sampl healthi human individu studi uncultur virus concentr tangenti flow filtrat viral rna extract clone shotgun viral cdna librari sequenc analysi vast major viral sequenc plant pathogen rna virus abund fecal viru studi pepper mild mottl viru pmmv high concentrationsup virion gram dry weight fecal matter pmmv detect fecal sampl collect healthi individu contin indic plant viru preval human popul number pepperbas food test posit pmmv suggest dietari origin viru intriguingli fecal pmmv infecti host plant suggest human vehicl dissemin plant virus
BMC Mol Biol	19387028	2004-09-01	PMC1314898	16293192	background salmonid fish studi model fish speci report systemat evalu refer gene qrtpcr studi lack stabil potenti refer gene examin tissu atlant salmon salmo salar determin suitabl gene quantit realtim rtpcr analys rel transcript level gene encod rrna ribosom protein actin glyceraldehydepdehydrogenas gapdh paralog gene encod elong factor efaa efab quantifi gill liver head kidnei spleen thymu brain muscl posterior intestin untreat adult fish addit group individu smoltif base calcul perform genorm vba applet determin stabl gene set test gene cdna sampl rank examin gene adult atlant salmon efabefaaactin rrnasgapdh calcul total individu stage smoltif process presmolt smolt smoltifi seawat desmoltifi freshwat gene rank efabefaasactin rrnagapdh conclus work suggest efaa efab gene refer gene qrtpcr examin gene express atlant salmon
BMC Dev Biol	17135444	2010-06-30	PMC1315359	16324220	background realtim quantit pcr sensit effici techniqu examin gene transcript pattern preimplant embryo order gain embryo develop optim assist reproduct technolog critic succes applic realtim pcr care assai design reaction optim valid maxim sensit accuraci studi publish gapd actb rrna singl refer gene prior verif express stabil normal data unstabl control result erron conclus refer gene studi transcript level commonli refer gene actb gapd histon ha tbp hprt sdha ywhaz rrna determin preimplant stage cell cell blastocyst hatch blastocyst order select stabl gene normal quantit data preimplant embryo stage conclus genorm applic ywhaz gapd sdha stabl gene examin embryon stage commonli actb highli regul recommend geometr refer gene accur normal factor allow small express differ reliabl measur
PLoS Med	20592218	2009-10-28	PMC1315361	16354103	the revis intern health regul wilson colleagu long overdu emin face challeng increasingli global world
Respir Res	19864385	2005-12-01	PMC1318487	16283933	background fatal human respiratori diseas associ influenza subtyp hn document hong kong vietnam thailand cambodia demonstr patient hn diseas unusu high serum level ip interferongammainduc protein compar human influenza viru subtyp hn hn virus ahong kong hn potent induc proinflammatori cytokin tumor necrosi factora chemokin ip primari human macrophag vitro suggest cytokin dysregul plai role pathogenesi hn diseas respiratori epitheli cell primari target cell replic influenza virus pertin investig cytokin induct profil hn virus cell method quantit rtpcr elisa compar profil cytokin chemokin gene express induc hn virus ahk hn avietnam avietnam hn human hn viru human primari alveolar bronchial epitheli cell vitro demonstr comparison human hn virus hn hn virus potent induc ip interferon beta rant regul activ normal cell express secret interleukin il primari human alveolar bronchial epitheli cell vitro hn virus vietnam hn appear potent induc ip hn viru conclus hn hn subtyp influenza virus potent induc proinflammatori cytokin chemokin primari human respiratori epitheli cell subtyp hn viru hyperinduct cytokin relev pathogenesi human hn diseas
PLoS Med	16339072	2017-04-26	PMC1324949	16379498	background tuberculosi caus mycobacterium tuberculosi remain lead mortal worldwid ctype lectin dcsign major tuberculosi receptor human dendrit cell reason dcsign interact tuberculosi pathogen variat gene broad rang influenc pathogenesi number infecti diseas includ tuberculosi method find test polymorph cd gene encod dcsign associ suscept tuberculosi sequenc genotyp analys south african cohort exclus popul stratif cohort observ associ cd promot variant and decreas risk develop tuberculosi geograph distribut variant observ allel combin confin eurasian popul conclus observ variant confer protect tuberculosi addit geograph distribut allel phylogenet statu increas frequenc nonafrican popul result host genet adapt longer histori exposur tuberculosi character biolog consequ dcsign variat tuberculosi will crucial better appreci role lectin interact host immun system tubercl bacillu pathogen
PLoS Med	28125358	2015-08-28	PMC1324951	16379499	background cellular local sever acut respiratori syndrom coronaviru sarscov lung patient sar confirm etiolog associ viru diseas understand pathogenesi diseas knowledg comprehens studi investig viral infect cellular level human method find collect largest seri fatal case sar autopsi materi merg patholog materi region involv worldwid sar outbreak hong kong china toronto canada develop monoclon antibodi sarscov nucleoprotein situ hybrid ish analyz autopsi lung tissu patient sar hong kong toronto compar assai pulmonari patholog clinic cours ill patient sarscov nucleoprotein rna detect immunohistochemistri ish alveolar pneumocyt frequent macrophag local detect patient di week ill onset patient di week symptom onset conclus pulmonari alveolar epithelium chief target sarscov macrophag infect subsequ viral replic appear limit week symptom onset evid continu widespread replic period antivir therapi consid futur treatment focus twoweek period acut clinic diseas
PLoS Med	27852864	2011-02-01	PMC1326257	16401173	the pervas burden lung infect receiv proportion attent biomed public health commun argu mizgerd
PLoS Med	21345285	2014-02-26	PMC1351155	16420098	the big project ethic concern surround global health
BMC Public Health	24574391	2016-02-01	PMC1351169	16403223	background studi aim provid awar attribut fraction cancer japanes gener popul method nationwid repres sampl japanes ag older ask percept level concern environment genet risk factor relat cancer prevent omnibu survei interview conduct subject men women risk factor candid attribut fraction cancercaus viral bacteri infect consid highest tobacco smoke stress endocrinedisrupt chemic hand attribut fraction cancer char fish meat alcohol drink consid low compar risk factor candid risk factor attribut fraction respons higher women men subject tend respond higher valu estim epidemiolog evid west attribut fraction cancer specul genet determin cancer consid prevent improv lifestyl conclus awar attribut fraction cancer japanes gener popul domin cancercaus infect occup exposur air pollut food addit major lifestyl factor diet
BMC Bioinformatics	26572912	2018-12-12	PMC1352377	16401352	background highli accur statisticsbas system viral phage genom annot genemark system genefind viru phage genom suffer basic drawback paper put forward altern approach viral phage genefind improv qualiti annot newli sequenc genom system zcurvev viral phage genom satisfactori fair comparison current softwar function genemark total viral genom annot genemark select test consequ averag specif system match averag sensit zcurvev smaller viral genom kb constitut main part viral genom sequenc higher genemark addition genom amsacta moorei entomopoxviru lowest genom gc content sequenc organ accuraci zcurvev better genemark predict hundr falseposit gene zcurvev analyz wellstudi genom hiv hbv sarscov perform zcurvev gener better genemark final zcurvev download local facilit util genemark download base comparison suggest zcurvev serv prefer genefind tool viral phage genom newli sequenc joint applic system zcurvev genemark lead better genefind system zcurvev freeli conclus zcurvev serv prefer genefind tool viral phage genom anonym viral phage genom newli sequenc
BMC Genomics	30541833	2011-03-16	PMC1360066	16417644	background viru taxonomi base morpholog characterist nonphenotyp measur comparison viru famili examin phylogenet signal viru nucleotid usag pattern determin ancestr relationship wellstudi model tail morpholog bacteriophag classif comparison nucleotid usag pattern tetranucleotid usag deviat tud pattern chosen phylogenet signal rrna bacteriophag uniqu tud pattern repres genom signatur conserv host rang analysi tudbas phylogeni indic host influenc bacteriophag evolut phylogeni phage host support coevolut tudbas phylogeni eukaryot virus indic cluster base nucleic acid type genom size similar eukaryot viru phylogeni base tud gene content substanti tud methodolog conclus differ phenotyp tud analysi provid clue viru ancestri infer tud analysi complementari approach morphologybas system analysi viru evolut
BMC Biotechnol	21411570	2014-09-22	PMC1373654	16401354	background develop practic gene pointofcar test devic gpoct devic requir innov detect method demonstr the gene amplif reaction expens equip studi method sequencespecif visual detect minut amount nucleic acid precipit reaction addit cation polym amplicon loop mediat isotherm amplif lamp oligo dna probe label fluoresc dye prepar multipl nucleic acid templat templat amplifi lamp reaction exist probe complet lamp reaction optim amount low molecular weight polyethylenimin pei precipit insolubl lamp ampliconpei complex fluoresc label oligo dna probe hybrid lamp product incorpor precipit precipit emit fluoresc correspond amplifi nucleic acid templat color emit fluoresc detect easili nake ey convent uv illumin conclus presenc absenc minut amount nucleic acid templat detect simpl manner visual assess color lamp ampliconpei complex precipit conclud detect method facilit develop small simpl gpoct devic
BMC Infect Dis	25243477	2017-05-05	PMC1382231	16466582	background develop test diagnosi prognost assess sever acut respiratori syndrom sar base detect sarscoronaviru rna serum realtim quantit revers transcriptas polymeras chain reaction rtpcr studi evalu feasibl autom serum rna extract procedur order increas throughput assai method autom nucleic acid extract platform magna pure lc instrument roch diagnost evalu develop modifi protocol complianc recommend biosafeti guidelin health organ base magna pure total nucleic acid larg volum isol kit extract sarscoronaviru rna modifi protocol compar columnbas extract kit qiaamp viral rna mini kit qiagen quantit perform analyt sensit precis newli develop autom protocol free carryov contamin compar perform standard protocol kit design magna pure lc instrument autom method sensit precis led consist lower serum sarscoronaviru concentr compar columnbas extract method conclus diagnost effici prognost serum sarscov rna rtpcr test critic associ analyt sensit quantit perform contribut rna extract rtpcr compon test recommend columnbas manual rna extract method
BMC Vet Res	27035780	2002-11-01	PMC1386657	16445856	background previou studi demonstr high replic porcin circoviru pcv gnotobiot pig correl absenc pcvneutral antibodi aim studi investig correl spf pig pmw experiment reproduc natur pmwsaffect pig total antipcv antibodi titr pmwsaffect healthi anim seroconvert time point titr pmwsaffect anim lower compar healthi anim healthi anim evolut pcvneutral antibodi coincid total antibodi pmwsaffect anim neutral antibodi sera field studi detect low titr dpi sera experiment inocul spf pig differ evolut specif antibodi isotyp titr pcv healthi pig igm antibodi persist the studi pmwsaffect pig decreas remain low titr titr antibodi isotyp igg igg iga lower pmwsaffect pig compar healthi group mate studi conclus studi describ differ develop humor immun respons pig subclin infect pcv pig experi high level pcvreplic experi led develop pmw observ contribut better understand pathogenesi pcvinfect
Virol J	12409364	2004-05-12	PMC1388193	16451721	a yearold man present nasal obstruct nasal fossa year durat nasal endoscopi reveal inferior turbin head round neoplasm cm diamet cytolog studi nasal scrape specimen disclos numer cluster columnar cell cytomegali promin multinucl markedli spars shorten cilia cytoplasm contain acidophil area small round area stain cell larg intracytoplasm vacuol acidophil pa serolog test nest polym chain reaction pcr techniqu serum nasal pharyng smear reveal epsteinbarr viru ebv infect confirm electron microscopi clinic cytolog featur resolv month initi evalu conclus author advis carri clinic endoscopi serolog evalu endonas neoplasm routin perform cytolog studi nasal scrape specimen sampl test posit ebv nasal nasopharyng endoscopi perform regularli detect evid nasopharyng carcinoma npc
J Autoimmune Dis	15140958	2010-09-22	PMC1397830	16504001	epidemiolog data notion multipl sclerosi ms acquir autoimmun diseas environment factor infecti genet suscept individu case viral induc demyelinatimg encephalomyel human be experiment model presenc igg oligoclon band cerebrospin fluid indic infecti factor viral absenc specif viru identif ms central nervou system support notion hand partial respons patient ms immunosuppress immunomodulatori therapi support evid autoimmun etiolog ms autoimmun hypothesi share critic infecti autoantigen specif caus ms identifi absenc identifi infecti agent viral rule presenc time point concomit long term trigger autoimmun cascad event concept emerg attempt explain autoimmun mechan ongo neurodegener ms basi infecti viral hypothesi
Global Health	20861329	2008-10-01	PMC1403753	16441899	unpreced migrat core dimens contemporari global challeng popul health increas human mobil health outcom shape transnat interact care provid care recipi meet set nationalityethn match option review articl explor transnat compet tc educ prepar ethnic social discord clinic encount relev tc core skill domain analyt emot creativ commun function migrat health medicalschool curriculum elabor pedagog approach prepar transnat healthcar consult present focu clinicalclerkship learn experi educ prepar contemporari medic encount includ comprehens set patientfocus interperson skill adapt wide varieti servic user global practic site possess util address qualiti patient care sociopolit constraint migrat health
Microb Cell Fact	18675785	2001-04-15	PMC1420323	16512917	develop nucleic acidbas detect system main focu group high technolog compani enorm work field broad versatil varieti sens devic optic electr system labeldepend labelfre approach singl multianalyt arrai format wide rang possibl field diversifi competit challeng requir ideal detector suitabl nucleic acid analysi includ high sensit high specif protocol complet short time offer time low detect limit system miniatur autom advantag convent technolog detect need field electr system technolog nucleic acidbas detect enabl mode make miniatur micro nanomet scale biomonitor devic fusion modern micro nanofabr technolog molecular biotechnolog electr biosensor reli convers watsoncrick basepair recognit event electr signal advanc rapidli receiv attent valuabl tool microbi pathogen detect pathogen pose seriou threat human anim plant detect analysi element public health convent method detect pathogen microorgan toxin exist current appli improv molecularbas detect methodolog chang tradit detect techniqu introduc era rapid miniatur autom electr chip detect technolog pathogen identif sector review develop current direct nucleic acidbas electr detect discuss
BMC Infect Dis	11264376	2006-07-19	PMC1421410	16512903	background continu outbreak highli pathogen hn avian influenza asia urgent effort improv current diagnost aid contain viru lower threat influenza pandem report develop pcrbase assai highli specif hn avian influenza viru method onestep reversetranscript pcr assai develop detect hn avian influenza viru specif assai test subtyp influenza viru viral bacteri pathogen field sampl valid field specimen vietnam malaysia assai specif cross reactiv number infuenza strain human respiratori pathogen detect allanto fluid hn posit sampl suggest reliabl sampl sourc accur detect conclus assai develop studi indic primer specif hn influenza viru field test assai highli diagnost tool help identifi control influenza epidem
BMC Health Serv Res	16848925	2015-09-02	PMC1431529	16480500	background scienc syndrom surveil infanc number syndrom surveil system evalu success predict infecti diseas event major syndrom surveil system base emerg depart set vari level enhanc data sourc telephon helplin health care patient satisfact project look telephon helplin sourc data syndrom surveil attempt canada notabl except statement uk nation nh direct system syndrom surveil tool conduct methodsdesign purpos propos studi evalu effect ontario telephon nurs helplin system realtim syndrom surveil system implement success impact outbreak event detect ontario data collect retrospect reason call assign algorithm will link syndrom categori analyt method normal threshold syndrom will ascertain will allow evalu system sensit specif posit predict step will includ prospect monitor syndrom activ tempor spatial discuss studi protocol current report studi grant ethic approv implement hope syndrom surveil system will displai high sensit specif detect true outbreak ontario detect convent surveil system futur will publish peerreview journal contribut grow bodi evid syndrom surveil provid uscentr perspect
Retrovirology	26339053	2014-01-01	PMC1431560	16549011	background abil emerg pathogen infect speci divers pathogen variant exist reservoir degre genom plastic determin abil adapt environ simian immunodefici virus sivcpz sivsm demonstr tremend success infect speci includ human hiv hiv epidem siv diversif studi popul level essenti substrat crossspeci transmiss siv sequenc divers type extent viral diversif individu reservoir anim elucid character intrahost siv divers perform sequenc analys clonal viral envelop env vv gag variant individu sivsminfect sooti mangabei time sivsm demonstr extens intraanim vv length variat amino acid divers le continu variat vv nlink glycosyl consensu sequenc frequenc locat posit select predomin evolutionari forc tempor sequenc shift suggest continu select evolv antibodi respons contrast gag purifi select sivsm vv sequenc diversif great hiv infect human indic extens viral diversif inevit lead aid conclus posit diversifi select natur reservoir host engin driven evolut uniqu adapt sivhiv envelop protein studi emphas retrovir diversif individu host reservoir anim critic substrat facilit crossspeci transmiss
PLoS Med	26966339	2008-12-24	PMC1435785	16608385	osterhau haagman discuss studi plo medicin support cynomolgu macaqu model studi sar pathogenesi test intervent strategi
PLoS Med	19109397	2005-04-27	PMC1435788	16605302	background emerg sever acut respiratori syndrom sar global health caus major econom disrupt adequ anim model requir studi underli pathogenesi sarsassoci coronaviru sarscov infect develop effect vaccin therapeut report find measur clinic diseas nonhuman primat nhp infect sarscov method find order character clinic relev paramet sarscov infect nhp infect cynomolgu macaqu sarscov three group group infect nare bronchu group ii nare conjunctiva group iii intraven nonhuman primat group ii develop mild moder symptomat ill nhp demonstr evid viral replic develop neutral antibodi chest radiograph anim group ii reveal unifoc multifoc pneumonia peak dai postinfect clinic laboratori test chang inocul mucos rout produc promin diseas intraven inocul half group anim infect recombin infecti clone sarscov deriv sarscov urbani strain infecti clone produc diseas indistinguish wildtyp urbani strain conclus sarscov infect cynomolgu macaqu reproduc sever ill major adult human case sar similar milder syndrom sarscov infect characterist young children
Virol J	16103185	2018-09-06	PMC1444920	16571117	background sar coronaviru sarscov etiolog agent sever acut respiratori syndrom sarscov infect tissu nonlymphat origin cytokin profil cell determin cours diseas investig cytokin respons human nonlymphat cell line caco hek fulli permiss sarscov comparison establish cytokineinduc virus reveal sarscov weakli trigger cytokin respons sarscov activ transcript interferon ifn ifn ifn ifn interferoninduc antivir gene isg mxa chemokin rant interleukin il interestingli sarscov induc chemokin ip il colon carcinoma cell caco embryon kidnei cell conclus data indic sarscov suppress antivir cytokin system nonimmun cell larg extent bui time dissemin host synthesi ip il establish marker acutestag sar escap virusinduc silenc cell type progress infiltr immun cell infect lung observ sar patient product chemokin infect tissu cell
Microb Cell Fact	30067309	2009-09-27	PMC1444932	16556312	background brucella abortu facult intracellular pathogen infect cattl human current vaccin reli live attenu strain abortu revert pathogen statu total safe human develop mucos live vaccin foodgrad lactic acid bacterium lactococcu lacti antigen deliveri vector attract altern safer vaccin strategi abortu report construct lacti strain genet modifi produc abortu groel heatshock protein candid antigen cellular locat intracellular secret secret form groel stabli produc lacti suggest detriment groel protein intracellularli produc bacterium trace amount matur groel detect supernat fraction induc lactococc cultur groel precursor remain stack cell fraction attempt rais secret yield groel fuse synthet propeptid secret antigen improv conclus lacti produc secret stabl form groel extracellular medium despit low secret effici groel antigen interact cell envelop lacti secret best achiev product protein yield cellular locat lacti strain secret groel potenti vivo immun
PLoS Med	19687041	2013-03-27	PMC1450020	16640458	background emerg hypervirul subtyp avian influenza underlin devast effect pandem influenza viru acquir abil spread effici human control hamper limit vaccin suppli global spread delai larg increas occur intern air travel expect lead rapid global dissemin previou pandem method find evalu potenti local control measur travel restrict imped global dissemin develop stochast model intern spread influenza base extens coupl epidem transmiss model model capabl accur forecast local global spread epidem pandem influenza scenario restrict air travel surprisingli delai epidem travel ceas epidem detect conclus intervent reduc local transmiss influenza effect reduc rate global spread vulner implement delai air travel restrict plausibl scenario achiev delai small compar time need accumul substanti vaccin stock
BMC Public Health	23536670	2010-09-01	PMC1456961	16597331	background movement evidencebas practic field suggest public health ph challeng better address credibl health risk effect ph practic ph unmet addit review relev literatur studi perform comprehens review exist resourc collect data repres ph group focus identifi current practic express ideal system access method nineteen individu interview conduct employe domain state health depart communic diseas control commun health promot subsequ focu group gather addit data prefer method access deliveri format content qualit method identifi theme interview focu group transcript inform express improv access includ singl portal access good search engin automat notif newli access best practic area interest extend biomed subject matter improv access grei literatur systemat review summari fulltext articl better method index filter search effect wai archiv access inform express prefer improv system familiar pubm listserv introduc system organ deliveri hypothet ideal model organ deliveri develop base inform state prefer deliveri featur model endors subject review conclus critic ph practition met effici propos dual strategi promot increment improv exist deliveri system base express prefer ph user system concurr develop rigor evalu model organ deliveri draw success resourc oper deliv clinic medic practition
BMC Med Ethics	20833378	2016-10-19	PMC1459179	16626488	background number comment sar expos vulner health care system govern structur health care profession hcp hospit system bore brunt sar outbreak continu struggl aftermath crisi hcp clinic care public health sever test sar unpreced demand skill expertis person commit profess sever expos seriou risk morbid mortal evidenc health organ figur show report case hcp di infect despit challeng profession code ethic silent issu duti care communic diseas outbreak provid guidanc expect hcp approach duti care face risk discuss aftermath sar spectr pandem avian influenza imper reconsid oblig hcp patient sever infecti diseas diseas pose risk provid care press organ repres hcp clear indic standard care expect member event pandem paper address issu special oblig hcp infecti diseas outbreak argu press clarifi right respons hcp current context pandem flu prepared right respons codifi profession code ethic final histor account treatment duti care profession health care code ethic summari honest critic examin role hcp communic diseas outbreak need order provid guidelin profession right respons ethic duti oblig paper hope open social dialogu advanc public debat increasingli urgent issu
Microb Cell Fact	27619693	2014-12-08	PMC1459189	16584558	the quantit detect low analyt concentr complex sampl urgent biomed food environment field biosensor hybrid devic compos biolog receptor signal transduc repres valuabl altern biolog analyt instrument high specif biomolecular recognit vast rang exist protein ligand enabl macromolecul effici receptor cover divers applic addit appropri protein engin approach enabl improv receptor function enhanc affin specif ligand bind proteinonli sensor develop receptor signal transduc part protein cell protein produc transduc case chemic coupl requir product process conveni protein platform rigid restrict proper signal transduct occur ligandinduc conform chang context insert protein engin offer possibl develop devic effici respond ligand interact dramat conform chang specif magnitud sens respons adjust conveni level specif analyt speci report will discuss major engin approach design instrument relev exampl proteinonli biosensor
PLoS Med	25488991	2006-05-26	PMC1459482	16683867	background ebola viru hemorrhag fever syndrom associ high mortal human absenc effect therapi ebola viru infect develop vaccin strategi outbreak immun dna andor replicationdefect adenovir vector rad encod ebola glycoprotein gp nucleoprotein np confer specif protect immun nonhuman primat gp exert cytopath effect transfect cell vitro multipl gp form identifi natur rais question optim human vaccin method find address question explor efficaci mutant gp multipl ebola viru strain reduc vitro cytopath analyz protect effect primat challeng model np delet gp transmembran domain elimin vitro cytopath reduc protect efficaci order magnitud contrast point mutat identifi abolish cytopath retain immunogen confer immun protect absenc np minim effect rad dose establish particl log lower conclus express specif gp vector rad suffici confer protect lethal challeng relev nonhuman primat model elimin np vaccin dose reduct rad particl diminish protect simplifi vaccin provid basi select human vaccin candid
BMC Infect Dis	16731945	2015-02-01	PMC1468415	16672072	background cytokin plai role antivir action examin polymorph ifntnf il affect suscept outcom sever acut respiratori syndrom sar method casecontrol studi carri chines sar patient healthi control test polymorph ifntnf il associ sar ifn allel associ suscept sar dosedepend manner individu ifn aa genotyp fold confid interv ci fold ci increas risk develop sar polymorph il tnf associ sar suscept conclus ifn allel risk factor sar suscept
BMC Genomics	25669994	2017-05-05	PMC1481559	16709242	background evolut viral quasispeci influenc viral pathogenesi respons antivir treatment mutant cloud infect organ repres stage genet antigen diversif rna virus foot mouth diseas viru fmdv anim pathogen antigen variant fmdv classic diagnos immunolog rtpcrbase method dna microarrai increasingli analysi gene express singl nucleotid polymorph snp fmdv microarrai describ detect simultan fmdv serotyp encourag develop oligonucleotid microarrai probe fine genet antigen composit fmdv diagnosi vaccin design gain insight molecular epidemiolog pathogen fmdv microarrai design optim detect snp major antigen site viru screen point mutant genom region encod antigen site fmdv csc achiev hybrid pattern mutant includ specif posit neg signal crosshybrid signal intens depend thermodynam stabil probetarget pair arrai bioinformat classif method develop evalu hybrid signal statist analysi procedur allow accur classif variant genom conclus specif approach base microarrai platform aim distinguish point mutant determin antigen host cell tropism gh loop capsid protein vp develop procedur gener applic test specif discriminatori power microarraybas diagnost procedur multipl oligonucleotid probe
Respir Res	30555771	2004-06-11	PMC1481583	16686949	background patient chronic obstruct pulmonari diseas copd experi exacerb condit exacerb event defin term subject descriptor symptom dyspnoea cough sputum worsen warrant chang medic manag reliabl marker reflect patholog mechan underli exacerb sever surrog assess treatment effect clinic studi exist studi variabl suggest marker chang stabl exacerb phase copd attempt find best surrog exacerb review literatur identifi marker chang consist manner sever exacerb event method search standard databas juli major keyword term studi provid demograph spirometri potenti marker clear elig criteria includ studi central tendenc dispers variabl marker report collect tabul sampl size atser exacerb sever level iii criteria similar patient level ii iii data redefin categori exacerb outpati level inpati level ii iii combin approach perform fix metaanalysi report variabl includ total studi report juli studi investig patient copd arteri carbon dioxid tension breath rate statist level exacerb sever inpati set measur weak relationship level set insuffici data permit metaanalysi conclus arteri carbon dioxid breath rate vari consist manner exacerb sever patient set measur weak correl explor futur longitudin studi assess suggest mathemat model techniqu
Virol J	15194770	2012-01-01	PMC1481635	16729896	chloroquin aminoquinolon wellknown antimalari effect biochem properti appli inhibit viral replic report chloroquin inhibit influenza viru replic vitro ic chloroquin influenza virus hn hn lower plasma concentr reach treatment acut malaria potenti chloroquin to limit rang antiinfluenza drug explor antivir drug plai vital role influenza pandem prepared
Virol J	24392458	2006-07-12	PMC1483818	16579862	background amphotrop murin leukemia viru amlv enter mous fibroblast cell niht caveoladepend endocytosi size omegalik shape caveola amlv initi bind cell caveola raft suggest precaveola investig amlv initi bind receptor pit sodiumdepend phosphat transport raft caveola cholesterolrich microdomain high amount cellbound amlv attach larg raft niht time investig larg raft enrich caveolin major structur compon caveola addit natur occurr niht cell result patch smaller raft amlv cell incub parallel vesicular stomat viru glycoprotein vsvg pseudotyp mlv particl pattern larg raft cell incub amlv vsvg pseudotyp mlv particl prefer attach larg microdomain conclus high concentr amlv particl bound larg raft niht cell suggest role microdomain earli amlv bind event
PLoS Med	16840309	2015-10-21	PMC1483912	16796401	background experiment anim data protect sever acut respiratori syndrom coronaviru sarscov infect human monoclon antibodi mab feasibl effect immun prophylaxi human broad coverag strain sarscov control potenti neutral escap variant will requir combin virusneutr noncompet mab properti method find human mab cr complet prevent lung patholog abolish pharyng shed sarscov infect ferret gener vitro sarscov variant escap neutral cr singl pl mutat glycoprotein spike escap viru vitro experi confirm bind cr recombin fragment amino acid residu harbor mutat abolish screen antibodyphag librari deriv blood convalesc sar patient antibodi complementari cr novel mab cr identifi neutral cr escap virus compet cr bind recombin fragment bound fragment deriv civet cat sarscovlik strain sz escap variant gener cr mixtur mab neutral sarscov synergist fashion recogn epitop receptorbind domain dose reduct indic observ cr cr neutral enhanc sarscov infect subneutr antibodi concentr concern antisarscov antibodi convert abort infect primari human macrophag sarscov product conclus combin noncompet human mab cr cr control immun escap extend breadth protect time synergi cr cr allow lower total antibodi dose administ passiv immun prophylaxi sarscov infect
BMC Biotechnol	26488462	2007-04-01	PMC1484482	16643647	background realtim quantit pcr power accur techniqu examin gene transcript pattern biolog condit critic step compar transcript profil accur normalis studi publish realtim pcr hors normalis occur refer gene gapdh actb valid express stabil result unreli conclus demonstr express level call housekeep gene vari consider tissu cell type diseas stage clinic sampl associ malign diseas goal studi establish reliabl set refer gene studi concern normal equin skin equin sarcoid common skin tumour hors studi gene transcript level commonli refer gene actb bm hprt ubb tuba rpl determin normal equin skin equin sarcoid appli genorm applet set gene tuba actb ubb stabl normal skin bm actb ubb equin sarcoid conclus base tuba actb ubb bm actb ubb propos refer gene panel accur normalis quantit data normal equin skin equin sarcoid normal skin equin sarcoid compar geometr ubb actb bm recommend reliabl accur normalis factor
Virol J	17413061	2017-06-13	PMC1488829	16719922	background respiratori syncyti viru rsv infect major bronchiol infant risk factor develop asthma allerg asthmat suscept rsv infect viral exacerb method effect corticosteroid treat rsv infect controversi test fluticason propion fp salmeterol sal versu fp sal fp rsvinduc airwai inflamm mice sensit challeng ovalbumin ova infect rsv infect treat fp sal fp intranas airwai hyperreact ahr inflamm rsv titer examin group treat fp lower ahr compar group treat fp sal group treat fp decreas nonsignific ahr compar control treatment fp decreas percentag eosinophil neutrophil bronchoalveolar lavag fluid lung patholog compar fp sal fp decreas eosinophil neutrophil lymphocyt sal decreas eosinophil neutrophil lymphocyt fp treatment mice infect rsv absenc allergen sensit decreas rsv titer lung reduct neutrophil compar fp sal conclus indic fluticason combin salmeterol effect treatment decreas airwai hyperreact inflamm allergensensit rsvinfect mice
Global Health	29291217	2013-05-06	PMC1502134	16603071	background antimicrobi resist underappreci threat public health nation globe global boom understand intern pattern resist countri experi pattern resist late worri intern spread larg countri group countri leap ahead integr rest china standout case high distinct pattern resist coordin respons help control spread resist literatur limit evid issu method studi pattern antibiot resist three geograph separ cultur econom distinct countri china kuwait unit state gaug rang depth global health threat potenti growth global expand primari measur preval resist specif bacteria specif antibiot propos illustr method aggreg specif bugdrug data aggreg measur summar resist pattern countri studi extent correl countri pattern drug resist find china highest level antibiot resist kuwait studi resist pattern common bacteria china preval resist hospitalacquir infect high rang commun acquir infect rang china rapid growth rate resist averag growth studi span kuwait second averag growth period lowest pattern resist three countri highli correl correl china kuwait kuwait correl pair china conclus antimicrobi resist seriou grow problem three countri strong intern converg countri resist pattern find chang greater intern travel will accompani global futur determin drug resist pattern intern converg diverg prioriti
Emerg Themes Epidemiol	23650365	2013-11-29	PMC1513225	16674820	current migrant mobil individu migrant worker asylum seeker expand global popul grow social demograph polit dispar exist migrant popul place origin destin relat health determin effect dispar observ individu popul level migrat health diseas dispar influenc epidemiolog diseas global nation receiv migrant specif diseasebas outcom vari migrant group locat gener epidemiolog principl appli situat number individu move differ diseas preval tradition migrat health activ design nation applic lack integr intern perspect futur health challeng migrat effect address collabor global undertak paper review epidemiolog relationship health dispar bridg migrat describ grow role migrat popul mobil global diseas epidemiolog implic nation intern health polici program plan present
BMC Bioinformatics	24293627	2016-11-02	PMC1513606	16579851	background bind peptid epitop major histocompat complex protein mhc event cellular immun respons accur predict bind short peptid mhc molecul long princip challeng immunoinformat model mhcpeptid bind emphas quantit predict categor peptid binder nonbind strong binder weak binder method seek predict precis bind affin develop quantit support vector machin regress svr approach call svrmhc model peptidemhc bind affin nonlinear method svrmhc gener model outperform exist linear model addit method adopt factor encod scheme svrmhc take account similar physicochem properti amino acid constitut input peptid appli mhcpeptid bind data three mous class mhc allel svrmhc model produc accur predict produc comparison base receiv oper characterist roc analysi indic svrmhc outperform promin method identifi bind peptid conclus method demonstr perform quantit model mhcpeptid bind identifi strong binder svrmhc promis immunoinformat tool inconsider futur potenti
PLoS Med	27807242	2011-10-31	PMC1518680	16848617	the author describ progress obstacl har rna interfer prevent treat viral infect
BMC Bioinformatics	22042838	2012-11-01	PMC1523220	16643672	background viru detect method gear detect specif singl virus target lack capabl uncov novel virus emerg viral infect address issu develop comput method identifi conserv viral sequenc genu level viral genom genbank establish viru probe librari viru probe identifi virus discern genera emerg uncharacter microarrai approach ident viru test sampl determin signal genu speciesspecif probe genera emerg uncharacter virus determin base hybrid viral sequenc conserv probe exist viral genera detect classif procedur determin ident viru directli detect signal rapid identif viru conclus demonstr valid feasibl strategi small number viral sampl probe design algorithm appli publicli viral sequenc databas strategi separ genu speci probe set enabl straightforward viru ident calcul directli base hybrid signal viru identif strategi great potenti diagnosi viral infect viru genu specif probe databas associ summari tabl at
PLoS Comput Biol	22653487	2005-10-01	PMC1523295	16863395	the develop dna microarrai technolog decad ago led establish function genom activ success scientif disciplin todai ongo develop immunom microarrai technologya spatial address largescal technolog measur specif immunolog responseth challeng function immunom emerg bear similar function genom immunon data identifi biolog marker involv autoimmun diseas allergi viral infect human immunodefici viru hiv influenza diabet respons cancer vaccin review intend provid coher vision nascent scientif field specul futur direct discuss length issu epitop predict immunom microarrai technolog applic comput statist challeng function immunom base discoveri regul mechan cell respons envis immunom microarrai tool advanc system biologi cellular immun respons immunom regulatori network model
Virol J	16210485	2013-08-21	PMC1524727	16737539	lassa viru glycoprotein synthesis precursor pregpc lumen endoplasm reticulum cotransl cleavag signal peptid immatur gpc posttranslation process ntermin subunit gp ctermin subunit gp host cell subtilas skisp glycoprotein precursor eleven potenti nglycosyl site report investig nglycan proteolyt cleavag cell surfac transport disrupt consensu sequenc eleven potenti nglycan attach site individu glycoprotein mutant disrupt nglycosyl site proteolyt process remain nglycosyl site gpc cleavag despit lack proteolyt process cleavagedefect mutant transport cell surfac remain complet endo hsensit find indic nglycan need correct conform gpc order cleav skisp
Virol J	23966408	2009-04-24	PMC1525181	16772029	background studi gamma interferon ifn synerg ifn inhibit herp simplex viru type hsv replic vitro ifn respons repres earli host defens event viral infect fact treatment meliacin plant antivir amelior sever herpet infect femal mice infect intravagin hsv want investig administr meliacin hsv infect mice alter homoestasi ifn host respons purpos studi the compound cinnamoyldihydroxymeliacarpin cdm respons meliacin antivir action hsv inhibit exert ifn ifn combin hsv ifn synerg ifn inhibit hsv replic vero cell treatment ifn ifn weak antivir action hsv plaqu format viral replic onset viral cpe vero cell synergist inhibit interferon combin addit cdm treatment contribut protect cell viru cytopath strong inhibit hsv titer presenc cdm ifn induct induct period infect complet ifn treatment period reduc viru yield addit ifn antivir action conclus report indic presenc cdm alter antivir activ ifn ifn synerg exert combin result envis administr cdm vivo affect biolog activ ifn mediat innat resist hsv infect
Arthritis Res Ther	19286607	2009-11-03	PMC1526600	16507143	macrophagelik synoviocyt fibroblastlik synoviocyt fl activ cell rheumatoid arthriti ra close articular cartilag posit enabl invad cartilag macrophagelik synoviocyt fl express matrix metalloproteinas mmp interact arous great interest articl studi express cd call extracellular matrix metalloproteinas induc monocytesmacrophag fl ra patient potenti role enhanc mmp invas synoviocyt express cd fl deriv ra patient osteoarthr patient express cd monocytesmacrophag rheumat synovi fluid healthi peripher blood analyz flow cytometri level cd mmp mmp mrna fl detect rtpcr role cd mmp product cell invas vitro studi cocultur fl human thp cell monocytesmacrophag gel zymographi invas assai the express cd higher ra fl osteoarthr fl higher monocytesmacrophag rheumat synovi fluid monocytesmacrophag healthi peripher blood rtpcr express cd mmp mmp mrna higher ra fl osteoarthr fl elev secret activ mmp mmp observ ra fl cocultur differenti thp cell ra synovi monocytesmacrophag compar cocultur undifferenti thp cell healthi control peripher blood monocyt invas assai increas number invad cell cocultur ra fl differenti thp cell ra synovi monocytesmacrophag cd antagonist peptid inhibit mmp product invas potenti studi demonstr cd overexpress monocytesmacrophag fl ra patient respons enhanc mmp secret activ invas synoviocyt find cd factor progress joint destruct ra cd potenti therapeut target ra treatment
Respir Res	19772353	2013-04-01	PMC1533820	16834785	background pneumococc pneumonia common death infecti diseas pneumococcilung cell interact test hypothesi pneumococci activ pulmonari epitheli cell cytokin releas cjunnhtermin kinas jnk method human bronchial epitheli cell beasb epitheli hek cell infect pneumonia rx cytokin induct measur rtpcr elisa bioplex assai jnkphosphoryl detect western blot nuclear signal assess electrophoret mobil shift assai emsa chromatin immunoprecipit chip jnk modul small molecul inhibitor sp ap transfect domin neg mutant pneumonia induc releas distinct cc cxc th cytokin growth factor human lung epitheli cell beasb pneumococci infect jnk phosphoryl beasb cell inhibit jnk small molecul inhibitor sp reduc pneumococciinduc il mrna express releas il il regul il promot jnkphosphoryl activ protein ap pneumonia timedepend induc dna bind ap phosphoryl subunit cjun maximum infect recruit serphosphoryl cjun rna polymeras ii endogen il promot pneumonia infect chromatin immunoprecipit ap repressor afo reduc il releas tlroverexpress hek cell induc pneumococci tnf antisenseconstruct target ap subunit fra fra inhibitori pneumococciinduc il releas conclus pneumoniaeinduc il express human epitheli beasb cell depend activ jnk recruit phosphoryl cjun il promot
Respir Res	23547115	2013-05-22	PMC1533821	16827942	pneumonia common diseas caus great divers infecti agent respons enorm morbid mortal worldwid bronchial lung epithelium compris larg surfac host environ attack primari target lung infect act mechan barrier evid suggest lung epithelium function sentinel system pathogen equip transmembran cytosol pathogensens pattern recognit receptor epithelium detect invad pathogen complex signal epitheli cell activ essenti particip initi orchestr subsequ innat adapt immun respons review summar progress focuss molecular mechan pathogen detect host cell signal transduct subsequ activ lung epitheli cell pathogen virul factor point open question analysi lung epitheli function host respons pneumonia pave develop innov highli need therapeut pneumonia addit antibiot
BMC Genomics	23698310	2017-02-15	PMC1534038	16772042	background dna sequenc easier cheaper increas number close viral genom sequenc deposit genbank annot sever limit research maintain comprehens genom databas set viru famili viral bioinformat resourc center viral bioinformat canada research unnecessarili spend time annot viral genom close rel annot virus design implement novel tool genom annot transfer util gatu transfer annot annot refer genom target genom greatli reduc labori task gatu transfer annot refer genom close target genom user final control annot includ gatu detect open read frame target refer genom user varieti bioinformat tool determin orf includ annot process complet gatu save newli annot genom genbank embl xmlformat file softwar code java run varieti comput platform userfriendli graphic user interfac design user train biolog scienc conclus gatu greatli simplifi initi stage genom annot close genom refer intend gene predict tool complet annot system reduc time requir annot gene matur peptid help standard gene name organ transfer refer genom annot target genom program freeli gener public licens access document tutori 
BMC Public Health	28202753	2010-04-06	PMC1538585	16686946	background case definit recogn element public health surveil system assur compar consist surveil data crucial impact sensit posit predict surveil system reliabl case definit rare investig systemat method conduct roundrobin test local health depart lhd state health depart shd germani classifi select case exampl case definit multivari analysi investig factor link classif agreement gold standard defin expert panel total classif lhd shd report sensit posit predict polio case exampl lowest report precis salmonellosi case exampl highest ci case definit checklist format clinic criteria higher report precis case definit narr descript ci report precis higher shd compar lhd ci conclus find led systemat revis german case definit build basi gener recommend creation case definit includ testabl yesno criteria checklist format improv reliabl softwar data transmiss design strict case definit find studi applic case definit countri intern network share structur editori characterist case definit evalu studi revis
Microb Cell Fact	20406307	2014-11-26	PMC1538998	16796731	the live bacteria induc immun respons to carri vaccin compon attract vaccin strategi advantag live bacteri vaccin includ mimicri natur infect intrins adjuv properti possibl administ oral deriv pathogen nonpathogen food bacteria current evalu live vaccin pathogen bacteria demand attenu weaken virul bacteria vaccin deliveri vehicl impli construct recombin strain gene cassett encod antigen increas knowledg mucos immun avail genet tool heterolog gene express concept live vaccin vehicl gain renew interest administr live bacteri vaccin pose risk addit vaccin recombin bacteria releas live recombin organ natur place vaccin debat applic genet modifi organ review overview live bacteri vaccin market describ develop live vaccin focu attenu bacteria foodrel lactic acid bacteria outlin safeti concern identifi hazard associ live bacteri vaccin suggest consid develop
BMC Infect Dis	25428874	2004-02-06	PMC1550407	16824203	background host genet factor plai role suscept resist sar associ coronaviru sarscov infect studi carri investig associ genet polymorph oligoadenyl synthetas oa gene myxoviru resist mxa gene suscept sar chines han popul method hospitalbas casecontrol studi conduct collect sar case close contact uninfect control enrol studi point real time polymeras chain reaction pcr pcrbase restrict fragment length polymorph rflp analysi detect singl nucleic polymorph snp oa mxa gene factor associ sar infect collect pretest questionnair univari multivari logist analys conduct polymorph untransl region utr oa gene associ sar infect compar aa genotyp ag gg genotyp associ protect sar infect or ci gt genotyp posit mxa gene promot associ increas suscept sar infect compar gg genotyp ci associ ag genotyp oa gt genotyp mxa remain multivari analys adjust sar protect measur ci ci conclus snp oa utr mxa promot region appear associ host suscept sar chines han popul
BMC Infect Dis	14766963	2009-04-01	PMC1550408	16834781	background substanti proport respiratori tract diseas suspect infecti origin etiolog unknown case caus describ human bocaviru hbov aim studi investig frequenc potenti clinic relev hbov pediatr patient method test nasopharyng aspir npa pediatr inpati acut respiratori tract diseas univers wrzburg germani presenc hbov dna specif posit pcr reaction confirm sequenc hbov dna npa median ag infant children hbov infect year ag year rang dai year infect hbov yearround occur winter month coinfect hbov posit sampl rsv influenza adenovirus frequent detect coinfect agent sequenc determin pcr product np region reveal high ident nucleotid sequenc year comparison swedish virus st st associ hbov distinct respiratori tract manifest appar conclus hbov frequent npa hospit infant children acut respiratori tract diseas prove clinic relev hbov challeng applic koch revis postul high rate coinfect hbov respiratori tract pathogen associ hbov respiratori tract diseas remain unproven
Crit Care	19189850	2012-04-01	PMC1550819	16356209	introduct sever acut respiratori syndrom sar crisi propos test protocol cardiac arrest patient sar protocol rapidli effect institut teamwork train highfidel simul method phase curriculum design sarsspecif cardiac arrest protocol three step plan protocol repeat simul protocol classroom subsequ simul cardiac arrest hospit ward phase train healthcar worker hcw protocol train involv seminar practic wear mandatori person protect system pp cardiac arrest simul subsequ debrief simul provid insight consid earlier phase develop exampl singl person don pp worn sar patient minut multipl member cardiac arrest team dress simultan time don pp increas minut error infect control medic manag advanc cardiac life support acl correct conclus sar crisi realtim highfidel simul allow train hcw week debrief error manag hcw requir manag sar cardiac arrest wear unfamiliar equip modifi acl protocol insight gain experi will valuabl futur infecti diseas challeng critic care
Crit Care	22233583	2012-01-04	PMC1550925	16611370	introduct aetiolog lower respiratori tract infect young children admit paediatr intens care unit picu difficult establish infect believ caus respiratori virus diagnost studi perform compar convent viral test develop realtim pcr techniqu method sampl children ag year present tertiari picu suspect lower respiratori tract infect test convent method viral cultur immunofluoresc realtim pcr winter season decemb convent method check respiratori syncyti viru influenzaviru parainfluenzaviru rhinovirus adenovirus realtim pcr test respiratori syncyti viru influenzaviru parainfluenzaviru rhinovirus adenovirus human coronavirus oc nl human metapneumoviru mycoplasma pneumonia chlamydia pneumonia total patient includ posit respiratori viru convent method realtim pcr confirm posit addit realtim pcr identifi virus patient yield total patient posit sampl viru detect children conclus realtim pcr respiratori virus sensit reliabl method picu patient lower respiratori tract infect increas diagnost yield twofold compar convent method
PLoS Comput Biol	22219187	2016-01-01	PMC1557587	16948530	liveviru vaccin activ humor cellmedi immun requir singl boost gener provid longer immun protect kill subunit vaccin growth liveviru vaccin attenu minim potenti pathogen effect mechan attenu convent serialtransf viral adapt wellunderstood method attenu base ration engin viral genom offer greater control link defin genet modif chang viru growth to establish link genotyp growth phenotyp develop comput model intracellular growth vesicular stomat viru vsv wellstudi nonseg negativestrand rna viru model incorpor establish regulatori mechan vsv integr kei wildtyp infect step hijack host resourc transcript translat replic assembl releas progeni vsv particl gener wildtyp model allow genom rearrang match experiment observ attenu rank recombin vsv strain alter genom posit nucleocapsid gene final simul captur report experiment show alter posit vsv gene potenti attenu vsv growth overexpress immunogen vsv surfac glycoprotein model will facilit engin liveviru vaccin link genom manipul control chang viru geneexpress growth
BMC Health Serv Res	28220053	2015-07-01	PMC1559606	16889656	background sever acut respiratori syndrom sar epidem threw turmoil half subsequ paper address impact health servic util consid palli hospic care aim studi describ chang hospic inpati util sar epidem in taiwan method data sourc complet dataset inpati admiss nation health insur databas beforeandaft comparison daili monthli util hospic analys limit ward offer inpati servic year comparison extend total hospit bed util patient admit hospic ward peak period sar epidem hospic ward oper hospic util began decreas middl april reach minimum gradual recov level previou novemb hospic mark reduct util hospit bed slower recoveri threemonth lag total patient admit hospic ward mayjun contrast mayjun gender ag diagnosi distribut differ conclus hospic inpati util taiwan sensit emerg epidem gener inpati util wellbalanc network seamless continu care ensur
J Ethnobiol Ethnomed	25708857	2014-05-21	PMC1559680	16893454	thi paper investig common ethnoveterinari medicin hors trinidad west indi british columbia canada area common market pharmaceut involv north american race circuit conduct medicin plant hors widespread data ethnoveterinari medicin hors kei inform interview hors owner trainer breeder jockei groom anim care specialist area trinidad british columbia bc participatori valid workshop held bc extens literatur review botan identif plant plant treat racehors trinidad bc mostevid effect plant plant trinidad bc describ evalu paper alo vera curcuma longa ricinu communi area need trinidad identifi plant respond claim studi conduct temper chines medicin plant bc ethnoveterinari remedi reflect stronger evid efficaci
BMC Infect Dis	24850726	2004-03-02	PMC1560143	16899110	background respiratori syncyti viru rsv pathogen sever ill infant young children studi assess data rsv collect european influenza surveil scheme eiss build rsv surveil system europ method influenza rsv data winter season analys england franc netherland scotland data sentinel physician network sourc hospit collect respiratori specimen test influenza rsv viru cultur polymeras chain reaction amplif data rsv enter time eiss databas rsv contribut notic influenzalik ill england sentinel rsv detect common ag group young children total number sentinel swab test posit rsv scotland franc report highest percentag rsv detect year ag group n netherland rsv detect person ag year conclus recommend respiratori specimen collect influenza surveil test systemat rsv emphas commun deriv data data hospit rsv surveil rsv data eiss enter time manner consid eiss model develop rsv surveil system equival influenza surveil europ
BMC Public Health	14993176	2006-01-26	PMC1562405	16907978	background march outbreak sever acut respiratori syndrom sar occur northern vietnam outbreak began travel arriv hong kong sought medic care small hospit hospit hanoi initi seriou substanti transmiss event hospit subsequ limit spread commun method survei hospit personnel exposur patient symptom diseas outbreak addition serum specimen collect assai antibodi sarsassoci coronaviru sarscov antibodi jobspecif attack rate calcul nest casecontrol analysi perform assess risk factor acquir sarscov infect fiftythre clinic nonclin staff consent particip exclud job categori worker highest sar attack rate occur nurs work outpati inpati gener ward nurs assign oper roomintens care unit experienc lowest attack rate clinic staff serolog evid sarscov infect detect individu includ nonclin worker identifi sar case report fever cough enter patient room view patient behavior associ highest risk infect univari analysi odd ratio confid interv conclus studi highlight job categori activ associ increas risk sarscov infect demonstr broad divers hospit worker vulner outbreak find help guid recommend protect vulner occup group implic respiratori infect influenza
Emerg Themes Epidemiol	16439530	2005-01-01	PMC1562421	16907980	surprisingli human mix pattern relev spread closecontact infect measl influenza meningococc diseas studi aim estim number partnership individu stabil degre mix assort respect ag defin level put atrisk event casual physic contact convers intim contact sexual natur ask univers student volunt record detail contact level three separ dai intim contact stabl short time period evid repeat casual contact individu contact increasingli assort intimaci increas will aid develop parameteris model close contact diseas direct outbreak investig
Respir Res	16273643	2010-11-29	PMC1563466	16904002	background caveola involv divers cellular function signal transduct cholesterol homeostasi endo transcytosi serv entri site microorgan occurr epithelium airwai expect examin method western blot realtim quantit pcr analysi abrad tracheal epithelium laserassist microdissect combin subsequ mrna analysi examin express cav cav major caveolar coat protein rat tracheal epithelium fluoresc immunohistochemistri perform locat caveola cav airwai epithelium rat mice human electronmicroscop analysi identif caveola clsmfret analysi determin interact cav cav situ western blot laserassist microdissect identifi protein transcript cav cav airwai epithelium realtim quantit rtpcr analysi abrad tracheal epithelium reveal higher express cav cav immunoreact cav cav coloc cell membran basal cell basolater ciliat epitheli cell larg airwai rat human label cav cav observ epitheli cell small bronchi convent doublelabel indirect immunofluoresc combin clsmfret analysi detect associ cav epitheli cell presenc caveola confirm electron microscopi contrast human rat cavimmunoreact caveola confin basal cell mice epitheli caveola absent cavdefici mice implic requir caveolar protein epitheli caveola format conclus caveola caveolin integr membran compon basal ciliat epitheli cell indic crucial role cell type addit physiolog role involv airwai infect
BMC Genomics	21115835	2009-07-22	PMC1564015	16911805	background mast cell establish effector igetrigg allerg reaction immun respons parasit infect studi indic mast cell plai role adapt innat immun suggest innov view regul immun respons profil transcriptom human mast cell sensit ig stimul fcri aggreg data gene examin gene differenti regul stimul mast cell compar restingunstimul mast cell major function categori upregul gene includ cytokin chemokin gene involv innat adapt immunerespons observ increas express genetranscript igesensit data valid realtimepcr elisa western blot confirm ig trigger mast cellimmedi respons calcium signal degranul proteinphosphoryl conclus report repres substanti advanc understand genom wide effect trigger passiv sensit activ stimul human mast cell support mast cell potenti involv wide rang inflammatori respons
BMC Infect Dis	19625413	2014-07-15	PMC1564025	16914034	background inanim surfac describ sourc outbreak nosocomi infect aim review summar data persist nosocomi pathogen inanim surfac method literatur systemat review medlin languag restrict addit cite articl report assess standard textbook topic review report experiment evid durat persist nosocomi pathogen type surfac includ gramposit bacteria enterococcu spp includ vre staphylococcu aureu includ mrsa streptococcu pyogen surviv month dry surfac gramneg speci acinetobact spp escherichia coli klebsiella spp pseudomona aeruginosa serratia marcescen shigella spp surviv month bordetella pertussi haemophilu influenza proteu vulgari vibrio cholera persist dai mycobacteria includ mycobacterium tuberculosi sporeform bacteria includ clostridium difficil surviv month surfac candida albican nosocomi fungal pathogen surviv month surfac persist yeast torulopsi glabrata describ month shorter candida parapsilosi dai virus respiratori tract corona coxsacki influenza sar rhino viru persist surfac dai virus gastrointestin tract astroviru hav polio rota viru persist month bloodborn virus hbv hiv persist week herp virus cmv hsv type persist hour dai conclus common nosocomi pathogen surviv persist surfac month continu sourc transmiss regular prevent surfac disinfect perform
PLoS Med	24941423	2017-01-18	PMC1564166	16968120	background sar outbreak present clinician lifethreaten diseas experi treat effect treatment option health organ expert panel sar treatment request systemat review comprehens summari treatment sarsinfect patient order guid futur treatment identifi prioriti method find respons request conduct systemat review publish literatur ribavirin corticosteroid lopinavir ritonavir lpvr type interferon ifn intraven immunoglobulin ivig sar convalesc plasma vitro studi sar patient search clinic trial evid treatment acut respiratori distress syndrom sourc data literatur databas medlin embas biosi cochran central regist control trial central februari data public extract evid studi classifi predefin criteria total sar treatment studi vitro studi three acut respiratori distress syndrom studi met inclus criteria vitro studi ribavirin lopinavir type ifn inhibit sarscov tissu cultur sarsinfect patient report ribavirin studi classifi inconclus harm studi convalesc plasma ivig three ifn type lpvr inconclus studi steroid inconclus classifi caus harm conclus despit extens literatur report sar treatment determin treatment benefit patient sar outbreak harm clinic trial design valid standard protocol dosag time accru data real time futur outbreak monitor specif advers effect help inform treatment
PLoS Med	28100617	2014-02-03	PMC1564167	16968121	background despit success biolog agent therapi autoimmun inflammatori diseas rheumatoid arthriti ra patient fail respond adequ treatment make continu search therapi extrem prevail hypothesi reactiv oxygen speci ro promot inflamm challeng polymorph ncf decreas oxid burst increas diseas sever mous rat arthriti model base find develop therapi arthriti oxid burstinduc substanc method find treatment rat phytol tetramethylhexadeceneol increas oxid burst vivo correct the genet polymorph arthritispron ncf rat importantli phytol treatment decreas autoimmun respons amelior acut chronic phase arthriti compar standard therapi ra antitumour necrosi factor methotrex phytol equal good better therapeut properti final phytol mediat hour administr involv modul cell activ inject prevent adopt transfer diseas arthritogen cell conclus treatment arthriti rospromot substanc phytol target newli discov pathwai lead autoimmun inflammatori diseas introduc novel class therapeut treatment ra chronic inflammatori diseas
PLoS Med	24491580	2004-12-20	PMC1564183	16968115	background influenc air travel influenza spread subject numer investig simul empir evid provid understand role airlin travel largescal influenza spread mount threat influenza pandem simul studi conclud air travel restrict impact cours pandem assess empir data role airlin volum yearli interregion spread influenza unit state method find measur rate interregion spread time influenza unit state season weekli influenza pneumonia mortal center diseas control prevent season character bandpass filter domest airlin travel volum novemb surround thanksgiv holidai predict rate influenza spread intern airlin travel influenc time influenza mortal flight ban terrorist attack septemb subsequ depress air travel market provid natur experi evalu flight restrict decreas air travel associ delai prolong influenza season conclus provid empir evid role airlin travel longrang dissemin influenza influenc intern air travel time influenza introduct influenc domest air travel rate interregion influenza spread pandem prepared strategi account benefit airlin travel restrict influenza spread
Virol J	15613297	2011-01-12	PMC1564392	16948846	background widespread interest innat immun modul defens strategi infecti pathogen rotaviru model system develop cellbas moderatethroughput screen mt assai identifi compound reduc rotaviru infect vitro longterm goal discov immunomodulatori agent enhanc innat respons viral infect natur product librari consist compound screen assai compound reduc infect cytotox identifi time cours analysi compound character effect inflammatori gene express inhibit replic pretreat time minim hour compound mangostin glycyrrhetin acid activ nfb induc il secret assai adapt viru system amen full autom adapt highthroughput format conclus identif compound effect inflammatori antivir gene express confer resist rotaviru infect vitro suggest assai appropri platform discoveri compound potenti amplifi innat antivir respons
Environ Health Perspect	21228237	2013-08-01	PMC1570072	16966082	the health sector compon nation assess publish synthes anticip health impact climat variabl chang categori health outcom impact attribut temperatur extrem weather event storm flood air pollut water foodborn diseas vector rodentborn diseas health sector assess hsa conclud climat variabl chang increas morbid mortal risk climatesensit health outcom net impact uncertain object studi updat hsa base public address potenti impact climat variabl chang unit state health outcom categori literatur publish hsa support initi conclus data refin quantit exposurerespons relationship health point extrem heat event air pollut unit state continu high capac plan respond climat chang progress literatur implement adapt strategi measur larg knowledg gap remain substanti addit improv understand weather climat directli indirectli influenc human health fill knowledg gap will help better defin potenti health impact climat chang identifi specif public health adapt increas resili
Virol J	28500595	2015-02-26	PMC1592083	16987422	background infecti bronchiti highli contagi constitut common difficult poultri diseas control ibv endem countri rais chicken exist dozen serotypesgenotyp amino acid differ protein vaccin challeng strain ibv result poor protect tropism ibv includ respiratori tract tissu proventriculu caecal tonsil alimentari tract oviduct kidnei infecti bronchiti viru ibv strain close massachusett mass serotyp isol broiler chicken suffer sever renal respiratori distress isol serolog identifi dotelisa character rtpcr genotyp gene sequenc analysi align sequenc isol ibv strain reveal high homolog isol mass serotyp inocul strain reproduc diseas experiment dayold chicken mortal sever renal moder respiratori distress mark histopatholog chang kidnei trachea observ experiment infect chicken protect studi live attenu vaccin low protect rate spite high sequenc homolog protect base criteria viru reisol attempt trachea tracheal renal histopatholog ibv antigen detect immunofluoresc antibodi techniqu kidnei section conclus period evalu crossprotect capabl ibv vaccin versu recov field isol perform ensur optimum control ibv
Emerg Themes Epidemiol	25714162	2004-05-12	PMC1594563	17014728	individu reason expect freedom decis health individu wish conflict individu best interest individu right restrict benefit limit individu behaviour person wish good popul gener discuss issu right individu conflict individu popul benefit relat infecti diseas
BMC Health Serv Res	15140961	2017-07-03	PMC1609112	17026763	background provinci transfer author centr ptac establish emerg respons ontario canada sever acut respiratori syndrom sar outbreak prior data relat interfacil patient transfer collect systemat manner emerg set comprehens databas complex data collect process establish time ontario populationbas data patient movement healthcar facil popul twelv ptac databas store patient transfer data larg databas populationbas patient transfer databas ptac databas believ largest exampl hous novel dataset patient transfer databas valid paper present valid ptac databas method random sampl patient interfacil transfer record compar correspond institut patient record send healthcar facil measur agreement includ sensit calcul common data variabl randomli select patient transfer record correspond institut patient record locat data variabl categori patient demograph facil identif time transfer reason urgenc transfer strong agreement level commonli data variabl accuraci rate rang error rate rang variabl sensit valu rang conclus high level agreement institut patient record ptac data field compar studi support valid ptac databas time populationbas patient transfer databas establish creat emerg situat data collect depend frontlin medic worker ptac data achiev high level valid higher purpos built databas creat nonemerg set
BMC Microbiol	28708965	2017-11-01	PMC1609170	17020602	background believ animaltohuman transmiss sever acut respiratori syndrom sar coronaviru cov the sar outbreak worldwid spike protein best character protein sarscov plai kei role sarscov overcom speci barrier accomplish interspeci transmiss anim human suggest major target select pressur process adapt evolut protein exact posit select site associ process remain unknown investig adapt evolut protein identifi twelv amino acid site protein posit select pressur base phylogenet tree epidemiolog investig sar outbreak divid three epidem group interspeci earlymid late epidem group studi posit select detect group repres cours sarscov interspeci transmiss viral adapt human host contrast purifi select detect late group indic protein experi variabl posit select pressur reach stabil total site interspeci epidem group site earlymid epidem group identifi posit select identifi site group site suggest posit select site changeabl group larger proport posit select site locat receptorbind domain rbd heptad repeat hrhr region interspeci epidem group greater percentag site occur hrhr region rbd earlymid epidem group function domain protein experi posit select epidem group addit three specif replac fs ls human sarscov strain interspeci epidem group reveal select sweep forc evolut gene jump sarscov human host residu posit select site associ receptor recognit andor membran fusion crucial residu animaltohuman transmiss sarscov subsequ adapt human host conclus variat posit select pressur posit select site contribut adapt evolut protein anim human
BMC Bioinformatics	28642032	2018-04-09	PMC1618411	17038191	background phage displai basic explor proteinprotein interact site network appli develop drug vaccin diagnost promis method epitop map algorithm assist autom phage displai base epitop map attract group exist tool implement onlin servic make conveni commun access util evalu mimox free web tool help map nativ epitop antibodi base user suppli mimotop antigen structur mimox code perl modul bioperl project section mimox simpl interfac clustalw align set mimotop simpl statist method deriv consensu sequenc emb jalview java applet view manag align second mimox map singl mimotop consensu sequenc set mimotop correspond antigen structur search cluster residu repres nativ epitop naccess evalu surfac access candid cluster jmol embed view interact context initi case studi mimox reproduc map exist tool findmap dex provid novel ration conclus webbas tool call mimox develop phage displai base epitop map publicli onlin servic area conveni commun access util evalu complement exist program mimox freeli 
Health Res Policy Syst	29632005	2019-01-22	PMC1618830	17038194	if sustain humantohuman transmiss hn realiti will longer deal sporad avian flu born migratori flight path bird aviat flu wing subson speed commerci air conduit corner planet earth air transport featur differenti dai transmiss scenario inabl prevent spread influenza intern air travel reckon health organ constitut major weak current global prepared plan pandem flu despit lesson sar surpris aviationrel health polici option rigor evalu scientif aim strengthen public health measur air transport front energet pursu
BMC Infect Dis	30667224	2012-08-31	PMC1618839	17026751	background soest counti health depart inform unusu larg number patient hospit atyp pneumonia method exploratori interview patient mention visit farmer market sheep lamb serolog test confirm diagnosi fever ask local health depart germani identii notifi fever patient visit farmer market investig risk factor infect conduct case control studi case fever patient control randomli select soest citizen cohort studi vendor market sheep exhibit market herd origin sheep herd held vicin soest test coxiella burnetii burnetii total report fever case link outbreak incub period dai interquartil rang dai case control studi identifi close proxim stop second sheep pen risk factor vendor meter sheep pen increas risk diseas compar locat farther wind plai role clinic attack rate adult children estim case hospit ew lamb herd test posit burnetii antibodi conclus size point sourc natur outbreak permit assess fundament seldom studi epidemiolog paramet consequ outbreak recommend pregnant sheep displai public trimest test anim pet zoo regularli burnetii
BMC Public Health	22941090	2017-10-25	PMC1618842	16984658	background system routin public health surveil reli central collect identifi individu identifi person health phi record individu identifi patient record essenti condit mandat report tuberculosi sexual transmit diseas routin requir effect syndrom surveil public concern routin collect larg quantiti phi support nontradit public health function altern surveil method reli central identifi phi databas increasingli desir method nation bioterror syndrom surveil demonstr program ndp exampl altern model phi system initi process secur infrastructur health care provid collect hold data uniform softwar distribut support ndp highli aggreg count data transfer datacent statist process displai detail patient level health care provid elucid signal observ aggreg data ad hoc queri describ benefit disadvantag associ distribut process model routin autom syndrom surveil conclus welldefin surveil requir model deploi low risk inadvert disclosur phi featur particip surveil system feasibl organ appeal individu phi hold design implement distribut system support nonroutin public health requir
BMC Infect Dis	29070690	2013-06-26	PMC1624840	17049088	background minor probabl sar case caus transmiss assess epidemiolog clinic factor sar patient associ increas probabl transmiss method epidemiolog clinic data probabl sar patient admit tan tock seng hospit casecontrol approach patient probabl sar subsequ transmit diseas patient analys case patient transmiss control multivari logist regress analysi patient analysi transmiss transmiss covari posit associ transmiss univari analysi includ delai isol dai ill admiss nonisol facil preexist chronic respiratori diseas immunosuppress diseas oxygen short breath vomit higher lactat dehydrogenas level higher neutrophil count multivari analysi three factor delai isol admiss nonisol facil higher lactat dehydrogenas level iul conclus clinic epidemiolog factor help explain transmiss observ instanc other
BMC Immunol	23804635	2014-05-21	PMC1636068	17076905	background major obstacl design effect vaccin hiv hypervari hiv envelop glycoprotein hiv vaccin candid util envelop glycoprotein singl viru isol elicit broadli reactiv humor immun hypothesis cocktail hiv gp protein multipl epitop increas breadth immun respons hiv compar evalu immunogen hiv vaccin gp protein combin fourteen gp primari hiv isol immun hamster amplifi character gp primari subtyp isol syncytium nonsyncytium induc properti express protein chines hamster ovari cho cell line purifi protein combin fourteen gp vaccin golden hamster polyval vaccin higher antibodi titer hiv subtyp isol mn sf compar group receiv gp protein polyval vaccin higher neutral antibodi respons hiv primari isol interestingli polyval vaccin group highest prolif immun respons substanti proport crosssubtyp cd reactiv hiv subtyp ae conclus polyval approach achiev modest increas breadth humor cellular immun qualit chang vaccin gp quantit improv vaccineinduc immun
BMC Microbiol	24850744	2016-10-01	PMC1660542	17094812	background coagulaseneg staphylococcu epidermidi major frequent infect relat implant medic devic pathogen epidermidi attribut capac form biofilm surfac medic devic greatli increas resist convent antibiot chronic infect urgent design novel antibiot staphylococci infect kill cell embed biofilm report seri novel inhibitor histidin kinas hk yycg protein epidermidi discov structurebas virtual screen sbv small molecular leadcompound librari experiment valid candid deriv sbv target homolog model yycg hatpasec domain epidermidi compound displai activ inhibit epidermidi growth displai bactericid effect plankton biofilm cell epidermidi compound bind yycg protein inhibit autophosphoryl vitro indic potenti inhibitor yycgyycf twocompon system tc essenti epidermidi importantli compound affect stabil mammalian cell hemolyt activ concentr studi conclus novel inhibitor yycg histidin kinas potenti lead develop antibiot infect staphylococci structurebas virtual screen sbv technolog screen potenti inhibitor bacteri tcss rapid efficaci tradit screen technolog
Virol J	27734858	2015-12-07	PMC1676004	17121680	background molecular level concern differ andor similar alcohol hepat viru induc liver diseas global transcript profil oligonucleotid microarrai perform liver biopsi patient cirrhosi caus chronic alcohol consumpt chronic hepat viru hcv global gene express pattern vari depend etiolog liver diseas greater number differenti regul gene hcvinfect patient gene express chang observ hcvinfect cirrhot liver expectedli associ activ innat antivir immun respons compar sever ctp class cirrhosi etiolog identifi gene express pattern differenti ethanolinduc cirrhosi class ctp class ethanolcirrhot liver uniqu express pattern gene implic inflammatori respons includ macrophag activ migrat lipid metabol oxid stress gene conclus stage liver cirrhosi differenti base gene express pattern ethanolinduc hcvinduc diseas addit gene regul innat antivir immun respons mechan respons differenti chronic liver damag hcv ethanol close regul lipid metabol effect macrophag activ deposit extracellular matrix compon
Health Res Policy Syst	26643325	2016-07-10	PMC1712227	17156457	background health organ organis recognis rigor process ensur health care recommend inform best evid thirteenth seri review prepar background advic advisori committe health achiev object review literatur applic transfer adapt guidelin method search databas exist systemat review relev primari methodolog review titl citat retriev abstract full text articl citat appear relev topic check refer list articl relev question snowbal techniqu addit definit come concern belong nation term intern conclus base evid consider organis logic argument kei question answer identifi systemat review address kei question individu studi project publish peer review literatur internet develop intern recommend resourc develop high qualiti recommend limit internation develop recommend facilit access pool resourc reduc unnecessari duplic involv intern scientist prioriti intern health problem problem low middleincom countri advantag greatest factor influenc transfer recommend set consid systemat flag includ modifi factor variat valu cost avail resourc central local prepar systemat review evid profil coordin central collabor organ produc systemat review central develop evid profil adapt specif local circumst consider model involv central coordin work undertaken centr locat avail resourc cost presenc modifi factor valu assess local support undertak assess need guidelin applic provid local support adapt implement recommend develop tool build capac learn intern experi intern network support evidenceinform health polici evidenceinform polici network evipnet recommend adapt provid detail guidanc adapt intern recommend local adapt process systemat transpar involv stakehold report kei factor influenc decis includ flag intern guidelin reason modif made
BMC Musculoskelet Disord	27395034	2007-10-24	PMC1712335	17156487	background earli recoveri arthroplasti need help benchmark progress appropri decis concern patient rehabilit purpos studi model earli recoveri physic function patient undergo total hip tha knee tka arthroplasti physic perform selfreport measur method sampl conveni subject complet test ag year underw tha ag year tka postop patient treat standard care pathwai rehabilit protocol repeat measur design patient assess multipl time point postop month outcom measur includ lower extrem function scale lef physic function subscal western ontario mcmaster univers osteoarthr womac pf minut walk test mwt time test tug time stair test st averag recoveri curv measur character hierarch linear model predictor recoveri sequenti model valid basic development model slope recoveri greater week seconddegre polynomi growth term week squar provid reason fit data studi interv pattern recoveri observ selfreport measur physic function perform measur contrast model womac pf lef site arthroplasti predictor physic perform measur model patient post tka initi demonstr higher function site arthroplasti predict rate chang patient post tha week surgeri tha group surpass function patient post tka conclus knowledg predict growth curv will assist clinician referenc patient progress determin critic time point measur chang studi contribut evid highlight benefit physic perform measur learn patient actual level disabl
PLoS Med	17957181	2012-02-23	PMC1716185	17194199	background sever acut respiratori syndrom coronaviru sarscov identifi etiolog agent sever acut respiratori syndrom diseas character sever pneumonia death sarscov zoonot viru cross speci barrier origin bat speci includ civet raccoon dog domest cat swine rodent sarscov vaccin confer longterm protect vulner senesc popul epidem strain zoonot strain emerg anim reservoir report comprehens investig sar vaccin efficaci young senesc mice homolog heterolog challeng method find venezuelan equin enceph viru replicon particl vrp express epidem urbani sarscov strain spike glycoprotein vrp nucleocapsid protein strain vrpn demonstr vrp vrpn vaccin provid complet short longterm protect homolog strain challeng young senesc mice test vrp vaccin efficaci heterolog sarscov phylogenet analys synthet biologi revers genet construct chimer viru icgdo encod synthet glycoprotein gene genet diverg human strain gdo cluster zoonot sarscov icgd replic effici human airwai epitheli cell lung young senesc mice highli resist neutral antisera direct urbani strain vrp vaccin provid complet shortterm protect heterolog icgd challeng young mice limit protect vaccin senesc anim vrpn vaccin fail protect homolog heterolog challeng enhanc immunopatholog eosinophil infiltr lung sarscovchalleng mice vrpninduc patholog present dai peak dai persist dai mediat cellular immun respons conclus studi identifi gap challeng vaccin design control futur sarscov zoonosi vulner elderli popul avail sarscov viru bear heterolog glycoprotein robust challeng inoculum evalu vaccin efficaci zoonot strain sourc futur outbreak
Crit Care	22295161	2010-06-29	PMC1751045	17022805	introduct respiratori virus major respiratori tract infect preval virusposit respiratori sampl signific patient requir mechan ventil remain unknown method conduct cohort studi consecut adult ventil hour admit bed medic intens care unit month period respiratori sampl time intub assess cultur indirect immunofluoresc assai molecular method systemat tracheobronchi aspir patient virusneg respiratori sampl time intub consid unexpos serv control group fortyf virus isol patient rhinoviru commonli isol viru byherp simplex viru type viru influenza multivari analysi control acut pathophysiolog chronic health evalu ii score patient respiratori disord admiss adjust odd ratio confid interv chronic obstruct pulmonari diseaseasthma patient adjust odd ratio confid interv admiss novemb march adjust odd ratio confid interv independ associ virusposit sampl patient admit respiratori disord tracheobronchi aspir posit respiratori virus time intub adjust hazard ratio confid interv independ associ better surviv control simplifi acut physiolog score ii admiss cardiogen shock cardiac arrest remain patient virusposit sampl intub predict surviv conclus confirm pathogen role respiratori virus intens care unit rhinoviru prognost virusassoci respiratori disord better respiratori disord
PLoS One	20616085	2011-12-28	PMC1762333	17183647	background rapid respons outbreak emerg infecti diseas imped uncertain diagnos delai commun understand ineffici respons contribut epidem theori develop understand studi societ learn emerg outbreak patient remov acceler gather dissemin method find develop extens standard outbreak model simpl stochast epidem account societ learn express expect outbreak size distribut epidem durat rapid learn notic final outbreak size learn exhibit diminish return relax exampl estim learn rate outbreak sever acut respiratori syndrom sar singapor evid relax week outbreak inconclus estim societ learn occur half actual rate expect final size outbreak reach case three time observ number infect contrast expect outbreak size societ learn effect case conclus rate societ learn greatli affect final size diseas outbreak justifi invest earli warn system attent diseas outbreak govern author public submit burden emerg infect includ risk global pandem effici reduc improv procedur rapid detect outbreak alert public health offici aggress educ public start outbreak
PLoS One	22205023	2008-11-01	PMC1762347	17183670	the distribut multihost pathogen host rang condit popul dynam structur host coinfect pathogen consequ evolut host pathogen hostpathogen coevolut interest distribut pathogen host rang random associ host pathogen pathogen share host analys issu propos indic observ pattern host infect pathogen observ pattern coinfect test analys pattern conform random reflect associ appli test preval plant virus wild plant speci evidenc hostviru associ host virus select virus host interestingli hostselect virus preval suggest host specialis success strategi multihost pathogen analys virus tend associ posit coinfect host develop indic test provid tool analys strong common associ group pathogen will help understand model popul biologi multihost pathogen
PLoS One	18692098	2005-12-01	PMC1762349	17183651	most individu infect sar coronaviru sarscov spontan recov clinic intervent immunolog correl associ patient recoveri current unknown report sequenti monitor recov patient twoyear period character tempor chang sarscovspecif antibodi respons cytotox cell ctl respons persist robust antibodi ctl respons studi subject studi period moder declin year onset symptom identifi potenti major ctl epitop protein base elispot analysi pool peptid despit potent immun respons clinic recoveri peripher lymphocyt count recov patient restor normal level summari studi time character tempor dynam chang humor ctl respons natur histori sarsrecov individu support notion high sustain level immun respons correl diseas outcom find direct implic futur design develop effect therapeut agent vaccin sarscov infect
PLoS One	16105977	2014-05-19	PMC1762437	17205139	previou studi hiv pgag immun mice demonstr target antigen cellular compart major histocompat complex type ii mhc ii complex molecul dna antigen formul encod gag chimera mous lysosomeassoci membran protein mlampgag studi analyz magnitud breadth gagspecif tlymphocyt antibodi respons elicit rhesu macaqu immun dna encod human lampgag hlampgag chimera elispot analys indic averag gagspecif ifn respons elicit hlampgag chimera detect three nake dna immun immun macaqu reach averag spotform cell sfc pbmc high ifn elispot respons detect cddeplet cell indic cd tcell plai major role respons tcell respons of macaqu test elispot overlap amino acid aa peptid pool ten peptid encompass complet gag protein sequenc mamu immun macaqu respond twelv pool mamu macaqu pool indic hlampgag dna antigen formul elicit broad tcell respons gag addition strong hivspecif igg respons igg antibodi titer increas dna inject indic strong amnest bcell respons highli elev macaqu three immun serum macaqu recogn peptid aa peptid librari cover complet gag amino acid sequenc addit hivspecif iga antibodi plasma extern secret includ nasal wash data support find increas immunogen genet vaccin encod lamp chimera includ respons dna vaccin nonhuman primat
BMC Med	24843159	2008-07-02	PMC1764026	17166291	background epidemiolog focus evalu convent method control strategi event epidem pandem travel restrict suggest effici reduc spread contagi diseas threaten public health paper studi depth effect travel restrict studi investig level travel restrict speed geograph spread outbreak diseas sever acut respiratori syndrom sar method stochast simul model incorpor survei data travel pattern municip sweden collect year test scenario travel restrict travel distanc km ban account level complianc ban journei drastic reduc speed geograph spread outbreak complianc result robust rate intermunicip transmiss intens conclus studi support travel restrict effect mitig futur diseas outbreak
BMC Bioinformatics	18596085	2013-04-07	PMC1764468	17254296	background genom sequenc data step gener part list life understand underli principl biocomplex genom sequenc initi human model organ target effort understand principl evolut applic envisag improv human health effort culmin develop dedic resourc larg number viral genom sequenc group individu interest studi antigen variat strain speci independ effort enabl virus attain statu bestrepres taxa highest number genom lack concert effort viral genom sequenc remain entri public repositori virgen curat resourc viral genom analys releas grown term coverag viral famili develop modul annot analysi current releas includ data twentyf famili broad host rang releas taxonom descript virus virgen ictv nomenclatur wellcharacteris strain identifi repres entri viral speci nonredund dataset subsequ annot analys sequencedbas bioinformat approach virgen archiv precomput data genom proteom comparison data modul structur viral protein pdb incorpor uniqu featur virgen predict conform sequenti epitop antigen protein inhous develop algorithm step revers vaccinolog conclus structur organ genom data facilit data mine tool opportun knowledg discoveri approach achiev goal carri function annot compar genom virgen comprehens viral genom resourc serv annot analysi pipelin develop curat public domain viral genom data step curat annot genom data applic valuead deriv data substanti case studi
BMC Public Health	23378666	2008-04-16	PMC1764890	17192198	background conflict profession duti fear influenza transmiss famili member health care profession hcp method survei employe univers hospit ethic issu aris manag influenza pandem respond agre profession accept hcp abandon workplac pandem order protect famili disagre statement opinion higher rate disagr physician nurs compar administr respond decis report work pandem left individu hcp disagre statement hcp perman dismiss report work pandem respond agre hcw children care influenza patient conclus modest major hcp minor hospit administr recognis oblig treat patient despit potenti risk profession ethic guidelin allow balanc societi person risk need help hcp fulfil duti case pandem influenza
Acta Vet Scand	18417574	2012-03-23	PMC1766361	17204146	mycoplasma alkalescen argininemetabol mycoplasma associ mastiti arthriti cattl routin bacteriolog examin bronchoalveolar lavag sampl calv pneumonia singl herd denmark identifi alkalescen sampl organ sole bacterilog find sampl combin mannheimia haemolytica haemophilu somni salmonella dublin report isol alkalescen denmark
PLoS Med	22447593	2007-05-01	PMC1769412	17227133	background proteom analysi amniot fluid presenc biomark characterist intrauterin inflamm sought valid prospect clinic util proteom profil mass restrict score method find enrol consecut women singleton pregnanc admit preterm labor preterm prematur ruptur membran women clinic indic amniocentesi rule intraamniot infect proteom fingerprint score gener fresh sampl amniot fluid surfaceenhanc laser desorpt ioniz seldi mass spectrometri presenc absenc biomark score interpret relationship amniocentesistodeliveri interv placent inflamm earlyonset neonat sepsi neonat admit newborn special care unit women sever amniot fluid inflamm score shorter amniocentesistodeliveri interv women score inflamm minim score inflamm median rang d versu d versu d minim degre inflamm associ preterm birth membran statu associ score sever histolog chorioamnion neonat hematolog indic earlyonset sepsi correl score adjust gestat ag birth ci compar laboratori test routin diagnos amniot fluid inflamm infect score highest accuraci detect inflamm white blood cell count cellsmm combin gram stain score best rapid predict intraamniot infect posit amniot fluid cultur conclus high score associ preterm deliveri histolog chorioamnion earlyonset neonat sepsi studi proteom analysi amniot fluid accur test diagnosi intraamniot inflamm addit score gram stain best combin test rapidli predict infect
Virol J	17353353	2009-03-01	PMC1774570	17194306	background genom coronavirus structur nonstructur gene includ socal accessori gene group coronavirus encod singl accessori protein spike envelop gene human coronaviru hcov prototyp viru split gene encod put orfa orfb protein determin primari hcove isol exhibit unusu genom organ analyz orfab region current clinic isol netherland three earli isol collect common cold unit ccu salisburi uk dutch isol ident orfab region amino acid level ccu isol ident dutch isol nucleotid level close prototyp hcove remark analys reveal laboratori adapt prototyp hcove nucleotid delet orfab region clinic isol carri singl orf nt size encod singl protein amino acid homologu orf protein encod hcovnl pedv conclus genom organ group coronavirus hcovnl pedv hcove ident extens cultur hcove laboratori strain truncat orf indic protein essenti cell cultur highli conserv amino acid sequenc orf protein clinic isol suggest protein plai role vivo
PLoS Pathog	19135223	2009-04-01	PMC1779296	17238286	prophylaxi high dose neutral antibodi typic offer protect challeng virus produc acut infect studi investig abil neutral human monoclon antibodi kz protect ebola viru rhesu macaqu antibodi fulli protect guinea pig infect rhesu macaqu mgkg neutral human monoclon antibodi kz intraven challeng plaqueform unit ebola viru second dose mgkg antibodi challeng control anim expos viru absenc antibodi treatment passiv transfer neutral human monoclon antibodi fail protect macaqu challeng ebola viru minim explos viral replic infect inabl antibodi impact infect neutral escap appear ebola viru mechan infect propag vivo macaqu uniqu insensit high concentr neutral antibodi
PLoS Med	19250860	2016-11-01	PMC1779818	17253901	singh colleagu discuss threat region global public health pose xdrtb kwazulunat propos measur control outbreak
BMC Bioinformatics	27872939	2008-02-13	PMC1783863	17244370	background condit strand bia number gs equal cs dna strand total number equal strand consider local deviat equal asymmetri nucleotid composit extens analyz prokaryot eukaryot genom chromosom organ transcript orient process organ carri analysi intrastrand nucleotid distribut graphic method develop graphdna java applic simpl userfriendli interfac visual dna nucleotid composit program accept genbank embl fasta file input displai multipl dna nucleotid composit graph skew walk singl window allow direct comparison sequenc illustr dna skew character poxviru coronaviru genom conclus graphdna platformindepend open sourc tool analysi nucleotid trend dna sequenc multipl sequenc format read multipl sequenc plot singl window
PLoS One	18272716	2014-01-01	PMC1791715	17299582	background neg binomi distribut commonli biologi model overdispers count data attent focus neg binomi dispers paramet substanti literatur exist estim attent focus dataset highli overdispers accuraci confid interv estim typic explor methodolog articl present simul studi explor bia precis confid interv coverag maximumlikelihood estim highli overdispers distribut addit explor smallsampl bia neg binomi estim studi address estim dataset influenc type event undercount diseas transmiss data subject select bia success outbreak conclus maximum likelihood estim bias upward small sampl size underreport zeroclass event bias downward factor consid confid interv estim asymptot sampl varianc tend exhibit coverag nomin level overestim compris great major coverag error estim outbreak dataset increas bia estim add upward bia estim vari invers degre overdispers find overestim degre overdispers rare dataset
Genome Biol	25030927	2003-07-01	PMC1794587	17109749	protein microarrai provid versatil method analysi protein biochem activ exist dna microarrai analyt method translat protein microarrai differ technolog report approach procat correct background bia spatial artifact identifi signal filter nonspecif spot normal signal protein abund procat power flexibl approach analyz type protein microarrai
Infect Agent Cancer	12805436	2012-03-01	PMC1796861	17266760	a quantit pcr method establish quantifi human bocaviru hbov genom copi clinic specimen children lower respiratori tract infect lrti china total respiratori tract specimen test sputum sampl posit genom copi rang sampl main clinic symptom patient posit hbov dna pneumonialik syndrom repres high fever cough hbov etiolog agent lrti children china
Microb Cell Fact	22085393	2019-07-29	PMC1796898	17254338	with advanc robot comput capabl fabric high qualiti glass slide coincid increas genom public databas microarrai technolog increasingli laboratori fact field vari toxicolog evolutionari biologi drug develop product diseas character diagnost develop cellular physiolog stress respons forens benefit research familiar microarrai current articl review address fundament principl technolog proper design experi microarrai technolog simpl conceptu practic requir care plan detail understand limit inher consider exceedingli difficult ascertain valuabl microarrai data text aim outlin kei featur microarrai technolog pai attent current applic outlin public experiment design statist method potenti review meant comprehens substant highlight concept detail step conduct interpret microarrai experi collect includ text will highlight versatil microarrai technolog provid glimps futur hold
PLoS Pathog	31355779	2017-11-15	PMC1797619	17305426	viral membran fusion proce sequenc step driven trigger conform chang viral envelop glycoprotein socal fusion protein highresolut structur snapshot viral fusion protein prefus postfus conform difficult defin intermedi structur fusion pathwai transient natur flavivirus possess class ii viral fusion protein mediat fusion acid ph convert dimer trimer hairpinlik structur fusion process tickborn enceph viru exposur virion alkalin acid ph trap particl intermedi conform dimer dissoci interact target membran fusion peptid proceed merger membran treatment low ph lead fusion suggest monom correspond asyetelus intermedi requir convert prefus dimer postfus trimer nonphysiolog condit allow dissect flaviviru fusion process identif separ step membran insert multipl copi monom preced format hairpinlik trimer sequenc event insight understand dynam process viral membran fusion
Virol J	30222502	2003-10-01	PMC1810241	17326843	background respiratori infect neurovirul vaccinia viru vv strain western reserv wr acut infect lung dissemin viru organ lethal mice mechan lethal wellunderstood studi analyz viru replic host immun respons intranas infect lethal nonleth dose vv wr strain virul wyeth strain wr strain replic vigor lung brain wyeth strain differ viru titer brain mice infect higher lethal dose lower nonleth dose wr strain suggest amount viru replic brain sole determin factor lethal wr strain grew better primari mous lung cell wyeth strain lethal infect wr strain associ reduc number lymphocyt alter phenotyp cell lung compar nonleth infect wr wyeth strain sever thymu atrophi reduct cd cd doubl posit cell observ lethal infect conclus lethal induc intranas infect high dose wr strain caus higher replic viru lung cell immun suppress earli phase infect uncontrol viru replic lung
Virol J	14573573	2011-10-12	PMC1810517	17324273	background coronavirus infecti diseas human includ sever acut respiratori syndrom sar continu potenti emerg anim speci major factor host rang coronaviru receptor util host cell case coronavirusreceptor interact understood notabl except receptor util group coronavirus includ avian infecti bronchiti viru ibv felin aminopeptidas fapn serv function receptor group coronavirus includ felin infecti periton viru fipv canin coronaviru transmiss gastroenter viru tgev human coronaviru hcove report suggest role fapn ibv entri miguel pharr gt wang role felin aminopeptidas receptor infecti bronchiti viru review arch virol transient transfect constitut express fapn bhk cell rescu fipv tgev infect nonpermiss bhk cell fapn express rescu infect prototyp ibv strain mass account previou suggest fapn serv ibv receptor felin cell infect prototyp strain ibv mass low suscept compar primari chick kidnei cell bhk cell suscept ibv strain includ ark arkdpi iowa effici level infect increas fapn express conclus conclud fapn function receptor ibv ident current investig
Virol J	21998418	2017-07-18	PMC1828050	17343744	background complet genom sequenc astrovirida includ human nonhuman mammalian avian speci consensu topolog astrovirus deriv nucleotid substitut fulllength genom nonsynonym nucleotid substitut three orf analys synonym substitut displai loss tree structur suggest satur substitut model deviant pattern synonym substitut viru speci analyz complet astrovirida famili infer adapt molecular evolut site branch high rate synonym mutat observ nonhuman viru speci deviant pattern synonym substitut capsid structur gene purifi select domin forc astroviru gene codon site valu dnd ratio indic sitespecif molecular adapt viru evolut site glycin residu rgd motif orf human astroviru serotyp rgd integrin recognit motif astroviru speci conclus phylogenet analysi direct maximum likelihood approxim allow inclus evolutionari histori improv estim dn ds site enhanc valu dnd promin domain charg environment commun fi vp domain orfa domain dedic intrins viru function fi vp orfb viru polymeras integrin recognit plai kei role astroviru target cell attach
J Ethnobiol Ethnomed	28422322	2007-06-01	PMC1831764	17324258	background medicin plant option livestock farmer allow allopath drug certifi organ program afford allopath drug minor health problem livestock method conduct semistructur interview particip purpos sampl medicin plant treat rang condit draft manual prepar data evalu particip participatori workshop plant rumin health diet repres plant famili plant abscess berberi aquifoliummahonia aquifolium echinacea purpurea symphytum officinal bovista pila bovista plumbea achillea millefolium usnea longissima curcuma longa salix scouleriana salix lucida caprin arthriti caprin arthriti encephalitiseuphrasia officinali matricaria chamomilla ey problem wound injuri treat bovista spp usnea longissima calendula officinali arnica sp malva sp prunella vulgari echinacea purpurea berberi aquifoliummahonia aquifolium achillea millefolium capsella bursapastori hypericum perforatum lavandula officinali symphytum officinal curcuma longa syzygium aromaticum pseudotsuga menziesii coccidiosi plant diarrhea scour plantago major calendula officinali urtica dioica symphytum officinal pinu ponderosa potentilla pacifica althaea officinali anethum graveolen salix alba ulmu fulva mastiti treat achillea millefolium arctium lappa salix alba teucrium scorodonia galium aparin anethum graveolen rubu sp increas milk productiontaraxacum officinal zea mai symphytum officinal udder edema ketosi treat gaultheria shallon vaccinium sp symphytum officinal hedera helix alchemilla vulgari fed retain placenta conclus plant show high level valid hedera helix retain placenta euphrasia officinali ey problem plant high valid wound injuri includ hypericum perforatum malva parviflora prunella vulgari treatment high valid endoparasit includ juniperu communi pinu ponderosa anxieti pain treat melissa officinali nepeta caesarea
BMC Infect Dis	17544561	2019-01-24	PMC1832202	17355639	background plan public health respons pandem influenza reli predict model impact intervent strategi evalu focus produc predict local specif condit design publicli plan tool appli public health administr provid tool reproduc explicitli formul structur design oper optim combin compet requir precis realism gener influsim determinist compart model base system differenti equat extend classic seir model clinic demograph paramet relev pandem prepared plan allow produc time cours cumul number influenza case outpati visit appli antivir treatment dose hospit death work dai lost sick associ econom aspect softwar program java oper platform independ execut regular desktop comput conclus influsim onlin softwar effici assist public health planner design optim intervent pandem influenza reproduc infect dynam pandem influenza complex comput simul offer time reproduc higher comput perform better oper
BMC Evol Biol	30674714	2016-05-18	PMC1839080	17359548	background mechan larg dna virus increas genom size addit modul acquir virus host genom gene duplic phylogenet analysi larg dna virus method base align difficult presenc horizont gene transfer event composit vector approach sensit event appli reconstruct phylogeni larg dna virus consist biologist systemat outlier provid unclassifi virus cladist relationship famili conclus composit vector approach phylogenet tree larg dna virus compar biologist systemat provid recov phylogeni virus
Virol J	27189860	2017-11-29	PMC1839082	17352827	nucleic acid polymeras structur motif function aspart acid conserv class nucleic acid polymeras motif remain understood rnadepend rna polymeras mutat residu alanin polioviru replicon mutant replic reduc level addit mutat ac motif yield high level replic polioviru polymeras conserv residu essenti polioviru replicon function
BMC Infect Dis	29048984	2016-10-01	PMC1845150	17359545	background preval selfreport prevent behavior respons anticip local humantohuman hn transmiss outbreak factor associ behavior examin method random anonym crosssect telephon survei hong kong chines adult public hong kong adopt selfprotect behavior wear face mask public venu increas frequenc handwash behavior protect wear face mask experienc influenzalik ill ili seek medic consult make declar cross border ili compli quarantin polici multivari analys indic factor ag fulltim employ perceiv suscept perceiv efficaci prevent measur perceiv higher fatal compar sar perceiv chanc major local outbreak worri selffamili member contract viru associ inclin adopt selfprotect measur analys educ level variabl perceiv efficaci perceiv major local outbreak associ behavior direct protect conclus event humantohuman hn outbreak public hong kong adopt prevent measur help spread viru commun
J Ethnobiol Ethnomed	27564783	2014-08-01	PMC1847427	17376227	given increas tradit medicin possibl ensur success integr public health framework explor paper discuss link biodivers tradit medicin address implic public health explor biodivers ecosystem servic global human health risk human impact ecosystem biodivers human health welfar
BMC Infect Dis	23337126	2009-07-29	PMC1847518	17371589	background host genet factor determin tuberculosi tb slca nramp gene studi extens genet associ tb inconsist find addit studi look sex ag relationship slca polymorph tb method casecontrol studi conduct total pulmonari tb patient sex agematch control tb recruit subject ethnic chines basi linkag disequilibrium pattern three genet marker slca nearbi ilrb locu select examin associ tb suscept marker genotyp singl strand conform polymorph analysi fragment analysi amplifi product statist differ allel genotyp frequenc link marker slcab classic call dn utr slca locu patient control stratif sex posit associ identifi femal group allel genotyp frequenc stratif ag posit associ demonstr young ag group ag year allel genotyp frequenc posit find remain correct multipl comparison differ male group older ag group differ marker slca marker ilrb marker conclus studi confirm associ slca tb suscept demonstr time associ restrict femal young ag group
PLoS One	19640987	2014-01-29	PMC1847702	17440617	background ubiquitin ubiquitinlik protein ubl design modifi polypeptid eukaryot coval bind ubiquitin ubl substrat protein revers specif hydrolas set cystein proteas ce clan target ubiquitin ubl homolog eukaryot prokaryot virus find clone analyz coli protein elad distantli eukaryot ce clan member ulpsenp proteas famili specif sumo nedd misannot put sulfatasephosphatas elad effici specif deubiquitin enzym vitro interestingli elad intestin pathogen coli strain conspicu absent extraintestin pathogen strain expec homolog proteas acanthamoeba polyphaga mimiviru alpha betaand gammaproteobacteria conclus express ulpsenprel hydrolas bacteria extend plant pathogen medic relev strain escherichia coli legionella pneumophila rickettsia chlamydia salmonella elad ortholog ssel identifi virul factor deubiquitin activ counterpoint phylogenet function examin reveal ancient eukaryot ulpsenp proteas potenti ubiquitinspecif hydrolysi suggest earli common origin peptidas clan
Virol J	24478444	2018-11-01	PMC1851004	17386116	background sever acut respiratori syndrom sar caus larg outbreak pneumonia beij china revers transcriptas polymeras chain reaction rtpcr detect quantifi sarscov sera selfcollect throat wash fecal sampl patient laboratoryconfirm sar manag singl institut sarscov detect rate sera highest dai ill detect highest throat wash dai onset symptom highest sarscov rtpcr rate viral load log fecal sampl collect week onset clinic ill fecal sampl frequent sarscov rtpcr posit dai occasion sera sarscov detect week ill conclus context extens outbreak major pressur hospit resourc patient selfcollect sampl altern nasopharyng aspir laboratori confirm sarscov infect
Virol J	30622783	2013-07-02	PMC1852297	17397531	backgroundaim role humor immun hepat viru hcv infect understood increas interest character neutral antibodi serum hcvinfect patient focu reduct assai evalu neutral antibodi respons rang noncytopath virus base develop hcv cell cultur system genotyp jfhstrain develop focu reduct assai hcvneutral antibodi method focu reduct assai base standard microneutr assai immunostain foci tissu cultur plate count neutral antihcv antibodi titer purifi serum immunoglobulin sampl seventyseven individu determin focu reduct neutral assai titer determin log reciproc antibodi dilut reduc number viral foci igg antibodi purifi serum order avoid facilit hdl hcv entri assai cutoff elisa rna hcvneg sampl log correspond dilut assai compar commerci hcv elisa exhibit specif sensit valu good reproduc intraassai interassai coeffici variat assai crossreact antihiv antihb heterophil antibodyposit sampl neutral antibodi titer log homolog sampl hcv genotyp infect patient harbor genotyp jfh log heterolog sampl patient infect genotyp type confirm presenc broadli crossneutr antibodi report hcv pseudoparticl system conclus studi present simpl specif reproduc cell culturebas assai determin hcvneutral antibodi human sera assai tool gaug relationship neutral antibodi respons viral load kinet acut chronic infect patient investig erad prevent hcv infect neutral antibodi
BMC Biotechnol	24319606	2003-10-01	PMC1852797	17411439	background embryon chicken egg midth centuri grow wide rang anim virus high titer egg limit product recombin protein describ system base sendai viru minigenom produc larg amount heterolog viral glycoprotein allanto caviti embryon egg solubl form human respiratori syncyti viru hrsv human metapneumoviru hmpv fusion protein devoid transmembran cytoplasm domain produc allanto fluid sendai minigenom system step rescu cell cultur sendai viru minigenom encod protein interest help wild type sendai viru second step propag recombin defect virus helper viru allanto caviti chicken embryon egg passag optim protein product compar product protein cultur supernat cell infect vaccinia recombin yield allanto fluid fold higher mutant form solubl protein easili construct sitedirect mutagenesi express egg approach conclus simplic economi sendai minigenom system high yield achiev allanto fluid egg attract method express solubl glycoprotein aim structur studi
BMC Evol Biol	14573572	2007-06-27	PMC1853084	17359539	background phylogeni rapidli evolv pathogen difficult resolv small number substitut accumul short time diverg improv resolut phylogeni propos insert delet indel addit substitut accomplish joint estim align phylogeni bayesian framework draw infer markov chain mont carlo joint estim align phylogeni sidestep bias stem condit singl align account ensembl nearoptim align introduc novel markov chain transit kernel improv comput effici propos nonloc topolog rearrang block sampl align topolog paramet addit extend previou indel model increas biolog realism place indel preferenti longer branch demonstr abil indel increas phylogenet resolut exampl drawn withinhost viral sequenc sampl demonstr align uncertainti account final codonbas substitut model affect align qualiti phylogenet infer unrealist forc indel codon conclus indic indel improv phylogenet resolut diverg pathogen align uncertainti consid analys
PLoS One	17596360	2010-08-30	PMC1855431	17502915	a broad spectrum detect platform sequenc level resolut target region impact public health case manag expand understand etiolog diseas develop respiratori pathogen microarrai rpm demonstr capabl platform purpos newli develop rpm analyz wellcharacter nasal wash specimen patient present febril respiratori ill washington metropolitan region specimen rpm compar composit refer assai viral bacteri cultur appropri rtpcrpcr panel rpm assai agreement organ detect compar refer method addition rpm provid sequenc allow phylogenet classif circul influenza virus clinic specimen allow monitor genet variat antigen variabl predict multipl pathogen detect specimen notabl increas abund respiratori colon esp pneumonia viral infect firstev comparison broadspectrum viral bacteri identif technolog type larg batteri convent gold standard assai confirm util approach medic surveil investig complex etiolog ill caus respiratori coinfect
PLoS One	21798778	2013-09-16	PMC1868897	17520018	the sever acut respiratori syndrom coronaviru sarscov genom predict encod function open read frame lead express structur nonstructur protein product function larg number viral orf understood unknown order gain insight function mode action interact protein clone viral orfeom perform genomewid analysi intravir protein interact intracellular local pairwis interact test yeasttwohybrid matrix analysi posit nonredund interact includ interact identifi interact subsequ confirm coip mammalian cell nsp nsp orfb wide rang interact viral protein nsp interact replicas protein nsp nsp nsp nsp nsp nsp nsp nsp nsp indic crucial role major player replic complex machineri nsp essenti viral replic vitro nsp accessori protein orfb plai pivot role viral replic delet viru displai normal plaqu size growth characterist vero cell expect virushost interplai pathogen larg number interact enhanc global stabil sar proteom network plai unreal role regul proteinprotein interact interact identifi provid valuabl materi futur studi
PLoS One	24043791	2005-09-01	PMC1876810	17551582	despit intens ongo kei aspect spatialtempor evolut foot mouth diseas fmd epidem great britain gb remain unexplain develop markov chain mont carlo mcmc method estim epidemiolog paramet outbreak rang simpl transmiss model simplifi assumpt infecti farm complet observ equival assum farm proactiv cull diagnos fmd infecti infect estim transmiss paramet vari time highlight impact control measur progress epidem demonstr statist evid assort contact pattern anim speci predict risk map transmiss potenti geograph area gb present fit model
Virol J	16145100	2010-06-03	PMC1878474	17477867	chloroquin aminoquinolin malaria therapi emerg investig antivir drug broad spectrum antivir activ explor low phdepend influenza virus affect antivir effect chloroquin clinic achiev concentr test antivir effect drug select human avian virus belong subtyp displai ph requir correl respons chloroquin nhcl lysosomotrop agent increas ph intracellular vesicl timeofaddit experi inhibitori chloroquin maxim drug time infect lost postinfect time correspond viruscel fusion clear correl ec chloroquin vitro electrostat potenti ha subunit ha mediat viruscel fusion process studi highlight critic host cell factor intravesicular ph determin antiinfluenza activ chloroquin lysosomotrop agent
BMC Infect Dis	20484391	2018-01-10	PMC1878480	17456233	background interferongamma kei cytokin protect respons intracellular pathogen singl nucleotid polymorph snp locat intron human ifn gene put influenc secret cytokin impact infect outcom demonstr tuberculosi complex diseas aim investig put associ ifngta snp american tegumentari leishmaniasi atl influenc snp secret ifn vitro method brazilian atl patient cutan cl mucos leishmaniasi healthi volunt evalu genotyp region ifn gene carri amplif refractori mutat system armspcr leishmaniainduc ifn product peripher blood mononuclear cell pbmc cultur supernat assess elisa differ ta snp frequenc case control versu cl patient cutan leishmaniasi case exhibit aa genotyp produc lower level ifn tatt genotyp mucos case high low ifn produc clearli demonstr differ cytokin product observ ifng carrier conclus ta polymorph associ suscept sever leishmaniasi despit ifng ta snp involv pathogenesi leishmaniasi influenc amount cytokin releas cl patient prevent diseas develop hand case potenti polymorph regulatori gene tnf il involv interf ifn secret
PLoS Med	29321332	2017-02-01	PMC1880850	17535101	background prophylact therapeut strategi combat human infect highli pathogen avian influenza hpai hn virus need gener neutral antihn human monoclon antibodi mab test efficaci prophylaxi therapi murin model infect method find epsteinbarr viru immort memori cell vietnames adult recov infect hpai hn virus supernat cell line screen viru neutral assai cell line secret neutral antibodi clone mab purifi crossreact antibodi strain hn test vitro neutral assai prophylact therapeut efficaci vivo test mice vitro mab fla fld neutral clade clade ii hn virus whilst fla fld neutral clade virus vivo fla fla confer protect lethal mice challeng avietnam hn dosedepend manner mab prophylaxi provid statist reduct pulmonari viru titer reduc associ inflamm lung restrict extrapulmonari dissemin viru therapeut dose fla fla fld fld provid robust protect lethal postinfect avietnam hn mab fla fld fld fla therapeut activ vivo clade ii viru aindonesia hn conclus studi provid proof concept fulli human mab neutral activ rapidli gener peripher blood convalesc patient mab effect prevent treatment hn infect mous model panel neutral crossreact mab prophylaxi adjunct treatment human case hn influenza
PLoS Med	27865780	2005-05-12	PMC1880862	17535110	the editor discuss initi prepar respond global public health threat rapid advic guidelin group revis intern health regul
BMC Biol	15890958	2013-09-23	PMC1884140	17490473	background polymorph activ compon nicotinamid adenin dinucleotid phosphat nadph oxidas complex neutrophil cytosol factor ncf identifi regul arthriti sever mice rat discoveri search nadph oxidaseactiv substanc potenti approach treat autoimmun disord rheumatoid arthriti ra compound induc ncfdepend oxid burst phytol strong amelior arthriti rat underli molecular mechan clearli understood aim studi geneexpress profil understand protect arthriti activ nadph oxidas immun system subcutan administr phytol lead accumul compound inguin lymph node peak level reach dai administr global geneexpress profil inguin lymph node perform dai induct pristaneinduc arthriti pia phytol administr differenti express gene divid pathwai consist gene regul interferon ifn regul pathwai associ arthriti develop ifn regul pathwai associ diseas protect phytol importantli molecular pathwai confirm differenti arthritissuscept dark agouti rat ncfda allel allow low oxid burst arthritisprotect dancf rat ncfe allel allow stronger oxid burst conclus natur occur genet polymorph ncf gene modul activ nadph oxidas complex regul sever arthriti ncf allel enhanc oxid burst protect arthriti oper ifnassoci pathwai arthritisdriv allel oper ifnassoci pathwai treatment arthritissuscept rat nadph oxidaseactiv substanc phytol protect arthriti interestingli treatment led restor oxidativeburst induct strikingli ifndepend pathwai diseaseprotect ncf polymorph
BMC Vet Res	24062443	2019-01-01	PMC1884148	17484782	background quantif gene express tissu sampl requir refer gene normalis transcript number sampl refer gene stabil vari tissu tissu diseas state evalu stabil refer gene commonli human gene express studi realtim revers transcript pcr mathemat algorithm establish refer gene stabli express normal diseas canin articular tissu canin cell line stimul lipolysaccarid lp optim refer gene compar gene express data normal diseas infrapatella fat pad rpla ywhaz ideal refer gene compar normal osteoarthrit oa cartilag rpla sdha best refer gene compar normal ruptur canin cranial cruciat ligament bm tbp best refer gene normalis gene express data normal lp stimul cell line sdha ywhaz sdha hmb dh express stabil valu dh number refer gene requir reduc pairwis variat cell line cartilag cranial cruciat ligament fat tissu refer gene stabil level gene express conclus refer gene demonstr stabl express canin articular tissu identifi singl refer gene identifi stabl express tissu type studi underlin necess select refer gene basi tissu diseas specif express profil evalu highlight requir identif refer gene greater express stabil canin articular tissu gene express studi
PLoS One	30844806	2019-07-03	PMC1888730	17565384	eudoc dock program predict smallmoleculebound protein complex identifi drug lead chemic databas expand applic eudoc program supramolecular chemistri test abil reproduc crystal structur smallmolecul complex select crystal structur smallmolecul guesthost complex eudoc reproduc crystal structur guest structur massweight root squar deviat mwrmsd rel correspond crystal structur addit averag interact energi guesthost complex kcalmol half test smallmoleculebound protein complex kcalmol interact energi calcul eudoc complex reproduc mwrmsd neighbor host crystal structur guesthost complex includ multimer host system complex reproduc mwrmsd water molecul exclud host system demonstr influenc crystal pack small molecul complex eudoc predict smallmolecul complex design materi molecular sensor multimer inhibitor proteinprotein interact
Theor Biol Med Model	31270229	2014-09-17	PMC1892008	17547753	background time variat transmiss potenti rare examin regard pandem influenza paper reanalyz tempor distribut pandem influenza prussia germani daili number death total septemb februari distribut time delai onset death order estim effect reproduct number defin actual averag number secondari case primari case time discretetim branch process appli backcalcul incid data assum three serial interv dai estim reproduct number exhibit clear associ estim choic serial interv longer assum serial interv higher reproduct number estim reproduct number declin monoton time indic pattern secondari transmiss vari time tendenc consist differ estim reproduct number pandem influenza studi high estim origin long serial interv model assumpt transmiss rate take account time variat appli entir epidem curv conclus find order offer robust assess critic clarifi detail natur histori diseas includ serial interv heterogen pattern transmiss addit human contact behavior influenc transmiss individu countermeasur household quarantin maskwear explor construct effect nonpharmaceut intervent
Virol J	25231316	2012-04-01	PMC1892777	17555580	cyclooxygenas cox plai role viral infect respect replic pathogenesi investig role cox mous hepat coronaviru mhv infect cycl block cox activ inhibitor rna interfer mhv infect cell cox inhibitor reduc mhv infect postbind step earli replic cycl viral rna viral protein synthesi subsequ loss progeni viru product cox activ appear requir effici mhv replic provid potenti target anticoronavir therapi
BMC Public Health	22474009	2011-08-01	PMC1894789	17535426	background state local health depart unit state acceler effort prepar highimpact public health emerg compon activ develop conduct exercis program assess capabl train staff build relationship paper summar lesson learn tabletop exercis public health emerg prepared process develop conduct evalu method develop conduct evalu tabletop exercis partnership state local health depart particip evalu action report tabletop exercis evalu form identifi aspect exercis public health emerg respons particip challeng highlight lesson learn tabletop exercis design design exercis involv substanti collabor repres particip health depart assur scenario credibl focus attent local prepared prioriti logist feasibl implement execut exercis health depart struggl common set challeng relat diseas surveil epidemiolog investig commun command control health care surg capac contrast perform strength vari particip site reflect specif attribut individu health depart commun experi actual public health emerg emphasi prior prepared effort conclus design conduct evalu tabletop exercis describ report benefit collabor plan involv stakehold particip health depart exercis develop facilit particip agenc exercis identifi strength vulner emerg prepared addit work need develop reliabl metric gaug exercis perform inform followup action step develop reevalu exercis design assess impact postexercis intervent
BMC Public Health	21727183	2012-12-26	PMC1894965	17535440	background extraordinari infect control measur limit access medic care greater toronto area sever acut respiratori syndrom sar outbreak object studi determin period infect control measur associ chang popul mortal sar method observ studi death registri data poisson regress interrupt timeseri analysi examin allcaus mortal rate exclud death sar sar outbreak popul ontario group greater toronto area rest ontario base level restrict deliveri clinic servic sar outbreak chang mortal greater toronto area period sar outbreak compar correspond time period rate ratio allcaus mortal sar outbreak confid interv ci compar ci compar interrupt time seri analysi chang mortal rate greater toronto area associ period sar outbreak conclus limit access medic servic sar outbreak toronto observ impact shortterm popul mortal effect morbid longterm mortal assess effort futur infecti diseas outbreak influenza agent consid effect access essenti health care servic
PLoS Med	23269787	2010-08-25	PMC1896205	17593895	background advanc diseasesurveil system deploi worldwid provid earli detect infecti diseas outbreak bioterrorist attack method improv detect capabl system broad practic impact current gener surveil system vulner dramat unpredict shift healthcar data monitor shift occur major public event olymp result popul surg public closur shift occur epidem pandem result quarantin worriedwel flood emerg depart convers public stai hospit fear nosocomi infect surveil system robust shift healthcar util adjust baselin alertthreshold util level util shift trigger alarm result publichealth crise major public event threaten undermin healthsurveil system time need method find address challeng introduc class epidemiolog network model monitor relationship healthcar data stream monitor data stream extract extra relationship data stream model potenti improv detect capabl system model relat natur potenti increas system robust unpredict baselin shift implement model evalu effect histor emerg depart data hospit singl metropolitan area record period autom epidemiolog geotempor integr surveil realtim public healthsurveil system develop children hospit informat program harvardmit divis health scienc technolog behalf massachusett depart public health perform experi semisynthet outbreak magnitud simul baselin shift type magnitud the network model provid better detect local outbreak greater robust unpredict shift refer timeseri model approach conclus integr network model epidemiolog data stream interrelationship potenti improv current surveil effort provid better local outbreak detect normal circumst robust perform face shift healthcar util epidem major public event
BMC Infect Dis	20739537	2015-04-01	PMC1899505	17540042	background chemokin plai role inflamm antivir action examin polymorph rant ip mig affect suscept outcom sever acut respiratori syndrom sar method test polymorph rant ip mig associ sar hong kong chines sar patient control confirm beij chines sar patient control rant allel associ sar suscept hong kong chines ci individu rant cg gg genotyp fold ci fold ci increas risk develop sar allel confer risk death genedosag depend manner cg gg individu fold ci fold ci increas risk replic rant data beij chines allel associ suscept sar cg ci gg ci associ admiss intens care unit death sar conclus rant allel plai role pathogenesi sar
J Transl Med	25664975	2006-08-01	PMC1904179	17553144	although risk transfusiontransmit infect todai lower suppli safe blood product remain subject contamin identifi human pathogen continu improv implement donor select sensit screen test effect inactiv procedur ensur elimin reduct risk acquir transfus transmit infect addit ongo educ uptod infecti agent transmit blood compon promot report advers event compon transfus transmit diseas surveil collabor parti involv transfus medicin includ nation haemovigil system crucial protect secur blood product suppli emerg bloodborn pathogen
BMC Bioinformatics	16882658	2013-03-06	PMC1913542	17559689	background wide affymetrix microarrai broaden field biolog probeset annot issu standard affymetrix probeset annot gene level probeset precis link gene probeset intens interpret gene express increas knowledg gene multipl transcript variant clearli bring necess updat genelevel annot refin transcriptlevel perform rigor align affymetrix probe sequenc comprehens pool current transcript sequenc link probeset intern protein gener transcriptlevel proteinlevel annot tabl popular affymetrix express arrai mous genom arrai human genom ua arrai applic annot reexamin exist express data set increas express consist synonym probeset strengthen express correl interact protein conclus refin standard affymetrix annot microarrai probeset gene level transcript level protein level achiev reliabl interpret experiment data lead discoveri profound regulatori mechan
BMC Med Inform Decis Mak	23303217	2011-09-28	PMC1919360	17567912	background real time surveil detect abnorm diseas pattern base differ pattern observ predict model histor data outbreak detect strategi depend specif fals alarm rate interpret alarm evalu specif tradit model autoregress serfl trim season waveletbas gener linear appli year emerg depart visit respiratori infect syndrom pediatr hospit find specif model nonconst function dai week month year studi develop outbreak detect method call expectationvari model base gener addit model achiev constant specif account expect number visit varianc number visit expectationvari model achiev constant specif three time scale earlier detect improv sensit compar tradit method circumst conclus model varianc visit pattern enabl realtim detect constant specif time constant specif public health practition better interpret alarm better evalu costeffect surveil system
PLoS One	21957308	2013-05-22	PMC1919423	17653289	background famili ubiquitinlik molecul ubl compris member sequenc structur function similar ubiquitin isg homolog ubiquitin vertebr upregul induct type interferon isg coval attach protein analog ubiquitin actual support ubiquitin conjug factor specif proteas revers modif ubiquitin ubl hydrolyz coval bond ctermini substrat protein tail region ubiquitin isg ident hypothes promiscu deubiquitin proteas dub exist capabl recogn ubiquitin isg clone express human dub repres major clade usp proteas famili util suicid inhibitor base ubiquitin isg identifi usp usp isot usp isot usp isgreact proteas addit bona fide isgspecif proteas usp ubp usp proteasomeassoci dub isg isopeptidas activ increas complex proteasom conclus evolutionari standard isg newcom ubl util conjug deconjug machineri establish rel ubiquitin function overlap posttransl modifi extens appreci explain innocu phenotyp isg null mice
PLoS One	23698304	2015-09-21	PMC1920550	17653272	to identifi malaria antigen vaccin develop select helic coil coil domain protein predict parasit erythrocyt stage correspond synthet peptid expect mimic structur nativ epitop chemic synthes peptid recogn human immun sera preval peptid specif antibodi affinitypurif malaria immun sera immun mice antibodi cross reaction specif origin peptid react nativ parasit protein infect erythrocyt activ inhibit vitro parasit growth circular dichroism studi indic select peptid assum partial high helic content demonstr bioinformaticschem synthesi approach describ lead rapid identif molecul target biolog activ antibodi identifi suitabl vaccin candid strategi principl extend vaccin discoveri wide rang pathogen
BMC Genomics	26401072	2015-03-06	PMC1925091	17597519	background mammalian angiotensin convert enzym ac plai kei role blood pressur regul multipl acelik protein exist nonmammalian organ ac homologu ac identifi mammal report identif characteris gene encod third homologu ac term ac mammalian genom ac gene locat chromosom downstream ac gene multipl sequenc align molecular model emploi characteris predict ac protein mous rat cow dog predict protein mutat critic residu involv catalysi includ catalyt glu hexxh zinc bind motif gln est reversetranscript pcr indic gene express human predict ac protein intact hexxh motif delet insert gene est identifi conclus genom mammalian speci gene encod novel singl domain acelik protein ac mous rat cow dog ac catalyt glu replac gln put zinc bind motif indic speci ac lack catalyt activ zinc metalloproteas human evid ac gene express presenc delet insert sequenc indic ac pseudogen
Genome Biol	25673302	2016-09-07	PMC1929155	17531104	dna microarrai genom sensor great potenti clinic diagnost bias inher random pcramplif crosshybrid effect inadequ microarrai analysi limit detect sensit specif studi relationship viral amplif effici hybrid signal targetprob anneal specif custom microarrai platform novel featur platform includ develop robust algorithm accur predict pcr bia dna amplif improv pcr primer design power statist concept infer pathogen ident probe recognit signatur compar realtim pcr microarrai platform identifi pathogen accuraci sensit specif panel patient specimen find microarrai robust accur diagnosi pathogen substanti microarrai technolog clinic diagnost
BMC Public Health	27605677	2009-10-27	PMC1934907	17634112	background communitywid prepared pandem influenza issu featur promin new media current prioriti health author countri small medium busi sector major provid privat sector employ australia prepared sector pandem influenza studi aim investig associ individu percept prepared pandem influenza small medium busi owner manag method semistructur facetofac interview conduct small medium busi owner manag south wale western australia elig small medium busi defin employe binomi logist regress analysi identifi predictor consid impact plan need help prepar pandem influenza cent particip report busi plan pandem influenza cent report thought impact pandem influenza busi cent state requir help prepar pandem belief sever pandem influenza abil respond independ predictor plan pandem influenza percept risk pandem influenza predictor consid impact need help prepar pandem conclus find small medium busi australia current prepar pandem influenza belief risk sever abil respond effect threat pandem influenza predictor prepared campaign target small medium busi emphasis sever consequ busi pandem occur time reassur effect strategi capabl implement small medium busi deal pandem
BMC Infect Dis	19770157	2018-05-02	PMC1939851	17629919	background influenza pandem prepared plan current develop refin nation intern level attent administr antivir drug contact reduct effect mitig strategi advantag limit se effect intervent depend factor explor sensit analys base mathemat model method freeli plan tool influsim investig pharmaceut nonpharmaceut intervent mitig influenza pandem examin intervent schedul restrict stockpil contact reduct social distanc measur isol case determin cours pandem wave success intervent time applic antivir drug combin quick implement contact reduct measur requir protract peak epidem reduc height delai initi antivir treatment parsimoni limit stockpil result pessimist outcom lead paradox stockpil deplet earlier compar earli distribut antivir drug conclus pharmaceut nonpharmaceut measur exclus protract pandem wave essenti win time wait vaccin develop product height peak epidem easili overtax gener practition hospit public health system caus bottleneck basic emerg medic care
BMC Public Health	29717637	2005-12-12	PMC1939990	17650342	background factor structur item gener health questionnair ghq studi survei subject experienc niigatachuetsu earthquak richter scale japan method psycholog distress measur year earthquak ghq subject respons rate suffer earthquak ghq score binari chronic likert score method confirmatori factor analysi reveal factor structur ghq categor regress analysi perform evalu relationship background factor ghq score confirmatori factor analysi reveal model consist factor chronic method best goodnessoffit model factor structur recoveri scale factor social dysfunct remark impair compar factor dysphoria categor regress analysi reveal factor includ advanc ag associ psycholog distress advanc ag impair recoveri factor social dysfunct score total ghq score conclus twofactor structur ghq conserv survei month year earthquak impair recoveri abil cope daili problem subject experienc earthquak remark year earthquak
PLoS Pathog	16352560	2007-01-17	PMC1941747	17696607	attenu viral vaccin gener target essenti pathogen factor report ration design attenu recombin coronaviru vaccin base delet code sequenc nonstructur protein nsp cell cultur nsp mous hepat viru mhv sarscoronaviru homolog reduc cellular gene express nsp mhv replic vitro vivo analyz recombin mhv encod delet nspcode sequenc recombin mhv nsp mutant grew tissu cultur sever attenu vivo replic spread nsp mutant viru restor wildtyp level type interferon ifn receptordefici mice indic nsp interfer effici type ifn system importantli replic nsp mutant viru profession antigenpres cell convent dendrit cell macrophag induct type ifn plasmacytoid dendrit cell impair low dose nsp mutant mhv elicit potent cytotox cell respons protect mice homolog heterolog viru challeng present attenu strategi paradigm develop highli effici coronaviru vaccin
PLoS Pathog	17229691	2005-03-01	PMC1941749	17696609	the pathogenesi sever acut respiratori syndrom coronaviru sarscov mediat disproport immun respons abil viru circumv innat immun function genom analyz earli host respons sarscov infect lung adolesc cynomolgu macaqu macaca fasciculari lung patholog observ human adult sar analysi gene signatur reveal induct strong innat immun respons character stimul cytokin chemokin gene includ interleukin il il ip correspond host respons acut respiratori distress syndrom oppos vitro experi sarscov induc wide rang type interferon ifn nuclear transloc phosphoryl signal transduc activ transcript lung macaqu immunohistochemistri reveal antivir signal pathwai differenti regul distinct subset cell studi emphas induct earli ifn signal critic confer protect sarscov infect highlight strength combin function genom immunohistochemistri unravel pathogenesi sar
PLoS Biol	15709076	2006-07-26	PMC1945040	17696647	positivestrand rna virus largest genet class virus includ seriou human pathogen positivestrand rna virus replic genom associ intracellular membran rearrang singl doublemembran vesicl exact site rna synthesi crucial topolog relationship relev membran vesicl interior surround lumen cytoplasm gener defin appli electron microscop tomographi complementari approach flock hous viru fhvinfect drosophila cell provid analysi replic complex sole fhv rna replic factor protein fhvspecif bromouridin triphosph incorpor local inner outer mitochondri membran insid nm vesicl spherul fhvinduc compart viral rna synthesi fhv spherul outer mitochondri membran invagin interior connect cytoplasm neck channel nm diamet suffici ribonucleotid import product rna export tomograph biochem impli fhv spherul averag three rna replic intermedi interior membranespan selfinteract protein identifi spherul site protein nascent rna accumul defin spherul topolog dimens stoichiometri reveal natur detail organ function fhv rna replic complex insight appear relev positivestrand rna virus support propos structur evolutionari parallel retroviru doublestrand rna viru virion
Virol J	16873249	2014-11-01	PMC1950496	17598900	background pcrbase detect identif virus assum stabl genom high mutat rate lead extens chang viral nucleic acid sequenc make dedic pcr primer problemat bioterror viral consensu sequenc genet modifi countermeasur rtpcr dna chip detect great develop rapid univers viru detect identif technolog report viral genom dna rna separ host nucleic acid plasma filtrat nucleas digest randomli amplifi singl pcr mixtur primer design resist primerdim amplif vvvvvvvvaa or primer term novel pcr method random multiplex rtpcr hundr overlap pcr amplif occur simultan method successfullydetect partial sequenc separ virus human plasma virusspecif reagent adenoviru type coxsackieviru respiratori syncyti viru method sensit genom equivalentsml repres fastest detect unknown virus conclus studi develop random multiplex rtpcr lead diagnost assai univers detect virus donat blood product patient suffer idiopath diseas state viral etiolog
PLoS Pathog	25483547	2012-10-18	PMC1950948	17722980	understand mechan help promot protect immun respons pathogen major challeng biomed goal design innov therapeut vaccin strategi natur killer nk cell directli contribut control viral replic help orchestr global antivir defens unknown address question advantag welldefin molecular interact involv recognit mous cytomegaloviru mcmv nk cell congen mutant mice wildtyp versu genet engin virus examin consequ antivir cd cell respons specif defect abil nk cell control mcmv system allow demonstr knowledg time nk cell acceler cd cell respons viral infect vivo identifi underli mechan abil nk cell limit ifn product level immunosuppress host achiev earli control cytomegaloviru dramat reduc activ plasmacytoid dendrit cell pdc cytokin product preserv convent dendrit cell cdc compart acceler antivir cd cell respons convers exogen ifn administr resist anim ablat cdc delai cd cell activ face nk cell control viral replic collect data demonstr abil nk cell respond earli cytomegaloviru infect critic contribut balanc intens innat immun respons dampen earli immunopatholog promot optim initi antivir cd cell respons extent nk cell respons benefit host direct antivir effect extend prevent innat cytokin shock promot adapt immun
BMC Mol Biol	23087112	2008-04-02	PMC1976117	17651481	background realtim revers transcriptas quantit polymeras chain reaction realtim rtqpcr accur measur gene express biolog system comparison sampl requir transform data process call normalis refer housekeep gene candid gene select basi constitut express sampl allow quantif chang gene express refer gene identifi organ univers optim tissu type diseas situat microarrai data identifi refer gene gener total rna isol normal osteoarthrit canin articular tissu bone ligament cartilag synovium fat rtqpcr assai design appli articular tissu refer gene express stabil rank compar three mathemat algorithm twelv potenti refer gene identifi microarrai data gene mitochondri ribosom protein mrp stabli express articular tissu evalu gene hira interact protein isoform hirp stabli express tissu evalu commonli refer gene glyceraldehydephosph dehydrogenas gapdh stabli express tissu evalu consist agreement rank order refer gene observ bestkeep genorm method tend agre ident stabli express gene stabli express gene tissu refer gene identifi microarrai data normalis convent manner stabl identifi microarrai data normalis realtim rtqpcr methodolog conclus microarrai data normalis convent manner filter simpl stepwis procedur identifi refer gene will demonstr good measur stabil mitochondri ribosom protein refer gene worthi investig canin tissu diseas method refer gene stabil assess will gener agre stabli express gene coregul present
PLoS One	18385249	2011-10-12	PMC1976596	17895966	bacteri viral upper respiratori infect uri produc highli variabl clinic symptom identifi etiolog agent proper treatment depend correct identif pathogen involv antibiot provid benefit viral infect describ rapid sensit genotyp assai microarrai uri identif standard amplif hybrid techniqu electrochem detect ecd semiconductorbas oligonucleotid microarrai assai develop detect bacteri pathogen bordetella pertussi streptococcu pyogen chlamydia pneumonia mycoplasma pneumonia viral pathogen adenoviru coronaviru oc hk influenza parainfluinza type and respiratori syncyti viru platform form basi fulli autom diagnost system flexibl custom suit addit pathogen multipl probe flexibl platform allow test probe empir select highli reactiv probe iter evalu ecd enzymat reaction creat electr signal read directli arrai imag analysi expens delic optic scan equip assai sensit specif excel multiplex format
PLoS One	21994442	2007-01-01	PMC1989136	17912345	background human rhinovirus hrv preval human pathogen consist serotyp classifi group sequenc variat hrv infect wide spectrum clinic outcom rang asymptomat infect sever lower respiratori symptom defin role specif strain hrv ill difficult tradit serolog requir viral cultur neutral test serotypespecif antisera insensit labori method find directli type hrv nasal secret infant frequent respiratori ill develop sensit molecular type assai base phylogenet comparison bp variabl sequenc noncod region homolog sequenc serotyp nasal sampl infant test multiplex pcr assai respiratori virus hrv common viru sampl type complet sampl hrv identifi surprisingli hrv match serotyp nucleotid diverg nearest refer hrv novel virus strain hrv segreg hrva hrvb human enteroviru distinct genet group strain cultur tradit cell line conclus molecular analysi hrv detect sick infant unrecogn strain includ strain repres hrv group find indic number hrv strain consider larger serotyp identifi tradit diagnost techniqu provid evid hrv group
PLoS One	17200195	2015-02-01	PMC2034598	17957264	the sar coronaviru sarscov spike largest viral spike molecul share function class viral fusion protein previou structur studi membran fusion protein crystallographi static molecular fragment isol transmembran domain studi produc purifi irradi sarscov virion retain morpholog fusogen cell cultur cryoelectron microscopi imag process investig conform chang occur entir spike intact virion bind viral receptor angiotensinconvert enzym ac ac bind structur chang appear initi step viral membran fusion precis local receptorbind fusion core domain entir spike receptor bind subsequ membran fusion distinct step spike bind three ac molecul sarscov spike ideal model system studi receptor bind membran fusion nativ state emploi cryoelectron microscopi singleparticl imag analysi
BMC Genomics	25680079	2007-01-31	PMC2072959	17697331	background develop technolog practic resequ genom bacterium experiment manipul critic accuraci techniqu establish confid mutat detect order evalu accuraci genom resequenc microarraybas compar genom sequenc servic provid nimblegen system resequenc coli strain kohara refer complet sequenc tradit sequenc method cg detect small sequenc differ larg delet element insert detect larg chromosom invers addit confirm cg detect snp delet element insert genom sequenc attribut chang occur creation lambda clone librari fals posit rate snp kb genom sequenc conclus cg effect detect multipl mutat bacterium rel highli costeffect prone error mutat occur repeat sequenc sequenc high degre secondari structur undetect critic follow region interest snp call indic delet element insert
PLoS Med	17267508	2004-10-26	PMC2080649	18031197	indonesia refus share sampl hn viru health organ distress danger global public health argu author
PLoS Med	15507655	2015-12-09	PMC2100141	18052607	the author discuss humor immun respons hiv approach design vaccin induc viral neutral protect antibodi
PLoS Negl Trop Dis	26656704	2017-04-28	PMC2100376	18060089	background despit serious denguerel diseas estim case dengu fever case dengu hemorrhag feverdengu shock syndrom year clear understand dengu pathogenesi remain elus lack diseas model anim complex immun interact dengu infect studi host respons immunopathogenesi difficult develop genom technolog microarrai high throughput quantit pcr allow research studi gene express chang broader scale approach investig host respons dengu virusinfect cell line patient develop dengu fever methodologyprincip find microarrai high throughput quantit pcr method monitor host respons dengu viral replic cell infect model dengu patient blood sampl identifi differenti express gene three major pathwai nfb initi immun respons type interferon ifn ubiquitin proteasom pathwai highli upregul gene chemokin ip itac ligand cxcr receptor increas express ip itac peripher blood ten patient earli onset fever confirm elisa highli upregul gene ifn pathwai viperin overexpress cell reduct viral replic upregul gene ubiquitinproteasom pathwai prompt test proteasom inhibitor alln reduc viral replic conclusionsignific unbias gene express analysi identifi host gene associ dengu infect valid function studi part host respons potenti biomark diseas control dengu viral replic repres viabl target drug therapi
J Immune Based Ther Vaccines	28455446	2012-01-18	PMC2104530	17953756	background clear vaccin therapeut potenti biolog weapon mass destruct emerg diseas anthrax caus bacterium bacillu anthraci biolog warfar agent bioterrorist weapon antibiot therapi effect earli stage anthrax infect expos individu symptomat anthraci exotoxin accumul bipartit exotoxin major contribut factor morbid mortal observ acut anthrax infect method recombin anthraci protect antigen pa coval coupl novel nontox muramyl dipeptid ntmdp deriv hyperimmun goat three time cours week goat plasmapheres igg fraction affin purifi fab deriv character vitro vivo protect lethal toxin mediat intox antipa igg confer protect cell toxin neutral assai mice expos ld bacillu anthraci am spore intranar inocul demonstr surviv postinfect administ singl bolu dose mgkg bodi weight antipa igg post spore challeng antipa fab fragment retain neutral protect level vitro vivo conclus protect afford gmpgrade caprin immunotherapeut postexposur pilot murin model suggest effect treat postexposur symptomat human anthrax patient bioterror event indic recombin pa coupl ntmdp potent induc neutral antibodi promis vaccin candid anthrax eas product eas coval attach immunostimulatori activ ntmdp indic superior adjuv alum tradit adjuv vaccin formul
BMC Evol Biol	22258263	2012-09-26	PMC2110893	17945019	background impact pathogen evolut mammalian immun system debat protein regul immun respons serv cellular receptor pathogen forefront pathogendriven host evolut cea carcinoembryon antigen gene famili code protein tremend speciesspecif variat human rodent cea gene famili lineag placent mammal expect gain insight evolut rapidli diverg cea famili analyz cea famili dog describ complet cea gene famili dog gene code itimbear immunoregulatori molecul ceacam rise expans canin cea gene famili gene duplic human mice murin human ceacam carcinoembryon antigenrel cell adhes molecul secret gpianchor dog ceacam repres itambear transmembran protein protein ceacam exhibit complet sequenc ident ligandbind domain ceacam antagon signal motif cytoplasm tail comparison nonsynonym synonym substitut indic ceacam domain strongest purifi select canin ceacamrel ceacam addit ceacam express pattern rest immun cell tissu ceacam activ ceacam mrna ceacam mrna differenti regul conclus ceacam ceacam pair immun receptor identifi cea gene famili express cell involv finetun cell respons direct gene convers accompani purifi select express immun cell suggest possibl ceacam evolv respons select pressur impos speciesspecif pathogen
J Orthop Surg	23015702	2015-04-29	PMC2146995	17937789	background increas bone marrow lipid deposit steroidassoci osteonecrosi impli abnorm fat metabol plai role develop increas lipid deposit explain elev adipogenesi marrow mesenchym stem cell msc remain unclear close associ elev adipogenesi steroidassoci develop object studi design test hypothesi close associ elev adipogenesi steroidassoci develop method rabbit model induc base establish protocol dynamicmri emploi local intraoss perfus evalu bilater femora week induct bone marrow harvest evalu abil adipogen differenti marrow msc cellular mrna level involv adipogenesisrel gene peroxisom proliferatoractiv receptor gamma ppar bilater femora dissect examin marrow lipid deposit quantifi fat cell number fat cell size lipid deposit area lesion investig associ adipogenesi lipid deposit perfus function regard occurr rabbit divid lesion group lesion group investig associ adipogenesi lipid deposit perfus function regard extens rabbit divid subsingleles group son group lesion submultipleles group mon group lesion local intraoss perfus lower mon group compar son group marrow fat cell number area larger mon group compar son group adipogen differenti abil msc ppar express mon group elev compar son group conclus find support hypothesi close associ elev adipogenesi steroidassoci osteonecrosi develop
Microb Cell Fact	25926649	2017-03-14	PMC2148055	17927824	the yeast saccharomyc cerevisia wellestablish model system understand fundament cellular process relev higher eukaryot organ viru area saccharomyc cerevisia proven fruit review will discuss main achiev yeastbas studi basic appli viru includ analysi function individu protein pathogen virus elucid kei process viral replic develop system allow replic higher eukayot virus yeast yeast antivir drug develop vaccin product
PLoS Pathog	28292961	2011-06-13	PMC2151085	18260686	accord current model retroviru infect receptor bind surfac subunit su envelop glycoprotein env trigger conform chang transmembran subunit tm mediat viru fusion cell membran understand occur investig role receptor tva avian leukosi virusa alva infect find tva bind induc format reactiv thiolat cy cyss su chemic genet inactiv cyss complet abrog alv fusion infect remark cyss mediat isomer sutm disulfid bond requir tvainduc activ tm includ prehairpin associ membran low ph assembl helic bundl find indic contrari current model receptor activ tm suffici alv fusion infect format reactiv thiolat addit receptordepend step
BMC Med Inform Decis Mak	21670307	2017-06-02	PMC2203979	17919318	background time seri method commonli detect diseas outbreak signatur signal influenza outbreak anthrax attack vari respiratoryrel diagnost syndrom data sourc typic involv compon time seri method model baselin background distribut time seri process assum outbreak signatur ii detect outbreak signatur filterbas time seri method method consid time seri model chest radiograph data midwest children emerg depart model incorpor covari patient visit count smooth ambient temperatur seri time seri depend daili weekli season scale respiratoryrel outbreak signatur detect base filter onestepahead predict error time seri model respiratorycomplaint background simul experi base stochast model anthrax attack illustr the choic filter statist model radiographattribut outbreak signatur detect conclus demonstr season autoregress integr averag time seri model sarima covari model respiratoryrel time seri data find homogen time seri model respiratorycomplaint background midwest emerg depart studi simul balanc specif sensit timeli detect outbreak signatur differ emerg depart choic filter linear exponenti filter provid good balanc
BMC Health Serv Res	28574743	2015-12-15	PMC2204002	17999757	background influenza pose concern epidem respiratori infect intervent design prevent spread respiratori infect famili physician fp offic posit influenc health canadian main purpos paper estim explicit cost intervent method cost analysi respiratori infect control conduct cost estim perspect provinci govern addit threshold analysi conduct estim threshold intervent effect gener potenti save term avert healthcar cost intervent exce explicit cost inform requir implicit cost save high element cost hospit event contact influenza number patient pass physician offic pertin point proport infect peopl requir hospit import exist literatur indirect approach calcul threshold uncertain piec reduct probabl infect spread direct result intervent intervent worthwhil week intervent cost amount total prorat length flu season prorat entir calendar year variabl cost incur week project amount particip medic practic fix train cost practic equival week intervent week flu season entir oneyear period conclus base conserv estim direct cost save indic outreach facilit intervent program cost effect achiev reduct probabl infect order percentag point facilit intervent initi tailor environ famili medic practic walkin clinic promis improv respiratori infect control physician offic
PLoS One	26491099	2009-11-01	PMC2204050	18231581	in respons viral infect express numer host gene includ number proinflammatori cytokin chemokin upregul transcript translat level cell infect coronaviru transcript translat gene differenti induc drastic induct express transcript level observ cell infect coronaviru induct gene translat level minim moder investig underli mechan yeast twohybrid screen carri sarscov protein bait reveal subunit eukaryot initi factor eif eiff interact ntermin region sarscov spike protein interact subsequ confirm coimmunoprecipit immunofluoresc stain parallel experi confirm eiff interact protein coronaviru avian coronaviru infecti bronchiti viru ibv interact led inhibit translat report gene in vitro express system intact cell interestingli ibvinfect cell stabli express flagtag eiff higher translat il il suggest interact coronaviru protein eiff plai function role control express host gene gene induc coronaviru infect cycl studi reveal novel mechan exploit coronaviru regul viral pathogenesi
PLoS One	20352075	2008-11-05	PMC2204055	18231585	background heighten increas concern influenza pandem sought better understand influenza pandem devast epidem previou centuri methodologyprincip find data commun maryland usa ship experienc welldocu outbreak influenza likelihoodbas method nonparametr method estim serial interv reproduct number cours outbreak analysi basic reproduct number lower maryland commun enclos popul ship se addition effect reproduct number declin epidem level ship dai commun dai serial interv ship consist se se serial interv commun vari se se conclusionssignific illustr consid popul dynam make statement epidemiolog paramet influenza method emploi estim reproduct number serial interv easili replic popul diseas
Crit Care	18987156	2010-06-01	PMC2206456	17362525	introduct accur time diagnosi communityacquir bacteri infect patient system inflamm remain challeng clinician laboratori combin marker oppos singl improv diagnosi surviv compar diagnost characterist novel routin biomark sepsi combin method prospect cohort studi includ patient system inflammatori respons syndrom suspect communityacquir infect conduct medic emerg depart depart infecti diseas univers hospit multiplex immunoassai measur solubl urokinasetyp plasminogen activ supar solubl trigger receptor express myeloid cell strem macrophag migrat inhibitori factor mif parallel standard measur creactiv protein crp procalcitonin pct neutrophil composit marker construct includ linear combin three best perform marker includ area receiv oper characterist curv auc compar perform individu marker total patient elig analysi bacteri infect auc detect bacteri inflamm confid interv ci supar ci strem ci mif ci pct ci neutrophil count ci crp ci composit threemark test ci composit sixmark test auc sixmark test greater singl marker conclus combin marker improv diagnost accuraci detect bacteri versu nonbacteri inflamm measur supar strem mif limit singl marker pct crp exhibit accept diagnost characterist trial registr nct 
Virol J	20545782	2009-01-22	PMC2216015	18053162	the choic appropri housekeep gene normalis purpos essenti requir design qpcr experi qpcr measur viral cellular gene transcript level context viral infect virus interfer host cell pathwai compon tradit housekeep gene encod studi determin reliabl housekeep gene context heavili studi viral infect human immunodefici viru type herp simplex viru type cytomegaloviru varicella zoster viru infect varieti cell type viru strain research virus shortlist potenti housekeep gene normalis qpcr experi
PLoS One	19053779	2014-03-21	PMC2229842	18286178	the effect collabor tool grow multidisciplinari proteomewid project distribut team common data dispar store separ locat contextu collabor molecular model environ cme interact communitybas collabor system allow research organ visual data twodimension threedimension basi share manag collabor real time cme store industrystandard databas access appropri permiss comput network directori servic anonym internet cme applic web browser system address aspect collabor context manag cme allow research atom structur model imag contextu basi attach share annot specif atom molecul specif region imag annot provid addit atom structur imag data evalu amend project member
Microb Cell Fact	24471431	2016-12-21	PMC2231387	18072968	leptospirosi seriou infect diseas caus pathogen strain leptospira spirochet human anim long expect find effect vaccin prevent leptospirosi immun high risk human anim leptospirosi vaccin vaccin unsuccess clinic applic despit decad million dollar spent review advanc recombin outer membran protein omp vaccin lipopolysaccharid lp vaccin inactiv vaccin attenu vaccin dna vaccin leptospirosi review comparison vaccin lead develop potenti method combat leptospirosi facilit leptospirosi vaccin vaccin ontolog databas built scientist work leptospirosi vaccin start tool
Immunome Res	28003365	2007-08-30	PMC2244602	18179690	background applic peptid base diagnost therapeut mimick protein antigen experienc renew interest select design rational peptid driven tcell epitop predict experiment model structur bcell epitop predict hydrophil plot experi structur ration select peptid product function alter neutral antibodi practic imposs altern antigen reduct requir synthes peptid success candid is central technic interest investig integr bcell epitop predict variabl antigen conserv pattern posttransl modif ptm predict improv state art field applic machinelearn method promis result find protein region lead product function alter antibodi character distinct increas cumul sum three present paramet concept maxim antigen minim variabl minim likelihood posttransl modif identif relev site lead biolog interest observ antigen approach work individu area roc curv aroc valu hand portion reveal equival low aroc valu indic nongaussian distribut third antigen seemingli intang approach exist distinct class bioinformat detect epitop predict separ side studi hand curat dataset valid protect classif base dataset machinelearn method improv predict power class separ equilibr dataset conclus comput method automat select rank peptid stimul protect function alter antibodi integr variabl posttransl modif pattern conserv bcell antigen improv ration select random guess find antigen approach work better dataset protein essenti side method optim presum best applic peptid tend unmodifi invari answer diagnosi treatment pathogen infect addit potenti improv applic machinelearn method random forest
BMC Immunol	17762021	2013-03-27	PMC2245908	18211710	background class major histocompat complex mhc molecul bind cell short peptid deriv intracellular process protein peptid repertoir specif molecul larg extent determin molecular structur accommod socal main anchor posit present peptid receptor extrem polymorph polymorph influenc peptidebind repertoir despit polymorph class molecul cluster set molecul bind overlap peptid repertoir decad ago introduc concept cluster human leukocyt antigen hla allel defin group denomin supertyp basi main anchor specif util origin supertyp classif subsequ arrang deriv demonstr larg number epitop identif studi origin approach report provid updat classif hlaa class allel supertyp analysi incorpor larg amount class mhc bind data sequenc decad result hlaa allel examin assign origin supertyp allel expect associ repertoir overlap multipl supertyp interestingli current analysi identifi addit supertyp specif conclus result updat analysi hla supertyp associ defin hlaa allel expect facilit epitop identif vaccin design studi investig diseas associ correl immun addit approach util transpar allow util classif approach go forward
Retrovirology	23678200	2009-12-09	PMC2248597	18186934	background identifi unusu variant molonei friend ecotrop mous gammaretrovirus alter host rang cytopath cell wild mous speci mu dunni cytopath attribut amino acid substitut critic env residu involv receptor interact sf molonei variant spl sa friend mous leukemia viru fs mlv dunni cell carri variant cat cell surfac viru receptor dcat examin role receptor variant cytopath host rang express dcat mcat nih origin cell infect ecotrop mlv evalu transfect suscept viru infect virusinduc syncytium format dcat transfect mcat transfect suscept virusinduc cytopath cytopath respons accompani accumul unintegr viral dna dcat transfect reproduc rel resist dunni cell molonei mlv mcat transfect rel resist nih cell spl western analysi glycosyl inhibitor mutagenesi remov receptor glycosyl site identifi role cellspecif glycosyl modul viru entri conclus viru entri virusinduc syncytium format cat receptor mediat small number critic amino acid residu receptor viru env viru entri modul glycosyl cellular protein cell virusspecif
BMC Public Health	20007278	2007-10-17	PMC2249581	18201388	background intern concern emerg infecti diseas eid bioterrorist attack public health requir earli outbreak detect system diseas surveil team organ establish hospit emerg departmentbas syndrom surveil system edsss capabl automat transmit patient data electron hospit respons emerg care countri center diseas control taiwan taiwancdc start march report describ challeng step involv develop edsss time improv public health decisionmak method june march compar surveil system consult physician pediatrician intern medicin physician involv infecti diseas control syndrom surveil team taiwan work realtim outbreak diseas surveil rod laboratori univers pittsburgh creat taiwan edsss system evalu analyz daili electron data receiv realtim hospit particip system april march taiwan edsss identifi winter summer spike syndrom group influenzalik ill respiratori syndrom ill total number visit higher weekend nation holidai dai chines lunar year weekdai identifi increas upper lower total gastrointestin gi syndrom group start novemb clear spike enteroviruslik infect coincid school semest edsss surveil influenzalik ill enterovirusesrel infect improv taiwan pandem flu prepared diseas control capabl conclus taiwan edsss repres nationwid realtim syndrom surveil system establish asia experi report encourag countri develop surveil system system adapt cultur languag environ better global surveil infecti diseas intern collabor
Respir Res	17942560	2018-12-13	PMC2253533	18234086	background tnf contribut pathophysiolog airwai inflamm exampl nasal administr tnf produc late phase coappear granulocyt plasma exud marker mucos surfac object studi examin indic granulocyt presenc activ respons intranas tnf challeng method healthi subject patient allerg rhiniti examin season subject nasal challeng tnf shamcontrol crossov design nasal lavag carri prior hour post challeng nasal biopsi post challeng nasal lavag fluid level myeloperoxidas mpo eosinophil cation protein ecp analyz indic neutrophil eosinophil activ il macroglobulin analyz marker proinflammatori cytokin product plasma exud nasal biopsi number neutrophil eosinophil monitor nasal lavag fluid level mpo record hour post tnf challeng increas healthi subject patient allerg rhiniti cf sham challeng macroglobulin increas healthi subject patient allerg rhiniti lavag fluid level ecp il tnf challeng tnf increas number subepitheli neutrophil number eosinophil conclus tnf produc nasal inflammatori respons human characteris late phase hour post challeng neutrophil activ plasma exud
BMC Genomics	30545855	2012-11-19	PMC2254600	18179705	background emerg health threat zoonot origin overwhelm major caus agent rna virus includ limit hiv influenza sar ebola dengu hantaviru increas better understand global viral divers enabl better surveil predict pandem threat will requir rapid flexibl method complet viral genom sequenc adapt sispa methodolog genom sequenc rna dna virus demonstr util method type sourc virus obtain complet genom sequenc virus rang size kb median depth coverag techniqu gener full viral genom sequenc presenc host contamin viral prepar cell cultur supernat allanto fluid fecal matter conclus method describ great util gener genom assembl virus sequenc virus greatli diverg famili uncharacter virus fulli describ mix viral infect
Mol Vis	23166232	2011-03-01	PMC2254967	18334931	purpos human endonucleas integr apoptosi unwant harm cell elimin rapid turnov ocular surfac epithelium microbi colon eyelid continu sourc dna tear determin princip sourc endonucleas activ tear method endonucleas human tear identifi sephadex gel filtrat dna hydrolyz activ measur convers puc plasmid dna circular form agaros gel fraction endonucleas activ isol combin conasepharos dna oligo dt cellulos anion exchang chromatographi molecular weight dna hydrolyz protein estim zymogram calibr size exclus chromatographi dnase activ character activ varieti ph ion concentr presenc inhibitor includ nicl zncl gactin aurintricarboxyl acid ata determin mode hydrolysi cleav end dna digest tear dnase analyz label termin deoxynucleotidyl transferas polynucleotid kinas pretreat alkalin phosphatas tear lipocalin tl account dna catalyt activ tear second endonucleas kda respons activ depend enzym endonucleas enhanc activ physiolog ph inhibit aurintricarboxyl acid catalyz hydrolysi dna produc ohp end enzym distinguish inhibitori nicl size cleav dna fragment conclus magnesium depend extracellular endonucleas identifi tear major human extracellular nucleas tl princip endonucleas human tear fluid tear endonucleas uniqu characterist differ human endonucleas
BMC Public Health	20732424	2012-02-08	PMC2258284	18234083	background grow epidem emerg infecti diseas rais set approach includ health promot school hp framework promot better health hygien built concept hp framework hong kong healthi school award scheme includ person health skill kei aspect improv student hygien knowledg practic studi examin differ student percept knowledg health behaviour school adopt hp framework adopt method crosssect studi multistag random sampl conduct school award hsa school involv award scheme adopt concept hp nonhp hsa group primari school secondari school enter studi student student sampl nonhp group primari school secondari school enter studi student student sampl selfadminist questionnair measur instrument student hsa categori better statist signific person hygien practic knowledg health hygien access health hsa school report better school health polici higher degre commun particip better hygien environ conclus student school adopt hp framework posit health behaviour profil nonhp school causal relationship establish hp appear viabl approach address communic diseas
BMC Bioinformatics	22318146	2019-09-01	PMC2259420	18315850	background tcell epitop promiscu bind multipl allel human leukocyt antigen hla supertyp prime target develop vaccin immunotherapi relev larg proport human popul presenc cluster promiscu tcell epitop immunolog hotspot observ antigen cluster exploit facilit develop epitopebas vaccin select small number hotspot elicit requir tcell activ function larg size pathogen proteom includ variant strain comput tool autom screen select immunolog hotspot hotspot hunter webbas comput system largescal screen select candid immunolog hotspot pathogen proteom analysi antigen divers allow screen select hotspot specif common hla supertyp hla class a class ii dr system artifici neural network support vector machin method predict engin soft comput principl emploi integr predict produc method robust predict perform experiment valid predict hotspot hunter identifi major real hotspot user predict hotspot singl protein sequenc set align protein sequenc repres pathogen proteom featur global view local hotspot proteom set enabl analysi antigen divers shift hotspot protein variant system allow integr predict supertyp identif hotspot common multipl supertyp target select featur system shortlist candid peptid hotspot formul epitopebas vaccin effect multipl variant pathogen applic larg proport human popul conclus hotspot hunter publicli access gener comput tool aid epitopebas vaccin design
Virol J	31700931	2016-03-01	PMC2263041	18218114	background speci flaviviru genu pose public health problem increas case dengu japanes enceph viru asia frequent outbreak yellow fever viru africa south america ongo spread west nile viru america geograph burden flaviviru diseas flaviviru infect indistinct confus febril ill review specif publish primer describ univers primer pair detect wide rang flavivirus includ virus recognis subgroup bioinformat analysi publish fulllength flaviviru genom reveal conserv region target primer degener primer flavf flavr design region gener base pair cdna product region amplifi encod methyltransferas rnadependentrnapolymeras ns code sequenc onestep rtpcr test success standard condit rna flaviviru strain repres speci cdna viru isol sequenc phylogenet analys databas search confirm ident templat rna conclus comprehens test reveal broad specif primer discuss advantag univers primer
PLoS One	26803471	2017-02-09	PMC2263130	18350167	background cytotox cell ctl crossreact believ plai pivot role gener immun respons extent mechan ctl crossreact remain unknown studi ctl clone recogn highli divers peptid share obviou sequenc ident emerg realiz field cell receptor tcr recogn multipl distinct ligand princip find analyz peptid scan hiv epitop slfntvatl sfl tcr specif posit depend biochem amino acid substitut drastic affect recognit inspir develop gener model tcr peptid recognit amino acid similar matric model predict crossreact divers set ctl epitop model demonstr seemingli distinct cell epitop low sequenc ident fact biochem expect addition analysi hiv immunogen data model ctl tendenc respond peptid resembl selfantigen conclus cell crossreact extent greater earlier appreci explain amino acid similar present paper will help resolv longlast discuss field cell crossreact
Respir Res	28177862	2014-03-13	PMC2266731	18215329	background acut respiratori ill ari childhood caus respiratori virus result morbid associ cost famili societi despit ubiqu lack interdisciplinari epidemiolog econom collect primari impact data associ indirect cost famili ari children method conduct month cohort studi preschool children impact diari record pcr test nosethroat swab virus ari appli valu estim virusspecif cost ari impact diari communitymanag ill januari januari cost ari au confid interv influenza ill cost compar rsv expens singleviru ill confid interv overlap carer time usual activ dai hour influenza ari minut ari categori conclus societ perspect communitymanag ari cost burden famili societi point estim cost communitymanag influenza ill healthi preschool ag children three time greater ill caus rsv respiratori virus indirect cost carer time usual activ kei cost driver ari children parentcollect specimen enhanc ari surveil reduc potenti hawthorn caus complianc studi procedur find reinforc integr epidemiolog econom ari children allow comprehens costeffect assess prevent therapeut option
PLoS One	24627473	2016-03-11	PMC2266793	18350141	background common cold questionnair ccq discrimin viral infect peopl acut asthma unknown aim assess abil ccq detect viral infect monitor recoveri viral induc asthma exacerb confirm virolog test methodologyprincip find studi subject yr admit hospit acut asthma diagnos posit neg viral infect molecular virolog test respiratori sampl ccq asthma histori asthma control questionnair complet repeat week sensit specif respons chang ccq assess receiv oper curv roc analysi size calcul ccq discrimin viral nonvir infect subject asthma sensit specif roc analysi differenti posit neg viru subject asthma ccq larg respons chang recoveri size subject recov viral exacerb remain posit virolog test followup despit improv clinic symptom ccq reflect clinic improv subject provid addit complement virolog test conclusionssignific ccq instrument monitor respons viral infect peopl asthma reliabl differenti viral nonvir asthma exacerb achiev ccq requir specif virolog test combin virolog test ccq outcom measur evalu therapi viralinduc asthma
PLoS Pathog	26969707	2012-06-27	PMC2267009	18369467	the reoviru fusionassoci small transmembran fast protein function virusencod cellular fusogen mediat effici cellcel viruscel membran fusion ectodomain residu unclear diminut viral fusion protein mediat initi stage membran contact close membran apposit fusion reaction preced actual membran merger fast protein lack specif receptorbind activ natur biolog context promot cellcel fusion reli cadherin promot close membran apposit fast protein reliant cadherin engag mediat membran apposit indic abil effici util adhesin fusion reaction indic surrog adhes protein bridg membran close nm apart enhanc fast proteininduc cellcel fusion activ actin remodel requir maxim fusion activ fast protein exampl membran fusion protein evolv function opportunist fusogen design exploit convert natur occur adhes site fusion site capac surrog noncogn adhesin activ actin remodel enhanc cellcel fusion activ fast protein featur perfectli suit structur function evolut fusogen minim fusion compon virusencod cellular fusion machin provid basi reconcil rudimentari structur fast protein capac fuse cellular membran
BMC Biol	22745375	2018-09-05	PMC2267159	18197965	background studi organ interact fusion domain fusion peptid fp transmembran domain tmd influenza viru envelop glycoprotein role membran fusion essenti cellular traffick biomolecul spermegg fusion fluoresc gel electrophoresi experi reveal tight selfassembl tmd model membran weak nonrandom interact tmd fp membran complex central tmd oligom pack fp antiparallel fashion fp insert membran alter bind tmd infrar studi exhibit enhanc membran perturb complex format model built illustr role tmd late stage influenza virusmedi membran fusion reaction conclus tmd oligom anchor fusion protein membran minim destabil membran associ fp complex exert synergist membran perturb contribut complet membran fusion late phase fusion proteininduc fusion cascad present work character natur interact tmd membran tmd complex fp step lead pore initi dilat virusinduc fusion data propos fusion model highlight kei role tmdfp interact implic fusion reaction mediat type viral fusion protein understand molecular mechan membran fusion assist design antivir drug
PLoS One	30185587	2016-07-24	PMC2268738	18382652	background human rhinovirus hrv frequent detect pathogen acut respiratori tract infect arti preval recurr structur clinic impact individu member complet code sequenc unknown highli diverg hrv strain report catalogu molecular clinic featur distinguish diverg hrv strain undertook time silico analys polyprotein sequenc perform retrospect review medic record case variant prototyp strain hrvqpm detect methodologyprincipl find genom analys reveal diverg strain resid clade call hrv shortest polyprotein picornavirus investig structurebas amino acid align identifi conserv motif share member genu rhinoviru substant delet insert uniqu diverg strain delet region encod protein tradition involv antigen serv hrv hev receptor footprint hrv strain cultur creat homolog model predict hrvqpm structur protein silico comparison confirm hrvqpm close major group hrv hrvqpm frequent detect infant expiratori wheez persist cough admit hospit requir supplement oxygen viru detect posit individu observ contribut object clinic impact rang mild sever conclus diverg strain meet classif requir exist speci genu rhinoviru enteroviru hrv strain partit speci put call human rhinoviru popul member detect high frequenc individu respiratori symptom requir hospit admiss
Clin Dev Immunol	27439538	2012-01-01	PMC2270750	17162377	human immunodefici viru hiv infect repres major health threat develop costli treatment infect individu multipl highli effici antihiv drug afford industri countri effici vaccin strategi requir prevent spread infect molecular biologi coronavirus featur human coronaviru hcov indic hcov ebas vaccin vector class highli effici vaccin receptor hcov human aminopeptidas hapn cd express human dendrit cell dc macrophag indic target hcov ebas vector profession antigen present cell achiev receptormedi transduct second hcov structur gene replac multipl transcript unit encod antigen viruslik particl vlp hcov ebas vector rna abil transduc human dc mediat heterolog gene express cell final coronaviru infect associ respiratori enter diseas natur transmiss coronavirus occur mucos surfac human hcov common cold infect upper respiratori tract hcov infect encount children reinfect occur frequent adult preexist immun hcov will impact vaccin effici hcov ebas vector human
Virol J	22027386	2017-11-29	PMC2270820	18269761	background enter caus spectrum virus fulli characteris test stool sampl cell cultur viru isol type current method studi vidisca viru identif method appli untyp viru isol human parechoviru hpev type strain design bnist genom contemporari hpev determin complet genom sequenc novel strain result recombin structur protein gene ancestor contemporari hpev strain nonstructur protein gene unknown ancestor close hpev contrast nonstructur protein gene hpev prototyp strain nonstructur protein gene bnist hpev prototyp strain cosegreg bootscan analysi prototyp strain conclus hpev nonstructur protein gene form distinct element pool circul hpev nonstructur protein gene complex hpev evolut requir connect viru ecolog diseas pattern human
BMC Genomics	29187543	2015-02-25	PMC2270836	18251995	background felin immunodefici viru fiv natur infect multipl speci cat human immunodefici viru human fiv infect aidslik diseas mortal domest cat feli catu serv natur model hiv infect human african lion panthera leo exot felid speci diseas etiolog introduc fiv infect clear studi indic fiv moder sever cd deplet studi compar genom method evalu full provir genom geograph distinct fiv subtyp isol freerang lion genom organ fivpl subtyp bp lion serengeti nation park tanzania fivpl subtyp bp isol lion okavango delta botswana resembl fiv genom sequenc puma palla cat domest cat ltr gag pol vif orfa env rev ltr region compar analys fulllength fiv consist subtyp fivfca palla cat fivoma puma fivpco subtyp recapitul speciesspecif monophyli fiv mark high level genet divers speci fivpl gene region env lion subtyp monophylet margin palla cat fivoma fiv sequenc analys indic su tm region env vari subtyp fivpl subtyp domest cat fivfca fivpl subtyp fivoma reflect recombin strain wild conclus studi demonstr necess wholegenom analysi complement populationgenebas studi limit util uncov complex event recombin lead function differ virul pathogen fulllength lion lentivirus integr advanc compar genom human pathogen emerg diseas wild popul endang speci
Source Code Biol Med	25717099	2016-12-01	PMC2275240	18302744	background construct complex spatial simul model network epidemiolog daunt task larg amount data involv parameter data frequent resid larg georeferenc databas process assign compon model construct model simul analyz epidemiolog scenario workflow achiev effici comput tool autom timeconsum task paper simul softwar epigrass aim help design simul networkepidem model kind node behavior network epidemiolog model repres spread directli transmit diseas bustransport network connect midsiz citi brazil topolog context start point epidem great control prevent perspect conclus epigrass facilit greatli construct simul analysi complex network model output model standard gi file format facilit postprocess analysi sophist gi softwar
Dev Immunol	27552081	2010-01-01	PMC2276095	12739787	primari biliari cirrhosi pbc autoimmun diseas character intrahepat bile duct destruct product antimitochondri antibodi ama absenc anim model strike imped defin molecular basi diseas previou work suggest sjlj mice immun pyruv dehydrogenas complex pdce major mitochondri autoantigen pbc lead develop lymphoid cell infiltr portal tract model system coin autoimmun cholang hypothes patholog augment immun occur presenc ifn inject sjlj mice immun pdce purpos control casein subgroup mice treat exogen ifn expect mice immun pdce ifn develop high titer ama contrast mice immun casein develop antinuclear antibodi importantli liver mice immun pdce andor immun casein displai lymphoid cell infiltr portal tract irrespect bile duct size differ experiment control group histolog analysi autoimmun cholang mice antigen nonspecif
Dev Immunol	20933203	2011-05-01	PMC2276106	12885151	the plagu board health fear enter german troop milanes enter likewis paus invad ravag great itali manzoni bethroth 
Virol J	21531955	2012-04-01	PMC2276200	18267012	background la cross viru lacv famili bunyavirida identifi human pathogen isol yearold girl fatal enceph la cross wisconsin lacv major pediatr enceph north america infect person year result sever diseas central nervou system cn initi step establish anim model support vaccin develop examin lacv infect pathogenesi immunogen weanl mice rhesu monkei intraperiton inocul mice lacv replic organ reach cn replic high titer caus death neurolog diseas peripher site lacv replic highest titer nasal turbin presum lacv enter cn olfactori neuron nasal olfactori epithelium mous infecti dose lethal dose lacv administ intranas intraperiton lacv highli infecti rhesu monkei infect anim pfu infect asymptomat monkei develop strong neutral antibodi respons conclus mice lacv gain access cn blood stream olfactori neuron abil effici infect mice intranas rais possibl lacv rout infect natur host rhesu monkei suscept lacv infect develop strong neutral antibodi respons inocul pfu mice rhesu monkei anim model lacv vaccin immunolog test rhesu monkei model optim
Virol J	22349524	2007-04-01	PMC2288602	18282283	background member baculovirida encod type protein mediat viruscel membran fusion penetr host cell align primari amino acid sequenc indic baculoviru fusion protein group nucleopolyhedrovirus npv form gp superfamili structur viral penetren determin gp superfamili includ glycoprotein gp encod member thogotoviru genu orthomyxovirida entri protein baculovirus group ii npv granulovirus class penetren class iii penetren encod member rhabdovirida herpesvirida intern fusion domain compris beta sheet beta sheet domain extend alpha helic domain membran proxim stem domain carboxyl termin anchor sequenc structuralfunct motif character class iii penetren locat collinearli gp group baculovirus glycoprotein encod thogotovirus structur model base prototyp class iii penetren vesicular stomat viru glycoprotein vsv establish thogoto viru thov gp autographa california multipl npv acmnpv gp demonstr feasibl cystein linkag glycosyl site thov gp acmnpv gp appear model locat glycosyl site vsv conclus protein gp superfamili class iii penetren
PLoS One	17413076	2007-06-20	PMC2288676	18414668	background interleukin il describ proinflammatori cytokin report induc bacteria treatment cultur cell il product exogen pathogen infect human individu method find studi il level increas serum sampl cohort patient infect influenza viru compar healthi individu proinflammatori factor cyclooxygenas coxassoci prostaglandin upregul fold express il influenza viru infect human lung epitheli cell block select cox inhibitor ns aspirin antiinflammatori drug indic il induc cox inflammatori cascad interestingli coxassoci pge product activ influenza viru infect suppress overexpress il increas ilspecif sirna suggest feedback mechan il cox conclus il induc influenza viru infect cox inflammatori cascad provid il potenti target antiinflammatori medicin screen
Immun Ageing	26468537	2007-11-14	PMC2291031	18289372	background safeti immunogen mfadjuv subunit influenza vaccin submf fluad novarti vaccin evalu elderli chines subject year ag preliminari phase openlabel studi assess safeti dai postvaccin compar observerblind randomis control clinic trial perform assess safeti immunogen versu nonadjuv subunit influenza vaccin subunit agripp novarti vaccin subject randomis receiv submf subunit vaccin toler vaccinerel seriou advers event report phase trial observerblind studi local system reaction gener vaccin dai postvaccin injectionsit indur frequent subunit group mild pain inject site fever frequent submf recipi vaccin induc increas geometr titr gmt three strain test versu baselin gmt ahn ahn higher submf group p gmt ratio ahn ahn higher submf group p percentag subject achiev seroprotect seroconvers dai greater submf recipi reach signific ahn conclus mfadjuv subunit influenza vaccin toler elderli chines subject induc higher level immunogen nonadjuv subunit influenza vaccin popul high risk influenzarel complic clinic trial registri nct
BMC Infect Dis	18003804	2014-06-30	PMC2291466	18312678	background host genet factor plai role occurr progress sarscov infect studi investig relationship tumor necrosi factor tnf gene polymorph occurr sarscov infect role prognosi patient lung interstiti fibrosi femor head osteonecrosi method associ genet polymorph tnf gene suscept sever acut respiratori syndrom sar conduct hospitalbas casecontrol studi includ sar patient health care worker healthi control relationship tnf gene polymorph interstiti lung fibrosi femor head osteonecrosi carri casecas studi discharg sar patient pcr sequenc base type pcrsbt method determin polymorph tnf gene locu promot region univari logist analysi conduct analyz collect data compar tt genotyp ct genotyp locu associ protect sar orci tt genotyp ct cc associ risk femor head necrosi orsci glucocorticoid adjust ct ci combin ct cc genotyp ci site tnf gene time ac genotyp manifest risk associ femor head necrosi orci adjust ci cure sar patient compar cc genotyp conclus snp tnf gene promot region associ sarscov infect snp affect interstiti lung fibrosi cure sar patient ctcc ac genotyp risk factor femor head necrosi discharg sar patient
BMC Infect Dis	27591245	2018-01-17	PMC2292190	18307785	background hepat ha lowincid nonendem diseas canada unit state larg differ ha incid canada haendem countri travel contributor hepat preval canada smaller incid differenti canada us moder higher ha incid volum travel canadian time higher travel volum endem countri travel constitut sourc low moder risk canadian travel knowledg travel includ potenti risk factor ha infect canadian epidemiolog analys object studi dynam model investig effect hepat incid canada implement vaccin vari volum travel canadian method develop analyz agestructur compartment model transmiss vaccin hepat canada model parameter data seropreval case report travel pattern potenti hepat preval hepat preval canada captur term repres infect canadian travel model suggest ha case canada mid attribut travel univers vaccin programm attain coverag young children mid reduc canadian incid year conclus data parameter model consid exploratori analysi plausibl assumpt determin ha preval canada current suppos intern travel continu grow make vaccin polici relev popul countri border multicountri model will wider predict aid polici develop
BMC Biotechnol	29343585	2013-07-08	PMC2315644	18371201	background describ technic solut optim pichia pastori shake flask cultur exampl product stabl human type ii collagen product recombin protein pastori perform control gene express strong aox promot induc addit methanol optim process aox promot pastori gener bioreactor fedbatch ferment control continu addit methanol avoid methanol toxif carbonenergi starvat develop feed protocol studi aoxcontrol recombin protein product shake flask shake flask limit possibl measur control appli onlin po monitor demonstr puls feed methanol long phase methanol exhaust consequ low express aox control gene provid solut appli fedbatch strategi shake flask present solut appli wireless feed unit flexibl posit allow computercontrol feed profil human collagen ii exampl quasicontinu feed profil simplest fedbatch ferment higher product level human collagen ii product higher proteolyt stabil compar control cultur increas express human collagen prolyl hydroxylas monitor mrna protein level conclus recommend standard protocol methanol addit shake flask puls feed nonoptim lead repeat long phase methanol starvat problem solv appli fedbatch technolog present wireless feed unit onlin monitor system offer flexibl simpl lowcost solut initi optim product shake flask perform parallel fedbatch strategi appli earli screen step laboratori access highcost complic bioreactor system
PLoS Pathog	23964302	2019-01-01	PMC2322833	18451981	sarscoronaviru sarscov replic transcript mediat replicationtranscript complex rtc virusencod nonstructur protein nsp primari constitu sarscov nsp produc autoprocess larg precursor polyprotein rtc believ associ characterist virusinduc doublemembran structur cytoplasm sarscovinfect cell investig link structur viral rna synthesi dissect rtc organ function isol activ rtc infect cell develop robust assai vitro activ synthesi genom rna subgenom mrna faithfulli reproduc rtc vitro system positivestrand rna synthes protein synthesi requir rtc activ vitro rtc activ enzymat put membranespan nsp viral rna cosedi heavi membran structur pellet rtc requir addit cytoplasm host factor reconstitut vitro activ newli synthes subgenom rna appear releas genom rna remain associ rtccontain fraction rtc activ destroi deterg treatment suggest role membran rtc appear protect membran newli synthes viral rna replicasetranscriptas subunit proteas nucleaseresist suscept degrad addit nonion deterg data establish vital function depend sarscov rna synthesi virusinduc membran structur
BMC Bioinformatics	30850053	2010-06-23	PMC2322988	18366693	background hierarch cluster tree hct dendrogram singular decomposit svd dimensionreduc repres map popular method twowai sort genebyarrai matrix map emploi gene express profil hct dendrogram tend optim local coher cluster pattern svd lead eigenvector identifi better global group transit structur studi propos flip mechan convent agglom hct ranktwo ellips improv svd algorithm sort purpos seriat chen extern refer hct produc permut good local behaviour ranktwo ellips seriat best global group pattern smooth transit trend algorithm automat integr desir properti method user access cluster visual environ gene express profil preserv coher local cluster identifi global group trend conclus demonstr exampl propos method possess better numer statist properti meaning biomed insight sort algorithm sort proxim matric gene arrai addit genebyarrai express matrix greatli aid search comprehens understand gene express structur softwar propos method 
BMC Bioinformatics	17768509	2013-08-01	PMC2335115	18366721	background larg number thesauri biomed domain lack coverag term variant form automat thesauru construct base pattern suggest hearst clear automat construct pattern semant relat domain pattern captur synonymi assumpt extant resourc parser limit factor languag desir find pattern syntact analysi final consist applic result desir pattern form synonym set sound method automat gener regular express pattern expand seed pattern heurist search develop featur vector base occurr term pair develop pattern allow binari classif term pair synonym nonsynonym model result probabl graph find synonym set equival wellstudi problem find optim set cover achiev precis recal method outperform handmad resourc mesh wikipedia conclus conclud automat method plai practic role develop thesauri expand exist small amount train data resourc parser conclud accuraci improv group synonym set
BMC Biotechnol	23767796	2017-04-05	PMC2362111	18384691	background exon skip oligonucleotid eso omethyl om morpholino chemistri restor dystrophin express muscl fiber mdx mous current test phase clinic trial duchenn muscular dystrophi dmd eso remain limit effect inadequ deliveri profil synthet cation copolym polyethylen imin pei polyethylen glycol peg regard effect agent enhanc deliveri nucleic acid applic examin pegpei copolym facilit esomedi dystrophin express intramuscular inject tibiali anterior ta muscl mdx mice util set pegpei copolym kda pei kda peg bind om eso high affin form stabl nanoparticul low surfac charg three weekli intramuscular inject of eso complex peikpeg copolym dystrophinposit fiber normal level dystrophin express week initi inject greater inject eso complet ineffect effort enhanc biocompat cellular uptak peikpeg peikpegk copolym function coval conjug nanogold ng adsorbt colloid gold cg surprisingli inject dose regimen differ dystrophin express western blot ngpeikpeg cgpeikpegk nonfunction peikpeg copolym doserespons experi cgpeikpegk copolym total eso rang yield maximum dystrophin express improv dystrophin express normal level week twiceweekli inject ngpeikpeg copolym complex eso inject inject dose regimen dystrophinposit fiber stain treat muscl group reveal overt sign cytotox conclus conclud pegyl peik copolym effici carrier local deliveri om eso warrant develop potenti therapeut treatment dmd
PLoS One	28381581	2009-09-01	PMC2364642	18478070	background jena viru jv bovin noroviru enter diseas cattl repres potenti model studi enter noroviru infect pathogenesi posit sens rna genom jv organis orf nonstructur protein orf major capsid protein orf minor capsid protein lack cell cultur system studi jv replic meant work reli vitro system studi nonstructur protein synthesi process princip find three major orf protein identifi vitro translat jv rna nterm protein detect nterm encod genom sequenc gs test ireslik function bicistron system displai evid ireslik activ site translat initi jv determin predict nucleotid insert epitop gs jv nterm protein identifi vitro rna transfect cell conclus vitro transcriptiontransl system current best system analys protein synthesi process jv studi human norovirus jv initi appear express ntermin protein present possibl encod rna sequenc regulatori function involv translat initi ireslik manner case determin site translat initi nterm protein detect epitop tag vitro vivo larger predict nterm protein detect process form vivo demonstr initi translat orf polyprotein activ viral proteas find indic block norovir replic cultur cell li elsewher
PLoS One	19501622	2009-05-06	PMC2367437	18478121	background cytokin plai role antivir action examin polymorph interleukin il receptor ilrb affect suscept outcom sever acut respiratori syndrom sar method casecontrol studi carri chines sar patient healthi control genotyp snp il rb gene agtc gc ct determin pcrrflp haplotyp estim genotyp data expectationmaximis algorithm comparison patient close contact individu ct ct tt genotyp fold confid interv ci fold ci increas risk develop sar three polymorph differ detect allel genotyp frequenc patient control addition estim frequenc multiplelocu haplotyp reveal potenti risk haplotyp gcct sar infect conclus data indic genet variant ilrbconf genet suscept sar infect associ progress diseas chines popul
Genome Biol	19420084	2013-05-10	PMC2375028	17868443	dna microarrai offer possibl test presenc thousand microorgan singl experi lack reliabl bioinformat tool analysi data develop detectiv packag statist softwar detectiv offer power simpl visual normal signific test tool detectiv perform better publish softwar larg publicli dataset
PLoS Pathog	23667257	2014-10-01	PMC2376094	18516228	throughout process pathogenhost coevolut virus develop batteri distinct strategi overcom biochem immunolog defens host virus acquir capac subvert host cell apoptosi control inflammatori respons evad immun reaction elimin infect cell program cell death ancestr defens mechan infect disabl host cell apoptosi repres oblig step viral life cycl convers virus advantag stimul apoptosi kill uninfect cell immun system induc breakdown infect cell favor viral dissemin viral polypeptid homolog hostderiv apoptosisregulatori protein member bcl famili viral factor homolog host protein target kei compon apoptot machineri summar current knowledg viral modul mitochondri apoptosi focus mechan viral protein control host cell death apparatu
PLoS One	24747011	2019-08-13	PMC2386233	18509464	background footandmouth diseas fmd highli contagi diseas livestock sever econom loss suscept clovenhoof anim tradit inactiv vaccin prove effect lead outbreak fmd incomplet inactiv fmdv escap live viru vaccin product workshop urgent develop novel fmdv vaccin safer effect econom tradit vaccin methodolog princip find recombin silkworm baculoviru bmpac contain intact pa proteas code region fmdv asia hnkcha develop indirect immunofluoresc test sandwichelisa verifi bmpac express target cassett express product silkworm dilut fold antigen immun cattl specif antibodi induc vaccin anim challeng virul homolog viru anim complet protect clinic symptom allevi delai remain pd bovin protect dose test perform assess bovin potenc subunit vaccin result subunit vaccin achiev pd dose conclus strategi develop subunit fmdv vaccin
Int J Health Geogr	31409714	2015-06-10	PMC2386448	18402711	background earli detect diseas outbreak enabl public health offici implement diseas control prevent measur earliest time time period geograph diseas surveil system base cylindr spacetim scan statist extens diseas surveil satscan softwar pure spatial set method propos detect spatial diseas cluster spatial scan statist aim detect irregularli shape cluster detect circular spatial scan statist base flexibl pure spatial scan statist propos flexibl shape spacetim scan statist earli detect diseas outbreak perform propos spacetim scan statist compar cylindr scan statist benchmark data order compar perform develop spacetim power distribut extend pure spatial bivari power distribut daili syndrom surveil data massachusett usa illustr propos test statist conclus flexibl spacetim scan statist suit detect monitor diseas outbreak irregularli shape area
J R Soc Interface	26063435	2010-06-01	PMC2386895	18055417	in network node preferenti contact node assort mix dissimilar disassort mix number contact pattern contact support epidem dynam efficaci control measur contact trace aim identifi isol node infecti contact stochast simul investig effect mix pattern epidem dynam contacttrac efficaci uncontrol epidem outbreak occur lower infect rate assort mix network faster initi epidem growth rate shorter epidem durat disassort mix network contact trace perform better assort mix epidem size larg trace rate low perform better disassort mix higher contact rate assort mix network diseas spread highli connect node balanc contact trace identifi node convers true disassort mix diseas trace target highli connect node small epidem contact trace effect disassort network greater resili assort network link remov multistep contact trace effect singlestep trace assort mix smaller disassort mix network
PLoS One	23637477	2012-10-02	PMC2386973	18509538	background primari health care gener practic will frontlin respons pandem influenza framework guid systemat plan task apprais plan relev gener practic aim develop framework will facilit plan gener practic apprais pandem plan australia england usa zealand canada methodologyprincip find adapt haddon matrix develop framework popul cell multimethod studi incorpor peerreview grei literatur interview gener practition practic nurs senior decisionmak desktop simul exercis framework analys publiclyavail jurisdict plan manageri level countri framework identifi function domain clinic care influenza public health respons intern environ macroenviron gener practic plan address domain plan ignor sketchi noninfluenza clinic contribut gener practic public health surveil collabor gener practic address plan interrelationship broader health system frequent conclus studi provid framework guid gener practic plan pandem influenza framework help identifi critic shortcom plan engag gener practic effect plan challeng govern structur primari health care weak identifi implic practic research
BMC Genomics	23003343	2004-04-08	PMC2387173	18423000	background infecti salmon anemia viru isav multisystem diseas respons sever loss salmon aquacultur better understand factor explain variat resist individu famili essenti develop strategi diseas control approach compar global gene express microarrai fish dy earli late time cours infect highli pathogen isav tissu gill heart liver spleen infect atlant salmon cohabit isav glesvaer isol collect three stage time cours experi earli em cumul mortal cm dai postinfect dpi intermedi cm dpi late lm cm dpi mortal viral load equal em drop markedli lm fish gene express analys salmonid fish cdna microarrai sfa realtim qpcr reveal larg group gene highli upregul tissu em implic innat antivir respons cellular stress despit equal level mhc class em lm increas splenic cardiac express immunoglobulinlik gene lm suit adapt immun marker activ hepat respons isav character differ em lm express chaperon gene involv eicosanoid metabol develop classif high low resist phenotyp base small number gene process qpcr analys liver linear discrimin analysi gene lipoxygenas activ protein cytochrom galectin annexin suffici correct assign individu em lm uninfect group insepar em three prognost marker involv metabol inflammatori regul conclus studi add understand molecular determin resist acut isav infect suscept individu character high viral replic dramat activ innat immun respons provid protect abil endur high level infect sustain period associ lower inflammatori respons subsequ protect viral clearanc confer activ adapt immun
PLoS Pathog	15073334	2012-02-27	PMC2390764	18535660	virion thought essenti protein govern viru egress host cell initi replic target cell time influenza virion viral protein analys envelop virus reveal protein host cell detect virion address true influenza viru complementari mass spectrometri approach perform comprehens proteom analysi purifi influenza viru particl addit aforement virusencod protein detect presenc hostencod protein includ cytoplasm membranebound protein group function categori cytoskelet protein annexin glycolyt enzym tetraspanin interestingli number report virion viru famili proteas treatment virion combin immunoblot analysi verifi presenc cellular protein determin locat core influenza viru particl immunogold label confirm presenc membranebound host protein influenza viru envelop identif cellular constitu influenza virion implic understand interact influenza viru host bring step closer defin cellular requir influenza viru replic host protein incorpor ar essenti role repres novel target antivir drug attenu virus vaccin purpos
BMC Med Res Methodol	22371588	2019-01-30	PMC2394529	18405357	background graphic displai allow research summaris commun kei find studi diagnost present easili interpret convei test characterist diagnost accuraci potenti clinic practic predict method discuss type graphic displai commonli encount primari diagnost accuraci studi systemat review studi systemat review graphic displai diagnost primari studi systemat review identifi primari studi systemat review fiftysix percent primari studi systemat review graphic displai dotplot boxand whisker plot commonli graph primari studi includ studi roc plot common type plot includ systemat review includ review primari studi systemat review includ probabilitymodifi plot conclus graphic displai current underus primari diagnost accuraci studi systemat review studi diagnost accuraci studi includ multipl type graphic order provid detail overview diagnost accuraci commun inform clinic practic predict work requir improv graphic displai better commun util test clinic practic implic test individu patient
PLoS One	30701479	2017-02-01	PMC2398778	18545680	virus adapt host evad defens mechan cellular metabol benefit alter cell metabol sideeffect antivir respons contribut symptom develop virul viru spill usual host speci novel will fail infect transmit host case viru transmit persist fix benefici mutat allow better exploit host situat repres case emerg viru report evolut experi plant viru allow infect evolv nave host serial passag viral genom accumul chang three nonsynonym amino acid substitut viral vpg protein respons appear symptom substitut viral protein epistat contribut exacerb sever dna microarrai analys evolv ancestr virus affect global pattern host gene express radic wai major differ gene involv stress pathogen respons activ infect evolv viru suggest select favor viral strategi escap host defens
PLoS Pathog	28148802	2016-03-30	PMC2398782	18551169	coronavirus induc infect cell format doubl membran vesicl site rna replic format vesicl observ indic role endoplasm reticulum format mous hepat coronaviru mhv replic complex rc mhv replic sensit brefeldin bfa consist express dominantneg mutant arf mimic action drug inhibit mhv infect profoundli immunofluoresc analysi quantit electron microscopi demonstr bfa block format rc se reduc number mhv rna replic sensit bfa mdck cell express bfaresist guanin nucleotid exchang factor gbf individu knockdown golgiresid target bfa transfect small interf rna sirna gbf big big critic involv mhv rna replic arf cellular effector gbf appear involv mhv replic sirna target small gtpase inhibit mhv infect collect demonstr gbfmediat arf activ requir effici mhv rna replic reveal earli secretori pathwai mhv replic complex format close connect
Virol J	27190593	2013-08-28	PMC2413216	18495043	background previou studi demonstr envelop protein dengu virus purifi select pressur genet differ fulllength viral genom denv studi complet genom sequenc denv strain collect geograph locat isol year determin sequenc divers select pressur site denv genom gene analyz maximum likelihood bayesian approach phylogenet analysi reveal taiwan indigen denv isol denguedhf epidem sporad case three genotyp ii iii associ denv circul indonesia thailand sri lanka sequenc divers select pressur genom region denv genotyp examin understand global denv evolut highest nucleotid sequenc divers fulli sequenc denv strain nonstructur protein sd envelop protein gene region sd analysi posit select pressur denv occur nonstructur protein gene region posit select site detect posit ns gene conclus studi confirm envelop protein purifi select pressur present higher sequenc divers detect posit select pressur nonstructur protein genotyp ii indic denv origin southeast asia monitor emerg denv strain epidem potenti better epidem prevent vaccin develop
BMC Public Health	23986588	2008-11-19	PMC2423372	18518971	background healthcar worker hcw will kei player respons pandem influenza will front exposur infect respond effect pandem reli major medic nurs laboratori hotel servic staff continu work plan assum pandem normal healthcar servic level will provid anticip caseload increas essenti care will provid abil nh provid expect servic level entir depend hcw continu work normal methodsdesign studi design twophas multimethod studi incorpor focu group questionnair survei phase qualit method will collect view purpos sampl hcw determin rang factor associ respons prospect work pandem influenza phase find focu group combin literatur will inform design survei determin generalis factor enabl estim proport hcw factor andor continu work influenza pandem discuss greater normal health risk healthcar worker work pandem worker concern infect famili membersfriend hcw will liabl worker care sick famili member friend vital motiv hcw will continu work crisi factor influenc decis worknot work identif subsequ manag factor implement strategi will allevi concern fear hcw remov potenti barrier work
PLoS One	19019822	2013-09-01	PMC2423471	18560560	background isg ubiquitinlik protein highli induc type interferon cooper activ specif ubiquitin enzym isg conjug substrat increas evid point role protein isgyl antivir antitumor defens princip find identifi isg monkei owm hypereffici protein modifi western blot analysi visual effici conjug owmisg rel huisg human hu monkei mous mo celllin substrat owmisg identifi tandem affin purif lcmsm identif outnumb huisg ubiquitinconjug enzym identifi novel isgyl substrat introduct mutat huisg improv isgyl capac addit qktadn mutat yield huisg variant isgyl effici compar owmisg homolog model structur superposit situat interact interfac activ enzym analysi ubel residu interfac reveal strike homolog owmubel huub activ enzym ubiquitin observ effici activ agmisg huisg moisg huub provid explan owm hyperisgyl conclus studi disclos poor conjug compet huisg compar owmisg map critic determin effici conjug hyperisgyl greatli assist isgyl studi enhanc function posit regul interferonrel immun respons antitumor modul
Virol J	24041193	2011-02-08	PMC2426676	18519001	background human metapneumoviru hmpv infect acut lower respiratori tract ill infant immunocompromis elderli current licens prevent measur hmpv infect variant hmpvnl requir trypsin supplement growth tissu cultur delet gene evalu replic rhmpvm viru vitro vivo vitro studi ablat increas propens insert nucleotid polyu tract genom rna addit viral transcript upregul level genom rna remain compar rhmpv delet alter ratio hmpv genom copi transcript vivo rhmpvm attenu compar rhmpv lung nasal turbin hamster hamster immun dose rhmpvm protect challeng pfu wild type wt hmpvnl conclus hmpv alter regul transcript influenc fidel polymeras complex viral genom replic hamster model rhmpvm attenu protect suggest delet result potenti live vaccin candid thorough knowledg hmpv polymeras complex role hmpv replic studi develop potenti live hmpv vaccin candid lack express
PLoS One	21301484	2011-08-10	PMC2440516	18612413	background protein ubiquitin andor degrad ubiquitinproteasom system recogn critic mechan regul numer essenti cellular function the viral pathogenesi increasingli appar murin cardiomyocyt demonstr plai kei role replic coxsackieviru cvb human pathogen associ diseas elucid underli mechan examin interplai cvb focus role ubiquitin viral lifecycl methodologyprincip find assess situ hybrid western blot plaqu assai proteasom inhibit decreas cvb rna replic protein synthesi viral titer hela cell appar chang proteasom activ cvb infect viral infect led accumul proteinubiquitin conjug accompani decreas protein express free ubiquitin implic role ubiquitin upsmedi viral replic smallinterf rna demonstr genesilenc ubiquitin reduc viral titer downregul protein ubiquitin subsequ alter protein function andor degrad inhibit deubiquitin enzym enhanc inhibitori effect proteasom inhibitor cvb replic final immunoprecipit coxsackievir polymeras posttranslation modifi ubiquitin modif prerequisit function transcript regul viral genom conclus coxsackieviru infect promot protein ubiquitin contribut effect viral replic ubiquitin modif viral polymeras
PLoS One	21835786	2013-10-16	PMC2440799	18612429	background govern prepar potenti influenza pandem data assess impact intervent facemask worn gener popul access afford intervent effect worn routin circumst methodolog assess transmiss reduct potenti provid person respir surgic mask homemad mask worn varieti activ healthi volunt simul patient princip find type mask reduc aerosol exposur stabl time unaffect durat wear type activ high degre individu variat person respir effici surgic mask effici homemad mask mask type children protect outward protect mask wear mechan head effect protect mask wear healthi volunt conclusionssignific type gener mask decreas viral exposur infect risk popul level spite imperfect fit imperfect adher person respir provid protect mask worn patient offer great degre protect aerosol transmiss
PLoS One	24131722	2006-03-01	PMC2440807	18612434	cd prominin transmembran glycoprotein consid marker repres subset popul cancer stemlik cell report isol cdposit cell lccd cdneg cell lccd tissu sampl ten patient nonsmal cell lung cancer lc lc cell line lccd displai higher oct express abil selfrenew repres reservoir prolif potenti gener lung cancer cell lccd lccd highli coexpress multipl drugresist marker abcg resist chemotherapi agent cisplatin etoposid doxorubicin paclitaxel radiotherapi treatment oct sirna lentivir vector block capabl lccd form sphere facilit lccd differenti lccd addit knockdown oct express lccd inhibit abil tumor invas coloni format increas apoptot activ caspas poli adpribos polymeras parp final vitro vivo studi confirm treatment chemoradiotherapi lccd improv treatment oct sirna conclus demonstr oct express plai crucial role maintain selfrenew cancer stemlik chemoradioresist properti lccd futur warrant upregul express oct lccd malign lung cancer
PLoS One	16553546	2004-04-01	PMC2441860	18628832	the pathogenesi sar coronaviru cov remain understood current studi recombin baculoviru gener express spike protein sarslik coronaviru slcov isol bat vacb envelop membran protein sarscov coinfect insect cell recombin baculovirus led selfassembl viruslik particl bvlp demonstr electron microscopi incorpor protein vacb bs vlp confirm western blot immunogold label bvlp upregul level cd cd cd cd enhanc secret il il tnf immatur dendrit cell dc immun respons compar immatur dc inocul bvlp vlp form protein human sarscov bvlp stronger abil stimul dc term cytokin induct evidenc fold higher product il tnf studi indic ifn il popul cd cell increas cocultiv dc preexpos bvlp sarscov vlp observ differ dcstimul activ bvlp sar cov vlp protein agreement slcov dna vaccin evok vigor antibodi respons stronger cell respons sarscov dna mice data demonstr time slcov vlp form membran protein origin slcov isol bat bs human sarscov activ immatur dc enhanc express costimulatori molecul secret cytokin find studi provid vaccin develop understand pathogenesi sarslik cov
BMC Biotechnol	15071006	2005-12-12	PMC2443125	18573204	background human immunodefici viru type hiv infect peopl worldwid subsaharan africa high preval hiv subtyp southern africa necessit develop cheap effect vaccin product plant number techniqu develop hiv prgag promis hiv vaccin candid compar express truncat gag capsid subunit nicotiana spp transgen plant transient express agrobacterium tumefacien recombin tobamoviru vector investig influenc subcellular localis recombin protein chloroplast endoplasm reticulum er protein yield partial purifi select vaccin candid test stimul humor cellular immun respons mice transient transgen express hiv antigen success express prgag low system agrobacteriummedi transient express yield best pkg fresh weight chloroplast target protein level highest transient transgen express transientlyexpress immunogen mice homolog vaccin boost humor cell immun respons prime gag dna vaccin pthgagc conclus transient agroinfiltr best express of recombin protein test express higher level prgag highlight plastid signal peptid enhanc product recombin protein meant vaccin protein effect boost cell humor respons mice prime dna vaccin pthgagc show plantproduc protein potenti vaccin
BMC Public Health	16352564	2014-11-01	PMC2443801	18554408	background enter outbreak associ child care centr ccc document internation canada current literatur focus identifi potenti risk factor introduct transmiss enter diseas examin risk factor happen risk understood manag staff ccc challeng experi respond enter ill purpos studi explor understand knowledg action ccc staff enter ill outbreak identifi challeng staff encount manag method focu group conduct staff regul ccc southern ontario focu group held particip open end style interview data analyz content analysi ccc staff plai role prevent manag enter ill staff indepth knowledg children centr person experi assist make decis enter ill decis action differ guidanc provid public health offici face challeng time monei staf parent conclus ccc staff reli experi judgment coordin public health assist decisionmak manag enter ill outbreak advic guidanc public health offici ccc staff consist flexibl adapt varieti situat meet regulatori public health requir
BMC Evol Biol	25483511	2005-09-27	PMC2443812	18541033	precis date viral subtyp diverg enabl research correl diverg geograph demograph occurr histor data absent overwhelm major viral sequenc sampl time scale commensur rate substitut permit infer time subtyp diverg current research strategi approach task requir strong condit molecular clock assumpt substitut rate underli structur substitut rate process time subtyp diverg understood highli variabl simpl method estim rate substitut time diverg assum molecular clock accomplish blend estim substitut rate triplet date sequenc sequenc draw distinct viral subtyp provid zerothord approxim rate subtyp exampl calcul time diverg three gene influenza subtyp ahn subtyp outgroup time diverg year ago previou estim rang year ago
PLoS One	32169846	2011-10-19	PMC2453318	18629345	two sequenc major histocompat complex mhc region domest cat mbp separ ancient chromosom break mya chromosom invers annot detail gene annot mhc complet identifi code region human homologu function gene pseudounidentifi gene genscan blastn blastp repeatmask program region span mbp sequenc encod classic class ii antigen three dra three drb antigen lack function dp dq region antigen process molecul doadob dmadmb tapasin lmplmptaptap class iii gene nineteen class genesgen fragment flaia flai three class gene flaih ik encod function classic class antigen base deduc amino acid sequenc promot structur second region span mbp sequenc encod class gene crossspeci conserv gene exclud class ii function relatedassoci gene framework gene includ three olfactori receptor gene identifi felin endogen retroviru baboon retroviru deriv sequenc ec endogen retroviru sequenc brown bat endogen retroviru fervmlu fervmlu kbp interv middl class region mhc snp examin base comparison bac sequenc mhc homozyg wg sequenc snp mbp snp bp time higher rate averag heterozyg region wg snp bp genom higher snp rate observ human mhc snp bp
PLoS One	22013221	2015-06-17	PMC2464710	18648661	the conserv insect pollin draw attent report declin bee speci ecosystem servic provid issu brought head devast loss honei bee north america call coloni collaps disord understand bee declin wild bumbl bee bombu spp suffer seriou declin circumstanti evid suggest pathogen spillov commerci rear bumbl bee extens pollin greenhous crop construct spatial explicit model pathogen spillov bumbl bee laboratori experi literatur estim paramet valu spillov crithidia bombi destruct pathogen commonli commerci bombu monitor wild bumbl bee popul greenhous evid pathogen spillov compar fit model pattern bombi infect observ field model predict three month spillov transmiss commerci hive infect wild bumbl bee greenhous travel wave diseas predict form suddenli infect wild bombu spread greenhous rate kmwk field observ larg epizoot wave infect preval bombi greenhous consist model spillov allow bombi invad wild bumbl bee speci greenhous evid pathogen spillov commerci bee contribut ongo declin wild bombu north america improv manag domest bee exampl reduc parasit load overlap wild congen diminish elimin pathogen spillov
Proc Biol Sci	26085159	2019-03-21	PMC2475551	18505720	on averag speci human viru report year construct cumul speci discoveri curv human virus go fit statist model data shape curv suggest process viru discoveri complet gener credibl interv pool undiscov viru speci extrapol curv gener estim speci discov predict level health threat virus will conclud novel viru speci anticip public health plan systemat viru discoveri programm cover human potenti anim reservoir human virus consid
Crit Care	30963037	2012-11-01	PMC2481447	18460218	introduct anim studi acut lung injuri ali nebulis heparin limit damag fibrin deposit alveolar space microcircul human studi undertaken assess feasibl safeti potenti anticoagul effect administr nebulis heparin patient ali method open label phase trial escal dose nebulis heparin perform total ventil patient ali studi group administ total udai second group udai third group udai fourth group udai assess lung function includ paofio ratio lung complianc alveolar dead space fraction monitor anticoagul includ activ partial thromboplastin time aptt thrombin clot time bronchoalveolar lavag fluid collect prothrombin fragment tissu plasminogen activ level assess analysi varianc compar effect dose seriou advers event occur dose chang time paofio ratio lung complianc alveolar dead space fraction level dose trend increas aptt thrombin clot time level higher dose p highest dose aptt reach second cessat nebulis heparin aptt fell second bronchoalveolar lavag sampl trend reduc prothrombin fragment level higher dose tissu plasminogen activ level dose conclus administr nebulis heparin mechan ventil patient ali feasibl nebulis heparin associ seriou advers event higher dose increas aptt level larger trial requir investig safeti efficaci nebulis heparin trial consider system anticoagul effect trial registr australian clinic trial registri actrn
PLoS Pathog	23190778	2004-10-20	PMC2483250	18670648	fatal human respiratori diseas associ pandem influenza viru pandem hn virus character sever lung patholog includ pulmonari edema extens inflammatori infiltr quantifi cellular immun respons infect mous lung flow cytometri demonstr mice infect highli pathogen hp hn hn influenza virus exhibit high number macrophag neutrophil lung compar mice infect low pathogen lp virus mice infect pandem viru hn human isol consider similar lung cellular lung immun cell subpopul composit cellular immun tempor dynam interestingli similar observ hp hn viru consist elicit higher level proinflammatori cytokin lung primari human macrophag reveal critic differ pathogenesi hn infect infect hp influenza virus hn pandem viru lead rapid cell recruit macrophag neutrophil lung suggest cell plai role acut lung inflamm associ hp influenza viru infect addit primari macrophag dendrit cell suscept hn influenza viru infect vitro infect mous lung tissu
Reprod Biol Endocrinol	15496474	2004-05-01	PMC2483279	18620581	background rna interfer rnai valuabl tool investig gene function purpos studi examin avail target cell type effici rnai mous seminifer epithelium method experiment model base transgen mice express egfp enhanc green fluoresc protein rnai induc vivo transfect plasmid vector encod short hairpin rna shrna target egfp shrna transfect vivo microinject seminifer tubul rete testi squar wave electropor transfect report express red fluoresc protein hcred cell type effici transfect rnai evalu sertoli cell main transfect cell reduct level egfp protein detect cell transfect vivo vitro effici vivo transfect low conclus adult seminifer epitheli cell vivo posttranscript gene silenc mediat rnai shrna effici sertoli cell level rnai detect vivo vitro indic sertoli cell silenc machineri repress express endogen gene rnai
BMC Public Health	15107369	2014-10-20	PMC2483710	18620595	background mycobacterium tuberculosi infect ongo public health problem taiwan nation tuberculosi registri campaign case manag system implement studi examin monitor system identifi character delai treatment tb patient method record tuberculosi case treat taiwan nation tuberculosi registri campaign initi treatment dai diagnosi consid long treatment delai studi includ patient dai delai treatment dai patient treat diagnosi relationship number tb patient dai delai treatment diagnosi exhibit powerlaw distribut long tail powerlaw distribut indic extrem number occur neglect tuberculosi patient treat unusu long delai requir close observ follow conclus studi tb control gener acceptabl taiwan delai treatment increas risk transmiss improv protocol manag confirm tb case minim diseas transmiss
PLoS One	25331705	2015-06-01	PMC2483940	18682853	copi number variat cnv region human genom associ multipl diseas algorithm mathemat sound computation effici accur analyz cnv dna sampl util nanofluid devic digit arrai numer algorithm util comput copi number variat associ statist confid interv base probabl theori statist provid formula close approxim
BMC Evol Biol	25697779	2015-06-03	PMC2515104	18637173	background molecular event evolutionari forc underli lethal mutagenesi viru viru extinct excess mutat understood appli time phylogenet method partit analysi quasispeci paq monitor genet distanc intrapopul structur mutant spectra footandmouth diseas viru fmdv quasispeci subject mutagenesi base nucleosid analogu phylogenet paq analys reveal highli dynam variat intrapopul divers fmdv quasispeci popul divers suffer strike expans presenc mutagen compress presenc mutagen analogu discontinu mutat decreas sensit mutagen select pattern mutat popul agreement behavior correspond nucleotid analogu fmdv vitro mutat accumul prefer genom site dnd ratio indic oper neg purifi select popul subject mutagenesi evid unusu elev genet distanc fmdv popul approach extinct conclus phylogenet paq analysi provid adequ procedur describ evolut viral sequenc subject lethal mutagenesi method defin chang intrapopul structur precis mutat frequenc shannon entropi paq sensit variat intrapopul genet distanc strong neg purifi select oper fmdv popul subject enhanc mutagenesi quantif provid evid extinct impli unusu increas intrapopul complex support lethal defect model viru extinct
PLoS Pathog	26041291	2011-12-23	PMC2515348	18725937	hn highli pathogen avian influenza hpai virus serious asian poultri industri recurr virus pose threat emerg global pandem influenza point mutat reassort lead strain effect transmit human studi phylogenet evid interlineag reassort hn hpai virus isol human cat bird indonesia identifi potenti genet parent reassort genom segment parsimoni analys viral phylogeographi reassort virus origin greater jakarta surround subsequ spread region west java provinc addit bayesian method elucid genet divers dynam reassort strain genet parent reveal rapid initi growth genet divers reassort virus rel genet parent demonstr interlineag exchang genet plai pivot role determin viral genet divers focal popul studi reveal stronger diversifi select pb gene lineag preced subsequ emerg reassort virus discuss correspond mutat drive adapt onward transmiss newli form reassort virus
PLoS One	22263103	2004-07-29	PMC2522280	18776932	mathemat model describ global spread infecti diseas influenza sever acut respiratori syndrom sar tuberculosi tb consid sampl intern airport network support diseas spread consensu citi select select citi airport flight data commerci airlin report offici airlin guid oag examin network characterist network sampl select rule addit examin size sampl base largest flight volum largest metropolitan popul bia network characterist increas reduct sampl size small number area includ largest airport largest citi mostconnect citi central citi describ dynam global spread influenza analysi suggest small number citi captur network adequ describ global spread diseas influenza weak traffic flow small airport contribut nois mask spread ground transport
Cases J	15306400	2011-08-24	PMC2526065	18671866	we report case system lupu erythematosu sle year caucasian woman complic pneumonia sever respiratori failur requir icu treatment mechan ventil symptom develop gener control sle cours sudden immunosupres therapi methotrex cyclosporin methylprednisolon fulmin cours diseas interstiti pattern high resolut comput tomographi hrct neg repeat sputum blood bronchoaspir cultur enabl diagnosi fulmin lupu pneumon respons puls cyclophosphamid methylprednisolon good complic leukopenia hrct confirm remiss pulmonari chang fulmin lupu pneumon rare life threaten complic sle differenti diagnosi requir exclus pneumonia induc pathogen pneumocysti jirovevecii carinii mycobacterium sp intens immunosuppress therapi close cooper icu pulmonolog rheumatolog depart case minim risk fatal outcom
PLoS Pathog	21865394	2010-02-01	PMC2526176	18787698	a varieti human diseas associ gammaherpesvirus includ neoplasm lymphocyt burkitt lymphoma endotheli cell kaposi sarcoma gammaherpesviru infect result product lytic infect character express viral gene rapid cell lysi latent infect character limit viral gene express cell lysi report character endotheli cell infect murin gammaherpesviru hv viru phylogenet biolog human gammaherpesvirus endotheli cell support hv replic vitro uniqu proport cell escap lysi prolifer remain viabl cultur extend time infect endotheli cell nonadher alter size complex cellsurfac protein express cell uniformli infect express lytic transcript program base detect abund viral gene transcript gfp fluoresc viral genom viral surfac protein express addition endotheli cell continu produc infecti virion late dai postinfect outcom longterm infect promot hv vcyclin absenc vcyclin viabil reduc infect importantli infect primari endotheli cell demonstr increas viabil rel infect primari fibroblast increas viabil depend vcyclin final provid evid infect endotheli cell vivo immunedefici mice extend viabil viru product infect endotheli cell indic endotheli cell provid sourc prolong viru product identifi celltyp specif adapt gammaherpesviru replic infect endotheli cell clear healthi individu persist infect endotheli cell provid sourc continu viru replic immunecompromis individu context gammaherpesvirusassoci patholog frequent occur
BMC Res Notes	20007351	2016-03-10	PMC2527504	18710500	background extens sequenc effort place atlant cod gadu morhua year number est genbank reach despit north atlant fisheri potenti aquacultur gene express examin exist speci systemat evalu refer gene stabil quantit realtim rtpcr qrtpcr studi lack stabil potenti refer gene examin tissu atlant cod popul determin suitabl gene qrtpcr analys rel transcript level gene encod actin actb elong factor efa actinrel protein arp glyceraldehydepdehydrogenas gapdh ubiquitin ubi acid ribosom protein arp ribosom protein s ribosom protein rpl rpl rpl quantifi gill brain liver head kidnei muscl middl intestin juvenil fish three wild popul farm atlant cod refer gene stabil investig genorm normfind tool base calcul perform genorm determin stabl gene set test gene cdna sampl arp ubi rpl stabl gene tissu calcul normfind gene rpl efa rank prefer gene conclus work suggest ubi arp refer gene qrtpcr examin gene express studi wild popul atlant cod
PLoS One	26968698	2012-09-05	PMC2527531	18784843	background isol human antibodi current displai technolog limit constraint protein express fold posttransl modif describ discoveri platform util selfinactiv sin lentivir vector surfac displai highaffin singlechain variabl region scfv antibodi fragment human cell lentiviru particl methodologyprincip find bival scfvfc human antibodi fuse frame transmembran tm anchor moieti allow effici highlevel express human cell optim tm identifi addit amino acid hiv gp envelop incorpor motif increas scfvfc express human cell incorpor lentivir particl antibodydisplai human cell viru particl bound antigen sulfat cdr tyrosin residu properti broaden antibodi bind affin antigen recognit demonstr high level scfvfc express stabl integr achiev human cell transduct ir bicistron sin lentivector encod zsgreen scfvfc fusion protein express cassett fold enrich antibodi express cell achiev round antigen coupl magnet bead preselect fac sort final scfvfc displai human cell directli function biolog screen remark sensit conclusionssignific antibodi displai platform will complement exist technolog virtu provid properti uniqu lentivirus antibodi express human cell turn aid discoveri novel therapeut human mab
BMC Med Inform Decis Mak	22802440	2004-08-01	PMC2527556	18667084	background ideal method encourag uptak clinic guidelin hospit strategi suggest studi evalu impact academ detail computeris decis support system cdss clinician prescrib behaviour patient commun acquir pneumonia cap method manag patient present emerg depart three success time period evalu baselin academ detail cdss period rate empir antibiot prescrib concord recommend studi time compar pre post period interrupt time seri analysi odd ratio concord therapi academ detail period adjust ag ill sever suspicion aspir compar baselin period computeris decis support period compar academ detail period month computeris decis support period improv appropri antibiot prescrib demonstr greater expect occur time academ detail base predict binari logist model conclus deploy computeris decis support system associ earli improv antibiot prescrib practic greater chang academ detail sustain intervent requir evalu
BMC Vet Res	15269074	2015-09-23	PMC2531098	18700011	background enter redmouth erm diseas yersiniosi contagi diseas salmonid rainbow trout caus agent gramneg bacterium yersinia ruckeri diseas diagnos isol identif caus agent detect pathogen fluoresc antibodi test elisa pcr assai diagnost method labori time consum train personnel loopmedi isotherm amplif lamp assai develop evalu detect ruckeri etiolog agent enter red mouth erm diseas salmonid assai optimis amplifi yruiyrur gene encod ruckeri quorum sens system presenc specif primer set bst dna polymeras isotherm temperatur hour amplif product detect visual inspect agaros gel electrophoresi realtim monitor turbid format lamp amplicon digest hphi restrict enzym demonstr amplifi product uniqu specif assai verifi absenc amplif product test bacteria assai fold higher sensit compar convent pcr detect ruckeri pure bacteri cultur tissu homogen infect fish conclus ermlamp assai repres practic altern microbiolog approach rapid sensit specif detect ruckeri fish farm assai carri hour heat block water bath laboratori furnitur advantag ermlamp assai promis tool molecular detect enter red mouth diseas fish farm
BMC Infect Dis	26401043	2013-02-11	PMC2532688	18717989	background rabi major publichealth problem develop countri china reemerg human rabi china epidemiolog studi attent paid reason phenomenon parallel find previou report purpos studi character current trend human rabi china to defin better recommend improv postexposur prophylaxi pep schedul deliv rabi patient method updat epidemiolog data human rabi case januari juli retriev surveil databas report diseas manag ministri health china analys investig effici postexposur treatment rabi detail rabi patient includ antirabi treatment injuri incid ascertain guangdong provinci jurisdict risk factor patient predispos regimen patient receiv type pep analys identifi reason pep failur analysi larg number human rabi case rabi china control period larg jump number report rabi case peak incid rate peopl reach level remain analys pep rabi case collect guangdong provinc and patient seek medic servic receiv pep analysi pep rabi patient receiv type pep indic patient receiv proper time treatment wound postexposur vaccin rabi immunoglobulin conclus issu underreport rabi previou year factor appar upward trend human rabi year analysi pep guangdong provinc evid suggest failur receiv pep major factor number human case china data underlin greatli improv avail time applic highqual antirabi biolog vaccin immunoglobulin treatment human bite victim control dog rabi pet vaccin scheme plai huge role reduc rate human exposur educ public health care staff veterinarian will help chang current situat
PLoS Pathog	23401522	2019-02-13	PMC2533695	18818738	viral surveil program diagnost lab occasion infecti sampl fail type cell cultur serolog nucleic acid test sampl origin insect pool skunk brain human fece sewer effluent collect patholog inocul suckl mice studi sequenceindepend amplif partial purifi viral nucleic acid small scale shotgun sequenc mous brain muscl tissu singl viral agent identifi sampl viru viral genom acquir sequenc plasmid insert virus deriv human fece sewer effluent belong picornavirida famili amino acid ident picornavirus complet polyprotein sequenc viru strong similar simian picornaviru sequenc provision sapeloviru genu insect skunk deriv viral sequenc exhibit amino acid ident rang to segment genom virus reovirida famili isol highli diverg speci orthoreoviru genu speci orbiviru genu demonstr simpl inexpens rapid metagenom approach effect identifi highli diverg virus homogen tissu acut infect mice
PLoS Biol	30760529	2011-06-27	PMC2535663	18798692	positivestrand rna virus larg group includ human pathogen sarscoronaviru sarscov replic cytoplasm infect host cell replic complex commonli associ modifi host cell membran membran structur support viral rna synthesi rang distinct spherular membran invagin elabor web pack membran vesicl gener ultrastructur morphogenesi exact role viral replic remain defin character doublemembran vesicl dmv implic sarscov rna synthesi appli electron tomographi cryofix infect cell threedimension imag coronavirusinduc membran alter high resolut analysi defin uniqu reticulovesicular network modifi endoplasm reticulum integr convolut membran numer interconnect dmv diamet nm vesicl packet aris dmv merger convolut membran abundantli immunolabel viral replicas subunit doublestrand rna presum reveal site viral rna synthesi local dmv interior discern connect dmv interior cytosol analysi rais question mechan dmv format actual site sarscov rna synthesi data document extens virusinduc reorgan host cell membran network organ viral replic hide replic rna antivir defens mechan biochem studi viral enzym complex ultrastructur descript replic network will aid dissect earli stage coronaviru life cycl virushost interact
BMC Mol Biol	21709152	2010-11-01	PMC2535778	18771595	background phi polymeras base amplif method amplifi dna minim chang sequenc rel abund biomed applic rna viru detect microarrai challeng phi dna polymeras amplifi rna small cdna fragment base revers transcript viral rna genom ligat cdna fragment prior phi polymeras base amplif adapt quantitect transcriptom kit qiagen purpos design method transcriptom amplif wta wta amplifi cdna panel rna virus repres divers riboviru genom size amplifi rang genom copi number wta yield quantiti amplifi dna high gl target copi amplif factor vari demonstr coamplif occur viral rna mix bacteri dna conclus report scientif literatur show modifi wga wta approach appli viral genom rna size amplifi viral rna wta consider better sensit accuraci detect compar random rtpcr
BMC Biotechnol	21041640	2010-04-23	PMC2543005	18764933	background venezuelan equin enceph viru veev belong alphaviru group speci famili pathogen human recogn potenti agent biolog warfar terror object work gener recombin antibodi detect veev potenti bioterror assault natur outbreak veev work human antiveev singl chain fragment variabl scfv isol time human nave antibodi gene librari optim select process total eleven scfv identifi immunolog specif assess specif detect veev strain tc select antibodi fragment prove activ formalin inactiv viru particl recogn select antibodi fragment western blot analysi veev protein immunohistochemistri veev infect cell antiveev scfv phage clone crossreact alphaviru speci western equin enceph viru weev eastern equin enceph viru eeev antigen complex react chikungunya viru chikv detect reagent conclus time studi describ select antibodi human pathogen viru human nave scfv antibodi gene librari complet activ viru particl antigen broad sensit applic scfvpresent phage immunolog detect diagnosi alphaviru speci demonstr select antibodi fragment will improv fast identif veev case biolog warfar terrorist attack natur outbreak
BMC Genomics	20414733	2005-03-01	PMC2553098	18793412	bacil calmettegurin bcg attenu strain mycobacterium bovi current vaccin tuberculosi global distribut propag bcg contribut vitro evolut vaccin strain thought partial account outcom bcg vaccin trial previou effort molecular techniqu effect identifi larg sequenc polymorph bcg daughter strain lack resolut identifi smaller chang studi nimblegen tile arrai genom comparison bcg strain approach tandem dna resequenc identifi novel larg sequenc polymorph includ delet duplic specif bcg strain uncov polymorph phopphor locu importantli polymorph affect gene encod establish virul factor includ cell wall complex lipid esx secret system phopphor twocompon system studi demonstr major virul factor bcg strain provid molecular mechan vaccin phenotyp includ advers profil tuberculin reactiv protect efficaci find implic develop gener vaccin
PLoS One	15802951	2015-07-30	PMC2553179	18827877	analys viral proteinprotein interact step understand viral protein function underli molecular mechan studi adopt mammalian twohybrid system screen genomewid intravir proteinprotein interact sar coronaviru sarscov therefrom reveal number novel interact partli confirm vitro biochem assai three pair interact identifi detect direct nonstructur protein nsp nsp nsp nsp nsp nsp interact multifunct nsp nsp nsp uniqu protein member nidoviral larg rna genom includ coronavirus torovirus implic mechan replicationtranscript complex assembl function virus sarscov replicon express luciferas report control transcript regul sequenc viral protein sud domain nsp nsp provid tran stimul replicon report activ indic protein regul coronaviru replic transcript collect find provid basi platform character function mechan coronaviru protein
PLoS Pathog	26172429	2009-09-23	PMC2553261	18846208	poreform toxin pft constitut singl largest class proteinac bacteri virul factor bacteri pathogen host respons toxin complex understood find endoplasm reticulum unfold protein respons upr activ exposur pft caenorhabd elegan mammalian cell activ upr protect vivo pft anim lack irexbp atf arm upr sensit pft wildtyp anim upr act directli cell target pft loss upr lead normal respons unrel toxin pathogen bacterium indic pftprotect role specif mitogenactiv protein mapk kinas pathwai cellular defens pft find upr kei downstream target mapk pathwai respons pft loss function mapk pathwai lead failur pft properli activ irexbp arm upr uprmedi activ respons pft distinct canon uprmedi respons unfold protein term activ function sensit data demonstr upr fundament intracellular pathwai oper intrins cellular defens bacteri attack
BMC Bioinformatics	19776127	2017-07-18	PMC2553803	18783594	background pathogen detect dna microarrai potenti fast comprehens diagnost tool pathogen detect chip current util random primer specif primer rtpcr step bia inher random pcr amplif seriou problem larg inaccuraci hybrid signal paper studi effici random pcr amplif hybrid signal describ model predict amplif effici random primer target viral genom predict allow filter falseneg probe genom lie region poor random pcr amplif improv accuraci pathogen detect subsequ propos loma algorithm gener random primer good amplif effici wetlab valid gener random primer improv amplif effici conclus blind random primer attach univers tag randomtag primer pcr reaction pathogen sampl lead success amplif design randomtag primer consider perform pcr
BMC Infect Dis	28719693	2011-08-05	PMC2556339	18793441	background baselin data monitor popul perceiv threat pandem influenza perceiv behav event pandem influenza aim develop modul question telephon health survei percept threat pandem influenza prepared compli specif public health behaviour event pandem influenza method modul question develop field test adult south wale depart health inhous comput assist telephon interview cati facil question modifi field test adult modul incorpor south wale popul health survei quarter repres sampl adult complet modul respons weight state popul reliabl question accept kappa rang state popul thought pandem influenza extrem occur extrem concern famili pandem influenza occur level chang live life possibl pandem influenza event pandem influenza major popul vaccin isol wear face mask peopl higher level threat percept compli specif public health behaviour conclus state popul thought pandem influenza extrem occur higher proport concern famili pandem occur baselin data collect survei will monitor chang time popul percept threat prepared compli specif public health behaviour
PLoS One	21821742	2016-05-01	PMC2561066	18923707	background studi wild anim respond nativ parasit essenti understand immun system function natur environ immun defenc bring increas surviv resourc cost physiolog trait includ reproduct test hypothesi wild common shrew sorex araneu produc larg number offspr breed season short life span forgo invest immun immun system mainten increas longev bring opportun mate predict adult shrew shorter expect lifespan respond effect young anim infect methodologyprincip find examin haemolymphat tissu wildcaught common shrew light transmiss electron microscopi appli conjunct immunohistolog compar composit function tissu shrew ag extent type inflammatori reaction observ respons natur parasit infect ag mount system specif immun respons adult shrew sign lymphat tissu exhaust lymphat follicl adult smaller subadult wald exhibit greater level deplet wald conclusionssignific contrari expect shrew respond effect natur parasit indic immunosenesc adult pancrea aselli uniqu lymphoid organ aid provid effici immun respons storag larg number plasma cell allow older anim react effect encount parasit infect novel agent eventu deplet plasma cell reserv factor nearsynchron mortal adult shrew observ shortli breed
PLoS Pathog	27162653	2016-05-09	PMC2563037	18949029	high affin antigenspecif cell plai critic role protect immun respons epitop enhanc elicit potent cell respons subsequ lead stronger memori pool molecular basi enhanc unclear consensu peptidebind motif major histocompat complex molecul hkb design heteroclit version mous hepat virusspecif subdomin determin demonstr singl amino acid substitut secondari anchor residu posit increas stabil engin determin complex hkb structur basi enhanc stabil associ local alter pmhc conform result substitut recombin virus encod engin determin prime ctl respons react wildtyp epitop higher function avid protect select viru mutat second ctl determin consequ diseas progress persist infect mice collect find provid basi enhanc immunogen engin determin will serv templat guid develop heteroclit cell determin applic prevent ctl escap chronic viral infect tumor immun
PLoS One	27196775	2017-08-01	PMC2565067	18941622	background aim hepat viru hcvrelat liver diseas progress rapidli individu coinfect human immunodefici viru hiv underli immunolog mechan unknown examin hivspecif tcell identifi liver hcvhiv coinfect individu promot liver inflamm bystand immun respons method exvivo intrahepat lymphocyt hcv monoinfect hcvhiv coinfect individu assess immun respons hiv hcv antigen polychromat flow cytometri hcvhiv liver biopsi frequenc lymphocyt lower percentag cd tcell compar hcv biopsi coinfect intrahepat hivspecif cd cd tcell produc ifn tnf detect compar frequenc hcvspecif coinfect individu viralspecif cd tcell produc fibrogen cytokin tnf mono coinfect individu intrahepat hcvspecif tcell function compar hivspecif tcell coinfect haart associ reconstitut intrahepat cd tcell associ reduct hiv hcvspecif intrahepat cytokin respons conclus accumul function hivspecif tcell liver hcvhiv coinfect repres bystand role hiv induc faster progress liver diseas
Ann Clin Microbiol Antimicrob	29103421	2006-09-20	PMC2566554	18817537	background year realtim pcr lead techniqu nucleic acid detect quantif assai potenti greatli enhanc effici clinic laboratori choic primer probe sequenc critic accur diagnosi clinic current primerprob signatur design strategi limit signatur evalu method lack method assess qualiti signatur predict number true posit fals posit fals neg hit public sequenc data realtim pcr signatur describ literatur blast search base approach collect hit primerprob combin amplifi realtim pcr chemistri compar hit sequenc ncbi taxonomi tree signatur design detect publish signatur high specif fals posit low sensit high fals neg rate high sensit need offer revis methodolog signatur design design multipl signatur requir detect sequenc strain methodolog produc signatur predict higher sensit specif conclus current method realtim pcr assai design unaccept low sensit clinic applic addition sequenc data assai reassess redesign standard protocol gener assess qualiti assai great realtim pcr capac greatli improv clinic diagnost improv assai design evalu method present will expedit adopt techniqu clinic lab
BMC Evol Biol	16987975	2012-09-25	PMC2567993	18801176	background femal endoparasit ichneumonid wasp inject viruslik particl caterpillar host suppress immun particl classifi ichnoviru virion resembl ascoviru virion transmit parasit wasp attack caterpillar ascovirus replic dna produc virion polydnaviru dna consist wasp dna replic wasp genom direct particl synthesi structur similar ascoviru ichnoviru particl biologi transmiss ichnovirus evolv ascovirus molecular evid hypothesi lack famili uniqu poxd ntpase protein glypta fumiferana ichnoviru three diadromu pulchellu ascoviru protein encod orf align techniqu protein ichnoviru ortholog ascoviru virion protein conclus provid molecular evid support origin ichnovirus ascovirus later transfer ascovir gene ichneumonid wasp genom exampl symbiogenesi larg dna virus eukaryot organ discuss limit evid complementari studi reveal passiv later transfer viral gene polydnavir bacteri wasp genom occur repeatedli intim coupl recombin replic viral genom evolut impact passiv later transfer evolutionari relationship polydnavirus virus larg doublestrand genom consid context theori symbiogenesi
PLoS One	23010928	2007-06-20	PMC2569416	18958172	preexist immun human adenoviru serotyp ad common gener popul bypass preexist immun maxim ad vaccin efficaci vaccin intramuscular nasal oral po rout ad express ebola zair glycoprotein adzgp fulli protect nave mice lethal challeng ebola presenc preexist immun mice vaccin surviv frequenc ifn cd cell reduc by anim vaccin po rout neutral antibodi detect serum treatment group preexist immun compromis frequenc ifn cd cell nave preexist immun pei antiebola neutral antibodi nab reciproc dilut group number inf cd cell detect bronchioalveolar lavag fluid bal immun compromis preexist immun ad nave sfcmillion mnc pei preexist immun reduc nab level bal group improv immun respons oral vaccin adbas vaccin pegyl mice modifi vaccin surviv challeng reduc level ifn cd cell dai administr peg unmodifi pegyl increas nab level fold provid insight degre cell mediat immun protect ebola viru modif viru capsid influenc type immun respons elicit adbas vaccin
Virol J	17581984	2009-08-01	PMC2569924	18822184	background report apathogen tula hantaviru induc apoptosi vero epitheli cell assess molecular mechan induc apoptosi studi effect hantaviru infect cellular signal pathwai promot cell surviv observ tula virusinduc cell death process augment extern tnf tnf involv pathogenesi hantaviruscaus hemorrhag fever renal syndrom hfr investig effect hfrscaus hantavirusinfect cell studi apathogen tula topografov pathogen puumala seoul hantavirus abil regul cellular signal pathwai observ direct virusmedi downregul extern signalregul kinas erk surviv pathwai activ dramat enhanc tnf fold erk inhibit correl viral replic effici vari drastic hantavirus studi conclus demonstr presenc cytokin tnf increas hfr patient hantavirus capabl inactiv protein promot cell surviv erk impli hantavirusinfect epitheli cell barrier function compromis diseas individu partial explain mechan renal dysfunct proteinuria hfr patient
BMC Public Health	19540545	2016-01-01	PMC2571100	18831770	background australia experienc outbreak highli infecti equin influenza govern diseas control measur place control erad diseas measur includ movement restrict quarantin properti studi conduct assess psychosoci impact diseas paper report preval factor influenc psycholog distress outbreak method data collect onlin survei link direct popul number industri group psycholog distress determin kessler psycholog distress scale main outcom measur total peopl particip studi extrem high level nonspecif psycholog distress report respond studi report high psycholog distress compar level australian gener popul analysi backward stepwis binari logist regress analysi reveal live high risk infect red zone ci diseas buffer amber zone ci greater risk high psycholog distress live uninfect white zone preval high psycholog distress greater infect ei zone state elev level psycholog distress experienc horseown nation statist analysi indic group vulner high psycholog distress younger peopl lower level formal educ qualif respond princip sourc incom horserel industri high psycholog distress primari sourc incom link horserel industri ci conclus methodolog studi good intern valid limit generalis identifi bound sampl target popul accur studi collect psycholog distress data popul diseas outbreak potenti inform involv assess potenti psycholog impact human infecti diseas pandem influenza
PLoS Pathog	30090376	2018-07-04	PMC2572002	18989460	phylogenet analys provid strong evid amino acid chang spike protein anim human sar coronavirus sarscov zoonot transfer result posit select studi support amino acid chang anim human virus result interspeci adapt role neutral antibodi nab drive sarscov evolut intraspeci transmiss unknown detail examin sarscov infect anim human convalesc sera provid evid nab pressur lead strategi effect block viru evolut pathwai broaden activ nab focus domin neutral epitop contemporan crossstrain nab respons sarscov spike protein exist natur infect vitro immun pressur epitop strainspecif nab recapitul domin escap mutat anim human virus strategi block nab escapenatur occur evolut pathwai gener broad nab bnab activ escap mutant strain explor structurebas amino acid chang activationinduc cytidin deaminas aid hot spot light chain cdr complementar determin region introduc shuffl natur occur nonimmun human vl chain repertoir target mutagenesi success gener bnab demonstr nabmedi immun pressur drive forc posit select intraspeci transmiss sarscov somat hypermut shm singl vl cdr markedli broaden activ strainspecif nab strategi investig studi structur combin chainshuffl hotspot cdr mutagenesi exploit broaden neutral activ improv antivir nab therapi directli manipul viru evolut
PLoS Pathog	29970199	2010-08-04	PMC2572141	18989459	the type interferon ifn system defens viral infect virus develop mechan counteract respons interferon antagonist activ influenza virus observ level ifn gene induct action viral nonstructur protein ns data indic influenza virus suppress ifn gene induct inhibit type ifn signal mechan involv induct suppressor cytokin signal soc protein studi base observ cell infect influenza viru subsequ stimul ifn phosphoryl signal transduc activ transcript protein stat reduc impair stat activ action viral protein appear induc accumul viral triphosph rna cell soc protein potent endogen inhibitor janu kinas jakstat signal closer examin reveal soc soc mrna level increas rna nuclear factor kappa nfbdepend type ifnindepend manner earli viral replic cycl direct viral induct soc mrna protein express appear relev suppress antivir respons soc defici cell sustain phosphoryl stat correl elev express type ifndepend gene consequ progeni viru titer reduc soc defici cell cell soc express knockeddown sirna data provid evid influenza virus suppress type ifn signal level jakstat activ inhibitori induct soc gene express impair antivir respons
PLoS Biol	20686017	2003-08-01	PMC2573941	18959488	how understand rna virus usurp transform intracellular architectur host cell replic
Virol J	12869709	2008-07-30	PMC2575341	18925940	background europ northsouth downhil cline frequenc chemokin receptor ccr allel bp delet ccr rais interest question evolutionari biologist suggest the european colon princip roman instrument progress decreas frequenc southward statist analys suggest strong neg correl allel frequenc histor paramet includ colon date mediterranean civilis gene flow colon nativ popul extrem low colon respons spread diseas suggest dissemin parasit naiv popul induc breakdown ruptur fragil pathocenosi chang balanc diseas equilibrium state reach neg select null allel human diseas zoonos cat instrument decreas allel frequenc diffus europ gradual process princip roman cat zoonos transmit man implic felin lentiviru fiv ccr coreceptor discuss viru infect primat cell vitro induc clinic sign macaqu histor region null low frequenc ccr allel coincid histor rang wild felid speci harbor speciesspecif fiv conclus propos hypothesi actual european ccr allel frequenc result neg select diseas spread cat zoonosi plausibl hypothesi futur studi provid ccr plai antimicrobi role fiv pathogenesi studi ancient dna provid evid implic zoonos actual ccr distribut
PLoS Pathog	18667425	2014-06-04	PMC2576454	19008951	the earli system product interferon ifn essenti compon antivir host defens mechan thought contribut toxic side effect accompani gene therapi adenovir vector investig ifn respons human adenovirus ad mice compar respons normal myeloid mdc plasmacytoid pdcdeplet mice measur ifn mrna express organ cell type vivo ad elicit strong rapid ifn product exclus splenic mdc knockout mice strain ad wild type mutant uvinactiv map kinas inhibitor demonstr adinduc ifn respons requir tolllik receptor tlr cytosol sensor rna rigimda dna dai recognit interferon regulatori factor irf depend viral endosom escap signal map kinas sapkjnk irf ad induc ifn il vivo distinct pathwai confirm ifn posit regul il respons final measur tnf respons lp adinfect wild type ifnr mice ifn kei mediat adinduc hypersensit lp find indic endosom tlr signal pdc tlrindepend viru recognit splenic mdc produc robust earli ifn respons respons bulk ifn product induc adenoviru vivo signal requir tlrdepend cytosol ifn induct mechan novel cytosol viral induct pathwai hypersensit compon microbi flora invad pathogen explain toxic side effect adenovir gene therapi contribut pathogenesi adenovir diseas
Genet Vaccines Ther	24732460	2010-05-05	PMC2577087	18940009	in develop novel chimer htnvilg dna vaccin plasmid genet link il gene segment dna test candid vaccin chimer gene express eukaryot express system pcdna htnvilg express kda fusion protein co cell fusion protein activ parent protein balbc mice vaccin chimer gene elisa cell microcultur neutral test vitro detect humor immun respons immun balbc mice lymphocyt prolifer assai detect cellular immun respons the chimer gene simultan evok specif antibodi glycoprotein il immun mice group elicit neutral antibodi titer lymphocyt prolifer assai stimul index splenocyt chimer gene il higher group ilbas htnv dna induc humor cellular immun respons specif htnv candid dna vaccin htnv infect
BMC Public Health	20444893	2015-03-26	PMC2577657	18842127	background tuberculosi tb detect nation tb control program china passiv casefind guidelin influenc access health servic patient healthcar seek behavior intrigu topic correl men women knowledg tb healthcar seek behavior method crosssect studi separ carri yangzhong counti rural area china studi systemat sampl method includ subject conduct investig tb knowledg gener popul studi sourc popul screen peopl ag year stratifi clustersampl villag identifi prolong cough patient household individu interview carri gender differ knowledg tb healthcar seek behavior analyz gener popul men women knew prolong cough durat week longer symptom suspici tb fewer women men knew local appoint health facil tb diagnosi treatment current free tb servic polici women learn tb share initi contrari onset prolong cough women seek healthcar men larg women prefer visit lower level nonhospit health facil villag clinic drugstor conclus tb dot program rural chines gender issu consid reduc diagnost delai tb improv men women access qualifi health facil tb care strengthen awar tb improv access healthcar servic essenti tb control strategi current vertic tb control system
BMC Infect Dis	25960925	2018-04-01	PMC2577677	18947382	background antibiot recommend sever acut exacerb chronic obstruct pulmonari diseas aecopd admit intens care unit icu serum procalcitonin pct tool select patient lower probabl develop bacteri infect measur investig popul method conduct singl center prospect cohort studi consecut copd patient admit icu aecopd septemb septemb sputum sampl tracheal aspir test presenc bacteria virus pct level measur time admitt hour hour sensit immunoassai thirti aecopd patient includ requir ventil support admiss median interquartil rang pct level assess patient gl iqr time admiss gl iqr hour gl iqr hour highest pct pctmax level gl patient gl patient suggest low high probabl bacteri infect speci bacteria speci virus detect patient patient posit pseudomona aeruginosa pctmax gl three pctmax gl patient posit haemophilu influenza pctmax gl presenc absenc virus influenc pct time admiss gl conclus likelihood bacteri infect low copd patient admit icu aecopd pct gl suggest inappropri antibiot studi assess impact procalcitoninbas therapeut strategi critic copd patient
PLoS Pathog	29537337	2016-02-01	PMC2582959	19043556	ebola viru ebov human pathogen present public health concern emergingreemerg viru potenti biolog weapon substanti progress decad develop candid prevent vaccin protect nonhuman primat ebov prospect vaccin base recombin vesicular stomat viru vsv robust confer protect administ postexposur treatment concern rais replicationcompet vsv vector express ebov glycoprotein vector toler individu alter compromis immun system patient infect hiv ebov outbreak occur area central western africa high hiv incid rate popul order address concern evalu safeti recombin vsv vector express zair ebolaviru glycoprotein vsvgzebovgp rhesu macaqu infect simianhuman immunodefici viru shiv anim evid ill associ vsvgzebovgp vaccin suggest vaccin safe immunocompromis popul goal studi evalu safeti candid vaccin platform interest determin alter immun statu affect vaccin efficaci vaccin protect shivinfect macaqu death zebov challeng evalu cd cell anim anim succumb lethal zebov challeng lowest cd count suggest cd cell plai role mediat protect zebov
PLoS One	26741826	2010-01-25	PMC2583042	19030226	first discov earli reovirus respiratori enter orphan virus associ diseas name orphan virus group report isol melaka viru patient acut respiratori diseas provid data suggest orthoreoviru capabl humantohuman transmiss bat origin report melakalik reoviru name kampar viru isol throat swab year male patient kampar perak malaysia suffer high fever acut respiratori diseas vomit time viru isol serolog studi indic kampar viru transmit case individu caus respiratori diseas contact case sequenc analysi small class genom segment indic kampar melaka virus close confirm viru neutral assai show effect twowai cross neutral serum viru neutral the exact origin kampar viru unknown epidemiolog trace reveal hous case surround fruit tree frequent visit fruit bat high probabl kampar viru origin bat transmit human bat drop contamin fruit discoveri kampar viru highlight increas trend emerg bat zoonot virus expand understand bat sourc unknown virus
Virol J	20100751	2008-10-01	PMC2583970	18937850	background cotton blue diseas cbd global cotton crop patholog respons major econom loss preval major cottonproduc state brazil typic cbd symptom includ stunt internod shorten leaf roll intens green foliag yellow vein atyp cbd symptom includ reddish wither leav observ brazilian cotton field poleroviru name cotton leafrol dwarf viru clrdv associ cbd understand distribut genet divers clrdv brazil analyz cbdsymptomat plant suscept cotton varieti origin cottongrow state report clrdv divers plant typic atyp cbd symptom compar viral coat protein rna polymeras rdrp intergen region genom sequenc conclus viru widespread distribut low genet divers three diverg isol associ atyp cbd symptom diverg isol clrdvrelat coat protein distinct rdrp sequenc aros recombin event base taxonom rule famili luteovirida propos three isol repres isol speci genu poleroviru
BMC Med Genomics	18781156	2002-04-07	PMC2584050	18950519	background gastric cancer surviv remain poor reliabl method identifi highli curabl earli stage diseas multiprotein profil gastric fluid anatom site patholog reveal diagnost proteom fingerprint method protein profil gener gastric fluid sampl gastric cancer benign gastritid patient undergo elect clinicallyind gastroscopi surfaceenhanc laser desorptionion timeofflight mass spectrometri multipl proteinchip arrai proteom featur compar signific analysi microarrai algorithm twowai hierarch cluster second blind sampl set gastric cancer clinic benign gastritid valid signific analysyi microarrai proteom featur upregul downregul gastric cancer sampl multimark cluster distinct proteom profil independ ag ethnic eighteen cancer sampl cluster sensit noncanc sampl cluster second group noncanc sampl cluster cancer sampl includ premalign lesion adenomat polyp intestin metaplasia valid second sampl set sensit specif posit predict combin data select peptid sequenc identifi pepsinogen pepsin activ peptid downregul alphadefensin upregul conclus simpl reproduc multimark proteom assai supplement clinic gastroscop evalu symptomat patient enhanc diagnost accuraci gastric cancer premalign lesion
J Occup Med Toxicol	11934357	2007-08-03	PMC2585571	18990205	background increas evid exist heavi metal modul helper cell respons elicit patholog manifest interleukin il crucial innat cytokin regul xenobiot agent studi aim test il profil indic heavi metalsinduc immunomodul method human immunocompet cell activ monoclon antibodi heatkil salmonella enterica cultur absenc presenc cadmium cd acet mercur hg chlorid vivo experi set balbc mice expos subleth dose cd hg salt week cytotox assess mttreduct assai modul cytokin profil evalu enzymelink immunosorb assai elisa cytometr beadbas arrai cba realtim polymeras chain reaction rtpcr relev method cytokin quantif explor modul il profil cd hgexpos human pbmc dosedepend ifn level thpolar respons skew thth ratio vivo correl downregul il level case investig metal conclus infer il profil repres relev indic heavi metalinduc immun modul ii evalu cytokin profil cba relev adequ replac method elisa rtpcr basic immun diagnost iii target il therapeut approach promis modifi ththassoci immun disord
PLoS Pathog	17678556	2006-03-31	PMC2587711	19079577	two cardin manifest viral immun effici clearanc acut infect capac vaccin secondari viral exposur norovirus contribut cell viral clearanc vaccin elucid report cd cd cell requir effici clearanc primari murin noroviru mnv infect intestin intestin lymph node longlast protect immun gener oral live viru vaccin system vaccin mnv capsid protein effect protect mucos challeng vaccin capsid protein distantli human lordsdal viru provid partial protect fulli effect vaccin requir broad immun respons includ cd cell cd cell cell specif immun cell type vari intestin intestin lymph node perforin interferon gamma requir clearanc mnv infect adopt transfer lymphocyt vaccin host studi prove feasibl mucos system vaccin mucos noroviru infect demonstr tissu specif noroviru immun cell indic effici vaccin strategi induc potent cd cd cell respons
PLoS Pathog	16581910	2007-08-01	PMC2587915	19079579	a novel human coronaviru sarscov emerg suddenli caus human case death worldwid anim model fail faithfulli recapitul clinic cours sarscov human viru host factor mediat diseas pathogenesi remain unclear laboratori develop recombin mouseadapt sarscov rma lethal balbc mice contrast intranas infect young weekold cbl mice rma nonleth infect character high titer replic lung lung inflamm destruct lung tissu loss bodi weight provid model identifi host mediat protect report mice defici myd myd adapt protein mediat tolllik receptor tlr ilr ilr signal suscept rma infect genet absenc myd enhanc pulmonari patholog greater mortal dai postinfect myd mice higher viral load lung tissu cours infect despit increas viral load express multipl proinflammatori cytokin chemokin lung tissu recruit inflammatori monocytesmacrophag lung sever impair myd mice compar wildtyp mice mice defici chemokin receptor contribut monocyt recruit lung suscept rmainduc diseas exhibit sever lung patholog mydmic data mydmedi innat immun signal inflammatori cell recruit lung requir protect lethal rma infect
Asia Pac Fam Med	17670827	2017-09-22	PMC2588555	19014538	there three influenza pandem flu pandem highest mortal rate influenza viru infect human bird mutat mechan antigen drift antigen shift current hn avian flu viru limit outbreak poultri person direct contact infect poultri mortal rate infect human high avian influenza ai endem asia result unregul poultri rear rural area bird live close proxim human increas chanc genet reassort avian human influenza virus produc mutant strain easili transmit human global pandem sar person influenza infect contagi onset casedefin symptom limit effect case isol control strategi research carefulli orchestr public health measur limit spread ai pandem implement case appear control ai pandem nation global strategi need nation strategi includ sourc surveil control adequ stockpil antivir agent time product flu vaccin healthcar system readi global strategi earli integr respons curb diseas outbreak sourc util global resourc continu open commun critic
J Neuroinflammation	28937879	2011-11-01	PMC2588578	18947414	background worldwid billion peopl chronic infect toxoplasma gondii unknown consequ method better understand longterm effect pathogenesi common persist brain infect mice infect time human year equival earli mid adulthood studi month appear behavior neurolog function brain mri studi addit analys pathogenesi includ correl brain weight neurolog find histopatholog focus brain region full genom microarrai immunohistochemistri character inflammatori cell determin presenc tachyzoit bradyzoit electron microscopi studi marker inflamm serum histopatholog genet resist mice cytokin nramp knockout mice effect inocul isol parasit treatment sulfadiazin pd ligand studi twelv month infect time equival middl earli elderli ag mice behavior neurolog deficit brain mri mild moder ventricular dilat lower brain weight correl greater magnitud neurolog abnorm inflamm full genom microarrai brain reflect inflamm caus neuron damag gfap effect host cell protein process ubiquitin ligas synaps remodel complement increas express pdl ligand allow persist lcmv brain infect cd fatti acid translocas oxid ldl receptor mediat innat immun respons beta amyloid associ proinflamm alzheim diseas immunostain detect inflamm intraneuron cyst practic free tachyzoit rare bradyzoit perivascular leptomening inflammatori cell contigu aqueduct sylviu hippocampu cd cd cell activ microglia perivascular area brain parenchyma genet resist chronic infect mice inflamm conclus outbr mice chronic adult acquir gondii infect neurolog behavior abnorm secondari inflamm loss brain parenchyma perivascular inflamm promin contigu aqueduct sylviu hippocampu resist mice perivascular inflamm mous model chronic gondii infect rais question persist parasit brain inflamm neurodegener genet suscept host
Crit Care	22005305	2005-03-01	PMC2592769	18950526	introduct clinic observ anim model provid evid develop acut lung injuri ali phenomenon acut diffus lung inflamm critic patient influenc genet factor associ studi main tool explor common genet variat underli ali suscept andor outcom aim assess qualiti posit genet associ studi ali suscept andor outcom adult order highlight consist major limit method conduct broad pubm literatur search june origin articl english support posit associ genet variant contribut allcaus ali suscept andor outcom studi evalu base current recommend point qualiti score system deriv criteria gene consid unit replic gene categor biolog process gene ontolog search identifi total studi report posit find gene involv respons extern stimulu cell signal transduct gene encod interleukin mannosebind lectin surfact protein angiotensinconvert enzym replic studi averag studi intermedi qualiti score median interquartil rang conclus qualiti associ studi improv year better design studi includ replic previou find larger sampl size extend popul group european descent need identifi firm genet modifi ali
Virol J	15735160	2014-10-31	PMC2603006	19014487	background coronavirus broad rang diseas anim human human coronaviru hcov nl associ common cold viral plaqu assai enabl character viru infect allow purifi viru stock solut essenti drug screen hitherto cell cultur hcovnl low level viru replic weak diffus cytopathogen effect establish practic plaqu assai human pathogen cell cultur test suscept hcovnl infect human colon carcinoma cell caco replic viru fold effici commonli african green monkei kidnei cell llcmk caco cell cytopathogen effect dai post infect avicel agaros carboxymethylcellulos overlai prove suitabl plaqu assai best achiev avicel produc larg clear plaqu dai infect util plaqu assai agros overlai demonstr purifi viru increas viral infect log pfuml conclus caco cell support hcovnl better llcmk cell enabl cytopathogen plaqu assai avicel overlai favour plaqu quantif agaros overlai prefer plaqu purif hcovnl viru stock increas infect will benefici antivir screen anim model diseas experiment task
BMC Public Health	25362048	2016-05-01	PMC2605461	18973664	background attack sever acut respiratori syndrom sar develop qualifi public health leader urgenc build infrastructur need address public health emerg previou studi report train individu leader approach system scientif train model improv develop purpos studi develop deliv evalu participatori leadership train program emerg respons method fortyon public health leader provinc complet entir emerg prepared train program china program evalu anonym questionnair semistructur interview held prior train posttrain month train followup emerg prepared train posit shift knowledg selfassess skill public health leader ninetyf percent particip report train model scientif feasibl respons particip program avian influenza outbreak plan evalu leadership train program demonstr success approach method posit impact integr leadership train initi conclus emerg prepared train program met aim object satisfactorili improv emerg capabl public health leader suggest leadership train model effect feasibl improv emerg prepared capabl
PLoS One	26880796	2008-07-16	PMC2606062	19122813	background equin herpesviru type ehv member alphaherpesvirina spread nasal secret respiratori diseas neurolog disord abort viru equin pathogen current ehv vaccin partial protect effect metaphylact therapeut agent small interf rna sirna deliv intranas prove valuabl altern infect control sirna essenti ehv gene encod viral helicas ori glycoprotein evalu potenti decreas ehv infect mous model methodologyprincip fnding sirna therapi vitro reduc viru product plaqu size viral titer reduc fold pmol singl sirna pmol sirna combin sirna therapi vivo reduc viral replic clinic sign intranas treatment requir transport vehicl prove effect infect conclusionssignific sirna treatment potenti prevent earli treatment ehv infect
BMC Genomics	18632870	2013-08-21	PMC2607299	19046445	background febril respiratori ill fri high impact public health global econom pose difficult challeng differenti diagnosi issu detect genet divers pathogen human rhinovirus hrv enterovirus hev frequent fri resequenc pathogen microarrai technolog demonstr potenti differenti diagnosi respiratori pathogen simultan high confid design method select probe genet divers virus lack hrv hev test case assess gener design strategi detect serotyp genet divers virus minim number probe sequenc hrv hev capabl detect serotyp hrv hev determin implement resequenc pathogen microarrai rpmflu tessara rpmflu specif design probe valid hrv hev strain strain detect identifi speci level hrv strain hev strain differenti serotyp level conclus studi fundament evalu simultan detect differenti identif genet divers rna virus minim number prototyp sequenc demonstr newli design rpmflu provid comprehens specif analysi hrv hev sampl implic design strategi will applic genet divers virus
BMC Microbiol	23966403	2008-11-01	PMC2613400	19038059	background absenc effect drug control sar reli rapid identif case appropri manag close contact effect vaccin sar develop specif sensit laboratori test sar effect vaccin nation author gene encod truncat nucleocapsid spike protein sarscov clone express vector pqe fusion express escherichia coli fusion protein analyz reactiv sar patient sera antisera human coronavirus hcov hcov oc elisa ifa immunoblot assai evalu antigenspecif humor antibodi tcell respons mice fusion protein inject weekold balbc mice neutral test tcell analysi perform evalu antivir efficaci immun balbc mice challeng intranas sarscov dai post inject viral load determin fluoresc quantit rtpcr serolog diagnost sensit specif truncat sn fusion protein deriv sar viru crossreact human coronavirus high titer antibodi srascov appear immun mice neutral test antibodi fusion protein inhibit sarscov cell prolifer fusion protein induc antigenspecif tcell respons fluoresc quantit rtpcr balbc mice challeng intranas sarscov dai post inject complet protect viru replic conclus truncat sn fusion protein suitabl immunodiagnost antigen vaccin candid
PLoS One	19727424	2007-11-13	PMC2613559	19159014	mucos vaccin offer great advantag induc protect immun respons prevent viral transmiss dissemin report find headtohead comparison viral vector modifi vaccinia ankara mva novel replicationcompet modifi vaccinia tian tan mvtt induc neutral antibodi nab intramuscular mucos vaccin mice mvtt attenu variant wildtyp vtt histor smallpox vaccin million chines peopl spike glycoprotein sarscov test antigen gene construct ident genom locat vector gener vaccin candid mvtt mva ident dose mvtt induc lower level fold anti sarscov neutral antibodi nab mva intramuscular inocul mvtt capabl induc consist tofold higher level nab mva inocul intranas intraor rout level mvttsinduc nab respons fold higher induc intramuscular rout experi preexposur wildtyp vtt intranas intraor rout impair nab respons rout mvtt vaccin preexist antivtt nab respons efficaci intranas intraor vaccin tofold better intramuscular inocul despit subcutan preexposur wildtyp vtt data implic peopl maintain low level antivtt nab histor smallpox vaccin mvtt attract live viral vector mucos vaccin
PLoS One	17999949	2011-03-02	PMC2613561	19137067	background influenza pneumonia high mortal year pandem episod kill million peopl influenzarel mortal various ascrib ineffect host respons fail limit viral replic excess host inflammatori respons lung injuri impair ga exchang bacteri superinfect sought determin lung inflamm promot impair host surviv influenza pneumonia method find distinguish influenzarel death induc robust lung inflamm expos mice aerosol bacteri lysat prior challeng live viru treatment induc express inflammatori cytokin il tnf bronchoalveolar lavag fluid fold greater caus lethal influenza infect augment inflamm associ strike resist host mortal surviv reduc viral titer bacteri superinfect viru infect lung observ mice repeatedli expos bacteri lysat clinic desir influenza epidem tachyphylaxi induc viral resist bacteri lysat administ viral challeng mortal benefit ribavirin aerosol bacteri lysat host surviv synergist improv surviv conclus data indic innat immun resist influenza effect stimul ineffect excess inflamm major mortal influenza pneumonia
BMC Health Serv Res	21367909	2014-10-16	PMC2613902	18990210	background sar epidem healthcar util medic servic decreas longterm impact sar hospit perform discuss method municip hospit taipei citi shut month sar design sar infecti diseas hospit citi studi collect outpati inpati emerg servic volum year april march year averag monthli servic amount standard deviat compar patient volum hospit outpati number access depart arima model outpati volum presar year develop averag monthli servic volum outpati visit base year visit month number year base year averag emerg servic volum visit month base year base year three year averag inpati servic volum inpati dai month base year base year three year emerg servic volum recov level nonsignific differ second year sar addit depart famili medicin metabol nephrolog reach patient number arima model suitabl outpati volum presar year mape arima model presar year year conclus studi demonstr hospit complet shut sar diseas impact longer previou report depart experi recov period find studi identifi subspecialti vulner infecti diseas design hospit hospit consid subspecialti includ medic structur
Evol Bioinform Online	25323704	2009-03-01	PMC2614192	19204824	thi investig aim compar infer antelop phylogeni rrna cytochromeb cytb dloop segment mitochondri dna three comput model includ bayesian ba maximum parsimoni mp unweight pair group method arithmet upgma respect nucleotid sequenc three oryx speci oryx leucoryx oryx dammah oryx gazella outgroup addax nasomaculatu align subject ba mp upgma model compar topolog respect phylogenet tree rrna region possess highest frequenc conserv sequenc cytb dloop transit transvers rrna compar cytb transit transvers dloop transit transvers compar taxa three mitochondri segment clearli differenti genu addax oryx ba upgma model topolog gammacorrect bayesian tree ident irrespect marker type upgma tree rrna dloop sequenc ident oryx dammah group oryx leucoryx bayesian tree upgma tree base cytb phylogeni oryx dammah group oryx gazella low bootstrap support mp model fail differenti genu addax oryx find demonstr effici robust ba upgma method phylogenet analysi antelop mitochondri marker
PLoS One	19131084	2014-12-03	PMC2614347	19137069	lung cancer lead cancerrel mortal worldwid lack tumor specif remain major drawback effect chemotherapi doselimit toxic ligandmedi drug deliveri system render chemotherapi specif tumor cell toxic normal tissu studi isol novel peptid ligand phagedisplai peptid librari bound nonsmal cell lung cancer nsclc cell line target phage bound nsclc cell line normal cell target phage synthet peptid recogn surgic specimen nsclc posit rate of specimen sever combin immunodefici scid mice bear nsclc xenograft target phage bound tumor mass tumor home abil target phage inhibit cognat synthet peptid control wtymut peptid target peptid coupl liposom carri doxorubicin vinorelbin therapeut chemotherapeut agent surviv rate mice human lung cancer xenograft markedli increas target liposom increas drug accumul tumor tissu fold compar free drug enhanc cancer cell apoptosi higher concentr bioavail doxorubicin current studi suggest tumorspecif peptid creat chemotherapi target tumor cell treatment nsclc design target gene transfer vector diagnosi malign
PLoS Biol	25473061	2006-12-20	PMC261870	14624234	becaus constant threat pose emerg infecti diseas limit exist approach identifi pathogen great demand technolog method viral discoveri describ dna microarraybas platform novel viru identif character central approach dna microarrai design detect wide rang virus novel member exist viral famili microarrai contain highli conserv mer sequenc fulli sequenc refer viral genom genbank outbreak sever acut respiratori syndrom sar march hybrid microarrai reveal presenc uncharacter coronaviru viral isol cultiv sar patient character viru kb unknown viru genom clone physic recov viral sequenc hybrid individu arrai element sequenc fragment confirm viru member coronaviru famili combin arrai hybrid direct viral sequenc recoveri prove gener strategi rapid identif character novel virus emerg infecti diseas
PLoS One	17182688	2016-12-30	PMC2625438	19156204	background immunopathogenesi chikungunya viru circul level immun mediat growth factor analyz patient infect singaporean chikungunya fever outbreak earli establish biomark associ infect andor diseas sever method find adult patient laboratoryconfirm chikungunya fever infect refer communic diseas centretan tock seng hospit period januari februari includ retrospect studi plasma fraction analyz multiplexmicrobead immunoassai patient common clinic featur fever arthralgia rash conjunct profil cytokin chemokin growth factor discrimin clinic form chikungunya healthi control patient classifi nonsever sever diseas level plasma cytokin growth factor elev statist analysi increas il il decreas rant associ diseas sever conclus comprehens report product cytokin chemokin growth factor acut chikungunya viru infect biomark distinguish mild diseas sever form chikungunya fever enabl identif patient poor prognosi monitor diseas
Virol J	28038565	2015-09-14	PMC2628353	19102764	an infecti bronchiti viru arkansa dpi ark dpi virul strain sequenc analyz compar ibv strain coronavirus genom ark dpi consist nucleotid exclud poli tail compris ten open read frame compar sequenc analysi ark dpi ibv strain strike similar conn grai jmk ark circul time period comparison ark genom coronavirus demonstr close relationship turkei coronaviru nonstructur gene untransl region utr clike proteinas clpro polymeras rdrp sequenc ident grai strain structur gene ident ark ident jmk conn ident conn strain recombin site intergen region spike gene gene independ recombin event occur entir genom ark dpi involv ibv strain suggest genom rna recombin occur genom number site specul ark dpi strain origin conn strain diverg evolv independ point mutat recombin field strain
BMC Genomics	26371252	2014-07-23	PMC2628393	18973670	background genom store build maintain organ complet sequenc genom opportun studi compar global properti genom analyz aspect content homo sapien mu musculu drosophila melanogast caenorhabd elegan arabidopsi thaliana saccharomyc cerevisia escherichia coli genom virtual bp oligom appear vertebr genom bp oligom speci rang oligom melanogast bp elegan bp thaliana bp cerevisia bp coli bp frequenc uniqu oligom genom follow pattern identifi set mer nucleotid mer human genom probe detect microb human sampl human sampl probe detect current fulli sequenc prokaryot fulli sequenc virus human genom compact sequenc space random genom identifi frequent mer human genom prove pcr primer identifi bacterium anaeromyxobact dehalogenan exception low divers oligom size genom gc content entropi code region human genom higher noncod region chromosom chromosom high proport code dna high entropi chromosom opposit low frequenc code region high entropi conclus measur frequenc oligom design pcr assai identifi chromosom organ hidden structur recogn detect novel microb human tissu
J Transl Med	25056903	2013-08-05	PMC2628881	19077207	member carcinoembryon antigen famili ceacam express depend tissu capabl regul divers function includ tumor promot tumor suppress angiogenesi neutrophil activ member famili ceacam ceacam ceacam ceacam recogn cda cdb cdc cdd mab express human neutrophil cda cdb cdc cdd antibodi increas neutrophil adhes human umbil vein endotheli cell monolay increas neutrophil adhes caus cd antibodi block cd mab associ upregul cdcd neutrophil surfac examin potenti interact ceacam neutrophil signal effect neutrophil adhes human umbil vein endotheli cell set cd mab test desensit stimul combin mab addit cd mab absenc calcium desensit neutrophil stimul cd mab current data desensit neutrophil ceacam select desensit ceacam cell remain respons neutrophil ceacam addit cell desensit ceacam respons stimul ceacam cda mab contrast desensit cell ceacam ceacam left cell unrespons cd mab cell desensit combin ceacam remain respons unrel control protein cd independ neutrophil ceacam signal ceacam appear plai uniqu role neutrophil ceacam model ceacam dimer form signal complex accommod observ interact occur cell express ceacam
PLoS Pathog	23918369	2010-07-01	PMC2629125	19197350	rift vallei fever viru rvfv genu phleboviru famili bunyavirida negativestrand rna viru tripartit genom rvfv transmit mosquito fever sever hemorrhag ill human fever high rate abort livestock nonstructur rvfv nss protein inhibit transcript host mrna includ interferon mrna major virul factor studi explor novel function rvfv nss protein test replic rvfv lack nss gene presenc actinomycin actd amanitin serv surrog host mrna synthesi suppress function nss presenc hosttranscript inhibitor replic rvfv lack nss protein carri nss induc doublestrand rnadepend protein kinas pkrmediat eukaryot initi factor eif phosphoryl lead suppress host viral protein translat rvfv nss promot posttranscript downregul pkr earli cours infect suppress phosphoryl eif accumul data suggest combin rvfv replic nssinduc host transcript suppress induc pkrmediat eif phosphoryl nss facilit effici viral translat downregul pkr inhibit pkrmediat eif phosphoryl distinct function nss suppress host transcript includ type interferon mrna downregul pkr work prevent host innat antivir function allow effici replic surviv rvfv infect mammalian host
J Ethnobiol Ethnomed	20579746	2013-03-18	PMC2630947	19138420	bear bile tradit chines medicin tcm thousand year modern investig wide rang pharmacolog action toxicolog side pure compound cure hepat biliari disord decad extens consumpt bear bile bear endang speci bear farm establish china extract bear bile live bear freedrip fistula techniqu bear farm extrem inhuman bear di ill chronic infect liver cancer effort nongovernment organ mass media chines govern bear farm ultim time systemat to find altern bear bile review focus literatur laboratori clinic bear bile substitut altern english chines databas examin substitut altern bear bile three aspect pure compound deriv bear bile bile anim herb tcm discuss strategi stop trade bear bile issu bear bile potenti altern candid exist problem altern work futur
BMC Biotechnol	23324616	2014-08-27	PMC2631500	19014469	background human monoclon antibodi mab gener result immun respons effect therapeut antibodi case infecti diseas immun respons protect human cytomegaloviru hcmv ubiquit opportunist viru seriou pathogen agent transplant patient therapeut armamentarium hcmv hyperimmun globulin antivir associ sever side effect emerg drugresist strain neutral human mab decis altern prevent primari reactiv hcmv infect patient purpos studi gener neutral mab hcmv immunolog repertoir immun donor aim design effici technolog reli discret sequenti step human blymphocyt stimul tlragonist il second addit remov cell infect ebv strategi clone secret igg neutral hcmv infect character mab neutral infect combin hcmv strain target cell potenc fold higher hcmv hyperimmun globulin current transplant recipi recombin human monoclon igg suitabl prophylact therapeut tool clinic applic gener conclus technolog describ proven reproduc effici rapid report techniqu adopt low cost cell biologi laboratori develop fulli human mab immunotherapeut us
BMC Genomics	25165113	2007-03-28	PMC2631582	19099596	background sodium channel heteromultimer integr membran protein belong superfamili ion channel mutat gene encod sodium channel protein link inherit genet disord febril epilepsi brugada syndrom ventricular fibril long qt syndrom channelopathi associ insensit pain spite effect sodium channel proteinsgen human health publicli resourc focus sodium channel support explor sodium channel report dragon databas explor sodium channel human ddesc comprehens sodium channel entiti gene protein metabolit enzym toxin chemic pharmacolog effect diseas concept human anatomi pathwai pathwai reaction potenti link ddesc compil base text datamin allow user explor potenti associ entiti sodium channel human automat gener novel hypothes conclus ddesc publicli resourc sodium channel human explor level databas freeli access academ nonprofit user worldwid web 
BMC Vet Res	17392374	2016-02-01	PMC2632637	19014526	background rotaviru rv member reovirida famili etiolog agent acut viral gastroenter young rotavirus wide host rang infect broad rang anim speci rotaviru infect exot anim paper report characteris rv strain giraff calf report describ identif detail molecular characteris rotaviru strain detect dayold giraff giraffa camelopardali present acut diarrhea rv strain detect giraff character molecularli gp detail sequenc analysi vp vp reveal ident amino acid sequenc level bovin rv borv conclus studi demonstr continu surveil rv strain anim popul will facilit identif rotaviru host report extend typic epidemiolog studi broader host rang will contribut time identif emerg strain type
Retrovirology	27757250	2007-04-11	PMC2633348	19077215	background elit nonprogressor plasma viral load copiesml antiretrovir naiv constitut tini fraction hivinfect individu year followup cohort longterm nonprogressor ltnp identifi individu transfusionacquir hiv infect remain ltnp year infect retain elit ltnp statu examin mechan differenti delai progressor ltnp cohort surviv advantag confer subject host genet factor hla chemokin receptor tlr polymorph viral attenu factor defect nef associ slow progress antivir immun respons differenti cours diseas second decad infect stabl pspecif prolif respons associ control viraemia retent nonprogressor statu respons absent declin viraem subject strong gagdomin cytotox lymphocyt ctl respons identifi ltnp pol dominantctl nefdefect hiv infect ctl associ control viraemia combin prolif respons ctl prevent late diseas progress individu sustain viral suppress ctl recognis numer gag epitop strong restrict respons immunodomin epitop effect time fail viraemia cours studi viral escap mutant hla brestrict gagp epitop detect individu declin neg prolif respons occur concurr increas viraemia conclus detect viraemia studi entri predict loss ltnp statu andor diseas progress differenti slow progressor elit ltnp retain potent virolog control sustain immunolog suppress viraemia independ associ preserv prolif respons strength breadth ctl respons declin protect respons preced correl loss nonprogressor statu andor sign diseas progress
Int J Mol Sci	17428862	2005-01-28	PMC2635621	19330066	sampl blood kidnei liver randomli select slaughter pig analyz ochratoxin hplc addit order occurr nephropathi histolog examin carri liver sampl contain ota rang ngg incid ota serum kidnei maximum concentr ngml ngg histopatholog examin kidnei confirm tubulopathi edema cell vacuol addit hemorrhag necrosi proxim kidnei tubul cell found
Int J Mol Sci	15681402	2008-09-19	PMC2635728	19325804	despit fact nonvir nucleic acid deliveri system gener consid effici viral vector gain interest year superior safeti profil compar viral counterpart synthet vector cation polym branch dendrim cation liposom cellpenetr peptid cpp repres assort fairli unrel sequenc essenti characteris high content basic amino acid length residu cpp capabl mediat cellular uptak hydrophil macromolecul peptid nucleic acid sirna aptam antisenseoligonucleotid internalis cell low rate appli numer sequenc report cellpenetr properti transport varieti cargo mammalian cell year appar endocytosi major rout internalis mechan underli cellular transloc cpp understood subject controversi discuss review will summaris latest develop peptidebas cellular deliveri nucleic acid cargo will discuss mechan entri intracellular fate cargo correl studi uptak versu biolog activ cargo technic problem pitfal
Int J Mol Sci	18793145	2005-05-26	PMC2635754	19325820	develop antivir focus vaccin treatment specif viral agent effect approach limit situat etiolog agent unknown target viru undergon mutat recombin reassort augment innat immun respons effect altern diseas amelior nonspecif broadspectrum immun respons induc doublestrand dsrna poli iclc oligonucleotid odn unmethyl deocycytidyldeoxyguanosinyl cpg motif offer protect bacteri viral pathogen genet makeup zoonot origin drug resist
PLoS One	15919828	2011-11-29	PMC2644758	19240806	background amplif reaction reveal singl virus viral coinfect caus acut bronchiol infant rv appear grow involv earli respiratori diseas remain controversi object determin prospect respect role rsv rv hmpv coinfect sever acut bronchiol young infant method princip find infant median ag month enrol prospect studi infant year hospit episod bronchiol winter epidem season high risk sever diseas sever assess record sao admiss daili clinic score scale durat oxygen supplement length hospit virus identifi amplif reaction rsv rv hmpv dual rsvrv viru coinfect rv compar rsv dual rsvrv infect caus sever diseas lower clinic score p shorter time oxygen supplement dai dai dai shorter hospit stai dai dai dai convers rsv infant longer durat hospit comparison rsvrv hmpv multivari analys type viru carri independ associ durat hospit conclus studi underlin role rv earli respiratori diseas frequent carri young infant acut bronchiol rsv caus sever diseas convers rv lesser sever addit dual rsvrv infect observ sever
Curr Genomics	22124328	2014-02-01	PMC2647156	19412418	the hla region encod molecul plai kei role immun system strong associ hla region autoimmun diseas aid establish fifti year associ compon hla class ii encod hladrbdqadqb haplotyp detect aid includ rheumatoid arthriti type diabet grave diseas molecul encod region plai kei role exogen antigen present cd cell indic pathwai aid initi progress compon hla class iii region investig associ aid apart associ hlab ankylos spondyl difficult determin addit suscept loci independ strong linkag disequilibrium ld hla class ii gene advanc statist analysi ld recruit larg aid dataset allow investig hla class iii region revisit associ hla class region independ hla class ii effect detect aid includ strong associ hlab type diabet hlac multipl sclerosi grave diseas provid evid role bacteri viral infect cd cell aid onset advanc determin primari associ hla region aid will increas understand mechan diseas pathogenesi aid develop novel therapeut target futur
Interdiscip Perspect Infect Dis	24506781	2018-10-31	PMC2648660	19266090	season variat smallpox transmiss press ecolog question relev bioterror prepared studi reanalyz histor dataset record monthli case death addit time seri analys report data estim spectral analysi effect reproduct number calendar time meteorolog variabl extract report india compar smallpox mortal annual cycl smallpox transmiss clearli monthli report estim shortterm epidem data clearli exhibit annual peak januari mortal reveal neg associ correl humid find smallpox transmiss greatli vari season enhanc dry weather
BMC Bioinformatics	30381484	2008-10-15	PMC2648740	19208150	background sar coronaviru main proteinas sar covmpro enzym replic sever acut respiratori syndrom viru activ site region sar covmpro divid subsit understand bind mode sar covmpro specif substrat contribut structuralbas drug design purpos investig bind mode sar covmpro octapeptid region subsit molecular dock molecular dynam md simul approach turn helix chain residu sar covmpro directli involv inducedfit model enzymesubstr complex subsit enzym neg charg region presenc glu md simul glu enzym plai kei role electrostat bond ply octapeptid conclus md simul carri sar covmprooctapeptid complex hypothesi propos glu sar covmpro residu subsit involv bind ply octapeptid
PLoS One	18601651	2014-03-10	PMC2649436	19270739	background iberian lynx lynx pardinu consid endang felid speci order save speci spanish author implement captiv breed program recruit lynx wild context retrospect survei preval select felin pathogen freerang lynx initi methodolog princip find systemat analyz preval viral protozoan cytauxzoon feli bacteri hemotrop mycoplasma infect remain freerang iberian lynx doana sierra morena area southern spain except felin immunodefici viru fiv evid infect test felin pathogen iberian lynx fourteen lynx felin leukemia viru felv provirusposit eleven antigenem felv posit anim test neg viral infect sixmonth period provirusposit antigenem lynx di infect felv infecti agent associ mortal sequenc felv surfac glycoprotein gene reveal common origin ten eleven sampl ten sequenc close felva origin isol cat usa endogen felv sequenc detect conclusionssignific conclud felv infect origin domest cat invad lynx habitat data time frame coinfect outcom felvinfect contrast domest cat felv strain lynx highli virul speci data argu vaccin lynx domest cat lynx habitat order prevent spread viru reduct domest cat popul lynx popul maintain
Clin Mol Allergy	24614365	2005-03-01	PMC2651109	19154602	virus predomin infecti asthma exacerb develop addit evid suggest viral infect causal role develop childhood asthma articl will describ gener percept link infect asthma chang centuri focu develop provid insight contribut virus asthma pathogenesi highlight area includ contribut sever earli life viral infect asthma incept genet determin sever viral infect infanc differ innat adapt immun system cytokin respons viral infect asthmat nonasthmat subject potenti vaccin strategi prevent sever earli life virallyinduc ill
PLoS Genet	15750141	2014-08-14	PMC2652835	19300501	popul human immunodefici viru type hiv undergo surprisingli larg amount genet drift infect patient despit larg popul size predict determinist model propos explain phenomenon implicitli assum process viru replic contribut genet drift develop assai measur amount genet drift hiv popul replic cell cultur assai reli creation hiv popul size measur variat frequenc neutral allel assai hiv undergo ten time genet drift expect popul size defin number infect cell cultur larg portion increas genet drift nonsynchron infect target cell infect synchron genet drift viru fold higher expect popul size stochast natur biolog process involv viral replic contribut increas genet drift hiv popul propos appreci effect will allow better understand evolutionari forc act hiv infect patient
PLoS Biol	25125497	2009-01-01	PMC2653555	19278295	rabi elimin domest dog popul western europ north america continu kill thousand peopl africa asia year quantit understand transmiss dynam domest dog popul critic assess global elimin canin rabi report extens observ individu rabid anim tanzania gener uniqu detail analysi transmiss biologi explain epidemiolog featur includ level variat epidem trajectori basic reproduct number rabi low studi area rural africa histor global rang find strong support feasibl control endem canin rabi vaccin wildlif area larg wild carnivor popul rapid turnov domest dog popul major obstacl success control develop countri regular puls vaccin will requir maintain populationlevel immun campaign analys sustain intern commit global elimin rabi domest dog popul danger vector human realist goal
PLoS One	18796313	2011-05-17	PMC2653722	19287488	coronaviru protein essenti compon virion plai pivot role virion assembl bud matur protein integr viral envelop three transmembran domain flank short aminotermin ectodomain larg carboxytermin endodomain studi copurif protein coronaviru infecti bronchiti viru ibv actin understand cellular factor involv virion assembl bud matur process ibv bait yeast twohybrid screen identif actin interact partner interact subsequ confirm coimmunoprecipit immunofluoresc microscopi mammalian cell mutat amino acid protein abolish interact introduct ak mutat infecti ibv clone system block infect clone viral rna replic subgenom mrna transcript activ detect disrupt actin filament cellperm agent cytochalasin earli stage infect cycl led detect viral protein synthesi infect cell releas viru particl cultur media treatment late stage infect cycl affect releas viru particl media suggest disrupt actin filament block virion assembl bud releas viru particl studi reveal essenti function actin replic cycl coronaviru
BMC Public Health	21586499	2016-05-11	PMC2654560	19216738	background healthcar worker hcw will plai kei role respons pandem influenza uk healthcar system abil cope influenza pandem will depend larg extent number hcw work crisi uk emerg plan will improv planner better understand reason uk hcw absente motiv work influenza pandem paper report qualit studi explor uk hcw view work influenza pandem order identifi factor influenc willing abil work identifi potenti sourc perceiv duti hcw work method qualit studi focu group interview hcw rang role grade tend feel motiv sens oblig work influenza pandem number barrier prevent identifi perceiv barrier abil work includ oneself transport difficulti childcar respons perceiv barrier willing work includ prioritis wellb famili member lack trust goodwil nh lack risk expect crisi fear litig feel employ staff serious barrier abil barrier willing difficult separ conclus particip tend feel gener oblig work influenza pandem barrier work generalis reduc nh workforc pandem barrier identifi barrier willing abil suggest pandem plan account possibl staff absent reason current anticip uk plan document staff physic attend work unwil barrier mitig employ ill transport infrastructur number remedi step lesson impact provid accommod build reciproc provis guidanc barrier work lie abilitywilling continuum absente reduc step prevent barrier willing perceiv barrier abil
PLoS Pathog	27170751	2010-02-08	PMC2654722	19325881	brome mosaic viru bmv protein multipl kei role viral rna replic local perinuclear endoplasm reticulum er membran peripher membran protein induc er membran invagin rna replic complex form recruit stabil bmv polymeras apol rna replic templat site establish activ replic complex replic rna cap ntpase rna helicas function identifi bmv amphipath helix helix nmr analysi defin structur propens insert hydrophob membranemimick micel helix essenti effici aer membran associ normal perinuclear er local delet mutat helix abolish rna replic strikingli mutat helix rise dramat opposit function phenotyp impli helix act molecular switch regul intric balanc separ function class helix delet amino acid substitut markedli inhibit amembran associ abolish er membran invagin viral rna templat recruit replic doubl amedi increas apol accumul second class helix mutat maintain effici amembran associ amplifi number ainduc membran invagin fold enhanc viral rna templat recruit fail stimul apol accumul provid insight pathwai rna replic complex assembl helix critic assembl function viral rna replic complex includ central role target replic compon control mode action
Virol J	20142477	2011-04-01	PMC2654877	19138419	viral infect frequent cite major environment factor involv subacut thyroid autoimmun thyroid diseas review examin data role virus develop thyroid focus human data review virolog data type thyroid level evid epidemiolog data serolog data circul virus direct evid thyroid tissu infect interpret epidemiolog serolog data cautiou prove pathogen respons diseas direct evid presenc virus compon organ retrovirus hfv mump subacut thyroid retrovirus htlv hfv hiv sv gravess diseas htlv enteroviru rubella mump viru hsv ebv parvoviru hashimoto thyroid remain determin respons thyroid diseas innoc bystand studi need clarifi relationship virus thyroid diseas order develop strategi prevent andor treatment
BMC Biotechnol	21460211	2015-11-09	PMC2656497	19187544	background common method gmo detect base amplif gmospecif dna amplicon polymeras chain reaction pcr appli loopmedi isotherm amplif lamp method amplifi gmorel dna sequenc intern commonlyus motif control transgen express eventspecif planttransgen junction test specif sensit techniqu gmo studi detect gmo equival background dna dilut templat detect singl copi templat lamp conclus work gmo detect carri lamp routin screen specif event detect sensit abil amplifi target high background dna demonstr highlight advantag isotherm amplif appli gmo detect
BMC Infect Dis	26554031	2017-03-01	PMC2656517	19171043	background epidemiolog studi strong associ ureaplasma urogenit tract diseas human healthi human colon ureaplasma role pathogen remain controversi order to defin role host diseas develop rodent model urinari tract infect uti fischer rat anim inocul steril broth log cfu ratadapt strain ureaplasma parvum infect anim exhibit distinct profil asymptomat uti uti complic struvit urolithiasi inoculum dose parvum incid uti anim inocul cfu parvum remain infect inoculum dose influenc immun respons parvum asymptomat uti character minim immun respons monocyt lymphocyt limit lesion elev urinari level ifn il mcp uti complic struvit format character exagger immun respons neutrophil lesion extens uroepitheli hyperplasia predomin il il grokc urin anim asymptomat uti high rate kidnei infect conclus complic associ parvum infect depend hostspecif factor ureaplasma microbi load immun respons rat occur human ureaplasm associ diseas model infect tool elucid parvumhost interact confer uti diseas
PLoS One	28251928	2014-03-25	PMC2657001	19293944	background sustain outbreak highli pathogen avian influenza hpai hn avian speci increas risk reassort adapt human abil spread chicken reduc threat help maintain capac eggbas vaccin product vaccin offer potenti control avian diseas major concern current vaccin potenc inabl protect evolv avian influenza virus methodolog princip find abil dna vaccin encod hemagglutinin ha protein hpai hn serotyp evalu abil elicit neutral antibodi protect homolog heterolog hpai hn strain challeng mice chicken dna immun needl syring pressur inject devic vaccin elicit antibodi neutral multipl strain hpai hn combin respons dosedepend breadth determin choic influenza viru ha vaccin monoval trival ha vaccin test mice confer protect lethal hn avietnam challeng week vaccin chicken protect observ heterolog strain hpai hn vaccin trival serotyp dna vaccin dose low dna intramuscular needl inject needlefre devic conclusionssignific dna vaccin offer gener approach influenza viru immun applic multipl anim speci addit abil substitut plasmid encod strain enabl rapid adapt vaccin newli evolv field isol
Virol J	24668816	2020-02-14	PMC2657138	19196466	background infecti bronchiti viru induc diseas respiratori system ibv strain variabl tissu tropism affect oviduct kidnei proventricul associ ibv strain aim studi investig immunohistochemistri ihc tissu tropism avian infecti bronchiti viru ibv strain experiment infect chicken embryo chicken embryo inocul allanto sac eid ibv dai ag postinocul pi embryo chorioallanto membran cam sampl fix paraffinwax embed allanto fluid collect titrat chicken embryo kidnei cell cek sensit ihc detect ibv antigen cam inocul egg match viru reisol detect cek ihc antigen ibv detect nasal epithelium trachea lung spleen myocardi vasculatur liver gastrointestin tract kidnei skin sclera ey spinal cord brain neuron inocul embryo consist viru isol denot wide tissu tropism ibv chicken embryo importantli infect vasculatur smooth muscl proventriculu ibv strain conclus ihc addit tool diagnosi ibv infect chicken allow studi foster deeper understand pathogenesi infect ibv strain virul underlin embryon tissu addit cam sourc gener ibv antigen diagnost purpos
Microb Cell Fact	32060123	2014-11-03	PMC2658664	19183481	background cellular protein patp lsmp dhhp requir replic positivestrand virus potenti target antivir drug priorit host target antivir drug screen compar metabolom analysi saccharomyc cerevisia refer strain mat leu ly ura delet strain pat lsm dhh perform gcm analysi permit quantif polar metabolit identif of metabolit variat strain identifi partial squar latent structur discrimin analysi plsda analysi reveal differ pat refer strain character euclidian distanc normal peak area growth rate specif product rate ethanol glycerol strain conclus hypothes human analog yeast patp best drug target candid
PLoS Pathog	25368412	2004-07-01	PMC2658809	19343214	the abil nw clade arenaviru enter cell human transferrin receptor tfr strictli correl abil hemorrhag fever amapari amav tacarib tcrv nonpathogen nw clade arenavirus human tfr close nw arenavirus hemorrhag fever pseudotyp virus bear surfac glycoprotein gp amav tcrv infect cell tfr ortholog mammalian speci includ respect natur host small rodent neacomi spinosu fruit bat artibeu jamaicensi mutat residu human tfr function receptor tcrv mutat residu function receptor amav data support vivo role tfr replic nw clade arenavirus modest chang gp nonpathogen arenavirus human tfr emerg human pathogen
BMC Genomics	15243082	2011-05-02	PMC2660370	19196461	background haemophilu parasui hp swine pathogen glsser diseas character fibrin polyseros mening arthriti molecular mechan underli pathogenesi diseas remain understood resist porcin immun system hp invas studi investig global chang gene express spleen hp infect affymetrix porcin genechip total differenti express de transcript identifi porcin spleen dai hp infect uniqu gene differenti express pattern base analysi blastx gene ontolog de gene involv immun respons includ gene inflammasom retn sa sa sa adhes molecul cldn cspg cd lgal transcript factor zbtb slca cebpd cebpb acutephas protein complement saa ltf hp differenti gene epitheli cell keratinocyt tgm msab csta gene antigen process present hlab hladrb immunostimul analys indic mrna level sa sa sa porcin pk cell increas sustain administr lipopolysaccharid lp polyic addit map de gene porcin health trait qtl region gene distribut porcin qtl region final de gene valid quantit pcr conclus find demonstr unrecogn chang gene transcript associ hp infect vivo potenti cascad identifi studi clearli merit investig data provid clue natur immun respons mammal identifi candid gene resist hp
BMC Health Serv Res	21587153	2015-08-05	PMC2661074	19216792	background gener consensu influenza pandem inevit health care worker hcw essenti health system respons studi explor hcw attitud pandem influenza aim studi explor hcw knowledg attitud intend behaviour pandem influenza method crosssect investig conveni sampl clinic nonclin hcw tertiaryreferr teach hospit sydnei australia conduct june octob selfadminist questionnair distribut hospit person ward depart main outcom measur intent work attend quarantin antivir perceiv prepar respond categor main group occup nurs medic alli ancillari studi hcw perceiv pandem influenza seriou half correctli defin respond believ depart prepar pandem work pandem patient colleagu influenza main determin variat studi occup factor demograph health belief nonclin staff unsur intent respond consid neuraminidas inhibitor antivir medic oseltamivirzanamivir protect pandem influenza believ vaccin benefit conclus identifi issu undermin best pandem plan low level confid antivir effect measur secondli nonclin worker overlook group lack knowledg awar undermin pandem plan issu includ high level confid dietari measur protect influenza belief ancillari worker antibiot protect health care worker strategi includ clinic ancillari staff ensur adequ busi continu hospit hcw educ psychosoci support staff commun improv knowledg appropri pandem intervent confid antivir
BMC Immunol	26246575	2007-10-17	PMC2662797	19298652	background acut infect respiratori pathogen pneumonia viru mice pvm local product proinflammatori chemokin ccl neutrophil recruit respons pvm infect reduc dramat ccl mice work demonstr cclmediat neutrophil recruit coordin interferongamma ifn neutrophil recruit respons pvm infect diminish fivefold ifn receptor genedelet mice neutrophil ifnr mice express transcript ccl receptor ccr respond function ccl vivo absenc pvm infect ccl overexpress elicit neutrophil recruit absenc ifn interestingli supplement ifn restor neutrophil recruit sustain weight loss ccloverexpress ifn mice cclmediat neutrophil recruit result pulmonari edema respiratori failur characterist sever viral infect suggest ccl ifn suffici promot neutrophil recruit patholog activ conclus find reveal heretofor unrecogn hierarch interact ifn ccl demonstr ifn crucial cclmediat neutrophil recruit vivo
PLoS One	17942557	2012-06-14	PMC2663817	19357776	the plasmodium falciparum cystein proteas falcipain falcipain degrad host hemoglobin provid free amino acid parasit protein synthesi hemoglobin hydrolysi describ order process initi aspart proteas cystein proteas inhibitor complet block process suggest cystein proteas initi hemoglobin hydrolysi character specif role falcipain three approach random p amino acid substrat librari falcipain falcipain demonstr strong prefer cleavag site leu posit second overlap peptid span globin proteolysisdepend label hydrolysi cleavag site third intact hemoglobin numer cleavag product identifi hemoglobin hydrolysi malaria parasit highli order process proce rapid cleavag falcipain multipl site falcipain falcipain strong specif leu small peptid substrat agreement specif optim small molecul inhibitor identifi consist princip role falcipain falcipain hydrolysi hemoglobin falciparum possibl develop small molecul inhibitor optim specif antimalari agent
PLoS Pathog	22700978	2004-09-14	PMC2663820	19381259	acut gastroenter ag common ill ag group worldwid caus estim three death annual virus rotaviru adenoviru calicivirus major ag patient causal agent despit extens diagnost test propos novel virus reason diagnost gap molecular screen investig cluster undiagnos case larger case control studi etiolog pediatr ag degener oligonucleotid prime dop pcr nonspecif amplifi viral dna fecal specimen amplifi dna clone sequenc analysi novel viru detect elucid analysi genom indic member bocaviru genu parvovirina variant nucleotid level closest formal recogn rel human bocaviru hbov propos second speci bocaviru hbov fecal sampl collect case control pair ag studi test bocavirusspecif pcr hbov sequenc confirm detect case ag preval compar control group children hbov preval exceed rotaviru astroviru preval noroviru genogroup adenoviru univari analysi match pair mcnemar test odd ratio associ ag hbov infect confid interv cours screen second novel bocaviru detect design hbov speci hbov preval hbov low associ ag hbov hbov newli discov bocavirus hbov thirdmostpreval viru rotaviru astroviru associ pediatr ag studi
Hum Resour Health	15367599	2004-01-01	PMC2666626	19327137	debat resourcerich countri health care profession help plight subsaharan africa appear lock mindset domin gloomi statist onewai monetari aid establish project link primari care clinic base twowai share educ onewai aid unit kingdom colleagu learn malawi factfind visit malawi help clarifi aspect health care relev health care profession develop includ unit kingdom commentari articl focus encourag debat discuss rethink relationship colleagu health care environ consid work theme twowai share learn onewai aid
Int J Health Geogr	15147652	2018-11-01	PMC2666650	19291326	background fall issu great public health concern studi focus outdoor fall urban commun hong kong urban environment hazard placespecif depend built featur landscap characterist habitu activ fall examin respect local situat paper spatial analysi method map fall occurr examin environment attribut fall urban commun hong kong nearest neighbour hierarch nnh standard deviat ellips sde techniqu offer addit insight circumst environment factor contribut fall affirm multifactori natur fall specif locat select group popul conclus techniqu detect hot spot fall yield meaning enabl identif high risk locat combin descript spatial analys benefici polici maker prevent measur devis base type environment risk factor identifi analys prelud establish hypothes focus studi
Proteome Sci	30996690	2009-07-29	PMC2666657	19323824	background ozon major compon air pollut exposur power oxid agent exacerb lung condit involv innat immun surfact proteina spa plai role innat immun particip directli host defens exert opsonin function indirectli abil regul alveolar macrophag innat immun cell mechan respons ozoneinduc pathophysiolog oxid stress understood method emploi dimension differ gel electrophoresi ddige discoveri proteom approach coupl malditoftof compar bronchoalveolar lavag bal proteom wild type wt spa knockout ko mice assess impact ozon filter air express bal protein panther databas publish literatur identifi protein three function group identifi protein focus analysi protein fell three categori defens immun redox regul protein metabol modif chaperon respons oxid stress acut ozon exposur ppm hour chang level express protein group protein redox group decreas protein involv protein metabol increas roughli equal number increas decreas defens immun group respons wt ko mice respect percent chang consist greater ko mice chang achiev statist signific ko mice level express filter airexpos ko mice closer ozoneexpos wt mice filter airexpos wt mice conclus postul spa plai role reactiv oxid scaveng wt mice absenc ko mice presenc absenc ozon exposur pronounc presum chronic oxid stress
BMC Public Health	19641063	2014-05-12	PMC2666722	19284644	background despit seri prevent measur high incid sever acut respiratori syndrom sar observ health care worker hcw sar epidem studi aim determin prevent measur effect protect hcw infect effect method retrospect studi perform frontlin health care worker care sar patient second affili hospit third affili hospit sun yatsen univers hcw igg sar igg sar defin case group control group logist regress conduct explor risk factor sar infect hcw adjust ag gender marit statu educ level profession titl depart individu work multivari logist regress analysi indic incid sar hcw posit associ perform tracheal intub sar patient method air ventil ward avoid facetofac interact sar patient number pair glove worn hcw care seriou sar case conclus measur good air ventil sar ward effect minim prevent sar transmiss hcw hospit
BMC Infect Dis	31434737	2001-07-15	PMC2670846	19284571	background border quarantin includ influenza pandem plan detail guidelin formul includ consider optim quarantin length motiv situat small island nation will experi introduct pandem influenza airport examin potenti effect quarantin border control measur method analys detail epidemiolog characterist influenza effect quarantin border island model rel reduct risk releas infecti individu commun explicitli account presenc asymptomat infect individu potenti benefit ad rapid diagnost test quarantin process consid predict effect prevent releas infecti individu commun achiev quarantin period longer dai rapid diagnost test combin quarantin length quarantin achiev effect shorten dai sensit analysi reveal quarantin dai quarantin dai combin rapid diagnost test prevent secondari transmiss caus releas infecti individu plausibl rang preval sourc countri modest number incom travel individu conclus quarantin border island nation contribut prevent arriv pandem influenza delai arriv small island nation recommend consider quarantin dai quarantin dai combin rapid diagnost test avail
PLoS Pathog	11413307	2013-01-01	PMC2671596	19424420	the abil pathogen escap host immun respons crucial establish persist infect influenc virul recombin observ contribut process gener novel genet variant distinct recombin pattern describ viral pathogen influenc bias recombin process rel select forc act newli form recombin understand influenc determin recombin contribut pathogen genom proteom evolut previou recombinationdriven protein evolut focus simpl protein context direct evolut experi studi recombin envelop gene hiv primari isol belong subtyp recombin natur hivaid pandem character earli step gener recombin provid novel insight evolutionari forc shape recombin pattern viral popul combin effect mechanist process determin locat recombin breakpoint hiv envelop gene purifi select act dysfunct recombin explain entir distribut breakpoint gene natur constraint account surpris pauciti recombin breakpoint infect individu highli variabl gene appar random hiv evolut recombin fact predict anticip addit domin purifi select local area hiv genom defin region function constraint recombin appear strong point vulner aspect hiv biologi
Aust New Zealand Health Policy	23405047	2018-10-01	PMC2672090	19358710	background intern health regul emerg global spread infecti diseas trigger reassess rich countri support capac develop communic diseas control low medium incom countri lmic lmic three type public health train universitybas model stream train specialis worker fieldbas program low rate product teach base prioriti host countri second model effici accord worker suffici statu enabl impact polici third potenti capac develop measur lmic practic face challeng limit abil promot capac develop discuss describ australia master appli epidemiolog mae model establish fieldbas train strengthen control communic diseas central attribut model partner complement health depart initi enhanc workforc skill health system perform evidencebas polici program practic summari mae experi throw light wai australia collabor region capac develop initi kei share vision region approach integr train initi strengthen servic pool human financi technic resourc focu communic diseas find recommend generalis area public health
PLoS Pathog	30185285	2014-12-10	PMC2673688	19436701	transmiss avian influenza virus bird human rare event avian influenza virus infect ciliat epithelium human airwai vitro vivo vitro model human ciliat airwai epithelium hae demonstr human avian influenza virus effici infect temperatur human distal airwai avian human influenza virus restrict infect cooler temperatur human proxim airwai data support hypothesi avian influenza virus ordinarili adapt temperatur avian enter tract rare infect human differ host airwai region temperatur critic residu posit avian influenza viru polymeras subunit pb identifi confer temperaturedepend mammalian cell revers genet avian residu attenu human viru account infect c determin mechan temperatur restrict avian influenza virus hae gener recombin human influenza virus avictoria hn apr hn genet background contain avian avianlik glycoprotein virus avictoria lq sg mutat hemagglutinin ha neuraminidas achickitali apr achickitali exhibit temperatur restrict approach wholli avian influenza virus data influenza virus bear avian avianlik surfac glycoprotein reduc capac establish product infect temperatur human proxim airwai temperatur restrict limit zoonot transmiss avian influenza virus suggest adapt avian influenza virus effici infect repres critic evolutionari step enabl humantohuman transmiss
PLoS One	25505063	2012-10-01	PMC2674933	19404494	background host respons viral infect includ immun activ program cell death mitochondri antivir signal adaptor mav ip visa cardif critic host defens viral infect induc type interferon ifni role virusinduc apoptot respons elucid princip find mav apoptosi independ function initi ifni product mavsinduc cell death requir mitochondri local caspas depend displai hallmark apoptosi mav fibroblast resist sendai virusinduc apoptosi function screen identifi hepat viru nsa sever acut respiratori syndrom coronaviru sarscov nonstructur protein nsp inhibitor mavsinduc apoptosi method immun evas signific studi describ novel role mav control viral infect induct apoptosi identifi viral protein inhibit host respons
Open Virol J	23028052	2015-12-01	PMC2675550	19440455	hendra nipah virus emerg paramyxovirus infect diseas anim human diseas manifest gener vascul multipl organ sever respiratori central nervou system high case fatal persontoperson transmiss associ niv outbreak reemerg hev emphas necess effect therapeut novel agent year henipaviru reveal complet understand pathogenesi consequ viabl approach vaccin therapeut emerg strategi target earli step viral replic includ receptor bind membran fusion anim model develop prove valuabl evalu efficaci therapeut agent regim assess protect host immun drug pharmacokinet will crucial advanc therapeut compound
PLoS Pathog	27257648	2011-08-10	PMC2677460	19461876	to support replic virus advantag numer cellular factor process largescal screen identifi hundr factor virus exploit influenza viru infect posttranslation activ pipk cellular inhibitor interferoninduc dsrnaactiv eif kinas pkr report infect pipk knockout mice influenza viru increas lung patholog immun cell apoptosi pkr activ mortal analysi lung transcript profil includ induc reconstruct pandem viru reveal increas express gene associ cell death immun inflammatori respons experi repres mammalian infect model demonstr role pipk antivir respons pipk repres class molecul cellular inhibitor host defens cihd pipk activ viru infect inhibit virusinduc apoptosi inflamm prolong host surviv prolong viral replic
Respir Res	21832018	2004-11-23	PMC2678087	19386108	chronic obstruct pulmonari diseas copd treatabl prevent diseas state characteris progress airflow limit fulli revers copd diseas lung appreci manifest diseas lung lead notion copd system diseas current diagnosi copd reli descript measur enabl classif symptom lung function limit exist diagnost strategi copd discuss system biologi approach diagnosi build current molecular knowledg diseas describ approach reli labelfre sens technolog highthroughput surfac plasmon reson spr describ
BMC Vet Res	15561861	2007-11-27	PMC2679002	19389228	introduct order identifi prioriti build integr surveil system effect model predict human risk zoonot diseas improv understand practic option link surveil data anim human conduct analysi literatur character linkag anim human health data discuss find relat zoonot surveil linkag human anim data method canari databas onlin bibliograph databas animalsentinel studi search articl classifi linkag categori studi identifi assign linkag categori involv descript analyt molecular human outcom human anim health descript linkag common anim human health outcom present quantit linkag rare analyt linkag util anim data quantit predict human risk categori includ molecular linkag human outcom health outcom anim human discuss limit anim data quantit predict human risk list method literatur perform analyt linkag lack analyt linkag literatur sole technolog barrier includ access electron databas statist softwar packag geograph system gi problem lack understand research anim data sentinel human health research perform zoonot surveil awar animalsentinel approach predict human risk consid analyt method link anim human data qualit work order examin research decis linkag strategi anim human data
Parasit Vectors	18042961	2016-11-14	PMC2679399	19426446	the extinct speci globe acceler directli indirectli human activ biolog impoverish habitat fragment climat chang increas toxif rapid global movement peopl live organ work synergist diminish ecosystem function unpreced level diseas emerg driven humaninduc environment degrad pose threat surviv health biodivers emerg disciplin conserv medicin address concern entiti human global climat habitat destruct alter biodivers includ wildlif popul domest anim pathogen parasit pollut conserv medicin focus explicit linkag entiti crisi disciplin conserv medicin ultim will depend applic solv problem perspect scientif find conserv medicin provid input biomed educ polici manag ecosystem habitat imperil speci sentinel speci present select provid insight state health ecosystem base userdefin research conservationist policymak object diseas parasit toxic climat chang habitat destruct coupl util vulner speci perceiv stress scientif gener sentinel speci empow stakehold decisionmak mitig action support predict capabl util speci select consid relev conservationist societi larg educ outreach social scienc wild canid serv excel sentinel speci emerg canin vectorborn diseas canin vectorborn diseas antibodi pathogen identifi wild canid includ viscer leishmaniosi lyme diseas heartworm hepatozoonosi anaplasmosi report relat wildlifedomest anim interact globalis transloc habitat fragment climat chang pathogen relationship wild canid describ perform elucid role extant speci wild canid epidemiolog canin vectorborn diseas
PLoS One	28830113	2012-04-24	PMC2682562	19478856	background possibl human hn pandem fact hn virus resist antivir drug newer strategi effect therapi warrant previou studi singl mab immun prophylaxi protect hn infect singl mab effect neutral broad rang strain hn control potenti neutral escap mutant methodsprincip find select mab recogn epitop hemagglutinin molecul mab neutral vitro escap mutant combin effect neutral virus clade influenza hn virus combin chimer mab administ passiv pre post challeng mld mous lethal dose hpai hn influenza virus protect mice clade virus clade test efficaci singl dose combin mab versu dose dose combin therapi earli clearanc viru lung complet prevent lung patholog hn infect mice escap variant detect therapi conclusionssignific studi provid proof concept synergist action mab combin requir prevent gener escap mutant enhanc therapeut efficaci passiv therapi hn infect combin therapi allow lower dose antibodi administ passiv therapi influenza infect reduc econom cost outbreak
PLoS One	22532677	2018-08-01	PMC2682565	19479060	rna interfer rnai power inhibit viral infect select sirnaresist virus major concern rnai antivir therapeut studi conduct lentivir vector hshort hairpin rna shrna express cassett deliv small interf rna sirna mammalian cell vector express enhanc green fluoresc protein egfp surrog marker stabl shrnaexpress cell line establish inhibit effici ration design sirna target conserv region influenza viru genom assess sirna target influenza gene sim potent inhibit viral replic sim effect hn viru highli pathogen avian influenza viru hn addit inhibit sim inhibit np mrna accumul protein express long term inhibit sim demonstr emerg sirnaresist mutant influenza quasispeci observ studi suggest gene optim rnai target antivir therapi find provid develop rnaibas prophylaxi therapi human influenza viru infect
BMC Infect Dis	30068648	2013-05-30	PMC2683852	19405982	background pathogenesi sever acut respiratori diseas syndrom sar fulli understood casecontrol studi report associ suscept sar mannanbind lectin mbl china downstream protein mbl variant mblassoci serin proteas masp gene associ sar coronaviru sarscov infect popul method thirti individu sar chosen analysi masp polymorph pcr direct sequenc tag singl nucleotid polymorph tagsnp chosen pairwis tag algorithm frequenc tag snp rs rs rs rs ascertain sar patient control subject beckman snpstream ultra high throughput genotyp platform associ allel genotyp masp tagsnp suscept sarscov beij guangzhou popul diplotyp rs rswere analyz associ suscept sar statist evid associ observ beij guangzhou sampl group homogen demograph genet paramet join analysi statist evid associ conclus data role masp polymorph sar suscept northern southern china
Evol Bioinform Online	23719292	2017-09-01	PMC2684125	19461973	research routin adopt molecular clock assumpt conduct sequenc analys estim date viral origin human comput method examin extent practic result inaccur retrodict fail account dynam molecular evolut affect greatli estim case date overestim ag sarscovhuman infect instanc
Evol Bioinform Online	28601703	2009-10-21	PMC2684143	19468314	genom signatur data vector deriv composit statist dna selforgan map som neural network method conceptualis relationship complex data genom signatur paramet som train phase investig accuraci output map conclud larger som longer train sensit phylogenet classif unknown dna sequenc classif larger som accur increas number iter train phase som increas accuraci improv sensit optim length dna sequenc kmer genom signatur deriv shorter valu effect gener indic small rapidli train som gener good larger longer train analysi genom signatur gener applic som complex data set microarrai data
BMC Plant Biol	19846633	2011-08-17	PMC2684537	19397807	background phaseolu vulgari common bean second legum crop soybean consequ yield loss fungal infect uromyc appendiculatu bean rust strong consequ resist gene identifi confer resist bean rust infect downstream gene mechan involv bean resist infect character subtract bean cdna librari compos unisequ construct enrich sequenc regul bean rust race virul strain race avirul strain cultivar earli gallatin carri resist gene construct librari allow identif bean est ad sequenc plant regul select bean gene respons bean rust infect confirm qrtpcr plant gene express race hour infect process vari time point hour inocul presenc avr gene race lead hypersensit respons bean plant biphas pattern gene express observ gene regul respons fungal infect conclus enrich public databas bean est add genom resourc crop plant analysi gene respons bean rust infect foundat studi mechan fungal diseas resist express pattern bean gene rust infect share featur legum infect biotroph fungi find suggest vulgarisu appendiculatu pathosystem serv model explor legumerust interact
BMC Public Health	21849459	2018-07-25	PMC2684743	19426508	background aspect heath care sector ask account perform pose uniqu challeng local public health unit tradit focu popul health emphasi diseas prevent health promot protect relianc measur health statu imprecis partial pictur perform health unit provinci institut clinic evalu scienc base ontario canada introduc publichealth specif balanc scorecard framework conceptu deliber decis undertaken health unit adopt framework discuss pose ponder answer kei question assist appli framework develop indic question involv develop perform indic level perform measur primari intend audienc type indic popul health statu determin quadrant type indic popul resourc servic quadrant type indic popul commun engag quadrant type indic popul integr respons quadrant link quadrant compar we move baselin report card continu qualiti improv manag tool summari inclus participatori process chosen defin creat indic popul quadrant exampl indic popul quadrant scorecard present kei decis highlight facilit process
PLoS Negl Trop Dis	30045987	2012-07-20	PMC2685481	19503815	background pcr evolv promis tool cruzi detect diagnosi control chaga diseas gener techniqu hamper complex lack standard methodolog develop phase evalu cruzi oligoctest simpl standard dipstick format detect pcr amplifi cruzi dna specif sensit assai evalu blood sampl chaga nonendem endem control person biolog sampl patient reservoir anim vector collect chile princip find lower detect limit cruzi oligoctest pg fg dna cruzi lineag ii test specif confid interv ci control sampl sensit ci ci ci human rodent vector sampl conclus cruzi oligoctest high sensit specif divers panel biolog sampl tool step simplifi standard molecular diagnosi chaga diseas
BMC Health Serv Res	22820337	2003-12-11	PMC2685796	19435526	background aim studi assess outsourc situat taiwanes hospit compar differ hospit ownership accredit level method combin kind method questionnair survei indepth interview ceo sampl hospit hospit notforprofit public hospit sampl hospit data taiwan depart health qualifi list hospit accredit return questionnair analyz statistica version softwar nonmed item medic wast common trash highest rate percent outsourc gift store percent linen percent follow close lowest rate outsourc util mainten percent medic item highest rate outsourc ambul unit percent hemodialysi center close rate percent depart nutrit pharmaci nurs outsourc rate lower percent taiwan hospit conserv willing outsourc medic item the satisfact pair ttest nonmed item higher score medic item factor analysi three factor medic item outsourc perform financ human resourc medic item factor oper satisfact exam factor valid reliabl satisfact model confirm factor analysi cfa conduct structur equat model sem method model fit conclus hospit public hospit benefit outsourc reviv fulltimeequival human resourc limit
Biomark Insights	14671089	2006-04-01	PMC2688344	19578519	colorect cancer crc second common cancerrel death europ prognosi depend stage diagnosi current suitabl tumour marker earli detect crc retrospect studi discrimin crc serum protein profil surfac enhanc laser desorpt ionisationtim flight mass spectrometri selditof ms aim prospect valid profil addition assess applic followup surgeri investig tissu protein profil patient crc adenomat polyp ap serum tissu sampl collect patient malign indic colonoscopi patient ap crc colonoscopi serum sampl control con patient ap crc tissu sampl ap crc analys describ peak intens compar nonparametr test discrimin power differenti express protein assess support vector machin svm confirm decreas serum level apolipoprotein crc current popul differ observ con ap apolipoprotein ci level chang month postsurgeri gradual return normal level observ protein differ ap crc tissu peak mass apolipoprotein peak increas crc compar ap prospect valid serum decreas apolipoprotein crc serum protein profil yield svm classifi suitabl sensit specif classif patient group
PLoS One	16597852	2010-08-18	PMC2688756	19503812	background epidemiolog intervent aim control spread infecti diseas mechan carri associ cost methodolog describ flexibl statist framework gener optim epidemiolog intervent design minim total expect cost emerg epidem simultan propag uncertainti underli diseas model paramet decis process strategi produc framework adapt vaccin schedul iter adjust reflect anticip trajectori epidem current popul state updat paramet estim conclus simul studi base classic influenza outbreak demonstr advantag adapt intervent nonadapt term cost resourc effici robust model misspecif
Microb Cell Fact	20719951	2007-03-01	PMC2689190	19442264	bacteria simpl cost effect host produc recombin protein physiolog featur limit obtain nativ form protein specif structur class instanc polypeptid undergo extens posttransl modif extent product protein depend disulfid bridg stabil consid difficult coli eukaryot prokaryot organ cytoplasm reduc consequ disulfid bond format impair subcellular compart disulfid bridg stabil protein structur high abund secret protein eukaryot cell bond form oxid environ endoplasm reticulum export process bacteria possess special subcellular compart export system enzymat activ aim format qualiti control disulfid bond oxid periplasm articl review strategi exploit physiolog mechan bactera produc properli fold disulfidebond protein
PLoS Med	17389543	2013-12-01	PMC2694988	19554084	in articl plo medicin holger schnemann colleagu describ process health organ rapidli develop clinic manag guidelin emerg situat situat includ outbreak emerg infecti diseas author discuss develop rapid advic guidelin pharmacolog manag avian influenza hn viru infect guidelin recommend antivir drug oseltamivir dose daili dai debat nichola white argu dose inadequ robert webster elena govorkova combin antivir therapi tim uyeki remind clinic care patient hn entail antivir treatment issu appli therapi patient hospit sever diseas novel swineorigin influenza hn viru infect
Virol J	24297769	2009-11-11	PMC2696427	19497115	background anatid herpesviru ahv alphaherpesviru associ latent infect mortal duck gees current worldwid waterfowl product sever describ fluoresc quantit realtim pcr fqpcr method develop fast measur ahv dna base taqman mgb technolog detect limit assai standard dna copi sensit log higher convent gelbas pcr assai target gene realtim pcr reproduc satisfactori low intraassai interassai coeffici variat conclus high sensit specif simplic reproduc ahv fluorogen pcr assai combin wide dynam rang high throughput method suitabl broad spectrum ahv etiolog applic
BMC Microbiol	19906918	2013-12-01	PMC2697166	19486515	background number scarlet fever occurr report fluctuat consider central taiwan nation isol streptococcu pyogen collect scarlet fever patient central taiwan character emm sequenc standard pulsedfield gel electrophoresi pfge method nation weekli report data collect investig epidemiolog trend total emm type identifi pyogen isol preval emm type emm emm emm emm emm pfge analysi smai suggest except strain common emm type belong clone larg emm clone dna resist cleavag smai preval emm clone major pfge strain minor strain minor strain emerg popul disappear major strain remain preval year declin larg fluctuat scarlet fever case associ shuffl preval emm clone dramat drop scarlet fever case central taiwan countri associ occurr sever acut respiratori syndrom sar outbreak occur latefebruari midjun taiwan conclus occurr scarlet fever central taiwan caus emm type account isol collect pyogen strain defin pfge genotyp emerg last year fluctuat number scarlet fever case year attribut shuffl preval emm clone sar outbreak 
Biotechnol J	24055466	2008-02-20	PMC2699044	19226552	mammalian cell express system choic therapeut protein requir complex posttransl modif tradition cell grown medium supplement serum animalor humanderiv compon support viabil product protein typic excipi stabil final drug formul transmiss hepat hepat hiv plasmaderiv factor viii concentr catastroph consequ hemophilia patient regulatori concern inher potenti transmiss infecti agent heterogen lack reliabl serum suppli trend emerg elimin plasmaderiv addit product formul recombin protein therapeut practic began product treatment hemophilia progress expand entir industri plasmafre method produc recombin therapeut accomplish cell cultur media final product formul animalor humanderiv addit number recombin therapeut protein treatment diseas produc plasmafre process object improv safeti elimin bloodborn pathogen reduc immunogen review describ factor drove develop plasmafre protein therapeut exampl advanc manufactur remov human animalderiv product step recombin protein product
PLoS One	18287238	2012-10-01	PMC2699471	19568424	background lactat dehydrogenaseelev viru ldv natur infecti agent mice virus ldv widespread rapid transient activ cell cell lymphoid tissu blood mechan activ fulli describ focu current studi princip find induc earli lymphocyt activ ifn cytokin induc ldv infect neutral ifn plasma infect mice ablat abil activ lymphocyt vitro primari sourc virusinduc ifn vivo plasmacytoid dendrit cell pdc deplet cell prior ldv infect test lymphocyt activ deplet pdc vivo erad ldvinduc ifn respons lymphocyt activ primari receptor pdc singl strand rna virus ldv tolllik receptor tlr pattern recognit receptor infect tlrknockout mice reveal ifn respons lymphocyt activ depend tlr signal vivo interestingli viru level tlr knockout mice pdcdeplet mice indistinguish control indic ldv resist system ifn respons conclus indic ldvinduc activ lymphocyt recognit ldv nucleic acid tlr pattern recognit receptor pdc respond lymphocyteinduc ifn respons
BMC Public Health	22835485	2015-07-01	PMC2700101	19473550	background thailand join health organ effort prepar threat influenza pandem regular monitor prepared health facil assess percept frontlin respons health personnel studi aim document pattern percept health personnel threat influenza pandem method methodolog appli set health personnel charg influenza pandem prepared three southernmost provinc thailand subject ask rank statement issu influenza pandem predesign score sheet quasinorm distribut continu point bipolar scale rang disagre agre factor analysi method emploi identifi pattern base similar dissimilar health personnel three main pattern percept influenza pandem moder correl coeffici pattern rang pattern health personnel label pessimist perceiv low selfefficaci pattern ii label optimist perceiv threat low sever low vulner pattern iii label mix perceiv low selfefficaci low vulner three pattern subject high expect execut recommend measur mitig impact threat influenza pandem multimeasur high factor score pattern conflict area vulner impact influenza pandem factor score high low neutral pattern ii iii conclus strong consist percept respons efficaci influenza pandem low prioriti convinc health personnel efficaci recommend measur lack selfefficaci subgroup indic program manag improv selfconfid health personnel particip emerg respons
PLoS One	26136579	2007-02-01	PMC2700284	19572016	coronaviru host cell specif determin specif interact viral spike protein host cell receptor avian coronaviru infecti bronchiti ibv adapt embryon chicken egg primari chicken kidnei ck cell monkei kidnei cell vero human anim cell report acquisit cellcel fusion activ amino acid mutat protein determin infect ibv cultur cell express protein deriv vero ckadapt strain effici induct membran fusion express protein clone third passag ibv chicken embryo ep appar syncytia format construct chimer construct sitedirect mutagenesi point mutat lf amino acid posit heptad repeat region protein respons acquisit cellcel fusion activ gd point mutat domain acquir propag veroadapt ibv vero cell enhanc cellcel fusion activ protein reintroduct gene veroadapt ibv allow recoveri variant introduc compensatori mutat distant region requir restor cellcel fusion activ protein carri infect recov variant cultur cell studi demonstr acquisit cellcel fusion activ protein determin select andor adapt coronaviru chicken embryo cultur cell human anim origin
BMC Immunol	17317569	2013-02-12	PMC2700820	19505311	background sar outbreak uniqu opportun studi human respons novel viru report dendrit cell dc involv immun escap mechan sarscov studi focuss gene express tolllik receptor tlr chemokin receptor ccr death receptor ligand sarscov infect dc compar adult cord blood cb dc find explan agedepend sever sar result demonstr sarscov modul tlr tlr gene express induc express ccr ccr ccr strong induct tnfrelat apoptosisinduc ligand trail fa ligand gene express sarscov infect dc interestingli express gene studi higher cb dc adult dc conclus upregul chemokin ccr facilit dc migrat infect site lymph node increas trail induc lymphocyt apoptosi find explain increas lung infiltr lymphoid deplet sar patient explor biolog signific find warrant
PLoS One	23403421	2016-03-01	PMC2701634	19578544	revers transcriptas human immunodefici viru hiv plai kei role initi viral replic target develop antihiv drug previou studi mutat ya ia turn glnarg abrog viral replic replic capac activ discord studi investig alanin substitut site affect viral replic activ protein undetect viral particl mutant prgagpol mutant properli express transport incorpor proteas inhibit assai demonstr correl degrad mutant activ viral proteas nativ gel analysi indic mutat amino acid conform chang lead format higher order oligom dimer increas protein instabl suscept viral proteas residu critic stabil resist viral proteas conserv amino acid residu strain hiv lent support conclus knowledg gain prove drug design
Genet Vaccines Ther	26994705	2015-04-15	PMC2702340	19505299	background hepat core protein attract target hcv vaccin aim extermin hcv infect cell highli immunogen natur infect core appear low immunogen experiment set aim design hcv vaccin prototyp base core devis immun regimen lead potent anticor immun respons circumv immunogen limit earlier observ method plasmid encod core translat initi signal pcmvcore kozak sequenc pcmvcorekozak hcv ir pcmvcoreir design express varieti eukaryot cell polyprotein correspond hcv amino acid aa express coli cbl mice immun dose pcmvcorekozak pcmv balbc mice immun pcmvcore pcmvcorekozak pcmvcoreir empti pcmv ii lastli balbc mice immun core aa prime boost pcmvcorekozak prime core aa boost iii antibodi respons htincorpor cytokin secret corecor peptidestimul splenocyt assess immun plasmid differ coreexpress capac mous fibroblast transfect pcmvcore pcmvcoreir pcmvcorekozak express ng core cell singl immun highli express pcmvcorekozak induc specif ifn il weak antibodi respons singl immun plasmid direct low level core express induc level cytokin strong tcell prolifer pcmvcoreir antibodi titer pcmvcore boost pcmvcorekozak induc low antibodi respons corespecif tcell prolifer ifn secret subsid plasmid inject led decreas specif il secret best heterolog pcmvcorekozak primeprotein boost regimen gener mix ththcellular respons corespecif antibodi titer conclus administr highli express hcv core gene larg dose repeat inject smaller dose suppress corespecif immun respons induc heterolog dna primeprotein boost regimen circumv neg effect intracellular core express
BMC Health Serv Res	25878106	2012-03-01	PMC2703635	19505330	background consider discuss surround advanc hospit provid better childbirth care local commun hospit studi examin shift childbirth servic advanc hospit medic center region hospit local commun hospit clinic district hospit sampl popul track sevenyear period includ month sever acut respiratori syndrom sar epidem taiwan sar epidem pregnant women avoid matern servic advanc hospit concern rais maintain qualiti matern care increas demand childbirth servic local commun hospit studi analyz impact shift matern servic hospit level neonat mortal matern death method populationbas studi conduct data taiwan nation health insur annual statist monthli counti neonat moral rate base presar sampl januari decemb estim linear regress model includ trend continu variabl repres yearli chang binari variabl month counti control season countyspecif effect estim coeffici predict neonat mortal rate countymonth compar differ observ mortal rate sar period predict rate examin shift matern servic sar epidem neonat mortal rate analysi total observ insignificantli neg standard predict error sar period result subsampl area advanc hospit neg standard predict error sar period find indic despit increas local commun hospit neonat mortal sar epidem increas decreas area advanc hospit conclus increas matern servic local commun hospit occur sar epidem taiwan observ increas neonat matern mortal associ increas demand local commun hospit
BMC Biotechnol	22179147	2014-10-01	PMC2703641	19523201	background bud baculovirus util vaccin product antibodi function analysi transmembran protein studi produc purifi recombin bombyx mori nucleopolyhedroviru rbmnpvhprr displai human prorenin receptor hprr connect flag peptid sequenc surfac particl bind analysi hprr human prorenin rbmnpvhprr produc silkworm larva purifi hemolymph size exclus chromatographi rapid method bmnpv titer determin hemolymph perform quantit realtim pcr qpcr correl coeffici bmnpv determin endpoint dilut qpcr method rbmnpvhprr bacmidinject silkworm larva produc recombin baculoviru plaqu form unit pfu hemolymph time higher transfect solut bm cell purif yield sephacryl sf column chromatographi fold larval hemolymph dai postinject pi fold dai pi protein pattern rbmnpvhprr purifi dai ratio envelop protein kda vp nucleocapsid protein increas dai pi hprr detect purifi rbmnpvhprr dai pi conclus success purif rbmnpvhprr indic baculoviru product silkworm larva purif hemolymph sephacryl sf column chromatographi provid econom approach obtain purifi bmnpv stock high titer largescal product hprr util bind analysi screen inhibitor hprr
PLoS One	25275122	2004-01-01	PMC2703826	19593433	background replic coronavirus take place cytoplasm doubl membran vesicl dmv origin endoplasm reticulum er three transmembran nonstructur protein nsp nsp nsp understood membran anchor coronaviru replic complex nsp local er membran express recruit replic complex infect cell reveal transmembran region ctermini expos cytosol methodologyprincip find determin crystal structur ctermin hydrophil domain nsp nspc mhv strain cs sitedirect mutant highli conserv amino acid region to possess fold wildtyp wt structur featur monom link cysci disulfid bond asymmetr unit monom arrang ctermini opposit orient form open conform mutat cy ser affect monom structur mutant dimer adopt strikingli conform crystal pack crosslink ctermini parallel ntermini monom form close conform wt nspc exist dimer solut dissoci easili monom reduc environ conclusionssignific nspc expos reduc cytosol monom nspc physiolog structur serv basi function studi nsp
PLoS Biol	14681353	2016-12-15	PMC2705187	19621064	dysfunct cftr cystic fibrosi cf airwai epithelium perturb normal regul ion transport lead reduc volum airwai surfac liquid asl mucu dehydr decreas mucu transport mucu plug airwai cftr express ciliat epitheli cell surfac submucos gland ductal epithelium submucos gland acinar cell critic question develop gene transfer strategi cf airwai diseas airwai region requir cftr function epitheli cell requir cftr express restor normal asl volum regul mucu transport cf airwai epithelium vitro model human cf ciliat surfac airwai epithelium cf hae test human parainfluenza viru piv vector engin express cftr pivcftr deliv suffici cftr cf hae restor mucu transport correct cf phenotyp pivcftr deliv cftr airwai surfac epitheli cell express cftr protein cf hae fold endogen level noncf hae effici cftr deliveri fulli correct basic bioelectr defect cl epitheli ion transport restor asl volum regul mucu transport level approach noncf hae determin number cf hae surfac epitheli cell requir express cftr restor mucu transport normal level amount pivcftr express cftr surfac epitheli cell cf hae correl increas asl volum mucu transport rate data demonstr time knowledg restor normal mucu transport rate cf hae achiev cftr deliveri surfac epitheli cell vivo experiment appropri model will requir determin level mucu transport will afford clinic benefit cf patient predict futur goal correct gene transfer cf human airwai vivo attempt target surfac epitheli cell achiev mucu transport rate compar noncf airwai
BMC Pulm Med	27981468	2004-01-01	PMC2705343	19450259	background herp simplex viru type hsv describ respiratori tract infect critic patient individu immunocompromis continu matter debat circumst hsv relev pathogen pneumon role critic ill investig prospect intervent studi compar systemat data role hsv pneumon outpati autoimmun diseas mainten regimen immunosuppress method retrospect review chart patient rheumatoid arthriti vascul system lupu erythematosu sle outpati clinic german univers hospit year episod admiss ward diagnosi pneumoniapneumon identifi type pneumonia clinic featur retrospect studi patient rheumatoid arthriti vascul sle admit ward diagnos pneumoniapneumon bronchoscopi total case pulmonari infect associ hsv lower respiratori tract identifi case suggest caus role hsv sole agent caus pneumon prove clinic respons antivir treatment remain case hsv appear bystand bacteri infect mainten therapi leflunomid inhibit hsv assembl vitro associ milder cours pneumon patient detect hsv associ stronger immunosuppress regimen vasculit diseas conclus studi analyz frequenc hallmark case hsv associ pneumon occur compar larg cohort patient rheumatolog autoimmun diseas area controversi studi evid hsv isol pneumon immunocompromis studi provid estim frequenc relev hsv infect bacteri agent outpati autoimmun diseas
Virol J	15534914	2018-02-01	PMC2705359	19534833	the glycosyl membran protein sever acut respiratori syndrom associ coronaviru sarscov main structur compon virion mediat assembl bud viral particl membran topolog sarscov function signific nglycosyl complet understood interact surfac glycoprotein biochem immunofluoresc analys consist short glycosyl ntermin ectodomain three transmembran segment long immunogen ctermin endodomain nglycosyl site highli conserv group coronavirus studi recombin sarscov express glycosylationdefici reveal nglycosyl influenc shape virion infect cell cultur function analysi truncat protein ntermin amino acid compris three transmembran domain suffici mediat accumul golgi complex enforc recruit viral spike protein site viru assembl bud ergic
BMC Public Health	29480460	2014-06-19	PMC2706246	19515246	background statist algorithm routin detect outbreak welldefin syndrom influenzalik ill method appli detect emerg diseas preexist paper present method aim facilit detect outbreak priori knowledg clinic present case method method visual represent symptom diseas code patient consult intern classif primari care version icpc surveil data transform colorcod cell rang white red reflect increas frequenc observ sign graphic refer frame mimick bodi anatomi simpl visual observ colorchang pattern time concern singl code combin code enabl detect set interest method demonstr retrospect analys data set descript patient refer hospit gener practition gp particip french sentinel network descript patient directli consult hospit emerg depart inform imag colorchang alert pattern emerg case health consequ august heat wave visual gp data pass unnot convent surveil system flu epidem routin detect standard statist techniqu recogn visual data conclus human visual patternrecognit capac detect onset unexpect health event impli conveni imag represent epidemiolog surveil welltrain epidemiolog watcher condit met imagin epidemiolog watcher signal epidemiolog alert base imag wall present local region andor nation surveil pattern special field epidemiologist assign valid signal detect
Virol J	24947513	2012-08-06	PMC2706813	19552824	background diarrhea third lead infecti death worldwid estim respons death year infecti diarrhea establish diarrhea case unknown etiolog effort identifi novel virus causal agent diarrhea high throughput mass sequenc analyz stool sampl collect patient acut diarrhea sequenc limit similar picornavirus detect stool sampl collect australia child acut diarrhea combin mass sequenc rtpcr race race bp fragment viral genom sequenc phylogenet analysi demonstr viru highli diverg close member genu kobuviru tent name novel viru klasseviru detect klasseviru rtpcr diarrhea specimen collect patient st loui unit state untreat sewag collect barcelona spain conclus klasseviru undescrib picornaviru global widespread three contin investig determin klasseviru human pathogen need
PLoS One	22869823	2017-06-21	PMC2707627	19617915	background glioblastoma frequent malign primari brain tumor poor prognosi translat therapeut strategi glioblastoma experiment phase clinic limit insuffici anim model lack featur human tumor lentivir gene therapi attract therapeut option human glioblastoma valid clinic relev anim model methodologyprincip find rodent xenograft model recapitul invas angiogen featur human glioblastoma analyz transduct pattern therapeut efficaci lentivir pseudotyp vector lymphocyt choriomening viru glycoprotein lcmvgp vesicular stomat viru glycoprotein vsvg pseudotyp lentivir vector effici transduc human glioblastoma cell vitro vivo contrast pseudotyp gammaretrovir vector evalu clinic therapi glioblastoma ineffici gene transfer vitro vivo pseudotyp lentivir vector transduc cancer stemlik cell character cd nestin soxexpress abil form spheroid neural stem cell medium express astrocyt neuron differenti marker serum condit therapeut approach suicid gene herp simplex viru thymidin kinas hsvtk fuse egfp lentivir vector mediat complet remiss solid tumor mri highli surviv benefit compar control group recurr tumor surviv egfpposit tumor cell advoc prodrug applic cycl enhanc prolong therapeut conclusionssignific conclus lentivir pseudotyp vector promis candid gene therapi glioma patient ineffici gene deliveri gammaretrovir vector clinic therapi gbm confirm high reproduc invas glioma anim model translat research
J Inflamm (Lond)	28637751	2015-07-28	PMC2708161	19545424	background peptidylprolin isomeras protein mitosi gene interact pin regul turnov induc nitric oxid synthas ino murin aortic endotheli cell maec stimul coli endotoxin lp interferon ifn degrad ino reduc calpain inhibitor suggest pin affect induct calpainsensit inflammatori protein cyclooxygenas cox maec method maec transduc lentiviru encod inact control short hairpin sh rna target pin reduc pin cell treat lpsifn calpain inhibitor carbobenzoxyvalinylphenylalanin zvf pd cycloheximid cox inhibitor determin pin deplet cox calpain lp ifn induc cox treatment lp ng ifn induc cox protein fold control shrna maec induct greater fold pin shrna cell coxdepend prostaglandin product increas fold kd maec increas control cell addit increas cox protein pin deplet posttranscript induct cox mrna lpsifn cell lack pin loss cox protein treatment cycloheximid block protein synthesi reduc cell lack pin comparison control cell indic degrad enzym reduc zvf pd enhanc induct cox lpsifn zvf slow loss cox treatment cycloheximid cox degrad exogen calpain vitro contrast ino physic interact cox pin detect suggest effect pin calpain cox affect cox degrad cathepsin activ unalt deplet pin reduc calpain activ comparison control shrna cell conclus pin reduc calpain activ slow degrad cox maec recapitul inhibitor calpain sensit cox ino calpain pin limit induct calpain substrat maintain calpain activ endotheli cell
PLoS One	31214462	2009-07-01	PMC2710004	19623263	the genu orthopoxviru speci virus includ caus agent smallpox variola viru addit smallpox member genu capabl caus human infect includ monkeypox cowpox zoonot rodentborn poxvirus singl assai accur identifi orthopoxvirus provid valuabl tool rapid broad orthopoviru identif develop panorthopoxviru assai identif member genu base pcr reaction target orthopoxviru dna rna helicas polymeras gene amplicon detect electrosprai ionizationmass spectrometri pcresim ibi system demonstr assai detect identifi divers collect orthopoxvirus provid subspeci character virus blood rabbitpox infect rabbit assai sensit stochast limit pcr detect viru blood plaqueform unit millilit rabbitpox virusinfect rabbit
J Occup Med Toxicol	19570858	2009-08-01	PMC2710320	19549302	thi articl review biolog occup medicin literatur hn pandem influenza impact infect control cost busi continu set health care commun literatur hn biologi review includ treatment infect control mechan pertain occup medicin plan activ potenti arriv pandem avian influenza grow rapidli publish molecular biologi hn remain pauciti literatur occup medicin impact organ review summar basic scienc surround hn influenza rais kei concern pandem plan occup medicin profession workplac health care set will impact greatli hn pandem occup physician will plai essenti role corpor prepar respons busi continu strategi
PLoS One	19524994	2011-07-01	PMC2712091	19633719	background human rhinovirus hrv highli preval acut respiratori infect children classifi three speci hrva hrvb hrvc character sequenc untransl region utr vpvp region genom increas interest novel hrv strain identif worldwid distribut carri clinic molecular diagnosi hrv strain year studi children acut respiratori infect visit district hospit shanghai methodologyfind clone sequenc nt fragment cover utr vpvp capsid gene sixtyfour hrvinfect outpati diagnos children acut low respiratori tract infect sampl coinfect hrva hrvb hrvc compar analysi vpvp sequenc hrv high divers strain hrva hrvb speci preval of strain belong identifi hrvc speci analyz fragment utr character subspeci hrvc hrvcc cluster differ hrva hrvb hrvca previou recombin region sequenc hrva fulllength sequenc strain hrvca hrvcc subspeci compar analysi confirm close relationship structur protein appar addit recombin event gene utr hrvca strain doubl tripl infect hrvc respiratori syncyti viru andor bocaviru diagnos hrvinfect patient correl sever clinic outcom observ conclus studi high divers hrv strain bronchiti pneumonia children predomin hrvc hrva hrvb observ subspeci hrvc identifi divers to recombin hrva strain hrvc strain appear higher clinic impact hrva hrvb respiratori compromis
PLoS Pathog	30404801	2015-09-14	PMC2712770	19649323	although viral infect minor symptom number result seriou ill viral diseas symptom result direct viral replic host cell indirect immunopatholog consequ dendrit cell dc kei determin viral diseas outcom activ immun respons viral infect direct cell distinct helper type respons virus skew cytokin secret dc induc andor downregul immun system aim facilit prolong releas progeni interact dc virus absenc diseas complet recoveri natur function dc prevail lead chronic ill death function outmanoeuvr virus exploit dc
PLoS One	26289159	2004-01-13	PMC2713419	19641620	intravascularthrombosi extravascularlipiddeposit kei pathogen event consid interrupt intraoss blood suppli develop steroidassoci osteonecrosi clinic emploi agent capabl simultan target kei pathogen event experiment studi demonstr constitut flavonoid glycosid deriv herb epimedium ef compos flavonoid compound common stem nuclear exert dosedepend inhibit thrombosi lipiddeposit reduc incid steroidassoci rabbit direct action common metabolit potenti cellular target involv pathogen pathwai underli mechan explain counteract endothelium injuri excess adipogenesi find encourag design clinic trial investig potenti ef prevent steroidassoci on
Transfus Med	14722270	2014-11-12	PMC2713854	19392949	dengu common arthropodborn infect worldwid peopl year endem countri dengu viru singlestrand rna viru major serotyp infect serotyp confer homotyp immun heterolog immun secondari infect serotyp lead sever diseas major rout transmiss occur aed aegypti mosquito vector dengu transmit blood transfus organ transplant infect spectrum clinic ill rang asymptomat infect undifferenti fever dengu fever dengu haemorrhag fever dhf dengu shock syndrom dss dengu spread rapidli area increas frequenc major outbreak trend observ increas ag infect patient will impact blood suppli avail blood donor defer dengu infect exposur infect risk transmiss transfus blood asymptomat viraem donor will increas screen test dengu effect pathogen reduct process blood suppli implement costli measur carefulli consid demand platelet fresh frozen plasma will rise increas number dhfdss evidencebas guidelin clinic blood compon manag patient dhfdss establish inappropri will contribut challeng face blood servic
Acta Crystallogr D Biol Crystallogr	25392228	2007-12-19	PMC2714721	19622868	coronavirus famili positivestrand rna virus includ pathogen human anim larg coronaviru genom kb encod nonstructur protein nsp deriv replicas polyprotein autoproteolyt process nsp assembl viral replicationtranscript complex nsp nsp nsp believ anchor enzym complex modifi intracellular membran largest coronaviru nsp subunit hydrophob predict embed membran report conserv ctermin domain aminoacid residu delin predict face cytoplasm isol solubl domain librarybas construct screen prototyp crystal structur resolut nsp felin coronaviru unmodifi semetsubstitut protein crystal condit tetragon crystal belong space group phase problem initi solv singl isomorph replac anomal scatter sira molecular replac sirasderiv composit model structur consist singl domain helic content displai uniqu fold engag proteinprotein interact
Ital J Pediatr	18094154	2019-05-29	PMC2717562	19555507	background childhood asthma caribbean advanc preval morbid viral respiratori tract infect report trigger exacerb infect asthma spars caribbean territori examin distribut respiratori virus associ season acut stabl asthmat children trinidad method crosssect studi wheez children attend emerg depart nebulis stabl control subject yr ag asthma clinic nasal specimen collect dry januari raini june decemb season multitarget sensit specif highthroughput respiratori multicod assai test respiratoryviru sequenc distinct group human rhinoviru respiratori syncyti viru parainfluenza viru influenza viru metapneumoviru adenoviru coronaviru enteroviru wheez children higher preval respiratori virus compar stabil asthmat versu acut asthmat thrice infect respiratori viru ci predomin pathogen detect acut versu stabl asthmat rhinoviru rv respiratori syncyti viru rsv enteroviru strong odd rhinovir infect observ nebulis children compar stabl asthmat ci rv preval year dry raini season associ frequent detect viru dry raini season conclus emerg wheez ill childhood link infect rhinoviru trinidad tropic environ viralinduc exacerb asthma independ season tropic climat clinic virolog investig recommend role infect rhinoviru caribbean childhood wheez
Biomark Insights	31142674	2010-03-10	PMC2717845	19662225	sixteen longsag librari clinic stage cervic intraepitheli neoplasia enabl identifi novel cellsurfac biomark indic cin stage compar gene express profil cervic tissu earli advanc stage cin gene identifi novel genet marker fiftysix cellsurfac gene product differenti express progress cin cell surfac protein examin establish capac optic contrast agent bind contrast agent visual will allow realtim assess physiolog state diseas process bring vast benefit cancer care data discuss public submit ncbi gene express omnibu geo httpwwwncbinlmnihgovgeo access geo seri access number gse
BMC Public Health	20219910	2003-02-15	PMC2718884	19607669	background countri effect diseas surveil system earli detect outbreak revis intern health regul ihr enter forc health organ member state expand tradit infecti diseas notif includ surveil public health event potenti intern caus agent clearli establish guidelin countri conduct surveil type emerg diseas syndrom report enforc discuss commonli establish concept syndrom surveil develop region encompass prediagnost real time fashion investig public health action syndrom surveil north america europ typic thought highli complex technolog driven autom tool earli detect outbreak low technolog applic syndrom surveil worldwid augment tradit surveil summari paper review exampl novel applic detect vectorborn diseas foodborn ill sexual transmit infect hope demonstr syndrom surveil basic version feasibl effect tool surveil develop countri facilit complianc ihr guidelin
Curr Oncol	12552021	2008-09-10	PMC2722059	19672425	purpos radiotherapi oncolog emerg aspect manag cancer patient emergencieswhich includ malign spinal cord compress brain metastas superior vena cava obstruct uncontrol tumour hemorrhag requir treatment hospit hour weekend hospit holidai remain consensu radiat oncologist indic appropri radiotherapi treatment weekend treatment decis remain subject main aim studi document incid indic patient receiv emerg treatment weekend schedul hospit holidai singl institut secondari aim investig complianc treatment institut qualiti assur polici local provinci method septemb septemb patient treat weekend defin commenc pm fridai conclud schedul workdai hospit holidai retrospect identifi oncolog patient system schedul modul relev patient datainclud patient ag sex primari cancer site specif radiat field rational treatment refer hospit total treatment dose radiat dose fraction inpati outpati statu durat treatmentwer collect subsequ analyz comparison local polici perform subject year period patient prescrib urgent radiotherapi weekend hospit holidai cohort treat saturdai sundai saturdai sundai patient present lung prostat breast cancer top reason referr emerg weekend treatment includ spinal cord compress brain metastas superior vena cava obstruct indic treatment gener qualiti assur polici implement local provinci conclus patient treat weekend hospit holidai gener treat appropri intent treatment indic studi compli provinci polici pattern care studi literatur local polici appear robust polici improv allow cohes radiat oncologist pattern care group patient comparison practic institut valuabl kei step develop sound guidelin member radiotherapi commun follow
BMC Infect Dis	18786990	2012-11-12	PMC2722662	19630992	background nosocomi infect major threat patient intens care unit icu limit data exist epidemiolog icuacquir infect china retrospect studi carri determin current statu nosocomi infect china method retrospect review nococomi infect icu tertiari hospit east china perform nosocomi infect defin definit center diseas control prevent patient nosocomi infect rate incid densiti rate nosocomi infect excess length stai distribut nosocomi infect site determin pathogen antimicrobi suscept profil investig patient admit period time patient nosocomi infect rate patient dai lower respiratori tract infect lrti account infect urinari tract infect uti bloodstream bsi gastrointestin tract gi infect chang lrti uti bsi infect rate year gi rate decreas in addit baumannii albican epidermidi frequent pathogen isol patient lrti uti bsi rate isol resist commonli antibiot rang conclus high stabl rate nosocomi infect icu tertiari hospit china year differ distribut infect site pathogen antibiot suscept profil report western countri guidelin surveil prevent nosocomi infect implement order reduc rate
PLoS One	23148211	2006-12-12	PMC2722738	19688094	background weekli proport laboratori test posit influenza public health surveil system identifi period influenza activ aim estim sensit influenza test canada base nation respiratori viru surveil system method find weekli number influenzaneg test model function laboratoryconfirm posit test influenza respiratori syncyti viru rsv adenoviru parainfluenza virus season trend poisson regress sensit calcul number influenza posit test divid number influenza posit test modelestim number fals neg test sensit influenza test estim ci vari depend season region conclus estim sensit influenza test report nation laboratori surveil system consider report test characterist laboratori test number factor explain differ includ sampl qualiti specimen procur issu test characterist improv diagnosi permit better estim burden influenza
BMC Med	17164340	2014-10-29	PMC2727531	19635124	background pneumonia main ill death children year ag better describ epidemiolog viral communityacquir pneumonia cap develop countri method juli june examin nasopharyng aspir npa case pneumonia health organ criteria children month recruit random trial zinc supplement field clinic bhaktapur nepal specimen examin respiratori syncyti viru rsv influenza viru type infa infb parainfluenza viru type piv piv piv human metapneumoviru hmpv multiplex revers transcriptas polymeras chain reaction pcr assai identifi viru isol npa specimen valid pcr result yield rsv infa piv piv hmpv infb piv cap occur epidem pattern substanti tempor variat three year studi largest peak pneumonia occurr coincid peak rsv infect occur epidem raini season winter monthli number rsv infect posit correl rel humid rs temperatur rainfal hmpv epidem occur three winter season monthli number hmpv case associ rel humid rs conclus respiratori rna virus detect npa cap case studi commonli isol virus rsv infa piv rsv infect contribut observ cap epidem occurr viral cap commun reflect overlap microepidem respiratori virus highlight challeng develop implement effect public health control measur
Case Rep Med	25359769	2012-12-05	PMC2729489	19707475	liquoric activ substanc glycyrrhizin inhibit convers precursor cortisol cortison inhibit enzym betahydroxysteroid dehydrogenas imbib liquoric act hyperaldosteron present typic symptom includ high blood pressur low blood potassium muscl pain weak articl apprais physiolog pharmacolog effect health liquoric critiqu product liquoric describ typic case report liquoriceinduc hypertens apprais oral effect consumpt liquoric product
PLoS One	17121693	2016-10-11	PMC2729920	19718434	background case fatal ratio cfr ratio death infecti diseas number case assess virul calcul ratio cumul number death case cours epidem result bias cfr studi develop simpl method unbias estim confirm cfr ccfr confirm case denomin earli stage epidem death methodologyprincip find method adjust bias ccfr factor underestim inform time symptom onset death examin approach analyz outbreak sever acut respiratori syndrom hong kong unbias ccfr estim investig publish epidemiolog dataset novel swineorigin influenza hn viru infect usa canada observ death permit estim distribut time onset death uncertainti address sensit analysi maximum likelihood estim unbias ccfr influenza lie rang assum paramet space factor underestim estim influenza virul compar earli estim mexico death model permit estim conserv upper bound ccfr conclus mind ccfr entir popul vulner variat subpopul underdiagnosi method assess virul earli stage epidem inform polici maker public
PLoS One	27729455	2015-06-16	PMC2730015	19714250	dna sequenc normal characterbas represent appear formid mix nucleotid appar order nucleotid frequenc distribut sequenc studi extens simpl rule chargaff centuri ago equat total number purin pyrimidin duplex dna sequenc difficult trace relationship base studi charact represent dna sequenc graphic represent provid clue novel represent dna sequenc provid overview base distribut composit sequenc provid insight hidden structur report observ base graphic represent intrapurin intrapyrimidin differ sequenc conserv gene gener follow quadrat distribut relationship arisen mutat sequenc evolutionari time scale hitherto undescrib relationship gene sequenc consid report hypothes relationship characterist sequenc barrier larg scale sequenc alter overrid characterist monitor process inbuilt dna sequenc relationship rais possibl intron sequenc plai role maintain characterist indic intronl phenomena
Proteome Sci	26077642	2014-12-03	PMC2731080	19664241	background predict function unknown protein essenti goal bioinformat sequenc similaritybas approach function predict inadequ absenc sequenc sequenc similar protein sequenc statist weak studi aim develop accur predict method identifi protein function irrespect sequenc structur similar highli accur predict method capabl identifi protein function base sole protein sequenc properti describ method analys identifi specif featur protein sequenc highli correl protein function determin combin protein sequenc featur best characteris protein function thirtythre featur repres subtl differ local region full region protein sequenc introduc basi featur extract sole protein sequenc model built predict function protein broad rang cellular compon molecular function biolog process accuraci protein function predict random forest featur select rang local sequenc broad rang applic predict protein function conclus accur predict method machinelearn approach base sole protein sequenc properti primari contribut paper propos pnprd featur repres global andor local differ sequenc base posit andor neg charg residu assist predict protein function addit identifi compact featur subset predict function protein indic sequencebas classifi provid good broad rang protein propos featur predict function combin tradit featur support creation discrimin featur set specif protein function
PLoS Pathog	25473044	2012-03-21	PMC2734983	19855817	interspeci transmiss pathogen result emerg infecti diseas human domest wild anim genom tool highthroughput sequenc mrna express profil microarraybas analysi singl nucleotid polymorph provid unpreced wai analyz divers genom emerg pathogen molecular basi host respons compar contrast outcom emerg infect close pathogen host speci delin host pathwai determin outcom zoonot transmiss adapt newli invad speci ultim challeng link pathogen host genom data biolog outcom zoonot transmiss translat integr data novel intervent strategi eventu will allow effect control newli emerg infecti diseas
PLoS Pathog	22438550	2013-11-08	PMC2736567	19806178	a number paramyxovirus respons acut respiratori infect children elderli immunocompromis individu airwai inflamm exacerb chronic diseas asthma understand molecular pathogenesi infect search cellular target virul protein human parainfluenza viru type hpivc hpivc interact directli ctermin domain stat grb protein measl nipah virus fail bind stat explain report capac hpivc block type interferon signal interact grb unexpect adaptor protein bridg epiderm growth factor egf receptor mapkerk pathwai signal cascad involv airwai inflammatori respons report hpiv infect transient express hpivc increas cellular respons egf assess elk transactiv phosphoryl level erk ribosom subunit protein translat initi factor eif inhibit mapkerk pathwai prevent viral protein express infect cell altogeth data provid molecular basi explain role hpivc virul factor determin pathogenesi demonstr paramyxovirida evolv singl virul factor block type interferon signal boost simultan cellular respons growth factor
BMC Med Genomics	24212098	2009-10-01	PMC2736983	19656400	background gene express studi requir appropri normal method method stabli express refer gene suitabl refer gene appear uniqu tissu identifi optim set stabli express gene human blood normal method wholegenom affymetrix human arrai examin sampl male femal ag includ control subject patient tourett syndrom stroke migrain muscular dystrophi autism top stabli express gene broad rang express level identifi valid best candid gene perform quantit rtpcr subset gene trap decr fpg farp mapr pex gin cry csnkg agalt commonli emploi refer gene gapdh actb bm hmb ppib report stabli express blood express stabil rank analysi perform genorm normfind algorithm refer gene rank base express stabil minimum number gene need nomal calcul genorm fewest stabli express gene need acur normal rna express studi human blood combin trap fpg decr ppib confirm rank best candid control gene altern algorithm normfind conclus refer gene identifi studi stabli express blood human gender multipl diseas condit ag importantli function cell express independ gene normal gene microarrai rtpcr blood studi human physiolog metabol diseas
PLoS One	19461111	2015-12-01	PMC2738425	19756151	background grai wolv cani lupu reintroduc yellowston nation park ynp year absenc recoveri effort popul close monitor pup surviv reduc suggest diseas outbreak methodologyprincip find analyz sympatr wolf coyot cani latran red fox vulp vulp serolog data ynp span identifi longterm pattern pathogen exposur identifi associ risk factor examin evid diseaseinduc mortal wolv surviv data high constant exposur canin parvoviru wolf seropreval coyot canin adenoviru wolf pup yr adult yr coyot juvenil yr adult yr canin herpesviru wolf coyot juvenil young adult yr adult yr suggest pathogen enzoot ynp wolv coyot averag of wolv exhibit exposur protozoan parasit neospora caninum individu odd exposur tend increas ag tempor variabl wolf coyot fox exposur canin distemp viru cdv tempor variabl evid distinct multihost outbreak and smaller isol outbreak wolv interior ynp year high wolfpup mortal in northern region park correl peak cdv seropreval suggest cdv contribut observ mortal conclusionssignific pathogen examin appear jeopard longterm popul canid ynp cdv appear capabl caus shortterm popul declin addit cdv maintain frequenc futur epizoot expect futur manag northern rocki mountain wolf popul
BMC Bioinformatics	26459826	2006-01-01	PMC2739203	19682364	background grow divers biolog data tag uniqu identifi uid associ polynucleotid protein ensur effici computermedi data storag mainten process identifi inform peopl substitut biolog meaning name present facilit util dissemin sequencebas knowledg substitut commonli manual tediou exercis prone mistak omiss introduc snad sequenc annotationbas design mediat automat convers sequenc uid associ multipl align phylogenet tree suppli plain text list biolog meaning name acronym convers direct precompil userdefin templat exploit wealth annot cognat entri extern databas exampl demonstr tool gener name practic purpos virolog conclus tool control annotationbas convers sequenc uid biolog meaning name acronym develop servic foster link qualiti sequenc annot effici commun knowledg dissemin research
PLoS One	16391044	2017-02-01	PMC2739295	19763259	background process secretas typei membran protein substrat trigger signal cascad releas intracellular domain icd nuclear transloc modul transcript gene regul divers arrai cellular biolog process list secretas substrat grow enzym cancer alzheim diseas therapeut target map secretas activ suscept gene transcript sharpen view specif gene molecular function biolog pathwai methodologyprincip find identifi gene molecular function transcription secretas activ cellular transcriptom chines hamster ovari cho cell enhanc inhibit secretas activ analyz compar cdna microarrai function cluster fatigo identifi gene reveal underrepres group multipl activ function singl gene pronounc transcript suscept secretas activ evalu realtim pcr valid gene strikingli decreas transcript ptprg amn increas transcript upp support data cell cycl disturb relev cancer stem cell neurodegen diseas map interact protein encod valid gene exclus reli evidencebas data reveal broad effect wnt pathwai member includ wnta dvl intriguingli transcript tera gene unknown function secretas activ alter analyz human alzheim diseas brain cortic conclusionssignific investig effect secretas activ gene transcript reveal cluster molecular function gene hold potenti better understand biologi secretas role cancer alzheim diseas patholog
Virol J	29104445	2004-11-24	PMC2739521	19698190	dure outbreak sar prototyp viru isol patient frankfurtgermani strain frankfurt oppos sarscoronaviru strain frankfurt nucleotid delet transmembran domain orf protein overexpress hek cell fulllength protein variant delet caus interferon beta induct cleavag procaspas studi role orf context viru replic clone full genom cdna copi frankfurt bacteri artifici chromosom downstream rna polymeras promot transfect cap rna transcrib construct yield infecti viru indistinguish origin viru isol presum frankfurt ancestor intact orf reconstruct caco huh cell vero cell variant carri orf delet replic advantag parent viru fold increas viru rna supernat associ chang induct secret type interferon alter induct apoptosi cell cultur pretreat cell interferon beta caus delet viru replic higher titer parent strain fold vero cell fold caco cell syrian golden hamster inocul intranas plaqu form unit viru titer infecti viru viral rna lung increas fold delet viru differ explain earlier observ enhanc virul frankfurt hamster compar sarscoronaviru refer strain identifi sarscov protein attenu factor sarscoronaviru genom attenu focus earli phase infect invivo orf contribut delai accumul viru patient suggest limit spread sar epidem
J Hematol Oncol	15564515	2017-06-13	PMC2739531	19709441	background gener enhanc express antichymotrypsin clusterin clu antitrypsin aat haptoglobin chain hap leucin rich glycoprotein lrg sera patient epitheli ovarian carcinoma eoca report studi compar express serum acutephas protein app patient stage cancer alter stage correl express high abund serum app demonstr sera patient studi express hap aat appear demonstr posit correl three initi stage cancer invers correl detect express lrg clu patient diagnos stage iv cancer express serum app conform alter progress chang conclus highlight potenti prognost signific select high abund serum app patient eoca
PLoS Comput Biol	28606192	2004-10-01	PMC2740835	19779555	as kei factor endem epidem dynam geograph distribut virus frequent interpret light genet histori infer histor dispers migrat pattern virus restrict modelfre heurist approach provid insight tempor set spatial dynam introduct probabilist model evolut offer uniqu opportun engag statist endeavor introduc bayesian framework infer visual hypothesi test phylogeograph histori implement charact map bayesian softwar sampl timesc phylogeni enabl reconstruct time viral dispers pattern accommod phylogenet uncertainti standard markov model infer extend stochast search variabl select procedur identifi parsimoni descript diffus process addit propos prior incorpor geograph sampl distribut character altern hypothes spatial dynam visual spatial tempor summar infer virtual globe softwar describ bayesian phylogeographi compar previou parsimoni analysi investig influenza hn origin hn epidemiolog linkag sampl local analysi rabi west african dog popul reveal viru diffus enabl endem mainten continu epidem cycl analys conclud phylogeograph framework will asset molecular epidemiolog easili gener infer biogeogeographi genet data organ
J Biomed Sci	15365101	2017-09-01	PMC2741444	19725950	to search cellular gene upregul vaccinia viru vv infect differenti displayrevers transcriptionpolymeras chain reaction ddrtpcr assai examin express mrna mockinfect vvinfect hela cell mitochondri gene protein electron transport chain gener atp ii upregul vv infect upregul level vv infect confirm western blot analysi upregul reduc mapk inhibitor apigenin demonstr inhibit vv replic induct express occur viral dna replic ara inhibitor poxvir dna replic block induct atp product increas host cell vv infect oligomycin inhibitor atp product reduc atp level hr viru infect mockinfect cell inhibit viral protein express viru product suggest increas atp product requir effici vv product induct express bcl independ pathwai
PLoS One	28892451	2018-11-21	PMC2743193	19774076	background destruct architectur subsequ function integr lung pulmonari viral infect attribut extent pathogen replic hostgener inflamm associ recruit immun respons presenc antigen dispar pulmonari virus emerg novel virus assur recurr lung damag infect resolut primari viral infect develop safe broad spectrum immunoprophylact strategi capabl enhanc protect immun respons lung limit immunemedi lung damag immunoprophylact strategi describ util protein cage nanoparticl pcn acceler clearanc divers respiratori virus primari infect host immun respons lung damag methodologyprincip find mice pretreat pcn independ specif viral antigen protect subleth lethal dose influenza virus mouseadapt sarscoronaviru mous pneumoviru treatment pcn increas surviv mark enhanc viral clearanc acceler induct viralspecif antibodi product decreas morbid lung damag enhanc protect appear depend prior develop induc bronchusassoci lymphoid tissu ibalt lung respons pcn treatment mediat cd cell cell depend mechan conclusionssignific immunoprophylact strategi describ util infectionindepend induct natur occur ibalt prior infect pulmonari viral pathogen strategi nonspecif enhanc primari immun respiratori virus restrict antigen specif inher typic vaccin strategi pcn treatment asymptomat applic importantli amelior damag inflamm associ recruit immun respons lung
BMC Pregnancy Childbirth	30463962	2018-01-10	PMC2744663	19723332	background optimismpessim healthrel qualiti life compar cultur method three sampl pregnant women final trimest recruit china ghana unit state particip complet survei includ life orient test revis lotr optimismpessim measur short form sf qualiti life measur question address health demograph factor threecountri set creat analysi match women ag gestat ag enrol number previou pregnanc anova posthoc pairwis comparison compar cohort multivari regress analysi creat model identifi variabl associ optimismpessim lotr score vari cultur sampl ghanaian pregnant women optimist pessimist chines pregnant women optimist pessimist subscal analysi kei variabl predict varianc optim score countri origin work monei level educ treat emot issu medic qualiti life score vari countri sampl pronounc differ occur vital measur pregnant women report lower vital score chines ghanaian pregnant women sampl conclus rais question countri origin influenc optimismpessim pregnant women warrant explor underli conceptu optimismpessim health qualiti life countri
PLoS Pathog	29321322	2012-05-09	PMC2745574	19798426	ifn plai critic role limit viral spread restrict viral tropism protect mice neurotrop coronaviru infect ifn depend mechan underli innat antivir function cn understood role rnase viral encephalomyel explor base function inhibit translat induc apoptosi propag ifn pathwai rna degrad intermedi infect rnase defici rl mice subleth demyelin mous hepat viru variant reveal major mice succumb infect dai pi rnase defici affect control infecti viru diminish ifn express cn increas morbid mortal attribut alter proinflammatori signal composit cell infiltr cn uniqu phenotyp infect rl mice manifest earlier onset increas sever demyelin axon damag brain stem spinal cord evid enhanc neuron infect increas tissu damag coincid sustain brain stem infect foci microglia infect grei matter increas apoptot cell data demonstr novel protect role rnase viral induc cn encephalomyel reflect viral control propag ifn mediat signal protect function associ cell type specif region restrict viral replic grei matter amelior neurodegener demyelin
PLoS One	22573863	2006-11-28	PMC2745575	19779614	the niaid nation institut allergi infecti diseas biodefens proteom program aim identifi target potenti vaccin therapeut diagnost agent concern bioterror includ bacteri parasit viral pathogen program includ proteom center gener divers type pathogenhost data includ mass spectrometri microarrai transcript profil protein interact protein structur biolog reagent biodefens resourc center wwwproteomicsresourceorg develop bioinformat framework emploi proteincentr approach integr support mine analysi larg heterogen data underli approach data warehous comprehens protein gene identifi map annot extract molecular databas valuead annot provid kei protein experiment find control vocabulari avail pathogen host omic data integr framework allow global analysi data comparison experi organ illustr case studi present identif hypothet protein differenti gene protein express host system mous macrophag human hela cell infect bacteri bacillu anthraci salmonella typhimurium viral orthopox pathogen suggest protein priorit addit analysi function character analysi vacciniahuman protein interact network supplement protein accumul level led identif human keratin type ii cytoskelet protein potenti therapeut target comparison complet genom pathogen variant coupl experiment complet proteom allow identif priorit ten potenti diagnost target bacillu anthraci integr analysi data set multipl center reveal potenti function signific hidden relationship pathogen host protein provid system approach basic understand pathogen target identif
PLoS Negl Trop Dis	17251145	2013-04-01	PMC2745658	19787037	the diagnosi rabi routin base clinic epidemiolog exposur report rabiesendem countri diagnost test convent assai appear neg undertaken late diseas despit clinic diagnosi tendenc time unreli test rare optim entir depend natur qualiti sampl suppli cours three decad applic molecular biologi aid develop test result rapid detect rabi viru test enabl viral strain identif clinic specimen current number molecular test complement convent test rabi diagnosi challeng st centuri develop rabi diagnost technic natur test challeng st centuri diagnost test develop twofold firstli achiev internation accept valid test will lead accept organis global secondli area test need develop region financi logist barrier prevent implement develop countri poor healthcar infrastructur recognis molecularbas diagnost assai will unafford routin costbenefit ratio measur adopt rapid afford rabi diagnost test develop countri highlight share transfer technolog laboratori twin develop develop countri importantli develop countri benefit molecular method tool capabl differenti diagnosi human diseas clinic symptom antemortem test human rabi molecular techniqu barrier insurmount expect test accept implement need will provid substanti improv rabi diagnosi surveil advent molecular biologi technolog initi combin advanc biologi disciplin will support develop techniqu capabl high throughput test low turnaround time rabi diagnosi
J Immune Based Ther Vaccines	23478444	2009-06-15	PMC2746192	19735569	experi year ago demonstr inject sequenc dna encod pathogen stimul immun realiz dna vaccin numer potenti advantag convent vaccin approach includ inher safeti rapid product time attribut dna vaccin ideal develop emerg pathogen advanc optim aspect dna vaccin acceler approach concept realiti contemporari human trial licens human dna vaccin approv anim health indic rapid manufactur capabl dna vaccin emerg infecti diseas includ current novel hn influenza pandem preexist immun limit advanc dna vaccin approach potenti power weapon protect emerg pandem human pathogen
BMC Gastroenterol	19416076	2003-08-01	PMC2746226	19698126	background studi aim assess nationwid trend incid sever gallston diseas taiwan adult ag method retrospect longitudin studi conduct taiwan nation health insur databas collect patient incid sever gallston diseas acut cholecyst biliari pancreat acut cholang gallstonerel procedur elect nonelect cholecystectomi endoscop retrograd cholangiopancreatographi ercp led hospit admiss identifi icdcm diagnost procedur code annual incid rate gallstonerel complic procedur calcul confid interv ci estim assum poisson distribut hospit admiss rate sever gallston diseas increas advanc ag agestandard rate ci popul men women men higher rate acut cholecyst lower rate elect cholecystectomi men women ag hospit admiss gallstonerel complic procedur increas ag incid biliari pancreat acut cholang hospit admiss gallston receiv ercp increas substanti chang incid acut cholecyst despit decreas rate elect cholecystectomi conclus populationbas studi substanti increas rate admiss sever gallston diseas ag concurr incid biliari pancreat acut cholang risen ag 
Health Qual Life Outcomes	12876183	2007-11-21	PMC2748069	19674476	background wisconsin upper respiratori symptom survei wurss illnessspecif healthrel qualityoflif questionnair outcom instrument object question wurss assess symptom function impair associ common cold instrument measur chang time respons minim differ mid detect wurss descript statist area time sever curv auc sampl size trial requir detect mid auc criteria factor analysi underli dimension structur common cold reliabl item domain summari score repres wurss consider wurss compar wurss jackson sf studi design set peopl jacksondefin cold recruit commun madison wisconsin particip enrol hour cold symptom monitor dai ill half sampl fill wurss morn wurss even half revers daili order extern compar sf hour recal gener health measur yield separ physic mental health score eightitem jackson cold assess symptom function impair qualiti life particip monitor persondai particip ag year sd major femal white repres substant educ incom divers wurss item demonstr perform embed wurss standalon wurss minim differ mid guyatt respons wurss wurss factori analysi suggest dimens structur wurss three dimens structur wurss composit reliabl coeffici rang cronbach alpha rang wurss version correl jackson scale w sf physic health w sf mental health w conclus wurss wurss perform illnessspecif qualityoflif evalu outcom instrument construct valid support data present wurss cover symptom wurss exhibit perform term reliabl respons importancetopati converg measur
Virol J	18032504	2016-08-15	PMC2749830	19737402	the genu toroviru order nidoviral includ number speci infect livestock virus linear positivesens ssrna genom kb encod larg polyprotein express genom rna addit protein express nest set cotermin subgenom rna report describ bioinformat discoveri code orf overlap the polyprotein code sequenc orfa read frame orf strong code signatur fact conserv amino acid level overlap region orfa propos orf util nonaug initi codon conserv cug codon strong kozak context upstream orfa aug initi codon novel amino acid protein dub k
Virol J	27528677	2015-09-16	PMC2751755	19754946	background goos parvoviru gpv dependoviru associ latent infect mortal gees current sever gees product worldwid object studi develop fluoresc quantit realtim polymeras chain reaction pcr fqpcr assai fast accur quantif gpv dna infect gosl aid understand regular distribut pattern nosogenesi gpv vivo detect limit assai standard dna copi sensit log higher convent gelbas pcr assai target gene realtim pcr reproduc satisfactori low intraassai interassai coeffici variat conclus high sensit specif simplic reproduc gpv fluorogen pcr assai combin high throughput method suitabl broad spectrum gpv etiologyrel applic
PLoS Genet	26378161	2019-04-01	PMC2752168	19855822	it argu arriv genom era shift paradigm vaccin therapeut develop microbiolog sequencebas approach genom sequenc provid unattain rout investig mechan underpin pathogenesi genom transcriptom metabolom structur genom proteom immunom exploit perfect identif target design vaccin drug predict effect patient human genom studi provid insight aspect host biologi infecti diseas evergrow bodi genom data genomebas approach will plai critic role futur enabl time develop vaccin therapeut control emerg infecti diseas
PLoS One	30753961	2005-02-11	PMC2752805	19809496	background mothertochild transmiss mtct main hiv infect children worldwid ctype lectin receptor dendrit cellspecif icamgrab nonintegrinrel dcsignr cdl liverlymph nodespecif icamgrab nonintegrin lsign interact pathogen includ hiv express maternalfet interfac hypothes influenc mtct hiv method find investig potenti role dcsignr mtct hiv carri genet associ studi dcsignr wellcharacter cohort hivinfect mother infant recruit harar zimbabw infant harbour copi dcsignr andor haplotyp hh hh hh fold increas risk utero iu hiv infect fold increas risk intrapartum ip hiv infect adjust number matern factor implic h haplotyp share singl nucleotid polymorph snp promot region pa intron inta associ increas risk iu p ip inta hiv infect promot variant reduc transcript activ vitro homozyg infant bear pa inta mutat observ fold decreas level placent dcsignr transcript disproportion express membranebound isoform compar infant noncarri conclus dcsignr plai crucial role mtct hiv impair placent dcsignr express increas risk transmiss
Virol J	15709046	2008-10-08	PMC2753318	19765297	background borna diseas viru bdv type member bornavirida famili virus induc fatal neurolog diseas hors sheep anim propos role psychiatr diseas human bdv glycoprotein extens glycosyl protein migrat appar molecular mass kilodalton kda bdv posttranslation cleav cellular subtilisinlik proteas furin subunit kda amino termin protein gp kda carboxyl termin protein gp class iii viral fusion protein vfp encod member rhabdovirida herpesvirida baculovirida intern fusion domain compris beta sheet beta sheet domain extend alpha helic domain membran proxim stem domain carboxyl termin anchor proteom comput analys structuralfunct motif character class iii vfp locat collinearli bdv structur model establish bdv base postfus structur prototyp class iii vfp vesicular stomat viru glycoprotein vsv conclus encod member bornavirda class iii vfp gammapenetren
BMC Bioinformatics	18842892	2004-07-29	PMC2753849	19758451	background arrai compar genom hybrid fast costeffect method detect genotyp compar genom sequenc unknown bacteri isol method microarrai applic requir adequ coverag probe target region interest unbias tile probe entir length genom flexibl design approach wholegenom tile requir genom sequenc advanc accur analysi uncharacter bacteria arrai queri fulli repres set sequenc speci pangenom prior microarrai includ singl strain arrai conserv sequenc gene famili arrai omit gene sequenc variant pangenom paper present probe select algorithm panarrai tile multipl genom minim number probe arrai built cluster gene famili panarrai unbias probecentr approach reli annot gene cluster multialign probe evenli tile sequenc pangenom consist level coverag minim requir number probe probe conserv multipl strain pangenom select addit probe span polymorph region genom viabil algorithm demonstr arrai design bacteri pangenom design probe arrai fulli tile genom listeria monocytogen strain overlap probe greater twofold coverag conclus panarrai oligonucleotid probe select algorithm tile multipl genom sequenc minim number probe capabl fulli tile genom speci singl microarrai chip uniqu pangenom tile arrai provid maximum flexibl analysi uncharacter strain
J Health Popul Nutr	15306390	2012-02-08	PMC2754025	18330067	acut viral bronchiol common respiratori infecti diseas infanc prospect studi carri infant ag month evalu nutrit breastfeed statu risk factor unfavour evolut previouslyhealthi infant care hospit immunofluoresc test viru anthropometr assess perform outcom length oxygenus length hospit stai type hospit unit need seventythre percent infant wellnourish undernourish nutrit risk overweight obes eightyon percent undernourish nutrition atrisk infant wellnourish overweight obes infant receiv exclus breastfeed median length hospit stai dai oxygenus hour nutrit statu affect clinic cours previouslyhealthi infant acut viral brochiol durat exclus breastfeed type breastfeed invers length oxygenus length hospit stai shorter exclus breastfeed observ infant assign paediatr ward intens care unit conclus longer durat breastfeed associ better clinic outcom
BMC Infect Dis	22318134	2014-11-24	PMC2754485	19772586	background serum procalcitonin pct consid predict likeli develop bacteri infect emerg set studi describ pct level overtim relationship bacteri infect chronic obstruct pulmonari diseas copd critic patient pneumonia method conduct prospect cohort studi icu univers hospit consecut copd patient admit pneumonia septemb septemb includ respiratori sampl test presenc bacteria virus procalcitonin sequenti assess patient classifi probabl presenc bacteri infect thirti patient includ pct level assess patient median valu gl iqr time admiss gl iqr hour gl iqr hour highest pct pctmax level gl patient greater gl patient suggest low high probabl bacteri infect fifteen bacteria virus detect patient bacteria detect patient pctmax level gl contrast bacteria detect patient estim bacteri infect pct level pctmax gl conclus base pct level cut gl appropri gl propos sever lower respiratori tract infect predict probabl bacteri infect sever copd patient pneumonia studi test procalcitoninbas antibiot strategi need copd patient sever pneumonia
PLoS One	25329858	2012-04-18	PMC2754531	19816578	we demonstr replac gene avirul strain beaudett infecti bronchiti viru ibv gene virul strain recombin viru beaurm vitro cell tropism virul viru avirul order investig structur accessori gene plai role pathogen replac beaudett strain recombin ibv chimaer viru replicas gene deriv beaudett rest genom demonstr exchang larg region ibv genom kb transient domin select method recoveri viabl recombin ibv demonstr interchang complet replicas gene replac replicas gene beaudett deriv gene analysi chimaer viru avirul indic structur accessori gene deriv virul isol ibv restor virul loss virul associ beaudett strain resid replicas gene
PLoS Biol	17715225	2007-08-29	PMC2757898	19855827	in likelihood matter time public health system will face major biolog threat intention dispers origin newli emerg infecti diseas increas reactiv biodefens proactiv increas prepared achiev goal essenti scientif public health commun fulli embrac genom revolut novel bioinformat comput tool great stride understand novel emerg threat develop genom graduat special field scienc tool will routin laboratori clinic set technolog afford genom proactiv build prepared respons biolog threat piec includ major continu fund advanc nextgener sequenc technolog bioinformat infrastructur open access data metadata set place genom plai central role public health system
PLoS Biol	17728234	2012-01-06	PMC2757903	19855828	infecti diseas global coordin genomicbas movement link sequenc effort develop respons tool mitig impact exist emerg threat
PLoS One	22319149	2017-05-03	PMC2757906	19823675	background small molecul inhibitor rna viru replic potent antivir drug dissect select step replic process identifi antivir compound tomato bushi stunt viru tbsv model posit strand rna viru test acridin deriv chlorpromazin cpz quinacrin qc activ prionbas diseas methodologyprincip find report cpz qc compound inhibit tbsv rna accumul plant protoplast vitro assai reveal inhibitori effect compound manifest step tbsv replic qc multipl step includ inhibit select bind replic protein viral rna templat requir recruit viral rna replic ii reduct minusstrand synthesi tombusviru replicas iii inhibit translat uncap tbsv genom rna contrast cpz inhibit vitro assembl tbsv replicas bind cpz intracellular membran rna viru replic conclusionsignific cpz effect inhibitor plant virus includ tobacco mosaic viru turnip crinkl viru cpz broad rang antivir activ inhibitor constitut effect tool studi similar replic strategi rna virus
PLoS One	28148840	2016-12-01	PMC2759292	19834602	background virus interact exploit host cellular machineri multipl propag mekerk signal pathwai posit regul replic rna virus signal pathwai hepat viru hcv replic product understood method studi advantag wellcharacter mekerk inhibitor mekerk domin neg mutant investig role mekerk signal pathwai hcv gene express replic inhibit mekerk signal enhanc hcv gene express minusstrand rna synthesi viru product addit enhanc independ interferon ifn antivir activ requir prior activ mekerk signal pathwai mek erk erk involv hcv replic regul hcv rna translat conclus demonstr neg regulatori role mekerk signal pathwai hcv replic potenti risk target signal pathwai treat prevent neoplast transform hcvinfect liver cell
J Biomed Sci	27262925	2003-09-01	PMC2759930	19778418	background envelop glycoprotein hepat viru hcv mediat bind viru target cell receptor precis role viral entri remain elus method understand involv fusion peptidelik domain posit residu envelop glycoprotein hcv infect mutant ala asn substitut residu conserv hcv protein flavivirus fusion protein paramyxovirus construct sitedirect mutagenesi effect membran fusion viral infect examin mutat synthesi cell surfac express envelop protein alter format noncoval ee heterodim bind larg extracellular loop cd cy residu locat posit involv intra intermolecular disulfid bond format except ga mutant increas cell fusion mutant displai reduc margin inhibit cell fusion capac compar wildtyp wt ee ga mutant except human immunodefici viru type hivhcv ee pseudotyp analys higher onecycl infect mutant exhibit greatli partial reduc viral entri versu wt pseudotyp ga dn mutant wtlike profil ee incorpor hiv particl ca ga ga pseudotyp bound huh cell effect wt pseudotyp reduc infect pseudotyp abil inhibit cell fusion conclus indic specif residu structur fusion peptidelik domain requir mediat cell fusion viral entri
AIDS Res Ther	12954672	2018-11-07	PMC2761414	19799780	hiv infect gut associ lymphoid tissu galt earli transmiss multipl rout infect galt consequ serv major reservoir hiv infect constantli hiv cd cell intestin lumen examin hypothesi monitor hiv rnadna cd mrna fecal sampl chronic infect subject antiretrovir therapi art compar level hiv rnadna urin blood subject hiv dna rna cd mrna detect fece sampl infect subject detect plasma viral load detect subject art undetect plasma viral load urin sampl hiv dna detect infect subject detect plasma viral load subject art undetect plasma viral load phylogenet analysi envelop sequenc hiv reveal distinct viru popul concurr collect serum fece urin sampl subject addit studi demonstr time presenc cd mrna fecal specimen hiv infect subject assess galt pathogenesi hiv infect
BMC Infect Dis	30404792	2016-10-19	PMC2761921	19788751	background island nation explicit compon influenza pandem plan provid travel warn restrict incom travel potenti restrict quantifi method develop probabilist model paramet publish model influsim travel data pacif island countri territori pict indic pict travel data escap major pandem viral strain low contagi impos tight travel volum reduct cours pandem contagi viral strain pict probabl escap total number travel pandem exce r pict aim probabl pandem arriv conclus island nation reli intens travel volum restrict avoid arriv pandem influenza subsequ wave island nation plan multipl addit intervent screen quarantin rais probabl remain pandem free achiev substanti delai pandem arriv
PLoS Pathog	27795416	2018-05-23	PMC2762542	19851468	sever acut respiratori syndrom caus substanti morbid mortal epidem featur human diseas duplic balbc mice infect mouseadapt version viru ma develop respiratori diseas high morbid mortal sever diseas correl slow kinet viru clearanc delai activ transit respiratori dendrit cell rdc drain lymph node dln consequ defici virusspecif cell respons defect correct mice treat liposom clodron deplet alveolar macrophag inhibitori am believ prevent develop immun respons environment antigen allerg respons interact lung dendrit cell cell inhibitori effect nullifi mice am pretreat poli ic directli activ am rdc tolllik receptor tlr adopt transfer activ rest bone marrowderiv dendrit cell bmdc protect mice lethal ma infect relev sar human character prolong viru persist delai develop sarscovspecif immun respons individu sever diseas
Thorax	29575495	2013-12-26	PMC2764123	19574243	background pseudomona aeruginosa common bacteri pathogen patient cystic fibrosi cf current infect control guidelin aim prevent transmiss contact respiratori droplet rout consid possibl airborn transmiss hypothesis subject cf produc viabl respir bacteri aerosol cough method crosssect studi undertaken children adult cf chronic infect aeruginosa cough aerosol sampl system enabl fraction respiratori particl size cultur viabl gramneg nonfer bacteria cough aerosol collect min voluntari cough sputum induct procedur toler standardis quantit cultur genotyp techniqu aeruginosa isol cough aerosol subject produc sputum sampl aeruginosa sputum pair cough aerosol indistinguish molecular type case genotyp isol ambient room air viabl aerosol collect voluntari cough particl aerodynam diamet aeruginosa burkholderia cenocepacia stenotrophomona maltophilia achromobact xylosoxidan cultiv respiratori particl size rang posit room air sampl associ high total count cough aerosol magnitud cough aerosol associ higher forc expiratori volum higher quantit sputum cultur conclus cough patient cf produc viabl aerosol aeruginosa gramneg bacteria respir size rang suggest potenti airborn transmiss
Virol J	24371236	2015-07-09	PMC2765438	19818146	background cytotox tlymphocyt immun respons control hiv replic infect human immun pathwai viral peptid infect cell present tlymphocyt polymorph human leukocyt antigen hla hla allel exert select pressur peptid region immun escap mutat occur target site enabl viru adapt infect host pattern ongo immun escap revers associ human hla allel studi extens mutat revert transmiss host hla allel escap mutat incur fit cost todat attempt studi perman loss ctl epitop escap mutat fit set determin extent adapt hiv three wellcharacter hla allel initi exposur viru human cytotox immun respons transmiss chimpanze gener chimpanze consensu sequenc approxim viru sequenc initi transmit human host method base peptid bind affin hla crystal structur predict peptid target hla allel sequenc codonbas phylogenet model quantifi averag select pressur act region period zoonosi event correspond branch phylogenet tree lead common ancestor of hiv sequenc evid adapt evolut period observ region recognis hla common african popul evid adapt evolut observ site target hlab rare allel african popul conclus ancestr hiv viru experienc period posit select pressur immun respons associ hla allel common infect human popul propos perman escap immun respons target unconstrain region viru
BMC Infect Dis	26158319	2011-08-10	PMC2765446	19807908	background outbreak pandem flu influenza hn swine flu earli provid major challeng health servic previou pandem led stockpil good victimis popul group cancel travel boycot food pork examin initi behaviour attitudin respons influenza hn swine flu dai pandem alert level region differ respons method respond complet crosssect internet paperbas questionnair studi malaysia europ measur assess chang transport usag purchas preparatori good pandem perceiv risk group indic anxieti assess estim mortal rate season flu effect season flu vaccin chang pork consumpt respond concern flu victim malaysian european report reduc public transport malaysia europ flight cancel malaysia europ purchas preparatori materi face mask malaysia europ malaysia europ intend european malaysian discuss pandem friend group high risk infect includ immun compromis mention respond pig farmer elderli prostituteshighli sexual activ homeless data collect europ greatli underestim mortal rate season flu believ season flu vaccin protect swine flu reducedstop eat pork purchas antivir drug intend pandem worsen conclus initi respons influenza larg region differ anxieti malaysian anxiou reduc travel bui mask food discuss famili friend reinforc exist anxieti level group homosexu prostitut homeless perceiv greater risk lead increas prejudic pandem european underestim mortal season flu requir protect season flu inocul
PLoS Pathog	21835784	2018-10-05	PMC2765826	19888339	nipah viru broadli tropic highli pathogen zoonot paramyxoviru genu henipaviru natur reservoir speci pteropu fruit bat nipah viru repeatedli caus outbreak decad associ sever fatal diseas human anim ferret model nipah viru pathogenesi describ respiratori neurolog diseas infect anim sever diseas occur viral dose low tcid dai infect underli patholog ferret close resembl nipah viru infect human character widespread multisystem vascul viru replic highli vascular tissu includ lung spleen brain recover viru varieti tissu ferret model crossreact neutral human monoclon antibodi target henipaviru glycoprotein evalu vivo potenti therapeut agent ferret receiv ten hour high dose oralnas nipah viru challeng protect diseas control di studi success postexposur passiv antibodi therapi nipah viru human monoclon antibodi
Health Res Policy Syst	30235060	2015-09-25	PMC2765941	19785747	sever influenza pandem place histori assum pandem emerg human viru adapt avian viru strain mexico develop nation prepared respons plan influenza pandem focus risk commun health promot healthcar epidemiolog surveil strateg stockpil develop plan challeng april influenza ahn strain swine origen detect mexico situat face decis action allow control epidem wave countri document describ critic moment face explicitli point lesson learn focus decid support govern nation pandem influenza plan coordin govern level presenc solidar intern organ time daili diagnosi posit popul prevent hygien measur recommend health author intern commun will mexican experi interest global health
BMC Med Res Methodol	26403694	2020-03-02	PMC2766390	19804650	background quantit survei articl applic bibliometr effect tool grasp trend medic field type survei appli infecti diseas previou studi insuffici underestim articl publish nonenglish region journal method combin scopu pubm databas scientif literatur english nonenglish keyword directli link infecti diseas control identifi intern region infecti diseas journal order ascertain newli select journal appropri survei wide rang articl compar number origin articl review regist select journal infecti diseas categori scienc citat expand sci infecti diseas categori subsequ appli newli select journal survei number origin articl review origin asian countri period journal written english nonenglish languag newli select infecti diseas journal journal publish origin articl review asian origin regist sci infecti diseas categori asian origin categori asian trend analysi journal japan highest percentag origin articl review area notic increas articl reveal studi period china india taiwan larg number high increas rate origin articl asian countri adjust public origin articl countri popul gross domest product gdp singapor taiwan product conclus survei select journal sensit sci infecti diseas categori viewpoint avoid underestim number infecti diseas articl asian origin survei method applic grasp global trend diseas method requir develop
Implement Sci	32274354	2007-04-25	PMC2766417	19828086	background despit support meter dose inhal spacer devic mdispac pediatr emerg depart ped acut exacerb asthma uptak practic slow object studi determin barrier support implement mdispac identifi factor associ earli late adopt mdispac canadian ped method compar case studi design classifi tertiari care pediatr hospit ped base stage implement data collect focu group interview physician regist nurs rn respiratori therapist rt individu interview patient care medic director site initi code base ottawa model omru categori element influenc uptak innov fifti healthcar profession healthcar institut particip studi lack leadership form champion lack consensu benefit mdispac staff perceiv resist patientspar perceiv increas cost workload associ mdispac preval barrier adopt mdispac common strategi earlyadopt site includ activ particip profession group adopt process addit wellplan execut educ compon staff patient famili earli adopt site mdispac includ clinic protocolpathwai conclus potenti barrier support implement identifi will help ed adopt mdispac futur intervent intend increas mdispac ped will sensit barrier identifi studi
Virol J	17460051	2011-01-01	PMC2770056	19821998	background vesicular stomat viru vsv prototyp rhabdoviru best studi member order mononegaviral compel evid envelop virion releas infect cell carri numer host cellular protein plai role viral replic cellular protein incorpor vsv virion systemat studi reveal host protein composit virion vsv member mononegaviral proteom approach identifi cellular protein purifi vsv virion creat snapshot stage virushost interact guid futur experi aim understand molecular mechan viruscel interact highli purifi prepar vsv virion three cell line human mous hamster origin analyz presenc cellular protein mass spectrometri confirm presenc previouslyidentifi cellular protein vsv virion identifi number addit protein virion total sixtyfour cellular protein identifi multipl prepar combin immunoblot proteinas protect assai verifi presenc protein integrin heat shock protein kda heat shock cognat kda protein annexin elong factor virion conclus knowledg systemat studi host protein composit virion vsv member order mononegaviral futur experi need determin identifi protein interact vsv interact benefici neutral antivir respect vsv replic identif host proteinsviru interact benefici viru excit provid wai combat viral infect control host compon
PLoS One	21975583	2007-10-01	PMC2770169	19888418	background natur cat popul felin immunodefici viru fiv transmit bite individu factor densiti cat popul sexratio strong effect frequenc fight individu appear popul risk factor fiv methodologyprincip find studi popul risk factor data fiv preval cat popul northeastern franc investig kei social factor cat popul densiti cat sexratio number male ag male femal popul overcom problem depend infect statu data sexuallystructur dynam stochast model ag male femal p maletofemal transmiss rate multipl test effect realiti final studi area data explain simpl model invok risk factor conclus conclus hostparasit system gener fluctuat stochast transmiss process natur larg explain larger variabl observ diseas preval popul expect final determin confid interv simpl model paramet aid manag diseas
PLoS One	17698038	2013-01-30	PMC2773421	19924243	background entri envelop virus host cell requir activ viral envelop glycoprotein cleavag intracellular extracellular proteas order gain insight molecular basi proteas cleavag impact effici viral entri investig suscept recombin nativ fulllength sprotein trimer trispik sever acut respiratori syndrom coronaviru sarscov cleavag airwai proteas methodologyprincip find purifi trispik protein cleav vitro three airwai proteas trypsin plasmin tmprssa high perform liquid chromatographi hplc amino acid sequenc analys identifi arginin residu r potenti proteas cleavag site proteasedepend enhanc sarscov infect demonstr ac express human bronchial epitheli cell hbe airwai proteas regul infect sarscov fashion depend previou receptor bind role arginin residu mutant construct ra ra rara mutat r affect express sprotein differenti efficaci pseudotyp sarscovpp ra sarscovpp mutant exhibit lack viru entri enhanc proteas treatment conclusionssignific sar sprotein suscept airwai proteas cleavag proteas mediat enhanc viru entri depend specif conform sar sprotein ac bind data direct implic cell entri mechan sarscov respiratori system expand possibl identifi potenti therapeut agent sarscov
PLoS One	23363823	2005-10-13	PMC2773932	19915717	sever acut respiratori syndrom sar caus coronaviru sarscov acut infecti diseas mortal typic clinic featur associ sar pulmonari fibrosi associ lung failur aftermath sar epidem progress understand underli molecular mechan infect larg gap remain knowledg sarscov interact host cell onset infect rapidli chang viral genom add variabl equat focus novel concept microrna mirnamedi hostviru interact bronchoalveolar stem cell basc onset infect correl bascmicrornom target basc viral genom work encompass mirna arrai data analysi target predict mirnamrna enrich analysi develop complex interact map diseaserel factor mirna basc sar pathwai will provid clue diagnost marker view interplai lead diseas progress observ reveal basc sca cd cd pecam subset oct ac epitheli coloni cell bronchoalveolar duct junction prime target cell sarscov infect upregul basc mirna coopt sarscov suppress replic evad immun elimin success transmiss take place viral nucleocapsid spike protein target coopt downregul mir mir basc control stage basc differenti activ inflammatori chemokin downregul ac effect account success viral transmiss replic basc caus continu deterior lung tissu appar loss capac lung repair investig reveal mode exploit cellular mirna machineri viru advantag
Acta Vet Scand	16227251	2005-08-01	PMC2776595	19878595	background sweden subtyp verocytotoxinproduc escherichia coli vtec origin defin phage type carri vtx gene major report human infect year includ sporad case outbreak plausibl explan thi subtyp better adapt colonis cattl excret greater concentr longer period vtec subtyp method experiment studi calv inocul coloni form unit cfu strain ccug repres subtyp vtec ptvtxvtxc uninocul calv cohous inocul calv initi vtec strain isol dairi herd natur occur infect farm link human infect strain faecal sampl collect month period analys vtec immunomagnet separ im im posit sampl analys direct plate elucid shed pattern sampl collect pharynx inocul calv prove cultureposit faec hour inocul uninocul calv dai postinocul calf persist cultureposit dai remaind vtec count faec decreas week pharyng sampl cultureneg vtec conclus studi contribut concern dynam specif subtyp vtec colonis dairi calv subtyp vtec ptvtxvtxc frequent isol swedish cattl major report human infect sweden year calv inocul repres strain specif subtyp number bacteria declin week calf classifi highshedd excret high level bacterium prolong period
Curr Pharm Des	26648515	2003-12-01	PMC2778081	19075740	cellular uptak therapeut oligonucleotid subsequ intracellular traffick target site repres major technic hurdl biolog effect potenti drug laboratori worldwid focu develop suitabl deliveri system nonvir system cation polym cation liposom polymer nanoparticl cellpenetr peptid cpp repres attract concept bypass problem poor membran permeabl charg macromolecul uptak se case repres main obstacl nucleic acid deliveri vitro increasingli appar intracellular traffick bottleneck consequ order optim deliveri system sidebysid analysi nucleic acid cargo intern correspond biolog requir determin efficaci review will concentr peptidemedi deliveri sirna steric block oligonucleotid discuss method quantit assess amount cargo correl number biolog effect appli easi handl report system illustr current limit nonvir nucleic acid deliveri system data exampl discuss option enhanc traffick molecul entrap cellular compart
PLoS One	14652258	2009-09-09	PMC2778948	19956642	background furin repres crucial member secretori mammalian subtilas proprotein convertas pc proprotein convertas subtilisinkexin pcsk superfamili link cancer tumorgenesi viral bacteri pathogenesi result consid major target intervent diseas methodologyprincip find report time synthesi biolog evalu newli design potent furin inhibitor highli reactiv betaturn induc radic gener enediynyl amino acid eda moieti eda insert p residu hfurin peptid deriv primari cleavag site furin prodomain hexadecapeptid deriv inhibit furin vitro ic nm measur fluorogen substrat bocrvrrmca inhibit furinmedi cleavag fluorogen peptid deriv hsarscov spike protein ic nm addition block furinprocess growth factor propdgfa vegfc link tumor genesi cancer circular dichroism studi inhibitor displai betaturn structur western blot confirm abil protect furin protein degrad conclusionsignific find impli potenti therapeut agent intervent cancer furinassoci diseas
Mol Microbiol	19740921	2012-01-01	PMC2779471	17176260	pregnancyassoci malaria pam caus plasmodium falciparuminfect erythrocyt i bind chondroitin sulphat csa placenta pamassoci clonal variant surfac antigen vsa pregnancyspecif vsa vsapam includ pfemp variant varcsa target iggmedi protect immun pam report investig specif natur acquir immun pam human monoclon igg antibodi react exclus intact csaadher i express vsapam react western blot highmolecularweight kda protein react dblx dbl domain varcsa express baculoviru construct surfac transfect jurkat cell panel recombin antigen repres dblx domain falciparum field isol evalu bcell epitop divers parasit isol identifi bind site monoclon antibodi chimer dblx construct find highfrequ memori respons vsapam indic varcsa primari target natur acquir pamspecif protect immun demonstr human monoclon antibodi conformation intact recombin antigen vsa character
BMC Public Health	22641221	2013-04-10	PMC2779504	19922686	a descript communic diseas histori develop mathemat model diseas transmiss includ reason mathemat model histori mathemat model foundat laid late nineteenth centuri the accomplish mathemat model challeng futur purpos demonstr mathemat model understand manag infecti diseas transmiss
PLoS One	23576515	2007-07-01	PMC2779851	19997505	background late april novel influenza viru hn gener refer swine flu spread globe infect hundr thousand peopl dai initi outbreak mexico extens media coverag high degre uncertainti transmiss mortal rate associ viru caus widespread concern popul spread infecti diseas influenc behavior chang social distanc earli phase epidem data risk percept behavior respons novel viru collect substanti delai epidem cours methodologyprincip find report onlin survei gather data risk percept influenza ahn outbreak dai widespread media coverag april find initi high level concern level anxieti wane percept viru threat data provid evid emot statu mediat behavior respons intriguingli princip compon analysi reveal strong cluster anxieti swine flu bird flu terror three threat receiv great deal media attent fundament uncertainti gener inordin amount fear visavi actual threat conclusionssignific respond behavior vari predict wai interest find affect variabl selfreport anxieti epidem mediat likelihood respond will engag protect behavior understand protect behavior social distanc vari specif factor mediat help design epidem control strategi
Respir Res	17369487	2013-07-02	PMC2780994	19874627	background highli pathogen avian influenza hpai hn viru entrench poultri asia africa continu infect human zoonot caus acut respiratori diseas syndrom death evid viru spread respiratori tract dissemin infect primari target cell hpai hn viru human lung alveolar epitheli cell alveolar epithelium adjac lung microvascular endothelium form host barrier initi infect dissemin influenza hn infect human polar cell polar influenza viru entri egress secret cytokin chemokin viru infect cell central pathogenesi human hn diseas aim studi influenza hn viru replic host innat immun respons polar primari human alveolar epitheli cell lung microvascular endotheli cell relev pathogenesi human hn diseas method vitro model polar primari human alveolar epitheli cell lung microvascular endotheli cell grown transwel cultur insert compar infect influenza subtyp hn hn virus apic basolater surfac demonstr influenza hn hn virus effici infect alveolar epitheli cell apic basolater surfac epithelium releas newli form viru apic side epithelium contrast influenza hn viru hn viru effici infect polar microvascular endotheli cell apic basolater aspect mechanist explan hn viru infect lung system circul epidemiolog evid implic ingest viruscontamin food sourc infect instanc data suggest viremia secondari exampl gastrointestin infect lead infect lung hpai hn viru potent induc cytokin ip rant il comparison hn viru alveolar epitheli cell virusinduc chemokin secret apic basolater aspect polar alveolar epithelium conclus predilect virus rout entri egress infect cell understand pathogenesi influenza hn infect help unravel pathogenesi human hn diseas
BMC Health Serv Res	24319610	1999-12-15	PMC2781002	19895692	background methodolog approach estim distanc health servic studi focus cardiac catheter servic euclidean manhattan minkowski distanc metric estim distanc patient resid hospit distanc metric typic produc accur estim actual measur metric singl model travel network distanc metric actual measur directli spatial analyt model euclidean distanc appropri metric minkowski distanc promis method distanc estim metric contrast road distanc travel time measur optim minkowski distanc implement spatial analyt model method road distanc travel time calcul postal code resid patient undergo cardiac catheter pertin hospit minkowski metric optim approxim travel time road distanc distanc estim distanc measur compar descript statist visual map method optim minkowski metric implement spatial weight matrix spatial regress model identifi socioeconom factor associ cardiac catheter minkowski coeffici best approxim road distanc best approxim travel time good predictor road distanc provid best singl model travel patient resid hospit euclidean metric optim minkowski metric altern implement regress model compar minkowski method produc reliabl tradit euclidean metric conclus road distanc travel time measur accur estim directli implement spatial analyt model euclidean distanc underestim road distanc travel time manhattan distanc overestim optim minkowski distanc partial overcom shortcom singl model travel network method flexibl suitabl analyt model accur tradit metric ultim increas reliabl spatial analyt model
PLoS Med	10572179	2004-05-26	PMC2782135	20016686	maria yazdanbakhsh peter kremsner argu better awar surveil clinic manag common febril diseas africa influenza
BMC Microbiol	15163702	2013-09-25	PMC2782262	19682357	background amino acid substitut target enzym ergp azol antifung contribut clinicallyrelev azol resist candida albican simpl molecular method rapid detect erg gene mutat advantag screen tool identifi potentiallyresist strain track movement complement dna sequenc develop padlock probe roll circl amplif rcabas method detect seri mutat albican erg gene refer azoleresist isol mutat method estim frequenc erg mutat type australian clinic albican isol reduc suscept fluconazol fluconazolesuscept isol rca compar dna sequenc rca assai correctli identifi erg mutat refer albican isol appli test strain rca method agreement dna sequenc erg mutationspecif probe missens mutat detect sequenc isol reduc fluconazol suscept detect rca missens mutat detect method fluconazolesuscept strain dna sequenc reveal mutat nonsuscept isol homozyg nucleotid chang except mutat lead amino acid substitut fluconazolesuscept strain heterozyg amino acid substitut common set isol de kt vi vi substitut uniqu isol reduc fluconazol suscept isol ge gs kr yh sf rk dna sequenc reveal novel substitut gv isol conclus sensit rca assai describ simpl robust rapid method detect erg polymorph excel concord erg sequenc valuabl tool track emerg spread azoleresist albican studi epidemiolog erg mutat rca method applic studi azol resist fungi
BMC Microbiol	24068007	2015-09-01	PMC2782265	19674441	background human immunodefici viru type hiv major caus pathogen acquir immun defici syndrom aid larg number hivrel studi base three nonhuman model anim chimpanze rhesu macaqu mous differ hosthiv interact human model organ remain unexplor descript capih compar analysi protein interact hiv webbas interfac provid compar human three model organ context hosthiv protein interact capih identifi genet chang occur hivinteract host protein total ortholog protein set capih identifi amino acid substitut insertionsdelet potenti posttransl modif occur compar speci capih interact interfac displai hosthiv protein interact network presenceabs ortholog protein model organ network genet chang occur protein node function domain potenti protein interact hot site genet chang capih interfac freeli access httpbioinfodbbnhriorgtwcapih conclus capih exemplifi larg diverg exist diseaseassoci protein human model anim newli develop medic test model anim enter clinic trial advis compar analys perform ensur proper translat animalbas studi case aid hosthiv protein interact differ great extent compar speci integr protein network comparison speci will light aid studi
Respir Res	26210298	2012-01-25	PMC2783028	19909524	background inflammatori process lung injuri lead pulmonari fibrosi pf describ pf mice infect hn viru method eightweekold balbc mice inocul intranas mid achickenhebeihn virus lung injuryfibrosi evalu observ hydroxyprolin concentr lung index histopatholog dai postinocul hninocul mice present stage pulmonari diseas period infect acut stage infectedmic typic diffus pneumonia inflammatori cellular infiltr alveolar interstiti edema hemorrhag dai postinocul restor stage infectedmic develop pf sever dai postinocul surviv mice underw sever interstiti intraalveolar fibrosi thicken alveolar wall collaps alveoli larg fibrot area dramat elev hydroxyprolin level hninfect mice deposit collagen lung confirm fibrosi lung dry lungtobodi weight ratio increas infect group associ format pf hninfect mice conclus find hninfect mice develop typic pf restor period will contribut investig fibrogenesi potenti therapeut intervent human hn diseas
Aging (Albany NY)	22276951	2016-10-24	PMC2784685	19946382	dyslipidemia character increas triglycerid lowdens lipoprotein ldl level decreas highdens lipoprotein hdl level atherogen lipid profil predispos risk individu coronari arteri diseas incomplet understood mechan apolipoprotein apod atyp apolipoprotein canon apolipoprotein produc liver intestin apod express mammalian tissu apod share degre homolog amino acid sequenc apolipoprotein apod structur lipocalin divers famili lipidbind protein respons transport lipid small hydrophob molecul metabol plasma apod hdl lesser extent low densiti lipoprotein ldl lowdens lipoprotein vldl genet variant apod associ abnorm lipid metabol increas risk develop metabol syndrom increas apod deposit detect atherosclerot lesion human establish cardiovascular diseas mice prematur atherosclerosi apod associ antioxid antistress activ contribut lifespan expans fruit fli elderli subject patient alzheim exhibit markedli elev apod product brain apod emerg player lipid metabol ag focu review advanc understand apod lipid metabol address apod dysregul contribut pathogenesi dyslipidemia atherosclerosi will discuss function implic apod ag
PLoS Med	27791106	2008-04-28	PMC2784942	20016689	jonna mazet colleagu describ work tanzaniabas hali project adopt health approach address emerg zoonos recogn interconnected human anim environment health
BMC Bioinformatics	19066576	2018-08-22	PMC2787530	19930702	background autom surveil internet time sensit method alert global emerg infecti diseas threat healthmap gener onlin system design monitor visual realtim basi diseas outbreak alert report onlin new media public health sourc healthmap specif interest nation intern public health organ intern travel task surveil autom discoveri geograph refer contain retriev outbreak alert task refer geopars typic approach geopars demand expens train corpu alert manual tag human human reader perform kind task lexic contextu knowledg develop approach reli small expertbuilt gazett limit human input focus learn context geograph refer appear set experi approach exhibit substanti capac discov geograph locat initi lexicon conclus analysi provid framework futur autom global surveil effort reduc manual input improv timeli report
PLoS One	30135128	2008-04-10	PMC2788226	20011515	background bat suspect natur reservoir host number emerg zoonot virus includ nipah viru hendra viru sever acut respiratori syndrom coronaviru ebola viru discoveri sarslik coronavirus chines horsesho bat attempt isol slcov bat fail attempt isol batborn virus mammalian cell line unsuccess stabl bat cell line need help investig tool assist studi bat immunolog virushost interact methodologyfind black fly fox pteropu alecto captur wild transport live laboratori primari cell cultur prepar varieti method cultur media primari cell cultur organ cell immortalis occur spontan retrovir system immortalis cell transfer stabl product simian viru larg antigen human telomeras revers transcriptas protein initi infect experi clone unclon cell line hendra nipah virus demonstr vari degre infect effici cell line infect cell tissu type conclusionssignific approach develop optimis studi applic bat speci process gener cell line number bat speci methodolog establish studi
BMC Bioinformatics	18403718	2010-04-01	PMC2788353	19958512	background aminotermin signal peptid sp short region guid target secretori protein correct subcellular compart cell cleav passeng protein reach destin explos growth sequenc technolog led deposit vast number protein sequenc necessit rapid function annot techniqu subcellular local kei featur myriad softwar predict tool develop autom task assign sp cleavag site sequenc review perform reliabl commonli sp predict tool signal peptid data manual curat organ three dataset repres eukaryot gramposit gramneg bacteria dataset evalu thirteen predict tool publicli signalp hmm ann version maintain consist achiev best accuraci three benchmark experi rang predict tool narrow perform gap conclus major tool evalu studi encount difficulti discrimin secretori nonsecretori protein challeng clearli remain pinpoint correct sp cleavag site composit score scheme emploi signalp help explain accuraci predict task divid number separ step allow score tackl aspect predict
PLoS One	20129638	2013-05-08	PMC2790604	20016834	background flaviviru infect cell produc infecti virion subvir particl form assembl prm envelop protein believ undergo matur process dengu recombin subvir particl produc cell cultur modifi chimer protein nativ form prm methodologyprincip find codon optim strategi effici express nativ viral protein product recombin subvir particl rsp dengu viru dv serotyp stabl hela cell express dv prme establish helaprm rsp analyz immunofluoresc transmiss electron microscopi protein endoplasm reticulum er assembl rsp observ biochem character dv rsp secret reveal prm protein cleavag homodimer protein releas supernat indic rsp undergo matur process dengu viru puls chase experi hour requir secret dv rsp helaprm develop semiquantit assai screen human sirna librari target gene involv membran traffick knockdown gene reduct dv rsp secret observ increas rsp level cell supernat conclusionssignific data describ effici product rsp nativ prm envelop protein dengu serotyp dengu rsp correspond produc cell line safe novel tool studi viral egress develop vaccin drug dengu viru
PLoS One	25534600	2005-05-01	PMC2791231	20020050	the sever acut respiratori syndrom coronaviru sarscov report apoptosi infect cell protein includ accessori protein proapoptot protein local endoplasm reticulum ergolgi compart role caus er stress investig transient transfect cell cell express protein er stress base activ gene er chaperon grp grp er stress differenti modul unfold protein respons upr includ inositolrequir enzym ir activ transcript factor atf pkrlike er kinas perk pathwai individu test aexpress cell perk pathwai activ aexpress cell base increas phosphoryl eukaryot initi factor alpha eif inhibitori effect dominantneg form eif grp promot activ increas translat activ transcript factor atf mrna atfdepend activ cebp homolog protein chop gene promot activ perk innat immun suppress type interferon ifn signal protein induc serin phosphoryl ifn alphareceptor subunit ifnar degrad motif increas ifnar ubiquitin confoc microscop analysi increas transloc ifnar lysosom compart flow cytometri reduc level ifnar aexpress cell provid mechanist detail proapoptot effect sarscov protein potenti role attenu interferon respons innat immun
PLoS One	15963157	2017-11-01	PMC2791869	20027293	background june health organ declar phase novel influenza ahn pandem septemb novel viru report contin impact countri northern hemispher limit return viru second wave encount popul nonimmun vaccin model control strategi reduc spread goal defer epidem wave countri detect earli stage methodologyprincip find construct determinist seir model ag distribut size popul germani base observ number import case earli find epidemiolog characterist describ fraser scienc propos twostep control strategi initi effort trace quarantin select prophylact treatment contact case second step measur focus household case result peak epidem delai week case detect cumul attack rate chang dose antivir number treatment cours popul sensit analysi case detect rate variat major effect delai conclusionssignific control strategi reduc spread diseas earli phase pandem wave lead substanti delai epidem prophylact treatment offer contact case amount antivir need limit
PLoS One	28768664	2011-01-13	PMC2792043	20020057	background influenza virus seriou infect prevent treat vaccin antivir agent vaccin effect number limit influenza strain resist current antiinfluenza drug increasingli isol necessit explor novel antiinfluenza therapi methodologyprincip find investig potenti aurintricarboxyl acid ata potent inhibitor nucleic acid process enzym protect madindarbi canin kidnei cell influenza infect neutral red assai ata protect rtpcr elisa confirm ata reduc viral replic releas pretreat cell ata fail inhibit viral replic preincub viru ata effect reduc viral titer suggest ata elicit inhibitori effect directli interact viru electron microscopi reveal ata induc viral aggreg cell surfac prompt determin ata inhibit neuraminidas ata compromis activ virusderiv recombin neuraminidas oseltamivirresist hn strain hy sensit ata final observ addit protect infect cell simultan treat ata amantadin hydrochlorid antiinfluenza drug inhibit mion channel influenza viru conclusionssignific collect data ata potent antiinfluenza agent directli inhibit neuraminidas effect antivir compound combin amantadin hydrochlorid
BMC Immunol	21233414	2017-09-26	PMC2792222	19958537	background spike protein major structur glycoprotein coronaviru cov causal agent sever acut respiratori syndrom sar protein potent target sarsspecif cellmedi immun respons mechan cov pathogenesi sar role special ctl viru clearanc uncharacter describ studi lead identif novel hlaarestrict epitop conserv region protein sarscov sequenc analyz predict candid peptid conserv region protein base hlaa bind proteosom cleavag candid peptid test hlaa bind assai candid peptid sp vlndilsrl induc specif ctl vivo pbl healthi hlaa donor hlaakb transgen mice immun plasmid encod fulllength protein immun mice releas ifn lyse target cell stimul sp peptidepuls autolog dendrit cell comparison candid conclus sp natur process epitop propos sp epitop help character mechan viru control immunopatholog sarscov infect
PLoS One	28949786	2004-08-12	PMC2793014	20027307	background express minor virion structur protein vp caliciviru murin noroviru mnv believ occur unusu mechan termin codondepend reiniti translat process translat upstream open read frame orf termin codon proport subunit remain associ mrna reiniti aug downstream orf typic close proxim consist vp start codon aug mnv overlap codon upstream vp orf uaa pentanucleotid uaa ug princip find confirm mnv vp express regul terminationreiniti defin mrna sequenc requir effici reintiat depend nt rna upstream uaa ug site chemic enzymat probe reveal rna region highli structur includ essenti stretch base complementari rrna helix motif rel posit motif respect uaa ug site impact effici process terminationreiniti mnv insensit initi inhibitor edein conclus terminationreiniti signal mnv close resembl influenza bm virus strategi basepair mrna rrna plai role tether subunit mrna termin vp codon data indic accur recognit vp orf aug prerequisit effici reiniti translat system
PLoS One	15308692	2017-07-07	PMC2794544	20041158	to estim frequenc molecular epidemiolog clinic associ infect newli describ speci variant human rhinovirus hrv diagnost respiratori sampl refer diagnost test edinburgh screen vpencod regionbas select polymeras chain reaction pcr hrvc parallel pcr test respiratori virus hrvc third frequent detect respiratori syncyti viru rsv adenoviru infect episod detect subject month infect target young median ag month infect year occur year peak incid earli winter month hrvc detect frequent subject lower lrt upper respiratori tract urt diseas control respiratori symptom hrvc monoinfect second frequent detect viru rsv diseas present case hrv variant classifi vpvp sequenc genotyp defin type increas current total worldwid sequenc comparison untransl region utr major group speci describ hrvca remaind form phylogenet distinct utr group hrvcc multipl bidirect recombin event hrvca hrvcc variant hrv speci repres parsimoni explan interspers phylogeni relationship vpvpencod region differ ag distribut season diseas associ identifi hrvca hrvcc variant hrvcinfect subject markedli reduc detect frequenc rsv respiratori virus provid evid major interf hrvc suscept respiratori viru infect hrvc diseas associ preval evid interf effect respiratori virus mandat incorpor rhinovirus futur diagnost virolog screen
PLoS One	28856034	2009-01-01	PMC2795195	20046873	background initi report novel influenza strain hnpdm estim case fatal rate cfr season influenza juli argentina report case death repres cfr potenti explan increas cfr includ viru reassort genet drift infect vulner popul viru genom sequenc argentinian sampl repres sever mild diseas indic evid reassort mutat associ resist antivir drug genet drift contribut virul evid increas frequenc risk factor hnpdm diseas methodsprincip find examin nasopharyng swab sampl np case hnpdm infect argentina masstag pcr test addit microbi agent studi popul consist hnpdminfect subject sampl june juli thirtynin sever diseas defin death hospit mild diseas addit agent potenti pathogen identifi sampl includ streptococcu pneumonia haemophilu influenza human respiratori syncyti viru n human rhinoviru n human coronavirus oc klebsiella pneumonia acinetobact baumannii serratia marcescen staphylococcu aureu methicillinresist aureu mrsa presenc pneumonia correl sever diseas pneumonia sever case versu mild case onethird hnpdm np pneumonia subject sever diseas pneumoniaeposit np subject year ag adjust odd ratio sever diseas presenc pneumonia confid interv ci conclusionssignific associ pneumonia morbid mortal establish current previou influenza pandem studi demonstr prognost signific noninvas antemortem diagnosi pneumonia infect provid insight clinic manag
Environ Health	18988270	2004-07-10	PMC2796493	20102582	ar pathogen outdoor air health issu will problem futur work group call airpath outdoor environ human pathogen air set univers colleg london uk aim open discuss creat network investig scienc impact outdoor pathogen object paper review discuss area sourc human pathogen outdoor air current develop futur techniqu we identifi atrisk group relat activ environ prepar anticip challeng environment chang emerg diseas control prevent pathogen outdoor environ work benefit wider commun polici maker provid concis overview aspect consider work
BMC Infect Dis	15175231	2015-04-01	PMC2797517	19961583	background streptococcu pneumonia common commun acquir pneumonia bacteremia excess wintertim mortal pneumonia centuri season invas pneumococc diseas ipd describ understood improv understand environment influenc diseas season urgenc global climat chang method evalu case ipd report philadelphia counti pennsylvania poisson regress model incorpor season smoother identifi associ weekli weather pattern case count associ acut daytodai environment fluctuat ipd occurr evalu casecrossov approach modif ag sex strata explor metaregress model creat stratumspecif estim ipd incid greatest wintertim spectral decomposit reveal peak week consist annual period adjust season yearli increas report temperatur weekli incid associ clearski uv irr unit increas ci uv highest young strata decreas ag shorter time scale associ increas ambient sulphur oxid link diseas risk highest tertil exposur ci conclus confirm wintertim predomin ipd major urban center major predictor ipd philadelphia extend period low uv radiat explain observ wintertim season mechan action diminish light exposur diseas occurr direct effect pathogen surviv host immun function alter ohvitamind metabol find diminut futur ipd risk climat chang expect wintertim season driven temperatur
BMC Microbiol	25834017	2011-05-11	PMC2797526	19958557	background porcin rotaviru infect morbid mortal swine industri necessit develop effect vaccin prevent infect immun respons associ protect mucos natur induct mucos immun prevent porcin rotaviru infect lactobacillu casei express major protect antigen vp porcin rotaviru ppgvp vpltb heatlabil toxin subunit echerichia coli ppgvpltb fusion protein immun mice oral express recombin ppgvp ppgvpltb confirm sdspage western blot analysi surfacedisplai express casei verifi immunofluoresc mice oral immun recombin proteinexpress casei produc high level serum immunoglobulin igg mucos iga iga titter mice immun ppgvpltb higher titter ppgvpimmun mice induc antibodi demonstr neutral effect rv infect conclus demonstr vp administ context casei express system effect method stimul mucos immun ltb serv stimul mucos immun suggest strategi adapt pig
PLoS One	21561912	2010-10-01	PMC2797616	20062534	background studi suggest autophagi util cell protect mechan listeria monocytogen infect methodologyprincip find find autophagi measur role vacuolar escap intracellular growth primari cultur bone marrow deriv macrophag bmdm defici autophagi atg provid evid pore form activ cholesteroldepend cytolysin listeriolysin llo induc autophagi subsequ infect monocytogen infect bmdm monocytogen induc microtubuleassoci protein light chain lc lipid consist autophagi activ mutant lack llo infect bmdm express lcgfp demonstr wildtyp monocytogen encapsul lcgfp consist autophagi activ mutant lack llo bacillu subtili express llo cytolysin perfringolysin pfo induc lc coloc lc lipid llocontain liposom recruit lcgfp indic llo suffici induc target autophagi absenc infect role autophagi variabl effect depend cell type assai atg mous embryon fibroblast monocytogen primari vacuol escap defect bacteria escap grew atg bmdm conclusionssignific propos membran damag caus llo trigger bacterialtarget autophagi autophagi affect fate wildtyp intracellular monocytogen primari bmdm
PLoS One	21487503	2004-05-12	PMC2797643	20062542	background part india chandipura viru chpv emerg enceph caus pathogen epidem sporad form pediatr diseas rapid cours lead mortal absenc specif treatment effect rna interfer rnai evalu method find efficaci synthet short interf rna sirna short hairpin rna shrna protect mice chpv infect assess target gene gene role viral replic lethal natur real time step rtpcr plaqu assai assess gene silenc pacgfpnchpvp sirna effici reduc express gene invitro quantit assai document log reduct viru titer sirna transfect hr post infect pi sirna combin result enhanc effici sirna toler mismatch center compar shrna sirna effect inhibit chpv replic extend surviv mice infect intracrani ld chpv treat cation lipid complex sirna simultan infect ld treatment dose sirna simultan second hr pi surviv surviv mice log chpv titer brain histopatholog chang antibodi respons gene express profil sirna treat mice interferon respons dose sirna hr hr pi second dose hr surviv suggest potenti applic therapi conclus highlight therapeut potenti sirna treat rapid fatal chandipura enceph
BMC Med Genet	15140959	2005-08-31	PMC2797785	20003397	background dcsignr call cdl extens studi role host genet predisposit viral infect variabl number tandem repeat vntr neckregion dcsignr highli polymorph polymorph investig genet predisposit infecti diseas conflict report infect major human death mechan natur select hypothes vntr polymorph dcsignr human life span method collect pericentenarian individu ag femal ag male geograph match control ag han chines vntr polymorph neck region determin pcr genotyp call separ pcr product agaros gel total genotyp allel popul genotyp distribut allel frequenc homozygot proport differ pericentenarian control group gender differ lifespan ubiquit observ anim kingdom stratifi sampl gender genotyp femal pericentenarian group femal control group margin level signific differ correct bonferroni method suggest differenti dcsignr vntr genotyp sex studi warrant confirm preliminari find investig mechan underli function conclus studi indic absenc associ neck region polymorph dcsignr longev han chines popul question dcsignr affect longev genderspecif pattern remain open
Alcohol Res Health	16140741	2006-12-12	PMC2798743	20041042	human studi identifi classifi brain system predispos individu develop alcohol disord modifi alcohol anim model alcohol essenti mechanist understand chronic voluntari alcohol consumpt compuls brain system damag damag resolv current knowledg neurosci alcohol depend evolv interchang gather human alcohol anim model alcohol studi human anim model provid support involv specif brain structur cours alcohol addict includ prefront cortex basal ganglia cerebellum amygdala hippocampu hypothalamicpituitaryadren axi
BMC Health Serv Res	17185361	2009-06-01	PMC2801490	20003505	background purpos studi establish teach hospit accredit standard anew hope taiwan teach hospit live expect societi ensur qualiti teach method develop process last year separ three stage stage center leadership meet consensu build second draft standard expert focu group third pilot studi subsequ revis teach hospit accredit standard categori standard educ resourc item teach train plan outcom item item develop clinic faculti continu educ item academ exchang commun educ item administr item conclus standard proven feasibl pose reason challeng pilot studi hope standard will strengthen teach improv qualiti hospit servic time
BMC Infect Dis	19634389	2009-12-03	PMC2803793	20015403	background global erad program poliomyel laboratori diagnosi plai critic role isol polioviru pv stool sampl acut flaccid paralysi afp case studi develop revers transcriptionloopmedi isotherm amplif rtlamp system rapid highli sensit detect enteroviru includ pv identifi stool sampl posit enteroviru includ pv method primer set design rtlamp detect enteroviru prefer pvlike ntr viral genom sensit rtlamp system evalu prototyp strain enteroviru detect enteroviru stool extract examin rtlamp system detect copi viral genom pvsabin strain min rtlamp primer set rtlamp system prefer human enteroviru speci hevc strain includ pv exhibit sensit prototyp strain heva hevb detect limit copi stool extract pv hevc heva isol cell cultur system posit rtlamp method posit rate posit rate rtlamp system stool extract hevb isol lower hevc posit rate stool sampl neg enteroviru isol cell cultur system sampl posit rtlamp posit rate sampl enteroviru identifi sequenc analysi util seminest pcr system conclus rtlamp system develop studi high sensit compar cell cultur system detect pv heva hevc sensit hevb rtlamp system direct detect enteroviru stool extract
Interdiscip Perspect Infect Dis	19965751	2012-01-11	PMC2804041	20069111	method diagnosi infecti diseas stagnat year major advanc clinic diagnost test introduct pcr technolog investig test form backbon modern microbiolog laboratori base labourintens technolog microscopi malaria press includ rapid test sacrif sensit valuead test pointofcar test high lowresourc set year focus altern method improv diagnosi parasit diseas includ immunoassai molecularbas approach proteom mass spectrometri platform technolog review summar progress approach parasit diagnosi discuss merit disadvantag test
Virol J	22238297	2013-08-01	PMC2804611	20025741	influenza viru infect preval diseas human antibodi hemagglutinin prevent infect hemagglutinin major constitu current vaccin antibodi direct highli conserv extracellular domain mediat protect influenza infect anim model activ vaccin gener consid best approach combat viral diseas passiv immun attract altern acut expos immun comprom individu young children elderli describ novel method rapid isol natur human antibodi mammalian cell displai approach isol human monoclon antibodi direct highli conserv extracellular domain influenza protein identifi antibodi bound peptid high affin recogn nativ cellsurfac express protect mice lethal influenza viru challeng therapeut treatment dai infect effect suggest mspecif monoclon great potenti immunotherapeut agent influenza infect
BMC Public Health	23848522	2019-02-01	PMC2804616	20015400	background restrict measur quarantin draw sharp relief dynam interplai individu right citizen hand collect right commun concern infecti diseas outbreak sar pandem influenza intensifi understand public percept quarantin social distanc measur method conduct telephon survei gener popul greater toronto area ontario canada computerassist telephon interview cati technolog final sampl individu achiev standard randomdigit dial data indic strong public support quarantin requir seriou legal sanction fail compli support conting implement legal safeguard protect inappropri provis psychosoci support conclus engend strong public support quarantin restrict measur govern offici public health policymak implement comprehens system support safeguard educ inform frontlin public health worker engag public larg open dialogu ethic restrict measur infecti diseas outbreak
BMC Immunol	30307795	2010-03-29	PMC2804704	20017901	background mycobacterium tuberculosi mtb major morbid mortal combat pathogen immun cell releas cytokin includ tumor necrosi factor tnf pivot develop protect granuloma previou bacillu calmett guerin bcg mycobacterium model investig immun respons mtb stimul induct tnf mitogenactiv protein kinas mapk human blood monocyt mapk phosphatas mkp regul mapk activ examin mkp plai role bcginduc mapk activ cytokin express primari human blood monocyt treat bcg assai mkp express demonstr exposur bcg increas express mkp addition induct mkp regul mapk extracellular signalregul kinas erk surprisingli mkp express block specif sirna decreas level phosphomapk mapk erk tnf induc bcg conclus tnf pivot granuloma format indic unexpect posit function mkp mycobacteri infect oppos usual phosphatas activ
Virol J	20351207	2013-11-06	PMC2805634	20034394	background spike protein sar coronaviru sarscov mediat entri viru target cell includ receptor bind membran fusion close viral membran protein three distinct motif juxtamembran aromat central highli hydrophob stretch cystein rich motif investig role aromat hydrophob part entri sar cov cellcel fusion investig describ sar pseudotyp particl system sarspp fluorescencebas cellcel fusion assai mutagenesi aromat domain crucial sarspp entri cell role pore enlarg introduct lysin residu hydrophob stretch block entri suggest border actual transmembran domain surprisingli replac glycin residu situat close aromat domain lysin residu toler introduct lysin adjac glycin model propos fusion later flexibl transmembran domain plai critic role tryptophan cystein conclus aromat domain plai crucial role entri sar cov target cell posit aromat domain hydrophob domain rel essenti characterist membran fusion process
Virol J	24198430	2004-08-01	PMC2805635	20040105	ebnac ebvencod nuclear protein essenti prolifer ebv infect blymphocyt ebnac amino acid yeast hybrid screen interact growth arrest dnadamag protein gadd protein overexpress gadd interact ebnac nuclear cytoplasm compart amino acid gadd includ ppa interact hsv icp homolog domain requir interact interact lost mutant ebnac dvievid aviavia abolish ebnac coactiv abil sumo interact bcell gadd ebnac complex ppa microcystin sepharos affin purif lymphoblastoid cell ebnac protein level condit hydroxytamoxifen surprisingli ebnac maintain phosphoryl eif serin ii protect er stress induc activ unfold protein respons measur xbp versu xbp protein express ntermin atf cleavag report assai overexpress gadd enhanc ebnac abil coactiv ebna activ lmp promot collect data ebnac interact gadd activ upstream compon upr eif phosphoryl prevent downstream upr event xbp activ atf cleavag
Brain Pathol	15258011	2009-10-01	PMC2805866	19243383	sinc incept global gene express profil platform mid increas public differenti express gene process epileptogenesi mesial tempor lobe epilepsi presenc latenc period manifest seizur chronic epilepsi opportun therapeut intervent molecular biologi level global express profil techniqu gene publish demonstr differenti express mesial tempor epilepsi major chang specif laboratori experiment condit gene demonstr chang public review current statu gene express profil epileptogenesi standard guidelin greater accuraci reproduc result
BMC Genomics	19857081	2010-01-01	PMC2806348	20003521	background delta smelt hypomesu transpacificu pelag fish speci list endang usa feder californian state endang speci act consid indic ecosystem health habitat rang limit sacramentosan joaquin estuari california usa anthropogen contamin multipl stressor system currentus insecticid major concern interrog tool requir monitor effect contamin delta smelt potenti popul declin speci creat microarrai investig genomewid effect caus stressor appli tool assess effect pyrethroid insecticid esfenvaler larval delta smelt select gene investig molecular biomark quantit pcr analys exposur esfenvaler swim behavior larval delta smelt concentr low gl differ express measur gene involv neuromuscular activ alter express gene associ immun respons apoptosi redox osmot stress detoxif growth develop appear invok esfenvaler exposur swim impair correl express aspartoacylas aspa enzym involv brain cell function associ numer human diseas select gene investig molecular biomark strong link determin measur downregul aspa observ behavior respons fish expos environment relev pyrethroid concentr conclus studi microarrai technolog approach screen gener molecular biomark endang nonmodel organ identifi specif gene directli link subleth toxicolog endpoint chang express level neuromuscular gene measur swim impair develop microarrai appli larval fish expos esfenvaler contamin sacramentosan joaquin estuari permit identif specif biomark provid insight factor contribut delta smelt popul declin
Respir Res	19909375	2018-07-19	PMC2806365	20040086	background urokinas uk ukgh hour infusionuk accp recommend regimen treat acut pulmonari embol pe unclear dose time reduc compar efficaci safeti ukg hour uk uk regim select pe patient method random trial involv patient conduct patient acut pe randomli assign receiv uk uk efficaci determin improv heart dysfunct perfus defect post uk treatment bleed incid death rate pe recurr evalu improv heart dysfunct lung perfus defect observ group bleed incid low group major bleed directli associ uk infus occur patient uk group uk group mortal rate low report fatal recurr uk group uk group rate bleed death pe recurr compar separ hemodynam instabl massiv anatom obstruct subgroup differ conclus uk regimen exhibit efficaci safeti uk regimen acut pe trial registr clinic trial regist httpclinicaltrialsgovctshownct identifi nct 
PLoS One	30026186	2016-03-01	PMC2806912	20090947	influenza hn viru continu enzoot poultri transmit zoonot human swineorigin hn viru emerg pandem virul human remain modest comparison zoonot hn diseas human respiratori epithelium primari target cell influenza virus elucid viral tropism host innat immun respons influenza hn viru human bronchial epithelium help understand pathogenesi establish primari cultur undifferenti differenti normal human bronchial epitheli nhbe cell infect highli pathogen influenza hn viru avietnam season influenza hn viru ahong kong viral replic kinet cytokin chemokin respons compar qpcr elisa vitro cultur differenti nhbe cell acquir physiolog properti normal human bronchi tissu express high level link sialic acid receptor human airwai trypsinlik hat proteas contrast low express nondifferenti nhbe cell compar hn viru hn viru replic effici induc stronger type interferon respons undifferenti nhbe cell contrast differenti cultur hn viru replic effici elicit lower interferonbeta respons comparison hn viru data differenti bronchial epitheli cell major influenc cell permiss human hn avian hn virus host innat immun respons reduc viru replic effici partial account lower interferonbeta respons influenza hn viru infect differenti nhbe cell influenza infect bronchial epithelium will lead tissu damag associ epithelium regener data gener undifferenti nhbe cultur relev diseas pathogenesi
PLoS One	26727924	2013-12-18	PMC2806919	20090954	human lung epitheli cell target encount invad sever acut respiratori syndromeassoci coronaviru sarscov cell support growth sarscov infect capabl secret inflammatori cytokin initi eventu aggrav host innat inflammatori respons caus detriment immunemedi patholog lung comprehens evalu complex epitheli signal sarscov crucial pave better understand sar pathogenesi base microarraybas function genom report global gene respons cell clone bronchial epitheli cell deriv calu cell tempor spatial activ nuclear factor nfb activ protein ap interferon regulatori factor irf infect cell hr post infect pi activ antivir gene includ interferon ifn inflammatori mediat ifnstimul gene isg time ifn ifn capabl exert unrecogn nonredund complementari abil limit sarscov replic express detect infect bronchial epitheli cell hr pi collect highlight mechan sequenti event antivir signal pathwai trigger sarscov bronchial epitheli cell identifi novel cellular target futur studi aim advanc strategi sar
Bioinform Biol Insights	24352473	2013-09-01	PMC2808184	20140073	background precis determin conform epitop neutral antibodi repres kei step ration design novel vaccin power experiment method gain insight physic chemic natur conform epitop select linear peptid bind high affin monoclon antibodi interest phage displai technolog structur character conform epitop mimotop straightforward the interpret peptid sequenc phage displai experi focus linear sequenc analysi find consensu sequenc common sequenc motif fulli autom search method episearch predict locat conform epitop surfac antigen algorithm peptid sequenc phage displai experi input rank surfac expos patch frequenc distribut residu peptid patch test perform episearch algorithm experiment data set phage displai experi human epiderm growth factor receptor herneu antibodi mab boc target domain fviii antibodi mab mab hiv envelop protein gp mab target hiv capsid protein sar coronaviru spike protein exampl conform epitop determin xrai crystal structur antibodyantigen complex highest score patch episearch cover case residu experiment observ conform epitop input option program includ map singl peptid set peptid antigen structur the calcul visual interact web server avail user access episearch web server httpcurieutmbeduepisearchhtml
BMC Public Health	23774793	2017-11-01	PMC2808319	20034405	background commun quarantin controversi decis prepar inform specif quantit evid benefit casestudi report sar outbreak discuss role quarantin commun transmiss literatur yield quantit estim reduct secondari case attribut quarantin area health polici costeffect analysi method data ontario canada sar outbreak novel express impact quarantin present secondari case count differ sccd reflect reduct averag number transmiss aris sar case quarantin rel quarantin onset symptom sccd estim poisson neg binomi regress model ident link function compar number secondari case case quarantin rel nonquarantin case invers statist propos number need quarantin nnq prevent addit secondari transmiss estim sccd fewer secondari case quarantin versu nonquarantin case nnq expos individu commun quarantin prevent addit case transmiss commun analysi suggest quarantin effect prevent measur estim lack statist precis conclus rel health polici area literatur quarantin lack quantit express effect agreement best report differ outcom attribut control measur hope discuss present calcul express impact popul control measur studi quarantin effect present methodolog statist challeng discuss need understand cost benefit enact quarantin includ discuss quantit benefit commun decisionmak public evalu
Crit Care	29107643	2015-07-15	PMC2811892	20003352	introduct human host immun respons infect variant ahn pandem influenza viru nvhn understood util system cytokin antibodi level evalu differ earli immun respons mild sever patient infect nvhn method profil cytokin chemokin evalu haemagglutin inhibit activ quantit qualit measur host immun respons serum dai symptom onset cohort nvhn infect patient sever patient requir hospit respiratori insuffici admit intens care unit mild patient exclus flulik symptom group healthi donor includ control differ level mediat group assess parametr umann whitnei test associ variabl determin calcul spearman correl coeffici viral load perform serum realtim pcr target neuraminidas gene increas level innateimmun mediat ip mcp mip absenc antinvhn antibodi character earli respons nvhn infect hospit mild patient high system level typeii interferon ifn group mediat involv develop thelper il il il il thelper tnf il ilp respons exclus hospit patient il ilp il constitut hallmark critic ill studi invers associ il il pao critic patient conclus infect nvhn induc typic innat respons mild sever patient sever diseas respiratori involv character earli secret th cytokin associ cell mediat immun commonli link pathogenesi autoimmuneinflammatori diseas exact role th mediat evolut nvhn mild sever diseas merit investig detriment benefici role cytokin plai sever ill
PLoS One	26001777	2018-07-06	PMC2815781	20140251	for decad type influenza viru infect human attribut viral subtyp ahn ahn contrast avian vertebr speci reservoir type influenza viru genom divers host strain repres combin viral hemagglutinin viral neuraminidas subtyp viral genom segment reassort mutat emerg reservoir spawn influenza viru strain immin epidem pandem threat human health poultri product tradit method detect differenti influenza viru subtyp timeconsum laborintens culturebas remark insensit antibodybas molecular diagnost assai base revers transcriptasepolymeras chain reaction rtpcr short assai cycl time high analyt sensit specif diagnost test determin viral gene nucleotid sequenc distinguish strain variant detect pathogen specimen decisionqu strain variantspecif pathogen gene sequenc critic public health infect control surveil epidemiolog medicalveterinari treatment plan resequenc pathogen microarrai rpmflu robust highli multiplex target gene sequencingbas altern tradit cultur biomarkerbas diagnost test rpmflu singl simultan differenti diagnost assai subtyp combin type influenza virus viral bacteri pathogen influenzalik ill pathogen target rpmflu coinfect compound morbid andor mortal patient influenza inform specif singl rpmflu test repres specimenspecif viral gene sequenc determin viru type ahn subtyp virul hostrang resist antivir agent
PLoS Pathog	29980611	2003-09-11	PMC2816698	20140199	the innat immun respons essenti control west nile viru wnv infect respons propag regul adapt immun vivo defin ip central adaptor protein rigilik receptor rlr signal essenti trigger innat immun effect develop regul adapt immun pathogen wnv ip mice exhibit increas suscept wnv infect mark enhanc viral replic dissemin earli viral entri cn infect cultur bonemarrow bm deriv dendrit cell dc macrophag mac primari cortic neuron ipsdepend rlr signal essenti trigger ifn defens control viru replic kei target cell infect intriguingli infect ip mice displai uncontrol inflamm includ elev system type ifn proinflammatori cytokin chemokin respons increas number inflammatori dc enhanc humor respons mark complet loss viru neutral activ increas number virusspecif cd cell nonspecif immun cell prolifer peripheri cn uncontrol inflammatori respons associ lack regulatori cell expans occur acut wnv infect enhanc inflammatori respons absenc ip coupl failur protect wnv infect data defin innateadapt immun interfac mediat ipsdepend rlr signal regul quantiti qualiti balanc immun respons wnv infect
PLoS One	12970436	2012-09-01	PMC2817000	20161706	background urgent medic innov approach control influenza emphas widespread resist circul subtyp hn virus lead antivir drug oseltamivir pandem threat pose occurr human infect highli pathogen avian hn virus evolv swineorigin hn influenza pandem discov class human monoclon antibodi abil neutral broad spectrum influenza virus includ h h subtyp potenti prevent treat influenza human report latest efficaci data repres antibodi novel class methodologyprincip find evalu prophylact therapeut efficaci human monoclon antibodi cr lethal challeng highli pathogen avian hn viru ferret optim model human influenza infect surviv rate clinic relev diseas sign chang bodi weight temperatur viru replic lung upper respiratori tract macro microscop patholog investig prophylact administr mgkg cr prior viral challeng complet prevent mortal weight loss reduc amount infecti viru lung abolish shed viru pharyng secret prevent hninduc lung patholog administ therapeut dai challeng mgkg cr prevent death anim blunt diseas evidenc decreas weight loss temperatur rise reduc lung viral load shed lung damag conclusionssignific data demonstr prophylact therapeut efficaci class human monoclon antibodi highli stringent clinic relev anim model influenza justifi clinic develop approach intervent season pandem influenza
Adv Bioinformatics	21945356	2019-03-27	PMC2817497	20150956	synonym codon usag protein code gene thirti complet sequenc mycobacteriophag genom studi multivari statist analysi major factor influenc codon usag identifi composit bia codon prefer highli express gene codon highli prefer codon strong neg correl effect number codon nc gc content observ show codon usag effect gene nucleotid composit translat select identifi plai role shape codon usag oper level translat accuraci high level heterogen genom length gene identifi influenc codon usag phage genom mycobacteriophag cooper identifi highli bias genom better translat effici compar host specif trna gene
PLoS One	24210098	2006-09-27	PMC2818714	20161764	on june health organ declar outbreak novel influenza hn pandem limit suppli antivir vaccin countri individu wai reduc spread pandem hn option cost effect easi implement experi sar hn epidem peopl wear facemask protect infect quantifi impact facemask reduc spread diseas construct analyz mathemat model popul peopl wear facemask pandem quantifi impact mask spread influenza estim paramet valu effect facemask data studi respir surgic facemask respir effect reduc suscept infect popul wear reduc number influenza hn case conclud model worn properli facemask effect intervent strategi reduc spread pandem hn 
Virol J	17005682	2006-11-10	PMC2819038	20078868	background human pathogen coronaviru nl hcovnl group alpha coronaviru commonli associ respiratori tract infect addit nonstructur structur protein coronavirus accessori protein function unknown studi focus hcovnl open read frame orf highli conserv accessori protein coronavirus insilico analysi amino acid sequenc hcovnl orf predict tripl membranespan protein express infect caco llcmk cell confirm immunofluoresc western blot analysi protein detect endoplasmat reticulumgolgi intermedi compart ergic coronaviru assembl bud take place subcellular local studi recombin orf protein transfect huh cell reveal occurr ergic golgi lysosom compart fluoresc microscopi differ tag envelop membran nucleocapsid protein orf protein coloc extens ergic ntermin flagtag orf protein antiserum specif cterminu verifi propos topolog extracellular nterminu cytosol cterminu invitro translat analysi subsequ endoglycosidas digest orf protein nglycosyl nterminu analysi purifi viral particl reveal orf protein incorpor virion addit structur protein conclus studi extens express analysi group hcovorf protein evid orf protein structur nglycosyl virionincorpor protein
Int J Environ Res Public Health	17569723	2019-02-07	PMC2819778	20195435	avian colibacillosi salmonellosi consid major bacteri diseas poultri industri worldwid colibacillosi salmonellosi common avian diseas communic human articl vital epidemiolog pathogenesi diagnosi control public health concern avian colibacillosi salmonellosi better understand address review articl will assist poultri research poultri industri continu progress reduc elimin avian colibacillosi salmonellosi poultri flock reduc potenti hazard public health pose bacteri diseas
Int J Environ Res Public Health	30753384	2013-11-30	PMC2819789	20195446	the basic reproduct number summari measur transmiss potenti infecti diseas estim earli epidem growth rate likelihoodbas method estim develop studi correct concept actual reproduct number offer simpl framework estim assum exponenti growth case propos method appli hiv epidem european countri yield valu rang consist base eulerlotka equat method permit calcul expect spreadsheet
Virol J	24296690	2014-02-26	PMC2820015	20064199	hiv particl assembl mediat viral gag protein occur plasma membran coloc hiv envelop lipid rich microenviron cell signific viral protein modul envelop associ microdomain plasma membran enrich glycosylphosphatidylinositolanchor protein primari cd cell natur target hiv understood primari cd cell natur target hiv vivo gag modul hiv envelop associ gm gangliosid cd rich cellular compart deterg resist membran data strengthen evid gagenv interact envelop associ lipid raft gpianchor protein effici assembl matur virion product infect primari cd cell
PLoS One	24574399	2011-09-21	PMC2822845	20174643	background april case pandem hn influenza hnsw viru detect franc virolog surveil undertaken refer laboratori french defenc zone methodologyprincip find report virolog analys perform public hospit marseil month outbreak nasal swab test rapid influenza diagnost test ridt rtpcr assai epidemiolog characterist suspect case analyz includ detect influenza viru respiratori virus three month total patient test includ patient infect hnsw viru distribut ag group ridt analyz ii sera receiv april randomli select inpati test standard hemagglutin inhibit assai antibodi novel hnsw viru iii earli late juli viral isol character sequenc complet hemagglutinin neuraminidas gene iiii epidemiolog characterist cluster case occur juli summer camp analyz conclusionssignific studi present virolog epidemiolog data infect pandem ahn viru europ distribut ag group to report season hn seropreval data european popul previou exposur individu year influenza virus antigen pandem hn viru genom analysi indic strain harbour aminoacid pattern neuraminidas gene appear secondarili tend supplant strain final contrast previou report data support ridt detect infect children context investig group case
Virol J	21940406	2018-09-26	PMC2823673	20082709	background grow concern rais pandem potenti highli pathogen avian influenza hpai hn virus consequ urgent develop effect safe vaccin diverg hn influenza virus studi design tetrabranch multipl antigen peptid mapbas vaccin design memap sequenc overlap highli conserv extracellular domain matrix protein hpai hn viru investig immun respons crossprotect clade hn virus result memap vaccin induc strong mespecif igg antibodi respons dose immun mice memap presenc freund aluminium alum adjuv memap vaccin limit viral replic attenu histopatholog damag challeng mous lung memapbas vaccin protect immun mice clade vn clade szh hn viru challeng counteract weight lost elev surviv rate lethal challeng hn virus conclus memap present hn viru great potenti develop effect subunit vaccin prevent infect broad spectrum hpai hn virus
PLoS Pathog	30258004	2004-04-01	PMC2824749	20174607	the gene express plusstrand rna virus polycistron genom depend translat replic genom mrna synthesi subgenom sg mrna arterivirus coronavirus distantli member nidoviru order emploi uniqu mechan discontinu minusstrand rna synthesi gener subgenomelength templat synthesi nest set sg mrna nonstructur protein nsp arteriviru equin arter viru eav multifunct regul viral rna synthesi virion biogenesi implic control balanc genom replic sg mrna synthesi emploi revers forward genet gain insight multipl regulatori role nsp analysi reveal rel abund viral mrna tightli control intric network interact involv nsp subdomain distinct nsp mutat quantit balanc viral mrna speci data implic nsp control accumul fulllength subgenomelength minusstrand templat viral mrna synthesi moder differenti chang viral mrna abund nsp mutant alter viral protein level progeni viru yield greatli reduc pseudorevert analysi provid compel genet evid balanc eav mrna accumul critic effici viru product report proteinmedi mrnaspecif control nidoviru rna synthesi reveal exist integr control mechan finetun replic sg mrna synthesi viru product establish major role nsp coordin arteriviru replic cycl
PLoS One	23118695	2011-04-08	PMC2825274	20179772	the rapid emerg subsequ spread novel influenza ahn viru hn prompt health organ declar pandem st centuri highlight threat influenza public health healthcar system widespread resist class influenza antivir adamantan neuraminidas inhibitor occur pandem season virus render drug margin util treatment modal worldwid virtual hn season hn strain resist adamantan rimantadin amantadin major season hn strain resist oseltamivir prescrib neuraminidas inhibitor nai address effect therapi evalu vitro activ tripl combin antivir drug tcad regimen compos drug mechan action drugresist season hn influenza virus amantadin ribavirin oseltamivir combin test amantadin oseltamivirresist influenza virus vitro infect model mdck cell data tripl combin highli synergist drugresist virus synergi tripl combin greater synergi doubl combin test includ combin nai surprisingli amantadin oseltamivir contribut antivir activ tcad regimen amantadin oseltamivirresist virus concentr activ singl agent concentr clinic achiev data demonstr tcad regimen compos amantadin ribavirin oseltamivir highli synergist resist virus includ hn tcad regimen overcom baselin drug resist class approv influenza antivir repres highli activ antivir therapi season pandem influenza
Proc Biol Sci	21478364	2007-09-27	PMC2825776	19692402	some zoonot pathogen sporad infect human rare propag succeed overcom speci barrier establish human popul adapt driven select pressur human host plai role allow pathogen cross speci barrier simpl mathemat model studi potenti epidemiolog marker adapt circumst ongo adapt signal larg cluster human infect pathogen caus hundr case transmiss indic speci barrier cross final case report monitor detect immin emerg event distinguish evolutionari scenario adapt signal larg cluster infect emerg occur prior warn lack transmiss rule adapt zoonos occur zoonot case continu sporad zoonot infect onward humantohuman transmiss offer extra pathogen adapt final simpl method monitor outbreak sign emerg discuss public health implic
PLoS Negl Trop Dis	17921318	2009-11-04	PMC2826407	20186330	background canin rabi thousand human death year africa continu increas contin methodologyprincip find paper identifi common reason lack effect canin rabi control africa a low prioriti diseas control result lack awar rabi burden epidemiolog constraint uncertainti requir level vaccin coverag possibl sustain cycl infect wildlif oper constraint includ access dog vaccin insuffici knowledg dog popul size plan vaccin campaign limit resourc implement rabi surveil control address issu turn present data field studi model approach tanzania includ burden diseas evalu detail epidemiolog studi oper data vaccin campaign demograph ecolog set econom analys costeffect dog vaccin human rabi prevent conclusionssignific conclud insurmount problem canin rabi control africa elimin canin rabi epidemiolog practic feasibl mass vaccin domest dog domest dog vaccin costeffect approach prevent elimin human rabi death
Acta Vet Scand	19889777	2010-05-01	PMC2828449	20053278	the descript distribut phylogeni felin coronavirus fcov studi cat suspect felin infecti periton fip malaysia ascit fluid andor biopsi sampl subject revers transcript polymeras chain reaction rtpcr target conserv region untransl region utr fcov genom percent sampl anim posit presenc fcov fcov posit cat cat male year ag fcov posit case includ domest short hair dsh persian siames cat nucleotid sequenc select amplifi product fip case determin sequenc comparison reveal field isol homolog point mutat extent homolog decreas compar refer strain branch pattern phylogenet tree distinct cluster malaysian isol fall main genet cluster find provid genet fcov malaysia
Virol J	20491978	2004-10-26	PMC2829536	20144216	background influenza respiratori diseas serious threaten human health fact influenza viru critic contribut mortal induc influenza cytokin storm produc excess immun respons trigger viru result inflammatori reaction lung tissu fatal lung tissu injuri increas influenza mortal antivir drug immunosuppress drug includ infect treatment present hypothesi complement center inflammatori reaction complement system activ bodi will strong inflammatori reaction tissu injuri patholog process studi prove inflammatori injuri lung tissu caus influenza viru close complement activ inhibit complement activ reduc inflammatori injuri lung tissu complement physiolog defens patholog damag medium systemat inhibit result side effect includ infect design target complement inhibitor complement activ site cr target vector complement inhibitor cd crry target inflammatori site special inhibit complement activ local injuri local inflammatori reaction inhibit test hypothesi crcd crcrry target complement inhibitor fusionexpress biolog activ examin vivo vitro test cr target complement inhibitor treat mous influenza viral pneumonia model pb treatment group control surviv lung tissu injuri mice observ cr target complement inhibitor pneumonia induc influenza viru evalu implic hypothesi cr target complement inhibitor expect ideal drug viral pneumonia
BMC Biotechnol	15507608	2012-07-11	PMC2831817	20163718	background fibroblast growth factor fgf promis drug candid combat metabol diseas highlevel express purif recombin fgf rfgf escherichia coli coli difficult rfgf form inclus bodi bacteria make difficult purifi high concentr bioactiv rfgf overcom problem fuse fgf sumo small ubiquitinrel modifi polymeras chain reaction pcr express fuse gene coli blde induc iptg sumofgf express high level concentr reach total protein exceed solubl protein fuse protein purifi deae sepharos ninta affin chromatographi cleav sumo proteas puriti rfgf high perform liquid chromatographi hplc higher low endotoxin level euml vivo anim experi rfgf produc method decreas concentr plasma glucos diabet rat streptozotocin stz inject conclus studi demonstr sumo fuse fgf promot solubl express coli make conveni purifi rfgf better method produc rfgf pharmaceut develop
BMC Public Health	22787223	2010-11-01	PMC2831836	20170529	background fever undifferenti clinic featur enhanc sensit syndrom surveil system studi spatiotempor associ febril patient allow earli detect case cluster indic immin threat infecti diseas outbreak commun method captur consecut emerg depart visit led hospit district hospit hong kong period sep oct record demograph data provision diagnos temperatur present residenti locat patientepisod geocod residenti address appli geograph system technolog studi geograph distribut case associ buffer zone spatial case cluster defin three spatial associ febril patient three consecut dai sixti patientepisod elig analysi fever oral temperatur present patientepisod residenti care home elderli rche detect total case cluster studi period cluster case older ag resid rche median patient rang time span dai rang dai cluster twenti cluster patient live build block rche conclus technic feasibl perform surveil febril patient studi spatiotempor associ earli detect impend infecti diseas threat
Virol J	20800257	2012-04-01	PMC2831879	20144233	the sar coronaviru sarscov open read frame orf encod amino acid accessori protein sequenc homolog protein protein viru particl interact host protein implic involv pathogen process includ apoptosi inhibit cellular protein synthesi activ mitogen activ protein kinas studi data demonstr sarscov protein interact human apahydrolas asymmetr diadenosin tetraphosph hydrolas ec apahydrolas respons metabol allarmon nucleotid apa involv regul cell prolifer dna replic rna process apoptosi dna repair interact apahydrolas identifi yeast twohybrid screen interact confirm coimmunoprecipit cultur human cell transient express vhi tag ha tag apahydrolas human tissu cultur cell transient express apahydrolas tag egfp dsred protein coloc cytoplasm
BMC Biol	22492163	2010-02-04	PMC2832619	20132533	background rapidli evolv gene famili involv immun respons reproduct biolog function assign carcinoembryon antigen cea gene famili gain insight evolutionari forc shape cea gene famili analys gene famili mammalian speci includ monotrem marsupi lineag phylogenet analysi provid convinc evid primordi cea gene famili mammal consist gene includ immun inhibitori receptorencod ceacam cearel cell adhes molecul ancestor analysi substitut rate nucleotid sequenc code ligand bind domain ceacam indic select diversif consequ exploit ceacam varieti viral bacteri pathogen cellular receptor depend extent amplif ancestr ceacam number ceacamrel gene vari consider mammalian speci lagomorph bat analys speci itam immunoreceptor tyrosinebas activ motif itamlik motifcontain protein exist igvlik ligand bind domain close ceacam human ceacam protein function ceacam decoi receptor granulocyt mediat uptak destruct specif bacteri pathogen itamlik motif close relationship ceacam itamencod rel appear maintain gene convers reciproc recombin surprisingli secret ceacam resembl immunomodulatori ceacamrel trophoblastspecif pregnancyspecif glycoprotein psg human rodent evolv limit set mammal appear psglike gene correl invas trophoblast growth speci conclus phylogenet studi provid evid pathogenhost coevolut particip fetalmatern conflict process led highli speciesspecif divers mammalian cea gene famili
Virol J	19861680	2012-08-22	PMC2832772	20100346	background overlap gene common rna virus serv mechan optim code potenti compact genom annot overlap gene difficult convent genefind softwar number complementari approach systemat identifi undetect overlap gene rna viru genom articl gather number promis candid overlap gene interest commun overlap gene predict present astrovirus seadornavirus cytorhabdovirus coronavirus famili astrovirida reovirida rhabdovirida coronavirida respect
Virol J	22915803	2009-08-01	PMC2834657	20167059	background hepat viru hcv bloodborn flaviviru infect million peopl worldwid concern stabil hcv reliabl procedur inactiv viru method current studi thermost cell culturederiv hcv hcvcc jfh strain environment temperatur room temperatur abil heat uvc light irradi aldehyd deterg treatment inactiv hcvcc evalu infecti titer treat viral sampl determin focusform unit ffu assai indirect immunofluoresc assai hcv ns hepatoma huhcd cell highli permiss hcvcc infect mtt cytotox assai perform determin concentr aldehyd deterg longer cytotox hcvcc cultur medium surviv room temperatur dai viru stabl drastic loss infect week hcvcc cultur medium sensit heat inactiv min incub c min requir elimin hcvcc infect addit normal human serum hcvcc alter viral stabil suscept heat uvc light irradi wavelength nm intens wcm effici inactiv hcvcc min exposur formaldehyd glutaraldehyd ionic nonion deterg destroi hcvcc infect effect treatment conduct presenc cell cultur medium human serum conclus provid quantit evid potenti varieti approach inactiv hcv abil hcvcc surviv ambient temperatur warrant precaut handl dispos object materi contamin hcv
PLoS Med	19608822	2012-09-01	PMC2834705	20231868	karen edmond anita zaidi highlight approach reduc burden neonat sepsi worldwid
Viruses	22958246	2006-10-30	PMC2835314	20221421	coronavirus infect speci anim includ human caus acut chronic diseas organ system murin coronaviru mous hepat viru mhv infect mous anim model studi central nervou system diseas includ enceph demyelin diseas multipl sclerosi hepat studi adapt immun respons mhv scant type interferon ifn respons mhv relationship mhv ifn respons paradox type ifn respons crucial aspect host defens mhv natur host induct ifn infect mous fibroblast cell line vitro mhv resist antivir effect ifn mous fibroblast cell line human cell mhv circumst compromis antivir effect ifn signal nucleocapsid protein nsp nsp protein mhv report ifn antagonist activ primari cell type plasmacytoid dendrit cell pdc macrophag ifn induc mhv infect antivir state establish primari cell type neuron astrocyt hepatocyt fail produc ifn infect vivo depend ifn produc pdc macrophag protect mhv mhv induct ifn abil induc antivir state respons interferon extrem cell type depend ifn induc protect mhv pathogenesi requir orchestr activ cell type cell type involv limit mhv replic liver immun privileg cn
Viruses	17075062	2011-06-01	PMC2836126	20224751	assai simultan detect multipl potenti agent bioterror limit multiplex pcr rtpcr enzym hybrid assai mpcreha mrtpcreha develop simultan detect cdc categori bioterror agent bio dna assai develop detect variola major vm bacillu anthraci ba yersinia pesti yp francisella tularensi ft varicella zoster viru vzv bio rna assai mrtpcreha develop detect ebola viru ebola lassa fever viru lassa rift vallei fever rvf hantaviru sin nombr speci hsn dengu viru serotyp sensit specif assai test genom dna recombin plasmid posit control rna transcript control surrog spike clinic sampl common respiratori pathogen analyt sensit limit detect lod dna asssai genom dna copiesml ba ft yp lod vzv organ tcidml lod recombin control rang copiesml ba ft yp vm rna assai demonstr lod rna transcript control copiesml extract copiesml extract ebola rvf lassa hsn lod dengu organ dilut dengu ldml ldml dengu lod extract recombin plasmid dna control copiesml input copiesreact ebola rvf lassa hsn crossreact primer probe assai detect common respiratori pathogen target analyt clinic sensit estim surrog clinic sampl test biot dna assai sampl test biot rna assai clinic specif biot dna assai biot rna assai surrog sensit assai ci ft ba px yp vm vzv dengu ci ba px dengu spike clinic specimen specif biot multiplex assai spike specimen ci compar assai cultur serolog pcr biot dna mpcreha biot rna mrtpcreha rapid sensit specif assai detect categori bioterror agent standard thermocycl
BMC Struct Biol	21572336	2018-08-15	PMC2836360	20170556	background catalyt activ influenza neuraminidas facilit elut progeni virion infect cell prevent selfaggreg mediat catalyt site locat bodi region activ site molecul led develop effect inhibitor oseltamivir zanamivir high rate mutat interspeci reassort viral sequenc report oseltamivir resist strain underlin determin addit target site develop futur antivir compound comput studi hn gene sequenc identifi base highli conserv region termin gene extend graphic numer analys larger number hn sequenc hn swine flu sequenc access genbank graphic represent model gene sequenc graphic slide window method gswm protein sequenc scan sequenc block amino acid time protein sequenc descriptor defin model protein slide scan method allow compar strain block level variabl statist correl averag solvent access residu block singl amino acid posit variabl correl indic impact stretch variabl chemic environ close ctermin gswm descriptorvari increas averag solvent access asa support conserv predict secondari structur termin rna visual evid crystallograph structur conclus identifi termin segment conserv rna protein sequenc surfac expos structur chemistri reveal probabl role stretch tetramer stabil particip biolog process associ conserv surfac residu rna doubl hairpin secondari structur segment major hn strain support observ paper propos conserv region probabl site design inhibitor broadspectrum pandem control flu virus structur
PLoS One	29570986	2016-05-13	PMC2836373	20300175	background studi drugtarget interact network topic drug develop timeconsum costli determin compoundprotein interact potenti drugtarget interact experi complement silico predict method provid time manner methodsprincip find realiz drug compound encod function group protein encod biolog featur includ biochem physicochem properti optim featur select procedur adopt mrmr maximum relev minimum redund method classifi protein famili target protein divid group enzym ion channel gprotein coupl receptor nuclear receptor independ predictor establish nearest neighbor algorithm oper engin predict interact drug protein group result success rate jackknif crossvalid test achiev predictor conclusionsignific indic network predict system establish promis encourag
BMC Vet Res	27226534	2005-07-01	PMC2837645	20175881	background structur contact individu plai role incurs spread contagi diseas human anim popul case avian influenza movement live bird risk factor geograph dissemin viru poultri flock live bird market lbm contribut epidemiolog avian influenza demograph characterist presenc hpai hn viru lineag relationship poultri produc live poultri trader lpt oper lbm adequ document hpai hnaffect se asian countri aim studi document studi flow live poultri poultri trade network northern vietnam explor potenti role risk hpai hn result indic lpt trade year oper retail market sourc poultri flock locat commun histori hpai hn outbreak lpt trade longer year oper wholesal market the network analysi indic lpt tend link commun infect statu conclus studi evid inform polici aim encourag biosecur practic lpt oper authoris lbm lpt plai role hpai hn transmiss contribut perpetu hpai hn viru circul group commun impact current diseas prevent control intervent enhanc dissemin outbreak risk implement formal data record scheme lbm incom outgo lpt
Virol J	16020687	2012-03-01	PMC2838858	20202190	measl caus measl viru mev common infect children mev member genu morbilliviru close rinderpest viru rpv pathogen cattl mev thought evolv environ cattl human live close proxim understand evolutionari histori mev answer question diverg time mev rpv investig diverg time relax clock bayesian phylogenet estim reveal mev evolutionari rate substitutionssiteyear conclud diverg time common ancestor current mev earli centuri diverg mev rpv occur centuri result unexpect emerg mev consid occur prehistor ag mev origin viru nonhuman speci caus emerg infecti diseas centuri case investig measl cours emerg infecti diseas
BMC Biotechnol	22733325	2012-10-17	PMC2841091	20146813	background despit current knowledg mutat gene nonsyndrom sensorineur hear loss snhl unifi clinic test develop comprehens detect mutat multipl gene design affymetrix resequenc microarrai capabl resequenc gene mutat snhl gjb gjb cdh kcne kcnq myoa otof pd myo slca tmie tmprss ushc hear loss arrai develop facil highlight approach adopt enhanc applic resequenc arrai clinic set leverag sequenc intens pattern featur respons diminish coverag accuraci develop novel algorithm sprofil resolv nocal gseq allow rang sequenc call maintain accuraci base dideoxi sequenc comparison conclus find provid insight critic issu diseasecent resequenc protocol suitabl clinic applic support arraybas resequenc technolog valuabl molecular diagnost tool pediatr snhl genet diseas substanti genet heterogen
PLoS One	23077320	2005-01-28	PMC2841200	20305786	groundnut bud necrosi viru gbnv member genu tospoviru famili bunyavirida infect larg number leguminosa solanacea plant india view elucid function nonstructur protein nss encod small rna genom rna nss protein gbnv tomato karnataka overexpress coli purifi ninta chromatographi purifi rnss protein exhibit rna stimul ntpase activ activ metal ion depend inhibit adenosin imido triphosph atp analog rnss hydrolyz datp interestingli addit ntpase datpas activ rnss exhibit atp independ rnadna phosphatas activ complet inhibit amp phosphat remov ssdna ssrna dsdna dsrna confirm rnss novel phosphatas activ ka mutat walker motif gxxxxgkt complet loss atpas activ phosphatas activ unaffect hand mutat walker motif dexx partial loss activ demonstr time nss bifunct enzym particip viral movement replic suppress host defens mechan
PLoS Pathog	15681451	2017-10-01	PMC2841620	20333243	virus cellular machineri enter infect cell studi address cell entri mechan nonenvelop adenovirus ad protein vi intern capsid protein rapidli expos cell surfac attach intern remain partial associ capsid intracellular transport ppxy motif protein vi recruit nedd ubiquitin ligas bind ubiquityl protein vi ppxy motif involv rapid microtubuledepend intracellular movement protein vi ad mutat ppxy motif effici escap endosom defect microtubuledepend traffick nucleu likewis deplet nedd ligas attenu nuclear accumul incom ad particl infect data provid evid virusencod ppxy motif requir viru entri signific pathogen
BMC Public Health	29276302	2010-11-11	PMC2841672	20226093	background pandem young adult infect increas potenti univers explos diseas outbreak centr outbreak manag essenti reduc impact institut surround commun onlin survei aim measur percept respons staff student pandem hn major univers sydnei australia method survei onlin june septemb sampl includ academ staff gener staff student univers total survei complet respond awar australian pandem situat report anxieti disinterest asianborn respond pandem seriou compar respond region respond lifestyl chang result pandem respond adopt specif behaviour chang adopt simplest health behaviour hand hygien adopt specif behaviour chang link anxieti asian origin student attend univers unwel compar staff member posit respons student indic potenti expand onlin teach learn resourc continu educ disast set willing receiv pandem vaccin associ season influenza vaccin uptak previou year conclus respons pandem subject chang pre earli midoutbreak stage lesson institut prepar second wave futur diseas outbreak includ promot posit public health behaviour young peopl student
J R Soc Interface	21070145	2013-10-28	PMC2842609	19535416	statist infer mechanist model partial observ dynam system activ area exist infer method place substanti restrict form model fit natur scientif hypothes entertain data evalu contrast socal plugandplai method requir simul model free restrict util plugandplai approach context investig measl transmiss dynam novel methodolog enabl answer question previou analys unabl address demonstr plugandplai method permit develop model infer framework applic data larg small popul novel insight natur heterogen mix comment includ extrademograph stochast deal environment stochast model misspecif approach applic epidemiolog ecolog system
PLoS One	24167297	2012-05-01	PMC2843722	20352112	effort develop broadli protect vaccin highli pathogen avian influenza hpai hn viru focus highli conserv influenza gene product viral nucleoprotein np ion channel matrix protein highli conserv strain influenza subtyp investig rel efficaci np compar ha protect hpai hn viru mice previou studi vaccin np recombin dna andor adenoviru vector adjuv confer protect lethal challeng absenc ha find protect efficaci np diminish virul dose challeng viru increas explor question model relev human diseas ferret immun dnarad vaccin encod np ha npm hanpm ha hanpm vaccin confer protect stringent viru challeng genebas vaccin np provid moder level protect low challeng dose insuffici confer protect immun high challeng dose hn ferret immunogen requir combinatori vaccin ha confer protect high dose lethal viral challeng
BMC Infect Dis	22300798	2015-11-23	PMC2844401	20187976	background infecti diseas outbreak critic learn concern knowledg attitud behavior public crucial improv commun effort public health offici clinician aim studi identifi awar attitud practic influenza hn saudi public method crosssect studi adult subject recruit shop mall riyadh jeddah conduct subject interview questionnair test knowledg attitud precautionari measur relat hn influenza pandem half particip high concern low level knowledg minim precautionari measur adjust variabl educ level predictor level concern greater precautionari measur particip male older better educ knowledg onethird particip convinc moh report diseas true particip report receiv health provid conclus high concern translat higher complianc precautionari recommend low level knowledg diseas public frequent commun physician public recommend help dispel myth diseas spread better role public plai limit spread diseas
PLoS Comput Biol	26596952	2006-11-01	PMC2845652	20361048	the trace infecti contact control strategi infecti diseas earli case novel infect endem sexual transmit infect mathemat model consid case partner notif sexual transmit infect model simpl allow gener conclus drawn contact network structur consid addit contact trace standard mass action model gener inadequ consid impact mutual contact cluster develop improv exist pairwis network model demonstr ceteri paribu cluster improv efficaci contact trace larg region paramet space result revers case highli effect contact trace develop stochast simul comparison simpl rewir method allow gener appropri compar network contribut gener theori networkbas intervent infecti diseas
BMC Infect Dis	17079322	2014-09-15	PMC2846943	20205702	typhoid enter fever common diseas develop countri current diagnost test inadequ studi pathogenesi genom provid insight organ enter fever better understand microorgan explain current typhoid methodolog limit diagnost develop strategi consider challeng discuss current posit typhoid diagnost highlight technolog improv potenti wai advanc area
BMC Infect Dis	25220505	2011-11-16	PMC2846944	20205928	background sever acut respiratori syndrom sar outbreak infect individu lead death epidemiolog studi sar compar epidemiolog featur region aim studi identifi similar differ sar epidemiolog three popul host viral genotyp method compar epidemiolog analysi sar base integr dataset sar patient hong kong beij taiwan epidemiolog clinic characterist incub onsettoadmiss onsettodischarg onsettodeath period case fatal ratio cfr present symptom describ compar region explor influenc demograph clinic variabl larg differ cfr three region three region incub period progress shorten onsettoadmiss interv epidem adjust sex health care worker statu nosocomi set older ag associ higher fatal adjust odd ratio aor confid interv ag aor confid interv ag compar ag year presenc preexist comorbid condit associ greater mortal aor confid interv conclus larg discrep crude fatal ratio three region partli explain epidemiolog clinic heterogen find underlin common data collect platform emerg epidem order identifi explain consist differ eventu clinic public health outcom infecti diseas outbreak increasingli highli interconnect world
Virol J	22090124	2015-10-01	PMC2847567	20236536	in mammalian cell nucleolar local influenza ns requir presenc ctermin nucleolar local signal nucleolar local signal strain influenza virus ns accumul nucleolu mammalian cell contrast ns test studi accumul nucleolu avian cell absenc describ ctermin nucleolar local signal nucleolar local ns avian cell appear reli nucleolar local signal conserv influenza viru strain
BMC Public Health	26253126	2007-02-08	PMC2847980	20233450	background strategi public health offici pandem physician recommend isol infect individu studi undertaken height australian pandem hn outbreak measur selfreport willing compli physician recommend stai dai compar respons current strain pandem influenza avian influenza season influenza common cold method data collect queensland social survei qss consist standard introduct demograph question question incorpor costshar arrang question respond anticip complianc physician advic stai common cold season influenza pandem hn influenza avian influenza incorpor qss respons record balanc likert scale rang veri discord respons diseas analys mcnemar test associ demograph variabl anticip complianc analys pearson chisquar chisquar linearbylinear associ confirm multivari logist regress establish statist signific selfreport anticip complianc increas common cold season influenza pandem hn influenza avian influenza versu season influenza anticip complianc differ pandem hn avian influenza ag sex associ anticip complianc set season influenza common cold notabl health commun servic worker compli physician advic stai season influenza conclus ninetyf percent peopl report compli physician advic stai dai diagnos pandem hn avian influenza expect compli set season influenza fewer expect compli diagnos common cold subpopul worthwhil target public health messag aim increas rate selfimpos isol season influenza includ male younger peopl healthcar worker
BMC Infect Dis	17289713	2016-09-14	PMC2848042	20178573	background survei assess knowledg attitud complianc standard precaut health careassoci infect hai associ determin healthcar worker hcw emerg depart itali method anonym questionnair selfadminist hcw randomli select nonacadem acut gener public hospit compris question demograph occup characterist knowledg risk acquir andor transmit hai fromto patient standard precaut attitud guidelin risk perceiv acquir hai practic standard precaut sourc hcw risk acquir hepat hcv human immunodefici viru hiv patient practic year work fewer hour week knew hcw transmit hcv hiv patient knew hcv hiv infect seriou receiv educ cours scientif journal glove mask protect eyewear hand hygien remov glove control measur nurs provid care fewer patient knew hcw hand vehicl transmiss nosocomi pathogen hcw transmit hcv hiv patient receiv educ cours scientif journal nurs know hcw hand vehicl transmiss nosocomi pathogen obtain educ cours scientif journal need associ higher perceiv risk acquir hai hcw glove perform hand hygien measur remov glove nurs provid care fewer patient knew hand hygien remov glove control measur conclus hcw high knowledg posit attitud low complianc concern standard precaut nurs higher knowledg perceiv risk appropri hai control measur physician hcw answer correctli appropri control measur receiv educ cours scientif journal
PLoS One	27629904	2014-10-29	PMC2848673	20376320	background rift vallei fever viru rvfv member genu phleboviru famili bunyavirida negativestrand rna viru tripartit genom rvfv transmit mosquito fever sever hemorrhag ill human livestock fever high abort rate methodologyprincip find sequenc analysi wildtyp rvfv zh prepar consist major viral subpopul singl nucleotid heterogen nucleotid segment residu encod glycin major viral envelop gn protein carri residu encod glutam acid correspond site zhderiv virus rzhmg rzhma carri ident genom sequenc the recov revers genet system intraperiton inocul rzhma mice caus rapid effici viral accumul sera liver spleen kidnei brain kill mice dai rzhmg caus low viremia titer replic effici rzhma organ attenu virul mice remark earli dai postinfect rzhmg virus carri emerg major viru popul replic virus retain input residu rzhmainfect mice conclusionssignific data demonstr singl nucleotid substitut gn protein rvfv mous virul viru popul carri virul viral genotyp emerg major viral popul dai mice inocul attenu viru
BMC Infect Dis	25355758	2009-03-19	PMC2850906	20170501	background nonpharmaceut intervent npi defens pandem influenza intervent dampen viru spread reduc contact infect suscept person curtail essenti societ activ appli judici optim control theori approach model balanc compet object epidem spread npi cost method appli optim control epidemiolog compartment model develop trigger npi implement object minim expect persondai lost influenza death npi implement model perform multivari sensit analysi base latin hypercub sampl studi effect input paramet optim control polici addit studi investig effect departur model assumpt includ exponenti termin time linear npi implement cost optim polici deriv control model linear npi implement cost linear cost lead bangbang polici npi appli maximum strength state criteria met multivari sensit analys present indic npi cost death rate recoveri rate influenti determin polici structur death rate basic reproduct number recoveri rate influenti determin expect cumul death appli npi polici cumul death exponenti gamma termin time close impli outcom appli bangbang polici insensit exponenti assumpt quadrat cost lead multilevel polici npi appli vari strength level base state criteria indic linear cost lead costli implement fewer death conclus applic optim control theori provid valuabl insight develop effect control strategi pandem find highlight establish sensit time surveil system pandem prepared
PLoS Comput Biol	19299732	2016-01-01	PMC2851561	20386735	the dynam infecti diseas spread direct persontoperson transmiss influenza smallpox hivaid depend underli host contact network human contact network exhibit strong commun structur understand commun structur epidem provid insight prevent spread diseas commun chang structur contact network pharmaceut nonpharmaceut intervent empir simul network investig spread diseas network commun structur find commun structur major impact diseas dynam network strong commun structur immun intervent target individu bridg commun effect simpli target highli connect individu structur relev contact network gener vaccin suppli limit great effici vaccin algorithm requir full knowledg network develop algorithm act local network identifi target success immun intervent algorithm gener outperform exist algorithm vaccin suppli limit network strong commun structur understand spread infecti diseas design optim control strategi major goal public health social network mark pattern commun structur base empir simul data demonstr commun structur diseas dynam implic design control strategi
PLoS Pathog	27350726	2005-05-09	PMC2851658	20386712	sever acut respiratori syndrom coronaviru sarscov infect caus sever stage lung diseas organ phase diffus alveolar damag elderli virushost interact govern develop acut stage lung diseas death unknown address question evalu role innat immun signal protect human urbani recombin mous adapt sarscov design rma contrast model viral pathogenesi infect type type ii type iii interferon knockout mice background urbani ma virus clinic diseas outcom includ transient weight loss denud bronchiol alveolar inflamm recoveri ident infect wildtyp mice suggest type ii iii interferon signal plai minor role regul sar pathogenesi mous model contrast infect stat mice sever diseas high viru titer extens pulmonari lesion mortal dai postinfect rma urbani virus nonleth balbc mice urbani sarscov infect stat mice caus dissemin infect involv liver spleen tissu dai find demonstr sarscov pathogenesi regul stat depend type ii iii interferon receptor independ mechan contrast document role innat immun propos stat protect mice role antagonist unrestrain cell prolifer
BMC Health Serv Res	15883361	2014-12-01	PMC2851711	20307302	background work hospit extraordinari infecti diseas outbreak stress contribut healthcar worker choos reduc patient contact psycholog train healthcar worker prior influenza pandem reduc stressrel absente establish train method chang behavior attitud resourceintens widespread studi test feasibl effect expens altern interact computerassist train cours design build resili stress work pandem method dosefind studi compar prepost chang three durat train measur variabl mediat stressrespons pandem train confid support train pandemicrel selfefficaci cope style interperson problem hospit worker cours randomli assign short session median cumul durat minut medium session minut long session minut version intentiontotreat analysi cours associ improv confid support train pandem selfefficaci interperson problem particip underutil cope problemsolv seek support overutil escapeavoid experienc improv cope comparison dose improv interperson problem medium long cours short cours trend higher dropout rate longer durat train conclus computerassist resili train healthcar worker appear benefit merit studi pandem condit compar three dose cours suggest medium cours optim
PLoS One	25268048	2002-06-15	PMC2852402	20404914	background human ceacam cellcel adhes molecul multipl function includ insulin clearanc liver vasculogenesi endotheli cell lumen format mammari gland bind human pathogen princip find three genom bac clone human ceacam gene microinject pronuclei fertil fvb mous oocyt embryo implant oviduct pseudopregn femal allow develop term dna newborn mice evalu pcr presenc human ceacam gene fece pcr posit offspr screen express human ceacam assai pcr posit line posit human ceacam express stabl transmiss gener expect transmiss frequenc heterozygot liver lung intestin kidnei mammari gland prostat posit dual express murin human ceacam mimic human tissu peripher blood bone marrow granulocyt stain human ceacam bound neisseria opa protein human neutrophil conclus transgen anim serv model bind human pathogen human ceacam
PLoS One	12021359	2004-09-27	PMC2854681	20418944	the transfer scientif data emerg challeng dataset continu grow size demand open access share increas current method file transfer scale larg file long transfer time studi biotorr websit allow open access share scientif data popular bittorr peertop file share technolog biotorr allow file transfer rapidli share bandwidth multipl institut reliabl file transfer builtin error check file share technolog biotorr multipl featur includ keyword search categori brows rss feed torrent comment discuss forum biotorr httpwwwbiotorrentsnet
PLoS Pathog	15452268	2015-09-30	PMC2858705	20421945	sarscoronaviru sarscov genom express depend synthesi set mrna presum cap direct synthesi viral protein infect cell sixteen viral nonstructur protein nsp nsp constitut unusu larg replicas complex includ methyltransferas put involv viral mrna cap format sadenosyllmethionin adometdepend guaninenmethyltransferas nmtase activ attribut nsp nsp predict adometdepend nucleosideomethyltransferas reconstitut complet sarscov mrna cap methyl vitro mrna cap methyl requir third viral protein nsp act essenti trigger complet rna cap format oblig sequenc methyl event initi nsp methyl cap rna transcript gener cap megppparna select omethyl omtas nsp complex activ nsp rise cap megpppaomerna sensit vitro inhibit assai activ aurintricarboxyl acid activ sarscov infect cell target mtase ic valu micromolar rang provid valid basi anticoronaviru drug design
PLoS Pathog	26423940	2007-10-24	PMC2858710	20421950	newcastl diseas viru ndv pathogen strain avian paramyxoviru apmv seriou diseas threat poultri industri worldwid viral divers high apmv genotyp recogn base phylogenet reconstruct gene sequenc modifi live vaccin develop decreas econom loss caus viru vaccin deriv avirul genotyp ii strain develop global australian strain belong genotyp develop vaccin asia studi evalu consequ attenu live viru vaccin evolut apmv genotyp phylogenet incongru tree base individu gene complet code region full length apmv genom suggest recombin sequenc data set subsequ recombin genom identifi contain sequenc genotyp ii popul histori vaccinerel genotyp ii strain distinct apmv genotyp genotyp ii emerg late centuri evolv slowli genotyp emerg despit vaccin effort genotyp ii virus experienc constant popul growth contrast contemporari genotyp popul declin late addition genotyp ii virus circul presenc homotyp vaccin pressur uniqu select profil compar nonvaccinerel strain collect data vaccin live attenu virus chang evolut apmv maintain larg effect popul size vaccinerel genotyp allow coinfect recombin vaccin wild type strain appli uniqu select pressur viral glycoprotein
PLoS Negl Trop Dis	17978761	2011-12-14	PMC2860491	20436958	chikungunya viru mosquitoborn emerg pathogen major health impact human fever diseas headach rash nausea vomit myalgia arthralgia indigen tropic africa larg outbreak report part south east asia neighbor island in europ posit case confirm unit state travel return outbreak area current vaccin antivir treatment threat emerg global pandem peculiar problem associ season epidem warrant develop effect vaccin review summar evid support concept
PLoS Med	22170925	2016-12-05	PMC2860492	20436959	as plo medicin seri global health diplomaci laihan chan colleagu provid case studi china grow engag global health diplomaci sar epidem
PLoS Negl Trop Dis	27920168	2007-02-14	PMC2860510	20436917	background unexpectedli high seropreval pathogen potenti human parvoviru bv observ malariaendem countri parallel local chloroquin cq firstlin treatment malaria aim studi assess cq common antimalari drug bv infect vitro epidemiolog consequ children papua guinea png methodologyprincip find viral rna dna protein analyz cell type infect bv presenc rang antimalari drug relationship bv infect statu prior aminoquinolin anemia assess png children year ag particip casecontrol studi sever infect cqtreat cell synthesi viral rna dna protein higher occur earlier control cell cq facilit bv infect minim intracellular degrad incom particl amodiaquin antimalari drug bv igm seroposit frequent children sever anemia hemoglobin gl healthi control children bv igm pcr posit aminoquinolin associ lower admiss hemoglobin concentr conclusionssignific data aminoquinolin drug metabolit exacerb bvassoci anemia promot bv replic consider choos nonaminoquinolin drug partner artemisinin compound combin antimalari therapi
BMC Public Health	17301158	2013-12-30	PMC2861057	20353568	background behaviour respons expect influenza pandem occur method survei compris question base risk percept theori pmt conduct dutch sampl fear influenza pandem occur high particip feel inform gener practition local health author consid trustworthi sourc consid urgent pertain protect measur particip report intent compli recommend protect measur respons efficaci low maladapt behaviour expect increas number individu school closur expect lead decreas work forc particip indic want antivir drug suppli insuffici conclus messag health protect behaviour local health author anticip balanc overreact underreact protect recommend health profession conflict compani polici unclear employe will react
PLoS One	24355931	2017-10-25	PMC2861591	20454449	background syndrom surveil increasingli detect unusu ill debat detect local outbreak evalu syndrom surveil detect local outbreak lowerrespiratori infect lri swamp true signal fals alarm method find retrospect hospit data simul prospect surveil lrielev total lri includ hospit patient place resid coverag popul larg outbreak legionnair diseas netherland posit control test outbreak detect local lri elev spacetim permut scan statist detect lri cluster evalu lriclust detect assess clustersign higher proport specif hospit discharg diagnos legionnair diseas overlap region influenza elev evalu number spacetim signal reduc restrict scan statist space time scanstatist detect local lri cluster repres averag cluster year legionnair diseas outbreak detect lriclust clustersign gener increas proport legionnair diseas patient cluster coincid local influenza andor respiratori syncyti viru activ cluster appear data artifact cluster defin repres undetect lrioutbreak restrict time spatial window scan statist detect legionnair diseas outbreak loss timeli signal gener time declin conclus knowledg studi systemat evalu perform spacetim syndrom surveil nationwid high coverag data longer period syndrom surveil detect local lrioutbreak time manner independ laboratorybas outbreak detect compar cluster year observ prompt investig syndrom hospitalsurveil valuabl tool detect local lrioutbreak
PLoS Pathog	29070693	2014-05-28	PMC2861712	20442788	the filovirus marburg ebola nonseg negativestrand rna virus caus sever hemorrhag fever high mortal rate human nonhuman primat sequenc event lead releas filoviru particl cell understood contrast mechan propos proceed submarinelik bud helic nucleocapsid emerg parallel plasma membran perpendicular rocketlik protrus infect cell marburg viru bsl contain condit reconstruct sequenc step bud process three dimens electron tomographi plasticembed cell find highli infecti filament particl releas earli stage infect bud proce later associ intracellular nucleocapsid length plasma membran rapid envelop initi nucleocapsid lead protrud intermedi scission local membran instabl rear viru prolong infect increas vesicul plasma membran correl chang shape infect releas virus observ demonstr cellular determin viru shape reconcil contrast model filoviru bud allow describ sequenc event place bud releas marburg viru propos repres gener sequenc event filament rodshap virus
BMC Cell Biol	24872591	2014-11-01	PMC2864199	20398401	background acquisit resist anoiki facilit surviv cell independ matrixdefici condit cell tumor progress product suspens cultur cell biomed engin evid suggest cd adhes molecul associ surviv cell tumor metastasi cellcel contact plai role resist anoiki function cd mediat cellcel contact anoikisresist remain limit selfcontradictori anoikisresist clone hekar deriv anoikissensit parent human embryon kidnei cell surviv anoiki format cellcel contact express habgcd member cd famili upregul protein locat cellcel junction upregul habgcd suspend hekar cell suppress anoiki mediat format cellcel adhes anoiki resist hekar cell requir ecadherinmedi cellcel contact knockdown habgcd ecadherin inhibit cellcel contact format increas anoiki sensit habgcd downregul ecadherin express hekar cell suppress knockdown ecadherin ecadherin sirna block ecadherin bind activ specif antibodi edta habgcd express final pretreat ly phosphoinositid kinas pikakt inhibitor disrupt cellcel contact decreas cell number case cell treat extracellular signalregul kinas erk inhibitor pd conclus provid evid habgcdmedi cellcel contact confer anoiki resist ecadherindepend manner cellcel contact mediat resist anoiki implic pik pathwai highli relev cell model hekar understand role habgcd cellcel contact anoiki resist help understand surviv cell anchorageindepend growth cell tumor metastasi suspens cultur produc biomed engin contribut better understand biologi hek cell spheroid major workhors produc human therapeut agent viral vaccin
BMC Infect Dis	25455030	2003-07-28	PMC2864274	20403201	background septemb pandem hn influenza vaccin adult children ag year australia accept novel vaccin influenc percept risk includ risk infect risk death sever ill risk seriou vaccin sideeffect survei sampl resid sydnei australia ascertain risk percept attitud pandem willing accept pandem hn influenza vaccin method sampl resid crosssect intercept design phase member public approach shop pedestrian mall undertak survei septemb octob survei measur perceiv risk serious diseas behaviour chang accept pandem hn vaccin issu relat uptak perceiv safeti respond major felt low low risk acquir hn respond believ diseas serious extrem affect health half report respons swine flu outbreak undertaken investig behaviour chang selfreport likelihood accept vaccin novel hn conclus particip high risk acquir pandem hn half sampl indic accept vaccin particip vaccin season influenza receiv hn vaccin concern safeti possibl side effect vaccin develop process address
J Oncol	12885925	2006-08-01	PMC2864512	20454584	solid tumor recruit blood vessel support growth uniqu molecul express tumor endotheli cell function target antiangiogen therapi cancer current effort focus develop therapeut agent capabl target cancer cell tumorassoci microenviron includ tumor blood vessel therapi hold promis high efficaci low toxic recogn strategi improv therapeut effect convent chemotherapeut encapsul anticanc drug target liposom bind cell surfac receptor express tumorassoci endotheli cell antiangiogen drug deliveri system target tumor blood vessel tumor cell articl review mechan advantag potenti method peptideconjug liposom destroi tumor blood vessel anticanc therapi
BMC Cancer	16886061	2010-11-03	PMC2868050	20346172	background clinic cours human papillomaviru hpv associ bowenoid papulosi condyloma acuminatum anogenit tumor unknown evalu molecul relev cellular prolifer regul apoptosi hpv associ anogenit tumor method investig level telomeras activ inhibitor apoptosi protein iap famili ciap ciap xiap cmyc mrna express level specimen bowenoid papulosi specimen condyloma acuminatum anogenit area phosphoryl akt pribosom protein s pebind protein ebp express level examin immunohistochemistri anogenit tumor posit telomeras activ posit telomeras activ detect bowenoid papulosi condyloma acuminatum compar normal skin contrast express level bowenoid papulosi indic ciap ciap xiap mrna upregul compar condyloma acuminatum sampl p normal skin p bowenoid papulosi high risk hpv promot iap famili cmyc condyloma acuminatum activ gene immunohistochem pakt ps express associ posit telomeras activ pebp express conclus combin analysi iap famili cmyc mrna express telomeras activ level paktp express provid clinic relev molecular marker hpv associ anogenit tumor
Int J Mol Sci	21048012	2011-09-06	PMC2869232	20480005	a shortcom correl distanc method base composit vector align develop phylogenet analysi complet genom distanc proper distanc metric strict mathemat sens paper propos correlationrel distanc metric replac dynam languag approach genom dataset emploi evalu effect replac biolog point view find proper distanc metric yield tree topolog asto distanc agre tree life base rrna major basic branch proper correlationrel distanc metric propos improv dynam languag approach phylogenet analysi
Int J Mol Sci	21900274	2014-01-27	PMC2869241	20479989	andrographolid deriv inhibit glucosidas investig relationship activ structur andrographolid deriv train set chosen andrographolid deriv princip compon analysi pca method quantit structureact relationship qsar establish d qsar method crossvalid standard error illustr dqsar model identifi molecular fragment crossvalid standard error demonstr dqsar model capabl explor spatial distribut fragment suggest propos combin d qsar model predict glucosidas inhibit activ andrographolid deriv
PLoS One	24490814	2005-11-23	PMC2871037	20498717	background highli pathogen avian influenza hpai viru hn multiorgan diseas death poultri econom loss poultri industri addit pose major public health threat transmit directli infect poultri human high mortal rate effect vaccin hpai hn protect commerci poultri provid control measur reduc likelihood birdtobird birdtohuman transmiss methodologyprincip find studi evalu vaccin potenti recombin solubl trimer subtyp hemagglutinin sh produc mammalian cell secret purifi sh biolog activ demonstr bind ligand sialic aciddepend manner protect chicken dosedepend manner lethal challeng hn singl vaccin protect anim challeng viru determin quantit rtpcr rna isol trachea cloaca swab mice vaccin sh provid complet protect challeng hpai hn conclusionssignific demonstr sh constitut attract vaccin antigen protect chicken mammal hpai hn recombin solubl hemagglutinin prepar produc high yield short lead time enabl rapid respons circul pandem influenza virus
PLoS One	16306602	2012-03-20	PMC2871038	20498718	background pandem influenza hn viru emerg help clinician triag adult acut respiratori ill score system influenzalik ill ili implement hospit civil de guadalajara mexico method medic histori laboratori radiolog collect emerg room er patient acut respiratori ill calcul iliscor patient evalu admiss iliscor clinician assess risk develop complic nasal throat swab collect intermedi highrisk patient influenza test rtpcr disposit iliscor oseltamivirtr versu untreat clinic characterist pandem influenza hn patient versu testneg patient compar pearson fisher exact wilcoxon ranksum test er patient initi hospit iliscor rest discharg includ ambulatori patient oseltamivir median iliscor untreat median iliscor fourteen untreat patient return hospit oseltamivir median iliscor patient test rtpcr pandem influenza season influenza detect twenti imag hospit pandem influenza patient bilater infiltr compar imag hospit testneg patient patient confirm pandem influenza present dai symptom onset requir mechan ventil di conclus triag system iliscor compliment clinician judgment need oseltamivir inpati care help hospit staff manag surg demand servic
BMC Microbiol	22605688	2007-08-22	PMC2871271	20406467	background carcinoembryon antigenrel cell adhes molecul ceacam immunoglobulin igrel glycoprotein serv cellular receptor varieti gramneg bacteri pathogen associ human mucosa neisseria gonorrhoea meningitidi moraxella catarrhali haemophilu influenza possess wellcharacter ceacambind adhesin ceacam typic involv cellcel attach epitheli differenti neovascularis regul tcell prolifer ceacam famili member homologu mammalian lineag unknown bacteri adhesin human pathogen recogn ceacam orthologu mammal sequenc comparison aminotermin igvariablelik domain ceacam reveal highest sequenc diverg human murin canin bovin orthologu strand compris bacteriabind ccfgface igfold gfptag solubl aminotermin domain ceacam demonstr bacteri pathogen select associ human mammalian ceacam orthologu fulllength human ceacam mediat intern neisseria gonorrhoea transfect cell murin ceacam fail support bacteri intern demonstr sequenc diverg ceacam orthologu function consequ regard bacteri recognit cellular invas conclus establish select interact humanrestrict bacteri pathogen human ceacam coevolut microbi adhesin correspond receptor mammalian cell contribut limit host rang highli adapt infecti agent
PLoS Negl Trop Dis	17715238	2016-07-20	PMC2872638	20502515	background ultrasonographi allow noninvas examin liver spleen understand schistosomiasi morbid methodologyprincip find peopl southwest china year particip test schistosoma japonicum infect stool standard measur liver spleen ultrasound evalu relationship schistosomiasi infect ultrasounddetect patholog impact target treatment morbid parenchym fibrosi network pattern liver uniqu japonicum associ infect time ultrasound ci infect intens test trend adjust ag sex year associ prior infect statu intens adjust ci test trend despit prompt treatment infect declin parenchym fibrosi time statist individu sever parenchym fibrosi grade enrol revers normal grade year liver abnorm consist associ japonicum infect conclusionssignific parenchym fibrosi appropri measur japonicum morbid document reduct diseas control effort ultrasound measur limit epidemiolog region infect level sever fibrosi revers treatment effort reduc exposur japonicum consid combin treatment prevent schistosomiasi morbid
PLoS Negl Trop Dis	27440901	2009-02-01	PMC2872645	20502522	vener syphili multistag sexual transmit diseas caus spirochet bacterium treponema pallidum tp describ cohort patient ag year secondari syphili ss identifi network public sector primari health care provid cali colombia elig particip studi subject requir cutan lesion consist ss reactiv rapid plasma reagin test rprtiter confirmatori treponem test fluoresc treponem antibodi absorpt test ftaab subject enrol women afrocolombian mestizo low socioeconom statu three subject newli diagnos hiv infect studi entri durat sign symptom patient dai patient report symptomat month rang dai typic palmar plantar exanthem ss common dermal manifest diffus hypo hyperpig macul papul trunk abdomen extrem three patient patchi alopecia blood wb sampl punch biopsi materi subset ss patient assai presenc tp dna polymeras gene pola target realtim qualit quantit pcr method twelv wb sampl studi quantifi tp dna rang tp pola copiesml blood posit wb dna extract hour collect tp dna skin biopsi test strain type analysi attempt skin wb sampl detect tp dna arp repeat size analysi tpr rflp pattern strain type identifi d wb sampl suffici dna type clinic microbiolog observ present cali syphili seropreval data provid addit evid vener syphili highli endem region colombia underscor health care provid region acut awar clinic manifest ss studi time quantit evid proport untreat ss patient substanti number circul spirochet tp persist blood skin ss patient despit presenc circul treponem opson antibodi robust proinflammatori cellular immun respons characterist stage diseas fulli understood requir studi
PLoS One	19047579	2001-08-15	PMC2872666	20502691	background sever diseas patient infect pandem influenza viru unclear methodologyprincip find cellular immunolog profil blood detail clinic postmortem find three patient rapidli progress infect includ pregnant patient di strike find reduct natur killer nk cell preserv activ effector cd lymphocyt viraemia patient nk cell comparison control group suggest reduct nk cell uniqu sever patient conclusionsignific report markedli reduc nk cell three patient sampl rais hypothesi nk role lymphocyt control viral burden host confront influenza viru subtyp
BMC Res Notes	11462055	2006-04-26	PMC2873344	20398263	background limit number speci specif antibodi fish protein differenti gene express analys vital studi host immun respons quantit realtim revers transcript pcr qrtpcr power tool purpos accuraci method will depend care select gene express stabl intern control experiment set find express stabil commonli housekeep gene betaactin actb elong factor alpha efa ubiquitin ubq glyceraldehydphosph dehydrogenas gapdh tubulin alpha tuba monitor salmonid cell line chse rt infect fastidi fish pathogen facult bacterium piscirickettsia salmoni aquabirnaviru ipnv infecti pancreat necrosi viru genorm analysi ubq efa appear stabl efa upregul late stage salmoni infect rt actb good perform case consid three stabl gene panel contrast infectiondepend differenti regul gapdh tuba demonstr conclus base data present cell cultur model chse rt initi choic ubq actb efa refer gene qrtpcr assai studi salmoni ipnv host immun respons
Virol J	16641296	2009-04-13	PMC2873380	20433729	thi studi evalu effici pediatr midturbin nasal flock swab parent children ag month year sign symptom respiratori diseas nasal sampl collect child randomis sequenc train pediatrician parent realtim polymeras chain reaction influenza viru detect rate sampl collect method cohen kappa cycl threshold valu comparison pediatriciancollect sampl sensit specif parent collect confid interv ci ci posit neg predict valu ci ci children satisfi parent collect median valu standard deviat find midturbin nasal flock swab design infant children parent reduc influenza viru detect rate direct involv parent increas patient accept simplifi collect suggest novel swab design consid epidemiolog survei vaccin efficaci studi
PLoS One	19364769	2013-01-01	PMC2873403	20502660	background toronto sar outbreak sarscov transmit hospit despit adher infect control procedur consider controversi procedur behaviour associ greatest risk sarscov transmiss method retrospect cohort studi conduct identifi risk factor transmiss sarscov intub laboratori confirm sar patient hcw involv care sar patient requir intub toronto outbreak identifi hcw provid care intub sar patient treatment transport enter patient room direct patient contact hour hour intub elig studi data collect patient chart review hcw intervieweradminist questionnair gener estim equat gee logist regress model classif regress tree cart identifi risk factor sar transmiss laboratoryconfirm intub sar patient identifi hcw involv care particip studi sarscov transmit hcw patient hcw infect patient multivari gee logist regress model presenc room fiberopt intub ecg unprotect ey contact secret patient apach ii score patient pafi ratio associ increas risk transmiss sarscov cart analys covari explain greatest amount variat sarscov transmiss covari repres individu patient conclus close contact airwai sever patient failur infect control practic prevent exposur respiratori secret associ transmiss sarscov rate transmiss sarscov vari patient
BMC Genomics	23207147	2015-07-10	PMC2873475	20403183	background ferret mustela putoriu furo repres attract anim model studi respiratori diseas includ influenza despit biomed number reagent molecular immunolog analysi restrict parallel sequenc effort produc extens est express sequenc tag dataset deriv normal ferret cdna librari mrna ferret blood liver lung spleen brain produc sequenc read assembl partial ferret gene gene combin ferret sequenc genbank develop ferret specif microarrai platform arrai detect tissu specif express pattern confirm quantit real time pcr assai set ferret gene transcript profil test tissu indic housekeep gene conclus tool develop studi allow function genom analysi develop reagent ferret model possibl
J Biomed Sci	26160613	2002-04-15	PMC2873498	20426849	background urgent develop innov therapi control advanc cancer combin antigenspecif immunotherapi employ immunomodulatori agent emerg plausibl approach control advanc cancer method current studi explor combin dna vaccin encod calreticulin crt link human papillomaviru type hpv antigen crte tlr agonist imiquimod abil gener especif immun respons antitumor effect tumorbear mice observ treatment crte dna combin imiquimod lead enhanc especif cd cell immun respons decreas number myeloidderiv suppressor cell tumor microenviron tumorbear mice treatment crte dna combin imiquimod lead improv antitumor effect prolong surviv treat mice addit treatment imiquimod led increas number nk cell cell tumor microenviron macrophag nk cell plai role antitumor effect mediat treatment crte dna combin imiquimod conclus data suggest combin therapeut hpv dna vaccin topic treatment tlr agonist imiquimod enhanc antitumor immun induc dna vaccin current studi implic futur clinic translat
BMC Public Health	11907209	2008-10-01	PMC2874530	20385030	background effici plan appropri public health intervent epidem govern consider factor gener popul knowledg epidem fear psycholog respons level complianc govern measur commun trust sourc survei french gener popul rare method crosssect studi conduct in repres sampl subject live rhnealp region southeast franc investig selfreport knowledg infecti diseas anxieti gener epidem risk refer avian influenza data reaction epidem confid level sourc collect respond knowledg aid avian influenza respond adequ knowledg avian influenza percentag higher inhabit ain district avian influenza epidem report express anxieti diseas total respond knowledg avian influenza state chang behaviour epizooti epidem perceiv real threat respond event highli contagi outbreak major respond follow advic author studi popul express high level confid physician scientist strong reserv politician deputi media conclus survei conduct month avian influenza outbreak epidem perceiv major threat studi popul the event highli infecti diseas popul compli advic public author
BMC Bioinformatics	18632980	2012-06-15	PMC2874555	20423529	background updat am algorithm identif posttransl modif ptm site protein base sequenc artifici neural network ann method queri protein sequenc dissect overlap short sequenc segment ten physicochem featur describ amino acid residu long segment repres point dimension space databas sequenc segment confirm experi posttransl modif site train set ann effici classif type modif predict power method estim recal sensit precis valu area receiv oper characterist roc curv leaveoneout test loocv differ perform differ optim neural network observ am tool integr heterogen classif scheme singl consensu scheme boost precis recal valu independ ptm type comparison current stateofth art method conclus standalon version am present effici indentifi posttransl modif proteom train dataset precompil binari am tool sourc code httpcodegooglecompautomotifserv apach licens scheme
PLoS Med	22706063	2018-07-02	PMC2876121	20520802	in wake sar epidem hn pandem plo medicin editor journal publish effici mechan share
PLoS Pathog	29967306	2009-06-08	PMC2880586	20532161	rotavirus lead sever dehydr diarrhea children worldwid rotavirusinduc immun respons cell respons extens character innat immun mechan involv control rotaviru infect increas level system type interferon ifn correl acceler resolut rotaviru diseas multipl rotaviru strain includ rhesu rotaviru rrv demonstr antagon type ifn product varieti epitheli fibroblast cell type mechan includ degrad multipl interferon regulatori factor viral nonstructur protein report demonstr stimul highli purifi primari human peripher plasmacytoid dendrit cell pdc live inactiv rrv induc substanti ifn product subset pdc rrv replic character pdc respons viral stimulu flow cytometri luminex reveal rrv replic small subset human primari pdc rrvpermiss small subset ifn product diminish pdc activ matur observ independ viral replic enhanc cell viru replic product ifn pdc rrv exposur requir viral dsrna surfac protein viral replic activ trypsin cleavag vp demonstr minor subset purifi primari human peripher pdc permiss rrv infect pdc retain function rrv stimulu addition studi demonstr trypsinindepend infect primari peripher cell rotaviru allow establish extraintestin viremia antigenemia importantli data provid evid ifn induct primari human pdc dsrna viru simultan demonstr impair ifn product primari human cell rrv replic rotaviru infect primari human pdc power experiment system studi mechan underli pdcmediat innat immun viral infect reveal novel dsrnadepend pathwai ifn induct
Virol J	19506055	2003-01-15	PMC2880969	20433759	a multiplex revers transcriptionnest polymeras chain reaction rtnpcr method develop detect differenti wildtyp vaccin strain canin distemp viru cdv pair primer p specif cdv correspond highli conserv region cdv genom common primer pair firstround pcr nest pcr primer specif cdv wildtyp strain forward primer common revers primer second round nest pcr primer p specif cdv wildtyp strain vaccin strain forward primer common revers primer second round nest pcr fragment bp amplifi vaccin strain genom rna fragment bp wildtyp strain genom rna rtnpcr fragment bp bp amplifi mix sampl vaccin wildtyp strain amplif achiev uninfect cell cell infect newcastl diseas viru ndv canin parvoviru cpv canin coronaviru ccv rabi viru rv canin adenoviru cav rtnpcr method detect field sampl suspect canin distemp heilongjiang jilin provinc sampl shandong provinc result sampl wildtypelik vaccinestrainlik rtnpcr method effect detect differenti wildtyp cdvinfect dog dog vaccin cdv vaccin clinic detect epidemiolog surveil
BMC Infect Dis	12502800	2011-12-22	PMC2881921	20459845	background influenza includ avian influenza major public health threat develop develop countri rapid accur detect kei compon strategi spread infect effici diagnosi influenzalikeil essenti protect health infrastructur event major influenza outbreak method develop multiplex pcr mtpcr assai simultan diagnosi respiratori virus caus influenzalik ill includ specif recognit influenza haemagglutinin subtyp h test clinic specimen diagnost refer laboratori compar standard techniqu sensit specif assai higher individu assai base direct antigen detect standard pcr rang control templat clinic specimen mtpcr assai provid differenti diagnos quantit viru clinic sampl conclus mtpcr power tool differenti diagnosi influenzalik ill clinic diagnost laboratori
PLoS Pathog	22194291	2005-10-27	PMC2883599	20548955	antivir monoclon antibodi mab repres promis therapeut mabsbas immunotherapi conduct consid blunt viral propag therapeut effect independ viru neutral modul endogen immun respons induct longterm antivir immun remain paramount challeng treat chronic infect ask neutral mab addit blunt viral propag exert immunomodulatori effect protect outcom support idea report mice infect frcase murin retroviru dai birth die leukemia month mount nonprotect immun respons rapidli subject short immunotherapi neutral mab surviv healthi mount longlast protect antivir immun strong humor cellular immun respons interestingli administ mab mediat lysi infect cell antibodydepend cell cytotox adcc mechan addit form immun complex ic infect cell enhanc antivir ctl respons fcrmediat bind dendrit cell dc importantli endogen antivir antibodi gener mabtreat mice displai properti allow contain viral propag enhanc memori cellular respons disappear administ mab data demonstr neutral antivir mab immunomodulatori agent capabl stimul protect immun last long the treatment role infectedcellsantibodi complex induct mainten protect immun enhanc primari memori antivir tcell respons indic target infect cell virus antibodi crucial elicit effici longlast antivir tcell respons consid design antivir mabbas immunotherapi
BMC Genet	16254327	2013-12-01	PMC2885306	20465856	background polymorph mannosebind lectin gene mbl affect concentr function effici protein haplotypespecif sequenc identifi mbl haplotyp associ enhanc suscept diseas work appli method chromosom gabones european adult three haplotyp group propos phylogenet nomenclatur standard mbl studi major phylogenet branch link polymorph associ high mbl product present high fst valu imbed region high nucleotid divers tajima valu compar small sampl size unphas genotyp data differ haplotyp frequenc estim fu li fst conclus extens test select neutral confirm stochast evolutionari factor major role shape polymorph gene worldwid
Retrovirology	23804121	2011-06-15	PMC2885308	20482880	background platelet associ hiv blood infect individu modul viral dissemin viru directli transmit bloodstream ctype lectin dcsign novel hiv attach factor clec express platelet facilit hiv transmiss platelet tcell studi molecular mechan clecmedi hiv transmiss bind studi solubl protein indic clec contrast dcsign recogn viral envelop protein cellular factor express kidneyderiv cell subsequ analys reveal cellular mucinlik membran glycoprotein podoplanin clec ligand express cell incorpor virion releas cell knockdown podoplanin cell shrna virion incorpor podoplanin requir effici clecdepend hiv interact cell line platelet flow cytometri reveal evid podoplanin express viabl tcell peripher blood mononuclear cell pbmc podoplanin detect hiv infect tcell apoptot bystand cell hiv infect cultur react antipodoplanin antibodi induct apoptosi cell pbmc suggest unexpect link apoptosi podoplanin express despit absenc detect podoplanin express hiv produc pbmc transmit tcell clecdepend manner indic tcell express unidentifi clec ligand conclus virion incorpor podoplanin mediat clec interact hiv deriv cell incorpor cellular factor respons clecdepend captur pbmcderiv virus evid podoplanin express connect apoptosi find deserv investig
Virol J	21680512	2013-09-17	PMC2885340	20459851	hand foot mouth diseas hfmd common contagi diseas children mild lifethreaten manifest caus enterovirus coxsackievirus human enteroviru hev highli variabl clinic manifest spring larg unpreced hfmd outbreak fuyang citi anhui provinc central southeastern china high aggreg fatal case studi epidemiolog clinic investig laboratori test genet analys perform identifi causal pathogen outbreak case report march hospit sever fatal hev confirm etiolog pathogen outbreak phylogenet analys entir vp capsid protein sequenc fuyang hev isol belong cluster subgenotyp addit genet recombin region rnadepend rna polymeras major compon viral replic complex genom fuyang hev strain coxsackieviru cva recombin viru conclus emerg recombin hev respons hfmd outbreak fuyang citi china 
BMC Infect Dis	24045953	2016-12-15	PMC2885389	20462419	background avian influenza ai public health challeng ongo spread pandem potenti nonpharmaceut measur prevent spread ai pandem effect measur depend behaviour popul risk percept central element chang behaviour studi aim investig perceiv vulner sever precautionari behaviour ai netherland consecut survei trend risk percept selfreport precautionari behaviour method webbas survei conduct includ respond oneyear period time trend analyz linear regress analys multivari analysi studi determin precautionari behaviour infect ai consid sever health problem score scale perceiv vulner lower score perceiv sever remain high perceiv vulner decreas oneyear period cover half respond report prevent measur report stai wild bird poultri multivari logist regress analysi factor associ prevent measur time survei higher ag lower level educ nondutch ethnic vaccin influenza higher perceiv sever higher perceiv vulner higher efficaci lower level knowledg ai think ai efficaci stronger predictor precautionari behaviour seldom ai ci compar ai ci conclus fact perceiv sever ai appear high remain time offer good point departur specif risk commun promot precautionari action commun aim improv knowledg diseas prevent action focu perceiv person vulner efficaci prevent measur
PLoS One	28087713	2011-04-13	PMC2885414	20559424	background declin serum concentr hydroxyvitamin fall winter distanc increas equat factor season increas preval influenza viral infect studi determin serum hydroxyvitamin concentr correl incid acut viral respiratori tract infect methodologyfind prospect cohort studi serial monthli concentr hydroxyvitamin measur fall winter healthi adult blind natur substanc measur particip evalu develop acut respiratori tract infect investig blind hydroxyvitamin concentr incid infect particip concentr vitamin determin ninetyf enrol particip complet studi light skin pigment lean bodi mass supplement vitamin correl higher concentr hydroxyvitamin concentr ngml associ twofold reduct risk develop acut respiratori tract infect mark reduct percentag dai conclusionssignific mainten hydroxyvitamin serum concentr ngml higher reduc incid acut viral respiratori tract infect burden ill caus fall winter temper zone find studi provid direct call futur intervent studi examin efficaci vitamin supplement reduc incid sever specif viral infect includ influenza gener popul subpopul lower hydroxyvitamin concentr pregnant women dark skin individu obes
BMC Genomics	21490188	2005-07-13	PMC2886062	20423525	background glycyrrhiza uralensi popular medicin plant flavor food tobacco limit genom transcriptom data biosynthet pathwai glycyrrhizin major bioactiv compound uralensi current unclear identif candid gene involv glycyrrhizin biosynthet pathwai will contribut understand biosynthet medicin chemistri compound gs flx platform titanium regent produc substanti express sequenc tag est dataset veget organ uralensi total est averag read length bp gener est combin uralensi est genbank combin est assembl uniqu sequenc contig singleton total uniqu gene element repres independ transcript annot blast search evalu swissprot kegg tair nr nt databas assembl sequenc annot gene name gene ontolog term respect gene glycyrrhizin metabol gene encod enzym total step glycyrrhizin skeleton synthesi pathwai identifi novel gene encod cytochrom enzym glycosyltransferas glycyrrhizin metabol total unigen homolog cytochrom ps glycosyltransferas cytochrom candid gene classifi cyp famili glycosyltransferas candid gene classifi categori analysi final cytochrom enzym glycosyltransferas select candid involv glycyrrhizin biosynthesi organspecif express pattern analysi base realtim pcr conclus gs flx platform titanium reagent studi highqual est databas uralensi base est analysi novel candid gene secondari metabolit pathwai glycyrrhizin includ novel gene encod cytochrom ps glycosyltransferas assist organspecif express pattern analysi unigen encod cytochrom ps unigen encod glycosyltransferas select candid involv glycyrrhizin biosynthesi
J Gen Virol	16014939	2001-03-01	PMC2886958	18931070	although group coronavirus sever acut respiratori syndromecoronaviru sarscov nl receptor angiotensin convert enzym ac entri host cell despit common receptor consequ entri sever respiratori distress case sarscov frequent mild respiratori infect nl wholli recombin system investig abil viru receptorbind protein spike protein bind ac solut cell surfac assai find nl protein weaker interact ac sarscov protein solut bind residu requir contact confirm acebind site nl li residu loweraffin interact ac partli explain patholog consequ infect sarscov nl
PLoS One	11238222	2011-09-07	PMC2887847	20585451	background decad increas interest lactic acid bacteria mucos deliveri vehicl vaccin antigen microbicid therapeut investig mechan mucos vaccin base recombin lactic acid bacteria break immunolog toler gut order elicit protect immun respons methodologyprincip find analyz lipid modif ospa local antigen deliveri vehicl number biochemistri techniqu examin ospaexpress plantarum break oral toler gut stimul human intestin epitheli cell peripher blood mononuclear cell monocyt deriv dendrit cell measur cytokin product leader peptid ospa target protein cell envelop plantarum respons protein export membran mutat lipid site ospa redirect protein local cell envelop lipidatedospaexpress plantarum induc secret proinflammatori cytokin il intestin epitheli cell addit break oral toler gut thth cell mediat immun product pro antiinflammatori cytokin human dendrit cell product igga igg antibodi conclusionssignific lipid modif ospa express plantarum modul immun respons antigen thth immun respons
PLoS Negl Trop Dis	21900533	2009-08-01	PMC2889823	20582307	background import case threaten rabi reemerg rabiesfre area dog human rabi case import franc rabiesfre countri summer event led unpreced media warn french public health director investig medic practic evolut offici elimin rabi impact subsequ episod rabi import nation newspap coverag demand deliveri antirabi prophylaxi regular transmiss epidemiolog develop french antirabi medic center armc network armc discuss indic rabi postexposur prophylaxi rpep methodologyprincip find annual data collect nation refer center rabi nrcr exhaust databas armc analyz weekli number patient consult armc rpep antirabiesimmunoglobulin arig prescript rate determin autoregress integr movingaverag model regress autocorrel error appli examin episod rabi event nation newspap coverag demand deliveri rpep slight continu declin rabiesded public health facil attend observ summer event patient consult rpep arig prescript increas elev medic resourc persist despit commun effort secondari human anim case conclus find demonstr appropri respons reemerg rabi case effect newspap report secondari case occur ensu demand medic resourc longlast effect rabiesrel public health resourc expens henceforth face event decisionmak anticip broad impact media commun counter emerg risk maintain optim public health organ implement postcrisi commun strategi
PLoS Negl Trop Dis	19728527	2007-12-26	PMC2889824	20582308	viral fusogen envelop protein target develop inhibitor viral entri report approach comput design peptid inhibitor dengu viru denv envelop protein highresolut structur data preentri dimer form protein predict strategi comput optim bind pseudoenergi design multipl peptid sequenc low micromolar viral entri inhibitori activ activ peptid dnopt oan design displac region domain ii hing domain idomain ii beta sheet connect fifti percent inhibitori concentr focu form unit assai antivir peptid interfer viruscel bind interact directli protein chang viral surfac biolay interferometri cryoelectron microscopi peptid character intermedi state membran fusion process investig denv receptor molecul lead compound drug discoveri
BMC Cancer	18160451	2001-03-15	PMC2891641	20537192	background genet test hereditari colorect cancer hcrc psycholog consequ test recipi prospect longitudin studi investig factor predict psycholog resili adult undergo genet test hcrc method longitudin studi carri april august hong kong chines hcrc famili member recruit offer genet test hereditari gastrointestin cancer registri determin psycholog outcom genet test selfcomplet questionnair administ predisclosur baselin week month year result disclosur valid psycholog inventori cognit style hope measur baselin psycholog distress depress anxieti measur time point particip subject individu men women ag year fap hnpcc famili complet studi includ mutat gene carrier pattern outcom trajectori creat establish norm outcom measur depress anxieti includ chronic dysfunct recoveri delai dysfunct and resili logist regress analys conduct hope baselin predict resili depress anxieti emploi outcom indic small number particip chronic dysfunct delai dysfunct group combin nonresili group comparison resili group subsequ analysi low frequenc particip exhibit recoveri trajectori anxieti depress exclud analysi regress equat baselin hope predictor resili outcom trajectori depress depress anxieti anxieti conclus current find hope predict resili hcrc genet test hong kong chines intervent increas level hope benefici psycholog adjust crc genet test recipi
BMC Infect Dis	11222704	2011-03-01	PMC2891756	20509887	background sar pandem hong kong panic worri preval commun gener public avoid stai public area avoid behavior greatli impact daili routin commun local economi studi examin preval avoid behavior avoid go visit crowd place visit hospit neg psycholog respons gener popul hong kong initi stage hn epidem method sampl respond recruit populationbas survei random telephon number respond complet structur questionnair telephon interview precommun spread phase hn epidem hong kong studi respond current avoid go visit crowd place hospit whilst felt worri contract hn sign emot distress femal older respond unconfirm belief mode transmiss feel worri emotion distress hn outbreak adopt avoid behavior perceiv high sever suscept hn doubt adequaci government prepared feel emotion distress conclus preval avoid behavior high cognit includ unconfirm belief mode transmiss perceiv sever suscept associ avoid behavior emot distress variabl public health educ provid clear messag rectifi relev percept
Acta Vet Scand	21233434	2014-04-23	PMC2891787	20525326	background bovin respiratori syncyti viru brsv bovin corona viru bcv cattl worldwid object evalu effect infect gener health reproduct paramet measur herd level explor associ antibodi statu herd characterist method collect pool milk sampl primipar cow swedish dairi herd septemb sampl analys immunoglobulin antibodi bcv brsv indirect enzymelink immunosorb assai herd level data septemb august access retrospect locat herd map geograph system ten herd antibodi neg virus compar herd posit bcv brsv posit herd higher bulk tank milk somat cell count bmscc compar neg herd median analyz health reproduct paramet consist favour herd neg virus differ statist higher proport herd profession technician artifici insemin farm personnel herd neg bcv compar posit herd conclus result herd antibodi posit bcv andor brsv higher bmscc compar herd neg bcv brsv tendenc neg herd better gener herd health compar posit higher proport bcv neg herd extern technician ai farm personnel indic avoid infect regular visit neg herd locat close proxim posit herd indic local spread airborn transmiss herd great herd stai free infect transmiss viru circul area
PLoS One	23529928	2004-09-27	PMC2891989	20585574	background hospitalacquir infect nosocomi pneumonia seriou mortal hospit patient admit intens care unit icu despit number studi report caus agent pneumonia complet molecular techniqu veget tobacco dna detect bronchoalveolar lavag patient ventilatorassoci pneumonia vap methodologyprincip find studi studi bronchoalveolar lavag bal patient admit icu ventilatorassoci pneumonia bal fluid assess molecular test cultur blood cultur identifi plant dna patient ventilatorassoci pneumonia inhal confirm case suspect case inhal frequent patient plant dna patient plant dna three patient nicotiana tabacum chloroplast dna identifi three patient smoker case cucurbita pepo moru bombyci triticum aestivum dna identifi case twentythre bacteri speci virus fungal speci identifi patient molecular cultur techniqu pathogen microorgan identifi report foodborn tobacco plantassoci pathogen conclusionssignific studi plant dna identifi bal fluid pneumonia patient explor aspir pneumonia signific presenc plant dna role pathogenesi pneumonia unknown remain investig identif plant potenti marker aspir patient pneumonia
PLoS One	15452254	2011-03-28	PMC2892040	20585587	background prgag gag polyprotein hiv serv scaffold virion assembl essenti progeni virion bud matur gag local plasma membran pm membran late endosom allow releas infecti viru directli cell membran andor exocytosi host factor involv gag traffick site unknown activ cd cell primari target hiv infect express class ii transcript activ ciita mhc class ii isotyp hladr gag hladr local pm membran endosom special vesicular mhc class ii compart miic hiv produc cell transient hladr express induc intracellular gag accumul impair viru releas methodologyprincip find demonstr stabl transient express ciita hiv produc cell induc hladrassoci intracellular retent gag increas infect virion phenomena recapitul class ii antigen present pathwai ciitamedi transcript activ viru gene interestingli demonstr ciita apart transcript effect act cytoplasm enhanc prgagpol gagpol level viral proteas gag process account increas infect virion ciitaexpress cell conclusionssignific studi demonstr ciita enhanc hiv gag process evid novel posttranscript cytoplasm function wellknown transactiv
Virol J	21444809	2005-11-01	PMC2892456	20515509	a duplex realtim revers transcriptas polymeras chain reaction rtpcr assai improv simultan detect highli pathogen hn avian influenza viru pandem hn influenza viru suitabl earli diagnosi influenzalik patient epidemiolog surveil sensit duplex realtim rtpcr assai tcid tissu cultur infect dose hn tcid pandem hn singletarget rtpcr pandem hn sensit hn primer probe cross reactiv detect subtyp influenza virus respiratori tract virus observ thirtysix clinic specimen test compar singl realtim rtpcr result duplex assai consist singl realtim rtpcr sequenc analysi
PLoS One	16272506	2012-06-08	PMC2892467	20592764	public health administr effect model predict excess influenzaassoci mortal monitor viral chang associ studi evalu matchingmismatch vaccin strain typesubtyp pattern chang taiwan influenza virus impact postsar sever acut respiratori syndrom public health effort excess influenzaassoci mortal elderli neg binomi model develop estim taiwan monthli influenzaassoci mortal elderli calcul three winter annual excess influenzaassoci mortal pneumonia influenza pi respiratori circulatori allcaus influenza season obtain influenza viru sequenc monthsyear death pi excess investig molecular variat vaccinemismatch influenza virus compar hemagglutinin ha circul vaccin strain higher isol rate hn vaccinemismatch influenza virus greater monthli pi mortal posit associ neg higher match hn public health effort postsar excess pi mortal winter higher year sd analysi reveal vaccinematch circul influenza virus associ lower excess pi mortal postsar winter presar winter stratif vaccinematch postsar substanti trend lower elderli excess pi mortal winter mismatch vaccin postsar period match vaccin presar period importantli three excess mortal highest interhospit nosocomi infect peak vaccinemismatch hn virus circul year high excess pi mortal exhibit lower amino acid ident percentag ha vaccin circul strain higher number variat epitop model help futur decis maker estim excess pi mortal effect select test viru strain antigen variat evalu public health strategi effect
PLoS One	22685135	2010-03-01	PMC2892511	20593027	varicellazost viru vzv glycoprotein ge essenti viru infect bind cellular receptor insulindegrad enzym id uniqu amino termin extracellular domain previou work id plai role vzv infect viru celltocel spread sole rout vzv spread vitro report recombin solubl id ride enhanc vzv infect earli step infect associ increas viru intern increas celltocel spread vzv mutant lack id bind domain ge impair syncytia format membran fusion pretreat cellfre vzv ride markedli enhanc stabil viru rang condit ride interact ge elicit conform chang ge render suscept proteolysi coincub ride ge modifi size ge propos conform chang ge elicit id enhanc infect stabil viru lead increas fusogen vzv infect abil ride enhanc infect cellfre vzv wide rang incub time temperatur suggest ride increas stabil varicella zoster vaccin
Virol J	20070197	2016-06-16	PMC2893155	20470403	background year attent spread influenza continu human outbreak hn hn pandem focu influenza respiratori virus increas accept decad intern travel jet aircraft major vector global spread influenza epidemiolog differ tropic temper region observ want studi indoor environment condit enclos locat tropic winter temper zone contribut aerosol spread influenza travel survei consist read temperatur versu rel humid rh enclos locat air travel visit tropic nation compar read australian citi includ ground transport hotel shop offic publicli access locat time cours read aircraft influenza transmiss risk contour map develop versu rh empir equat creat estim risk rel temperatur rh time parameter influenza transmiss risk transmiss risk contour equat transmiss risk countri locat compar influenza report countri higher risk enclos locat tropic includ automobil transport luxuri buse luxuri hotel bank branch temper locat high risk conclus environment control recommend public health mitig focus higher risk enclos locat public health method develop track potenti vulner aerosol influenza method present influenza model account differenti aerosol transmiss rh explain anomali influenza epidemiolog addit season temper climat
PLoS One	27312869	2008-06-25	PMC2893165	20596532	background function role elrposit cxc chemokin viral induc demyelin assess inocul neuroattenu jhm strain mous hepat viru jhmv cn suscept mice acut encephalomyel evolv chronic demyelin diseas model white matter patholog observ human demyelin diseas multipl sclerosi methodologyprincip find jhmv infect induc rapid sustain express transcript specif elr chemokin ligand cxcl cxcl bind receptor cxcr enrich spinal cord chronic infect inhibit cxcr signal neutral antiserum delai clinic recoveri cxcr neutral associ increas sever demyelin independ viral recrudesc modul neuroinflamm block cxcr associ increas number apoptot cell white matter tract suggest oligodendrocyt jhmv infect enrich oligodendrocyt progenitor cell opc cultur reveal apoptosi associ elev express cleav caspas mute bcl express inclus cxcl jhmv infect cultur restrict caspas cleavag increas bcl express associ decreas apoptosi cxcr defici oligodendrocyt refractori cxcl mediat protect jhmv induc apoptosi activ caspas regul bcl conclusionsignific find highlight unappreci role cxcr signal protect oligodendrocyt lineag cell apoptosi inflammatori demyelin initi viral infect cn
PLoS One	18579604	2012-07-30	PMC2893203	20596536	background midjun state victoria australia appear highest notif rate pandem hn influenza hypothesis commun transmiss pandem influenza establish victoria time test novel viru commenc contrast true pandem part australia includ western australia wa method data detail case followup patient confirm infect victoria wa demonstr differ pandem curv australian state opposit side contin model pandem state susceptibleinfectedremov model bayesian infer account import case epidem transmiss occur earlier victoria wa victorian case local acquir three brother famili contrast case wa associ import victoria plausibl model input data estim effect reproduct number victorian epidem requir invok earlier commenc transmiss explain observ data requir model epidem wa conclus strong circumstanti evid support model suggest commun transmiss pandem influenza establish victoria wa time test novel viru commenc australia viru enter victoria establish time identifi mexico
PLoS One	22847428	2015-08-01	PMC2894058	20613878	acid depend infect hela vero cell btv occur earlyendosom viru uptak clathrinmedi endocytosi forzan al virol report btv infect bhk cell depend low endosom ph viru entri infect inhibit dominantneg mutant ep ap aa splice variant dynamin inhibit clathrinmedi endocytosi addit infect inhibit deplet cellular cholesterol suggest viru entri mediat lipidraft depend process caveolaemedi endocytosi viru entri infect inhibit dominantneg dynamin mutant entri inhibit gener dynamin inhibitor dynasor indic viru entri dynamin depend entri btv colocalis lamp transferrin suggest viru deliv lateendosom compart pass earlyendosom btv entri infect inhibit eipa cytochalasind macropinocytosi inhibitor entri viru colocalis dextran marker macropinocytosisfluidphas uptak extend earlier observ btv btv infect bhk cell entri mechan clathrin cholesterolindepend requir dynamin share characterist common macropinocytosi
PLoS One	26293869	2019-04-04	PMC2894071	20614006	porcin reproduct respiratori syndrom prr econom diseas swine industri worldwid great econom loss year prr viru prrsv replic porcin alveolar macrophag pam dendrit cell dc develop persist infect antibodydepend enhanc ad interstiti pneumonia immunosuppress molecular mechan prrsv infect understood report genomewid host transcript respons classic north american type prrsv nprrsv strain ch infect solexaillumina digit gene express dge system tagbas highthroughput transcriptom sequenc method analys systemat relationship pulmonari gene express profil nprrsv infect infect patholog nprrsv appear util multipl strategi replic spread infect pig includ subvert host innat immun respons induc antiapoptot antiinflammatori state develop ad upregul express virusinduc proinflammatori cytokin chemokin adhes molecul inflammatori enzym inflammatori cell antibodi complement activ result develop inflammatori respons nprrsv infect process nprrsvinduc immunosuppress mediat apoptosi infect cell caus deplet immun cell induc antiinflammatori cytokin respons unabl erad primari infect system analysi will benefit better understand molecular pathogenesi nprrsv infect develop novel antivir therapi identifi genet compon swine resistancesuscept prr
Virol J	31285696	2005-05-01	PMC2894783	20478047	background sever acut respiratori syndromeassoci coronaviru sarscov spread rapidli high casemort rate nucleocapsid protein np sarscov critic pathogen studi sought discov host protein interact sarscov np surfac plasmon reson biomolecular interact analysi sprbia matrixassist laser desorptionion time flight malditof mass spectrometri proteasom subunit human fetal lung diploid fibroblast bs cell bound sarscov np interact confirm glutathion stransferas gst fusion protein pulldown techniqu coloc signal sarscov np proteasom subunit bs cell detect indirect immunofluoresc confoc microscopi subunit proteasom larg multiprotein complex compon ubiquitinproteasom pathwai involv varieti basic cellular process inflammatori respons conclus knowledg report sarscov np interact proteasom subunit host cell data enhanc understand molecular mechan sarscov pathogen sarscov interact host cell
BMC Infect Dis	15963171	2011-12-01	PMC2894833	20504379	background infecti diseas surveil laboratori confirm case timeconsum time lag number suspect case number confirm case studi propos dynam statist model estim daili number case daili cumul number infect case appli histor dengu fever data method durat diseas onset laboratori confirm assum follow gamma distribut nonparametr distribut condit probabl case real case unconfirm case calcul probabl observ confirm case integr estim daili number case cumul number infect case distribut onsettoconfirm time posit case neg case daili case cumul epidem curv estim propos method lower absolut rel bia valu estim sole base dailyconfirm case conclus propos method accur realtim estim daili case daili cumul number infect case model move window rel suspect case dynam updat paramet propos method will realtim evalu diseas outbreak case classif requir timeconsum laboratori process identifi confirm case
BMC Biol	22105170	2016-05-11	PMC2895587	20619006	blood pipelin immun system assess chang transcript abund blood genomewid scale afford comprehens view statu immun system health diseas review summar work approach identifi therapeut target biomark signatur field autoimmun infecti diseas technolog methodolog advanc will carri blood transcriptom field forward discuss
PLoS Pathog	27170754	2017-06-21	PMC2895667	20617182	reoviru infect lead apoptosi cultur cell murin central nervou system cn nfbdriven transcript proapoptot cellular gene requir effector phase apoptot respons extrins deathreceptor signal pathwai intrins pathwai involv mitochondri injuri implic reovirusinduc apoptosi mechan pathwai activ relationship nfb signal reoviru infect unknown proapoptot bcl famili member bid activ proteolyt cleavag reoviru infect understand reoviru integr host signal circuit induc apoptosi examin proapoptot signal infect biddefici cell reoviru growth absenc bid cell lack bid fail undergo apoptosi nfb activ requir bid cleavag subsequ proapoptot signal examin function signific biddepend apoptosi reoviru diseas monitor fatal enceph caus reoviru presenc absenc bid surviv biddefici mice enhanc comparison wildtyp mice peror intracrani inocul reoviru decreas reoviru virul bidnul mice accompani reduct viral yield find defin role nfbdepend cleavag bid cell death program initi viral infect link bid viral virul
BMC Public Health	28637754	2014-08-01	PMC2896940	20529345	background asiapacif southeast asia receiv substanti attent anticip epicentr pandem activ invest earlier review pandem prepared plan region reveal translat strateg plan oper plan lack countri low resourc object studi understand pandem prepared programm health system context challeng constraint specif asian countri cambodia indonesia lao pdr taiwan thailand viet nam prepandem phase start hn method studi reli system rapid assess sysra toolkit evalu prioriti diseas programm account programm gener health system wider sociocultur polit context compon review extern context stewardship organis arrang financ resourc gener alloc healthcar provis system qualit quantit data collect second half base review publish data interview kei inform explor current pattern health programm pandem respons studi health system countri vari regard epidemiolog context health care financ health servic provis pattern pandem prepar countri develop nation govern pandem prepared nation pandem influenza prepared plan avian human influenza ahi respons plan govern arrang natur plan differ develop countri focu surveil rapid contain poultri transmiss prepar pandem stage limit interfac linkag health system context pandem prepared programm countri explor conclus health system context influenc countri prepar pandem time invest pandem prepar asian countri contribut improv health system surveil laboratori capac monitor evalu public commun number suggest improv present strengthen pandem prepar mitig overcom underli health system constraint
BMC Evol Biol	25171002	2012-07-01	PMC2898692	20565983	background vast sequenc diverg viru group present great challeng alignmentbas analysi viru phylogeni problem caus uncertainti align exist tool phylogenet analysi base multipl align directli appli wholegenom comparison phylogenom studi virus grow interest alignmentfre method phylogenet analysi complet genom data alignmentfre method dynam languag dl method propos group appli phylogenet analysi bacteria chloroplast genom paper dl method analyz wholeproteom phylogeni larg dsdna virus parvovirus data set larg differ genom size tree analys good agreement latest classif larg dsdna virus parvovirus intern committe taxonomi virus ictv conclus method recov phylogeni larg dsdna virus parvovirus insight affili number unclassifi virus comparison alignmentfre method cv tree method recov phylogeni larg dsdna virus suitabl resolv phylogeni parvovirus smaller genom size
Biol Direct	22944661	2013-06-01	PMC2898770	20565756	background coleth synthet lethal document genet situat separ nonleth mutat lethal combin genom mutat call synthet lethal sl coleth invari posit sl set sl link coupl choic target drug design fastescap rna virus mutat viral escap loss affin drug induc synthet lethal amino acid sequenc align hiv proteas detect potenti sl coupl potenti sl set invari posit structur protein focus close access protein surfac bind put drug align hiv proteas amino acid sequenc identifi potenti sl coupl invari posit appli distanc access filter three candid drug design target flap cantilev fulcrum amino acid posit conclus three replicationcrit target locat activ site kei antiescap strategi biolog evid target posit perform essenti biolog function mutat variat escap antivir medic lethal limit apparit drugresist strain review articl review arcadi mushegian shamil sunyaev clau wilk
Acta Vet Scand	23522610	2014-09-01	PMC2898781	20492637	background bovin coronaviru bcv bovin respiratori syncyti viru brsv infect current widespread swedish dairi cattl popul survei antibodi level bulk tank milk high nationwid preval bcv brsv larg variat region swedish beef cattl popul investig perform preval geograph distribut bcv brsv crosssect serolog survei bcv brsv carri swedish beef cattl explor geograph pattern infect method blood sampl collect anim locat herd analyz presenc antibodi bcv brsv moran calcul assess spatial autocorrel identif geograph cluster perform spatial scan statist anim detect posit bcv brsv predomin locat centralwestern southern part sweden moran indic global spatial autocorrel bcv brsv appear spatial area southern sweden skaraborg skne higher preval bcv area identifi highpreval cluster brsv area southeast sweden kronobergbleking lower preval infect expect bcv brsv area middlewest sweden vrmlanddalarna lower preval brsv area beef herd densiti higher risk highpreval cluster conclus form basi investig betweenherd dynam risk factor infect order design effect control strategi
PLoS Negl Trop Dis	24709055	2009-08-26	PMC2903468	20644615	background venezuelan equin enceph viru veev respons vee epidem occur south central america veev envelop glycoprotein mediat cell membran fusion bind receptor elicit viru neutral antibodi construct e epitop map murin monoclon antibodi mmab epitop ecdefgh bound veevneutr antibodi map amino acid aa human antibodi repertoir veev epitop engag human virusneutr antibodi specif treatment vee virusneutr mmab potent protect therapeut agent mice challeng veev peripher aerosol rout fulli human mab hmab virusneutr activ prevent clinic treatment human vee method phagedisplai isol veevspecif hfab human bone marrow donor hfab character sequenc specif test veev subtyp crossreact indirect elisa vitro viru neutral capac especif neutral hfab fn convert igg bind site identifi competit elisa mmab prepar sequenc antibodi neutralizationescap variant find veevreact hfab construct human epitop map alphavir surfac protein e identifi neutralizationassoci epitop uniqu human immun respons aa resolut cryoelectron microscopi map sindbi viru protein probabl surfac locat human veev epitop conclus veevneutr capac hmab nigg exhibit human mmab hy igg hy igg limit veev infect mice prophylact therapeut administr cocktail fn hy igg bind epitop provid enhanc prophylaxi immunotherapi veev reduc possibl gener harm viru neutralizationescap variant vivo
Mediators Inflamm	19717445	2007-10-31	PMC2903949	20672047	in order establish infect virus suppress escap host immun defens system immunolog focus innat immun host defens pattern recognit molecul tolllik receptor tlr rigilik receptor rlr nodlik receptor nlr microbi compon recogn vagu common molecular shape socal pathogenassoci molecular pattern pamp pamp induc inflammatori reaction mediat activ transcript factor nfb interferon lead antivir immun respons virus capac suppress escap pattern recognit moleculemedi antimicrobi respons wai paper review strategi virus modul pattern recognit moleculemedi innat immun respons
Proteome Sci	17977985	2004-08-18	PMC2904733	20529248	background hepat viru hbv major liver infect human lack appropri cell cultur system support hbv infect effici cellular molecular mechan hepadnaviru infect remain incomplet understood duck heptat viru dhbv natur infect primari duck hepatocyt pdh provid valuabl model system studi hepadnaviru infect vitro report explor global chang cellular protein express dhbv infect pdh twodimens gel electrophoresi de combin malditoftof tandem mass spectrometri msm effect hepadnaviru infect hepatocyt investig dhbv infect pdh de analysi proteom profil pdh infect dhbv analyz postinfect compar uninfect pdh differenti express protein spot reveal de analysi select protein spot spot identifi correspond protein msm analysi match ortholog protein gallu gallu ana platyrhyncho avian speci includ alphaenolas lamin aconitas cofilin annexin downregul express betaactin annexin confirm western blot analysi potenti role differenti express protein virusinfect cell discuss conclus differenti express protein dhbv infect pdh reveal de involv carbohydr metabol amino acid metabol stress respons cytoskeleton process provid insight understand interact hepadnaviru hepatocyt molecular mechan hepadnaviru pathogenesi
AIDS Res Ther	15315997	2005-02-24	PMC2908552	20604950	background search diseas biomark human peripher fluid favor approach prevent therapeut year comparison normal versu diseas state identifi overexpress suppress critic protein ill directli alter patient cellular homeostasi analysi hiv infect serum attract medium identifi alter protein express eas noninvas method collect sampl correspond insight vivo interact viru infect cellstissu util proteom techniqu global identifi differenti express serum protein respons hiv infect undertak complic innat protein profil human serum deplet of abund serum protein twodimension gel electrophoresi coupl identif protein matrixassist laser desorptionion timeofflight malditof mass spectrometri allow identif differenti express low abund serum protein analyz compar serum sampl hiv infect subject treat highli activ antiretrovir therapi haart latent infect progress aid despit absenc treatment long term nonprogressor ltnp identifi uniqu serum protein differenti express ltnp hiv patient contribut abil patient combat hiv infect absenc haart focus cdk cell cycl inhibitor pinka treatment hiv latent infect cell line pinka decreas viral product despit express endogen cell conclus identif uniqu protein serv indic alter viral state respons infect natur phenotyp variabl respons hiv infect popul
PLoS Pathog	15731233	2012-08-29	PMC2908624	20661432	plasmacytoid dendrit cell pdcmediat protect cytopath viru infect involv molecular cellular tissuescal organismscal event order better understand multiscal interact implement system immunolog approach focus analysi structur dynam oper principl virushost interact constrain initi spread pathogen highresolut experiment data set come welldescrib mous hepat viru mhv model calibr basic modul includ mhv infect primari target cell pdc macrophag ms basic build block gener valid integr mathemat model vivo infect dynam paramet estim system indic capita basi infect pdc secret suffici type ifn protect ms cytopath viral infect extrem high protect capac pdc secur spleen capabl function sink viru produc peripher organ liver pdc popul spleen ensur robust protect viru variant downmodul ifn secret abil pdc protect sever diseas caus viru variant exhibit enhanc liver tropism higher replic rate appear limit system immunolog analysi suggest antivir therapi cytopath virus limit viral replic peripher target organ
BMC Bioinformatics	22933274	2007-08-20	PMC2909221	20584331	background analysi oligonucleotid microarrai data pathogen surveil discoveri challeng task target templat concentr nucleic acid integr host nucleic acid composit profound signal distribut exploratori analysi fluoresc signal distribut clinic sampl reveal deviat normal suggest distributionfre approach appli posit predict fals posit rate examin assess util three wellestablish nonparametr method analysi viral arrai hybrid data mannwhitnei spearman correl coeffici chisquar test three test chisquar prove conclus accept microarrai routin clinic diagnost will requir technolog accompani simpl reliabl analyt method report implement chisquar test yield combin low fals posit rate high degre predict accuraci
PLoS One	17709464	2003-07-01	PMC2909231	20668535	background pneumonia lead infecti diseas killer worldwid burden china understood data publish nonenglish literatur methodologyprincip find systemat review chines englishlanguag literatur studi primari data pneumonia incid mortal mainland china studi met inclus criteria qualiti studi highli variabl children year incid rang episod personyear mortal rang death popul incid mortal stabl decreas studi period higher rural compar urban area conclusionssignific pneumonia continu major public health challeng young children china estim pneumonia incid mortal vari reliabl surveil data prevent effort need achiev document addit declin area higher incid mortal rural set
Algorithms Mol Biol	12843048	2014-01-09	PMC2909241	20573197	background rna exhibit varieti structur configur consid structur tantamount noncross watsoncrick gubas pair secondari structur addit crossseri base pair interact call pseudoknot observ spectrum rna function context studi natur rna structur search ribozym design artifici rna interest find rna sequenc fold specif structur analyz induc neutral network establish invers fold algorithm rnainvers rnassd inforna limit rna secondari structur paper invers fold algorithm inv deal noncross canon pseudoknot structur paper invers fold algorithm inv detail analysi inv includ pseudocod inv allow design noncross nonplanar rna pseudoknot noncross rna structuresa class difficult construct dynam program routin inv freeli httpwwwcombinatoricscncbpcinvhtml conclus algorithm inv extend invers fold capabl rna pseudoknot structur comparison rnainvers idea instanc consid set compet structur result inv find novel sequenc rna secondari structur context compet structur exhibit crossseri interact
Proteome Sci	24407286	2013-12-11	PMC2909931	20534109	background infecti bronchiti viru ibv coronaviru domest chicken caus major econom loss poultri industri complex ibv life cycl small number viral structur protein virushost relationship remain discov goal perform twodimension gel electrophoresi fraction coupl mass spectrometri identif approach perform comprehens proteom analysi purifi ibv particl apart virusencod structur protein detect host protein purifi virion group function categori includ intracellular traffick protein molecular chaperon macromolcular biosynthesi protein cytoskelet protein signal transport protein protein degrad chromosom associ protein ribosom protein function protein interestingli total host protein report virion viru famili major vault protein tenp protein ovalbumin scaveng receptor protein identif host protein proteom method presenc protein purifi ibv prepar verifi western blot immunogold label detect conclus the standard proteom profil ibv facilit understand pathogen mechan
BMC Pediatr	24335315	2012-09-10	PMC2910686	20604923	background pneumonia pneumonia mp report communityacquir pneumonia case aim evalu differ clinic featur children mp ag chest radiograph pattern method diagnosi mp examin admiss discharg serolog test indirect microparticl agglutinin assai cold agglutinin titer total children mp group ag year ag patient year ag patient year ag patient group pneumonia pattern bronchopneumonia group patient segmentallobar pneumonia group patient eightysix patient seroconvert increas antibodi titer hospit three ag group oldest children longest durat fever highest creactiv protein crp valu sever pneumonia pattern patient segmentallobar pneumonia older longer fever durat lower white blood cell wbc lymphocyt count compar with bronchopneumonia patient group sever pulmonari lesion prolong fever highest crp highest rate seroconvert lowest lymphocyt count thrombocytosi observ patient admiss patient discharg conclus mp older children prolong fever sever pulmonari lesion sever pulmonari lesion associ absenc diagnost igm antibodi present lymphocyt count shortterm pair igm serolog test mandatori earli definit diagnosi mp
PLoS One	22966198	2006-03-29	PMC2910733	20676400	adenovir ad vector varieti vaccin applic includ cancer infecti diseas tradition adbas vaccin design express antigen transgen express antigen case convent adbas vaccin suboptim clinic suboptim attribut preexist ad serotyp ad immun order circumv antigen express transgen incorpor antigen capsidincorpor strategi develop adbas vaccin develop context diseas strategi embodi incorpor antigen peptid capsid structur viral vector major capsid protein hexon util capsid incorpor strategi hexon natur role gener antiad immun respons numer represent ad virion strategi develop incorpor heterolog peptid epitop major surfaceexpos domain ad capsid protein hexon studi focus gener multival vaccin vector present hiv antigen ad capsid protein hexon express hiv antigen transgen novel vector util hvr incorpor site twentyfour amino acid region hiv membran proxim ectodomain region mper deriv hiv glycoprotein gp gp studi illustr multival antihiv vector elicit cellular antihiv respons vaccin vector hiv antigen hvr elicit hiv epitopespecif humor immun respons
Health Qual Life Outcomes	16571824	2010-12-01	PMC2911409	20626865	background current studi explor preval depress mood chines undergradu student examin cope pattern degre flexibl flexibl pattern associ mood method set questionnair assess cope pattern cope flexibl depress symptom administ student men women total particip complet entir set questionnair report frequenc stress life event criterion need calcul varianc perceiv control find higher level depress symptom associ higher level event frequenc event impact lower level perceiv control cope effect ratio strategi situat fit depress symptom associ cognit flexibl varianc perceiv control gender moder of report associ conclus find indic chines univers student depress symptom report experienc greater number neg event nondepress univers student addit undergradu depress symptom undergradu util maladapt cope method find highlight potenti intervent aim help undergradu student lower cope flexibl develop skill cope stress life event
BMC Vet Res	21056544	2006-08-29	PMC2912257	20609252	background escherichia coli serogroup emerg zoonot bacteri pathogen caus rang symptom selflimit bloodi diarrhea sever hemorrhag coliti hemolyticurem syndrom human beef dairi cattl consid anim reservoir pathogen virul characterist coli eaea gene encod kda surfac protein intimin intimin requir attach effac interact enterohemorrhag coli human bovin neonat enterocyt studi undertaken test hypothesi adapt mucos immun respons direct intimin will reduc prevent enter colon fecal shed coli cattl cattl oral inocul milk control milk live attenu salmonella enterica serovar dublin vector milk live attenu recombin dublin express intimin vaccin dai dai calv challeng oral coli evalu vaccin recombin dublin express intimin reduc level coli fecal shed dai vaccin calv vector strain intiminexpress dublin strain level vector strain longer period compar level recombin vaccin strain calv receiv intiminexpress vaccin ceas shed dublin dai dai calv challeng coli dai determin fecal shed coli amount coli fece measur dai postchalleng observ transient clearanc coli fece vaccin calv magnitud fecal coli shed correl presenc intiminspecif fecal iga conclus oral vaccin live attenu recombin dublin express intimin reduc enter colon fecal shed coli transient clearanc coli associ enhanc igamedi mucos immun respons
BMC Pediatr	29707364	2013-08-08	PMC2914048	20646293	background sever acut respiratori syndrom sar outbreak toronto outpati clinic sickkid hospit close prevent diseas transmiss respons decis neonat neurodevelopment follow nnfu clinic staff select patient schedul appoint mailtelephon assess ag stage questionnair asq postponeskip visit object studi compar development assess outcom group nnfu clinic patient sar versu nonsar three standard clinic appoint method compar diagnost accuraci identif development delai patient manag referr therapi commun diagnosi strategi sar aprilmai standard assess method patient aprilmai nonsar case data patient visit month compar descript statist patient sar group nonsar patient gestat ag sex entri diagnosi ag clinic visit group nnfu clinic staff mail asq famili sar return contact telephon criteria identifi infant risk select mail asq phone interview clearli defin patient chart identif development delai sar versu respond mail questionnair referr therapi rate nonsar group lost follow rate sar group compar nonsar differ rate development delai group identifi visit conclus poor advanc plan led haphazard assess patient infecti diseas outbreak futur pandem plan consid plan outpati care hospit manag patient
PLoS Negl Trop Dis	23864330	2017-07-12	PMC2914747	20689813	background product nativ antigen serodiagnosi helminth infect labori hamper batchtobatch variat serodiagnosi echinococcosi cystic diseas screen test reli crude purifi echinococcu granulosu hydatid cyst fluid resolv limit associ nativ antigen serolog test standard highli pure antigen produc chemic synthesi offer consider advantag provid appropri diagnost sensit specif achiev methodologyprincip find make grow collect genom proteom data appli set bioinformat select criteria collect protein sequenc includ conceptu translat nucleotid sequenc data tapeworm echinococcu multiloculari echinococcu granulosu approach target alphahel coiledcoil intrins unstructur region parasit protein expos host immun system protein multiloculari protein granulosu peptid amino acid length design peptid chemic synthes spot microarrai screen reactiv sera infect human peptid react cutoff valid enzymelink immunosorb assai elisa peptid identifi fail differenti multiloculari granulosu infect peptid perform best reach sensit specif candid deriv echinococcu multiloculari antigen strong reactiv sera patient infect multiloculari granulosu conclusionssignific studi proof principl discoveri diagnost relev peptid bioinformat select complement screen highthroughput microarrai platform data singl peptid provid suffici diagnost sensit pool peptid antigen improv sensit combin peptid lead diagnost test replac complement convent immunodiagnosi echinococcosi strategi prove diagnost develop pathogen
BMC Public Health	28701392	2016-02-01	PMC2916908	20667076	background effect influenza pandem manag requir understand factor influenc behavior chang aim determin differ knowledg attitud practic cohort explor pertin factor influenc behavior tropic singapor method perform crosssect knowledg attitud practic survei singapor militari midaugust earlyoctob personnel exposur group laboratoryconfirm hn case close contact case healthcar worker gener personnel particip respond ag se year close contact highest knowledg score case highest practic score strong correl knowledg practic score knowledg attitud score predictor higher practic score higher knowledg score malai ethnic exposur group lower educ level predictor higher attitud score malai ethnic higher knowledg score predictor higher knowledg score contact conclus knowledg influenc attitud practic pandem person experi influenc practic behavior effort target educ gener popul improv practic current pandem futur epidem
BMC Public Health	26873679	2011-01-12	PMC2918554	20626872	background influenza pandem higher educ institut larg popul young adult seriou outbreak center outbreak manag essenti diseas control aim examin univers student knowledg attitud pandem influenza ahn vaccin prevent measur method crosssect studi conduct year univers student yeditep univers istanbul turkei st novemb data sociodemograph characterist student percept level knowledg attitud influenza pandem prevent measur collect selfadminist questionnair questionnair distribut student affili sanita univers club student health scienc studi group perceiv person risk influenza high perceiv moder view low indic unknown risk percept male lower femal risk percept student health scienc lower student scienc studi group indic main sourc hn mass media health scienc student tend reli internet sourc student vast major interview indic vaccin major concern vaccin safeti side effect vaccin particip carri prevent measur vast major believ hand wash face mask quarantina effect measur prevent conclus particip knowledg hn pandem diseas gap confus area futur plan manag strategi pandem outbreak higher educ institut strategi develop promot posit health behaviour univers student compat intern guidelin main sourc mass media polici develop attract attent student scientificbas sourc
Virol J	21228244	2013-01-30	PMC2918564	20663162	the bibl describ case woman high fever cure lord jesu christ base provid gospel mark matthew luke diagnosi etiolog febril ill discuss infecti diseas continu threat human influenza dawn human histori postul correct woman fever bibl earli descript human influenza diseas infecti diseas continu threat human influenza dawn human histori analys case high fever happen year ago biblic time discuss etiolog
BMC Public Health	23365447	2014-11-05	PMC2919480	20678192	background earli stage swine flu influenza hn outbreak larg major patient contact health servic ill uk nh direct telephon servic patient qualit interview identifi main reason peopl approach nh direct concern swine flu identifi aspect contact reassur framework approach method patient particip semistructur interview patient telephon nh direct concern swine flu assess ill reason seek advic swine flu includ presenc unexpectedli sever flulik symptom uncertainti catch swine flu concern pressur friend employ seek peac mind particip speak nh direct reassur help aspect includ swine flu rule receiv altern explan symptom clarif swine flu transmit perceiv credibl nh direct report increas anxieti particip subsequ sought addit advic swine flu conclus futur major incid involv form chemic biolog radiolog hazard larg number unexpos peopl seek health advic data provid telephon triag help instanc advic trust preexist servic
BMC Microbiol	25378490	2008-06-25	PMC2919482	20663197	background chlamydia induc persist infect associ wide rang chronic diseas human anim mix infect chlamydia porcin epidem diarrhea viru pedv result gener persist chlamydi infect test hypothesi vitro model dual infect cell cultureadapt pedv chlamydia abortu chlamydia pecorum vero cell establish infect cultur investig immunofluoresc transmiss electron microscopi tem reinfect experi chlamydiainfect cell normal inclus hpi dual infect chlamydia abortu reveal heterogen mix inclus type includ small inclus consist aberr bodi ab mediums inclus consist ab reticul bodi normal inclus aberr inclus observ dual infect experi chlamydia pecorum pedv tem examin mix infect chlamydia abortu chlamydia pecorum reveal aberr chlamydi inclus reticulatelik pleomorph ab diamet redifferenti elementari bodi eb detect reinfect experi coinfect cell produc fewer eb monoinfect cell conclus studi confirm pedv coinfect alter development cycl member speci famili chlamydiacea manner welldescrib persist induct method interestingli appear partial speciesspecif chlamydia pecorum appear sensit pedv coinfect chlamydia abortu evidenc tem observ homogen popul aberr inclus pedv chlamydia pecorum coinfect
PLoS Pathog	18579717	2010-12-15	PMC2920842	20711359	emerg influenza strain lead rapid global spread viru minim antibodi immun preexist cd tcell immun direct conserv intern viral region greatli amelior diseas mutat escap cell epitop substanti issu viru control vaccin design mutat result loss cell recognit variant gener crossreact cell respons studi revers genet modifi influenza np peptid partiallysolv expos residu npna mutat assess avail effect mechan underli influenzaspecif crossreact cell respons engin viru induc diminish cd cell respons select narrow cell receptor tcr repertoir region v partial explain hdbnpna structur loss contact npna peptid hdb includ contact posit plai role mediat tcrpmhci interact despit differ common crossreact tcr detect nave immun npnaspecif tcr repertoir npna epitop prime memori tcell equival recal respons mutant wildtyp wt viru markedli lower wtwt challeng decreas cd respons elicit heterolog challeng delai viral clearanc infect lung mice expos wt viru poor low avid respons secondari infect mutant protect efficaci crossreact cd cell recognis mutant viral epitop depend peptidemhci structur interact function avid studi support vaccin strategi includ immun commonli select crossreact variant mutat partiallysolv expos residu characterist compar npna
BMC Res Notes	21159873	2008-03-26	PMC2921379	20633290	background advanc dna sequenc technolog allow research progress analys singl organ deep sequenc sampl organ suffici sequenc depth detect subtl variat member speci mix speci share biomark rrna gene tradit sequenc analys sampl homogen popul base multipl sequenc align msa sequenc separ row similar align base column visual format intuit small set align sequenc represent cumbersom sequenc depth cover loci hundr thousand read deep find develop and softwar librari suit applic written perl statist analys deep sequenc fundament data structur underli and posit profil nucleotid distribut genom posit result multipl sequenc align msa tool includ root squar deviat rmsd plot allow visual comparison multipl sampl positionbyposit basi comput base convers frequenc transitiontransvers rate variat shannon entropi intersampl cluster visual dendrogram multidimension scale md plot thresholddriven consensu sequenc gener polymorph detect estim empir determin sequenc qualiti valu conclus sequenc technolog evolv deep sequenc will increasingli costeffici inter intrasampl comparison homogen sequenc will common provid softwar packag demonstr applic empiricallyderiv dataset investig download softwar sourceforg httpssourceforgenetprojectsandestool
BMC Infect Dis	18367528	2011-12-14	PMC2922213	20663229	background studi perform better assess percept motiv factor behavior associ hand wash prevent hn influenza transmiss peak pandem period korea method crosssect survei questionnair complet student univers campu suwon korea decemb survei includ question individu percept motiv factor behavior associ hand wash prevent hn influenza transmiss compar year prior particip report increas hand wash frequenc femal student practic frequent hand wash women perceiv effect hand wash lower ill sever person suscept hn infect higher studi particip femal perceiv hand wash effect ill sever greater wash hand frequent conclus korean student increas frequenc hand hygien practic pandem gender differ exist attitud behavior hand hygien diseas prevent factor hand wash behavior identifi the hn sar pandem suggest public educ campaign hand hygien effect alter individu hand hygien habit peak period influenza transmiss
Respir Res	22171261	2014-11-03	PMC2923116	20696083	background common cold preval contagi viral diseas human lack safe effect antivir treatment iotacarrageenan broadli activ respiratori virus invitro excel safeti profil studi investig efficaci safeti iotacarrageenan nasal sprai patient common cold symptom method random doubleblind placebocontrol exploratori trial human subject suffer earli symptom common cold receiv iotacarrageenan salin solut three time daili dai compar placebo administr iotacarrageenan nasal sprai reduc symptom common cold viral load nasal lavag patient earli symptom common cold proinflammatori mediat fgf fractalkin gro gcsf il il ip il ifn reduc iotacarrageenan group conclus iotacarrageenan nasal sprai appear promis treatment safe effect treatment earli symptom common cold larger trial indic confirm result
J Biomed Sci	26958719	2005-02-01	PMC2923119	20682079	enteroviru type ev proteas exhibit strong transcript activ yeast cell transcript activ proteas independ proteas activ ev proteas retain transcript activ truncat amino acid nterminu lost activ truncat amino acid nterminu delet amino acid cterminu acid domain cterminu protein essenti transcript activ delet amino acid eam acid domain lost transcript activ ev protein retain proteas activ ev proteas detect cytoplasm nucleu confoc microscopi analysi coxsacki viru proteas exhibit transcript activ yeast cell expect acid domain cterminu coxsacki viru proteas identifi truncat acid domain loss transcript activ interestingli acid region polioviru proteas critic viral rna replic transcript activ ev coxsacki viru proteas plai role viral replic andor pathogenesi
PLoS One	15695719	2007-12-01	PMC2923618	20805891	background commonli accept belief cancer cell modifi transcript state progress diseas propos progress cancer cell malign phenotyp effici track highthroughput technolog follow gradual chang observ gene express profil emploi shannon mathemat theori commun method base theori quantifi diverg cancer cell transcript profil appear cell origin tissu relev propos method evalu microarrai dataset public domain method principl applic highthroughput method methodologyprincip find melanoma prostat cancer dataset illustr emploi shannon entropi jensenshannon diverg trace transcript chang progress diseas establish variat measur correl establish biomark cancer progress theori measur allow identifi novel biomark progress sudden transcript chang lead malign phenotyp time methodolog valid larg number gene process implic progress melanoma prostat cancer conclusionssignific quantit guid rule unifi hallmark cancer cancer cell transcriptom chang lead measur observ transit normal shannon entropi valu measur highthrougput technolog time tumor cell increment diverg normal tissu profil increas disord creation state directli measur unifi hallmark allow the jensenshannon diverg identifi arrow time process gene express profil help map phenotyp molecular hallmark specif cancer subtyp deep mathemat basi approach allow principl hopefulli gener applic diseas
Cancer Cell Int	18022293	2014-07-30	PMC2924328	20682078	background leukemia lifethreaten cancer todai acut promyelogen leukemia apl common type leukemia natur compound exhibit antitumor effect lycorin natur alkaloid extract amaryllidacea exhibit antileukemia effect vitro vivo surviv rate hl cell expos lycorin decreas cell growth slow cell regener potenti inhibit hl cell exhibit typic apoptot characterist lycorin suppress leukemia growth reduc cell surviv induc apoptosi tumor cell purpos work elucid mechan lycorin induc apl cell hl cell treat concentr lycorin express tnf upregul concentrationdepend manner realtim quantit revers transcriptasepolymeras chain reaction western blot lycorin downregul prelat gene express includ cdc cyclin cdk cyclin promot bid truncat decreas ib phosphoryl block nfb nuclear import cytochrom releas mitochondria observ confoc laser microscopi conclus tnf signal transduct pathwai pmediat cellcycl inhibit involv apoptosi hl cell induc lycorin contribut develop lycorinebas antileukemia drug
Vet Med Int	25078906	2009-01-14	PMC2926681	20798771	felin coronavirus fcov infect fcov result divers rang sign clinic inappar infect highli fatal diseas call felin infecti periton fip fip seriou viral diseas cat effect vaccin cur treatment fip diagnost protocol fcov greatli assist manag control viru clinic find fip nonspecif help make differenti diagnosi haematolog biochem abnorm fip case nonspecif current serolog test low specif sensit detect activ infect crossreact fcov strain low pathogen felin enter coronavirus fecv revers transcriptas polymeras chain reaction rtpcr detect fcov rapid sensit interpret context clinic find definit diagnosi fip establish histopatholog examin biopsi paper describ compar diagnost method fcov includ account viru biologi epidemiolog pathogenesi
PLoS Negl Trop Dis	19144714	2015-09-16	PMC2927428	20808767	background fruit bat speci rousettu aegyptiacu identifi potenti reservoir highli pathogen filoviru marburg viru establish basi molecular understand biologi filovirus reservoir host adapt set molecular tool investig filoviru replic develop cell deriv speci rousettu aegyptiacu methodologyprincip find infect ebola marburg virus cell produc viral titer compar vero cell tcid analysi electron microscop analysi infect cell reveal morpholog sign filoviru infect describ human monkeyderiv cell line cell detect unusu high amount intracellular viral protein correl accumul high number filovir nucleocapsid cytoplasm establish protocol produc marburg infecti viruslik particl cell infect nave target cell investig primari transcript cell line test establish protocol reliabl rescu recombin marburg virus cell conclusionsignific data indic cell highli suitabl investig biologi filovirus cell deriv presum reservoir
BMC Infect Dis	26673332	2012-10-26	PMC2927599	20691095	background frequent occurr ferret badgerassoci human rabi case southeast china highlight lack laboratorybas surveil urg revisit potenti anim rabi transmiss determin ferret badger contribut human dog rabi case origin ferret badgerassoci rabi region activ rabi survei conduct determin frequenc rabi infect seropreval dog ferret badger method retrospect survei rabi epidem perform zhejiang jiangxi anhui provinc southeast china brain tissu ferret badger dog assai fluoresc antibodi test rabi viru isol sequenc phylogenet analysi sera ferret badger dog titrat rabi viru neutral antibodi vna test ferret badger present higher percentag rabi seroconvers dog endem region reach maximum collect sampl ferret badgerassoci rabi virus isol sequenc phylogenet cluster separ group nucleotid sequenc reveal homolog ferret badger isol homolog dog isol nucleoprotein glycoprotein gene rabi endem region conclus data ferret badgerassoci rabi form independ enzoot origin dog longterm rabi infest southeast china eventu role fb rabi public health remain unclear manag ferret badger bite rabi awar control region need
PLoS One	23104982	2011-03-01	PMC2929207	20805994	background base clinic represent diseas symptom multipl sclerosi mscl patient divid major subtyp relaps remit rr mscl primari progress mscl proteom analysi cerebrospin fluid csf detect number protein elev mscl patient aim differenti rr subtyp mscl compar csf protein methodologyprincip find csf sampl handl protocol quantit mass spectrometri measur report comparison mscl versu rr mscl observ number differenti abund protein protein jag vitamin dbind protein protein jag three time abund mscl compar rr mscl vitamin dbind protein detect rr mscl sampl protein valid independ techniqu western blot elisa differenti abund comparison mscl type conclusionssignific main find compar studi observ proteom profil csf rr mscl patient overlap larg extent number differ observ protein jag ligand multipl notch receptor involv mediat notch signal suggest literatur notch pathwai involv remyelin mscl lesion aberr normal homeostasi vitamin bound vitamin dbind protein implic mscl year vitamin directli indirectli regul differenti activ cd tlymphocyt prevent develop autoimmun process involv neuroprotect element mscl
BMC Public Health	20924362	2015-06-15	PMC2931476	20718996	background background pandem threat pose sar avian hn influenza studi delib forum elucid inform commun perspect aspect pandem plan method delib forum carri member south australian commun forum support qualit studi adult youth systemat review literatur involv extend group academ expert polici maker forum discuss record simultan transcript analys themat particip alloc scarc resourc antivir drug pandem vaccin base desir preserv societi function time crisi particip divid accept social distanc quarantin measur measur adopt thought reason financi household psycholog support essenti addit provid support particip gener impos strict sanction violat quarantin social distanc measur conclus recommend forum implement pandem plan sever pandem will challeng imposs implement success public engag pandem plan pandem effect commun kei point practic pandem judici support measur assist quarantin social isol measur
J R Soc Interface	26076321	2001-06-15	PMC2935601	20410190	recent outbreak novel infecti diseas sar influenza hn highlight threat crossspeci pathogen transmiss introduc popul pathogen adapt host evolv order escap extinct theoret argument empir studi suggest factor explain pathogen emerg includ host contact structur pathogen adapt pathwai mutat rate multityp branch process model spread introduc pathogen evolv strain extend previou model networkbas approach separ host contact pattern pathogen transmiss allow arbitrari adapt pathwai gener lead novel predict impact hypothes risk factor pathogen fit depend host popul circul riskiest contact distribut adapt pathwai depend initi transmiss emerg probabl sensit mutat probabl number adapt step requir possibl larg adapt step simultan point mutat recombin dramat situat increas mutat probabl increas risk emerg notabl except deleteri mutat avail
BMC Syst Biol	11356974	2013-12-20	PMC2936296	20727158	background innat immun respons defenc invad pathogen regul complex signal transcript network system biologi approach promis light regul innat immun analysi model network kei initi step process contextu catalogu compon system molecular interact compris network innatedb httpwwwinnatedbcom molecular interact pathwai databas develop facilit systemslevel analys innat immun describ innatedb curat project manual annot human mous innat immun interactom rich contextu detail novel curat softwar system develop ensur interact curat highli accur datastandard compliant manner interact protein dna rna curat biomed literatur data illustr innatedb curat innat immun interactom greatli enhanc network pathwai annot systemslevel analysi discuss challeng face curat effort provid line evid analysi innat immun interactom potenti identifi novel signal transcript posttranscript regul innat immun addition analys provid insight crosstalk innat immun pathwai biolog process adapt immun cancer diabet intriguingli suggest link pathwai implic innat immun respons conclus summari curat innatedb interactom wealth enabl systemslevel analysi innat immun
Virol J	24440876	2007-06-27	PMC2939558	20735849	background previou studi guinea pig infect transmit human influenza virus guinea pig anim model better understand influenza infect assess vaccin strategi fulli character model antibodi respons infectionreinfect human influenza awyom hn immun homolog recombin hemagglutinin ha protein studi serolog sampl collect test antiha immunoglobulin elisa antivir antibodi hemagglutin inhibit recognit linear epitop peptid scan pepscan anim inocul infecti viru demonstr pronounc viral replic subsequ serolog convers anim immun homolog ha antigen infect rapid rise antibodi titer ha glycoprotein elisa assai antivir antibodi measur assai detect second inocul pepscan data identifi recogn newli defin linear epitop conclus infect andor recombin ha immun guinea pig hn wyom influenza viru rapid product viralspecif antibodi demonstr strong immunogen major viral structur protein anim model influenza infect sensit immun respons support util guinea pig anim model influenza infect immun
Virol J	17596301	2003-10-27	PMC2939561	20799985	a conserv nucleic acid fragment nucleocapsid gene swine transmiss gastroenter coronaviru tgev chosen target special primer design loopmedi isotherm amplif lamp develop detect tgev incub product specif confirm hphi digest standard curv high accuraci tgev quantiz construct ad sybr greeni lamp reaction assai establish studi detect tgev crossreact virus demonstr high specif serial sampl dilut templat detect limit lamp pg rna time sensit pcr compar nestpcr
PLoS Pathog	14581523	2012-09-14	PMC2940758	20862324	arenavirida synthes viral mrna short cap primer presum acquir cellular transcript capsnatch mechan report crystal structur function character ntermin residu nl protein prototyp arenaviru lymphocyt choriomening viru nl domain bind cleav rna resolut crystal structur nl reveal type ii endonucleas architectur ntermin influenza viru pa protein superimposit structur mutagenesi revers genet studi reveal uniqu spatial arrang kei activ site residu pddexk type ii endonucleas signatur sequenc endonucleas domain conserv activ viru famili arenavirida bunyavirida orthomyxovirida propos arenaviru nl domain arenavirida capsnatch endonucleas
BMC Infect Dis	23093989	2013-01-09	PMC2941683	20799934	background april pandem influenza ahn viru emerg spread global object studi describ independ risk factor hospit mortal treatment corticosteroid patient influenza ahn infect method retrospect clinic data adult patient confirm infect influenza ahn hospit beij china octob decemb risk factor hospit mortal identifi multivari logist regress analysi patient male ag year comorbid patient common organ dysfunct includ acut respiratori failur alter mental statu septic shock acut renal failur oseltamivir initi patient patient receiv antivir therapi hour symptom onset fiftytwo patient treat system corticosteroid median daili dose twentyseven patient di hospit stai diabet odd ratio confid interv ci lactat dehydrogenas ldh level ci independ risk factor hospit death septic shock alter mental statu corticosteroid associ trend higher hospit mortal ci conclus hospit patient hn influenza rel poor outcom risk factor hospit help clinician identifi highrisk patient addit corticosteroid regard routin pharmacolog therapi
BMC Bioinformatics	23302888	2003-04-01	PMC2941692	20813045	background technolog enabl measur type genom epigenom scale rang atom nuclear data increasingli structur natur difficult coordin data set legitim integr visual dispar data set reveal structur relationship appar data isol appli objectori technolog develop download visual tool genom integr displai epigenom data prescrib threedimension physic model human genom order integr visual larg volum data novel statist mathemat approach develop reduc size data knowledg tool develop visual human genom threedimens describ major featur genom discuss multiscal data framework repres basic physic model demonstr issu benefit multiresolut data integr conclus genom softwar visual tool explor wide rang structur genom epigenet data data sourc differ scale integr hierarch framework easili adapt develop concern structur physic genom addit tool simpl annot mechan incorpor nonstructur genom uniqu abil manipul larg amount multiresolut data divers sourc uncov complex structur relationship genom
J Neuroinflammation	12634360	2009-11-11	PMC2942816	20828397	background neuroinflamm complex process involv cell immun system central nerv system cn polymorphonuclear neutrophil pmn abund class white blood cell typic type leukocyt recruit site inflamm cn astrocyt abund glial cell popul particip local innat immun respons trigger varieti insult studi investig impact astrocyt pmn function method primari astrocyt cultur deriv postnat cbl mice primari neutrophil isol week cbl mice pmn respiratori burst analyz hdcfda assai phagocytosi assai neutrophil incub fitclabel coli phagocytosi coli determin flow cytomet pmn degranul determin myeloperoxidas assai cytokin express determin realtim pcr determin involv signal pathwai protein lysat prepar western blot conduct assess activ akt erk vivo neutrophil primari astrocyt cultur studi demonstr astrocyt differenti regul neutrophil function depend interact cell type direct indirect direct cellcel contact astrocyt attenu neutrophil apoptosi respiratori bust degranul enhanc neutrophil phagocyt capabl proinflammatori cytokin express indirect interact neutrophil astrocyt attenu apoptosi enhanc necrosi neutrophil augment neutrophil phagocytosi respiratori burst inhibit neutrophil degranul addit astrocyt augment akt erk activ neutrophil conclus astrocyt differenti regul neutrophil function direct indirect interact cell type diversifi action astrocyt neutrophil provid protect potenti microbi infect compromis bloodbrain barrier integr neuropatholog condit complex action astrocyt neutrophil provid insight har inflammatori respons promot cn repair
BMC Bioinformatics	29870741	2017-05-17	PMC2942859	20822531	background decreas cost sequenc improv technolog easier common resequenc larg genom parallel sequenc small genom complet sequenc small genom dai increas number publicli genom type genom rapidli sequenc microbi viral genom respons infecti diseas accur gene predict challeng persist decod newli sequenc genom accur effici gene predict program highli desir rapid cost effect surveil rna virus full genom sequenc develop vigor viral genom orf reader web applic tool gene predict influenza viru rotaviru rhinoviru coronaviru subtyp vigor detect protein code region base sequenc similar search accur detect genom specif featur frame shift overlap gene embed gene predict matur peptid context singl polypeptid open read frame genotyp capabl influenza rotaviru built program compar vigor describ gene predict program zcurvev genemark flan specif sensit vigor greater rna viral genom test conclus vigor user friendli webbas genom annot program viral agent influenza rotaviru rhinoviru coronaviru sar coronaviru gene predict program rotaviru rhinoviru public access vigor accur predict protein code gene viral type capabl assign function predict open read frame genotyp influenza viru predict softwar design perform high throughput annot closur valid postsequenc product pipelin
Environ Health Perspect	28515297	2008-05-01	PMC2944079	20435545	background spread influenza highli pathogen avian influenza hn present threat human health avian influenza outbreak downwind area asian dust storm ad virus transport dust storm object develop techniqu measur ambient influenza avian influenza virus techniqu measur concentr virus ad dai background dai assess relationship ambient influenza avian influenza virus air pollut method highvolum air sampler parallel filter cassett evalu spike sampl unspik sampl air sampl monitor ad season filter cassett coupl realtim quantit polymeras chain reaction qpcr assai air sampl monitor ad season januari quantifi ambient influenza viru filtrationrealtim qpcr method ad dai background dai knowledg report describ concentr influenza viru ambient air spike unspik sampl concentr influenza viru sampl filter cassett higher highvolum sampler concentr ambient influenza viru higher ad dai background dai conclus data impli possibl longrang transport influenza viru
Virol J	18396047	2015-01-20	PMC2944171	20836894	background dengu fever viral reemerg diseas peopl tropic subtrop countri colombia viru detect earliest diseas major public health concern serotyp viru report huge outbreak report countri involv dengu viru serotyp denv studi origin genet divers distribut bp correspond carboxyl terminu envelop gene colombian isol order reconstruct phylogenet relationship estim time diverg analyz denv colombian isol belong defin genotyp viru isol clasifi genotyp repres sole introduct spread oldest strain close detect time america caribbean detect year disappear year split gener lineag evolv separ major aminoacid chang analyz region conclus denv circul colombia phylogenet relationship strain isol cover period time suggest viral strain detect year belong genotyp origin correspond multipl reintroduct event viral strain circul neighbor countri viral strain studi form monophylet group evid polyphylet origin report rapid spread pattern high evolut rate denv lineag
BMC Infect Dis	25605460	2012-01-01	PMC2944349	20822509	background renov adult intens care unit icu instal ten singl room enhanc infect control program conduct control spread methicillinresist staphylococcu aureu mrsa hospit method icu renov patient colon infect mrsa nurs singl room contact precaut incid mrsa infect icu monitor phase baselin period phase icu renov phase implement hand hygien campaign alcoholbas hand rub phase patient infect extend spectrum betalactamas esblproduc escherichia coli klebsiella speci chosen control manag open cubicl standard precaut major chang bed occup rate nurs workforc protocol environment cleans studi period stepwis reduct icu onset nonbacteraem mrsa infect observ phase phase phase patientdai icu onset bacteraem mrsa infect reduc phase phase phase patientdai infect esblproduc organ correspond reduct usag densiti broadspectrum antibiot fluoroquinolon increas phase trend improv icu onset mrsa infect segment regress analysi demonstr comparison sever acut respiratori syndrom sar epidem suggest death fellow healthcar worker occup acquir infect overwhelm complianc infect control measur conclus provis singl room isol facil promot hand hygien practic complianc infect control measur reli person commit increas person safeti threaten
PLoS One	24175205	2005-10-21	PMC2944876	20886082	background standard epidemiolog theori claim structur popul competit multipl pathogen strain determinist process mediat basic reproduct number imag text individu strain theori base analysi simul empir studi challeng predictor success princip find quantiti imag text valid predictor structur popul size infinit articl popul size finit dynam infect multistrain pathogen stochast process outcom predict evolutionari entropi theoret measur describ uncertainti infecti ag infect parent randomli chosen infect evolutionari entropi characteris demograph stabil robust popul infect statist paramet determin durat infect quantit pathogen strain standard epidemiolog theori base imag text measur select advantag limit popul size infin entrop select theori standard model approxim entrop select theori valid increas popul size conclus epidemiolog analysi base entropi explain empir observ emerg pathogen strain human influenza antigen drift phase exploit entropi perspect discuss epidemiolog pattern current hn swine flu outbreak
Curr Genomics	16227331	2018-03-14	PMC2945003	21286315	the proteom collect protein contemporari organ evolv recombin duplic limit set domain protein domain essenti main compon globular protein princip level protein function protein interact understood aspect domain evolut atom structur biochem function the amino acid sequenc chang bring fold function protein architectur increas wealth sequenc annot data brought genom evolutionari relationship constantli reveal unknown structur model phylogeni infer investig help predict function newli discov protein assist map unforeseen pathwai evolut reveal crucial coevolv inter intramolecular interact turn will help describ protein domain shape cellular interact network dynam regul cell addition studi design optim protein domain therapi review aim describ basic concept protein domain evolut illustr develop molecular evolut provid valuabl insight field compar genom protein interact network
BMC Public Health	29547975	2016-11-23	PMC2945945	20815888	background emerg influenza hnv face st centuri global pandem sever acut respiratori syndrom sar avian influenza hn prompt develop pandem prepared plan nation system public health law essenti public health stewardship implement public health polici intern coher will contribut effect region global respons undertaken law work tool diseas control europ cofund european union investig extent law europ support constrain pandem prepared plan nation differ constrain control effort method undertook survei nation public health law european state questionnair design diseas scenario base pandem influenza questionnair review workshop analys differ nation law support hinder region respons pandem influenza respond examin impact nation law movement good servic peopl border time pandem capac surveil case detect case manag commun control deploy strategi prevent contain mitig recoveri identif common disconnect state result studi differ europ extent nation pandem polici pandem plan integr public health law differ legisl legitimaci strateg plan state differ rang natur intervent measur author law extent border close movement person good pandem access healthcar nonresid person state propos emerg power overrid human right protect state propos limit intervent author public health law conclus differ creat problem european strategi evolv influenza pandem seriou public health challeng novel diseas influenza emerg pandem potenti insuffici understand europ role law pandem plan state build capac public health law support diseas prevent control polici suggest state guidanc eu manag pandem guidanc assist greater common legal approach state
Respir Res	27872356	2013-08-14	PMC2946301	20843364	background respiratori syncyti viru rsv infect restrict respiratori epithelium studi document presenc rsv system circul consist viru detect blood correl diseas sever method balbc mice inocul live rsv heatinactiv rsv medium subset rsvinfect mice treat antirsv antibodi postinocul rsv rna load measur pcr peripher blood dai postinocul correl upper lower respiratori tract viral load system cytokin respons lung inflamm pulmonari function immunohistochem stain defin local rsv antigen respiratori tract peripher blood rsv rna load detect peripher blood dai postinocul peak dai correl nasal lung rsv load airwai obstruct blood ccl cxcl express treatment antirsv antibodi reduc blood rsv rna load improv airwai obstruct immunostain identifi rsv antigen alveolar macrophag peripher blood monocyt conclus rsv rna detect peripher blood infect live rsv timecours parallel viral load assess respiratori tract correl rsvinduc airwai diseas
PLoS One	23946454	2008-03-19	PMC2947515	20927383	background proteasom inhibitor bortezomib repres advanc treatment multipl myeloma mm bortezomib inhibit activ proteasom induc cell death varieti tumor cell mechan cytotox understood methodologyprincip find investig differenti phosphoproteom proteasom inhibit stabl isotop label amino acid cell cultur silac combin phosphoprotein enrich lcmsm analysi total phosphoprotein identifi phosphoprotein fold greater chang bortezomib treatment phosphoprotein express alter encompass major protein class includ larg number nucleic acid bind protein sitespecif phosphopeptid quantit reveal ser phosphoryl stathmin increas bortezomib treatment suggest mechan associ bortezomibinduc apoptosi mm cell studi demonstr stathmin phosphoryl profil modifi respons bortezomib treatment regul stathmin phosphoryl specif serthr residu particip cellular respons induc bortezomib conclusionssignific systemat profil phosphoryl chang respons bortezomib treatment advanc global mechanist understand action bortezomib myeloma cell identifi uncharacter signal protein myeloma cell
PLoS One	18448489	2011-07-01	PMC2948498	20957032	background unusu high number sever pneumonia case consider mortal observ pandem hn viru infect global india mild critic case admit treat govern hospit initi phase pandem studi undertaken earli phase pandem methodolog role viral load host factor pathogenesi assess examin mild mp critic patient cip healthi control pune india sequenti blood lung aspir sampl collect cip viral load cytokineschemokin level determin plasma lung aspir patient tlr level determin stain fac analysi gene profil cell lung aspir pbmc taqman low densiti arrai antibodi titr isotyp ha protein base elisa princip find critic patient expir plasma sampl neg viru irrespect patient categori sequenti lung sampl cip lower viral load question associ viral replic sever antirphnhaigg titr higher critic patient categori circul exclus igg isotyp critic patient exhibit increas tlr decreas tlr express diseas sever correl increas plasma level ilra il il ccl ccl il major immunefunct gene downregul pbmc upregul cell lung aspir critic patient distinct pattern differenti fatal surviv patient observ sequenti sampl examin paramet conclus diseas sever associ pronounc impair host immun respons
Virol J	21734771	2001-11-15	PMC2949843	20849641	background porcin reproduct respiratori syndrom viru prrsv envelop viru bear sever econom consequ swine industri worldwid previou studi envelop virus incorpor cellular protein associ virion membran plai role viral infect studi sought proteom profil cellular protein incorpor associ virion highli virul prrsv strain gdby provid foundat investig role incorporatedassoci cellular protein prrsv infect experi sixti cellular protein identifi highli purifi prrsv virion twodimension gel electrophoresi coupl mass spectrometr approach identifi cellular protein group function categori includ cytoskelet protein chaperon macromolecular biosynthesi protein metabolismassoci protein calciumdepend membranebind protein function protein identifi protein report studi envelop virus guanin nucleotidebind protein tyrosin monooxygenasetryptophan monooxygenas peroxiredoxin galectin protein presenc select cellular protein actin tubulin annexin heat shock protein hsp calcium bind protein highli purifi prrsv virion valid western blot immunogold label assai conclus studi demonstr incorpor cellular protein prrsv virion valuabl investig effect individu cellular protein viral replic assembl pathogenesi
Virol J	11602703	2008-04-27	PMC2949849	20858246	rna interfer rnai technolog power tool function genom allow rapid drug target discoveri vitro valid target cell cultur rnai repres promis novel therapeut option treat human diseas cancer select gene silenc rnai achiev essenti nucleic acid base method cytoplasm deliveri short doublestrand ds interf rna oligonucleotid sirna gene silenc transient natur suitabl applic ii nuclear deliveri gene express cassett express short hairpin rna shrna process endogen interf rna lead stabl gene downregul process involv nucleic acid base drug highli charg cross cell membran free diffus vivo deliveri rnai therapeut technolog enabl rnai therapeut travers biolog membran barrier vivo virus vector deriv carri precis task major deliveri system shrna summar compar current viral deliveri system exampl vivo applic indic trend develop replic virus shrna deliveri cancer cell
PLoS Med	18438401	2010-07-01	PMC2950129	20957189	gabriel leung angu nicol provid reflect intern respons hn influenza pandem includ what chang anticip futur flu pandem
PLoS One	21178463	2015-09-30	PMC2950840	20949131	background clike proteas clpro sever acut respiratori syndromecoronaviru requir autoprocess polyprotein potenti target treat coronavir infect methodologyprincip find thorough understand substrat specif proteas substrat librari imag text variant creat perform satur mutagenesi autocleavag sequenc posit substrat sequenc insert cyan yellow fluoresc protein cleavag rate monitor vitro fluoresc reson energi transfer rel cleavag rate substrat sequenc correl structur properti p posit prefer residu high sheet propens prefer small hydrophob residu prefer hydrophob residu branch gln best residu posit observ cleavag detect met substitut posit prefer small residu p posit strong prefer residu substitut noteworthi solvent expos site p posit favour posit charg residu neg charg suggest electrostat interact plai role catalysi superact substrat combin prefer residu posit fold higher activ wildtyp sequenc conclusionssignific demonstr strong structureact relationship clpro substrat substrat specif profil studi provid insight ration design peptidomimet inhibitor
PLoS One	26424572	2017-04-01	PMC2953511	20976271	autopsi studi human highli pathogen avian influenza viru hn infect multipl human organ lung organ damag viral replic andor dysregul cytokin chemokin uncertainti exist partli limit number case analys studi full autopsi includ organ system conduct confirm hn human fatal case male year hour death addit respiratori system lung bronchu trachea viru isol cerebr cortex cerebr medullari substanc cerebellum brain stem hippocampu ileum colon rectum uret aortopulmonari vessel lymphnod real time rtpcr evid matrix hemagglutinin gene posit liver spleen addit posit tissu viru isol immunohistochemistri insitu hybrid stain accord evid viral infect real time rtpcr bronchu quantit rtpcr suggest high viral load associ increas host respons viral load organ cell immunolog system target viru infect pathogenesi hpai hn viru associ viru replic immunopatholog lesion addit immun cell exclud plai role dissemin viru vivo
PLoS One	28319790	2005-03-01	PMC2953514	20967280	background sourc influenc health protect behaviour influenza pandem emerg infecti diseas epidem uncertain methodolog data crosssect telephon interview hong kong adult june test theori dataderiv hypothes associ trust formalinform understand selfefficaci perceiv suscept worri hand hygien social distanc structur equat model multigroup comparison princip find trust formal governmentmedia influenza associ greater report understand ahn ahn prevent selfefficaci turn associ hand hygien trust inform interperson neg associ perceiv person ahn suscept neg associ perceiv selfefficaci posit associ influenza worri trust inform posit associ influenza worri turn associ greater social distanc multigroup comparison gender differ path trust formal understand ahn trust inform understand ahn understand ahn perceiv selfefficaci conclusionssignific trust governmentmedia associ greater selfefficaci handwash trust inform associ perceiv health threat avoid behaviour risk commun consid gender differ
PLoS One	15722333	2004-07-01	PMC2954148	20976274	yersinia pesti etiolog agent plagu kill peopl record histori mankind antibiot provid relief patient high bacteremia patient infect antibiot resist strain plagu virul factor pesti capsid protein lowcalcium respons lcr vprotein vantigen proven target activ passiv immun mous monoclon antibodi mab vantigen passiv protect mice murin model plagu antiyersinia pesti monoclon antibodi prophylact therapeut treatment human identifi antifspecif human mab antivspecif human mab m pan nave phagedisplai fab librari vantigen fab convert igg bind protect activ evalu bound weakli peptid locat nterminu protect mous antif mab bind bound vantigen peptid indic linear epitop bind peptid panel peptid suggest epitop conform better protect m pesti challeng plagu mous model synergist observ three antibodi combin incomplet complet protect achiev time postchalleng antibodi studi determin potenti therapeut prophylact pesti infect human
PLoS One	15362465	2007-01-17	PMC2954790	20976281	background electron medic record emr rich sourc har epidem surveil ask structur emr data coupl computer process freetext clinic entri enhanc detect acut respiratori infect ari methodolog manual review emr record outpati visit uncov refer case ari logist regress backward elimin determin candid structur emr paramet diagnost code vital sign order test imag medic contribut detect refer case develop computer freetext search identifi clinic note document nonneg ari symptom heurist build casedetect algorithm best combin retain structur emr paramet the text analysi princip find adjust group diagnost code identifi refer ari patient sensit specif posit predict ppv of addit structur clinic paramet consid contribut ari detect prescript cough remedi elev bodi temperatur diagnost code paramet increas detect sensit specif ppv declin ad text analysi increas sensit ppv drop algorithm requir satisfi queri structur emr paramet text analysi disclos ppv retain sensit conclus structur emr paramet freetext analys combin algorithm detect ari case level sensit precis highlight potenti path repurpos emr facilit discoveri epidem mass casualti
Virol J	17229702	2007-04-25	PMC2954857	20858291	background differenti diagnos japanes enceph viru jev infect flaviviru west nile viru wnv dengu viru dv infect greatli hinder serolog crossreact viru specif epitop benefit develop jev specif antibodi detect method identifi jev specif epitop fulli map character continu bcell epitop prmm protein jev map epitop prmm protein design set partial overlap fragment span prm fuse gst express express vector linear epitop vnkkeawldstkatri detect enzymelink immunosorb assai elisa remov amino acid residu individu carboxi amino termin peptid confirm minim unit linear epitop prmm keawldstkat epitop highli conserv jev strain epitop crossreact wnvposit denvposit sera conclus epitop jev specif lineal bcell epitp provid basi develop epitopebas viru specif diagnost clinic techniqu
Virol J	17460117	2010-03-23	PMC2955716	20863409	background spike protein coronavirus associ cellular molecul mediat infect target cell character cellular protein requir viru infect essenti understand viral life cycl provid cellular target antivir therapi identifi neural cell adhes molecul ncam novel interact partner phecov protein phage displai cdna librari cell construct librari screen solubl phecov glycoprotein coimmunoprecipit assai ncam bind partner spike protein solubl form antincam antibodi block associ phecov cell doublestrand sirna target ncam inhibit phecov infect conclus novel interact identifi ncam spike protein associ critic phecov infect
PLoS One	20332209	2010-07-14	PMC2956640	20976137	although metagenom emploi pathogen discoveri cost complex prevent practic frontlin diagnost unknown infecti diseas demonstr util metagenomicsbas strategi panvir microarrai virochip deep sequenc identif character pandem hn influenza viru nasopharyng swab collect earliest stage pandem mexico canada unit state virochip detect novel viru close swine influenza virus priori deep sequenc yield read correspond hn influenza sampl percentag align sequenc correspond hn rang coverag influenza genom sampl detect hn deep sequenc titer limit detect specif rtpcr percentag sequenc read linearli correl viru titer deep sequenc provid insight upper respiratori microbiota host gene express respons hn infect unbias analysi combin sequenc data outbreak sampl reveal hn genom assembl de novo refer sequenc includ assembl fulllength genom segment indic streamlin metagenom detect strategi replac multipl convent diagnost test requir investig outbreak novel pathogen provid blueprint comprehens diagnosi unexplain acut ill outbreak clinic public health set
PLoS One	20631148	2018-10-24	PMC2956653	20976145	the ongo emerg human infect origin wildlif highlight better knowledg microbi commun wildlif speci tradit diagnost approach limit evalu microbi biota healthi mule deer odocoileu hemionu analys lymph node metatranscriptom cdna librari individu pool sampl prepar retropharyng lymph node rna enrich polyadenyl rna sequenc roch life scienc technolog proteincod ribosom rna rrna sequenc taxonom profil protein rrna specif databas repres bacteri phyla detect librari base proteincod transcript indic viabl microbiota lymph node resid skin rumen ubiquit mule deer habitat domin classifi bacteri speci base detect rrna proteincod transcript identifi proteobacteri speci helicobact close helicobact cetorum helicobact pylorihelicobact acinonychi complex acinetobact acinetobact schindleri virus novel gamma retroviru member poxvirida retrovirida identifi addition evalu bacteri divers amplicon sequenc hypervari region rrna demonstr taxonom divers higher metatranscriptom approach data provid complet pictur microbi divers wildlif host advanc metatranscriptom studi microbiota wildlif tissu will facilit detect novel organ pathogen potenti human anim
Int J Microbiol	30355759	2013-07-31	PMC2958490	20981303	the diagnosi respiratori viru infect evolv year emerg pathogen develop novel detect method advanc improv sensit turnaround time diagnost test respiratori virus rais issu cost clinic signific detect multipl virus singl specimen molecular method articl review advanc specimen collect detect method diagnosi respiratori viru infect discuss perform characterist limit method
Retrovirology	23903541	2006-06-01	PMC2959034	20923574	background identif broad neutral epitop hiv envelop spike paramount hiv vaccin develop broad neutral epitop identifi surfac nativ hiv envelop spike recognit antibodi depend conform chang envelop spike hiv envelop spike transientlyexpos neutral epitop difficult identifi studi construct singl chain fv scfv deriv human monoclon antibodi genet link glycosylphosphatidylinositol gpi attach signal gpi attach signal scfv target lipid raft plasma membran addit demonstr gpianchor scfv secret counterpart neutral hiv degre breadth potenc gpianchor scfv exhibit extrem potent broad neutral activ multipl clade hiv strain test gpianchor scfv exhibit potent neutral activ secretori counterpart final demonstr express gpianchor scfv lipid raft plasma membran human cd cell confer longterm resist hiv infect hiv envelopemedi cellcel fusion infect hiv captur transfer human dc conclus gpianchor scfv gener effect identifi antibodi react transientlyexpos neutral epitop envelop protein hiv envelop virus gpianchor scfv breadth potenc great potenti develop antivir agent hiv prevent therapi
BMC Infect Dis	16757623	2004-06-25	PMC2959060	20920320	background data predict patient pandem influenza hn infect complic cours spars retrospect studi admiss serum creactiv protein crp level serv predictor ill sever method includ consecut adult patient present emerg depart maydecemb flulik ill confirm diagnosi pandem influenza hn infect serum crp level measur hour present patient proven addit concurr acut ill bacteremia exclud roc curv analysi kaplanmei curv cox proport hazard model evalu predict abil crp prognost factor seventeen enrol patient admit intens care unit icu requir mechan ventil three di median admiss serum crp level higher patient requir subsequ icu care mechan ventil patient mgl mgl mgl mgl cox proport hazard model identifi admiss serum crp level auscultatori find lung independ prognost factor icu admiss admiss serum crp level independ prognost factor mechan ventil thirti dai present the patient admiss serum crp level mgl lower tertil requir icu admiss mechan ventil time point patient admiss serum crp level mgl upper tertil need admit icu upper tertil group requir mechan ventil differ rate lower upper tertil group logrank icu mechan ventil conclus studi group serum crp level earli admiss stage patient present pandem hn influenza infect serv gaug predict diseas cours assist patient manag
Virol J	15220402	2005-02-04	PMC2965154	20946645	background dengu virus den wildest transmit mosquitoborn pathogen tropic subtrop region worldwid infect den sever flulik ill fatal hemorrhag fever rna interfer trigger longlength dsrna consid potent antivir pathwai mosquito limit studi small interf rna sirna conduct nt sirna target membran glycoprotein precursor gene den synthes transfect mosquito cell challeng den stabil sirna cell monitor flow cytometri antivir sirna evalu measur cell surviv rate mtt method viral rna quantit realtim rtpcr presenc cell sirna dai transfect dai incub den reduc cytopath increas cell surviv rate reduc viral rna copi ct detect transfect cell conclus data synthet sirna den membran glycoprotein precursor gene effect inhibit den viral rna replic increas cell surviv rate sirna offer potenti strategi prevent treatment den infect
PLoS One	15695582	2010-03-31	PMC2966397	21060827	coronavirus cov mild sever diseas human anim host rang environment spread underestim current investig potenti medic relev infecti bronchiti viru ibv belong gammacoronavirus costli respiratori viral diseas chicken role wild bird epidemiolog ibv understood studi examin cloacal faecal sampl collect wild bird speci beringia area presenc cov perform statist phylogenet analys detect divers cov rtpcr wild bird beringia area sequenc analysi detect virus gammacoronavirus ibv find wild bird carri gammacoronavirus asymptomat conclud cov widespread wild bird beringia geograph spread frequenc higher realis avian cov effici dissemin larg distanc genet reservoir futur emerg pathogen cov consid great anim health econom impact ibv emerg novel coronavirus sarscoronaviru investig role wildlif reservoir cov infect biologi epidemiolog
PLoS One	20357215	2017-12-20	PMC2966401	21060829	background molecular diagnost method complement exist tool improv diagnosi malaria requir good laboratori infrastructur restrict refer laboratori studi adopt molecular tool routin malaria endem countri will requir simpler molecular platform develop loopmedi isotherm amplif lamp method simpl improv better endem countri studi attempt improv method malaria diagnosi simpl portabl devic capabl perform amplif detect fluoresc lamp platform refer realamp method methodolog find publish genusspecif primer test util method dna deriv speci malaria parasit initi character clinic sampl falciparum determin sensit specif system compar microscopi nest pcr method addition directli boil parasit prepar compar convent dna isol method realamp method simpl allow realtim detect dna amplif time amplif vari gener minut humaninfect plasmodium speci detect sensit specif realamp detect falciparum compar microscopi and compar standard nest pcr method addit method consist detect falciparum directli boil blood sampl conclus realamp method great potenti field usabl molecular tool diagnosi malaria tool provid altern convent pcr base diagnost method field clinic oper program
PLoS Pathog	29435062	2006-07-01	PMC2973827	21079686	increas intracellular zn concentr zincionophor pyrithion pt effici impair replic varieti rna virus includ polioviru influenza viru virus attribut interfer viral polyprotein process studi demonstr combin zn pt low concentr zn pt inhibit replic sarscoronaviru sarscov equin arter viru eav cell cultur rna synthesi distantli nidovirus catalyz rnadepend rna polymeras rdrp core enzym multiprotein replic transcript complex rtc activ assai rtc isol cell infect sarscov eavthu elimin pt transport zn plasma membranew zn effici inhibit rnasynthes activ rtc virus enzymat studi recombin rdrp sarscov nsp eav nsp purifi coli subsequ reveal zn directli inhibit vitro activ nidoviru polymeras zn block initi step eav rna synthesi case sarscov rdrp elong inhibit templat bind reduc chelat zn mgedta inhibitori dival cation revers novel experiment tool vitro studi molecular detail nidoviru replic transcript
Biol Direct	16847084	2010-08-18	PMC2973933	20937149	background difficult measur precis phenotyp complex live organ propos method calcul minim amount genom need construct organ effect measur organism complex permut combin formula shannon concept demonstr calcul correl intuit organism phenotyp complex defin tradit taxonomi evolutionari theori virus human be effect gradual increas thousand bit hundr million bit simpler organ the complex organ the human genom estim effect function sequenc conclus effect quantit measur phenotyp complex live organ estim function fraction genom review articl review dr lavanya kannan nomin dr arcadi mushegian dr chao chen dr rietman nomin dr marc vidal
Immunome Res	20719948	2014-05-19	PMC2981880	21067543	immunoinformat emerg branch informat scienc long ago pullul tree knowledg bioinformat disciplin appli informat techniqu problem immun system great extent immunoinformat typifi epitop predict method disappointingli limit design discoveri vaccin area proper comput support gener lack extant vaccin base isol epitop correspond chemicallytr attenu pathogen correspond individu protein extract pathogen correspond complex carbohydr chapter attempt review progress asyetunderexplor area immunoinformat comput discoveri protein antigen effect develop antigen predict method reduc laboratori resourc requir identifi pathogen protein candid subunit vaccin review place antigen predict firmli context explor role revers vaccinolog design discoveri vaccin highlight compet ultim complementari methodolog approach subcellular locat predict identifi antigen sequenc similar sophist statist approach predict probabl antigen characterist explor system immunom approach predict immunogen prove help predict antigen
Immunome Res	24841273	2001-04-01	PMC2981881	21067547	virus fast evolv pathogen continu adapt highli variabl environ live reproduc strategi devot inhibit viru replic control spread host cope extrem heterogen popul potenti avoid medic intervent comput techniqu phylogenet method broaden pictur viral evolut time space mathemat model contribut progress unravel dynam viru replic fit virul integr multipl comput mathemat approach experiment data help predict behavior viral pathogen anticip escap dynam piec plai critic role aspect vaccin develop viral strain select vaccin ration attenu virus review aspect viral evolut address quantit discuss comput method potenti improv vaccin design
J Neuroinflammation	11282586	2018-05-30	PMC2984415	21034511	background wnvassoci enceph wnve character increas product proinflammatori mediat glial cell activ eventu loss neuron wnv infect neuron rapidli progress destruct infect nonneuron brain cell limit role neuron patholog consequ proinflammatori cytokin releas result wnv infect unclear object studi examin role kei cytokin secret wnvinfect neuron mediat neuroinflammatori marker neuron death method transform human neuroblastoma cell sknsh infect wnv multipl infect moi and wnv replic kinet express profil kei proinflammatori cytokin analyz plaqu assai qrtpcr elisa cell death measur sknsh cell presenc absenc neutral antibodi kei proinflammatori cytokin cell viabil assai tunel flow cytometri nave primari astrocyt treat uvinactiv supernat mock wnvinfect sknsh cell activ astrocyt measur flow cytometri elisa wnvinfect sknsh cell induc express il tnf dose timedepend manner coincid increas virusinduc cell death treatment cell antiil tnf reduct neurotox effect wnv treatment nave astrocyt uvinactiv supernat wnvinfect sknsh cell increas express glial fibrillari acid protein kei inflammatori cytokin conclus time neuron potenti sourc proinflammatori cytokin wnvinfect brain neuronderiv cytokin contribut wnvinduc neurotox cytokin releas neuron mediat activ astrocyt data defin specif role wnvinduc proinflammatori cytokin provid framework develop antiinflammatori drug muchneed therapeut intervent limit symptom associ wnve
PLoS One	29848753	2019-04-10	PMC2984494	21103348	mutat slca preval hereditari deaf deaf correspond mous model slca abnorm enlarg cochlear lumen goal studi determin cochlear enlarg origin defect cochlear fluid transport malfunct fluid transport connect compart vestibular labyrinth endolymphat sac embryon inner ear slca slca mice examin confoc microscopi vivo dai organ cultur cultur allow observ intact ligat partial resect inner ear cochlear lumen format base cochlea embryon dai enlarg evid slca compar slca mice slca slca mice separ cochlea vestibular labyrinth ligat reduc cochlear lumen resect endolymphat sac led enlarg cochlear lumen slca mice caus enlarg enlarg cochlear lumen slca mice ligat resect perform alter cochlea lumen conclus data cochlear lumen format initi fluid secret vestibular labyrinth temporarili control fluid absorpt endolymphat sac failur fluid absorpt endolymphat sac lack slca express appear initi cochlear enlarg mice human lack function slca express
PLoS Comput Biol	30971475	2014-11-10	PMC2987833	21124942	although vaccin pose best prevent influenza infect strain select optim implement remain difficult antigen drift lack understand global spread detect viral movement sequenc analysi complic skew geograph season distribut viral isol propos probabilist method account sampl bia spatiotempor cluster model region season transmiss binomi process analysi hn confirm eastsoutheast asia sourc season variant increas resolut observ transmiss countri level hn data reveal viral spread tropic network analysi suggest china hong kong origin season hn strain unit state region increas vaccin maxim disrupt global spread viru techniqu provid promis methodolog analysi season viru continu surveil influenza
Virol J	25385825	2008-02-01	PMC2988023	21047436	background spike protein sarscov mediat receptorbind induc neutral antibodi identifi receptorbind domain rbd protein major target neutral antibodi anim model propos rbdbase vaccin antigen immunogen rbd human character panel serum sampl recov sar patient includ antibodi respons rbd measur elisa microneutr assai rbd protein induc potent antibodi respons recov sar patient rbdspecif antibodi persist high titer three year followup affin purifi antirbd antibodi possess robust neutral activ conclus rbd sarscov highli immunogen human mediat protect respons rbdbase vaccin diagnost approach develop
BMC Public Health	18303361	2006-11-15	PMC2988738	21044300	the pandem hn influenza compound season influenza pose global challeng despit announc postpandem period august thewho hn viru continu circul season viru year nation health author remain vigil unpredict behaviour viru major popul live countri inadequ resourc purchas vaccin stockpil antivir drug basic hygien measur wear face mask hygien practic hand wash reduc spread respiratori virus immin issu translat measur daytodai practic experi sever acut respiratori syndrom sar hong kong gener practition gp discharg duti despit risk infect sar event highlight inadequ interfac primari secondari care valuabl health care resourc inappropri match commun wai gp contribut combat influenza pandem prompt detect monitor epidem miniepidem viral ill commun empow rais health literaci commun advoc person hygien precauti measur gp assist develop protocol primari care manag patient flulik ill conduct clinic audit standard prevent treatment measur gp adequ liaison public health agenc facilit earli diagnosi patient influenza articl summaris primari care action phase pandem discuss novel role gp altern sourc health care patient care secondari care level health care system remain sustain public health crisi
BMC Med Genet	17108024	2009-12-09	PMC2989958	21067616	background dendrit cellspecif intercellular adhes molecul grab nonintegrin dcsign pathogen recognit receptor innat immun system dcsign promot variant plai role suscept infecti diseas nasopharyng carcinoma npc malign common southern china dcsign promot variant effect suscept npc unknown aim studi ascertain potenti involv dcsign promot singl nucleotid polymorph snp npc suscept method conduct case control studi base cantones popul includ npc patient control match ag sex bp dcsign promot region directli sequenc sampl sequenc align snp search inspect dnastar analysi program haplotyp frequenc estim haploview associ snp risk npc analyz chisquar test noncondit logist regress analysi spss softwar total variant observ dcsign promot region dcsign gg aa associ npc risk adjust odd ratio or confid interv ci p subject carri risk allel dcsign fold ci increas risk develop npc haplotyp analysi reveal aaag associ protect npc associ permut test run conclus studi indic dcsign promot variant appear involv suscept npc detail mechan studi
PLoS Negl Trop Dis	20007283	2005-06-30	PMC2990691	21124882	background japanes enceph je caus mosquitoborn flaviviru endem entir southeast asian adjoin region current therapeut intervent je make dread encephalitid effect counter viru inhibit viral replic antisens molecul direct viral genom octaguanidinium dendrimerconjug morpholino vivomorpholino uncharg antisens oligom enter cell live organ endocytosi subsequ escap endosom cytosolnuclear compart cell hypothes vivomorpholino gener specif region untransl region jev genom administ experiment model je will antivir neuroprotect methodologyprincip find mice infect jev gp strain intraperiton administr morpholino mgkg bodi weight daili treatment surviv anim monitor dai death sacrif brain process immunohistochem stain protein extract plaqu assai immunoblot analysi perform brain homogen reduc viral load viral protein express greater surviv infect anim neuroprotect observ thionin stain brain section cytokin bead arrai reduct level proinflammatori cytokin brain morpholino treatment elev infect correspond reduc microgli activ brain oxid stress reduc stressrel signal molecul posit modul morpholino treatment vitro studi decreas infect viral particl product morpholino treatment conclusionssignific administr vivomorpholino effect increas surviv anim neuroprotect murin model je oligom repres potenti antivir agent merit evalu
BMC Infect Dis	15994805	2018-02-14	PMC2990753	21062471	background health care worker hcw present frequent concern health famili health high level psycholog distress previou diseas outbreak sar outbreak associ social isol intent absente aim assess hcw concern anxieti perceiv suffici intend behavior ahn influenza pandem associ psycholog distress method septemb st healthcar worker hcw tertiari teach hospit complet item questionnair concern worri ahn influenza pandem cassileth style questionnair parti ghq half studi hcw report worri ahn influenza pandem degre anxieti moder high median frequent concern infect famili friend health consequ diseas perceiv risk infect consid moder high median hcw restrict social contact fewer felt isol famili member friend hospit work low percentag indent leav avoid infect worri degre worri associ intend absente restrict social contact psycholog distress perceiv suffici aspect ahn influenza moder high the ahn influenza consid clear median perceiv suffici prognosi infect independ associ degre worri pandem conclus proport hcw experienc moder high anxieti pandem degre worri independ correl psycholog distress perceiv suffici ahn influenza prognosi associ reduc degre worri hospit manag consultationliaison psychiatri servic provid hcw order offer favour work condit time extrem distress current futur pandem
Mar Drugs	29444942	2007-08-01	PMC2992996	21116410	marin spong current richest sourc pharmacolog activ compound marin environ bioactiv molecul secondari metabolit main function enabl andor modul cellular commun defens produc function enzym cluster spong andor associ symbiot microorgan natur product lead compound spong promis pharmaceut agent approv antivir agent clinic advanc late stage clinic trial drug treatment human immunodefici viru hiv herp simplex viru hsv antivir lead marin origin report nucleosid araa vidarabin isol spong tethya crypta inhibit viral dna polymeras dna synthesi herp vaccinica varicella zoster virus discoveri type virus emerg drug resist strain develop antivir lead compound continu spong deriv antivir lead compound hopedto develop futur drug discuss review suppli problem major bottleneck develop compound drug clinic trial advanc field metagenom high throughput microbi cultiv rais possibl techniqu lead costeffect larg scale product compound perspect biotechnolog method respect marin drug develop discuss
Virol J	17434557	2017-07-12	PMC2994542	21073718	background hendra viru hev nipah viru niv newli emerg zoonot paramyxovirus discov outbreak queensland australia peninsular malaysia classifi henipaviru genu virus infect broad rang mammalian speci caus sever oftenleth diseas human anim repeat outbreak continu occur extens laboratori studi host cell infect stage hev niv role envelop glycoprotein hamper highli pathogen natur restrict biosafeti level bsl contain circumv problem develop henipaviru envelop glycoprotein pseudotyp lentiviru assai system luciferas gene green fluoresc protein gfp gene encod human immunodefici viru type hiv genom conjunct hev niv fusion attach glycoprotein function retroviru particl pseudotyp henipaviru glycoprotein displai proper target cell tropism entri infect depend presenc hev niv receptor ephrinb target cell function specif assai confirm lack reportergen signal particl bear glycoprotein prepar assai viru entri block infect carri presenc fusion inhibit ctermin heptad hr peptid wellcharacter crossreact neutral human mab specif henipaviru glycoprotein solubl ephrinb receptor addit util assai demonstr examin influenc cytoplasm tail fusion activ incorpor pseudotyp viru particl gener test panel truncat mutant niv hev conclus demonstr specif henipaviru entri assai develop niv hev glycoprotein pseudotyp reportergen encod retroviru particl assai conduct safe bsl condit will tool measur henipaviru entri studi glycoprotein function context viru entri assai character neutral antibodi viru entri inhibitor
PLoS One	28701403	2006-12-15	PMC2994772	21152402	background novel influenza pandem viru hnpdm caus consider morbid mortal worldwid aim studi evalu clinic cours durat viral shed hnpdm evolut emerg antivir resist hospit cancer patient sever hnpdm infect winter brazil method perform prospect singlecent cohort studi cancer center rio de janeiro brazil hospit patient cancer confirm diagnosi influenza hnpdm evalu main outcom measur studi inhospit mortal durat viral shed viral persist function molecular analys hnpdm suscept oseltamivir total hospit patient suspect influenzalik ill screen total diagnos hnpdm infect hospit mortal cohort thirteen patient requir intens care median ag studi cohort year year eighteen patient receiv chemotherapi previou month neutropen onset influenza total patient evalu durat viral shed displai prolong viral shed median rang dai associ emerg resist hnpdm viru viral evolut observ sequenti collect sampl conclus prolong influenza hnpdm shed observ cancer patient oseltamivir resist detect data sever cancer patient constitut pandem viru reservoir major implic viral propag
PLoS One	17158916	2010-02-05	PMC2994777	21152405	there increas concern impact veterinari drug livestock pathogen factor damag wildlif health threaten avian scaveng feed medic livestock carcass conduct comprehens studi fail egg dead nestl beard vultur gypaetu barbatu attempt elucid proxim breed failur declin product spanish pyrene high concentr multipl veterinari drug fluoroquinolon fail egg nestl associ multipl intern organ damag livestock pathogen caus diseas septicaemia swine pathogen infecti bursal diseas combin impact drug diseas stochast factor result devast effect exacerb high risk extinct consid current conserv program beard vultur scaveng speci danger veterinari drug highli pathogen poultri virus
Interdiscip Perspect Infect Dis	20139279	2019-07-01	PMC2995904	21151699	the infer popul dynam molecular sequenc data method surveil infecti diseas examin heterogen contact shape genealog parasit agent extens simul find contact heterogen strong structur genealog reflect epidemiolog relev quantiti proport popul infect compar simul beast reconstruct find contact heterogen increas number sequenc isol requir estim quantiti cours epidem data contactnetwork structur will requir addit sequenc data accur estim parasit agent genealog conclud network model will progress area
BMC Genomics	31475214	2016-08-03	PMC2996934	20576142	background domest cat offer enorm genom potenti veterinari descript hereditari diseas model occurr deadli felin virus felin leukemia viru felv felin coronaviru fecv felin immunodefici viru fiv homologu human scourg cancer sar aid realiz biomed potenti high densiti singl nucleotid polymorph snp map requir order accomplish diseas phenotyp associ discoveri descript remedi gener pair fosmidend sanger sequenc read cat combin data publicli cat genom sequenc sequenc read assembl form genom assembl allow discoveri three snp reduc potenti fals posit snp low coverag assembl low upperlimit sequenc coverag high lowerlimit qualiti discrep base potenti variant site domest cat breed femal abyssinian femal american shorthair male cornish rex femal european burmes femal persian femal siames male ragdol femal african wildcat sequenc lightli report total common snp suitabl domest cat snp genotyp arrai addit snp detect african wildcat domest cat breed empir sampl discov snp test sequenc cat snp valid rate conclus data provid larg collect map felin snp cat genom will allow develop snp genotyp platform map felin diseas
PLoS One	27489275	2006-12-20	PMC2997101	21151943	cluster hierarch cluster method understand analys data wide varieti knowledg domain notabl util system data classifi evolutionari context paper introduc hierarch cluster problem defin novel object function call arithmeticharmon cut problem find cut imag texthard imag texthard fixedparamet tractabl indic problem polynomi time algorithm approxim exact parameter local search base techniqu produc workabl algorithm implement memet algorithm problem demonstr effect arithmeticharmon cut number dataset includ cancer type dataset corona viru dataset favor perform compar current hierarch cluster techniqu imag textmean graclu normalizedcut arithmeticharmon cut metric overcom difficulti hierarch method repres interclust differ intraclust similar
BMC Public Health	17182757	2006-11-22	PMC2998491	21078169	background case influenza ahn swine flu confirm uk april novel viru identifi mexico rapidli evolv pandem swine flu outbreak pandem year encount major influenza outbreak studi examin public understand pandem explor peopl deciph threat perceiv control risk method purpos sampl recruit seventi three peopl women men focu group discuss time second wave swine flu case discuss evid public overreact peopl believ threat contract swine flu inevit assess selfefficaci protect low respond assess greater risk health vaccin diseas find led apathi uk govern recommend health protect behaviour suboptim level vaccin uptak gener peopl confus differ season influenza swine flu vaccin conclus suggest gap public understand hinder attempt commun novel flu virus futur gener support govern handl pandem public awar campaign deem ineffectu peopl chang current hand hygien practic support media deem overreport swine flu pandem
Environ Health	17121802	2012-09-17	PMC3000394	21078183	background damp mold qualit review associ varieti advers respiratori health effect includ respiratori tract infect publish metaanalys provid quantit summari associ respiratori infect demonstr causal relationship dampnessrel agent prevent exposur respiratori tract infect public health strategi report quantit metaanalys publish studi examin associ damp mold home respiratori infect bronchiti method primari studi meet elig criteria transform report odd ratio or confid interv ci log scale fix random effect model appli log or varianc studi contain multipl estim or model account correl multipl studi analyz set analys perform elig studi set restrict studi control ag gender smoke socioeconom statu subgroup studi assess explor heterogen funnel plot assess public bia summari estim or random effect model base studi rang ci exclud null case analysi model restrict analys base control multipl confound variabl chang find or ci random effect model studi adjust major confound variabl bronchiti respiratori infect respiratori infect exclud nonspecif upper respiratori infect respiratori infect children infant public bia evid estim attribut risk proport rang conclus residenti damp mold associ substanti statist increas respiratori infect bronchiti associ confirm causal effect control damp mold build prevent substanti proport respiratori infect
Parasite Immunol	22985881	2011-05-01	PMC3001033	19493213	pregnancyassociatedplasmodium falciparum malaria pam major morbid mortal african women offspr pam character accumul infect erythrocyt i adher chondroitin sulphat csa placent intervil space human monoclon igg antibodi specif variant surfac antigen vsa express csaadher i vsapam vitro select parasit nonpregn donor express vsapam select vsapam express preferenti transcript varcsa corrobor current effort develop pamspecif vaccin base varcsa
BMC Infect Dis	21598272	2004-07-29	PMC3001727	21083874	background european repres major intern travel clinician encount return patient essenti role recogn commun travelassoci public health risk method investig morbid travel associ infecti diseas european travel analys diagnos demograph clinic travelrel predictor diseas return travel present eurotravnet centr presum travel associ condit gastrointestin gi diseas account ill febril system ill dermatolog condit respiratori ill death record sepsi caus escherichia coli pyelonephr dengu shock syndrom plasmodium falciparum malaria gi condit includ bacteri acut diarrhea giardiasi amebasi febril system ill identifi pathogen malaria account case dengu includ chikungunya rickettsi diseas leptospirosi brucellosi epstein barr viru infect tickborn enceph tbe viral hepat dermatolog condit domin bacteri infect arthropod bite cutan larva migran anim bite requir rabi postexposur prophylaxi leishmaniasi myasi tungiasi case leprosi respiratori ill includ case tuberculosi includ case multidrug resist extens drug resist tuberculosi case influenza ill case legionnair diseas sexual transmit infect sti account total diagnos includ hiv infect syphili total case vaccin prevent diseas report purpos travel destin specif risk factor identifi diagnos chaga diseas immigr travel south america falciparum malaria immigr subsaharan africa travel europ associ health risk distinct profil eastern western europ conclus broad spectrum travel associ diseas diagnos eurotravnet core site diagnos vari region visit travel spectrum travel associ morbid dispel misconcept travel close europ health risk
BMC Infect Dis	15306395	2014-09-01	PMC3001728	21110854	background studi compar nasal swab invas nasopharyng aspir npa detect respiratori virus comparison perform immunocompet children upper respiratori tract symptom rang poor sensit swab higher sensit npa aim investig sensit flock nasal swab fn immunocompromis adult febril neutropenia method month adult hematolog disord present febril neutropenia enrol studi pair sampl fn npa collect outer nasal caviti nasopharynx sampl analyz panel respiratori virus quantit polymeras chain reaction indirect measur cell yield method copi number human beta actin gene determin cohen kappa calcul measur agreement method wilcoxon signedrank test comparison cell yield total pair sampl total patient collect twenti pair viru detect specimen in npa fn fn sensit viru rhinoviru npa superior fn collect epitheli cell conclus sensit low replac npa sampl techniqu patient categori
PLoS Negl Trop Dis	24980786	2007-11-20	PMC3001904	21179504	leptospirosi widespread zoonot infect resid tropic region infect anim human temper region agent leptospirosi compris member genu leptospira includ nonpathogen saprophyt speci leptospirosi vari sever mild nonspecif ill sever diseas includ multiorgan failur widespread endotheli damag hemorrhag to investig pathogen leptospir affect endotheli cell compar respons endotheli cell line infect pathogen versu nonpathogen leptospir microarrai analys suggest pathogen interrogan nonpathogen biflexa trigger chang express gene product involv cellular architectur interact matrix chang opposit direct infect biflexa predict increas maintain cell layer integr interrogan lead chang predict disrupt cell layer integr bacteri strain caus necrosi apoptosi cell prolong incub pathogen interrogan result disrupt endotheli cell layer assess microscopi abil bacteria cross cell layer disrupt endotheli layer integr abrog addit endotheli protect drug lisinopril physiolog relev concentr adhes interrogan endotheli cell bacteria disrupt endotheli barrier function promot dissemin bacteria contribut sever diseas manifest addit supplement antibiot therapi lisinopril deriv endotheli protect activ decreas sever leptospirosi
PLoS One	18025432	2004-05-01	PMC3002947	21179494	human adenoviru adhu vector robust vaccin platform presenc naturallyacquir neutral antibodi reduc vector efficaci potenti readministr studi evalu immun respons protect vaccin replicationincompet porcin adenoviru pav vector altern vaccin adhu avian influenza hn diseas model vaccin efficaci evalu balbc mice vaccin dose pav vector express optim ahanoi hn hemagglutinin antigen pavha compar adhuha control pavha rapidli gener antibodi respons neutral antibodi titer dai stronger cellular immun respons detect dai compar adhuha pavha vaccin administ dai challeng demonstr improv surviv lower viru load evalu longterm vaccin efficaci month postvaccin better protect pavha adhuha vaccin importantli oppos adhu pav vector neutral human antibodi pool individu pavbas vector capabl mediat swift strong immun respons offer promis altern adhu
J Inflamm (Lond)	15131154	2003-04-15	PMC3003652	21108806	by virtu direct contact environ lung constantli challeng infecti noninfecti stimuli necessit robust highli control host respons coordin innat adapt arm immun system mammalian tolllik receptor tlr function crucial sentinel microbi noninfecti antigen respiratori tract mediat host innat immun select induct inflammatori respons harm environment exposur toler innocu antigen requir maintain tissu homeostasi integr convers dysregul innat immun respons manifest sustain selfperpetu tissu damag control tissu repair articl review aspect tolllik receptor function relev develop acut lung injuri chronic obstruct lung diseas resist frequent associ microbi infect
PLoS One	12663759	2007-05-29	PMC3003686	21179411	we demonstr antigen chemic coupl surfac liposom consist unsatur fatti acid crosspres antigenpres cell apc cd cell process induct antigenspecif cytotox lymphocyt studi mechan liposomecoupl antigen crosspres cd cell apc investig confoc laser scan microscop analysi demonstr antigen coupl surfac unsaturatedfattyacidbas liposom receiv process mhc class class ii compart antigen coupl surfac saturatedfattyacidbas liposom receiv process class ii compart addit flow cytometr analysi demonstr antigen coupl surfac unsaturatedfattyacidliposom apc environ true saturatedfattyacidliposom kind inhibitor dimethylamilorid dma cytochalasin inhibit pinocytosi phagocytosi apc cultur apc prior antigen puls dma cytochalasin reduc uptak liposomecoupl antigen analysi intracellular traffick liposom antigen confoc laser scan microscopi reveal portion liposomecoupl antigen apc deliv lysosom compart agreement reduct antigen uptak apc antigen present apc inhibit dma reduct ifn product antigenspecif cd cell antigen coupl surfac liposom consist unsatur fatti acid pinocytos apc load class mhc process pathwai present cd cell liposomecoupl antigen expect applic develop vaccin induc cellular immun
Hepat Res Treat	17535926	2016-07-24	PMC3003998	21188201	recommend treatment chronic hepat interferon andor nucleostid analogu lead satisfactori result induct hbvspecif cell therapeut vaccin immunotherapi innov strategi overcom viru persist vaccin commerci hbv vaccin patient result effect control hbv infect suggest formul therapeut vaccin need woodchuck marmota monax preclin model develop therapeut approach chronic hepadnavir infect innov approach combin antivir treatment nucleostid analogu dna vaccin protein vaccin test woodchuck model paper summar data concern therapeut immun gene therapi recombin viral vector approach woodchuck encourag addit potenti innov immunomodulatori strategi evalu anim model
PLoS One	27190247	2010-05-13	PMC3004854	21187950	we describ benefit reconstruct ancestr sequenc ra resequenc microarrai rapid pathogen identif enterobacteriacea rpob sequenc model demonstr sharp improv call rate accuraci rass compar extant sequenc improv attribut lower sequenc diverg rass expand sequenc space cover microarrai extens novel microarrai design strategi virus antimicrobi resist element toxin straightforward
BMC Public Health	20467043	2012-04-01	PMC3005570	21143820	background overwhelm complex respons need sever acut respiratori syndrom sar epidem public health profession small island state barbado measur place improv respons event pandem method data studi collect barbado nation influenza surveil system revit compris ten sentinel site send weekli notif acut respiratori ill ari sever acut respiratori ill sari offic nation epidemiologist hn pandem meet nation pandem plan committe technic command committe conven pharmaceut nonpharmaceut intervent npi implement result meet form basi present paper june barbado report case hn june octob laboratori confirm case hn addit case occur januari outbreak period juneoctob surveil team receiv report ari case compar case period total hospit rate sari year peopl compar peopl barbado pandem respons character strong surveil system combin activ passiv surveil good risk commun strategi strengthen public privat sector partnership effect region intern collabor commun restrict strategi school workplac closur cancel group event util public health measur delai spread viru health care facil struggl provid adequ isol facil conclus number confirm case small surg ari sari case indic impact viru island moder result hn virolog surveil improv local region intern partnership strengthen
BMC Public Health	22511816	2013-01-01	PMC3005574	21143824	global nuclear prolifer bioterror emerg infect challeng nation capac achiev maintain global secur centuri emerg infecti diseas threat develop preliminari version intern health regul ihr health organ current hr major differ compar earlier version includ substanti shift contain border contain sourc event shift small diseas list smallpox plagu cholera yellow fever requir report public health threat shift preset measur tailor respons flexibl deal local situat ground ihr call account call strengthen nation capac surveil control prevent alert respons intern public health emerg tradit short list requir report global partnership collabor human right oblig account procedur monitor evolv regul measur revolv fund vaccin procur pan american health organ paho global health secur maintain respons urban yellow fever paraguai influenza hn pandem 
BMC Public Health	23611287	2003-11-01	PMC3005580	21143830	laboratori core capac countri develop implement intern health regul ihr laboratori servic plai major role kei process detect assess respons notif monitor event develop countri easili adapt wellorgan routin laboratori servic resourcelimit countri consider capac build gap exist paper discuss effort african field epidemiolog network afenet support laboratori capac develop africa region effort rang promot graduat level train program build advanc technic manageri leadership skill inservic short cours train peripher laboratori staff number specif project focu extern qualiti assur basic laboratori system strengthen laboratori manag accredit equip calibr harmon train materi network provis prepackag laboratori kit support outbreak investig evid indic posit effort laboratori capac region opportun exist support rollout project attend addit critic area biosafeti biosecu conclud afenet approach strengthen nation subnat system provid model adopt resourcelimit set subsaharan africa
BMC Public Health	14600110	2006-04-26	PMC3005581	21143831	background uganda current implement intern health regul ihr context integr diseas surveil respons idsr ihr requir countri assess abil nation structur capac resourc meet minimum requir surveil respons report describ the assess undertaken uganda method conduct descript crosssect assess protocol develop health organis data collect tool adapt local administ conveni sampl hr stakehold frequenc analys perform ugandan nation law relev ihr exist adequ support full implement ihr correspondingli design ihr nation focal point nfp surveil activ oper commun limit health sector district design diseas surveil offic idsr technic guidelin case definit infecti zoonot diseas surveil surveil guidelin health facil case definit health facil prioriti diseas list surveil guidelin case definit report tool base idsr strategi lack ihr rapid respons team nation district level lack food safeti chemic radionuclear expert guidelin outbreak respons food chemic radionuclear hazard comprehens prepared plan incorpor ihr lack nation district level nation laboratori polici exist strateg plan draft critic gap hamper effici function nation laboratori network final point entri ihr implement design conclus assess highlight critic gap guid ihr plan process ihr action plan develop foster nation intern public health secur
Immunome Res	16641297	2010-10-01	PMC3009956	21129215	background toxoplasmosi loss life cognit motor function sight vaccin greatli need prevent diseas purpos studi immmunosens approach develop foundat develop vaccin protect human hlaa supertyp three peptid identifi high bind score hlaa supertyp bioinformat algorhythm high measur bind affin hlaa supertyp molecul abil elicit ifn product human hlaa supertyp peripher blood cd cell seroposit seroneg person peptid administ univers cdt cell epitop padr akfvaawtlkaaa formul lipopeptid administ glase pamci we creat prepar induc ifn reduc parasit burden hlaaan hlaa supertyp allel transgen mice glase novel emulsifi synthet tlr ligand facilit develop helper cell respons peptid includ express tachyzoit bradyzoit sporozoit type ii parasit approach identifi initi peptid identifi addit peptid bioinformat bind affin assai studi respons hlaa human cell lastli immun hlaa transgen mice pool peptid administ padr glase pamci effect elicit ifn produc cd splenic cell protect immun includ peptid ksfkdilpk sag amltafflr gra rsfkdllkk gra stfwpcllr sagc ssayvfsvkspa avvsllrllkspa immun elicit robust protect measur reduc parasit burden luciferas transfect parasit luciferin novel hla transgen mous model imag xenogen camera conclus toxoplasma gondii peptid elicit hlaa restrict ifn produc cd cell human mice peptid administ adjuv reduc parasit burden hlaa transgen mice work foundat immunosens base vaccin defin novel adjuv newli identifi peptid vaccin prevent toxoplasmosi hlaa supertyp allel
PLoS Negl Trop Dis	20883160	2018-11-01	PMC3014977	21245921	background ctype lectin dcsign cd major dengu receptor human dendrit cell singl nucleotid polymorph snp promot region cd ag rs suscept infecti diseas reason variat dcsign gene broad influenc viral replic host immun respons method find studi rs snp associ suscept dengu fever df andor dengu hemorrhag fever dhf genotyp analysi taiwanes cohort gener monocytederiv dendrit cell mddc individu aa ag genotyp rs studi viral replic immun respons function valid total dna sampl genotyp includ df dhf nondengu febril ill ofi popul control strong associ ggag genotyp rs risk dhf compar df ofi control aa genotyp associ protect dengu infect compar ofi control mddc individu ag genotyp higher cell surfac dcsign express higher tnf ilp ip product aa genotyp respons dengu infect viral replic mddc ag genotyp lower aa genotyp genotyp mddc reveal increas viral replic addit antiip neutral antibodi conclusionssignific rs snp cd promot contribut suscept dengu infect complic dhf snp ag genotyp cell surfac dcsign express immun augment viral replic
PLoS One	30385576	2013-05-15	PMC3016318	21245928	background infrar thermal imag scanner iti appear attract option mass screen travel influenza publish data perform airport method iti measur cutan temperatur airlin travel agre tympan temperatur measur respiratori sampl predict iti tympan temperatur c influenza infect assess receiv oper characterist roc curv estim sensit specif posit predict ppv find front face iti predict tympan temperatur area roc curv ci set sensit specif ppv popul travel febril definit identifi influenza viru infect travel type type iti predict influenza infect area roc curv sensit specif ppv of influenzaposit travel tympan temperatur screen ci three influenza symptom conclus iti perform moder detect fever studi season epidem influenza type proport influenzainfect travel febril low iti better chanc identifi travel influenzainfect febril ill common influenza infect influenza infect influenza infect afebril find iti effect entri screen travel detect influenza infect intent prevent entri viru countri
PLoS Pathog	23678171	2012-04-01	PMC3017121	21253575	interferoninduc transmembran protein ifitm identifi viral restrict factor inhibit infect mediat influenza viru iav hemagglutinin ha protein ifitm protein restrict infect mediat entri glycoprotein gp marburg ebola filovirus marv ebov consist observ interferon restrict filoviru iav entri process ifitm protein inhibit replic infecti marv ebov observ distinct pattern ifitmmedi restrict compar iav entri process marv ebov restrict ifitm restrict ifitm murin ifitm restrict iav effici inhibit filoviru entri demonstr replic infecti sar coronaviru sarscov entri mediat sarscov spike protein restrict ifitm protein profil ifitmmedi restrict sarscov filovirus iav trypsin treatment receptorassoci sarscov pseudovirion bypass depend lysosom cathepsin bypass ifitmmedi restrict ifitm protein reduc cellular cathepsin activ limit access virion acid intracellular compart data indic ifitmmedi restrict local late stage endocyt pathwai ifitm protein differenti restrict entri broad rang envelop virus modul cellular tropism independ viral receptor express
BMC Genomics	22514506	2012-02-01	PMC3017867	21108826	background identifi bacteria virus complex sampl diseas diagnost product safeti environment character arraybas method proven util detect singl assai reason cost microb thousand sequenc method design panmicrobi detect arrai mda detect virus includ phage bacteria plasmid develop novel statist analysi method identifi mixtur organ complex sampl hybrid arrai arrai broader coverag bacteri viral target base sequenc data probe target microbi detectiondiscoveri arrai literatur familyspecif probe select sequenc viral bacteri complet genom segment plasmid probe design toler sequenc variat enabl detect diverg speci homolog sequenc organ match human genom sequenc blind test spike sampl singl multipl virus mda correctli identifi speci strain clinic fecal serum respiratori sampl mda detect character multipl virus phage bacteria sampl famili speci level confirm pcr conclus mda identifi suit virus bacteria complex sampl
Biochem Res Int	22418848	2018-06-27	PMC3017892	21234377	protein rna chaperon activ ubiquit protein plai role cellular mechan prevent rna misfold loosen misfold structur atp consumpt rna chaperon activ studi vitro vivo oligonucleotid ribozymebas assai function structur divers common chaperon mechan univers motif identifi grow databas protein rna chaperon activ establish base evalu chaperon activ describ assai exact mechan understood more believ disord region protein plai role mechan protein possess rna chaperon activ discuss here
Interdiscip Perspect Infect Dis	29950422	2011-05-02	PMC3017939	21234337	unlik local transmiss pandem influenza hn frequent driven school children case identifi longdist intran intern travel adult studi examin relationship probabl temporari extinct agedepend nextgener matrix focus impact assort prefer mix captur good approxim assort heterogen mix popul contribut nonmainten host host type sustain transmiss risk major epidem greatli diminish mix pattern assort scenario higher proport nonmainten host case elev probabl extinct despit presenc epidemiolog factor undoubtedli influenc delai import subsequ epidem domin adult import case repres factor explain delai geograph spread observ pandem
Epidemiol Perspect Innov	21536720	2012-05-21	PMC3018365	21159178	background effect respond infecti diseas outbreak requir wellinform respons quantit method analyz outbreak data estim kei paramet character spread outbreak includ reproduct number serial interv assum data collect complet realiti report delai undetect case lack sensit specif test diagnos diseas lead report error case count provid insight impact report error estim kei paramet proport case report chang studi period estim kei epidemiolog paramet bias data influenza ahn outbreak la gloria mexico provid estim paramet account report error bias report issu account conclus failur account miss data lead mislead inaccur estim epidem paramet
Int J Alzheimers Dis	22615273	2005-08-16	PMC3018626	21234306	herp simplex implic alzheim diseas viral infect produc alzheim diseas patholog mice viru express protein short contigu amino acid stretch aa vatch viralmatch homolog apo clusterin picalm complement receptor gene product relev alzheim diseas homolog protein express pathogen implic alzheim diseas homolog reiter dna level suggest gene associ studi track infect identifi kei gene demonstr role pathogen caus agent vatch interfer function human counterpart act dummi ligand decoi receptor interactom interfer immunogen antibodi gener respons infect target human counterpart produc protein knockdown gener autoimmun respons kill neuron human homologu resid scenario support immun activ alzheim diseas data classifi alzheim diseas autoimmun disord creat pathogen mimicri kei alzheim diseaserel protein prevent vaccin regular pathogen detect elimin stem immunosuppress antibodi adsorptionrel therapi
PLoS One	22431644	2009-12-01	PMC3020143	21264321	cd cell provid broad immun virus recogn type viral protein develop vaccin capabl induc longliv memori cd cell desir prevent diseas vaccin current exist design cd cell vaccin role cd cell induct mainten memori cd cell remain uncertain studi necess cd cell induct mainten memori cd cell investig mice immun liposomecoupl ctl epitop peptid ovaderiv ctl epitop peptid chemic coupl surfac liposom inocul mice primari secondari ctl respons induc confirm cd cellelimin mice suggest cd cell requir gener memori cd cell case immun liposomecoupl peptid surfacelink liposom antigen capabl induc longliv memori cd cell contribut cd cell applic develop vaccin prevent viral infect virus evad humor immun vari surfac protein influenza virus hiv hcv sar coronavirus ebola virus
PLoS One	19952110	2008-12-30	PMC3021518	21264238	the synthesi inact enzym precursor zymogen serv mechan regul execut select catalyt activ desir time andor site zymogen activ proteolyt cleavag virus encod proteas execut kei proteolyt step viral life cycl describ proof concept therapeut approach fight viral infect erad viral infect cell exclus limit viru product spread hepat viru hcv model design hcv ns proteaseactiv zymogen chimer toxin denot zymoxin recombin construct bacteri plant toxin diphtheria toxin dta ricin chain rta fuse ration design inhibitor peptidesdomain hcv ns proteasecleav linker toxin fuse bind transloc domain pseudomona exotoxin order enabl transloc mammalian cell cytoplasm toxin exhibit ns cleavag depend increas enzymat activ ns proteas cleavag vitro higher level cytotox observ zymoxin appli ns express cell hcv infect cell demonstr potenti therapeut window increas toxin activ correl ns proteas activ treat cell therapeut window larger cell express recombin ns hcv infect cell suggest zymoxin approach appropri applic lifethreaten acut infect higher level activ proteas expect
PLoS One	19116267	2009-12-04	PMC3022008	21264266	the spread infecti diseas commerci airlin travel realist threat light feasibl detect airborn pathogen sensor integr studi conduct comput investig contamin transport aircraft cabin perform studi consider sensor sensit timetoansw size weight power best commerci offtheshelf cot devic conduct comput fluid dynam simul investig three type scenario nomin breath breath minut cough time hour nomin breath sneez time hour nomin breath scenario implement infecti passeng expel air sneez cough state frequenc scenario implement addit case infecti passeng expel sneez hour comput base minut sampl specif cot aerosol collector biosensor biosensor provid answer minut manual prepar step includ princip find steadyst bacteria concentr aircraft high detect case infecti passeng exhal scenario and infecti passeng activ exhal scenario breath fail gener suffici bacteri particl detect scenario gener suffici viral particl detect feasibl sensit sensor cot devic current andor sampl individu passeng need detect bacteria virus aircraft
BMC Immunol	19966311	2018-09-14	PMC3023737	21194475	background immun spike protein sever acut respiratori syndrom sarscoronaviru cov mice produc neutral antibodi prevent infect caus sarscov polyethylenimin pei cation polym effect deliv plasmid dna studi immun respons balbc mice immun intranas rout sar dna vaccin pci peipci complex form examin size peipci nanoparticl appear nm express mrna protein confirm vitro mice immun peipci nanoparticl produc higher sspecif igg sera mucos secretori iga lung wash mice treat pci compar mice challeng pci number cell peipci vaccin mice elev costimulatori molecul cd cd class ii major histocompat complex molecul iad increas cdc dendrit cell cervic lymph node mice peipci vaccin percentag ifn tnf ilproduc cell higher peipci vaccin mice control mice conclus intranas immun peipci nanoparticl induc antigen specif humor cellular immun respons
Mol Cancer	30217848	2010-05-19	PMC3024302	21211062	cancer vaccin promis tool hand clinic oncologist tumorassoci antigen excel target immun therapi vaccin design optim design cancer vaccin combin best tumor antigen effect immunotherapi agent andor deliveri strategi achiev posit clinic vaccin deliveri system rout immun physicalchem deliveri method cancer therapi goal induc immun tumorassoci antigen basic deliveri approach includ physic deliveri achiev higher level antigen product formul microparticl target antigenpres cell apc demonstr effect anim model develop vaccin deliveri system will improv effici clinic trial futur nanoparticl np dendrim polymer np metal np magnet np quantum dot emerg effect vaccin adjuv infecti diseas cancer therapi cellpenetr peptid cpp attract carrier applic drug deliveri gene transfer dna vaccin review will focu util vaccin deliveri system prevent treatment cancer will discuss clinic applic futur prospect cancer vaccin develop
PLoS One	20484516	2011-06-22	PMC3024431	21283725	background influenza viru infect highli contagi sever respiratori disord rise thousand death year efficaci current approv defens strategi includ vaccin neuraminidas inhibitor limit viru frequent acquir resist antigen drift reassort establish novel effect therapeut strategi effect irrespect viral subtyp methodologyprincip find identifi rasphosphoinositid kinas pik signal pathwai hostcel regulatori mechan influenza viru entri bind ra pik involv clathrinindepend endocytosi endosom matur intracellular transport virus result decreas infecti efficaci subtyp influenza virus cell lack raspik interact influenza viru infect trigger ra activ subsequ pik activ earli endosom conclusionssignific demonstr raspik signal axi act hostori mechan viral intern viru incorpor process conserv viru subtyp speci signal pathwai provid target potent welltoler prophylact therapeut broad rang virus
Virol J	21697464	2019-02-20	PMC3024955	21223600	the filovirida famili compris ebola marburg virus lethal hemorrhag fever effect antivir therapi licens vaccin current human pathogen envelop glycoprotein gp ebola viru mediat entri target cell cytotox map highli glycosyl mucinlik region surfac subunit gp gp mechan underli cytotox properti gp unknown gain insight basi gpinduc cytotox hekt cell transient transfect fulllength mucindelet mucin ebola gp plasmid gp local examin rel nucleu endoplasm reticulum er golgi earli late endosom deconvolut fluoresc microscopi fulllength ebola gp observ accumul er contrast gpmucin uniformli express cell local er ebola major matrix protein vp coexpress gp investig influenc gp local gp vp coexpress alter gp local er vp coexpress nucleoprotein np local plasma membran np accumul distinct cytoplasm structur line vimentin structur consist aggresom serv assembl site filovir nucleocapsid collect data fulllength gp gpmucin accumul er close proxim nuclear membran underscor cytotox properti
Virol J	30787149	2015-04-13	PMC3024956	21205330	background rotaviru rv main sever gastroenter children effect vaccin regim rv reduc morbid mortal previou studi demonstr efficaci viruslik particl form rv vp vp vlp recombin adenoviru express rv vp rad elicit protect immun rv efficaci primeboost strategi incorpor vlp rad induc protect immun rv address assess immun effect regimen mice includ rad primevlp boost radvlp vlp primerad boost vlprad rad vlp mice immun vlprad regimen elicit stronger humor mucos cellular immun respons immun regimen rv challeng experi highest reduct viral shed achiev vlprad group compar radvlp vlp rad treatment group reduct rv shed mice correl fecal igg iga conclus vlp primerad boost regimen effect confer immunoprotect rv challeng mice find lai groundwork altern strategi novel rv vaccin develop
PLoS One	25871730	2018-01-05	PMC3025933	21283679	in respiratori infect children diagnost remain neg suggest patient infect unknown pathogen viru discoveri cdnaaflp vidisca viru discoveri method base recognit restrict enzym cleavag site ligat adaptor subsequ amplif pcr direct discoveri unknown pathogen nasopharyng swab difficult high concentr ribosom rna rrna act competitor current studi optim vidisca adjust revers transcript enzym decreas rrna amplif revers transcript hexam oligonucleotid anneal rrna residu cdna synthesi rrna templat reduc oligonucleotid anneal rrna extend dideoxycmodif modif reduct rrna amplif establish improv vidisca sensit high throughput sequenc vidisca eighteen nasopharyng swab analys respiratori virus identifi proper viru major sampl test median load vidisca posit sampl viral genom copiesml rang e optim vidisca subsequ highthroughputsequenc enhanc sensit drastic opportun perform viru discoveri directli patient materi
PLoS One	29305370	2017-11-27	PMC3026784	21283623	background cane toad bufo chaunu marinu notori vertebr pest introduc australia year effort identifi natur occur marinusspecif pathogen biolog control agent unsuccess explor altern approach entail genet modifi pathogen broad host specif longer caus diseas carri gene disrupt cane toad life cycl speci specif manner methodologyprincip find adult beta globin gene select model gene proof concept autoimmun biocontrol method cane toad previou report inject bullfrog tadpol adult beta globin alter form beta globin express metamorph reduc surviv marinu establish time switch tadpol adult globin exist inject marinu tadpol purifi recombin adult globin protein assess behaviour swim speed tadpol jump length metamorph development time metamorphosi weight length development stage protein profil adult globin genet adult globin mrna level measur unabl detect differ treat control anim globin deliveri bohl iridoviru australian ranaviru isol belong iridoviru famili reduc surviv metamorph alter form beta globin express metamorph conclusionssignific time switch tadpol adult globin occur marinu induc autoimmun disrupt metamorphosi short develop time marinu tadpol preclud approach
PLoS One	29180486	2003-07-01	PMC3026800	21283579	the broadspectrum antivir arbidol arb inhibit cell entri envelop virus block viral fusion host cell membran better understand arb mechan action investig interact phospholipid membran peptid demonstr arb associ phospholipid micromolar rang nmr reveal arb interact polar headgroup phospholipid membran interfac fluoresc studi interact arb tryptophan deriv membran peptid reconstitut liposom arb interact tryptophan micromolar rang interestingli appar bind affin lipid tryptophan residu compar arb ic hepat viru hcv membran fusion tryptophan residu membran protein bind preferenti membran interfac data arb increas strength viru glycoprotein interact membran dual bind mode involv aromat residu phospholipid complex inhibit expect viral glycoprotein conform chang requir fusion process find pave design drug exhibit arblik interfaci membran bind properti inhibit earli step viru entri attract target combat viral infect
PLoS One	12832676	2013-05-28	PMC3029370	21304591	develop effect vaccin prevent influenza highli pathogen avian influenza hpai caus influenza viru iav subtyp hn challeng goal studi design construct recombin influenza vaccin candid fuse hemagglutinin ha fragment aanhuihn fc human igg hafc foldon fc hafdc evalu immun respons crossprotect diverg strain hn viru recombin vaccin induc strong immun respons vaccin mice react ha protein inactiv heterolog hn viru protein crossneutr infect homolog strain clade heterolog strain belong clade hn pseudovirus three heterolog strain clade hn live viru importantli immun vaccin candid hafdc provid complet crossclad protect highdos lethal challeng strain hn viru cover clade test mous model studi suggest recombin fusion protein hafdc develop efficaci univers hn influenza vaccin provid crossprotect infect diverg strain highli pathogen hn viru
Virol J	23716702	2013-04-24	PMC3030507	21241515	background pneumonia caus adenoviru infect sever adenoviru serotyp commonli associ lower respiratori tract diseas outbreak report outbreak case sever pneumonia death infant shaanxi provinc china sampl adenoviru ad primari pathogen coinfect strain adenoviru strain enteroviru isol pharynx swab posit amplif adenoviru three coinfect respiratori syncyti viru posit rhinoviru posit parainfluenza neg adenoviru type adenoviru posit sampl hadv three hadv weak perform sequenc entir hexon gene adenoviru sequenc analyz adenoviru serotyp isol show nucleic acid homolog strain compar refer strain hadv genbank access number ay acut phase serum sampl patient sampl posit elisa detect hadv iga neutral titer convalescentphas sampl time higher acutephas sampl pair conclus conclud adenoviru viral pathogen hadv coinfect respons outbreak report infant pneumonia outbreak caus adenoviru serotyp shaanxi provinc china
J R Soc Interface	23616657	2012-07-11	PMC3033019	20573630	there limit understand kei determin spatial spread influenza pandem opportun elucid spatial determin spread larg scale better character spread major wave fit rang citytoc transmiss model mortal data collect popul centr england wale citi graviti model citytoc contact explor popul size distanc spread diseas test assumpt densiti depend connect citi emploi bayesian markov chain mont carlo method estim paramet model popul infect distanc densiti depend infer transmiss tree countri england wale model estim degre densiti depend connect citi prefer devianc criterion comparison earli major wave long distanc infect interact predomin local infect event epidem widespread fewer dispers citi statist power lack estim popul size depend degre densiti depend prefer model depend distanc find paramet estim england wale dataset appli data likelihood penalti
J Neuroinflammation	22787216	2015-02-01	PMC3033336	21235806	background complement protein activ product associ neuropatholog alzheim diseas ad receptor antagonist suppress neuropatholog murin model ad tg xtg genet defici cq tg mous model accumul fibrillar plaqu complement suffici tg reactiv glia decreas neuron integr improv suggest detriment consequ complement activ ad goal studi defin role classic complement activ pathwai progress patholog xtg mous develop tangl addit fibrillar plaqu close reflect human ad patholog assess influenc complement model ad higher level complement hemolyt activ method xtg mice defici cq xtgq gener xtg xtgq backcross bub mous strain higher vitro hemolyt complement activ mice ag perfus brain section stain patholog marker analyz proinflammatori marker express xtgq mice amount fibrillar amyloid reactiv glia hyperphosphoryl tau cqsuffici xtg ag analyz xtg xtgq bub background develop patholog earlier origin xtg background presenc cq neuropatholog proinflammatori marker contrast transgen model ad cq c immunoreact undetect plaqu xtg background associ reactiv astrocyt surround plaqu importantli properdin compon altern complement pathwai associ plaqu model conclus contrast investig transgen model ad develop neuropatholog xtg mice progress slower murin model influenc fibrillar amyloid mediat activ classic complement pathwai suggest altern complement pathwai activ cindepend cleavag account detriment effect mice prevent receptor antagonist pauciti complement activ factor slower kinet progress patholog xtg model diseas
PLoS Pathog	25611534	2018-09-02	PMC3033372	21304939	refold viral class membran fusion protein nativ state trimerofhairpin structur promot entri virus cell structur bovin leukaemia viru transmembran glycoprotein tm identifi group asparagin residu membranedist trimerofhairpin strikingli conserv diverg virus asparagin essenti surfac displai prefusogen envelop substitut residu dramat disrupt membran fusion data indic electrostat interact chlorid ion asparagin residu promot assembl profoundli stabil fusionact structur requir viral envelopemedi membran fusion blv tm structur reveal chargesurround hydrophob pocket central coil coil interact basic residu cluster pocket critic membran fusion form target peptid inhibitor envelop function chargesurround pocket electrostat interact small ion common class fusion protein suggest small molecul target motif prevent assembl trimerofhairpin therapeut inhibitor viral entri
Respir Res	30285588	2004-05-01	PMC3033824	21261956	background type ii alveolar epitheli cell aecii role innat immun system propos plai role antigen present lymphocyt contradictori publish concern surfac express molecul lymphocyt respons mix lymphocyt cultur aecii cell fresh cell explain observ discrep studi aim defin relev model accessori antigen present cell carefulli compar model express surfac molecul effici antigen present method compar flow cytometri surfac express major marker involv immunolog synaps cell popular model type ii alveolar epitheli cell freshli isol cell hladr cd cd icosl cd cd surfac express studi rest condit ifntnf treatment inflammatori cytokin modul marker major differ cell type low surfac express hladr cell compar constitut express freshli isol aecii surfac express costimulatori molecul famili low cd icosl bh absent cd freshli isol cell cell ifn tnf increas express classic costimulatori molecul cd icam cd lfa adhes molecul implic independ costimulatori signal express cell type conclus constitut express mhc class ii molecul altern costimulatori molecul freshli isol aecii render cell good model studi antigen present
BMC Res Notes	15115856	2008-11-19	PMC3035198	21214902	background health organ alert hn influenza pandem led implement measur admiss patient flulik symptom instruct adopt greek nation health system aim studi retrospect examin characterist subject admit unit infecti diseas symptom indic hn infect identifi differ hn posit neg patient patient emerg depart flulik symptom sore throat cough rhinorhea nasal congest fever admit unit infecti diseas pharyng nasopharyng swab swab test realtim reversetranscriptasepolymerasechainreact rtpcr find patient divid group group compris hn posit patient group control group compris hn neg patient group differ term patient ag comorbid length hospit temperatur elev hypoxemia renal liver function differ sever admiss creactiv protein crp white blood count wbc higher group group admiss obes patient group patient group bodi mass bmi lower hn posit hn neg patient conclus major patient group young male adult crp wbc bmi higher hn neg patient final clinic cours patient group mild unev
PLoS One	19019082	2010-01-01	PMC3035654	21347434	terminationdepend reiniti coordin regul express bm openread frame orf dicistron influenza segment rna start codon bm orf overlap codon orf pentanucleotid uaa ug ribosom termin codon reiniti translat overlap aug bm synthesi requir presenc translat nt rna upstream uaa ug termin upstream ribosom bind site turb region tether ribosom subunit mrna termin short region turb motif complementar helix rrna implic process provid evid direct interact mrna rrna antisens oligonucleotid target function analysi yeast cell turb bind initi factor eif protein stimul reiniti wildtyp defect turb exogen stabilis ribosomemrna interact posit turb respect uaa ug overlap crucial termin downstream complementari sequenc inhibit process reduc tether report mrna restart codon move downstream terminationreiniti inhibit abolish site reiniti flexibl reiniti distant aug inhibit eifgdeplet rrl suggest tether subunit move distanc requir linear scan
PLoS One	20375547	2004-05-12	PMC3036576	21347398	realtim pcr techniqu commonli detect viral genom human specimen requir valid extern intern control ec ic ic clinic sampl monitor extract revers transcript amplif step order detect falseneg pcrinhibit error technic procedur perform larg scale evalu bacteriophag ic routin molecular diagnosi allow propos simpl standard procedur design specif ec dna rna virus ii dna ms rna phage ic routin diagnosi technic format phage ic optimis valid subsequ ms ic evalu routin realtim pcr rtpcr virolog diagnost test seri clinic sampl repres distinct specimen type laboratori detect varieti dna rna virus frequenc ineffici detect ic analyz natur sampl inhibitor enzymat reaction detect high frequenc specif sampl type heparin blood bone marrow bronchoalveolar liquid stool ms phage ic prove costeffect flexibl adapt technic procedur realtim pcr detect virolog repres valuabl strategi enhanc qualiti routin molecular diagnosi laboratori inhous design diagnost system conveni associ specif synthet ec high rate inhibitor observ varieti specimen type stimul elabor improv technic protocol extract amplif nucleic acid
Int J Environ Res Public Health	15141005	2013-09-25	PMC3037052	21318006	the main purpos studi investig climat chang blood vesselrel heart diseas hypertens estim associ econom damag paper panel data model conting valuat method cvm approach appli empir indic number death cardiovascular diseas increas variat temperatur increas importantli number death cardiovascular diseas increas altern ipcc climat chang scenario the cvm approach person pai us year order avoid increas mortal rate cardiovascular diseas caus climat chang
BMC Infect Dis	24067959	2014-12-10	PMC3037318	21266085	background describ knowledg attitud critic care clinician hn influenza pandem method survei conduct intens care unit provinc china questionnair distribut complet three fiftysix respond report experi care hn patient despit fact respond ultim finish hn train program admit knowledg hn influenza total respond express willing care hn patient independ variabl associ increas likelihood care patient logist regress analysi physician nurs profession odd ratio knowledg train prior patient care odd ratio confid to protect patient odd ratio conclus critic care clinician report poor knowledg hn influenza finish relev knowledg train program implement appropri educ program improv complianc infect control measur willing work pandem
PLoS Pathog	28989404	2005-01-01	PMC3037360	21347350	grow experiment evid indic addit physic virion compon nonstructur protein hepat viru hcv intim involv orchestr morphogenesi dispens hcv rna replic nonstructur viral protein ns suggest plai central role hcv particl assembl despit genet evid understand ns proteinprotein interact role product infecti particl coimmunoprecipit andor fluoresc reson energi transfer fluoresc lifetim imag microscopi analys studi interact ns viroporin hcv glycoprotein addit alanin scan insert mutagenesi mutat context infecti viru investig function role ns hcv assembl final subcellular local ns mutant analyz confoc microscopi data demonstr molecular interact ns context infecti viru ns accumul time endoplasm reticulumderiv dot structur coloc envelop glycoprotein compon replic complex close proxim hcv core protein lipid droplet locat essenti viru assembl ns transmembran region crucial interact subcellular local specif mutat core envelop protein nsa report abolish viral assembl chang subcellular local ns protein observ indic ns protein attract envelop protein assembl site crosstalk nonstructur protein viru assembl
PLoS One	16094718	2014-10-26	PMC3037951	21347303	background hand foot mouth diseas hfmd outbreak lead clinic fatal complic increas late asia pacif region outbreak hfmd peak warmer season year underli factor annual pattern reason upsurg trend establish studi analyz shortterm chang weather incid hfmd singapor method rel risk weekli hfmd case temperatur rainfal estim period time seri poisson regress model allow overdispers smooth allow nonlinear relationship weather weekli hfmd case adjust season longterm time trend addition autocorrel control weather allow lag hfmd incid week weekli temperatur rainfal statist associ hfmd incid time lag week increas maximum temperatur elev risk hfmd incid ci simultan mm increas weekli cumul rainfal mm increas risk hfmd ci mm opposit mm increas rainfal decreas incid ci differ minimum maximum temperatur greater elev risk hfmd ci conclus find strong associ hfmd weather exact reason associ studi maximum temperatur moder rainfal preced hfmd incid help control curb upsurg trend hfmd
Acta Vet Scand	25363763	2009-12-01	PMC3038973	21269522	background felin endogen retroviru contain genom cat viru contamin live canin vaccin base cultur felin cell vivo infect acut subacut pathogen viral prolifer viru evalu experiment infect dog method specif pathogen free dog divid three group group consist femal male dog dog subcutan inocul neck stock viru group inactiv viru suspens group cell cultur medium group neg control assess blood cell count biochem properti blood sampl group collect dai inocul prior inocul and dai postinocul result experiment period dai dog inocul viru clinic sign increas rectal temperatur abnorm blood biochem characterist includ creactiv protein compar neg control reisol viru buffi coat cell group dog addition detect proviru genom dna isol peripher blood leukocyt lymph node spleen sternal bone marrow cell conclus sign viru prolifer subcutan infect dog potenti risk caus infect viru dog assess studi suspect viru virul dog
PLoS One	20174457	2009-12-09	PMC3041802	21364999	background coronavirus sever acut respiratori syndrom sar coronaviru scov mous hepat viru mhva evolv strategi disabl innat immun system product replic spread infect papainlik proteas domain plp catalyt domain nonstructur protein nsp mhva encod deubiquitinas dub inactiv ifn regulatori factor irf type interferon ifn respons princip find provid evid plp target tankbind kinas tbk upstream kinas irf ifn signal pathwai overexpress experi plp deubiquitin tbk reduc kinas activ inhibit ifn report activ albeit promiscu deubiquitin cellular protein plp inactiv tbk ifn respons tnf receptor associ factor traf defici cell suggest target tbk suffici plp inhibit irf activ notion support vitro kinas assai prior treatment tbk plp inhibit kinas activ phosphoryl irf intrigu plp overexpress system mhva infect system prove plp form inact complex tbk irf cytoplasm presenc plp stabil hypophosphoryl irftbk complex dosedepend manner conclus plp inactiv tbk prevent irf nuclear transloc inhibit ifn transcript activ identif conserv dub activ plp suppress ifn signal provid clue develop therapeut coronavirus infect
Ital J Pediatr	20007272	2004-08-01	PMC3042010	21281502	streptococc pharyng common patholog paediatr ag joint agreement manag condit author recommend perform microbiolog investig suspect bacteri case order treat confirm case antibiot prevent suppur complic acut rheumat fever differ author consid pharyng streptococc benign selflimit diseas consequ routin perform microbiolog test point judici antibiot reserv antimicrobi treatment wellselect case calcul number patient need treat prevent complic upper respiratori tract infect includ sore throat centor score order evalu risk streptococc infect debat interpret test vari consider penicillin consid treatment oral amoxicillin accept better palat suitabl option macrolid reserv rare case prove allergi lactam cephalosporin patient allerg penicillin except type hypersens propos treat relaps
BMC Infect Dis	15289516	2005-05-12	PMC3044667	21299840	background direct immunofluoresc assai dfa rapid inexpens method detect respiratori virus surveil epidemiolog studi publish base sole dfa includ respiratori picornavirus human metapneumoviru hmpv wish evalu dfa epidemiolog studi longterm observ respiratori virus includ respiratori picornavirus hmpv method children hospit respiratori ill univers hospit bern screen dfa common respiratori virus includ adenoviru respiratori syncyti viru rsv influenza parainfluenza viru assai respiratori picornavirus hmpv describ epidemiolog pattern respiratori virus detect dfa nasopharyng aspir collect patient year period addit assai respiratori picornavirus hmpv rais proport posit dfa respiratori picornavirus common virus detect patient year season pattern ag distribut studi virus agre report literatur hmpv epidem unexpect size observ conclus dfa valid rapid flexibl inexpens method addit assai respiratori picornavirus hmpv broaden rang viral detect dfa pcr era adapt method long term surveil respiratori virus pediatr popul
PLoS One	15890949	2003-03-01	PMC3044706	21383981	background analysi nih fund strongest predictor fund disabilityadjust lifeyear dali explain varianc fund congress request institut medicin iom evalu priorityset criteria nih fund iom recommend greater consider diseas burden examin associ current burden fund chang time method analyz public data nih fund common condit measur diseas burden health organ global burden diseas studi nation databas assess relationship diseas burden nih fund dollar univari multivari loglinear model evalu measur diseas burden sensit analys examin associ futur burden current futur measur diseas burden newli standard nih account method univari multivari analys diseasespecif nih fund level increas burden diseas measur dali account fund level variat factor predict fund multivari model condit receiv fund greater expect base diseas burden aid diabet mellitu perinat condit depress injuri chronic obstruct pulmonari diseas underfund estim futur burden current futur diseas burden altern nih account method conclus current level nih diseasespecif fund correl modestli diseas burden correl improv decad
BMC Bioinformatics	12584316	2014-02-03	PMC3045299	21272346	background investig covari interact group associ standard regress analys relationship respons variabl exposur difficult character relationship nonlinear linear model techniqu captur nonlinear content statist learn sl techniqu kernel capabl address nonlinear problem make parametr assumpt techniqu produc find relev epidemiolog interpret simul casecontrol studi contrast embed characterist separ boundari produc specif sl techniqu logist regress lr model repres parametr approach sl techniqu compris kernel map combin perceptron neural network lr model epidemiolog interpret sl method modifi produc analog interpret gener odd ratio comparison sl approach capabl gener odd ratio main effect risk factor interact better captur nonlinear relationship exposur variabl outcom comparison lr conclus integr sl method epidemiolog improv understand interpret complex exposurediseas relationship
PLoS One	24550280	2011-06-07	PMC3045447	21364899	background earli detect lung cancer improv chanc success treatment lung soft tissu complex threedimension configur convent xrai imag base pure absorpt low contrast imag soft tissu contrast agent difficult adequ lung lesion convent xrai imag method studi emerg imag techniqu inlin xrai phase contrast imag ilxpci power techniqu enabl highresolut investig soft tissu contrast agent appli ilxpci observ lung intact mous purpos defin quantit microstructur lung find threedimension model lung establish provid excel view lung airwai highlight ilxpci visual assess alveoli rare studi three dimens precis view individu alveolu achiev morpholog paramet diamet alveolar surfac area measur paramet great diagnosi diseas alveolu alveolar scar conclus indic ilxpci abil repres complex anatom structur lung offer perspect diagnosi respiratori diseas guid futur work studi respiratori mechan alveoli level
PLoS One	21548588	2018-01-11	PMC3046172	21386965	the nasopharynx ecolog nich commens bacteria potenti respiratori invas pathogen streptococcu pneumonia haemophilu influenza neisseria meningitidi disturb balanc nasopharyng np microbiom involv onset symptomat infect pathogen occur fall winter unknown season infect pattern associ concomit chang np microbiota young children gener prone respiratori invas infect character np microbiota healthi children barcod pyrosequenc vv hypervari region srrna gene compar microbiota composit children sampl winterfal children sampl spring sequenc gener repres taxonom phyla specieslevel phyla type otu predomin phyla proteobacteria firmicut bacteroidet actinobacteria fusobacteria moraxella haemophilu streptococcu flavobacteria dolosigranulum corynebacterium neisseria predomin genera interindividu variabl high otu level core microbiom defin microbiota profil vari season fallwint predomin proteobacteria rel abund sequenc versu spring fusobacteria absolut abund children versu spring spring predomin bacteroidet rel abund versu fallwint absolut abund versu fallwint firmicut increas brevibacillu lactobacillu speci absolut abund versu fallwint bacteroidet speci gener healthi ecosystem observ season effect attribut antibiot viral coinfect np microbiota young children highli divers appear season differ independ antibiot viral coinfect
Biol Direct	29322778	2006-10-19	PMC3046898	21324187	background elhaik graur josic comment genom order zcurv elhaik al direct quantiti defin denot correspond base frequenc zcurv three dimension curv repres dna sequenc manner uniqu reconstruct elhaik al major claim previou map system regular tetrahedron calcul radiu inscrib sphere mathemat error exponenti distribut narrowli distribut rang base chargaff second pariti rule pr equival shannon entropi deriv zcurv suffer dimension base analysi bacteri genom compon contribut varianc elhaik al mistakenli neglect paramet formula text calcul radiu inscrib sphere exponenti distribut restat previou conclus rang paraphras suggest rang elhaik al incorrectli disregard deviat pr treat deviat altogeth reduc variabl function singl variabl appli treatment dna sequenc basi demonstr invalid elhaik al confus numer small biolog insignific disregard distribut purinepyrimidin aminoketo base compon variat gc content rich locat replic origin bacteri archaeal genom studi gene recognit speci conclus elhaik al confus singl number zcurv seri coordin distinct case studi zcurv invalid equival deriv critic elhaik graur josic wrong review articl review erik van nimwegen
Virol J	17053248	2011-09-14	PMC3046927	21310026	background human metapneumoviru hmpv identifi viru acut respiratori tract infect arti infant children studi seroepidemeolog hmpv limit china assess seropreval hmpv infect china test total serum specimen presenc antihmpv igg antibodi children adult free acut respiratori ill beij china hmpv nucleocapsid protein antigen control human serum antibodi protein human respiratori syncyti viru hrsv viral agent respons ari children seroposit rate hmpv increas steadili ag mo ag rate drop mo yr ag seroposit rate hrsv increas steadili ag mo ag children ag month year seroposit rate antihrsv igg antibodi higher hmpv addition igg antibodi titer hmpv hrsv higher adult young children consist seroposit rate geometr titer antihmpv igg antibodi lower antihrsv igg antibodi children ag month year conclus indic hrsv exposur hmpv ubiquit beij popul seropreval antihmpv igg antibodi lower hrsv children month year suggest number repeat infect respons infect
Curr Genomics	21918226	2011-12-01	PMC3048312	21532834	genet materi plant distribut nucleu plastid mitochondria plastid central role carri photosynthesi plant cell plastid transform popular altern nuclear gene transform advantag high protein level feasibl express multipl protein polycistron mrna gene contain lack pollen transmiss progress plastid engin addit model plant tobacco transplastom crop plant gener possess higher resist biotic abiot stress molecular pharm mini review will discuss featur plastid dna advantag plastid transform will exampl transplastom plant develop plastid engin applic plastid transform
PLoS One	21971426	2012-03-09	PMC3048401	21390235	background madagascar despit influenza surveil establish etiolog preval virus influenza caus influenzalik ill ili methodologyprincip find juli june collect respiratori specimen patient present ili symptom public privat clinic antananarivo capit citi madagascar ili defin bodi temperatur cough symptom sore throat rhinorrhea headach muscular pain maximum durat dai screen specimen multiplex real time revers transcript andor polymeras chain reaction assai detect respiratori virus detect respiratori virus sampl influenza viru common viru rhinoviru rsv adenoviru coronaviru oc influenza viru parainfluenza viru parainfluenza viru coinfect occur infect patient rhinoviru detect viru children year detect viru associ ili ag group compar year risk detect viru higher risk detect rsv adenoviru rhinoviru adenoviru infect occur year round rsv influenza viru coronaviru oc defin period circul conclus studi respiratori virus plai role ili malagasi commun children year data provid better understand viral etiolog outpati ili describ time virus ag group period circul
Virol J	22408109	2016-12-05	PMC3048564	21310053	background outbreak avian influenza ai caus infect low pathogen hn virus occur poultri seriou econom loss asia middl east difficult erad hn viru low pathogen frequent caus appar infect control ai assess hn viru acquir pathogen h virus studi investig nonpathogen hn viru achickenyokohamaaq hn acquir pathogen chicken pair dibas amino acid residu introduc cleavag site ha molecul rgysub hn basic amino acid residu ha cleavag site replic mdck cell absenc trypsin consecut passag air sac chick acquir intraven pathogen chicken addit passag chicken inocul intraven passag viru rgysubp hn di indic pathogen compar highli pathogen avian influenza virus hpaiv defin organ anim health oie chicken inocul viru intranas rout surviv show clinic sign hand avirul hn strain aduckhokkaidovac vac hn acquir intranas pathogen pair dibas amino acid residu introduc cleavag site ha passag air sac inocul chick conclus demonstr hn viru potenti acquir intraven pathogen chicken morbid nasal rout infect lower hn hpaiv
BMC Fam Pract	27930303	2012-06-01	PMC3050701	21332976	background clinic proven overthecount otc treatment option increasingli selfmanag acut sore throat aim studi determin analges sensori benefit amylmetacresoldichlorobenzyl alcohol amcdcba throat lozeng formul variant amcdcba warm lozeng amcdcba cool lozeng compar unflavour nonmed placebo lozeng relief acut sore throat upper respiratori tract infect method multicentr randomis doubleblind singledos studi adult patient acut sore throat randomli assign receiv amcdcba warm lozeng amcdcba cool lozeng unflavour nonmed lozeng match size shape demulc baselin assess patient receiv assign lozeng complet rate assess timepoint minut post dose analges properti assess compar sever throat sore sore throat relief rate difficulti swallow throat numb function sensori emot benefit assess amcdcba warm amcdcba cool lozeng induc analges function sensori emot effect compar unflavour nonmed lozeng sore throat relief improv throat sore difficulti swallow throat numb observ earli minut last hour post dose sensori benefit warm cool associ amcdcba warm amcdcba cool lozeng experienc dose case last long lozeng dissolv emot benefit feel better happier distract frustrat report amcdcba throat lozeng variant differ advers event compar unflavour nonmed lozeng conclus amcdcba warm amcdcba cool lozeng welltoler effect otc treatment option offer function sensori emot benefit patient acut sore throat rapid efficaci effect provid trial registr isrctn isrctn
Virol J	22712035	2006-11-28	PMC3050824	21342525	background human cytomegaloviru hcmv preval congenit viral infect unit state europ caus morbid mortal mother child hcmv opportunist pathogen immunocompromis individu includ human immunodefici viru hiv infect patient aid solid organ allogen stem cell transplant recipi current treatment hcmvassoci diseas insuffici emerg druginduc resist cytotox necessit novel approach limit hcmv infect aim studi develop therapeut peptid target glycoprotein gb major glycoprotein hcmv highli conserv herpesvirida famili inhibit fusion viral envelop host cell membran prevent hcmv entri infect wimleywhit interfaci hydrophob scale wwih region gb identifi displai high potenti interact lipid bilay cell membran hydrophob surfac protein abil synthet peptid analog wwihsposit sequenc hcmv gb inhibit viral infect evalu human foreskin fibroblast hff infect townegfp strain hcmv moi preincub peptid rang concentr nm gfpposit cell visual hour postinfect fluoresc microscopi analyz quantit flow cytometri peptid inhibit hcmv infect demonstr inhibitori concentr curv indic peptid possess distinct biophys properti peptid inhibit viral infect concentr and inhibit concentr m peptid inhibit infect concentr m concentr peptid individu fail inhibit viral infect combin inhibit hcmv infect concentr conclus peptid design target put fusogen domain gb provid basi develop novel therapeut prevent hcmv infect
PLoS One	17476782	2012-10-24	PMC3050921	21408132	background streptococcu sui infect emerg zoonosi increas public health problem south east asia common acut bacteri mening adult vietnam risk factor underli diseas method find casecontrol studi appropri hospit match commun control patient conduct june potenti risk factor assess standard questionnair investig throat rectal sui carriag case control pig realtim pcr cultur swab sampl recruit case sui mening hospit control commun control multivari analysi risk factor identifi sui infect compar control group includ eat high risk dish includ dish undercook pig blood pig intestin ci ci occup pig ci ci exposur pig pork presenc skin injuri ci ci sui specif dna detect rectal throat swab patient cultur rectal sampl detect sampl healthi individu patient sui infect conclus case control studi largest prospect epidemiolog assess diseas identifi risk factor associ sui bacteri mening eat high risk dish popular part asia occup exposur pig pig product prepar pork presenc skin lesion risk factor address public health campaign aim prevent sui infect
Vet Res	23097437	2009-01-21	PMC3052182	21345199	avian paramyxovirus apmv frequent isol domest wild bird separ serotyp apmv case apmv infect nonavian speci investig apmv present consid human vaccin vector studi evalu replic pathogen apmv serotyp hamster hamster inocul intranas viru monitor clinic diseas patholog histopatholog viru replic seroconvers basi criteria apmv serotyp replic hamster apmv produc mild inappar clinic sign hamster apmv produc moder diseas gross lesion observ pulmonari surfac hamster infect apmv petechi ecchymot hemorrhag replic of apmv apmv confirm nasal turbin lung indic tropism respiratori tract histolog infect lung lesion consist bronchointerstiti pneumonia vari sever nasal turbin blunt loss cilia epithelium line nasal septa major apmvinfect hamster exhibit transient histolog lesion resolv dai post infect dpi hamster infect apmv produc serotypespecif neutral antibodi confirm viru replic demonstr apmv serotyp capabl replic hamster minim diseas patholog
Vet Res	19158265	2018-05-20	PMC3053234	21366902	antimicrobi resist primari public anim health issu persist spread resist strain popul contribut mainten reservoir lead treatment failur experiment trial carri studi horizont transmiss fluoroquinoloneresist escherichia coli strain inocul nave pig nave contact pig posit count fluoroquinoloneresist coli dai contact reinfect inocul pig caus newli contamin anim suspect maximum likelihood method base susceptibleinfectioussuscept si model determin transmiss paramet transmiss level identifi depend quantiti bacteria infect individu lowshedd bacteri count resist coli faec cfug ii high shedder bacteri count cfug transmiss anim pivot explain persist resist bacteria pig herd
PLoS One	29595997	2008-09-16	PMC3055876	21412418	background vaccin core compon mitig influenza pandem phn vaccin program efficaci depend popul complianc examin gener popul decisionmak phn vaccin modifi theori plan behaviour tbp methodolog conduct longitudin studi collect data introduct phn vaccin hong kong structur equat model sem test modifi tpb explanatori util vaccin uptak adult princip find subject complet baselin followup survei report likelyveri likelycertain vaccin intent month report receiv phn vaccin percept low risk phn concern advers effect vaccin primari justif avoid phn vaccin greater perceiv vaccin benefit concern vaccin sideeffect greater adher social norm vaccin anticip higher regret vaccin perceiv higher selfefficaci vaccin histori season influenza vaccin associ higher intent receiv phn vaccin turn predict selfreport vaccin uptak social norm anticip regret vaccin intent posit associ account varianc vaccin plan turn subsequ predict selfreport vaccin uptak account varianc report vaccin behaviour conclusionssignific perceiv low risk phn perceiv high risk phn vaccin inhibit phn vaccin uptak tpb addit compon contribut intend vaccin uptak social norm anticip regret associ vaccin intent plan vaccin plan proxim determin uptak phn vaccin intent intent unreli predictor futur vaccin uptak
PLoS One	18796655	2005-05-01	PMC3056798	21423764	lossoffunct mutat slcapendrin preval deaf deaf vestibular dysfunct correspond mous model slca associ enlarg acidif membran labyrinth relat onset express hco transport pendrin lumin ph enlargementassoci epitheli cell stretch determin express immunocytochemistri cell stretch digit morphometri ph doublebarrel ionselect electrod pendrin express endolymphat sac embryon dai cochlear hookregion utricl saccul ampulla upper turn cochlea epitheli cell stretch slca mice began ph chang occur cochlea endolymphat sac postnat dai stria vasculari outer sulcu reissner membran epitheli cell utricular saccular transit cell stretch sensori cell cochlea utricl saccul differ slca slca mice structur develop stria vasculari includ vascular retard slca mice conclus data demonstr enlarg stretch nonsensori epitheli cell preced lumin acidif cochlea endolymphat sac stretch lumin acidif alter celltocel commun lead observ retard develop stria vasculari step path deaf slca mice human lack function pendrin express
Evid Based Complement Alternat Med	15860716	2009-06-01	PMC3057194	21423688	tylosema esculentum marama bean tuber food tradit medicin diarrhoea southern africa rotavirus rv major diarrhoea infant young children immunocompromis peopl domest anim work determin antirv activ marama bean tuber ethanol water extract case intestin enterocyt cell human infant adult pig clab adult bovin cieb origin marama cotyledon ethanol extract mce cotyledon water extract mcw rv cytotox cell test seed coat tuber extract variabl level cytotox marama cotyledon ethanol water extract mce mcw resp mgml seed coat extract msce seed coat water extract mscw mgml ethanol increas cell surviv enhanc surviv cytopath effect rv vitro preincub treatment marama extract enhanc nitric oxid releas cell enhanc ter cm enterocyt barrier coincub rv marama cotyledon seed coat extract inhibit virion infect interfer replic accumul nitric oxid marama extract promis microbicid rv
Virol J	19485756	2014-12-02	PMC3059288	21375748	background exhal breath condens ebc sampl consid invent novel method isol respiratori virus method studi volunt experienc upper airwai infect recruit winter earli spring half winter ninetynin ebc screen commonli circul respiratori virus investig effici viru isol ebc nasal swab parallel subset volunt combin ecov devic rtube allow registr exhal volum breath frequenc collect number exhal viral particl liter air minut theoret estim viral screen detect virus ebc andor nasal swab rhinoviru human respiratori syncyti viru influenza influenza rhinoviru detect ebc ebc influenza posit report viral detect rate ebc lower detect rate observ nasal swab conclus promis ebc collect rtube reliabl diagnosi respiratori infect
Proteome Sci	25668673	2008-10-08	PMC3060854	21385394	background avian infecti bronchiti ib seriou diseas econom chicken caus avian infecti coronaviru ibv remain limit compar protein express profil chicken embryon tissu respons ibv infect ovo studi analyz chang protein express trachea kidnei tissu chicken embryo ibv infect ovo twodimension gel electrophoresi de coupl matrixassist laser desorptionion timeofflight tandem mass spectrometri malditoftof ms differenti express protein tracheal tissu differenti express protein kidnei tissu identifi protein cytoskeleton bind calcium ion stress respons antioxid macromolecular metabol alter protein confirm mrna level realtim rtpcr western blot analysi confirm chang annexin hspb ibv infect conclus best knowledg perform analysi proteom chang chicken embryon trachea kidnei tissu ibv infect ovo data facilit better understand pathogenesi ibv infect
PLoS One	18842706	2012-03-01	PMC3060926	21437206	the antigen structur membran protein hemagglutinin ha ahn influenza viru dissect highthroughput screen method complex antisera approach involv gener yeast cell librari displai pool random peptid control length cell surfac round fluorescenceactiv cell sort fac antisera mous goat human amino acid residu frequenc appear antigen peptid primari sequenc structur level determin identifi hot spot antigen region unexpectedli antigen structur antisera antigen region identifi locat conserv ha stem region respons membran fusion find corrobor studi crossneutr subtyp antibodi recogn ha stem region antigen peptid identifi provid clue creat peptid vaccin better access memori cell better induct crossneutr antibodi ha protein scheme studi enabl direct map antigen region viral protein recogn antisera dissect antigen structur viral protein
Virol J	22180660	2018-02-14	PMC3061939	21385403	background classic swine fever viru csfv belong genu pestiviru famili flavivirida virul strain classic swine fever viru csfv sever diseas pig character immunosuppress thrombocytopenia dissemin intravascular coagul econom loss pig industri worldwid method reveal proteom chang swine serum acut stage lethal csfv infect pig inocul virul csfv shimen strain remaind serv uninfect control serum sampl dai postinfect swine stage clinic symptom increas rectal temperatur sampl treat remov serum albumin immunoglobulin igg subject twodimens differenti gel electrophoresi quantit intens analysi reveal protein spot show fold quantit alter express ten spot identifi malditof ms ltq ms express protein increas decreas csfvinfect pig function protein includ blood coagul antiinflammatori activ angiogenesi conclus protein alter express implic pathogenesi classic swine fever provid clue identif biomark classic swine fever earli diagnosi
J Biomed Sci	29444939	2013-02-01	PMC3062584	21385449	antigenspecif immunotherapi dna vaccin emerg attract approach control tumor novel cancer therapi involv employ vascular disrupt agent dimethylxanthenoneacet acid dmxaa current studi aim test combin dmxaa treatment human papillomaviru type hpv dna vaccin enhanc antitumor effect especif cd cell immun respons treat mice determin treatment dmxaa gener therapeut effect tc tumor enhanc antigenspecif immun respons tumor bear mice combin dmxaa treatment dna vaccin gener potent antitumor effect especif cd cell immun respons splenocyt tumor bear mice dmxaamedi enhanc suppress especif cd cell immun respons gener crte dna vaccin depend time administr dmxaa applic antigenspecif vaccin addit determin induc nitric oxid synthas ino plai role immun suppress caus dmxaa administr dna vaccin studi implic futur clinic translat
Interdiscip Perspect Infect Dis	23600505	2011-09-28	PMC3062985	21437001	the scienc network revolutionis dynam interact element argu epidemiolog embrac potenti network theori disciplin review grow bodi concern spread infecti diseas network focus interplai network theori epidemiolog review split main section examin type network relev epidemiolog multitud wai network characteris statist method appli infer epidemiolog paramet realis network final simul analyt method determin epidem dynam network breadth area cover everexpand number public comprehens review work imposs provid personalis overview area network epidemiolog greatest progress year greatest potenti provid novel insight consider analyt approach statist method rapidli expand field review restrict attent epidemiolog issu
PLoS One	24920802	2006-02-16	PMC3063785	21455300	in abrisban hn season influenza viru strain acquir oseltamivirresist mutat hy neuraminidas gene previou studi demonstr mutat impair replic capac influenza viru vitro vivo abrisban hy oseltamivirresist mutant complet outcompet wildtyp wt strain influenza season primari ahn circul strain combin plaqu viral yield assai simpl mathemat model approxim valu extract basic viral kinet paramet vitro infect stgalimdck cell latent infect period time newli infect cell start releas virion wt strain hy mutant infect time time singl infecti cell infect min wt min hy mutant singlecycl viral yield experi provid qualit confirm find preliminari increas fit success abrisban hy mutant increas infect compens impair delai viral releas consist evid mechanist origin fit reduct recoveri express method appli reconcil seemingli contradictori plaqu yield assai complementari view replic kinet requir fulli captur strain fit
PLoS One	16497657	2017-06-01	PMC3063798	21455313	background domin viral etiolog respons acut respiratori infect ari understood hospit children resourcelimit tropic countri morbid mortal caus ari highest improv etiolog insight need improv clinic manag prevent object conduct threeyear prospect descript studi sever respiratori ill children month year ag largest referr hospit infecti diseas southern vietnam method molecular detect viral speci subtyp perform three type respiratori specimen nose throat swab nasopharyng aspir multiplex rtpcr kit seeplex rv detect seegen addit monoplex realtim rtpcr total children enrol novemb januari virus identifi case includ respiratori syncyti viru influenza viru human bocaviru enteroviru human coronaviru human metapneumoviru parainfluenza viru adenoviru human rhinoviru coinfect multipl virus detect patient combin diagnost yield nose throat swab nasopharyng aspir conclus part rsv influenza predomin viral pathogen detect vietnames hospit children combin nasal throat swab specimen choic sensit molecular detect broad panel viral agent requir better understand clinic signific singl versu multipl viral coinfect address role bacteri coinfect involv sever respiratori ill
PLoS One	28636442	2010-09-01	PMC3064566	21464976	background intern wildlif trade lead threat biodivers conserv convent intern trade endang speci wild fauna flora cite initi monitor regul intern trade wildlif credibl depend qualiti trade data report perform cite report focuss commerci trade nonn reptil amphibian thailand illustr trend speci composit number wildcaught captivebr specimen methodologyprincip find base data wcmccite trade databas establish total individu speci reptil amphibian includ global threaten speci import thailand major individu list captivebr smaller number wildcaught small number individu speci import thailand volum speci divers increas rapidli proport captivebr anim differ greatli year wildcaught individu sourc african countri captivebr individu asian countri includ noncit parti discrep export import thailand report import individu speci origin kazakhstan kazakhstan report export speci discrep involv smaller number individu speci import reptil thailand macao conclusionsignific increas import amphibian reptil thailand errat pattern proport captivebr specimen volum suggest caprici market error report larg discrep respect origin point misreport violat rule intent cite
PLoS One	21339837	2012-02-22	PMC3064580	21464989	background despit decadeslong bacillu atrophaeu var globigii bg simul biolog warfar bw agent knowledg genom composit limit abil differenti signatur deliber adapt select natur variat lack bacteri agent character lineag bgwith long histori simul bw oper focus classic bacteriolog marker metabol profil wholegenom shotgun sequenc wg archiv strain dai type strain compar simul strain laboratori media sampl produc multipl coloni morphotyp differ archiv isol trace microevolutionari histori isol wg data archiv presentdai strain morphotyp bacilluswid phylogenet analysi identifi subtili nearest neighbor atrophaeu genom atrophaeu averag ident subtili nucleotid level wg variant reveal strain mix highli popul uncov progress accumul mutat militari isol metabol profil microscop examin bacteri cultur reveal enhanc growth militari isol lactatecontain media militari strain exhibit hypersporul phenotyp conclus analysi reveal genom phenotyp signatur strain adapt deliber select trait desir simul organ demonstr power wholegenom modern systemslevel approach character microbi lineag develop valid forens marker strain discrimin reveal signatur deliber adapt
PLoS One	22357281	2003-06-01	PMC3064590	21464946	background plasmodium falciparum malaria endem area placent malaria pm complic malaria recurr malaria primigravida women irrespect acquir protect childhood caus interact parasiteexpress varcsa antigen chondroitin sulfat csa placent intervil space lack protect antibodi pm impair fetal develop excess inflamm process infect pregnanc women acquir immun pm confer antibodi varcsa ideal vaccin pm will induc antibodymedi immun respons block adhes infect erythrocyt placenta princip find antibodi rais rat individu domain varcsa block bind csa studi immun mice rat rabbit individu domain fulllength protein correspond fcr varcsa variant inher higher immunogen ctermin domain compar ntermin locat domain irrespect antibodi induc singl domain fulllength protein speciesspecif antibodi respons were direct singl domain fulllength varcsa protein conclusionssignific bind inhibitori antibodi appear conform bcell epitop nonbind inhibitori antibodi react highli ctermin varcsa molecul highli polymorph dbl domain differenti speciesspecif induct antibodi respons allow direct analysi function versu nonfunct bcell epitop
BMC Infect Dis	12782660	2014-04-09	PMC3065410	21401965	background infect caus human rhinovirus hrv trigger wheez young children wheezi ill increasingli recognis morbid african children contribut hrv aim studi determin role hrv acut wheez south african children method twenti children present consecut tertiari children hospit wheez ill novemb prospect enrol nasal swab revers transcript pcr screen sampl hrv presenc human metapneumoviru human bocaviru human coronavirusnl assess sampl pcrbase assai gener vial cultur pool monoclon antibodi detect common respiratori virus sampl phylogenet analysi determin circul hrv speci perform portion hrvposit sampl categor characterist analys fisher exact test hrv detect children year ag present symptom hrvposit neg group ill manag ambulatori therapi hospit treatment admit intens care inhospit death speci hrv detect hrvc common hrva hrvb infect respiratori virus occur hrvposit children hrvneg sampl conclus hrv commonest viral infect young south african children acut wheez infect associ mild moder clinic diseas
PLoS One	24719424	2008-11-01	PMC3065461	21464929	influenza viru ns protein multifunct virul factor consist rna bind domain rbd short linker effector domain ctermin tail understood ns multimer autoregul action rbd dimer function conserv apo dimer propos helixhelix strandstrand analyz rbd fulllength ns structur includ novel crystal structur ed diverg human avian virus form monomer mutant data reveal helixhelix interfac strictli conserv homodimer contact mutant ns unabl form helixhelix dimer compromis abil bind dsrna effici impli multimer influenc rbd activ bioinformat work suggest helixhelix interfac variabl transient allow monom twist rel separ regard mab recogn ns residu complet buri helixhelix interfac help highlight potenti conform popul ns put term helixclos helixopen virusinfect cell helixclos conform appear enhanc dsrna bind helixopen conform allow inaccess interact host factor data support model ns regul rbd remain dimer infect switch quaternari state order expand function space concept applic small multifunct protein
J Pregnancy	18803612	2014-06-20	PMC3065811	21490743	thi examin matern optimismpessim associ unplan cesarean deliveri china associ remain control clinic factor associ csection sampl primipar women third trimest pregnanc survei larg tertiari care hospit beij china postdeliveri data collect medic record bivari analysi optim pessim unplan csection optim pessim enter regress model optim longer statist pessim remain adjust clinic factor previou abort previou miscarriag pregnanc complic infant gestat ag infant birthweight labor durat birth complic selfrat difficulti pregnanc suggest matern mindset pregnanc role mode deliveri need elucid potenti causal pathwai test potenti intervent
J Drug Deliv	24951555	2017-01-01	PMC3065884	21490752	the purpos studi evalu vitro gene deliveri mediat asialofetuinappend cation liposom afliposom associ cyclodextrin cydafliposom hepatocyteselect nonvir vector cyd afliposom associ plasmid dna pdna cyclodextrin cyd pdnacydafliposom highest gene transfer activ hepg cell cytotox addit cyd enhanc encapsul ratio pdna afliposom increas gene transfer activ entrap ratio pdna afliposom increas cyd stabil liposom membran afliposom inhibit releas calcein afliposom stabil cyd involv enhanc gene transfer activ pdnacydafliposom potenti cyd enhanc transfect effici afliposom
Virol J	29063574	2015-09-03	PMC3066118	21401943	background hepat viru hbv major etiolog factor inflamm damag liver hepatocellular carcinoma transcript factor plai role disord gene express liver injuri caus hbv molecular mechan observ defin studi observ circul prostaglandin pge synthesi increas patient chronic hepat infect detect elev cyclooxygenas cox express hbv hbxexpress liver cell likewis associ hbx cebp contribut induct cox cox promot hypomethyl hbvposit cell specif demethyl cpg dinucleotid nfat site cox promot increas bind affin nfat cognat site promot increas cox express pge accumul dna methylatransferas dnmtb plai kei role methyl cox promot decreas bind promot respons region demethyl cpg site increas bind transcript factor hbvposit cell conclus indic upregul cox hbv hbx mediat demethyl event recruit multipl transcript factor bind promot
PLoS One	29769954	2003-05-15	PMC3066183	21479259	background describ human rhinoviru hrv detect sakaeo provinc thailand method septemb august test hospit patient acut lower respiratori ill outpati control fever respiratori symptom hrv polymeras chain reaction molecularlytyp select hrv compar hrv detect hospit patient control estim enrol adjust incid hrv detect hospit patient control children highest frequenc hrv detect hospit year year year control year year year enrol adjust hospit hrv detect rate highest person ag year personsyear year year three hrv speci identifi hrva common speci ag group includ children ag year adult ag group hrvc common speci year year ag group compar control hospit adult year children hrv detect odd ratio confid interv ci ci hospit children hrva ci hvrc ci detect conclus hrv rate high hospit children elderli asymptomat children substanti hrv detect hrv speci hrva hrvc detect epidemiologicallyassoci hospit ill treatment prevent modal effect hrv reduc hospit hrv thailand
PLoS One	12719562	2005-01-13	PMC3066203	21479269	the lewztmci rat anim model syndrom deaf aros spontan mutat homozyg anim locomotor abnorm later circl behavior addition impair vision observ anim behavior studi syndrom deaf retin degener featur usher syndrom human studi mutat identifi base substitut tc exon myo lead amino acid exchang leucin leu prolin pro carboxytermin myth domain protein tail region myo mrna express retina demonstr time help insitu hybrid pcr character visual phenotyp rat examin scotop photop electroretinographi addition histolog analys retina conduct complet loss sight detect sever degener photoreceptor cell interestingli manifest diseas sole depend mutat environment factor lewztmci rat featur entir rang symptom human usher syndrom strain appropri model diseas find displai mutat bind domain myosin xv nonsyndrom hear loss lead syndrom disord includ retin dysfunct
PLoS One	15650189	2015-10-05	PMC3068181	21479189	background establish function shape cell architectur cell polar protein propos particip lymphocyt migrat home scan activ antigen receptor stimul pal central compon cell polar network express function lymphocyt remain unknown investig pal cell contribut cellreceptor tcrmediat activ methodologyprincip find combin rtpcr immunoblot assai pal constitut express human lymphocyt jurkat cell sirnabas knockdown pal hamper tcrinduc activ optim prolifer lymphocyt provid evid pal deplet select hinder tcrdriven activ transcript factor nfb conclus cell polar protein pal express lymphocyt particip optim activ nfb tcr stimul
Trials	26434947	2004-08-01	PMC3068961	21388549	background swine origin influenza ahn infect hn emerg earli rapidli spread human infect individu symptom mild selflimit small number develop sever clinic syndrom character profound respiratori failur hospit mortal rang support care neuraminidas inhibitor main treatment influenza data observ intervent studi cours influenza favor influenc agent classic consid influenza treatment multipl observ studi suggest hmgcoa reductas inhibitor statin exert class attenu inflamm collabor hn adjuv treatment chat pilot trial sought investig feasibl conduct trial global pandem critic patient hn goal inform design larger trial power determin impact statin outcom methodsdesign multin pilot random control trial rct daili enter rosuvastatin versu match placebo administ dai treatment critic patient suspect probabl confirm hn infect propos random critic adult moder high suspicion hn infect requir mechan ventil receiv antivir therapi hour site investig coordin clinic pharmacist will blind treatment assign pharmaci staff will awar treatment assign propos approach inform consent includ priori consent substitut decis maker sdm waiv defer consent primari outcom chat trial proport elig patient enrol studi secondari outcom will evalu adher medic administr regimen proport primari secondari endpoint collect number patient receiv openlabel statin consent withdraw approv consent model recruit rate discuss aspect studi design includ includ central random preserv alloc conceal ensur studi blind compar match placebo novel consent model pose challeng investig conduct pandem studi implement requir trial design pragmat initi short time period amidst uncertainti scope durat pandem trial registr number isrctn
PLoS Pathog	15258616	2019-12-11	PMC3068995	21483486	influenza viru iav enter host cell bind hemagglutinin glycoprotein sialyl host cell receptor dynamindepend clathrinmedi endocytosi cme gener consid iav infect pathwai observ occurr uncharacter altern entri rout manipul entri paramet establish experiment condit allow separ analysi dynamindepend independ entri iav entri iav phosphatebuff salin complet inhibit dynasor specif inhibitor dynamin dynasoreinsensit entri pathwai function presenc fetal calf serum find confirm small interf rna target dynamin presenc serum iav entri pathwai oper condit entri fulli block combin treatment dynasor amilorid deriv eipa hallmark inhibitor macropinocytosi drug sensit dynaminindepend entri pathwai inhibitor dominantneg mutant actomyosin dynam number specif inhibitor growth factor receptor tyrosin kinas downstream effector point involv macropinocytosi iav entri consist iav particl solubl fitcdextran coloc cell vesicl addit classic dynamindepend clathrinmedi endocytosi pathwai iav enter host cell dynaminindepend rout characterist macropinocytosi
PLoS One	31846608	2017-01-01	PMC3069061	21483820	background earli event midgut epitheli cell aed aegypti mosquito dynam reorgan rough endoplasm reticulum rer whorl structur coincid onset blood meal digest base previou studi show feed amino acid meal induc tor signal ae aegypti proteom rnai function identifi midgut epitheli cell protein contribut rer whorl format methodologyprincip find adult femal ae aegypti mosquito maintain sugar unf fed amino acid meal midgut epitheli cell analyz electron microscopi protein biochemistri size number rer whorl midgut epitheli cell decreas feed kdelcontain protein alter express level lcmsm mass spectrometri analyz midgut microsom protein isol unf amino acid fed mosquito protein identifi chosen candid whorl form protein three candid protein copi coatom subunit alpha beta beta appear higher level microsom fraction unf mosquito rnai knockdown alphacopi express electron microscopi reveal size number rer whorl dramat reduc unf mosquito extend region swollen rer preval fed mosquito lastli defici alphacopi earli trypsin protein synthesi secret hr post blood meal pbm express late phase proteas hr pbm complet block conclus alphacopi requir format rer whorl midgut epitheli cell unf aa aegypti mosquito express late phase midgut proteas
BMC Neurol	27925805	2012-11-01	PMC3071317	21435231	background long term advers effect sever acut respiratori syndrom sar viral diseas understood method sleep physiolog somat mood symptom toronto subject healthcar worker femal male ag yr remain unabl return occup month rang month sar compar healthi femal subject clinic similar patient fibromyalgia syndrom fm postsar subject compar drug free femal patient ag yr fulfil criteria fibromyalgia chronic postsar character persist fatigu diffus myalgia weak depress nonrestor sleep associ remrel apneashypopnea elev sleep eeg cyclic altern pattern alpha eeg sleep anomali post sar patient symptom pre postsleep fatigu post sleep sleepi symptom patient fm symptom patient chronic fatigu syndrom postsar fm group sleep instabl indic high sleep eeg cyclic altern pattern rate postsar group lower rate alpha eeg sleep anomali compar fm patient postsar group report presleep postsleep musculoskelet pain symptom conclus clinic sleep featur chronic postsar form syndrom chronic fatigu pain weak depress sleep disturb overlap clinic sleep featur fm chronic fatigu syndrom
Virol J	23123061	2009-04-18	PMC3071789	21418610	on coronaviru strain isol brain tissu ten piglet evid clinic manifest vomit diarrhea dyskinesia jilin provinc china antigen genom character viru isol phevjlsp base multiplex pcr neg stain electron microscopi sequenc analysi hemagglutininesteras gene piglet diagnos porcin hemagglutin encephalomyel viru phev necropsi perform piglet major patholog chang includ mening hyperemia mening hemorrhag cortic hemorrhag minor chang observ organ histopatholog chang includ satellitosi neuronophagia cerebr cortex mice infect isol viru histopatholog chang symptom observ piglet exhibit typic chang nonsuppur enceph porcin hemagglutin encephalomyel viru damag nervou system impact organ viral strain isol phevjlsp sipe area jilin provinc china evolution closest hevn stain north american strain indic viral strain evolv phev north america
Virol J	19377073	2007-12-05	PMC3071790	21418614	a year activ surveil program influenza virus avian speci livebird market lbm bangkok thailand conduct sampl collect influenza viru subtyp hn hn isol healthi muscovi duck three virus character genom sequenc subsequ phylogenet analysi genet comparison phylogenet analysi viral gene virus cluster eurasian lineag influenza virus genet analysi hn hn virus displai low pathogen avian influenza characterist ha cleavag site receptor bind site conserv resembl lpai virus studi report isol hn hn virus bird lbm thailand genet divers virus circul lbm addit coinfect hn hn muscovi duck observ
PLoS One	18057251	2013-10-04	PMC3071823	21494680	nipah viru niv recogn in zoonot diseas outbreak associ highli lethal febril enceph human respiratori diseas pig period deadli outbreak document persontoperson transmiss potenti viru agent agroterror reinforc effect therapi prevent report describ vaccin potenti niv viruslik particl niv vlp compos three niv protein coexpress protein optim condit quantifi amount vlp viruslikevaccin desir properti includ describ vlp paramyxoviru particl fusogen induc syncytia format pcr arrai analysi niv vlpinduc activ innat immun defens pathwai surfac structur niv vlp imag cryoelectron microscopi dens order repetit consist deriv structur paramyxoviru measl viru vlp compos three viral protein design intracellular process appear niv virion size morpholog surfac composit vlp consist parent viru importantli retain antigen potenti final particl formul adjuv induc neutral antibodi respons balbc mice find indic vaccin potenti particl will basi undertak futur protect efficaci studi anim model niv diseas
PLoS One	24051429	2009-02-25	PMC3073942	21494599	new delhi metallobetalactamas ndm enzym bacteria resist broad rang betalactam antibiot drug inactiv betalactam antibiot drug hydrolyz indepth understand hydrolysi mechan threedimension structur ndm develop structur frame enzymeligand complex deriv dock imipenem meropenem typic betalactam antibiot drug ndm receptor reveal ndmimipenem complex antibiot drug hydrolyz sit bind pocket ndm form residu case ndmmeropenem complex antibiot drug hydrolyz bind pocket form twelv residu constitu residu bind pocket explicitli defin graphic label anticip find report provid insight develop antibiot drug overcom resist problem
PLoS One	19324683	2014-09-17	PMC3073975	21494554	the famili type interferon ifn consist ifn ifn produc stimul virus infect nonvir pathogen cours bacteri infect cytokin benefici detriment ifn primari member type ifn initi cascad ifn product address question cell respons ifn express infect intracellular pathogen listeria monocytogen genet approach newli establish report mice maximum ifn express observ hour post infect spleen surprisingli hour post infect colon cervic inguin lymph node colon lymph node independ type ifn signal bacteri dose strain cell specif report function condit delet defin cell express lysm major ifn produc cell defin tipdc highest neutrophil granulocyt dendrit cell plasmacytoid dendrit cell contribut type ifn product
Vet Res	25231300	2018-08-01	PMC3074528	21435235	porcin circoviru type pcv causal agent postwean multisystem wast syndrom pmw pcv small singlestrand circular dna virus cluster main genogroup pcva pcvb genogroup specif highlyconserv motif amino acid amino acid pcv capsid protein aim studi verifi motif locat capsid protein specif pcv genogroup contribut virul parent dna clone pcva pcvb construct mutant dna clone pcvamotif pcvbmotif exchang capsid motif genogroup dna clone character vitro vivo cell transfect dna clone produc infecti virus specificpathogenfre piglet transfect infecti dna clone pcvbmotif virul attenu pcvamotif virul drastic reduc compar parent virul amino acid posit capsid protein determin virul isol environ motif involv
PLoS One	30233866	2008-04-01	PMC3078118	21525985	background fulli human monoclon antibodi direct specif pathogen high therapeut potenti difficult gener methodologyprincip find memori cell immort express induc activ mutant transcript factor signal transduc activ transcript stat activ stat inhibit differenti cell increas replic life span clone cell line produc antibodi presenc interleukin turn stat method monoclon antibodi model antigen tetanu toxin conclusionssignific describ novel simpl method immort antigenspecif human cell isol human monoclon antibodi stat overexpress emploi isol antigen specif antibodi human memori cell
PLoS One	18221889	2011-04-01	PMC3078135	21525999	us random pcr amplif plasmid subclon dna sequenc detect bocaviru sequenc porcin stool sampl primer walk sequenc complet genom highli diverg bocavirus provision name porcin bocaviru isol pbovh porcin bocaviru isol pbova differ ns protein phylogenet analysi indic pbovh close kb central region porcin bocaviruslik viru pbolikev sweden describ pbova close porcin bocaviru genom pbov pbov china describ fecal sampl collect ag asymptomat swine chines provinc preval pbovh pbova virus pig coinfect pbova strain highli conserv pbovh strain divers group genotyp correspond describ pbov pbov describ partial bocaviru genom label v total three major porcin bocaviru clade describ studi will requir elucid pathogen impact divers bocavirus combin porcin virus
PLoS One	21420028	2010-08-02	PMC3078930	21533115	background acut respiratori infect ari lead morbid mortal children worldwid studi aim determin viral atyp bacteri sever clinic manifest ari preschool children lowincom famili northeast brazil method clinicaldemograph data nasopharyng aspir npa prospect collect children year present ari year paediatr ae depart diseas sever group presenc lower respiratori tract sign hospit admiss oxygen clinic manifest ari base discharg diagnosi hospit condit predomin bronchiol pneumonia episod viral wheezeasthma upper respiratori tract infect multiplex pcr detect common respiratori viral atyp bacteri pathogen npa find children median ag month recruit pathogen detect sampl coinfect common respiratori syncyti viru rsv adenovirus adv rhinovirus hrv bocaviru hbov human metapneumoviru hmpv mycoplasma pneumonia mpp preval detect coinfect rate sever clinic manifest ari apart rsv associ sever diseas sever case bronchiol mpp associ sever case pneumonia mpp detect children admit hospit pneumonia interpret studi underlin viral atyp bacteri pathogen ari preschool children highlight complex epidemiolog pathogen ag group gener virus atyp bacteria detect sever clinic manifest ari rsv mpp associ sever case bronchiol pneumonia respect
BMC Public Health	20679228	2015-02-18	PMC3079644	21435263	background health offici face challeng commun public emerg infecti diseas unknown sever hnswine flu pandem phn statement intend creat awar convei serious infecti diseas threat draw accus scaremong offici accus complac statement commun context new journalist reliant offici sourc understand issu pivot select emphasis aspect offici discours deem newsworthi to public paper present casestudi new commun emerg phn method conduct content analysi televis new item phn examin new current affair item broadcast freetoair sydnei televis channel april report octob prior vaccin releas statement serious diseas public minimis contagion govern respons emerg phn lead health stori week top week new item identifi yield statement analysi serious situat provid advic viewer involv assur govern coverag focus infectionmort rate spread viru public calm vulner group direct indirect advic viewer govern reassur effect manag conclus report phn sydnei australia gener nonalarmist convei phn seriou daili infect rate talli commentari chang pandem alert level seldom contextualis assist viewer understand person relev suggest futur report emerg infecti diseas enhanc
Virol J	25694520	2009-06-24	PMC3079669	21450075	background polioviru caus agent poliomyel human enteroviru member famili picornavirida rapidli evolv virus analysi codon usag reveal molecular evolut virus synonym codon usag pattern poliovirus genom acquir method rel synonym codon usag rscu valu effect number codon enc valu nucleotid content dinucleotid investig compar analysi codon usag pattern open read frame orf poliovirus isol includ genotyp genotyp genotyp result extent codon usag bia polioviru sampl low enc gener correl base composit codon usag bia suggest mutat pressur natur select main factor determin codon usag bia poliovirus depend rscu data wa variat bia codon usag three genotyp geograph factor codon usag pattern exist genotyp poliovirus gene length vaccin deriv poliovirus dvpv wild virus live attenu viru observ variat synonym codon usag viru gene rel abund dinucleotid cpg orf poliovirus expect valu dvpv attenu viru poliovirus genotyp conclus studi theoret understand polioviru evolut dvpv genotyp potenti develop polioviru vaccin
PLoS One	19553209	2013-01-01	PMC3080360	21533129	the sever acut respiratori syndrom sar epidem character increas pathogen elderli earli exacerb innat host respons sarscov zoonot pathogen enter human popul intermedi host palm civet prevent futur introduct zoonot sarscov strain subsequ transmiss human popul heterolog diseas model need test efficaci vaccin therapeut late human zoonot isol human zoonot sarscov strain infect cynomolgu macaqu radiolog histopatholog chang mild human case viral replic higher anim infect late human phase isol compar zoonot isol differ number host gene differenti regul host respons three sarscov strain top pathwai function appar earli infect major gene associ interferon signal pathwai studi character critic diseas model evalu licensur therapeut strategi sarscov human us
Genet Vaccines Ther	23297263	2015-08-26	PMC3080791	21477292	background envelop glycoprotein lymphocyt choriomening viru lcmv effici pseudotyp lentivir vector strain lcmv exploit high affin interact dystroglycan dg bind cell surfac subsequ fuse low ph endosom lcmv strain low dg affin util unknown receptor displai uniqu tissu tropism pseudotyp nonprim felin immunodefici viru fiv vector lcmv deriv glycoprotein high low affin dg evalu properti vitro vivo method pseudotyp fiv lcmv strain envelop glycoprotein engin point mutat envelop glycoprotein lf diminish dg affin direct bind altern receptor hypothes chang alter vivo tissu tropism enhanc gene transfer neonat anim mice hepat dg express greatest late gestat neonat time point displai surfac fiv lentiviru lf mutant glycoprotein bound weakli immobil dg addition lcmv pseudotyp fiv vector transduct neutral preincub solubl dg mutant glycoprotein pseudotyp vector vivo gene transfer adult mice envelop yield low transduct effici hepatocyt intraven deliveri mark contrast neonat gene transfer lcmv envelop notabl fivlf vector confer abund liver lower level cardiomyocyt transduct detect luciferas assai bioluminesc imag galactosidas stain conclus development regul receptor lcmv express abundantli neonat mice lcmv pseudotyp vector applic neonat gene transfer abbrevi armstrong armb baculoviru autographa californica gp gp chargecoupl devic ccd dystroglycan dg felin immunodefici viru fiv glycoprotein precursor gpc firefli luciferas luc lymphocyt choriomening viru lcmv nuclear target galactosidas ntlacz optic densiti od pb wv tween pbst rel light unit rlu rou sarcoma viru rsv transduc unit millilit tuml vesicular stomat viru vsvg wheat germ agglutinin wga reduct bind c
Environ Health Perspect	26311884	2014-10-29	PMC3080933	21118783	background link concentr particul matter pm respiratori morbid investig numer studi object aim studi analyz role particl size fraction respect respiratori health beij china method data particl size distribut nm pm pm nitrogen dioxid sulfur dioxid concentr meteorolog variabl collect daili march decemb concurr daili count emerg room visit erv respiratori diseas peke univers third hospit estim pollut effect singl twopollut gener addit model control meteorolog timevari covari timedelai associ estim polynomi distribut lag cumul effect singl lag model associ respiratori erv concentr nm particl number surfac area concentr magnitudethat increas respiratori erv interquartil rang increas air pollut concentr gener particl nm posit associ erv particl nm advers associ respiratori erv fraction ultrafin particl estim twopollut model consist conclus level air pollut beij advers associ respiratori erv concentr better surrog evalu respiratori health effect ambient air pollut pm particl number concentr beij
PLoS One	25355894	2003-04-15	PMC3081318	21544192	background simian hemorrhag fever viru shfv caus lethal outbreak hemorrhag diseas captiv primat distribut wild primat remain obscur describ discoveri genet character direct pyrosequenc novel diverg shfv variant coinfect singl male red colobu monkei kibal nation park uganda methodologyprincip find virus detect directli blood plasma pyrosequenc prior viru isol minim pcr amplif shfv variant shfvkrc shfvkrc highli diverg nucleotid sequenc ident shfv type strain lvr nucleotid sequenc ident demonstr greater phylogenet divers shfv document arteriviru variant genom architectur type strain three open read frame arterivirus conclusionssignific repres document shfv wild primat confirm unusu genet architectur shfv rel arterivirus demonstr degre evolutionari diverg shfv roughli equival degre diverg arteriviru speci presenc highli diverg shfv variant coinfect singl individu repres degre withinhost viral divers exce report arteriviru expand knowledg natur histori divers arterivirus underscor wild primat reservoir novel pathogen
PLoS One	12663803	2018-01-10	PMC3081840	21541353	dure comparison infect mndk cdindepend human immunodefici viru type hiv strain cell line hela cell suscept te cell hybridoma cell hela cell suscept cell suggest cellular factor enhanc mndk infect cell screen cdna express librari hela cell cystatin isol enhanc mndk infect cathepsin proteas natur ligand cystatin upregul hela cell specul high level cathepsin activ inhibitori cdindepend infect cystatin enhanc infect impair excess cathepsin activ consist idea pretreat hela cell cathepsin inhibitor fold enhanc mndk infect cathepsin activ low ph acid endosom examin potenti role endosom cdindepend infect suppress endosom acidif endocytosi inhibitor ep domin neg mutant reduc infect mndk cddepend infect impair endocytosi endosom acidif cathepsin activ involv cdindepend entri hiv
PLoS One	29321328	2008-03-01	PMC3082571	21541296	avian influenza surveil bangladesh passiv reli poultri farmer report suspect outbreak highli pathogen hn influenza activ surveil effort focus livebird market present preval influenza infect bird live bird market poultri market countri isol nonpathogen hn subtyp virus hn hn hn hn hn hn subtyp observ highli pathogen hnsubtyp viru observ extrem low preval surveil sampl current risk infect human retail poultri market bangladesh neglig high preval subtyp potenti interact highli pathogen hnsubtyp reassort attenu host morbid highlight activ surveil poultri market
PLoS One	18325350	2012-01-11	PMC3083406	21556151	background googl flu trend develop estim influenzalik ill ili rate internet search ili correl actual influenza viru infect method find influenza activ data three surveil system googl flu trend cdc outpati ili surveil network cdc ili surveil influenza virolog surveil system cdc viru surveil pearson correl coeffici confid interv ci calcul compar surveil data analysi perform investig outlier observ determin extent correl surveil data pearson correl coeffici describ googl flu trend cdc viru surveil studi period ci correl cdc ili surveil cdc viru surveil period ci outlier observ comparison influenza season exclus outlier observ improv correl googl flu trend cdc viru surveil ci cdc ili surveil cdc viru surveil ci conclus analysi demonstr googl flu trend highli correl rate ili lower correl surveil laboratoryconfirm influenza outlier observ occur influenza season character earli intens influenza activ alter health care seek behavior physician test practic internet search behavior
Int J Mol Sci	22238319	2006-05-01	PMC3083680	21541033	oxid stress consid major risk factor contribut increas lipid peroxid declin antioxid degen diseas glycyrrhizin cure allerg diseas medicin properti studi evalu role glycyrrhizin lipid peroxid antioxid statu blood nasal mucosa allerg rhiniti ar mice mice divid group normal control mice model control mc mice three glycyrrhizintr mice group lycopenetr mice sensitizationassoci increas lipid peroxid observ blood nasal mucosa mc mice activ antioxid enzym superoxid dismutas sod catalas cat glutathion peroxidas gshpx total antioxid capac taoc level glutathion gsh decreas blood nasal mucosa mc mice compar normal control mice normal lipid peroxid antioxid defens report glycyrrhizintr lycopenetr mice glycyrrhizin treatment enhanc ifn reduc il level glycyrrhizintr mice find demonstr glycyrrhizin treatment enhanc antioxid statu decreas incid free radicalinduc lipid peroxid improv immun activ blood nasal mucosa ar mice
PLoS One	16689659	2012-10-01	PMC3084774	21559474	current progress develop vaccin decreas incid fatal nonfat infect increas longev technolog develop combat emerg gener infecti diseas dna vaccin demonstr great potenti wide varieti diseas technolog gener immun respons vaccin combin deliveri electropor ep enhanc plasmid express immun ep system effect invas pain make desir vaccin lab develop noninvas electrod multielectrod arrai mea li flat surfac skin penetr tissu studi evalu mea dna vaccin hepat viru infecti model util guinea pig model skin thick morpholog human plasmid encod hepat surfac antigen hbsag deliv intraderm mea guinea pig skin increas protein express plasmid deliveri mea compar inject hour treatment influx cellular infiltr experiment group humor respons increas durat intens compar inject group electrod requir studi mea potenti electr mediat intraderm dna vaccin
PLoS One	22840606	2018-09-29	PMC3084784	21559424	structur group lilr leukocyt immunogloblin iglik receptor iglik transcript ilt leukocyt iglik receptor lir cd member term hlai human leukocyt antigen class molecul bind region hypothes bind hlai group lilr lilra secretori lilr greatli control inhibitori immun respons induc lilrb lilrb hlabind lilr molecul lilra bind lilra hlai report crystal structur lilra domain evalu dd domain domain bind classic nonclass hlai biacor surfac plasmon reson analysi spr lilra bind classic hlaa nonclass hlag reduc affin compar lilrb lilrb polymorph amino acid lilra structur support notion
PLoS One	30305999	2014-02-19	PMC3084832	21559411	melanoma lethal skin cancer thought immunogen natur focu cellmedi immun respons limit knowledg exist role matur cell describ approach includ cellbas elisa evalu matur igg antibodi respons melanoma human peripher blood cell observ increas antibodi respons melanoma patient primari metastat melanoma cell compar healthi volunt interestingli detect reduct antibodi respons melanoma advanc diseas stage patient cohort melanoma patientderiv cell cultur compar cultur healthi control produc antibodi recogn melanoma cell lastli patientderiv melanomaspecif monoclon antibodi select studi antibodi effect kill melanoma cell vitro antibodymedi cellular cytotox data demonstr presenc matur system cell respons melanoma patient reduc diseas progress ad previou report tumorreact antibodi patient sera suggest merit futur work elucid clinic relev activ humor immun respons cancer
PLoS One	24554650	2010-02-24	PMC3086881	21559329	dure summer itali experienc epidem caus chikungunya viru larg outbreak document temper climat countri laboratori confirm case concentr border villag northeastern itali compris inhabit seropreval estim work provid estim transmiss potenti viru assess efficaci measur undertaken public health author control epidem spread aim develop model describ tempor dynam compet vector aed albopictu explicitli depend climat factor coupl epidem transmiss model describ spread epidem human mosquito cumul number notifi case predict model averag ci good agreement observ data probabl observ major outbreak introduct infect human case estim rang basic reproduct number rang larger depend densiti mosquito turn depend season meteorolog effect local abiot factor confirm increas risk tropic vectorborn diseas temper climat countri consequ global epidem control perform time intervent transmiss potenti chikungunya viru sensibl high
Virol J	20181726	2013-01-01	PMC3087699	21496278	background hepat viru caus agent type viral hepat occasion acut hepat synonym codon usag pattern hav genom process evolut studi kei genet determin codon usag hav examin extent codon usag bia hav high picornavirida pattern synonym codon usag hav genom locat base composit close correl codon usag bia determin high codon bia hav mutat pressur natur select conclus hav present higher codon usag bia member picornavirida composit constraint element influenc variat synonym codon usag hav genom mutat pressur suppos major factor shape hyperendem codon usag pattern hav
PLoS One	23219434	2004-12-16	PMC3087751	21573230	background genet polymorph gene encod adrenerg receptor ar pivot role function autonom nervou system heart rate variabl hrv indic autonom function bottomup genotypephenotyp analysi investig associ ar gene polymorph heart rate dynam method total healthi han chines adult male femal ag year rang year recruit genotyp three common ar polymorph ar sergli ar arggli ar glnglu subject underw hour electrocardiogram monitor rest appli informationbas similar ib measur pairwis dissimilar heart rate dynam studi subject aid agglom hierarch cluster analysi categor subject major cluster distribut ar arggli genotyp nonrandom nonlinear hrv measur deriv ib method lower arg homozygot gly carrier nonrandom neg correl parasympatheticrel hrv variabl posit correl hrv indic reflect sympathovag shift sympathet activ conclus demonstr bottomup categor approach combin ib method hierarch cluster analysi detect subgroup subject hrv phenotyp associ ar polymorph provid evid ar polymorph associ accelerationdeceler pattern heart rate oscil reflect underli mode autonom nervou system control
PLoS Pathog	15604146	2010-05-19	PMC3088723	21573141	recombin evid impact viru evolut emerg pathotyp gener immens literatur distribut phenotyp effect caus genomewid random homolog recombin formal investig previou data subject promot implicit view viral recombin genom deleteri lethal nucleotid ident parent sequenc decid challeng view creat bank nearrandom recombin viral speci genu begomoviru famili geminivirida exhibit nucleotid ident test infect planta accumul recombin clone randomli extract bank bank creat dnashufflinga technolog initi appli random shuffl individu gene implement time shuffl fulllength viral genom describ system allow direct clone fulllength infecti geminiviru genom provid uniqu opportun gener hundr mosaic viru genom directli testabl infect subset randomli chosen recombin sequenc individu inocul tomato plant compar parent virus surprisingli recombin infecti accumul level compar intermedi parent clone indic experiment system despit fact parent genom differ lethal andor larg deleteri effect recombin rare strike contrast common view emerg previou studi publish virus
PLoS One	20484443	2007-03-24	PMC3089605	21573100	transmiss gastroenter viru tgev porcin coronaviru lithium chlorid licl effect dna virus herp simplex viru vaccinia viru report inhibitori licl avian infecti bronchiti coronaviru ibv infect rna viru current studi action mechan licl cell infect tgev investig plaqu assai dimethylthiahiazozydiphenyl tetrazoliumbromid mtt assai cell infect tgev inhibit dosedepend manner licl virusinfect cell cell infect cell virus pretreat drug inhibit tgev infect vitro licl observ viru dose cell line inhibitori licl tgev infect transcript confirm rtpcr realtim pcr target viral clproteas gene timeofaddit drug tgev infect indic licl act initi late stage tgev infect product viru detect postinfect drug treatment immunofluoresc flow cytometri analys base stain annexin propidium iodid stain nuclei indic earli late cell apoptosi induc tgev inhibit effici abil licl inhibit apoptosi investig analysi caspas express data indic licl inhibit tgev infect exert antiapoptot inhibitori licl observ porcin epidem diarrhea coronaviru report concern inhibitori lithium salt ibv cell cultur indic licl potent agent porcin avian coronavirus
PLoS One	17385026	2007-05-30	PMC3089607	21573102	sialic acid sa link galactos gal configur receptor avian human influenza virus demonstr chicken tracheal ciliat cell express link sa goblet cell express link sa addit plant lectin malii maamali bound surfac goblet cell suggest salink oligosaccharid galgalnac subtermin residu goblet cell link sa detect singl tracheal basal cell low multipl infect moi avian influenza viru hn exclus detect ciliat cell suggest ciliat cell major target cell hn viru moi ciliat goblet basal cell permiss aiv infect result clearli elucid receptor distribut avian influenza viru chicken tracheal epitheli cell illustr primari cell model evalu cell tropism respiratori virus poultri
BMC Bioinformatics	17537928	2005-06-01	PMC3090355	21489240	background viral zoonosi transmiss viru primari vertebr reservoir speci human requir ubiquit cellular protein receptor protein zoonosi occur direct transmiss vertebr human intermedi reservoir environment factor virus categor genotyp ssdna dsdna ssrna dsrna virus rna virus exhibit high mutat rate problemat reason zoonot virus rna virus chang envelop protein facilit bind receptor host speci studi sought predict zoonot propens analysi receptor characterist hypothes major barrier interspeci viru transmiss receptor sequenc vari speciesin specif amino acid sequenc receptor determin abil viral envelop protein attach cell analys hostcel receptor sequenc hydrophobicityhydrophil characterist analys properti similar receptor speci statist discrimin analysi predict likelihood transmiss speci conclus studi attempt predict zoonosi simpl comput analysi receptor sequenc differ method predict zoonot potenti newli discov viral strain
Virol J	15923443	2013-12-18	PMC3090357	21481279	hcv envelop protein name e plai role cell entri main pathwai direct fusion plasma membran receptormedi endocytosi fusion hcv envelop protein trigger low ph endosom lysosomotrop agent la chloroquin ammonium chlorid nhcl weak base penetr lysosom proton form increas intracellular ph investig antivir la chloroquin nhcl ph depend endocytosi hcv pseudoparticl hcvpp genotyp produc infect liver cell toxicolog effect chloroquin nhcl test liver cell mtt cell prolifer assai antivir screen chloroquin nhcl liver cell infect hcvpp genotyp presenc absenc concentr chloroquin nhcl luciferas activ determin luminomet demonstr chloroquin nhcl reduct viru infect mm concentr inhibit hcv fusion step increas lysosom ph will better option treat chronic hcv
Parasit Vectors	24352457	2008-02-11	PMC3090364	21489237	the intern promin accord health concept coordin activ involv human anim health modern incarn long tradit compar medicin root ancient civil golden era centuri explos knowledg field infecti diseas modern health focu zoonot pathogen emerg wildlif product anim speci health challeng rabi canin reservoir review consid role small companion anim health address major vectorborn infecti diseas share man dog cat leishmaniosi borreliosi bartonellosi ehrlichiosi rickettsiosi anaplasmosi challeng lie ahead field health discuss role newli form small anim veterinari associ health committe
PLoS One	18314500	2007-07-30	PMC3091021	21573031	virus common sourc infect immunocompet individu consid clinic meaning risk factor critic work examin associ viral infect diagnos hospit stai document admiss outcom icu patient evid immunosuppress admiss populationbas retrospect cohort studi univers healthsystem consortium uhc academ center year uhc allianc nonprofit academ medic center total critic patient analysi hospit complic examin patient group cohort absenc infect bacteri infect viral infect bacteri viral infect hospit admiss viral infect diagnos hospit increas risk complic season pattern viral infect specif virus associ poor outcom includ influenza rsv cmv hsv patient viral bacteri infect hospit greatest risk mortal rr ci multiorgan failur rr ci septic shock rr ci viral infect plai unrecogn role outcom icu patient serv biolog marker plai activ role develop advers complic interact coincid bacteri infect
BMC Public Health	17662167	2018-11-01	PMC3091536	21199571	background risk percept behaviour respons case emerg infecti diseas aim studi examin percept behaviour gener public earli phase influenza hn pandem netherland method crosssect followup onlin survei survei april survei june survei august adult ag year particip repres internet panel invit survei survei followup survei main outcom measur time trend risk percept feel anxieti behaviour respons survei factor associ prevent measur strong intent compli governmentadvis prevent measur futur survei august level knowledg influenza hn increas perceiv sever flu perceiv selfefficaci intent compli prevent measur decreas perceiv reliabl govern decreas august versu feel anxieti decreas june remain stabl june august perceiv vulner increas respond prevent measur versu prevent measur associ children household high anxieti high selfefficaci agreement statement avoid pai attent media influenza hn strong intent compli governmentadvis prevent measur futur associ higher ag high perceiv sever high anxieti high perceiv efficaci measur high selfefficaci find government reliabl conclus decreas trend time perceiv sever anxieti consist realiti clinic pictur influenza turn mild cours time intern health author initi overestim case fatal rate public stai calm remain high intent compli prevent measur
BMC Public Health	30392829	2016-03-21	PMC3091577	21050482	background profession hospit worker japan challeng pandem hn maintain hospit function critic situat pandem understand factor increas decreas willing work previou hospitalbas studi examin question hypothet event examin actual pandem survei factor influenc motiv hesit hospit worker work japan pandem hn method selfadminist anonym questionnair demograph charact stress factor distribut employe three core hospit kobe citi japan collect june juli month pandem hn japan total questionnair distribut valid questionnair receiv worker strong motiv strong hesit work demograph charact stressrel question categoris type odd ratio motiv hesit work factor increas motiv lower hesit increas motiv increas hesit increas motiv hesit strong feel support nation local govern multivari motiv ci hesit ci protect hospit multivari motiv ci hesit ci higher motiv lower hesit protect includ precaut prevent ill worker famili provid care reduc malpractic threat financi support famili worker die duti respond answer protect nation local govern weak answer protect hospit weak conclus factor conflict effect increas motiv hesit worker feel protect nation local govern hospit valuabl increas motiv lower hesit work
BMC Genomics	27001840	2015-06-02	PMC3091641	20663124	background rate emerg human pathogen steadili increas novel agent origin wildlif bat remark natur reservoir of pathogen virus human bat genom project current underwai circumst promis speed discoveri host factor coevolut bat virus genom assembl will provid low coverag make infer gene immunolog interest errorpron wildlif genom project underwai intend provid shallow coverag develop statist method assembl gene famili partial genom method take full advantag qualiti score gener basecal softwar incorpor complet probabilist error model overcom limit inher infer gene famili member partial sequenc valid method infer human ifna gene genom trace archiv infer typei interferon gene singl typeii interferon gene bat pteropu vampyru myoti lucifugu confirm infer direct clone sequenc ifna ifnb ifnd ifnk vampyru demonstr transcript infer gene interferoninduc stimuli conclus statist trace assembl describ reliabl method extract forthcom partial shallow genom sequenc project facilit studi wider varieti organ ecolog biomed signific human possibl
BMC Genomics	26038383	2014-03-07	PMC3091733	20961419	background resequenc microarrai call pathogenid develop explor strategi sequenc select design dedic influenza virus base consensu sequenc specif gene gener global align larg number influenza viru sequenc databank ha h h h n molecular type chosen test consensu sequenc comput tile microarrai total influenza viru sampl host origin human pig hors bird isol period year studi influenza virus correctli identifi case accur time emerg conclus pathogenid microarrai demonstr abil type subtyp influenza virus level viral variant minimum number tile sequenc valid strategi consensu sequenc exist natur microarrai design versatil rapid high discriminatori power pathogenid microarrai prove critic detect identifi viral genom reassort event novel viru epidem pandem potenti assist health author effici decis patient treatment outbreak manag
PLoS One	24601662	2015-05-10	PMC3091864	21573005	background studi assess effect pandem trival season vaccin prevent influenzalik ill ili ahn pandem franc compar vaccin effect ili versu laboratoryconfirm pandem ahn influenza assess bia caus nonspecif endpoint observ data methodolog princip find estim vaccin effect formula ppvpcvppvpcv ppv proport vaccin popul pcv proport vaccin influenza case peopl consid vaccin three week receiv dose vaccin ili pandem ahn laboratoryconfirm case surveil network gener practition epidem influenza isol pandem ahn pandem season vaccin uptak popul nation health insur databas telephon survei effect estim adjust ag week presenc residu bias explor calcul vaccin effect influenza period effect pandem vaccin prevent ili confid interv pandem confirm influenza effect season vaccin ili pandem confirm influenza conclus effect pandem vaccin prevent confirm pandem ahn influenza field high consist publish find lower ili unsurpris ili case caus influenza trival season vaccin statist effect prevent ili confirm pandem influenza better prevent confirm pandem influenza prevent ili lack differ indic select bia
PLoS One	25960542	2013-02-28	PMC3091876	21572957	public health surveil undergo revolut driven advanc field technolog countri experienc vast improv collect ingest analysi visual dissemin public health data resourcelimit countri lag challeng technolog infrastructur public health resourc cost proprietari softwar suit autom global electron biosurveil sage collect modular flexibl freelyavail softwar tool electron diseas surveil resourcelimit set sage tool concert exist surveil applic sage tool en mass endtoend biosurveil capabl flexibl allow develop inexpens custom sustain diseas surveil system abil rapidli assess anomal diseas activ lead effici limit resourc better complianc health organ intern health regul
BMC Public Health	23449786	2012-10-24	PMC3092412	21388562	the arm forc health surveil center global emerg infect surveil respons system afhscgei mission perform surveil emerg infecti diseas affect unit state militari mission accomplish orchestr global portfolio surveil project capacitybuild effort outbreak investig train exercis portfolio involv fund partner impact countri articl discuss current biosurveil landscap programmat detail organ implement kei contribut forc health protect global public health 
PLoS One	23100349	2012-08-29	PMC3093381	21589915	bat reservoir coronavirus cov zoonot virus sampl fece andor anal swab insectivor bat famili speci locat colorado detect alphacoronaviru rna bat speci big brown bat eptesicu fuscu preval longleg bat myoti volan preval brown bat myoti lucifugu preval western longear bat myoti evoti preval juvenil bat posit cov rna adult bat rural sampl site cov rna detect big brown longleg bat three sequenti summer studi cov rna detect big brown bat urban matern roost sampl period test individu tag big brown bat posit cov rna sampl cov rna neg nucleotid sequenc rdrp gene fell main cluster distinct bat nucleotid sequenc amplicon gene spike gene bigbrown longleg bat indic cov capabl infect bat genera data ongo evolut cov bat creat possibl continu threat emerg host speci alphacoronaviru rna detect high preval big brown bat roost close proxim human habit direct contact peopl suggest potenti opportun exist crossspeci transmiss virus cov surveil studi bat america warrant
BMC Infect Dis	22932899	2011-01-18	PMC3094225	21510889	background season respiratori syncyti viru rsv epidem occur annual temper climat result pediatr morbid increas health care cost rsv epidem gener occur octob april size time vari epidem season difficult predict accur predict epidem characterist support manag resourc treatment method goal examin empir relationship earli exponenti growth rate total epidem size time util specif paramet compartment model transmiss account variat season rsv epidem curv rsv test data primari children medic center collect children year ag juli june simpl linear regress explor relationship three epidem characterist final epidem size dai peak epidem length exponenti growth calcul week daili case data compartment model transmiss fit data paramet estim help describ variat season rsv epidem curv regress indic exponenti growth correl epidem characterist transmiss model indic start time epidem transmiss paramet covari epidem season conclus conclus exponenti growth empir season epidem characterist variat epidem start transmiss paramet epidem year explain variat season epidem size relationship public health health care provid infecti diseas research
Trials	21245143	2016-07-13	PMC3094234	21492416	background acut lower respiratori infect commonest morbid prevent mortal indigen infant infanc critic time postnat lung growth develop sever repeat lower airwai injuri young children increas likelihood chronic pulmonari disord life global bronchiol common form acut lower respiratori infect infanc compar nonindigen australian infant indigen infant greater bacteri densiti upper airwai sever bronchiol episod studi test hypothesi antimicrobi antiinflammatori properti azithromycin improv clinic outcom indigen australian infant hospitalis bronchiol method conduct dual centr randomis doubleblind placebocontrol parallel group trial northern australia indigen infant ag month expect number admit region hospit darwin northern territori townsvil queensland clinic diagnosi bronchiol fulfil inclus criteria randomis alloc conceal azithromycin mgkgdose placebo administ weekli three dose clinic data record daili nasopharyng swab collect enrol time discharg hospit primari outcom length oxygen requir durat stai base judg readi respiratori discharg main secondari outcom readmiss respiratori ill month leav hospit descript virolog bacteriolog includ develop antibiot resist data nasopharyng sampl will report discuss publish studi involv patient popul set macrolid antibiot treatment durat produc conflict randomis placebocontrol trial azithromycin indigen infant hospitalis bronchiol design determin reduc shortterm longterm morbid respiratori ill australian indigen infant high risk develop chronic respiratori ill azithromycin efficaci reduc morbidli indigen infant hospitalis bronchiol intervent lead improv short term long term health benefit trial registr australia zealand clinic trial regist anzctr actrn
Virol J	27413096	2012-01-01	PMC3094301	21510909	background nephropathogen avian infecti bronchiti ib caus unpreced econom loss commerci chicken industri china investig preval nephropathogen ib china ibv isol provinc identifi dwarf embryo test rtpcr strain isol winter spring wide ag rang ib outbreak dai viru recoveri trial strain death distress bird nephriti learn molecular evolutionari characterist circul field strain code region major spike protein gene strain rtpcr amplifi sequenc compar publish repres strain nucleotid amino acid sequenc analysi indic gene strain refer strain displai homolog rang to protein major pandem strain contain amino acid cleavag site hrrrr rrfrr phylogenet analysi reveal field isol ibv china belong abranch qxibvbranch hnbranch isol belong graybranch mbranch strain evolutionarili distant vaccin strain conclus studi suggest nephropathogen ibv alik strain china 
Evid Based Complement Alternat Med	24701402	2018-08-09	PMC3094709	20028719	the scutellaria speci lamiacea sourc flavonoid treat varieti diseas tradit medicin spite report cytotox antitumor effect speci genu anticanc research iranian speci litwinowii conduct cytotox properti total methanol extract litwinowii fraction investig cancer cell line includ ag hela mcf pc nih role apoptosi toxic explor cell cultur dmem medium incub concentr herb plant extract cell viabil quantit mtt assai apoptot cell determin propidium iodid stain dna fragment flow cytometri subg peak scutellaria litwinowii inhibit growth malign cell dosedepend manner solvent fraction litwinowii methylen chlorid fraction toxic compar fraction ic valu fraction ag hela mcf pc cell line determin gml scutellaria litwinowii induc subg peak flow cytometri histogram treat cell compar control cell indic apoptot cell death involv litwinowii toxic scutellaria litwinowii exert cytotox proapotot effect varieti malign cell line consid potenti chemotherapeut agent cancer treatment
Evid Based Complement Alternat Med	30093393	2010-07-07	PMC3096453	20008902	essenti oil star anis phenylpropanoid sesquiterpen exampl transanethol eugenol eudesmol farnesol caryophyllen caryophyllen oxid essenti oil examin antivir activ herp simplex viru type hsv vitro antivir activ analyz plaqu reduct assai mode antivir action determin addit drug uninfect cell viru prior infect herpesvirusinfect cell star anis oil reduc viral infect phenylpropanoid inhibit hsv infect sesquiterpen suppress herp viru infect star anis essenti oil isol compound exhibit antihsv activ direct inactiv free viru particl viral suspens assai test drug interact dosedepend manner herpesviru particl inactiv viral infect star anis oil rich transanethol reveal high select hsv isol compound caryophyllen displai high select presenc caryophyllen essenti oil contribut antivir abil indic phenylpropanoid sesquiterpen essenti oil contribut antivir activ hsv
BMC Infect Dis	20610717	2017-10-01	PMC3096599	21539735	background entri screen start search febril intern passeng infrar thermoscann emploi fever screen japan aim retrospect assess feasibl detect influenza case base fever screen sole measur method dataset collect narita intern airport pandem contain confirm influenza case diagnosi place airport earli stage pandem second contain select suspect fraction passeng selfreport detect infrar thermoscann screen septemb januari sensit fever detect hn estim diagnost perform infrar thermoscann detect hyperthermia cutoff level c estim sensit fever detect hn case arriv estim confid interv confirm hn case hn case antipyret medic arriv sensit specif infrar thermoscann detect hyperthermia rang posit predict appear low conclus sensit entri screen product sensit fever detect influenza case sensit infrar thermoscann detect fever addit presenc confound factor unrestrict medic passeng relianc fever feasibl entri screen measur
Virol J	28655566	2019-02-05	PMC3096946	21496223	background document untransl region utr positivestrand rna virus kei cisact regulatori sequenc highord structur element regulatori element control porcin arteriviru replic investig role conserv stemloop sl resid utr genom type ii porcin reproduct respiratori syndrom viru prrsv provid genet evid demonstr sl type ii prrsv utr nsl structur function substitut counterpart type prrsv esl function nsl depend gc rich stem structur ternaryloop size irrelev rna synthesi serial delet stem integr nsl crucial subgenom mrna synthesi extens basepair stem region delet altern nsllike structur sequenc util viru replic conclus conclud phylogenet conserv sl utr crucial prrsv viru replic subgenom mrna synthesi particular
PLoS One	30721153	2005-01-01	PMC3097202	21673789	background mass strand sperm whale physet macrocephalu remain peculiar unexplain event rare occur mediterranean sea solar cycl chang geomagnet field variat water temperatur weather condit coast geograph featur human activ propos decemb pod male sperm whale strand adriat coast southern itali sixth instanc basin methodologyprincip find complet necropsi perform three whale bodi good condit carri sampl tissu histopatholog virolog bacteriolog parasitolog screen vein ga emboli sampl ag determin genet studi gastric content evalu stabl isotop toxicolog specimen anim group determin genet photoidentif mediterranean popul death includ biolog agent ga fat embol syndrom associ direct sonar exposur environment pollut tissu concentr high organochlorin xenobiot gastric content morpholog tissu examin prolong starvat caus turn mobil lipophil contamin adipos tissu chemic compound subsequ enter blood circul impair immun nervou function conclusionssignific multifactori underli sperm whale mass strand propos base postmortem investig detail analys geograph histor background sperm whale wrong adriat sea danger trap mediterranean sperm whale seismic survei regard potenti cofactor evid direct impact detect
PLoS One	16038039	2013-01-14	PMC3097204	21611125	background scaveng abil suffici dival metal ion pivot pathogen bacteria surviv host atpbind cassett abctyp metal transport provid consider amount transit metal bacteri growth troa substrat bind protein uptak multipl metal ion function structur troa homologu epidem streptococcu sui isol sstroa character methodologyprincip find determin crystal structur sstroa highli pathogen streptococc toxic shock syndrom stsscaus streptococcu sui complex zinc induct coupl plasma mass spectrometri icpm analysi reveal aposstroa bind zn mn metal bind sstroa nanomolar affin stabil protein thermal unfold zn mn induc distinct conform chang sstroa compar apo form confirm circular dichroism cd nuclear magnet reson nmr spectra nmr data reveal znmn bind sstroa site adjac region final fold metalbound protein compact correspond apoprotein conclusionssignific find reveal mechan uptak metal ion sui mechan reason explan sstroa oper metal transport
PLoS One	23319741	2010-11-01	PMC3097245	21625607	import advanc immunodiagnosi tuberculosi tb base detect mycobacterium tuberculosi mtbspecif cell sensit specif immunolog approach low specif marker antigenspecif cell cell produc cytokin overlook approach studi mtbspecif peptid esatcfp stimul express cdl cd cell cell pleural fluid cell pfc patient tubercul pleurisi tbp cdcdl cdcdl cell express ifn il tnf il il stimul mtbspecif peptid addit cdcdl cell polyfunct cell simultan produc ifn il tnf displai effector effector memori phenotyp cdracdroccrcdlico determin specif cdcdl cell incub pfc estacfp peptid sort live cdcdl cdcdl cell flow cytometri demonstr sort cdcdl cdcdl fraction princip produc ifn il tnf il il restimul estacfp peptid data indic express cdl mtbspecif cd cell good marker evalu isol mtbspecif cell diagnosi tb
Biomed Imaging Interv J	20934458	2007-01-17	PMC3097804	21611071	thi retrospect descript studi chest imag find patient confirm ahn tertiari referr centr patient posit initi chest radiograph cxr find common find bibas airspac opac perihilar reticular alveolar infiltr select case highresolut comput tomographi ct imag groundglass chang widespread reticular chang atelectasi
BMC Bioinformatics	17229712	2007-01-01	PMC3098112	20144194	background polypeptid backbon potenti form amyloid fibril associ number degen disord likelihood amyloidosi occur physiolog condit depend amino acid composit protein explor naiv bayesian classifi weight decis tree predict amyloidogen immunoglobulin sequenc averag accuraci base leaveoneout loo cross valid bayesian classifi gener amyloidogen sequenc consist averag accuraci holdout test set compris nonamyloidogen sequenc loo cross valid accuraci increas train set augment holdout test set comparison averag classif accuraci holdout test set decis tree nonamyloidogen sequenc predict averag loo cross valid accuraci bayesian classifi depend train set size accuraci holdout test set decis tree nonamyloidogen predict accuraci conclus exploratori studi indic classif method promis provid straightforward predict amyloidogen sequenc number sequenc satisfi premis studi limit consequ smaller ideal train set size increas size train set clearli increas accuraci expans train set includ deriv align method sound accuraci classifi improv addit factor structur physicochem data consid develop type classifi applic evalu engin antibodi adapt evalu engin protein gener
Malar J	17242751	2007-02-01	PMC3098821	21529346	background develop plantbas vaccin plasmodium vivax vivax candid protein chosen merozoit surfac protein msp major asexu blood stage antigen current consid strong vaccin candid second circumsporozoit protein csp compon sporozoit bcell epitop method synthet chimer recombin bp gene encod pvmsp progli linker motif pvcsp synthes gene name mlc encod total amino acid recombin gene modifi regard codon usag optim gene express brassica napu ti plasmid induc gene transfer system mlc chimer recombin gene express napu gene express confirm polymeras chain reaction pcr betaglucuronidas report gene gu assai western blot mlc chimer recombin protein express napu molecular weight kda exhibit clinic sensit clinic specif assess enzymelink immunosorb assai elisa oral immun balbc mice mlc chimer recombin protein induc antigenspecif igg product addition threlat cytokin il tnf ifn increas spleen balbc mice conclus chimer mlc recombin protein produc napu potenti antigen diagnosi valuabl vaccin candid oral immun vivax malaria
Pulm Med	17308726	2008-07-28	PMC3099744	21637367	it obviou interstiti lung diseas viral lung infect progress rapidli exhibit featur lung morpholog final histopatholog featur common lung disord diffus alveolar damag dad histopatholog dad consid repres stage phenomenon acut behav interstiti pneumonia acut interstiti pneumonia aip acut exacerb idiopath pulmonari fibrosi ipf acut worsen dad occur patient nonspecif interstiti pneumonia nsip sever viral lung infect dad histopatholog lung better understand mechan underli dad reaction need clarifi treatment seriou lung diseas urgent intern effort studi dadassoci lung diseas prognosi patient dismal
PLoS One	18663227	2014-10-03	PMC3100328	21629775	although ecolog coinfect increasingli recogn analys microbi pathogen dynam wildlif focu ad hoc subset speci technolog limit detect demonstr express profil immunolog gene pattern recognit receptor cytokin transcript factor identifi preconcept likelihood acut microbi infect wildlif wood mous popul uk model identifi tempor cluster individu extrem express immunolog mediat multipl loci typic acut microbi infect cluster circumstanti associ demograph perturb summertim wood mous popul anim cluster higher individu macroparasit burden contemporari normal express pattern extrem transcript profil observ induc infecti agent implic macroparasit player mediat individu suscept resili infect form survei describ combin gener nucleic acid sequenc method broad detect microbi infecti agent individu anomal immunolog transcript profil power tool reveal unrecogn ecolog infecti agent circul wildlif popul
PLoS One	25281754	2008-09-01	PMC3100331	21629778	vuvuzela plastic blow horn sport fan achiev intern recognit fifa cup soccer tournament south africa hypothesis vuvuzela facilit gener dissemin respiratori aerosol investig quantiti size aerosol emit instrument plai healthi volunt ask blow vuvuzela individu concentr particl expel air measur channel laser particl counter durat blow veloc air leav vuvuzela record allow comparison activ undertaken sport event individu ask shout measur repeat paper cone confin exhal air triplic measur individu peak particl count litr vuvuzela litr shout repres log differ ci major particl captur vuvuzela shout micron diamet peak airflow record vuvuzela shout litr second conclud plastic blow horn vuvuzela capac propel extrem larg number aerosol atmospher size penetr lower lung respiratori pathogen spread contamin aerosol emit infect person investig requir assess potenti vuvuzela contribut transmiss aerosol born diseas recommend precautionari measur peopl respiratori infect advis blow vuvuzela enclos space risk infect other
Pulm Med	19693370	2018-07-16	PMC3100576	21637372	the pathogenesi acut exacerb idiopath pulmonari fibrosi ipf remain elucid evalu role inflammatori mediat acut exacerb concentr high mobil group protein hmgb chief mediat acut lung injuri inflammatori cytokin measur bronchoalveolar lavag fluid serial sampl ipf patient onset acut exacerb hmgb gradual increas alveolar fluid onset acut exacerb posit correl monocyt chemotact protein mcp potent fibrogen mediat lung tissu ipf patient autopsi acut exacerb intens cytoplasm stain hmgb observ alveolar epitheli cell alveolar capillari augment lesion capillari endotheli cell remark reduc express thrombomodulin intrins antagonist hmgb pathogen role hmgb mcp late phase acut exacerb ipf
Int J Mol Sci	30012613	2011-11-09	PMC3100839	21614200	protein microarrai power tool system biologi infecti diseas proteom microarrai assembl protein pathogen will plai increasingli role discoveri diagnost marker vaccin therapeut distinct format protein microarrai develop applic includ abundancebas functionbas method depend applic design issu consid multiplex label label free detect method develop challeng futur demand infecti diseas will impact applic protein microarrai discoveri valid biomark
PLoS One	22072787	2003-10-07	PMC3101222	21629701	the genu perkinsu occupi precari phylogenet posit gain better understand relationship perkinsid dinoflagel alveol analyz nuclearencod splicedlead sl rna mitochondri gene intron preval multiprotein phylogeni contrast canon nt sl dinoflagel dinosl marinu shorter nt longer nt sl sequenc dinosl major sl rna transcript rang size nt marinu nt chesapeaki larger typic nt dinoflagel sl rna phylogenet tree base predict protein sequenc marinu branch base dinoflagel clade includ ancient taxa oxyrrhi amoebophrya sister clade apicomplexan case cluster apicomplexan sister dinoflagel clade perkinsu spp gene examin intron higher intron preval dinoflagel examin perkinsu spp mitochondri cytochrom cytochrom oxidas subunit gene cdna reveal mrna edit transcript translat frameshift introduc agg ccc codon aggi code glycin ccccu prolin presenc numer uncharacter marin alveol group perkinsuslik lineag separ perkinsid core dinoflagel expand support affili genu perkinsu independ lineag perkinsozoa posit phyla apicomplexa dinoflagellata
PLoS Pathog	14561285	2016-01-11	PMC3102710	21637813	cellular viral sadenosylmethioninedepend methyltransferas involv regul process metabol detoxif signal transduct chromatin remodel nucleic acid process mrna cap sever acut respiratori syndrom coronaviru nsp protein sadenosylmethioninedepend nucleosideomethyltransferas activ presenc activ partner nsp report nspnsp complex structur resolut nsp bound nsp surfac area nsp function assai identifi kei residu involv nspnsp associ rna bind catalysi snlike mechan crystal structur inhibitor sinefungin bound sadenosylmethionin bind pocket tighter complex nspyfnsp provid structur insight regul rna cap enzym rna virus
PLoS One	26752023	2009-08-01	PMC3103500	21637748	background accessori protein sarscov small protein amino acid structur solv local extranuclear region postul possess nuclear export signal ne role ne function understood princip findingsmethodolog report demonstr absenc nuclear local signal nl enter nucleu passiv transport cell cycl inhibitor nuclear entri independ cell cycl interact cellular protein crm export nucleu activ ne reveal ne activ influenc halflif host cell death export signal defici sarscov protein induc apoptosi transient transfect cell elev caspas activ conclusionsignific nuclear shuttl interact crm essenti proper degrad block nuclear export protein induc apoptosi phenomenon critic provid novel role accessori protein sarscov
PLoS Med	29060084	2017-05-10	PMC3104979	21655318	background infect pregnanc potenti advers impact birth outcom evalu associ receipt inactiv influenza vaccin pregnanc prematur small gestat ag sga birth method find conduct cohort analysi surveil data georgia unit state pregnanc risk assess monitor system live birth june septemb matern influenza vaccin primari intervent evalu studi receipt influenza vaccin trimest pregnanc main outcom measur prematur gestat ag birth wk sga birth weight percentil gestat ag infant born put influenza season octob mother vaccin influenza pregnanc prematur compar infant unvaccin mother born period adjust odd ratio ci magnitud associ matern influenza vaccin receipt reduc likelihood prematur increas period local influenza activ adjust ci greatest widespread influenza activ period adjust ci compar newborn unvaccin women newborn vaccin mother lower odd sga adjust ci period widespread influenza activ adjust unadjust or preinfluenza activ period conclus studi demonstr associ immun inactiv influenza vaccin pregnanc reduc likelihood prematur local region widespread influenza activ period associ preinfluenza activ period period widespread influenza activ associ matern receipt influenza vaccin reduc likelihood sga birth articl editor summari
BMC Med	28488435	2016-12-01	PMC3108322	21521505	background viral respiratori infect common worldwid rang complet benign diseas lifethreaten ill symptom unspecif etiolog diagnosi rare establish lack suitabl diagnost tool improp antibiot common set detriment light develop bacteri resist suggest diagnost test reduc antibiot prescript rate object studi evalu access multiplex polymeras chain reaction pcr assai panel etiolog diagnosi acut respiratori tract infect arti impact antibiot prescript rate primari care clinic set method adult patient symptom arti prospect includ nasopharyng throat swab analys multiplex realtim pcr method target thirteen virus bacteria patient recruit outpati unit octob april sampl collect dai inclus initi visit dai followup visit patient randomis openlabel treatment protocol receiv rapid delai result dai twelv dai primari outcom measur antibiot prescript rate initi visit secondari outcom total antibiot prescript rate studi period total sampl patient randomis fortyon exclud leav patient analysi group patient randomis rapid result of patient receiv antibiot initi visit compar patient delai result group followup differ group rapid result group delai result group conclus access rapid method etiolog diagnosi arti reduc antibiot prescript rate initi visit outpati set sustain better defin follow manag patient result test warrant investig trial registr clinicaltrialsgov identifi nct
Pulm Med	27756680	2009-07-10	PMC3109313	21660284	highaltitud pulmonari edema hape lifethreaten diseas high altitud nonacclimat healthi individu rapidli ascend high altitud earli detect earli diagnosi earli treatment essenti maintain safeti peopl ascend high altitud construct worker tourist paper discuss method criteria earli diagnosi predict hape discuss prevent strategi option onsit treatment object improv understand hape highlight prevent earli diagnosi earli treatment hape improv safeti individu ascend high altitud
PLoS One	19592662	2011-08-01	PMC3110205	21687739	honei bee api mellifera plai critic role global food product pollin numer crop honei bee popul unit state canada europ suffer unexplain increas annual loss phenomenon coloni collaps disord ccd epidemiolog analysi ccd confound rel dearth bee pathogen field studi identifi constitut abnorm pathophysiolog condit honei bee coloni critic character spectrum exogen infecti agent healthi hive time conduct prospect studi larg scale migratori bee keep oper highfrequ sampl pair comprehens molecular detect method includ custom microarrai qpcr ultra deep sequenc establish season incid abund virus nosema sp crithidia mellifica bacteria ultra deep sequenc analysi identifi novel rna virus abund observ compon honei bee microbiom virus honei bee demonstr episod viral incid distinct pathogen pattern summer winter timepoint peak infect common honei bee virus nosema occur summer level trypanosomatid crithidia mellifica lake sinai viru novel viru peak januari
PLoS Med	21621287	2004-12-30	PMC3110256	21687693	background wintertim cooccurr peak influenza invas pneumococc diseas ipd document wintertim peak caus pathogen causal uncertain aim investig relationship influenza infect ipd ontario canada complementari methodolog tool method find evalu total number posit influenza test central ontario episod ipd torontopeel area ontario canada januari octob report populationbas surveil assess relationship season wave form influenza ipd fast fourier transform order examin relationship pathogen yearli timescal three complementari statist method timeseri method neg binomi regress casecrossov method evalu shortterm influenza dynam pneumococc risk annual period wintertim peak demonstr ipd period influenza regular longterm effect phase amplitud term pneumococc influenza season sine wave correl metaanalysi confirm heterogen influenza pneumococc phase term contrast influenza grangercaus pneumococc diseas shortterm associ ipd influenza demonstr week lag casecrossov odd ratio confid interv case ipd influenza case neg binomi regress analysi incid rate ratio confid interv case ipd influenza case conclus data support hypothesi influenza influenc bacteri diseas incid enhanc shortterm risk invas colon individu absenc correl season waveform hand suggest bacteri diseas transmiss lesser extent articl editor summari
Viruses	15626758	2010-11-05	PMC3111045	21666766	rift vallei fever rvf emerg zoonot diseas distribut subsaharan african countri arabian peninsula diseas caus rift vallei fever viru rvfv famili bunyavirida genu phleboviru viru transmit mosquito viru replic domest rumin high rate mortal abort rvfv infect human selflimit acut febril ill small number case progress neurolog disord partial complet blind hemorrhag fever thrombosi review describ patholog rvf human patient anim model summar role viral virul factor host factor affect rvfv pathogenesi
PLoS Pathog	21036828	2011-08-31	PMC3111541	21695242	transmiss gastroenter viru tgev genom three accessori gene gene member coronaviru genu encod hydrophob protein aa studi gene function recombin tgev viru lack gene engin rtgev mutant parent rtgevwt virus growth viral rna accumul kinet tissu cultur cell infect rtgev viru increas cytopath caus enhanc apoptosi mediat caspas activ macromolecular synthesi analysi rtgev viru infect led host translat shutoff increas cellular rna degrad compar rtgevwt infect increas eukaryot translat initi factor eif phosphoryl enhanc nucleas rnase activ observ rtgev viru infect cell suggest remov gene promot intensifi dsrnaactiv host antivir respons protein conserv sequenc motif mediat bind protein phosphatas catalyt subunit ppc kei regul cell antivir defens identifi postul tgev protein counteract host antivir respons associ ppc fact pulldown assai demonstr interact tgev protein protein mutant lack ppc bind motif interact protein requir infect eif dephosphoryl inhibit cell rna degrad inocul newborn piglet rtgev rtgevwt virus rtgev viru present acceler growth kinet patholog compar parent viru indic gene counteract host cell defens modifi tgev persist increas tgev surviv acquisit gene tgev genom provid select advantag viru
BMC Infect Dis	21880764	2005-03-21	PMC3112099	21575222	background china greatest risk pandem hn huge popul high residenti densiti unclear comprehens neg attitud emerg infecti diseas gener popul lead unnecessari worri panic object studi investig chines public respons hn pandem provid baselin data develop public educ campaign respons futur outbreak method closeend questionnair develop chines center diseas control prevent appli assess knowledg attitud practic kap pandem hn respond recruit urban rural area china sampl probabl proport size pp method respond clear food spread hn virusand report pandem impact life immun rate season flu hnvaccin farmer lower educ level main transmiss rout cough talk face face femal colleg educ higher percept risk complianc prevent behavior relationship knowledg risk percept ci knowledg practic ci studi subject regard behavior ahn vaccin factor current studi popul includ percept life disturb ci safeti ahn vaccin ci knowledg free vaccin polici ci state prioriti vaccin strategyor ci season influenza vaccin behavior ci conclus ahn epidem caus public panic knowledg ahn resid optimist public educ campaign side effect vaccin knowledg state vaccin strategi account
Virol J	15781480	2014-02-13	PMC3113310	21595942	background outcom viru infect depend precis coordin viral gene express genom replic abil control regul process analysi infect process virus tool bio gene technolog effici kill cancer cell trigger immun respons tumor method construct tissu celltyp specif virus typic suffer low targetcel specif high risk revers novel univers method regul viral infect therapeut applic virusbas system method aberrantli splice intron introduc crucial geneexpress unit adenoviru vector alphaviru dnarna layer vector effect viral gene express replic andor releas infecti genom studi cell cultur transfect cell spliceswitch oligonucleotid correct introduc function defect demonstr viral gene express replic andor releas infecti genom block introduct aberrantli splice intron insert intron adenoviru vector reduc express target gene fiftyfold insert alphaviru dnarna layer vector dramat releas infecti transcript suppress subsequ replic spread viru insert aberrantli splice intron hundredfold reduct infect dnarna layer vector system observ effect revert deliveri spliceswitch oligonucleotid correct splice defect conclus spliceswitch technolog origin develop genet diseas therapi control gene express viral vector approach repres novel univers power method control gene express replic viral spread extens virusinduc cytotox effect basic studi viru infect virusbas gene anticanc therapi
PLoS One	24524681	2006-12-01	PMC3113848	21695140	background apic membran antigen ama beststudi bloodstag malaria vaccin candid ama vaccin test malaria nave popul induc function activ antibodi judg growth inhibit assai gia vaccin fail induc higher growthinhibitori activ adult live malaria endem area vaccin induc function activ antibodi malariaexpos children inhibit gia baselin children level baselin inhibit method total igg purifi plasma collect pediatr trial immun pool total igg set total igg purifi adult immun ama ustot igg total igg amaspecif nonama igg affin purifi function activ igg evalu gia competit elisa perform ustot igg nonama igg malariaexpos children amaspecif igg malariaexpos children vaccine growthinhibitori activ concentr mix ustot igg nonama igg children interfer gia interestingli interfer higher nonama igg higher titer pool nonama igg compet antiama antibodi ustot igg competit elisa conclus children live malaria endem area fraction igg interfer biolog activ antiama antibodi judg gia mechan interfer resolv studi caus direct competit nonama igg ama protein studi indic antimalaria igg induc natur exposur interfer biolog antibodi induc amabas vaccin target popul
J Med Case Reports	16959328	2014-05-05	PMC3113999	21599907	emerg infecti diseas problem medicin case report document episod earli emerg phase small outbreak case report consid weak evid medic literatur report emerg infecti diseas doubt case report provid case seri review studi editori focus case report emerg infecti diseas medic societi public area highli welcom journal serv futur point refer
PLoS One	24799566	2014-10-13	PMC3114850	21695128	background accur data childhood pneumonia aetiolog essenti region mortal high order inform casemanag guidelin potenti prevent strategi bacteri conjug vaccin yield blood cultur low lung aspir cultur higher diagnost yield aim determin diagnost yield increas polymeras chain reaction pcr detect bacteria streptococcu pneumonia haemophilu influenza virus lung aspir fluid method total children radiolog focal lobar segment consolid lung aspir perform bacteri cultur pcr detect bacteria virus pneumocysti jirovecii children pneumococc aetiolog pneumococc bacteri load calcul blood lung aspir fluid blood cultur identifi bacteri pathogen patient addit pcr lung aspir sampl caus pathogen bacteri viral pneumocysti identifi singli coinfect children commonest bacteri organ spneumonia influenza commonest viru identifi adenoviru human bocaviru hbov singl coinfect conclus select group african children lung aspir pcr improv diagnost yield studi confirm major role spneumonia virus aetiolog childhood pneumonia africa
PLoS One	25313032	2009-05-01	PMC3115951	21698289	background doublestrand rna depend protein kinas pkr kei regul antivir innat immun respons mammalian cell pkr activ regul kilo dalton cellular inhibitor pipk inact state complex hsp normal condit case influenza viru iav infect pipk dissoci hsp inhibit pkr activ influenza viru compon respons pkr inhibit pipk activ hitherto unknown princip find human heat shock protein hsp identifi interact partner influenza viru nucleoprotein iav np yeast twohybrid screen interact confirm coimmunoprecipit studi mammalian cell transfect iav np express plasmid iav nphsp interact valid mammalian cell infect season pandem strain influenza virus cellular local studi np hsp coloc nucleu iav infect mammalian cell express np coincid dissoci pipk hsp decreas pkr phosphoryl observ plasmid base express np mammalian cell lead decreas pkr phosphoryl inhibit np express influenza viru replic led pkr activ concomit increas eif phosphoryl inhibit np express led reduc irf phosphoryl enhanc ifn product concomit reduct viru replic data np viral factor respons pipk activ subsequ inhibit pkrmediat host respons iav infect signific find demonstr novel role iav np inhibit pkrmediat antivir host respons help understand pipk mediat inhibit pkr activ iav infect
PLoS One	19279492	2017-08-01	PMC3115971	21698249	torovirus gastroenter caus agent infect anim speci human torovirus diseas describ time prototyp member genu equin toroviru bern viru bev induc apoptosi infect cell late time postinfect observ bev infect cell electron microscopi reveal hour postinfect cell exhibit morpholog characterist apoptot cell base find analyz apoptot marker observ protein synthesi inhibit rrna dna degrad nuclear fragment caspasemedi cleavag parp eifgi pkr eif phosphoryl process place peak viru product determin cell death receptor mitochondri pathwai involv apoptosi process induc bev bevinduc apoptosi late time postinfect viral progeni produc facilit viral dissemin vivo contribut viral pathogenesi
J Viral Hepat	28666653	2007-10-01	PMC3116152	20546498	summari determin structur core capsid unusu variant hepat viru genotyp hbvg resolut cryoelectron microscopi structur reveal surfac featur prototyp hbva genotyp hbvg novel uniqu bp insert downstream core gene start codon twelv amino acid insert ntermin core protein codon precor region prevent express hbeag hbvg replic patient associ coinfect genotyp hbv suggest hbvg reduc replic effici vivo local ntermin insert hbvg form addit mass core surfac adjac dimerspik model structur addit residu densiti posit insert interfer transloc nucleic acid pore core interior compart insert partial obscur residu core surfac plai role envelop secret virion affect structur rearrang trigger envelop dna secondstrand synthesi
Retrovirology	17652456	2006-03-01	PMC3118345	21569301	background gene trap insert mutagenesi highthroughput approach discov cellular gene particip viral infect screen librari cell select surviv lytic infect varieti virus cell harbor disrupt adam disintegrin metalloproteas allel surviv reoviru infect subsequ adam rna interfer replic hiv silenc adam express small interf rna sirna hour infect inhibit hiv replic primari human monocytederiv macrophag cd cell line agreement adam overexpress increas hiv replic adam downregul inhibit viral revers transcript indic viral entri uncoat independ adam express integr hiv cdna reduc adam downregul cell concomit ltr circl format detect suggest hiv enter nucleu adam silenc inhibit downstream report gene express viral protein translat interestingli metalloproteas domain adam requir hiv replic adam secretas proteolyt releas extracellular intracellular domain adam plasma membran support product infect conclus propos adam facilit replic level nuclear traffick collect data support model adam cleav adam secretas adam intracellular domain directli facilit hiv nuclear traffick adam repres novel cellular target class develop antiretrovir drug
BMC Genomics	16380562	2006-05-24	PMC3118785	21554741	background previou studi reveal diseas form streptococc toxic shock syndrom stss associ specif streptococcu sui serotyp ss strain achiev better understand pathogen evolut ss wholegenom level compar genom analysi ss strain select basi virul geograph origin perform nimblegen tile arrai result demonstr ss isol highli diverg genom pathogen island pai recogn uniqu chines epidem strain caus stss partial includ virul avirul strain abctyp transport system encod hypothes greatli contribut catastroph featur stss identifi polymorph gene encod candid virul factor plcr lipas sortas pilusassoci protein respons regul rev ctsr basi analysi region differ rd entir genom select ss strain model microevolut strain propos clue streptococcu pathogen evolut conclus deep compar genom analysi pai genom ss strain reveal detail virul strain acquir gene contribut stss lead better environment monitor epidem ss strain
PLoS One	16723558	2004-05-01	PMC3119054	21701677	some approach develop retriev data automat multipl remot biolog data sourc requir research remain onlin wait return requir highli network connect network overload exist approach design address problem retriev remot data mobil network environ resourc mobil devic limit network connect low qualiti mobil user onlin address aforement problem integr agent migrat approach multiag system overcom high latenc limit bandwidth problem move comput requir resourc servic importantli approach fit mobil comput environ present paper system architectur migrat strategi secur authent agent migrat demonstr remot data retriev genbank illustr feasibl propos approach
PLoS Negl Trop Dis	15138176	2009-06-01	PMC3119640	21713020	human experi primari dengu viru denv infect develop antibodi preferenti neutral homolog serotyp respons infect individu gener crossreact antibodi heterolog denv serotyp nonneutr dengu crossreact nonneutr antibodi enhanc infect fc receptor bear cell exacerb diseas actual bind site human antibodi denv particl defin character specif neutral potenc polyclon serum antibodi memori bcell deriv monoclon antibodi hmab individu expos primari denv infect denvspecif hmab serotyp crossreact weakli neutral hmab bound viral premembran protein site viru preserv viral envelop protein produc solubl recombin antigen protein modifi screen procedur detect rare antibodi bound isol map human antibodi neutral homolog serotyp denv mab indic individu expos primari denv infect small fraction total antibodi respons respons viru neutral
PLoS One	19527651	2002-11-01	PMC3119673	21712984	background highli refin surveil data ahn influenza pandem crucial quantifi spatial tempor characterist pandem spatialtempor dynam pandem influenza south america provid quantit descript agespecif morbid pandem pattern administr area peru method daili case influenzalikeil test ahn influenza viru infect laboratoryconfirm ahn influenza case report epidemiolog surveil system peru ministri health decemb analyz geograph spread pandem wave associ winter school vacat period demograph factor absolut humid estim reproduct number quantifi associ winter school vacat period ag distribut case nation pandem curv reveal bimod winter pandem wave peak limit school ag children lima metropolitan area second peak geograph widespread reproduct number estim lima metropolitan area rest peru associ time school vacat period chang ag distribut case earlier pandem onset correl larg popul size contrast associ pandem dynam absolut humid conclus indic substanti spatial variat pandem pattern peru pandem wave vari time impact ag region peru data hierarch transmiss pattern pandem influenza ahn driven larg popul center higher reproduct number pandem wave explain high contact rate schoolag children ag group earli wave
Virol J	12368326	2013-11-20	PMC3119933	21492483	background studi porcin encephalomyocard viru emcv viruslik particl vlp gener baculoviru express system test immunogen protect efficaci vivo vlp gener sf cell infect recombin baculoviru confirm nm transmiss electron microscopi tem immun mice crude protein vlp protect emcv infect swine increas neutral antibodi titer observ immun crude protein vlp addit high level neutral antibodi fold maintain test period second immun sever inject site reaction observ immun swine healthi immun period conclus recombin emcv vlp repres vaccin candid protect emcv infect pig farm
Microb Cell Fact	24257604	2006-03-28	PMC3120639	21595909	background express human viru surfac protein mammalian glycoprotein effici cell higher eukaryot yeast limit highlevel express activ viral surfac glycoprotein yeast understood identifi bottleneck perform detail studi overexpress recombin mump hemagglutininneuraminidas muhn measl hemagglutinin meh yeast saccharomyc cerevisia combin analysi recombin protein proteom approach overexpress recombin muhn meh protein larg aggreg inact total insolubl nativ condit major recombin protein immatur form nonglycosyl precursor fraction yeast lysat reveal core viral surfac protein aggreg consist muhn meh disulfidelink multim involv eukaryot translat elong factor eefa close associ small heat shock protein shsp remov denatur condit complex larg hsp bound aggreg core peripher easili remov high salt concentr proteom analysi reveal accumul unglycosyl viral protein precursor specif cytosol unfold protein respons uprcyto yeast cell character action regul small hsp versu larg chaperon hsp hsp hsp famili contrast environment stress respons synthesi recombin muhn meh larg hsp upregul shsp interestingli amount eefa increas stress respons conclus ineffici transloc muhn meh precursor er membran bottleneck highlevel express yeast overexpress recombin protein induc upr cytosol counterpart uprcyto repres subset protein involv heatshock respons involv eefa explain mechan larg chaperon small hsp upregul stress respons studi highlight differ viral surfac protein express yeast mammalian cell stage secretori pathwai
Virol J	16569857	2008-01-16	PMC3120787	21619646	background herp simplex viru type hsv infect number diseas rang simpl cold sore danger kerat lethal enceph interact viru host cell critic viral replic extens investig laboratori studi test hypothesi hsv lytic infect trigger express multifunct transcript factor egr mechan induct mediat signal pathwai nfb creb method sirc vero hek cell line infect hsv egr transcript protein detect rtpcr western blot local express profil egr investig immunofluoresc microscopi analys recruit transcript factor egr promot infect studi chromatin immunoprecipit chip inhibitor dominantneg mutant assess mechan egr induct effect address immunofluoresc microscopi western blot analys egr absent uninfect cell protein detect hour post treatment respons directli proport titer viru infect recombin hsv express egfp egr detect infect cell chip assai demonstr nfb camp respons element bind protein creb recruit egr promot infect addit studi inhibitor nfb dominantneg creb repress egr induct hsv infect conclus collect demonstr egr express rapidli hsv infect novel induct nfbcrebmedi transactiv egr induct plai kei role viral gene express replic inflamm diseas progress
Virol J	18199643	2007-03-07	PMC3120790	21639929	background avian influenza virus hn subtyp highli preval avian speci virus gener mild moder diseas infect wide varieti speci includ chicken quail turkei duck gees pheasant partridg pigeon transmit mammalian speci includ human acceler effort devis protect strategi stronger immun respons induc mous model immun bvdualha vaccin dna vaccin encod antigen complet protect lethal challeng hn viru observ mice conclus bvdualha util vaccin candid hn viru infect
BMC Public Health	17360568	2012-01-01	PMC3121631	21592390	background health care provid hcp plai role public health emerg prepared respons phepr awar public health threat emerg inform hcp public health issu phepr messag provid guidelin updat facilit surveil hcp will recogn control communic diseas prevent excess death mitig suffer public health agenc phepr messag hcp reach target audienc effect inform public health agenc phepr messag hcp reach target audienc effect inform conduct literatur review investig system tool public health gener phepr commun hcp identifi specif characterist messag deliveri mechan format associ effect phepr commun method systemat review peer nonpeerreview literatur focus question public health system exist commun phepr messag public health agenc hcp system evalu criteria evalu system evalu discov character effect wai public health agenc commun phepr messag hcp identifi system tool commun phepr messag public health agenc hcp articl assess phepr commun system messag method outcom studi compar effect deliveri format devic messag discov potenti high hcp experi messag overload redund phepr messag multipl format andor deliveri system conclus detail descript phepr messag public health hcp scarc literatur rare evalu systemat fashion meet presentdai futur emerg prepared attent to evalu effect system scientif rigor manner
BMC Bioinformatics	21817949	2013-04-10	PMC3121648	21635786	background current method protein function predict reli sequencebas comparison queri protein function annot provid seriou limit sequenc similaritybas approach identifi residu conserv protein low confid assign residueresidu correspond protein level sequenc ident compar protein poor multipl sequenc align method satisfactorystil provid reliabl low level sequenc ident goal current work develop algorithm help overcom difficulti facilit identif structur function relev residueresidu correspond compar protein structur stralsv structurealign sequenc variabl algorithm detect close structur fragment quantifi residu frequenc tight local structur align appli stralsv studi rnadepend rna polymeras polioviru demonstr algorithm determin region protein uniqu share structur similar protein consid distantli quantifi residu frequenc residueresidu pair extract local structur align infer potenti structur function specif residu determin highli conserv deviat consensu demonstr consider detail structur phylogenet deriv stralsv analys conclus stralsv structurebas algorithm identifi align structur fragment similar refer protein stralsv analysi quantifi residueresidu correspond identifi residu structur function unusu unexpect residu sequenc posit stralsv provid web servic httpproteinmodelorgastsstralsv
Virol J	23570618	2016-11-01	PMC3121704	21595869	background human bocaviru hbov discov parvoviru associ mild sever lower respiratori tract infect children aim work determin human bocaviru nasopharyng aspir npa infant qualit pcr determin acut human bocaviru infect estim immunoglobulin igm antibodi serum enzym link immunosorb assai twenti npa specimen patient respiratori manifest posit hbov qualit pcr elisa reveal posit hbov igm antibodi patient posit pcr control posit techniqu correl studi elisa pcr reveal high associ agreement pcr detect npa sampl hbov posit case patient identifi elisa high sensit efficaci pcr elisa sensit rtpcr sensit efficaci elisa versu rtpcr conclus hbov infect diagnos npa children convent pcr rapid sensit techniqu elisa reliabl serolog analysi diagnosi acut hbov infect estim igm antibodi serum
PLoS One	27467538	2018-11-14	PMC3121745	21731708	background gold standard respiratori viru test nasopharyng np swab collect healthcar worker midturbin mt swab altern eas collect selfcollect patient object studi compar respiratori viru isol flock mt swab compar flock np swab method octob healthi adult ag year recruit cohort symptom influenza ask np mt swab onset fever respiratori symptom acut onset swab test viral respiratori infect seeplex rv multiplex pcr detect kit seventi pair simultan np mt swab collect symptomat subject twenti pair posit np mt swab sixti pair concord sampl hcv ochku sampl rhinoviru ab posit np neg mt sampl hcv enl hcv ochku respiratori syncyti viru influenza posit mt neg np conclus flock mt swab sensit diagnosi multipl respiratori virus eas mt collect swab mt swab prefer method respiratori cell collect outpati studi light data larger studi perform ensur hold true data collect patient prefer collect method
PLoS Negl Trop Dis	30429338	2003-08-01	PMC3125144	21738801	background rabi fatal enceph caus lyssavirus evid lyssaviru circul emerg southeast asian bat crosssect studi conduct thailand assess rabiesrel knowledg practic person regularli expos bat bat habitat object identifi defici rabi awar describ occurr bat exposur explor factor associ transderm bat exposur method survei administ conveni sampl adult guano miner bat hunter game warden residentspersonnel buddhist templ mass bat roost occur questionnair elicit demograph experi bat exposur rabi knowledg particip ask describ action respons bat bite action bite rabid anim bivari analysi compar respons group multivari logist regress explor factor independ associ bitten scratch bat find peopl interview identifi bat potenti sourc rabi histori bat bite scratch report state would respons bat bite guano miner group indic anim bite mechan rabi transmiss respond appropri bat bite scratch guano mine bat hunt bat cave roost area time year associ histori bat bite scratch conclus find indic educ outreach rais awar bat rabi promot exposur prevent ensur appropri healthseek behavior batinflict wound atrisk group thailand
Vet Res	12876182	2010-02-25	PMC3125225	21592358	the success replic viral agent host complex process lead speci specif viru interspeci transmiss difficult despit difficulti natur host switch frequent virus lower vertebr fish virus virus to infect wide rang speci review will focu document report broad host rang variat host specif host shift event hypothes virus genera ranaviru novirhabdoviru betanodaviru isaviru herpesviru
BMC Biotechnol	20184396	2014-02-05	PMC3125328	21635725	background antibodi constitut power tool studi protein function protein local proteinprotein interact diagnost therapeut purpos highthroughput antibodi develop requir faster methodolog lower antigen consumpt describ novel methodolog select human monoclon recombin antibodi combin vitro protein express phage displai antibodi librari antibodi microarrai applic combin methodolog permit gener human singlechain variabl fragment scfv protein green fluoresc protein gfp thioredoxin trx short time low purifi protein scfv specif reactiv respect target work elisa western blot scfv recognis low ng protein respect target western blot conclus work describ novel miniatur methodolog human monoclon recombin antibodi target shorter time methodolog protein protocol easili adapt highthroughput procedur antibodi product
Virol J	24501399	2007-02-01	PMC3126774	21619712	twentyseven nanopeptid deriv matrix protein porcin reproduct respiratori syndrom viru prrsv screen abil elicit recal interferon ifn respons splenocyt balbc mice dna vaccin booster vaccin recombin vaccinia viru rwrprrsvm identifi peptid amino acid residu kfitsrcrl fgymtfvhf cd cytotox lymphocyt ctl epitop peptid elicit number ifn secret cell compar nonapeptid irrelev nonapeptid bioinformat analysi hkdrestrict ctl epitop hddrestrict ctl epitop multipl amino acid sequenc align prrsv sequenc submit genbank indic ctl epitop conserv consid mechan cellular immun respons prrsv
BMC Cell Biol	17156899	2009-04-22	PMC3126779	21639891	background nucleoli compos protein repres conspicu compart nucleu plai crucial role proper execut cellular process nucleoli carri ribosom biogenesi sequest associ kei molecul regul cell cycl progress tumorigenesi apoptosi stress respons nucleoli dynam compart character constant flux macromolecul complex dynam composit nucleolar proteom challeng link modif nucleolar composit downstream effect contribut quantit immunofluoresc method reli computerbas imag analysi demonstr effect techniqu monitor dynam associ protein rna nucleoli physiolog condit protocol describ emploi studi stressdepend chang nucleolar concentr endogen gfptag protein method appli measur de novo rna synthesi associ nucleoli techniqu describ easili combin autom high throughput screen ht platform make larg data set analyz biolog process locat nucleoli conclus protocol set stage analyz quantit fashion kinet shuttl nucleolar protein singl cell level larg number cell procedur describ compat high throughput imag acquisit analysi ht autom platform provid basi quantifi nucleolar compon activ numer sampl experiment condit grow amount nucleolar proteom improv quantit microscopi describ expect produc insight complex biolog function orchestr nucleolu
Viruses	19386706	2009-09-01	PMC3127449	21731813	network model contact process allow pathogen spread host remain unclear model best describ network question cluster network roughli defin propens triangl form dynam diseas spread perform simul studi signal epidem transmiss tree cluster simul susceptibleexposedinfectiousremov seir epidem reinfect network fix degre sequenc level cluster compar tree network degre sequenc cluster level find variat tree simul network level cluster bare greater simul network level cluster suggest cluster detect transmiss data reinfect occur
PLoS Comput Biol	19754694	2013-07-26	PMC3127811	21738461	the mitochondri protein repertoir vari depend cellular state protein compon modif caus mitochondri dna mtdna deplet wide rang human diseas nuclearencod mitochondri protein mt proteom chang dysfunct state studi investig system alter mtdnadeplet mitochondria network analysi gene express data modular quantifi proteom data protein function network system properti mitochondri dysfunct analyz discov upregul downregul protein organ predomin subnetwork exhibit distinct biolog process downregul network modul involv typic mitochondri function upregul protein respons mtdna repair regul mt protein express transport comparison proteom transcriptom data reveal cell attempt compens mtdna deplet modul coordin expressiontransport mt protein demonstr mt protein composit chang remodel function organ mitochondri protein network respons dysfunct cellular state human mt protein function network provid framework understand cell respond mitochondri dysfunct
BMC Public Health	24426285	2019-04-01	PMC3128025	21649919	background despit advanc surveil prevent pneumonia influenza pi remain lead mortal unit state elderli adult experi sever morbid influenzaassoci diseas highest rate season migrat compar subpopul object studi assess spatiotempor pattern influenzaassoci hospit elderli time geographi intens pi high season migrat individu florida state examin close harmon regress assess spatial tempor pattern pi hospit state resid method data medicareelig hospit unit state pi icdcm code abstract popul hospit classifi state resid provid state admiss compar admit octob march admit april septemb compar hospit profil data florida resid outofst resid state primari resid time year inseason outofseason observ distinct season pattern nonresid pi hospit compar typic winter destin state california arizona texa florida state state gener experienc higher proport nonresid pi summer month aprilseptemb state higher nonresid pi tradit peak influenza season octobermarch conclus studi quantifi spatiotempor pi hospit pattern elderli focus chang pattern season popul migrat understand migrat influenzaassoci diseas pattern vulner popul critic prepar prevent influenza outbreak vulner popul
BMC Infect Dis	31604530	2012-04-01	PMC3128050	21649905	background acut otiti media perfor aomwip remot indigen children month life streptococcu pneumonia haemophilu influenza moraxella catarrhali primari bacteri pathogen otiti media load predict clinic ear state hypothesi anteced respiratori viral infect increas bacteri densiti progress perfor method total nasopharyng swab indigen children retrospect examin panel respiratori virus screen pcr densiti pneumonia influenza catarrhali estim quantit real time pcr data report clinic ear state catarrhali influenza pneumonia respiratori virus common includ rhinoviru hrv polyomaviru hpyv adenoviru hadv bocaviru hbov coronaviru hcov geometr bacteri load higher children acut otiti media aom compar children evid otiti media children infect hadv time aom perfor conclus studi confirm posit associ nasopharyng bacteri load clinic ear state exacerb respiratori virus indigen children hadv independ associ acut ear state
Philos Trans R Soc Lond B Biol Sci	22173144	2018-09-05	PMC3130384	21624924	formal quantit approach predict likelihood infecti diseas outbreak diseas will spread control wellestablish methodolog includ risk factor analysi risk model dynam model predict model art drive effort area build undoubt success quantit model epidemiolog control human anim diseas aid influenza footandmouth diseas bse attent paid develop holist framework captur role underli driver diseas risk demographi behaviour land climat chang time consider room improv quantit analys output commun polici maker stakehold start point gener accept guidelin good practic develop predict model
PLoS One	30252202	2006-04-26	PMC3130781	21760897	background allogen bone marrow transplant allobmt cur therapi varieti hematolog diseas benefit includ graftversustumor gvt activ limit graftversushostdiseas gvhd carcinoembryon antigen cell adhes molecul ceacam transmembran glycoprotein epithelium cell tumor regul varieti physiolog patholog process tumor biologi leukocyt activ energi homeostasi previou studi ceacam neg regul inflamm inflammatori bowel diseas model method studi ceacam regul gvhd gvt allogen bone marrow transplant allobmt mous model vivo ceacam cell caus increas gvhd mortal gvhd colon greater number donor cell posit activ marker cdhi cdllo addition ceacam cd cell greater express guttraffick integrin cd cd cell increas number gut posttranspl ceacam recipi experienc increas gvhd mortal gvhd colon alloreact cell displai increas activ addition ceacam mice increas mortal decreas number regener small intestin crypt radiat exposur convers ceacamoverexpress cell caus attenu targetorgan system gvhd correl decreas donor cell number target tissu mortal final graftversustumor surviv ceacam lymphoma model improv anim receiv ceacam control cell conclus conclud ceacam regul cell activ gvhd target organ damag number donor cell lymphoid organ gvhd target tissu recipi allobmt ceacam regul tissu radiosensit express donor graft host tissu suggest target ceacam repres potent strategi regul gvhd gvt allogen transplant
PLoS Pathog	16641270	2014-07-21	PMC3131267	21750671	the inhibitori receptor program death pd capac maintain peripher toler limit immunopatholog damag precis role fulmin viral hepat fh describ investig function mechan pd fh pathogenesi induc murin hepat viru strain mhv high level pdposit cd cd cell nk cell macrophag observ liver spleen lymph node thymu tissu mhv infect pddefici mice exhibit higher express effector molecul initi fibrinogen deposit fibrinogenlik protein fgl wildtyp wt litterm result sever tissu damag produc mortal rate higher fluoresc doublestain reveal fgl pd coexpress cell quantit rtpcr demonstr higher level ifn tnf mrna transcript occur pddefici mice respons mhv infect convers vivo blockad ifn tnf led effici inhibit fgl express greatli attenu develop tissu lesion ultim reduc mortal upregul fgl pddefici mice determin mediat ifn tnf pd signal plai essenti role decreas immunopatholog damag induc mhv manipul signal strategi fh immunotherapi
PLoS One	25049413	2010-07-01	PMC3131282	21750710	machupo viru macv highli pathogen arenaviru hemorrhag fever human macv pathogen arenavirus enter cell gp attach glycoprotein bind cellular receptor transferrin receptor tfr tfr residu essenti interact describ cocryst macv gp bound tfr suggest gp residu associ creat macv gp variant test tfr bind viru entri evalu function signific addit residu human simian cell residu essenti expend gptfr interact macv entri macv gp residu critic interact tfr conserv arenavirus indic common basi receptor interact find open avenu ration develop viral entri inhibitor
Viruses	20617918	2017-12-01	PMC3133461	21755021	elicit antibodi potent broad neutral activ hiv immun remain challeng monoclon antibodi mab isol human hiv infect exhibit activ vaccin immunogen base structur epitop success elicit broadli neutral mab bnmab immunoglobulin ig gs igg highli somat hypermut imped elicit ig ms igm averag diverg germlin antibodi relev develop vaccin immunogen underexplor compar igg describ identif character human igmderiv mab hiv select larg phagedisplai naiv human antibodi librari construct blood lymph node spleen healthi donor antibodi bound high affin recombin envelop glycoprotein gp env hiv isol clade enhanc neutral infect hiv primari isol ccr coreceptor neutral cxcr isol test weakli antibodi low degre somat hypermut extens character bound highli conserv region partial overlap coreceptor bind site close overlap cd bind site exist conserv structur direct immun respons nonneutr enhanc antibodi repres strategi viru escap neutral immun respons studi will strategi plai role hiv infect human role mechan infect enhanc newli identifi mab reagent character conserv nonneutr weakli neutral enhanc epitop modifi remov candid vaccin immunogen
PLoS One	29312755	2012-02-25	PMC3133621	21779388	the size von willebrand factor vwf control adamtsdepend proteolysi associ hemostat activ factor regul adamtsdepend vwf proteolysi interact vwf includ coagul factor viii platelet glycoprotein heparin sulfat acceler cleavag vwf convers thrombospondin decreas rate vwf proteolysi adamt compet adamt domain vwf investig murin monoclon antibodi mab human vwf affect suscept vwf proteolysi adamt vitro mab domain human vwf evalu effect vwf cleavag adamt fluid shear stress staticdenatur condit addition epitop antivwf mab sz map recombin protein combin enzymelink immunosorb assai western blot analysi indic mab sz inhibit proteolyt cleavag vwf adamt concentrationdepend manner fluid shear stress staticdenatur condit bind epitop sz mab locat central domain vwf data antivwf mab vwfa domain ag reduc proteolyt cleavag vwf adamt shear stress suggest role region interact adamt
J Drug Deliv	22367226	2009-09-23	PMC3134826	21773041	the develop synthet peptidebas vaccin advantag comparison vaccin base live attenu organ inactiv kill organ toxin peptidebas vaccin revert virul form allow better conserv produc easili safe gener weaker immun respons vaccin inclus adjuv andor vaccin deliveri system need vaccin deliveri system micro nanoparticul attract particul natur increas crosspresent peptid addit passiv activ target antigen present cell particul adjuv directli activ innat immun system vivo summar micro nanoparticul vaccin deliveri system field synthet peptidebas vaccin strategi increas immunogen
PLoS Pathog	19776135	2009-11-01	PMC3136464	21779173	adenovirus dna virus natur infect vertebr includ human monkei wide rang clinic ill human infect individu strain convention thought speciesspecif appli virochip panvir microarrai identifi novel adenoviru tmadv titi monkei adenoviru deadli outbreak close coloni monkei titi monkei callicebu cupreu california nation primat center cnprc titi monkei hous build develop upper respiratori symptom progress fulmin pneumonia hepat monkei infect di human euthan wholegenom sequenc tmadv reveal adenoviru speci highli diverg share pairwis nucleotid ident adenovirus cultiv tmadv success human lung adenocarcinoma cell primari establish monkei kidnei cell onset outbreak research closest contact monkei develop acut respiratori ill symptom persist week convalesc serum sampl seroposit tmadv clinic famili member despit contact cnprc test posit screen set random adult blood donor western unit state detect tmadvspecif neutral antibodi individu find rais possibl zoonot infect tmadv humantohuman transmiss viru popul unusu high case fatal rate outbreak titi monkei nativ host speci tmadv natur reservoir viru unknown discoveri tmadv novel adenoviru capac infect monkei human suggest adenovirus monitor close potenti crossspeci outbreak
PLoS One	19625461	2008-10-01	PMC3136934	21779366	background neuron astrocyt gener common neural precursor neurogenesi preced astrocyt format embryogenesi mechan neural develop underli suppress desuppress differenti gene cell fate specif understood methodologyprincip find vitro system ntera cell induc differenti astrocytelik lineag reveal novel role sina maintain suppress gfap ntera cell sina coupl mecp bound gfap promot occup correl repress gfap transcript repress sina mecp essenti mechan underli inhibit cell differenti commit astrocytelik lineag sina mecp depart promot activ stat simultan bound promot exon gfap olig export nuclei cytoplasm suggest threedimension higherord structur provok stat bind promot proxim code region stat recruit cbpp exon target promot histon hk hk acetyl cbppmediat histon modif facilit chromatin remodel enhanc hk trimethyl recruit rna polymeras ii activ gfap gene transcript conclusionssignific provid evid exchang repressor activ complex epigenet modif critic strategi cellular differenti lineagespecif gene express
PLoS One	18925704	2013-10-09	PMC3138747	21789179	the major physiolog function milk transport amino acid carbohydr lipid miner mammalian offspr casein major milk protein secret form micel consist protein calciumphosph analys role milk protein casein inactiv correspond gene mice absenc casein protein curtail secret milk protein calciumphosph suggest role casein establish casein micel contrast secret albumin synthes mammari epithelium milk reduc absenc casein inhibit transcript casein gene casein defici sever delai pup growth lactat lifelong bodi size reduct compar control anim transient effect physic behaviour develop pup data support critic role casein casein micel assembl confirm lactat critic window metabol program milk protein concentr decis factor determin adult bodi weight
J Gen Virol	24109243	2014-07-02	PMC3139419	21307223	the arteriviru famili order nidoviral singlestrand positivesens rna virus includ porcin respiratori reproduct syndrom viru equin arter viru eav replic enzym translat genom rna structur protein encod set small partial overlap gene genom proxim region express synthesi set subgenom mrna gener function monocistron bicistron mrna encod gp protein orf encod major glycoprotein gp extens phylogenet analys indepth comput analysi reveal arteriviruswid conserv addit auginiti orf term orfa overlap orf pattern substitut sequenc align indic orfa subject function constraint amino acid level analysi substitut synonym site orf reveal greatli reduc frequenc substitut portion orf overlap orfa aa orfa protein gp express subgenom mrna translat initi mechan involv leaki ribosom scan inactiv orfa express revers genet yield sever crippl eav mutant displai lower titr tini plaqu phenotyp defect partial complement orfaexpress cell indic novel protein eighth structur protein arterivirus express arteriviru infect
PLoS One	24991014	2009-01-28	PMC3139623	21811589	chikungunya viru chikv insect born viru genu alphaviru acut febril ill human prolong arthralg diseas joint extrem reemerg viru form outbreak year pose seriou public health problem chikv posit sens singl strand rna genom nt open read frame viral genom encod polyprotein precursor nsp process structur protein nsp nsp nsp nsp sequenc base analys helicas domain nterminu proteas domain cterminu nsp detail biochem analysi ntpaserna helicas rna phosphatas activ recombin chikvnspt protein conserv ntpasehelicas motif nterminu partial papain proteas domain cterminu carri protein hydrolyz ntp dttp better effici atp datp gtp dgtp hydrolysi atp prefer substrat enzym chikvnspt triphosphatas rtpase activ remov phosphat rna ntpase rtpase activ protein complet depend ion rtpase activ inhibit atp show share bind motif ntp rna enzymat activ drastic reduc mutat ntp bind motif gkt cofactor ion bind motif dexx suggest common catalyt site
PLoS One	19176632	2012-04-18	PMC3139658	21811620	bat natur reservoir spectrum infecti zoonot diseas includ emerg henipavirus hendra nipah virus henipavirus observ natur experiment seriou fatal diseas mammal speci includ human interestingli infect fly fox henipavirus occur absenc clinic diseas extrem variat diseas pattern human bat led investig effect henipaviru infect innat immun respons bat cell line report henipaviru infect result induct interferon express virus inhibit interferon signal confirm interferon product signal block bat cell differ viral protein express level human bat host addit lack clinic sign bat henipaviru infect suggest bat control henipaviru infect unidentifi mechan interferon respons report henipaviru infect bat cell investig aspect innat immun system
J Parasitol Res	22513723	2011-04-01	PMC3140032	21785696	thi paper present type interplai parasit host show histori parasit effect parasit outcom war invas migrat develop numer region globe impact parasit diseas societi cours human evolut emphas press chang the parasit phenomenon propos term cohabit accur parasit live bacteria mammal consortium live be pangenom term parasitolog replac cohabitolog parasit host compos adapt system parasitizedhost cohabitantcohabit suggest switch paradigm base attrit destruct found adapt live togeth
PLoS One	19386712	2011-03-16	PMC3142118	21799777	control sever outbreak remain problem infecti diseas area time problem will sever popul densiti urban center grow social interact plai role determin infecti diseas spread organ peopl social line rise nonspati network infect spread infect network diseas transmiss mode ident highli diseas spread infect network estim common infect epidem sever diseas transmiss mode proofofconcept studi demonstr effect epidem mitig base estim infect network gener artifici social network size averag degre roughli cluster characterist start sir epidem network censor simul incid reconstruct infect network effici fragment estim network remov smallest number node identifi graph partit algorithm final demonstr effect target strategi compar tradit untarget strategi slow reduc size advanc epidem
Virol J	21411529	2011-06-15	PMC3142240	21679431	background planthopp sever affect crop caus mechan damag feed vector plant viru speci analysi gene express persist infect planthopp unveil molecular basi viral transmiss quantit realtim rtpcr rtqpcr current accur sensit method quantit gene express analysi order normal quantit data refer gene constant express experiment procedur need partial sequenc commonli refer gene actin tubulin tub glyceraldehyd phosphat dehydrogenas gapdh elong factor alpha efa ribosom protein rp polyubiquitin ubi delphacod kusch planthopp capabl persist transmit plant fijiviru mal de ro cuarto viru mrcv isol time specif rtqpcr primer design express stabil gene assai mrcvinfect nave planthopp genorm normfind bestkeep tool analysi ubi suitabl gene intern control quantit gene express studi mrcvinfect planthopp tub efa variabl efa upregul mrcv infect conclus rtqpcr platform gene express analysi mrcvinfect planthopp vector delphacod kusch develop work report refer gene select virusinfect insect serv preced futur gene express studi mrcv virusplanthopp pathosystem
PLoS One	21680514	2006-10-18	PMC3143116	21799782	the global spread infecti diseas facilit abil infect human travel thousand mile short time span rapidli transport pathogen distant locat mathemat model actual potenti spread specif pathogen assist public health plan case event model gener parsimoni consid compon system greatest extent demonstr discuss assumpt rel parameter structur treatment airlin travel mathemat model find common structur treatment travel lead underestim speed spread connect travel critic realist spread pattern model involv travel improv simpl structur chang requir attent detail parameter
Clin Trials	17050595	2012-04-04	PMC3145214	21730079	background asthma exacerb season greatest risk elementaryag student occur shortli return school summer break suggest season children viral respiratori tract infect regular hand wash effect method prevent spread viral respiratori infect achiev hand wash recommend school difficult design studi evalu hand sanit elementari school exacerb children asthma purpos describ process redesign trial respons chang safeti profil hand sanit chang hand hygien practic school method origin trial random longitudin subjectblind placebocontrol communitybas crossov trial primari aim evalu increment effect hand sanit addit usual hand hygien practic decreas asthma exacerb elementaryag children three event occur requir major modif origin studi protocol safeti concern aros hand sanit activ ingredi substitut placebo hand sanit commun prefer chang hand hygien practic school revis protocol random longitudin communitybas crossov trial primari aim evalu increment effect twostep hand hygien process hand hygien educ institution provid alcoholbas hand sanit versu usual care decreas asthma exacerb enrol complet student school intervent began august will continu studi limit chang design allow directli measur effect hand sanit supplement tradit hand wash practic conclus balanc rigor studi design accept commun requir investig activ involv commun collabor adapt studi protocol fit chang commun practic
PLoS One	22491448	2013-09-30	PMC3146468	21829490	background increas robust improv resist pathogen major select object livestock breed resist trait difficult imposs measur directli potenti indirect criteria measur immun trait underli hypothesi level focu specif pathogen defin individu immunocompet predict respons pathogen gener variat depend genet environment epigenet factor aim estim rel genet report larg genet survei innat adapt pig famili bred environ methodologyprincip find fifti studi larg white pig vaccin mycoplasma hyopneumonia analyz combin princip compon analysi pca genet paramet estim includ specif specif antibodi seric inflammatori protein cell subset hemogram flow cytometri vivo product cytokin ifn tnf il il il ifn il il il phagocytosi lymphocyt prolifer herit weak moder high herit valu phenotyp genet correl weak trait includ cell subset pca reveal cluster innat adapt conclusionssignific demonstr variat innat adapt genet control swine report smaller number trait laboratori limit redund trait observ confirm high degre complementar innat adapt data provid genet framework choos includ select criteria multitrait select programm aim improv product health trait
Philos Trans R Soc Lond B Biol Sci	24082102	2011-06-29	PMC3146780	21893549	the royal societi conven meet th novemb review current wai vaccin develop deploi recommend process acceler meet brought academ industri repres sponsor regul govern advisor repres intern public health agenc broad geograph background discuss held chatham hous rule highthroughput screen vaccin antigen candid drive forc vaccin discoveri multistakehold smallscal manufactur facil capabl rapid product clinic grade vaccin current expand human veterinari area tier regulatori standard differenti tailor experiment commerci vaccin allow acceler vaccin efficaci test improv crossfertil knowledg industri academia human veterinari vaccin develop lead rapid applic promis approach technolog product develop identif bestpractic develop checklist product develop plan implement programm lowcost opportun shorten timelin vaccin progress laboratori bench peopl it
BMC Infect Dis	21715659	2008-02-13	PMC3146830	21752259	background apriljuli outbreak hn scotland west scotland specialist virolog centr wossvc glasgow test clinic sampl hn patient clinic diagnos hn posit studi sought determin respiratori pathogen misdiagnos case hn time method examin sampl laboratori apriljuli patient clinic diagnos hn base accept criteria full respiratori screen real time revers transcriptas polymeras chain reaction rtrtpcr assai total respiratori pathogen detect confid interv sampl submit numer pathogen detect common rhinoviru confid interv parainfluenza confid interv confid interv adenoviru confid interv conclus studi highlight problem clinic algorithm detect hn clinician frequent misdiagnos common respiratori pathogen hn springsumm outbreak scotland undesir consequ relat treatment infect control public health surveil
BMC Public Health	18272713	2003-12-11	PMC3146865	21718518	background nonpharmaceut strategi vital curtail impact influenza intens studi public health strategi explicitli util weekend report capabl reduc influenza infect studi aim explor weekendextens strategi season pandem flu outbreak method weekendextens strategi design extend regular twodai weekend three dai combin continu discontinu pattern effect evalu establish agentbas spatial explicit simul model urban area buffalo ny extens dai weekendextens strategi remark reduc diseas attack rate season flu threedai continu extens suffici suppress epidem confin spread diseas pandem flu weekendextens strategi produc mitig effect extens exce three dai sensit analysi indic complianc level weekendextens strategi effect conclus attempt incorpor weekend influenza mitig strategi appropri extens regular twodai weekend potenti measur fight influenza outbreak minim interrupt normal rhythm socioeconomi concept weekend extens lack vaccin stockpil countri limit health resourc case unknown emerg infecti diseas
Proteome Sci	14671099	2007-09-13	PMC3148531	21703014	background actinobacillu pleuropneumonia app swine pathogen worldwid identif character novel antigen app vaccin candid underwai studi immunoproteom approach identifi app protein antigen elicit immun respons serotyp natur infect swine serotyp virul strain simmun rabbit protein total cell lysat serotyp app separ twodimension electrophoresi de western blot analysi reveal immunoreact protein spot separ ph rang spot ph rang convalesc sera swine immunoreact protein spot separ ph rang ph rang hyperimmun sera simmun rabbit protein includ antigen apxiia protect surfac antigen outer membran protein subunit nqra remain antigen report immunoreact protein app time knowledg conclus identifi total immunoreact protein app serotyp virul strain repres protein includ novel immunoreact factor research vaccin candid
Virol J	17850689	2011-07-20	PMC3148564	21708006	background cardiovirus positivestrand rna virus picornavirida famili enter infect rodent detect lower frequenc mammal pig human be cardioviru genu consist distinct speci encephalomyocard viru emcv theiloviru thv lot differ speci studi differ codon usag emcv thv compar enc valu emcv thv higher correl cg cg emcv thv r repect thv cg cg axi axi correl emcv rscu valu emcv speci prefer codon thv spice codon genu aga arg auu il ucu ser gga gly chosen preferenti correspond analysi detect major trend axi account total variat major trend second axi account total variat plot serotyp region coordin conclus extent codon usag bia emcv thv low mutat pressur main factor determin codon usag bia cg content plai role codon usag bia thv emcv synonym codon usag pattern emcv thv gene gene function geographi specif host specif serotyp factor effect codon bia thv locat variat synonym codon usag viru gene
J Med Case Reports	21775539	2016-03-01	PMC3148995	21718493	introduct case report describ rare condit communityacquir adenoviru pneumonia immunocompet adult diagnosi achiev multiplex realtim revers transcriptas polymeras chain reaction rtpcr assai highlight novel molecular diagnost techniqu patient hospit acut respiratori ill perform literatur search publish case summari clinic laboratori radiolog featur condit case present yearold immunocompet caucasian woman admit hospit acut febril respiratori ill associ rash blood test nonspecif abnorm test bacteri pathogen neg condit rapidli deterior hospit requir mechan ventil inotrop support multiplex realtim rtpcr assai perform respiratori specimen detect respiratori virus neg influenza posit adenoviru dna patient recov support treatment antibiot stop dai conclus communityacquir adenoviru pneumonia immunocompet adult civilian present nonspecif acut febril respiratori ill abrupt onset respiratori failur requir mechan ventil laboratori radiolog featur typic viral infect nonspecif novel multiplex realtim rtpcr test respiratori virus enabl rapidli diagnosi case technolog patient acut respiratori ill potenti util ration antibiot improv infect control measur
Virol J	26947079	2006-10-13	PMC3149004	21749712	background oral lichen planu olp decreas qualiti life spontan pain eat toothbrush uncomfort feel mouth addit olp associ hcvrelat liver diseas investig visual analogu scale va effect oral care gel refrecareh patient olp associ hcv infect olp patient ag year hcvrelat liver diseas recruit va score determin biochem examin blood type olp includ eros patient reticular refrecareh oral care gel therapeut dentifric hinokitiol appli patient thin layer oral membran meal bedtim dai applic refrecareh improv qualiti life term dry mouth breath odor oral fresh oral pain rest oral pain mealtim tast disord loss appetit sleep disord depress mood jitteri va score dry mouth breath odor oral fresh sleep disord increas dai applic refrecareh p p va score oral pain mealtim tast disord increas dai applic refrecareh absenc side effect conclus refrecareh improv qualiti life olp hepatologist educ patient oral hygien provid treatment liver diseas
PLoS One	17041212	2009-11-01	PMC3149051	21829638	mani natur productderiv lectin red algal lectin griffithsin grft potent vitro activ virus displai dens cluster oligomannos nlink glycan nlg surfac envelop glycoprotein oligomannos nlg host protein treatment antivir lectin trigger undesir side effect antivir lectin concanavalin banana lectin cyanovirinn cvn interact lectin undescrib cellular moieti report induc undesir side effect includ secret inflammatori cytokin activ host tcell grft cvn bind surfac human epitheli peripher blood mononuclear cell pbmc exclus oligosaccharidedepend interact contrast antivir lectin grft treatment induc minim chang secret inflammatori cytokin chemokin epitheli cell human pbmc measur cell viabil upregul marker tcell activ addit grft appear retain antivir activ bound surfac pbmc final rna microarrai studi cvn cona regul express multitud cellular gene grft treatment effect minim alter gene express profil human ectocerv cell studi indic grft outstand safeti profil evid induc toxic tcell activ deleteri immunolog consequ uniqu attribut natur productderiv lectin
BMC Infect Dis	19883590	2004-09-01	PMC3151229	21767379	background transmiss infecti diseas human popul complex process requir advanc individualbas model captur spacetim detail observ realiti method individu spacetim activitybas model istam appli simul effect nonpharmaceut control measur includ refrain social activ school closur household quarantin hypothet influenza outbreak urban area set control measur test refrain social activ complianc level ineffect household quarantin effect peak number case total number case larg differ complianc level household quarantin decreas peak number case complianc level decreas delai outbreak peak dai total number case decreas rang baselin coupl control measur household quarantin school closur effect strategi spacetim distribut infect class activ bundl ab suggest epidem outbreak strengthen children spread adult sensit analysi studi demonstr earlier implement control measur lead greater efficaci infecti diseas larger basic reproduct number effect nonpharmaceut measur limit conclus simul household quarantin effect control measur school closur household quarantin implement achiev greatest benefit agentbas model appli futur evalu efficaci control measur rang diseas outbreak rang set suffici case knowledg transmiss process fine scale
PLoS One	15343375	2007-08-01	PMC3151298	21850266	the epithelialmesenchym transit emt renal epitheli cell rtec pivot role develop renal fibrosi interact lymphocyt functionassoci antigen lfa leukocyt ligand intracellular adhes molecul icam plai essenti role inflammatori reaction pathogenet role emt rtec remain clarifi studi investig the interact lfa peripher blood mononuclear cell pbmc icam hk cell stimul tgf emt rtec icam highli express hk cell tgf stimul chemokin ccl cxcl increas hk cell cocultur pbmc hk cell prestimul tgf ngml hktgf express activ form lfa increas pbmc total lfa express chang express activ form lfa pbmc increas cocultur ccl cxcl knockdown hktgf express epitheli cell junction marker ecadherin occludin decreas mesenchym marker vimentin fibronectin increas hktgf cocultur pbmc hr hktgf pbmc phosphoryl erk smad smad increas hktgf pbmc snail slug signal increas hktgf pbmc migrat invas hk cell induc full emt high dose ngml longterm hr tgf stimul increas hktgf pbmc increas suggest hk cell stimul tgf induc conform activ lfa pbmc increas cxcl direct interact lfa pbmc icam hk cell activ erk signal acceler emt hk cell induc tgf
BMC Infect Dis	17670839	2012-03-01	PMC3152767	20353566	background issu global alert pandem influenza hn nation health agenc began screen travel entri airport port border cross delai local transmiss method review entri screen polici adopt nation ascertain date offici report laboratoryconfirm import hn case laboratoryconfirm untrac local hn case implement entri screen polici associ averag addit dai delai local transmiss compar nation implement entri screen lower bound confid interv consist addit delai upper bound extend dai addit delai conclus entri screen lead shortterm delai local transmiss novel strain influenza viru resourc requir implement balanc expect benefit entri screen
Virol J	22285270	2009-01-01	PMC3152912	21729293	background fiv infect frequent compromis pregnanc experiment condit accompani aberr express placent cytokin trophoblast produc numer immunomodul plai role placent develop pregnanc mainten hypothes fiv infect dysregul trophoblast immunomodul express aberr express molecul potenti inflamm compromis pregnanc purpos project evalu express repres protnf ifn il il il ilp ilp il gmcsf antiinflammatori cytokin il il il cd secondari costimulatori molecul express activ cell fiv primari receptor chemokin receptor cxcr fiv coreceptor sdf chemokin ligand cxcr fiv gag trophoblast earlyand lateterm pregnanc method anticytokeratin antibodi immunohistochemistri identifi trophoblast select collect cell laser captur microdissect extract total rna captur cell popul real time revers transcriptionpcr quantifi gene express detect il il il il ilp ilp cxcr trophoblast earlyand lateterm pregnanc express cytokin increas earli late pregnanc normal tissu clear proinflammatori microenviron evid trophoblast fivinfect queen stage pregnanc reproduct failur accompani downregul proand antiinflammatori cytokin cd detect trophoblast fiv gag detect ten trophoblast specimen collect fivinfect queen conclus felin trophoblast express arrai proand antiinflammatori immunomodul express increas earli late pregnanc normal tissu nonviabl pregnanc associ decreas express immunomodul regul trophoblast invas speci detect fiv rna trophoblast rare suggest high rate reproduct failur fivinfect queen direct result viral replic trophoblast influenc placent immun cell trophoblast function pregnanc mainten fivinfect cat requir addit studi
Toxins (Basel)	18773917	2007-03-07	PMC3153180	22069564	protein toxin confer defens predationgraz superior pathogen compet produc organ toxin perfect evolut poison animalspl pathogen bacteria decad lot effort invest studi mechan action contribut pathogen develop antidot neutral action parallel group turn explor pharmaceut potenti toxin effici impair essenti cellular process andor damag integr target cell review summar major advanc field toxin base therapeut offer comprehens descript mode action appli toxin
PLoS One	17344285	2015-06-10	PMC3153931	21857914	gillassoci viru gav infect penaeu monodon shrimp type speci okaviru ronivirida invertebr nidovirus current electrophoret mobil shift assai emsa histag fulllength truncat protein emploi examin nucleic acid bind properti gav nucleocapsid protein vitro emsa fulllength protein bind synthet singlestrand ssrna test independ sequenc ssrna includ sens region gav genom sens region rna segment mourilyan viru crustacean bunyalik viru gav protein bound doublestrand dsrna prepar gav orfb gene region bacteriophag genom ssdna emsa protein construct variablelength ntermin andor ctermin truncat local rna bind domain amino acid aa ntermin sequenc span met arg rna bind protein aa portion sequenc prolinearginin rich examin domain detail aa peptid mpvrrplppqpprnarli encompass sequenc synthes bind nucleic acid fulllength protein emsa data indic fundament role gav protein prolineargininerich domain nucleat genom ssrna form nucleocapsid synthet peptid form higherord complex presenc rna domain plai role proteinprotein interact stabil helic structur gav nucleocapsid
Virol J	26063432	2008-08-01	PMC3154182	21714915	background molecular polymeras chain reaction pcr base assai increasingli diagnos viral respiratori infect conduct epidemiolog studi molecular assai gener evalu compar convent direct fluoresc antibodi dfa viral cultur techniqu publish direct comparison molecular method institut sought perform realworld comparison molecular respiratori viral diagnost method experienc respiratori viru laboratori method test nasal throat swab specimen infant respiratori ill common respiratori virus multiplex assai respiratori multicodeplx assai rma individu realtim rtpcr rtrtpcr assai detect virus specimen discord rma assai detect human metapneumoviru hmpv respiratori syncyti viru rsv rtrtpcr detect influenza specul primer differ account discrep redesign primer probe influenza rma assai hmpv rsv rtrtpcr assai test repeat compar primer led improv detect hmpv rsv rtrtpcr assai rma assai remain term influenza detect conclus absenc gold standard clinic laboratori regularli correl molecular assai pcr base assai laboratori standard virolog method ensur consist accuraci
PLoS One	18556606	2005-10-13	PMC3154197	21853040	a common techniqu sensit specif diagnost viru detect clinic sampl pcr identifi virus assai diagnost microarrai probe human pathogen replac hundr individu pcrreaction remov clear clinic hypothesi suspect pathogen establish diagnost platform random amplif subsequ microarrai identif viral pathogen clinic sampl phi polymeraseamplif divers set clinic sampl gener viral materi success identif microbi detect arrai demonstr potenti microarrai techniqu broadspectrum pathogen detect conclud method detect dna rna viru sampl differenti viru subtyp propos assai diagnost analysi virus clinic sampl
PLoS One	16227244	2013-04-01	PMC3155524	21857979	background methicillinresist staphylococcu aureu mrsa nosocomi pathogen intens care unit icu worldwid includ taiwan neonat icu nicu endem mrsa methodologyprincip find control mrsa spread nicu implement seri infect control measur stepwis includ reinforc hand hygien januari augment asept care insert site central venou cathet juli introduct alcoholbas handrub april surveil cultur mrsa cohort care colon patient march februari surveil cultur subsequ decolon mrsa august juli implement measur mrsa healthcareassoci infect hai densiti reduc episod patientdai episod patientdai mrsa bloodstream infect reduc case case compar period surveil cultur decolon rate mrsa colon infect decreas period surveil decolon molecular analysi clinic isol studi period endem clone domin disappear commun clone increas conclusionsignific infect control measur mrsa hai control area high level endem mrsa infect nicu
PLoS Negl Trop Dis	23466910	2016-09-01	PMC3156690	21858242	the chikungunya viru infect zone spread africa part asia north america europ origin thought trigger diseas mild symptom chikungunya viru caus largescal fatal widespread econom loss link viru genet mutat evolut pauciti chikungunya immunolog progress investig serum level cytokineschemokin acut phase chikungunya diseas and month postinfect followup patient italian outbreak cxclmig cclmcp il cxclip rais acut phase compar followup sampl il tnf il il ifn il low initi acut phase level increas time point analysi symptom sever associ cxclmig cxclip igg level data insight chikungunya diseas establish subsequ convalesc imper treatment contain evolv frequent reemerg diseas
Comput Math Methods Med	26344899	2004-05-01	PMC3157160	21860658	the basic reproduct ratio fundament concept mathemat biologi threshold paramet intend quantifi spread diseas estim averag number secondari infect wholli suscept popul indic invas strength epidem diseas di diseas persist measur diseas strength estim effect control measur form backbon diseasemanag polici aspect matter flaw diseas persist diseas die model malaria valu depend method sole common properti threshold survei estim valu varieti diseas examin altern propos accompani caveat method calcul underli model assumpt evid threshold concept meaningless
PLoS One	15100436	2007-10-03	PMC3157400	21858150	background influenzalik ill ili caus varieti pathogen clinic observ help recognis myxoviru infect implement appropri prevent measur limit molecular tool underestim role common pathogen object earli week flu pandem clinic virolog survei conduct adult paediatr patient ili refer french univers hospit pari tour aim investig pathogen involv ili describ associ symptom method hnv pandem influenza diagnosi perform real time rtpcr assai viral aetiolog investig molecular multiplex assai respifind clinic data collect prospect physician standard questionnair week endonas swab collect patient sampl posit hnv respiratori pathogen detect hnv neg sampl posit respiratori agent singl infect mix infect preval virus hnv neg singl infect rhinoviru parainfluenza virus adenoviru hnv case identifi patient year year differ clinic symptom observ patient infect hnv pathogen conclus highlight high frequenc noninfluenza virus involv ili preepidem period flu alert lack specif clinic sign associ influenza infect rapid diagnost screen larg panel respiratori pathogen critic defin survei epidem situat provid critic patient manag
PLoS One	17913894	2010-03-25	PMC3158760	21886787	subtyp specif influenza viru iav determin surfac glycoprotein hemagglutinin ha neuraminidas ha distinct subtyp hh exist exist epidem strain hn iav chang frequent annual season epidem occasion pandem notori influenza pandem introduct pandem ahn iav hnpdm viru human reemphas public health concern hn iav studi identifi conserv epitop specif ha subtyp diagnost immun specif epitop hn iav complet assess studi linear epitop hnpdm viral ha protein identifi peptid scan librari overlap peptid convalesc sera hnpdm patient epitop aa immunodomin patient evok high titer antibodi mice multipl sequenc align silico coverag analysi epitop highli conserv influenza ha coverag complet absent subtyp coverag unidentifi linear epitop locat wellrecogn antigen site ha peptid elisa method base epitop develop high correl pearson correl coeffici hemagglutin inhibit test highli conserv subtypespecif immunodomin epitop form basi develop novel assai serodiagnosi activ surveil hn iav
Ann Intensive Care	20340160	2007-10-24	PMC3159899	21906331	a decad pass intens care unit icu bed critic patient cancer initi report dismal prognosi data increas number patient solid hematolog malign benefit intens care support dramat decreas mortal rate advanc manag underli malign support organ dysfunct led surviv gain patient lifethreaten complic malign infecti toxic advers effect oncolog treatment review will apprais prognost factor discuss perspect manag critic patient cancer prognost signific factor chang time exampl neutropenia autolog bone marrow transplant bmt advers prognost implic decad ago hematologist oncologist select patient icu admiss base characterist malign underli malign rare influenc shortterm surviv icu admiss data clearli support benefit icu support unselect critic allogen bmt recipi outcom need subgroup increas surviv report critic patient cancer outlin easytous evidencebas icu admiss triag criteria help avoid depriv life support patient cancer benefit lastli propos agenda address unansw question
Evid Based Complement Alternat Med	17959675	2019-12-13	PMC3159992	21869903	object assess benefici advers effect xiaoyaosan depress search strategi electron databas search decemb inclus criteria includ random clinic trial test xiaoyaosan placebo antidepress combin antidepress antidepress data extract analys studi select data extract qualiti assess data analys conduct cochran standard random trial involv patient includ methodolog qualiti evalu gener low pool xiaoyaosan combin antidepress effect comprehens score hamd score sd compar antidepress xiaoyaosan superior antidepress score hamd xiaoyaosan placebo score sd advers effect report trial xiaoyaosan conclus xiaoyaosan appear effect improv symptom patient depress poor methodolog qualiti major includ trial potenti benefit xiaoyaosan confirm rigor trial design report trial follow intern standard
BMC Public Health	31835015	2017-01-14	PMC3160373	21740552	background hospit epicentr newli circul infect healthcar worker hcw high risk acquir infecti diseas contract emerg infect studi aim explor european hcw percept attitud monitor absenc symptom report surveil newli circul infect method qualit studi themat analysi conduct focu group methodolog fortynin hospitalbas hcw hospit recruit focu group england hungari germani greec hcw perceiv risk factor occupation acquir infecti diseas exposur patient undiagnos infect breakdown infect control procedur immunonaveti symptomat colleagu concern lack monitor guidelin infecti hcw pose risk staff patient felt employ fail posit interest health staf demand loss incom pressur attend work unwel uk hungari greec particip felt monitor staff absenc routin disclosur symptom appropri provid effect effici system demonstr germani legisl privaci confidenti identifi barrier hcw highlight knowledg structur improv timeli recognit emerg infect includ increas suspicion awar staff standardis homogen absenc report system conclus monitor absenc infecti diseas symptom report hcw feasibl surveil emerg infect set prerequisit will tackl driver symptomat hcw attend work
PLoS One	28117797	2019-04-15	PMC3160845	21887246	we introduc method estim incid curv cocircul infecti pathogen infect probabl symptom profil deconvolut method util weekli surveil data symptom defin popul addit data symptom sampl virolog confirm infecti episod illustr method numer simul data survei conduct univers michigan campu describ data estim accur
PLoS One	30989427	2009-06-17	PMC3160895	21887285	the predict antibodyprotein antigen interact difficult huge variabl character structur antibodi region antigen bound antibodi call epitop experiment data indic antibodi react panel distinct epitop posit reaction challeng dream aim understand exist rule predict reactiv peptideepitop capabl bind human antibodi dream provid train set peptid experiment identifi high low reactiv human antibodi basi train set particip challeng ask develop predict model reactiv test set provid evalu perform model implement develop logist regress model predict peptid reactiv face challeng machin learn problem initi featur gener basi knowledg report dataset predict model second best perform challeng develop method base cluster approach insilico gener list posit neg peptid sequenc request dream bonu round addit challeng paper describ develop model term reactiv predict highlight open issu concern propens peptid react human antibodi
PLoS One	19535460	2001-03-01	PMC3161043	21887283	the delhi metallolactamas ndm report in swedish patient studi report klebsiella pneumonia ndm posit strain escherichia coli ndm posit strain highli resist antibiot test tigecyclin colistin longer reli treat infect ndm major global health threat studi perform model studi structur ndmantibiot complex reveal hydrolyt mechan highli conserv addit detail analysi indic flexibl hydrophob loop evolut positivecharg loop lead ndm posit strain potent extens antibiot resist compar mbl biolog experi reveal molecular basi antibiot catalysi ndm enzymat level ndm enzym highli potent degrad carbapenem antibiot suscept tigecyclin abil slow hydrolysi veloc meropenem ndm mutagenesi experi includ ka ke displai downregul meropenem catalysi prove accuraci model effect antibiot ndm posit pathogen studi will provid clue investig molecular basi extend antibiot resist ndm acceler search antibiot ndm posit strain clinic studi
PLoS One	11230424	2017-04-12	PMC3161733	21887228	the purpos current studi identifi potenti ligand develop novel diagnost test highli pathogen avian influenza viru hpai subtyp hn virus phage displai technolog hn virus immobil target biopan process mer phage displai random peptid librari round pan three phage express peptid hawdpipardpf aawhlivalapn atshlhvrlpsk specif bind activ hn virus isol put bind motif hn virus identifi dna sequenc term minimum quantiti virus phagebas elisa better antiserumbas elisa manual semiquantit endpoint rtpcr detect hn virus importantli select phage bear specif peptid hn virus capabl differenti viru avian virus enzymelink immunosorb assai
PLoS One	28404849	2010-12-29	PMC3161750	21887302	it report lactoferrin lf particip host immun respons sever acut respiratori syndrom coronaviru sarscov invas enhanc nk cell activ stimul neutrophil aggreg adhes investig role lf entri sar pseudoviru hekeacemyc cell reveal lf inhibit sar pseudoviru infect dosedepend manner analysi suggest lf block bind spike protein host cell indic lf exert inhibitori function viral attach stage lf disrupt interact spike protein angiotensinconvert enzym ac function receptor sarscov previou studi lf coloc distribut cellsurfac heparan sulfat proteoglycan hspg experi confirm conclus treatment cell heparinas exogen heparin prevent bind spike protein host cell inhibit sar pseudoviru infect demonstr hspg provid bind site sarscov invas earli attach phase addit ac hspg essenti cellsurfac molecul involv sarscov cell entri lf plai protect role host defens sarscov infect bind hspg block preliminari interact sarscov host cell find provid understand sarscov pathogenesi aid treatment deadli diseas
PLoS One	21191013	2011-04-01	PMC3161751	21887301	th cellmedi immun respons site activ infect restrict growth mtuberculosi mtb spontan resolut patient tubercul pleurisi tbp studi stimul cd cell pleural fluid cell pfc patient tbp express higher level cd pbmc patient tuberculosi tb healthi donor cdcd cell express tbet ilr stimul mtbspecif antigen cdcd cell express higher level ifn il tnf cdcd cell demonstr cdcd cell mtbspecif cell addit cdcd cell polyfunct cell simultan produc ifn il tnf displai effector effector memori phenotyp cdraccrcdlcd percentag cdcd cell posit correl polyfunct cell interestingli sort cdcd cdcd fraction flow cytometri produc ifn il tnf regul cdcd treg cell base express cd direct quantit qualit method detect evalu vivo gener mtbspecif polyfunct cd cell pfc patient tbp method potenti diagnosi enrich isol mtbspecif cell investig
PLoS One	20729636	2009-11-06	PMC3161824	21915247	positivestrand rna viru replic involv viral protein cellular protein replic step brome mosaic viru bmv wellestablish model dissect virushost interact virus rna replic gene express encapsid reproduc yeast saccharomyc cerevisia laboratori identifi nonessenti host gene loss inhibit enhanc bmv replic fold isol addit bmvmodul host gene classic genet underscor gene essenti cell growth contribut bmv rna replic frequenc greater nonessenti gene systemat identifi novel essenti host gene bmv rna replic test collect yeast strain singl essenti gene promot replac doxycyclinerepress promot allow repress gene express ad doxycyclin growth medium strain arrai of essenti yeast gene identifi essenti host gene deplet express reproduc inhibit enhanc bmv rna replic relev host gene involv ribosom biosynthesi cell cycl regul protein homeostasi cellular process bmv apol level increas strain deplet heat shock protein hsf proteasom compon pre rpt suggest gene affect bmv rna replic directli indirectli modul apol local posttransl modif interact partner investig divers function newli identifi essenti host gene advanc understand bmvhost interact normal cellular pathwai mode viru control
PLoS One	19897716	2007-03-14	PMC3162560	21887225	protein essenti macromolecul life carri cellular process protein aggreg perform function proteinprotein interact ppi network model aggreg expect uncov biologi ppi network topolog ppi network predict protein function role protein pathwai diseas receiv attent debat remain open network properti biolog central bc gene protein product involv ag cancer infecti diseas signal drugtarget pathwai exhibit topolog central compar rest protein human ppi network help resolv debat design networkbas approach appli insight biolog function diseas hypothes bc gene topolog central tc role human ppi network propos concept topolog central design central measur captur complex wire protein network identifi tc protein resid dens extend network neighborhood notion domin find domin set dss ppi network set protein protein ds neighbor ds clearli ds tc role enabl effici commun network part find statist enrich bc gene tc node outperform exist method indic gene involv kei biolog process occupi topolog complex dens region network correspond spine connect network part pass cellular signal effici network knowledg studi explor domin context ppi network
J Cardiothorac Surg	17360845	2014-10-29	PMC3162889	21767391	lung transplant treatment option patient advanc lung diseas surviv rate lung transplant recipi improv major obstacl limit better surviv bronchiol obliteran syndrom bo decad surviv lung retransplant improv transplant recipi bo manuscript review bo current therapeut strategi includ outcom lung retransplant
J Neuroinflammation	25355889	2015-04-15	PMC3162898	21812954	background activ glial cell tolllik receptor tlr intracellular pathogen recognit receptor promot releas toxic acut phase reactant tnf nitric oxid extracellular space prolong glial activ thought occur persist viral infect cn contribut neurodegener demyelin effect virusinduc glial activ oligodendrocyt fulli understood method determin effect glial activ oligodendrocyt viabil treat primari glial cultur isol neonat rat mice rna viral mimic polyic case tlr ligand tlr express determin western blot cytokin level measur rtpcr elisa intracellular cytokin stain oligodendrocyt precursor preol viabil determin alamar blue assai immunocytochemistri result stimul mix glial cultur polyic microglia activ tnf product preol toxic toxic polyic indirect fail affect preol viabil pure cultur despit fact preol express tlr polyicinduc loss preol abolish tnf tnfr defici mix glial cultur suggest tnftnfr signal requir polyic toxic microglia astrocyt express function tlr microglia produc tnf cultur consist find tlr agonist trigger tnf product preol toxic mix glial cultur conclus activ microglia polyic promot tnftnfrdepend oligodendrogli cell death data indic ongo viral infect cn microgli tnf detriment oligodendrocyt
Sci Pharm	25878116	2015-11-23	PMC3163371	21886894	human african trypanosomiasi hat call sleep sick caus subspeci parasit hemoflagel trypanosoma brucei occur subsaharan africa current chemotherapi human trypanosomias reli drug develop year ago undesir toxic side effect drugresist develop antitrypanosom drug prioriti area area lag review focu synthet comput base approach group develop newer antitrypanosom analogu improv efficaci oral bioavail the paper attempt investig relationship physiochem paramet antitrypanosom activ help develop potent antitrypanosom agent sleep sick
PLoS One	26595738	2013-02-06	PMC3163911	21904596	genet background plai role process sarscov infect sar develop protein interact nucleocapsid protein sar coronaviru sarscov heremansschmid glycoprotein ahsg requir macrophag deactiv endogen cation associ inflammatori regul cytochrom famili cypfa oxidas inactiv leukotrien ltb human neutrophil liver investig associ polymorph inflammationassoci gene sar develop linkag disequilibrium ld map gene built haploview data chbjpt version hapmap total ten tag snp select genotyp guangzhou cohort studi adjust ag sex ahsg snp cypf snp associ sar suscept rs adjust odd ratio aor confid interv ci rs aor ci rs aor ci valid associ ten tag snp genotyp beij cohort adjust ag sex rs aor ci associ sar suscept combin analysi studi confirm tag snp rs ahsg suscept variant aor ci statist analysi rs genotyp data patient healthi control hcw cohort expos sar viru support find snp rs transcript activ ahsg promot regul ahsg serum level studi demonstr aa genotyp rs lead higher ahsg serum concentr associ protect sar develop
PLoS Pathog	23388726	2005-06-01	PMC3164637	21909260	the oblig intracellular pathogen chlamydia trachomati replic membranebound inclus acquir host sphingomyelin sm process essenti replic inclus biogenesi previou studi demonstr sm acquir brefeldin bfasensit vesicular traffick pathwai paradox pathwai dispens bacteri replic find suggest lipid transport mechan involv acquisit host sm work interrog role specif compon bfasensit bfainsensit lipid traffick pathwai defin contribut sm acquisit infect trachomati hijack compon vesicular nonvesicular lipid traffick pathwai sm acquisit sm separ pathwai util pathogen wai trachomati select coopt three bfa target gbf regul arfdepend vesicular traffick earli secretori pathwai vesiclemedi sm acquisit arfgbfdepend pathwai sm acquisit essenti inclus membran growth stabil requir bacteri replic contrast trachomati coopt cert lipid transfer protein kei compon nonvesicular er transgolgi traffick ceramid precursor sm trachomati replic demonstr trachomati recruit cert er bind partner vapa sm synthas sm sm inclus propos protein establish onsit sm biosynthet factori inclus hypothes sm acquir certdepend transport ceramid subsequ convers sm trachomati replic sm acquir gbfdepend pathwai essenti inclus growth stabil reveal novel mechan intracellular pathogen redirect sm biosynthesi replic nich
PLoS One	15956420	2012-09-27	PMC3166170	21912629	we replac spike gene apathogen ibv strain beaur pathogen strain serotyp apathogen viru beaurm confer protect challeng construct recombin ibv beaur genet backbon beaur express spike protein pathogen ibv strain uk belong serogroup beaudett previou find beaurm clinic sign observ gene pathogen viru confer pathogen ribv beaur protect studi homolog protect beaur confer protect challeng wild type viru absenc clinic sign ibv rna assess qrtpcr fact viru isol trachea remov bird infect beaur challeng ibv uk degre heterolog protect challeng observ albeit lower level confirm extend previou find conclus swap ectodomain protein precis effect gener genet defin candid ibv vaccin
BMC Bioinformatics	23019323	2006-11-15	PMC3166288	21812952	background nucleolar local sequenc nolss short target sequenc respons local protein nucleolu larg number protein experiment detect nucleolu central role subnuclear compart cell nolss regulatori element control cellular traffic protein report nolss systemat character group target motif carri describ nod web server command program predict presenc nolss protein web server user submit protein sequenc nod input form provid graphic output nol score function protein posit web server conveni make predict protein command version nod return predict complet proteom nod base describ humantrain artifici neural network predictor stringent independ test predictor experiment valid nolscontain eukaryot viral protein nod sensit posit predict estim conclus nod tool provid predict nucleolar local sequenc divers eukaryot virus nod interact onlin httpwwwcompbiodundeeacuknod download local
PLoS One	17108019	2018-09-19	PMC3166308	21912667	background avian influenza ai highli pathogen fatal prevent behavior handwash wear face mask recommend psychosoci factor influenc peopl decis adopt prevent behavior studi aim explor risk percept factor associ handwash wear face mask prevent ai methodologyprincip find intervieweradminist survei conduct tradit market worker shopper taiwan decemb januari factor associ recommend ai prevent behavior tradit market wear face mask wash hand contact poultri includ correct knowledg fatal rate ai adjust odd ratio aor know sever case ai aor inform local ai outbreak aor live northeastern taiwan aor senior highschool educ aor univers higher educ aor gender interact particip senior highschool educ male engag recommend ai prevent behavior femal counterpart aor conclusionssignific specif concern ai risk percept associ recommend ai prevent behavior correct knowledg fatal rate ai inform sever case local outbreak ai link increas ai prevent behavior find underscor transpar deal epidem practic implic prevent policymak effect promot recommend ai prevent behavior public
Clin Proteomics	30232180	2005-04-01	PMC3167199	21906349	introduct sulfur mustard bi chlroethyl sulphid sm chemic warfar agent remain threat human health aim studi identifi protein express signatur biomark reflect chronic lung damag induc sm exposur method prior analysi plasma fraction ethanol precipit dimension sdspage fraction protein profil healthi expos patient lung diseas establish select protein spot identifi maldi tof msm haptoglobin isoform detect plasma lung diseas patient healthi control amyloid isoform detect plasma lung diseas patient healthi control low molecular weight protein enrich ethanol supernat compar ethanol precipit conclus previou studi ongo tissu remodel involv sm expos lung damag patient find improv patient care suitabl therapi
Emerg Health Threats J	15798110	2017-06-28	PMC3167643	22460287	vectorborn infecti diseas malaria dengu chikungunya west nile fever increasingli identifi major global human health threat develop develop countri success failur vector control rest natur scale behaviour respons expos popul largescal adopt recommend protect behaviour repres critic challeng address better understand individu perceiv react risk infect french oversea territori face largescal outbreak epidem chikungunya fever la union mayott success outbreak dengu fever caribbean island martiniqu assess popul perceiv respond risk natur scale protect clinic statu socioepidemiolog survei conduct island outbreak survei address three crucial interconnect question relev period person infect viru identifi factor shape risk acquir diseas socio demograph characterist live condit induc higher likelihood infect impact risk percept protect behaviour adopt mosquito bite ground survei gener framework propos help draw knowledg need reveal factor associ higher probabl infect outbreak emerg lesson learnt inform health author effort improv risk commun programm term target content messag explor strategi ensur sustain protect behaviour author compar three epidem vectorborn diseas elucid psychosoci factor determin popul perceiv respond risk infecti diseas
Emerg Health Threats J	28659436	2011-11-01	PMC3167650	22460280	intern popul mobil underli factor emerg public health threat risk manag global risk limit transmiss pathogen mobil popul link zone diseas emerg lowpreval nonendem area rapid highvolum intern movement background human movement global process econom trade transport environ climat chang civil secur influenc health impact diseas emerg concurr global system regulatori framework diseas surveil report affect organiz public awar event potenti public health signific intern regul direct diseas mitig control pace grow challeng associ volum speed divers dispar modern pattern human movement thesi human popul mobil major determin global public health support articl review publish literatur perspect determin health geneticsbiolog behavior environ socioeconom populationbas diseas preval differ exist nation intern health polici regul interregion shift popul demograph health outcom paper highlight emerg threat risk public health identifi gap exist framework manag health issu associ migrat suggest chang approach popul mobil global public health propos integr approach includ broad spectrum stakehold rang individu healthcar provid polici maker intern organ involv global health manag influenc global health event
Emerg Health Threats J	21940915	2014-06-30	PMC3167651	22460282	in event pandem pose widespread infect high death rate utilitarian mandat reduc harm relev moral trump ethic consider primaci utilitarian approach dictat posit assist cessat seriou outbreak role provid servic administ health care ensur respond support protect highest degre
Emerg Health Threats J	25017401	2013-11-22	PMC3167654	22460397	emerg infecti diseas eid current major threat public health worldwid eid event involv zoonot infecti agent central africa gener gabon privileg area emerg zoonot eid human incurs gabones forest exploit purpos lead intensifi contact human wildlif gener increas risk emerg zoonot diseas gabon endem potenti endem viral infecti diseas report zoonot origin involv famili virus notori dengu yellow fever ebola marburg rift vallei fever chikungunya virus potenti eid wildlif gabon plenti inventori gabones public health system cover geograph countri allow good access sanitari effici monitor emerg diseas access treatment prevent better urban area medic structur develop financi concentr popul equal distribut urban rural area spite gabon good field investig emerg reemerg zoonot eid gabones health structur cirmf advantag locat offer high qualiti research facil studi pathogen wildlif ecolog aim better understand contact transmiss mechan pathogen wildlif human emerg zoonot eid break speci barrier pathogen
Emerg Health Threats J	24266364	2004-10-01	PMC3167656	22460396	the emerg infect resurg oneshealth threat stem environment contamin purpos act bioterrorismcal worldwid effort improv earli outbreak detect goal amelior current futur risk case problem outbreak detect logist straightforward mathemat easi singl case diseas great concern constitut outbreak vast major maladi simpl analyt solut exist step develop reliabl sensit effect surveil system demonstr enorm complex transmiss manifest detect control emerg health threat commun explor potenti futur innov earli outbreak detect system overcom pitfal current surveil modern advanc assembl data techniqu collat process technolog enabl integr analysi will facilit paradigm outbreak definit detect anticip move forward direct will provid highli desir sensit specif earli detect requir meet emerg challeng global diseas surveil
Emerg Health Threats J	15472347	2015-12-09	PMC3167658	22460392	although ignor human rhinovirus hrv frequent respiratori tract infect rti group close novel rhinovirus discov base uniqu phylogenet posit distinct genom featur classifi separ speci hrvc discoveri hrvc virus detect patient worldwid report preval test specimen suggest speci contribut proport rti unrecogn hrvc predomin hrv speci higher detect rate speci hrva hrvb hrvc infect appear peak fall winter temper subtrop countri predomin raini season tropic children hrvc associ upper rti asthma exacerb wheez episod common complic viru detect children bronchiti bronchiol pneumonia otiti media sinus system infect complic pericard adult hrvc associ sever diseas pneumonia exacerb chronic obstruct pulmonari diseas larger clinic studi asymptomat control requir better defin signific hrvc infect adult popul basi vp sequenc analysi potenti distinct subgroup hrvc identifi complet genom sequenc need better defin genet divers hrvc
Virol J	26656689	2018-06-01	PMC3168426	21843374	background posit control integr compon sensit molecular diagnost tool mutat screen scenario pandem newli emerg diseas difficult acquir posit control host work describ develop synthet oligocassett posit control accur highli sensit diagnosi mutat relev influenza viru drug resist influenza antivir drug resist mutat exampl emploi util synthet pair long oligonucleotid complementari sequenc end util format oligonucleotid dimer dna polymer gener bp dsdna specif neuraminidas inhibitor nai resist mutat templat clone appli posit control downstream assai conclus approach improv develop diagnosi resist mutat term time accuraci effici sensit paramount monitor emerg spread antivir drug resist influenza strain broader applic molecular diagnost applic rapid molecular test relev mutat event pandem
PLoS One	29856201	2007-06-06	PMC3168876	21918681	annexin anxa protein implic divers cellular function includ exocytosi dna synthesi cell prolifer propos involv rna metabol associ cellular mrna identifi anxa rna bind protein rbp bind ibv infecti bronchiti viru pseudoknot rna confirm bind anxa ibv pseudoknot rna ultraviolet crosslink bind rna pseudoknot anxa protein vitro cell rna pseudoknot locat frameshift region ibv bait cellular rbp test anxa regul frameshft ibv pseudoknot rna dual luciferas assai overexpress anxa reduc frameshift effici ibv pseudoknot rna knockdown protein strikingli increas frameshift effici anxa cellular rbp modul frameshift effici viral rna enabl antivir cellular protein hint role rna metabol cellular mrna
Acta Crystallogr Sect F Struct Biol Cryst Commun	17553888	2006-03-14	PMC3169389	21904037	the seattl structur genom center infecti diseas ssgcid consortium research seattl biom emerald biostructur univers washington pacif northwest nation laboratori establish appli structur genom approach drug target infecti diseas organ ssgcid current fund fiveyear period nation institut allergi infecti diseas niaid determin threedimension structur protein varieti categori pathogen target select engag infecti diseas drugtherapi commun identifi drug target essenti enzym virul factor vaccin candid biomed relev combat infecti diseas proteinexpress system purifi protein ligand screen threedimension structur produc ssgcid constitut valuabl resourc drugdiscoveri freeli greater scientif commun issu acta crystallographica entir devot work ssgcid cover detail highthroughput pipelin present seri structur broad arrai pathogen organ background provid structur genom infecti diseas essenti compon ssgcid pipelin discuss survei progress present
J Transl Med	16537637	2015-09-23	PMC3169469	21762538	background hepat viru major chronic liver diseas lead perman liver damag hepatocellular carcinoma death present treatment interferon ribavirin limit benefit advers side effect anemia depress fatigu flulik symptom herbal plant centuri diseas includ viral diseas major sourc compound treat bacteri viral diseas materi studi design studi antivir glycyrrhizin gl hcv purpos hcv infect liver cell treat gl toxic dose hcv titer measur quantit real time rtpcr discuss demonstr gl inhibit hcv titer dose depend manner reduct hcv concentr compar studi interferon alpha investig synergist effect antivir compound interferon alpha data gl exhibit synergist combin interferon verifi transient transfect liver cell hcv core plasmid prove gl dose depend inhibit express hcv core gene mrna protein level gapdh remain constant conclus gl inhibit hcv full length viral particl hcv core gene express function dose depend manner synergist interferon futur gl interferon will better option treat hcv infect
Virol J	26401031	2012-03-20	PMC3169512	21806805	background despit success erad smallpox whole vaccin programm pox viru infect remain consider health threat smallpox bioterror agent continu occurr zoonot pox viru infect document relev deepen understand viru host interact permiss pox infect independ host surfac receptor correl abil viru infiltr antivir host respons directli depend host proteom set report proteom hek cell infect vaccinia viru strain ihdw analyz dimension gel electrophoresi maldipsdtof ms bottomup approach cellular viral proteom vacv ihdw infect hek cell uvinactiv vacv ihdwtreat noninfect cell compar derivat peptid sulfophenyl isothiocyan spitc carri ziptipc column enabl protein identif peptid primari sequenc provid improv sn ratio signal intens psd spectra express human protein modul viral infect effect uvinactiv infecti virus host proteom concern energi metabol protein associ gene express proteinbiosynthesi effect attribut viru entri virion protein modul protein involv apoptosi clearli correl infecti virus conclus proteom analysi infect cell insight apoptosi modul regul cellular gene express regul energi metabol confid protein identif clearli improv peptid derivat spitc solid phase support identifi protein describ context poxviru infect characteris identifi mean apoptosi modul pathogenesi
PLoS Pathog	22434910	2005-05-26	PMC3169548	21931555	recognit virus pattern recognit receptor prr interferon ifn induct kei event antivir innat immun respons target viral immun evas vaccinia viru vacv protein identifi inhibitor prrinduc ifn express function screen select vacv open read frame express individu mammalian cell member famili bcllike poxviru protein inhibit innat immun signal pathwai prr activ nfb ifn regulatori factor irf activ ifn promot induct data present inhibit irf activ transloc nucleu inhibit nfb activ inhibit irf irf activ downstream kinas tank bind kinas tbk ib kinas ikk phosphoryl activ irf inhibit tbk ikkindepend irf activ induct promot constitut activ form irf irf indic act level tbkikk complex consist notion immunoprecipit tbk complex scaffold protein tank sintbad nap express earli infect nucleu cytoplasm mutant virus cl gene delet mutat protein express replic cell cultur attenu vivo model infect compar wild type revert control contribut vacv virul inhibit prrinduc activ irf irf
BMC Res Notes	15919902	2014-08-01	PMC3170337	21849040	purpos hn vaccin gener debat concern safeti issu gener popul physician question safe vaccin investig safeti inactiv monoval hn pandem influenza vaccin method focus hn pandem influenza vaccin pandemrix appli report questionnair popul healthcar worker hcw medic student major univers hospit total individu vaccin consist hcw medic student vaccin rate employe higher major individu vaccin novemb total vaccin report lead advers reaction local reaction report myalgia arthralgia fatigu headach conclus data data nation intern institut point safe pandem influenza vaccin
Viruses	25010893	2014-04-02	PMC3172725	21927676	marburg ebola virus sever hemorrhag diseas human high fatal rate earli target cell filovirus monocyt macrophag dendrit cell infect spread liver spleen organ blood lymph flow hallmark filoviru infect deplet noninfect lymphocyt molecular mechan lead observ bystand lymphocyt apoptosi understood limit knowledg fate infect cell filoviru diseas review will explor intracellular event lead viru amplif cell damag filoviru infect will discuss cellular dysfunct cell death correl diseas pathogenesi
PLoS One	24566924	2013-08-23	PMC3173486	21935489	the emerg influenza virus resist exist class antivir drug rais concern novel antivir agent therapeut prophylacticali surfact protein spd belong famili ctype lectin effector molecul innat immun system activ bacteria virus includ influenza virus studi evalu potenti recombin porcin spd antivir agent influenza virus iav vitro determin rang antivir activ thirti iav subtyp hn hn hn origin bird pig human select test sensit recombin spd virus hemagglutin inhibit assai recombin porcin spd potent recombin human spd higher order oligomer form spd strongest antivir activ porcin spd activ broad rang iav strain neutral varieti hn hn iav includ pandem hn virus tissu section ferret human trachea demonstr recombin porcin spd prevent attach human season hn hn viru receptor epitheli cell upper respiratori tract conclud recombin porcin spd hold promis novel antivir agent influenza develop evalu vivo warrant
PLoS One	23977432	2015-08-10	PMC3174162	21935396	the induct strong mucos immun respons essenti build success hiv vaccin highli attenu recombin hiv vaccinia viru administ mucos high dose immun unabl induc strong mucos antibodi respons order solv problem studi interact recombin hiv vaccinia viru tiantan strain rvttgagpol mucos epitheli cell caco cell layer balbc mice evalu impact viru hiv antigen deliveri specif immun respons demonstr rvttgagpol infect caco cell layer nasal lung epithelia balbc mice progeni virus express releas apic surfac balbc mice infect limit respiratori system observ blood polar distribut limit antigen deliveri bodi limit immun respons improv stimul unpolar bud viru hiv antigen treat caco cell balbc mice colchicin balbc mice degre infect antigen express epithelia result specif immun respons increas correspondingli data polar bud limit antigen deliveri immun respons unpolar distribut increas antigen express deliveri enhanc specif immun respons conclus optim mucos hiv vaccin strategi
PLoS One	26261336	2007-11-21	PMC3174196	21935418	introduct mechan ventil mv mice increasingli requir experiment studi condit allow stabl ventil mice hour fulli defin addit previou studi document vital paramet lung mechan incomplet aim studi establish experiment condit paramet physiolog rang period purpos examin effect frequent short recruit manoeuvr rm healthi mice method mice ventil low tidal volum vt mlkg high tidal volum vt mlkg posit endexpiratori pressur peep cmho rm perform min min lung mechan forc oscil techniqu blood pressur bp electrocardiogram ecg heart frequenc hf oxygen satur bodi temperatur monitor blood gase neutrophilrecruit microvascular permeabl proinflammatori cytokin bronchoalveolar lavag bal blood serum histopatholog lung examin mv repetit rm min stabl respiratori mechan ventil rm worsen lung mechan alveolar collaps lead impair ga exchang hf bp anaesthesia ventil microvascular permeabl highest atelectat lung neutrophilrecruit structur chang strongest lung ventil high tidal volum cytokin il kc tnf ip elev bal serum ventil mice reduc recurr rm lung mechan oxygen pulmonari inflamm improv increas peep conclus recurr rm maintain lung mechan physiolog rang low tidal volum ventil healthi mice prevent atelectasi reduc develop pulmonari inflamm
PLoS One	18032495	2008-04-22	PMC3174198	21935470	the rna guanylyltransferas gtase involv synthesi mgppprna cap structur eukaryot mrna gtase member coval nucleotidyl transferas superfamili includ dna rna ligas gtase catalyz twostep reaction initi util gtp substrat form coval enzymegmp intermedi gmp moieti transfer diphosph rna transcript second step reaction form gppprna structur current studi combin virtual databas screen homolog model biochem assai search novel gtase inhibitor approach demonstr mycophenol acid mpa inhibit gtase reaction prevent catalyt transfer gmp moieti acceptor rna mpa repres novel type inhibitor rna guanylyltransferas inhibit second step catalyt reaction addit mpa cerevisia cell lead reduct cap mrna final biochem assai demonstr mpa inhibit dna ligas inhibit second step reaction biolog implic find mpamedi inhibit member coval nucleotidyl superfamili discuss
PLoS One	18427094	2012-04-27	PMC3174965	21949746	background differ clinic present outcom patient infect pandem influenza hn phn compar respiratori virus fulli elucid methodologyprincip find retrospect studi perform hospit patient peak phn season singl respiratori viru detect molecular assai target virusessubtyp rvp luminex xtag fiftytwo percent patient octob decemb singl respiratori viru phn rhinoviru rsv ab parainfluenza adenoviru coronaviru metapneumoviru season influenza detect individu phn compar virus fever cough sore throat nausea vomit abdomin pain lower white blood count l pvalu patient cough gastrointestin complaint presenc subject feverchil independ rais likelihood phn fiftyf percent cohort receiv antibacteri agent receiv oseltamivir receiv steroid mortal rate cohort wa higher individu phn compar virus conclusionssignific peak pandem influenza season rhode island half patient admit influenzalik symptom respiratori virus influenza a high proport patient treat antibiot phn infect higher mortal compar respiratori virus
BMC Infect Dis	22544935	2017-07-01	PMC3175217	21880131	background sever diseas caus pandem influenza ahnviru character presenc hypercytokinemia origin exacerb cytokin respons unclear observ uncontrol influenza viru replic influenc cytokin product object studi evalu relationship host cytokin respons viral level pandem influenza critic patient method twenti three patient admit icu primari viral pneumonia includ studi quantit pcr base method target influenza gene develop quantifi pharyng viral load addit multiplex base assai systemat evalu host cytokin respons viral infect admiss icu correl studi cytokin level viral load calcul spearman correl coeffici fifteen patient need intub ventil mechan ventil icu hospit viral load pharyng swab fold higher group patient worst respiratori condit admiss icu pharyng viral load directli correl plasma level proinflammatori cytokin il ilp ifn chemotact factor mip gmcsf angiogen mediat vegf immunomodulatori cytokin ilra correl studi demonstr exist posit associ level mediat evidenc simultan regul respons viru conclus sever respiratori diseas caus pandem influenza viru character exist direct associ viral replic host cytokin respons reveal potenti pathogen link sever diseas caus influenza subtyp hn
PLoS One	28187911	2010-04-02	PMC3176773	21949749	background mosquitoborn infecti diseas pose sever threat public health area current method pathogen detect surveil depend prior knowledg etiolog agent involv effici approach requir screen wild mosquito popul detect unknown pathogen methodologyprincip find studi explor gener sequenc identifi viral agent wildcaught mosquito extract total rna mosquito speci south china small bp length rna molecul purifi reversetranscrib cdna sequenc illumina gaiix instrument bioinformat analys identifi put viral agent conduct confirm pcr identifi nonenvelop singlestrand dna densoviru wildcaught culex pipien molestu mosquito major viral transcript region cover small viral rna peak high coverag strand sequenc ratio small rna indic molecul deriv viral rna transcript small viral rna overlap enabl contig assembl viral genom sequenc identifi small rna revers repeat region viral untransl region transcript expect conclusionssignific demonstr time high throughput sequenc small rna feasibl identifi viral agent wildcaught mosquito detect dna virus sequenc small rna insect underli mechan small viral rna biogenesi unclear data research high throughput small rna sequenc pathogen surveil wild mosquito vector
Virol J	20363828	2008-12-10	PMC3177912	21902821	background pig consid suscept influenza viru infect host origin earlier studi receptor avian sialic acidalphatermin saccharid saalpha swinehuman saalpha influenza virus upper respiratori tract experiment natur infect pig report influenza viru avian human sourc method studi investig receptor distribut entir respiratori tract pig specif lectin maackia amurensi maa ii sambucu nigra sna predilect site swine influenza viru siv subtyp hn hn avian influenza viru aiv subtyp hn investig respiratori tract experiment infect pig immunohistochem method siv antigen distribut bronchi epitheli cell nose trachea bronchiol alveolar type ii epitheli cell sever anim aiv lower respiratori tract alveolar type ii epitheli cell occasion bronchiolar epitheli cell saalpha predomin receptor area respiratori tract averag line epitheli cell contrari saalpha epitheli cell nose trachea bronchi small amount bronchiol alveoli reach averag epitheli cell interestingli receptor express saalpha markedli diminish influenza infect area compar noninfect area conclus differ predilect site siv aiv viru differ distribut saalpha saalpha receptor indic distribut influenza viru receptor pig human challeng theori pig act mix vessel human avian influenza virus aiv prefer infect alveolar type ii epitheli cell pig correspond find human emphasis resembl speci
PLoS One	19252833	2012-02-01	PMC3179484	21966414	sever studi highlight role plai murin natur killer nk cell control influenza infect human nk cell respons acut influenza infect includ infect pandem hn influenza viru document examin chang nk cell phenotyp function plasma cytokin level associ influenza infect vaccin absolut number peripher blood nk cell cdbright nk cell decreas acut influenza infect nk cell subset expand intramuscular influenza vaccin nk cell expos influenza antigen activ higher proport nk cell express cd studi subject infect season influenza strain vaccin led increas level cd nk cell notabl cdbright cd nk cell decreas amount subset peripher blood influenza infect individu studi subject infect pandem hn influenza viru final acut influenza infect associ low plasma concentr inflammatori cytokin includ ifn mip il il high level antiinflammatori cytokin il ilra altogeth data role cdbright nk cell subset respons influenza involv recruit infect tissu local product andor uptak inflammatori cytokin
PLoS One	22071509	2016-11-10	PMC3179511	21966512	background hepat viru hev nonenvelop plusstrand rna viru acut hepat capsid protein open read frame orf induc endoplasm reticulum stress orf express cell methodologyprincip find studi hev orf activ express proapoptot gene cebp homolog protein chop orf stimul chop promot aar amino acid respons element minor extent ers endoplasm reticulum stress respons element activ transcript factor atf protein bind activ aar regulatori site chop promot orf express lead increas phosphoryl eukaryot initi factor alpha eif turn initi translat atf mrna proapoptot gene chop trigger initi endoplasm reticulum stress induc apoptosi activ chop orf studi induc apoptosi bclassoci protein bax transloc mitochondria microarrai analysi reveal orf specif increas express chaperon hsp hspb cochaperon hsp coimmunoprecipit coip silico molecular dock analysi suggest hev orf interact hsp addit hsp nuclear accumul orf express cell conclusionssignific data provid insight simultan occur counteract effect hev orf strategi prevent host suicid complet viral replic cycl
Virol J	27834729	2009-01-21	PMC3179960	21902836	background chikungunya viru chikv surpris massiv reemerg outbreak indian ocean reach europ exhibit except sever physiopatholog infant elderli patient context analyz innat immun host respons trigger chikv autophagi compon innat immun respons involv host defens elimin pathogen autophag process observ hijack viru replic provid evid hallmark autophagi hek infect cell involv chikv replic method test capac chikv mobil autophag machineri perform fluoresc microscopi experi hekgfplc stabl cell lc distribut time cours chikv infect confirm perform electron microscopi hek infect cell test chikvinducedautophagi viral replic block autophag process pharmacolog ma genet inhibit sirna transcript beclin autophag protein analyz percentag infect cell viral rna load releas supernat induct autophagi rapamycin viral replic test increas number gfplc posit cell punctat stain enhanc number gfplc dot cell chikv trigger autophag process hek infect cell confirm electron microscopi analysi numer membranebound vacuol characterist autophagosom observ infect cell inhibit autophagi biochem reagent rna interfer dramat decreas chikv replic conclus autophagi plai promot role chikv replic investig detail relationship autophagi viral replic will greatli improv knowledg pathogenesi chikv provid insight design candid antivir therapeut
PLoS One	19158246	2004-11-24	PMC3180459	21966536	background procoagul membran microvesicl mv deriv platelet leukocyt circul receptormedi activ cellcel interact apoptosi platelet sentinel marker tolllik receptor tlr activ experi design evalu time cours mechan direct interact platelet leukocyt acut activ tlr bacteri lipopolysaccharid lp methodologyprincip find blood agematch male femal wild type wt tlr gene delet dtlr mice incub ultrapur coli lp ngml hour design period leukocyt antigen posit platelet platelet antigen posit leukocyt cellderiv mv quantifi flow cytometri number platelet leukocytederiv mv increas hour vitro exposur blood lp lp stimul number platelet stain posit platelet leukocytespecif antigen increas blood deriv wt dtlr mice block inhibit tlr signal mediat trif dai singl intraven inject lp ngmous nggm bodi wt wt mice platelet stain leukocyt antigen granulocyt monocyt apoptot bodi stain posit platelet antigen conclusionssignific hour exposur lp leukocyt exchang surfac antigen platelet tlr activ vivo leukocyt express platelet antigen retain singl exposur lp turn platelet pool acut express leukocyt antigen platelet hour exposur lp sustain express platelet antigen leukocyt singl acut exposur lp vivo explain associ platelet leukocyt respons bacteri infect chang thrombot propens blood
PLoS One	15564471	2011-06-01	PMC3181264	21980438	bat rich reservoir host varieti virus capabl spillov suscept mammal lethal consequ abil bat remain asymptomat viral infect rapid control viral replic earli immun respons innat antivir mechan type iii interferon ifn repres defenc viral infect mammal famili ifn pteropid bat insight type iii ifn system bat describ character type iii ifn receptor ifnr black fly fox alecto character ifnr ilr gene type iii ifn receptor complex bat ifnr complex wide tissu distribut cellular level epitheli immun cell respons ifn treatment demonstr bat ifnr chain act function receptor knowledg report repres descript ifn receptor speci bat respons bat cell ifn support role type iii ifn system epitheli immun cell bat
Ir Vet J	21427361	2010-07-07	PMC3182126	21917151	calfhood diseas major impact econom viabil cattl oper second three review seri consid manag diarrhoeic diseas prewean calv neonat calf diarrhoea oral rehydr therapi singl therapeut measur carri farmer success instig diarrhoea develop continu feed milk milk replac diarrhoeic calv prevent malnourish weight loss calv indiscrimin antibiot treatment uncompl diarrhoea discourag system calv benefit system antibiot treatment prevent septicaemia concurr diseas ancillari treatment specif prevent measur discuss eimeriosi high econom impact farm industri direct cost treatment calf loss decreas perform clinic subclin anim emphasi li prophylact metaphylact treatment degre damag intestin mucosa diarrhoea develop therapeut intervent unreward
PLoS One	20610424	2018-03-01	PMC3183080	21980532	background reflect true extent spread phnv influenza pandem commun level infect mild clinic symptom studi aim assess prospect studi attack rate phn viru reunion island risk factor infect season methodologyprincip find serosurvei conduct austral winter frame prospect popul studi pair sera collect individu belong household passag pandem wave antibodi phnv titer hemagglutin inhibit assai hia titer consid posit seropreval week detect phnv reunion island peopl year ag adult year elderli year baselin correct cumul incid rate ag group declin antibodi titer occur passag epidem wave seroconvers rate phn correl neg ag ag group seroconvers occur individu seroneg inclus compar initi seroposit conclus seroincid phnv infect three time estim clinic surveil indic third infect occur commun level escap medic detect peopl year ag group preepidem titer prevent seroconvers protect infect concern rais long term stabil antibodi respons
Virol J	29256824	2014-05-28	PMC3184106	21910859	background transmiss gastroenter viru tgev sialic acid bind activ believ enteropathogen appear dispens infect cultur cell aim studi determin sialic acid bind infect cultur cell unfavor condit comparison tgev strain mutant avian coronaviru ibv concern depend sialic acid bind activ method infect virus analyz plaqu assai adsorpt time min prior infect cultur cell treat neuraminidas deplet sialic acid cell surfac mocktreat second approach pretreat viru porcin intestin mucin perform plaqu assai min adsorpt time student ttest verifi signific result desialyl cell minor infect tgev strain purdu adsorpt period min allow initi infect adsorpt time reduc min infect desialyl cell decreas tgev pur mutant defici sialic acid bind lower titer parent viru min adsorpt time adsorpt time min titer lower tgev pur tgev strain tgev miller ibv beaudett reduct infect neuraminidas treatment cultur cell irrespect virion adsorpt time conclus sialic acid bind activ facilit infect tgev unfavor environment condit depend sialic acid bind activ effici infect differ analyz tgev strain
Viruses	25369598	2008-12-03	PMC3185462	21994534	human bocaviru hbov discov molecular viru screen techniqu respiratori sampl respiratori diseas children hbov distribut worldwid respiratori sampl fece urin serum hbov infect young children coinfect respiratori virus exacerb effort link hbov specif symptom purpos review overview hbov highlight find
Viruses	19052082	2016-08-01	PMC3185464	21994537	thi studi realtim pcr assai screen small sampl volum comprehens rang respiratori pathogen initi thermocycl limit cycl avoid competit reagent secondari realtim multiplex pcr supplementari seminest human metapneumoviru picornaviru pcr assai requir complet acut respiratori pathogen profil potenti pathogen detect pernas aspir collect children acut respiratori symptom multipl pathogen detect sampl tandem multiplex realtim pcr effici method rapid detect multipl pathogen
Viruses	27154756	2005-05-01	PMC3185465	21994538	after human coronavirus oc nl human coronaviru hku hcovhku fourth human coronaviru discov hcovhku group coronaviru cultiv content hcovhku genom lowest coronavirus complet genom sequenc coronavirus hcovhku extrem codon usag bia attribut importantli sever cytosin deamin hcovhku genom uniqu tandem copi base acid tandem repeat unknown function nterminu nsp insid acid domain upstream papainlik proteas three genotyp hcovhku homolog recombin genom observ incid hcovhku infect highest winter human coronavirus hcovhku infect report global median rang incid hcovhku associ upper lower respiratori tract infect selflimit common method diagnos hcovhku infect rtpcr realtim rtpcr rna extract respiratori tract sampl nasopharyng aspir npa pol nucleocapsid gene target amplif monoclon antibodi gener direct antigen detect npa antibodi detect escherichia coli bl baculovirusexpress recombin nucleocapsid hcovhku igg igm detect sera patient normal individu western blot enzymelink immunoassai
Viruses	15860708	2010-06-01	PMC3185486	21994544	the intern fecvfipv mutat theori three correl test sibshalfsib kitten healthi contact cat unrel cat di fip geograph dispar region coronaviru fece extraintestin fip lesion cat accessori structur gene sequenc snp delet caus truncat gene product isol diseas tissu cat suffer fip fecal isol cat intact gene accessori structur gene appear normal fecal lesion virus deliteri mutat gene uniqu cat indic origin cat subsequ pass horizont compartment parent mutant form absolut viru lesion type fece cat viru ident fecal type occasion identifi diseas tissu gene mutant studi horizont transmit parent fecal viru transmit contact cat di fip housem high rate mutabl structur accessori gene cat lead minor genet variant variant identifi diseas tissu fece cat laboratori cat inocul mixtur close variant fip cat develop diseas variant genet drift exist isol geograph distinct region western us
Viruses	19597128	2013-11-01	PMC3185490	21994549	bovin herpesviru bohv infect cell protein bicp transcript regulatori protein stimul product infect transient transfect assai bicp inhibit interferon depend transcript bicp induc degrad interferon stimulatori factor irf cellular transcript factor crucial activ beta interferon ifn promot activ studi conclud interact bicp irf inhibit transactiv ifn promot activ chc zinc ring gene finger locat amino terminu bicp function bicp recombin viru singl amino acid chang conserv cystein residu chc zinc ring finger bicp grow cultur cell reactiv latenc cattl confirm chc zinc ring finger crucial viral growth pathogenesi bicp delet mutant induc plaqu permiss cell induc autophagi cell type depend manner summari abil bicp stimul product infect repress ifn depend transcript plai crucial role bohv infect cycl
Viruses	23688437	2018-01-16	PMC3185500	21994554	typei interferon ifni cytokin essenti vertebr antivir defens includ herpesvirus ifni potent direct antivir activ mediat multipl immunoregulatori function promot dampen antivir adapt immun respons plasmacytoid dendrit cell pdc profession produc ifni respons virus includ herpesvirus test strong evid pdc plai major role initi orchestr innat adapt antivir immun respons depend activ pattern pdc respons protect detriment host summar discuss current knowledg pdc implic physiopatholog mous human herpesviru infect discuss pdc function manipul immunotherapeut set promot health diseas
Viruses	29194012	2010-06-10	PMC3185515	21994563	hcovnl identifi respiratori viru pathogenesi fulli unravel anim model current lack examin rhesu macaqu encount hcovnl infect life examin level antibodi hcovnl time anim till year three anim observ steep rise antibodi follow indic natur infect hcovnl
Viruses	20538854	2009-10-01	PMC3185524	21994575	defect interf di rna subvir rna produc multipl rna virus errorpron viral replicas dirna parasit rna deriv associ parent viru advantag viralcod protein factor multipl advanc field di rna biologi led greater understand gener evolut dirna mechan symptom attenu dirna versatil tool hand virologist complex surrog templat understand biologi helper virus eas genet manipul rapid discoveri cisact rna replic element requir replic recombin dirna exploit discov host factor modul tomato bushi stunt viru replic viral rna recombin review discuss current model gener evolut dirna role viral host factor dirna replic mechan diseas attenu
Viruses	19822888	2014-06-11	PMC3185532	21994559	the interferoninduc doublestrand dsrnadepend protein kinas pkr limit viral replic eifmedi block translat negativestrand rna virus activ pkr respons rna long remain elus dsrna canon activ pkr detect cell infect virus review focu activ rna molecul viru famili negativestrand rna virus discuss identifi noncanon activ triphosph rna vrnp influenza viru updat strategi select rna dna virus prevent activ pkr
Viruses	24920770	2006-01-01	PMC3185535	21994588	human rhinovirus hrv common cold complic respiratori infect hrv speci associ lower respiratori infect exacerb asthma type distribut strain connect kind lower respiratori condit clearli analys presenc hrv sputum specimen deriv militari recruit prediagnos asthma time acut respiratori infect cia studi analysi perform hrv hev realtim rtpcr assai subsequ studi type distribut hrv strain genet type vpvp genom region total specimen hrvposit hevposit differ hrv detect asthmat nonasthmat patient genet type strain belong hrva hrvb strain constitut hrvposit strain hrvc strain type time hrvposit case hevd strain type hev posit strain partial vp region three belong hrva three hevd hrva strain discov studi period hrvc strain origin winter spring specimen interestingli type hrvb strain origin summer season specimen
Viruses	17006978	2011-10-01	PMC3185540	21994565	the wu polyomaviru wupyv novel member famili polyomavirida detect respiratori tract specimen shotgun sequenc intriguingli viral genom detect respiratori tract specimen children respiratori diseas level coinfect establish respiratori virus rang studi report detect wupyv stool serum wupyv infect distinguish viral infect clinic symptom respiratori tract diseas pneumonia bronchiti frequent observ patient harbour wupyv detect viremia suggest system infect data prove wupyv human pathogen investig necessari
Viruses	21852642	2009-10-08	PMC3185542	21994570	sever human monoclon antibodi hmab antibodi fragment includ best character term structurefunct fab exhibit potent broad hiv neutral activ elicit blike antibodi vivo vaccin immunogen base hiv envelop glycoprotein env success highli diverg closest correspond germlin antibodi diverg hypothes high degre specif somat hypermut preclud bind hiv envelop glycoprotein env closest germlin antibodi identifi antibodi intermedi pathwai matur help design novel vaccin immunogen guid immun system enhanc elicit support hypothesi germlinelik monoval bival scfv fc fusion protein igg lack measur bind env measur elisa sensit rang evid confirm expand find panel env contrast germlinelik scfv bound env high nm affin to explor matur pathwai antibodi identifi intermedi antibodi test neutral activ intermedi antibodi neutral hiv isol weak potenc contrast germlinelik scfv neutral subset test hiv isol compar effici matur help explain high immunogen coreceptor bind site gp abund cdinduc cdi antibodi hivinfect patient cdi antibodi matur pathwai help identifi antigen bind germlin intermedi antibodi env conceptu novel type candid vaccin candid vaccin base immunogen help guid immun system complex matur pathwai elicit antibodi ident antibodi properti
Viruses	19815576	2007-05-01	PMC3185546	21994587	infecti bronchiti viru ibv highli contagi respiratori urogenit tract diseas chicken maryland md strain isol diseas chicken flock delmarva peninsula region understand genet divers phylogenet relationship exist strain md complet nucleotid sequenc code region kb md determin compar ibv strain coronavirus smn gene order case ibv strain spike gene md exhibit ident se strain delet spike gene noncod region gene untransl region utr arklik strain phylogenet analysi sequenc align demonstr md chimera gene segment close se conn jmk strain current studi evid genom mutat intergen recombin place evolut ibv strain md
Viruses	17434199	2017-06-29	PMC3185548	21994611	it mucos tissu largest surfac area human bodi front natur host defens pathogen fact infecti diseas pathogen gain entri suscept human host open mucos surfac human immunodefici viru type hiv sexual transmit viru target vagin gastrointestin mucosa entri site viral transmiss seed replic amplif hiv establish earli replic vagin rectal mucos tissu induct suffici mucos immun initi site hiv transmiss essenti protect vaccin despit fact current convent vaccin strategi remain unsuccess prevent hiv infect suffici financi support resourc to develop vaccin elicit protect mucos immun sexual transmiss interestingli chines ancestor invent variol intranas administr year ago led discoveri success smallpox vaccin final erad diseas hope mankind develop mucos aid vaccin will ultim help control aid pandem order discov effect mucos aid vaccin deep understand mucos immunolog test mucos vaccin strategi
Viruses	28465343	2009-07-08	PMC3185569	21994614	the type interferon system plai critic role limit spread viral infect virus induc product interferon ifn bind ifn receptor ifnar trigger jakstat signal cascad induct interferonstimul gene isg isg function inhibit viral replic regul host immun respons isg ubiquitinlik molecul isg induc protein ubiquitin ifn induc conjug cascad isg coval link varieti cellular protein suggest regul cellular process studi perform year isg plai central role host antivir respons virus mice lack isg displai increas suscept multipl virus virus develop immun evas strategi directli target isg pathwai work underwai determin mechan isg function antivir molecul therapi target pathwai develop futur
Viruses	19587037	2011-03-30	PMC3185573	21994622	ubiquitin plai critic role cellular process grow number virus evolv strategi exploit ubiquitinproteasom system includ member poxvirida famili member poxviru famili encod btbkelch ankyrinfbox protein interact cullin cullin base ubiquitin ligas multipl member poxviru famili encod ubiquitin ligas intrins activ review describ numer mechan poxvirus emploi manipul ubiquitinproteasom system
Viruses	21450819	2006-06-28	PMC3185581	21994630	respiratori virus diseas human character abrupt onset symptom studi human anim model symptom appear dai week infect initi symptom manifest viru recognit element innat immun respons earli viru replic undetect interv infect emerg symptom call incub period clinic score incub period describ viru infect underli mechan asymptomat phase comprehens document review studi interact human pathogen respiratori rna virus host emphasi mechan virus inhibit immun discuss concept stealth phase defin time infect earliest detect inflammatori respons propos stealth phase phenomenon respons suppress symptom incub period viral antagon inhibit major pathwai innat immun system allow extend time unhind viru replic
Viruses	16809333	2011-05-18	PMC3185585	21994625	positivestrand rna rna virus exploit host cell machineri subvert host protein membran alter cellular pathwai infect achiev robust replic rna virus polioviru pv build special intracellular compart call viral replic organel work altanbonnett laboratori insight format polioviru replic organel uniqu subcellular structur individu replic complex result dynam cellular membran remodel
Viruses	21593260	2014-05-07	PMC3185589	21994638	an ideal anim model studi human diseas util rout infect mimic natur transmiss pathogen abil diseas infecti dose equival caus diseas human diseas cours morbid mortal human diseas addition anim model mode transmiss mimic human case develop small anim model studi monkeypox viru mpxv extens short period time pathogen model studi antipoxviru agent will review mpxv small anim model develop studi therapeut agent
Viruses	22205743	2002-02-01	PMC3185593	21994631	the continu emerg reemerg pathogen repres ongo major threat popul hantavirus famili bunyavirida associ human diseas consid confin eurasia occurr outbreak in southwestern unit state led great increas studi virologist worldwid hantavir genotyp describ larg major half pathogen human hantavirus persist infect reservoir host america human diseas manifest cardiopulmonari compromis hantaviru cardiopulmonari syndrom hcp casefat ratio common viral serotyp habitat disturb largerscal ecolog disturb includ climat chang factor increas human caseload hcp consid featur influenc structur host popul dynam lead viral outbreak macromolecular determin hantavirus regard potenti contribut pathogen
Viruses	11773370	2009-12-01	PMC3185605	21994645	coval modif polyethylen glycol peg nontox polym food cosmet pharmaceut prepar year profoundli influenc pharmacokinet pharmacolog toxciolog profil protein peptidebas therapeut review summar histori pegyl peg chemistri highlight technolog context design develop recombin virus gene transfer vaccin diagnost purpos specif emphasi applic technolog adenoviru potent viral vector highli character toxic profil anim model
Viruses	20095306	2013-05-15	PMC3185611	21994652	the flaviviru genu includ virus remark abil produc diseas larg scale expans increas endem dengu west nile virus america exemplifi medic epidemiolog rapid detect viral infect induct innat antivir respons crucial determin outcom infect intracellular pathogen receptor rigi mda plai central role detect flaviviru infect initi robust antivir respons virus capabl produc acut ill human clear flavivirus util varieti mechan modul interferon respons nonstructur protein flavivirus reduc express interferon depend gene block phosphoryl enhanc degrad downregul express major compon jakstat pathwai studi indic interferon modul factor develop sever flavivir ill suggest increas understand viralhost interact will facilit develop novel therapeut treat viral infect improv biolog model studi flaviviru pathogenesi
Viruses	23678167	2012-03-20	PMC3185704	21994738	the aim manuscript describ modern advanc knowledg virus viral evolut appli field diseas ecolog conserv review progress virolog provid exampl inform empir field ecolog appli conserv includ discuss need breakthrough wai bridg commun gap field lab effort foster interdisciplinari effort includ tabl list definit kei term understand dynam zoonot pathogen reservoir host emphas tool assess risk factor spillov test hypothes treatment andor intervent strategi conclus highlight smart surveil viral discoveri effort predict model shift predict approach todai global societi hn pandem demonstr identif postemerg late prevent global spread integr molecular virolog ecolog techniqu will allow earlier recognit danger pathogen ideal jump wildlif reservoir human livestock popul seriou public health conserv issu
Viruses	22429763	2014-09-01	PMC3185718	21994689	influenza viru preval ancient infect human world popul infect influenza viru annual lead high morbid mortal infant elderli immunocompromis influenza outbreak lead roughli death year current vaccin antiinfluenza drug limit high mutat rate viru side effect year rna interfer trigger synthet short interf rna sirna rapidli evolv potent antivir regimen properli design sirna function potent inhibitor influenza viru replic sirna outperform tradit small molecul antivir number area eas design modest cost fast turnaround specif tissu deliveri remain major bottleneck clinic applic rnai gener intranas applic sirna respiratori virus includ limit influenza viru experienc success optim review here
Viruses	25068401	2014-05-02	PMC3185727	21994699	the discoveri character rna interfer rnai pathwai scientif develop year rnai cellular pathwai small rna control express gene degrad homolog rna prevent translat rna partial homolog impact basic biologi major front the discoveri microrna mirna regul cellular process requir viral infect includ hepat viru hcv second front small interf rna sirna robust tool mammalian cellular genet led identif hundr cellular gene hcv infect major push adapt rnai technolog clinic review explor impact rnai understand hcv biologi progress design rnaibas therapeut hcv remain obstacl
Viruses	24795379	2016-12-28	PMC3185738	21994708	the drastic increas number coronavirus discov coronaviru genom sequenc unpreced opportun perform genom bioinformat analysi famili virus coronavirus possess largest genom kb rna virus content vari variabl number small orf conserv gene orfab spike envelop membran nucleocapsid downstream nucleocapsid gene coronaviru lineag phylogenet three genera alphacoronaviru betacoronaviru gammacoronaviru betacoronaviru consist subgroup exist fourth genu deltacoronaviru includ bulbul coronaviru hku thrush coronaviru hku munia coronaviru hku emerg molecular clock analysi gene loci reveal time common ancestor humancivet sar coronaviru estim substitut rate substitut site year recombin coronavirus notabl strain murin hepat viru mhv strain infecti bronchiti viru mhv bovin coronaviru felin coronaviru fcov type canin coronaviru gener fcov type ii three genotyp human coronaviru hku hcovhku codon usag bia coronavirus observ hcovhku show extrem bia cytosin deamin select cpg suppress clone major independ biolog forc shape codon usag bia coronavirus
Viruses	28031438	2017-10-16	PMC3185791	21994773	viru infect elicit innat respons involv antivir factor activ factor turn block viral countermeasur ensu battl host virus crucial determin viru establish foothold andor induc adapt immun respons comprehens systemslevel understand repertoir antivir effector context virushost respons provid advantag devis novel strategi interfer initi establish infect effort identifi cellular factor comprehens unbias manner genomewid sirna screen system biologi omic methodolog reveal potenti antivir effector virus human immunodefici viru type hiv hepat viru hcv west nile viru wnv influenza viru review describ discoveri novel viral restrict factor discuss integr method system biologi comprehens identifi intim interact virus cellular innat resist
Viruses	29165604	2001-02-01	PMC3185800	21994782	sever independ group publish autophagi requir optim rna replic dengu viru denv initi postul autophagosom plai structur role replic complex format cryoem tomographi denv replic complex denv replic endoplasm reticulum er cisterna invagin classic autophagosom report autophagi plai indirect role denv replic modul cellular lipid metabol denvinduc autophagosom deplet cellular triglycerid store lipid droplet lead increas oxid energi product exampl viru trigger autophagi modul cellular physiolog review summar data discuss question implic autophagi denv replic
Viruses	11152533	2001-03-01	PMC3185804	21994781	human tlymphotrop viru type htlvi infect estim person worldwid number diseas associ viru includ adult tcell leukemia atl htlvassoci myelopathytrop spastic paraparesi hamtsp htlvi uveiti htlviassoci infect dermat increas risk develop hamtsp associ blood transfus screen htlv blood bank implement japan unit state franc netherland process includ detect enzym immunoassai eia confirmatori western blot wb recombin protein specif htlvi env glycoprotein incorpor wb strip htlvi seroposit defin presenc antibodi gp gp env protein band p gag band htlvii seroposit confirm presenc rgpii numer case document serum sampl reactiv eia incomplet band pattern displai subsequ confirmatori wb signific htlviii seroindetermin unclear higher incid exposur htlviii estim
Viruses	11160748	2011-04-01	PMC3185811	21994783	autophagi cellular process catabol cytoplasm compon maintain energi homeostasi stress respons autophagi machineri interconnect wide rang cellular pathwai enhanc spread pathogen limit highli activ area year independ laboratori report autophagi vesicl accumul hepat viru hcv infect cell autophagi protein function provir factor requir hcv replic review summar current interplai autophagi hcv mechan autophagi protein favor hcv propag
PLoS One	21050067	2008-06-01	PMC3186774	21991334	introduct establish strateg prioriti german nation public health institut rki guid institut midterm strateg decis priorit infecti pathogen nation surveil epidemiolog method delphi process intern rki extern expert metricconsensu approach score pathogen ten threetier criteria addit expert invit weight criterion lead calcul median weight score multipli rank pathogen total weight score divid prioriti group pathogen score eightysix expert particip weight case fatal rate rate criterion twentysix pathogen rank highest prioriti group pathogen internation recognis human immunodefici viru mycobacterium tuberculosi influenza viru hepat viru neisseria meningitid pathogen frequent caus larg outbreak campylobact spp nosocomi pathogen associ antimicrobi resist pathogen highest prioriti group includ helicobact pylori respiratori syncyti viru varicella zoster viru hantaviru discuss pathogen highest prioriti group high profil nation intern health polici document high score pathogen helicobact pylori respiratori syncyti viru hantaviru indic underrecognis current german public health framework process strengthen respect surveil system start priorit methodolog work modular structur set
PLoS Med	18582206	2019-03-26	PMC3186812	21990967	background emerg influenza pandem estim sever probabl sever outcom hospit infect public health prioriti influenza infect subclin serosurveil need allow reliabl realtim estim infect attack rate iar sever method find test sera collect wave pandem hong kong viral microneutr estim iar infectionhospit probabl ihp serial crosssect serolog data hospit data serolog data weekli real time reliabl ihp estim wk wk wk epidem peak individu ag y ratio iar preexist seropreval decreas ag major determin timeli reliabl estim began serosurveil wk commun transmiss confirm specimen week individu ag y reliabl ihp estim ag group wk peak old specimen week gener reliabl estim peak ratio iar preexist seropreval ag group low perform serial crosssect serosurveil deterior test specif preexist seropreval potenti limit mitig choos higher titer cutoff seroposit epidem doubl time longer serial crosssect serosurveil specimen week yield reliabl estim iar reach conclus serial crosssect serolog data clinic surveil data allow reliabl realtim estim iar sever emerg pandem serosurveil pandem consid articl editor summari
Viruses	30913880	2013-03-18	PMC3187592	21994724	although gener regard pathogen virus mutualist number exampl extrem mutual symbiogenesi studi exampl mutual common virus rare thought benefici effect host mutual popul dynam virus topic address experiment potenti understand mutual viru mutualist elucid understand dynam
Viruses	23249609	2015-04-01	PMC3187600	21994673	commentari wolf mc freiberg zhang akyolataman grock hong pw li watson nf fang aq aguilar hc al broadspectrum antivir target entri envelop virus proc natl acad sci 
Viruses	25765920	2015-11-02	PMC3187604	21994671	positivesens rna virus respons frequent devast diseas human anim plant develop effect vaccin antivir therapi target pathogen hinder incomplet understand molecular mechan involv viral replic common featur positivesens rna virus manipul host intracellular membran assembl function viral rna replic complex review will discuss interplai cellular membran positivesens rna viru replic will focu potenti structur function role cellular lipid process
Viruses	26575627	2014-01-01	PMC3187687	21994798	pathogen bacteri viral origin hijack pathwai oper eukaryot cell wai order gain access host establish eventu produc progeni detail molecular character subvers mechan devis pathogen infect host cell crucial gener target therapeut intervent review data indic coronavirus coopt membran carrier deriv endoplasm reticulum protein regul dispos misfold polypeptid replic addit model describ potenti mechan coronavirus emploi hijack
Viruses	23821643	2005-02-01	PMC3187689	21994806	recombin famili coronavirida document thought contribut factor emerg evolut coronavir genotyp speci coronaviru limit data frequenc extent recombin coronavirus natur avian gammacoronavirus emerg turkei coronaviru attribut sole recombin studi fulllength genom avian gammacoronaviru infecti bronchiti viru ibv isol sequenc fulllength ibv genom genbank analyz recombin evid recombin sequenc analyz distribut entir genom area highest occurr recombin locat region genom code nonstructur protein and structur spike glycoprotein extent recombin observ suggest princip mechan gener genet antigen divers ibv data indic reticul evolutionari chang recombin ibv plai major role origin adapt viru lead genet type strain viru
Viruses	15695669	2013-08-07	PMC3187694	21994795	while autophagi antivir defens picornavirida avoid case subvert pathwai promot replic evid indic picornavirus hijack autophagi order induc autophagosomelik membran structur genom rna replic express picornaviru protein induc machineri autophagi mechan virus emploi autophagi appear differ picornavirus upregul autophagi order promot viral replic member famili inhibit degrad autolysosom explor unusu relationship medic famili virus degrad mechan innat immun
Viruses	23926347	2002-10-01	PMC3187698	21994803	although singl strand ss dna virus infect human domest anim gener major diseas arthropod born ssdna virus plant result serious constrain food product temper region plant animalinfect ssdna virus appar metagenom survei ssdna molecul exist larg number divers ssdna virus terrestri aquat environ host rang virus span tree life compon global ecosystem line evid pivot evolutionari process gener global ssdna viru divers genet recombin high rate homolog recombin nonhomolog recombin genom compon reassort occur ssdna viru speci role type recombin plai daytodai biologi longer term evolut virus focu ecolog biochem select factor underli pattern genet exchang detect ssdna virus discuss consid assess adapt recombin ssdna viru evolut
PLoS One	12351731	2003-11-01	PMC3187809	21998709	type interferon ifn compris famili cytokin signal common cellular receptor induc plethora gene antivir activ recombin ifn treatment hepat viru infect multipl sclerosi malign capabl type ifn suppress viru replic result cytopath effect frequent measur bioactiv assai timeconsum requir appropri biosafeti contain studi improv ifn assai present base recombin vesicular stomat viru vsv replicon encod report protein firefli luciferas green fluoresc protein vector lack essenti envelop glycoprotein gene vsv propag proteinexpress transgen cell mammalian avian cell turn suscept infect complement replicon particl infect cell express report protein high level hour post infect human fibroblast treat serial dilut human ifn prior infect report express suppress method sensit faster classic ifn bioassai base vsv cytopath effect addit antivir activ human ifn interleukin type iii ifn determin calu cell ifn ifn acidst ifn resist alkalin treatment antivir activ canin porcin avian type ifn analys cell line deriv correspond speci safe bioassai will rapid sensit quantif multispeci type ifn antivir cytokin
BMC Health Serv Res	14623831	2014-12-01	PMC3189394	21929812	background surveil intervent resourceus activ strategi mitig unwant effect diseas resourc scarc alloc diseas mitig involv loss altern sourc benefit peopl societi maximum benefit resourc gain diseas mitig compar resourc cost guid decis object achiev optim net outcom discuss econom criteria guid decis aim optimis net benefit scarc resourc assess benefit diseas mitig except technic complex mitig econom evalu straightforward technic relationship surveil intervent argu analysi magnitud distribut benefit cost strategi outcom net term requir mitig consid three conceptu distinct stage stage sustain mitig object sustain free accept statu prevent increas pathogen elimin occur role surveil document pathogen remain defin threshold earli warn increas incid chang risk enabl earli respons pathogen contain situat assess stage ii investig surveil obtain critic epidemiolog decid appropri intervent strategi reduc erad diseas stage iii implement stage iii surveil inform choic time scale intervent document progress intervent direct preval reduct popul summari articl origin project develop conceptu framework practic tool econom evalu surveil explor technic relationship mitig sourc econom surveil intervent sourc econom cost crucial framework link kei technic relationship propos three conceptu distinct stage mitig identifi avian influenza salmonella foot mouth diseas present illustr framework
PLoS One	25225206	2006-08-01	PMC3189917	22016769	sever human monoclon antibodi mab neutral potenti subtyp describ three mab hj hgn hk patient hiv cohort institut tropic medicin itm aim gener immun antibodi equival plasma describ select character patient plasma mab rang neutral assai includ peripher blood mononuclear cell pbmc base assai replic primari virus cell base assai pseudovirus pv princip criterion select patient plasma activ extend incub phase pbmc assai neutral ab deriv memori cell select elisa envelop protein solid phase mab subsequ test highthroughput hospv assai assess function neutral studi indic strong profil patient plasma sole antibodi repres newli isol mab assai diverg larg indic neutral ab epitop hiv envelop plasma synergi ab spectrum mab cover rang crossreact plasma carefulli select patient irrespect neutral assai mab relev immunogen discoveri bind recombin glycoprotein immun respons target vivo observ illustr remain challeng requir success immunogen design develop
PLoS One	16893997	2008-11-01	PMC3189918	22022385	gp major envelop protein epsteinbarrviru confer bcell tropism viru interact lineag marker cd util gp gener tailor exosom ident tropism exosom target cotransf function protein normal malign human cell demonstr cotransf function cd protein tailor gp exosom malign blast patient chronic lymphocyt leukemia bcll render blast immunogen tumorreact autolog cell intriguingli engulf gp exosom bcll cell present gpderiv peptid restimul ebvspecif cell redirect strong antivir cellular immun respons patient leukem cell essenc gp confer bcell tropism exosom exosom engin simultan trigger viru tumorspecif immun respons simultan exploit gp tropism molecul tailor exosom neoantigen malign cell novel attract strategi immunotherapi bcll bcell malign
PLoS One	19030681	2018-06-27	PMC3189932	22016778	tolllik receptor tlr detect doublestrand ds rna activ innat immun respons polyic excel agonist tlr cell line human peripher blood mononuclear cell viral dsrna tend poor agonist lead hypothesi addit factor requir allow tlr respond viral dsrna tlr signal examin lung epitheli cell quantifi cytokin product human embryon kidnei cell quantifi luciferas report level recombin hepat viru polymeras enhanc tlr signal lung epitheli beasb cell media polyic viral dsrna polymeras genotyp jfh hcv poor enhanc tlr signal mutat favor conform bind better partial duplex rna polymeras coloc tlr endosom rnabind capsid protein cp positivestrand rna virus hepadenaviru hepat viru hbv potent enhanc tlr signal polyic viral dsrna truncat version hbv cp lack argininerich rnabind domain unabl enhanc tlr signal demonstr viral rnabind protein enhanc dsrnadepend innat immun respons initi tlr
J Trop Med	29950410	2019-07-24	PMC3191740	22007241	occurr virus acut respiratori tract infect nigerian children examin respiratori swab collect children refer hospit clinic acut respiratori symptom februari valid realtim rtpcr techniqu reveal nucleic acid viru group specimen human rhinovirus parainfluenza virus third children adenovirus enterovirus human metapneumoviru human bocaviru influenza viru common season occurr influenza viru respiratori syncyti viru detect rare conclud major group respiratori tract virus caus ill nigerian children
PLoS One	31341046	2011-06-13	PMC3192121	22022432	the genu orbiviru includ insect tickborn virus orbiviru genom compos segment dsrna encod structur protein vpvp nonstructur protein nsn open read frame orf span entir length genom segment seg encod vp viral helicas bioinformat analysi identifi overlap orf orfx seg orfx encod nonstructur protein identifi ns western blot confoc fluoresc microscopi antibodi rais recombin ns bluetongu viru btv insectborn great island viru giv tickborn demonstr protein synthesis btv giv infect mammalian cell btv ns express culicoid insect cell ns form aggreg cytoplasm nucleu consist identif nuclear localis signal ns sequenc bioinformat analys indic ns coiledcoil protein bind nucleic acid associ membran similar nucleolar protein utp processom subunit recombin ns giv protect dsrna degrad endoribonucleas rnase iii famili indic interact dsrna btv ns half put size giv ns protect dsrna rnase iii cleavag ns giv btv protect dna degrad dnase ns associ lipid droplet cell infect btv giv transfect plasmid express ns
PLoS One	21670291	2018-03-07	PMC3192122	22022474	background st march confirm case pandem influenza hn includ death report mainland china distribut characterist confirm case initi phase pandem countri unknown studi aim character geograph distribut patient characterist hn infect pandem identifi potenti risk factor associ advers patient outcom china retrospect analys hospit case confirm hn infect methodologyprincip find proport hazard model emploi detect risk factor advers outcom geostatist map character distribut confirm hn patient mainland china number case increas slowli rapidli june august year confirm case report provinc beij guangdong shanghai zhejiang fujian top region incid viru infect adjust gender ag chronic pulmonari diseas gener symptom delai dai hospit admiss hr ci delai onset hnspecif respiratori symptom hr ci associ advers patient outcom conclusionssignific pandem influenza east southeast coastal provinc popul citi sever region mainland china higher risk high level traffic high popul densiti high popul mobilityassoci hn transmissionth clinic symptom mild initi phase infect delai hospit admiss delai appear respiratori symptom major risk factor poor patient outcom find implic futur pandem prepared respons
BMC Musculoskelet Disord	29260651	2016-10-19	PMC3192716	21958301	background puls electromagnet field pemf stimul treat nonunion fractur femor head osteonecrosi effect prevent steroidinduc osteonecrosi purpos studi investig effect pemf stimul prevent steroidinduc osteonecrosi rat explor underli mechan method seventytwo male adult wistar rat divid three group treat pemf stimul group pemf group intraven inject lipopolysaccharid lp gkg dai intramuscularli inject methylprednisolon acet mpsl mgkg dai subject pemf stimul dai week methylprednisolonetr group mpsl group inject dose lp mpsl pemf group exposur pemf control group ps group inject salin mode time point incid osteonecrosi serum lipid level mrna protein express transform growth factor tgf proxim femur measur week mpsl salin inject incid osteonecrosi pemf group lower observ mpsl group osteonecrosi observ ps group serum lipid level lower pemf ps group mpsl group compar mpsl ps group mrna express tgf increas reach peak week pemf treatment remain high week declin week protein express tgf increas reach peak week pemf treatment remain high week conclus pemf stimul prevent steroidinduc osteonecrosi rat underli mechan involv decreas serum lipid level increas express tgf
PLoS One	27795425	2010-09-22	PMC3192755	22022394	bat increasingli recogn reservoir host larg number virus highli virul infect human livestock anim bat zoonot virus discov year reovirus respiratori enter orphan virus to acut respiratori infect human includ melaka kampar virus discov malaysia belong genu orthoreoviru famili reovirida report describ isol highli viru adult patient suffer acut respiratori ill malaysia direct evid bat origin epidemiolog studi indic potenti exposur patient bat onset diseas current studi demonstr spillov event strain orthoreovirus bat human occur regular basi call intens systemat surveil fulli assess true public health impact newli discov batborn zoonot reovirus
PLoS One	20861244	2012-06-01	PMC3192798	22022603	an adenoviru vector encod mous interferon alpha subtyp mdef evalu efficaci lethal vaccinia viru wr strain respiratori infect mice mdef administ singl intranas treatment prophylact therapeut dose plaqu form unitsmous prophylact treatment dai prior infect protect anim death protect treatment dai preinfect minim weight loss occur infect surviv anim rechalleng viru dai primari infect protect death indic mdef compromis immun respons initi infect postexposur therapi vaccinia viru exposur protect afford dose mdef dose effect comparison abil mdef dai prior infect inhibit tissu viru titer lung infect paramet lung liver spleen viru titer inhibit extent treatment lung weight lung hemorrhag score indic pneumon lung viru titer fold lower placebo group infect paramet mdef treat mice baselin contrast viral titer lung infect paramet high placebo group dai infect demonstr longact prophylact treatment capac mdef combat vaccinia viru infect
PLoS Pathog	22571706	2018-07-01	PMC3192843	22022266	the cap structur distinct featur eukaryot mrna eukaryot virus gener modifi viral rna mimic cellular mrna structur rna stabil protein translat viral immun escap sar coronaviru sarscov encod sadenosyllmethionin samdepend methyltransferas mtase sequenti methyl rna cap guanosinen ribos posit catalyz nsp nmtase nsp omtas uniqu featur sarscov nsp requir nonstructur protein nsp stimulatori factor execut mtase activ report biochem character sarscov omtas crystal structur nspnsp complex bound methyl donor sam sarscov nsp mtase methyl mgppparna mgpppgrna contrast nsp mtase function sequenceindepend manner demonstr nsp requir nsp bind mgppparna substrat sam cofactor structur analysi reveal nsp possess canon scaffold mtase associ nsp ratio structur nspnsp interact interfac nsp stabil sambind pocket extend substrat rnabind groov nsp consist find biochem assai nspnsp interfac repres better drug target viral mtase activ site develop highli specif anticoronaviru drug
Retrovirology	30044982	2004-11-01	PMC3193818	21943056	background type interferon ifn exhibit direct antivir effect distinct immunomodulatori properti studi analyz type ifn subtyp prophylact adenovirusbas antiretrovir vaccin mice friend retroviru fv hiv mice vaccin adenovir vector encod fv env gag protein combin vector encod ifn ifn ifn ifn ifn ifn ifn coadministr adenovir vector encod ifn ifn ifn ifn improv immun protect vaccin mice subsequ fv challeng infect high control fvinduc splenomegali reduc viral load level protect correl augment virusspecif cd cell respons enhanc antibodi titer mice vaccin hiv adenovir vector encod hiv env gagpol combin type ifn encod vector cd cell respons enhanc ifn subtyp conclus indic ifn subtyp potenti improv protect adenovirusbas vaccin retrovirus correl augment virusspecif cd cell antibodi respons coexpress select type ifn valuabl tool develop antiretrovir vaccin
PLoS One	15656475	2009-10-07	PMC3194813	22022592	identif type human enteroviru hev pathogen detect therapi previou phylogenybas type method base multipl sequenc align specif gene hev stabl respect choic gene report novel method identif type hev base deriv genom calcul kmer base barcod imag genom hev human virus fix k genom barcod defin term kmer frequenc distribut genom combin kmer phylogenet tree construct barcodebas distanc neighborjoin method set repres nonhev human virus hev sequenc tree clear separ hev virus nonhev virus accuraci separ hev distinct clad consist multipl sequenc alignmentbas phylogeni detail analys hev type method indic better agreement hev
PLoS Negl Trop Dis	19812072	2014-04-01	PMC3196478	22028943	zair ebolaviru zebov infect associ high lethal primat zebov target mononuclear phagocyt activ infect secret mediat believ trigger initi stage pathogenesi character respons target cell zebov infect understand pathogenesi point therapeut intervent gene express profil primari human macrophag expos zebov determin dna microarrai quantit pcr gain insight cellular respons cell entri chang mrna concentr encod cellular protein observ protein implic zebov infect inflammatori mediat elev acut phase diseas blood zebovinfect human interestingli cellular respons occur hour ebola virion exposur prior viru gene express observ support hypothesi virion bind entri mediat spike glycoprotein gp primari stimulu initi respons zebov virion lp viruslik particl consist zebov matrix protein vp gp vlpvpgp trigger compar respons macrophag includ proinflammatori proapoptot signal contrast vlpvp particl lack gp caus aberr respons suggest gp bind macrophag plai role cellular respons
Retrovirology	24769781	2012-01-11	PMC3196705	21843316	background foami virus fv orthoretrovirus express pol separ precursor protein gagpol fusion protein uniqu packag strategi involv recognit bride viral rna pol precursor gag potenti gagpol protein interact ensur pol particl encapsid prototyp fv pfv gagpol fusion protein construct gener examin pfv replic compat orthoretrovirallik pol express analysi nonparticleassoci secret pol precursor protein discov extracellular wild type pfv particl prepar origin copurifi simpl virion enrich protocol analysi method extracellular wild type pfv particl matur pprrt pin pol subunit character pfv gagpol fusion construct reveal pfv pol express orthoretrovir manner compat pfv replic long proteolyt process gag pol protein pfv gagpol translat hiv ribosom frameshift signal product replicationcompet virion cell particleassoci pol level reduc comparison wild type infram fusion pfv gag pol orf led increas cellular pol level particl incorpor margin elev report orthoretrovir construct fulllength infram pfv gagpol fusion construct wildtypelik particl releas infect characterist contrast infram pfv gagpol fusion ctermin gag orf truncat nonremov gag peptid addit pol displai wildtyp particl releas reduc particl infect pfv gagpol precursor fusion protein inactiv proteas highli defici regular particl releas coexpress pgag copackag protein conclus nonparticl associ pfv pol appear natur releas infect cell unknown mechan absenc particleassoci pol precursor suggest rapid process particl incorpor analysi pfv gagpol fusion construct demonstr orthoretrovirallik pol express compat fv replic princip long fusion protein process orthoretrovirus pfv particl releas infect toler larger differ rel cellular gagpol level
PLoS One	22238295	2009-02-01	PMC3197151	22043297	a highli conserv rnamotif unknown function call stemlooplik motif sm identifi the genom virus belong rna viru famili infect broad rang mammal bird speci includ astrovirida picornavirida coronavirida calicivirida sm extrem conserv motif ideal target screen virus harbour studi detect character novel virus harbour motif pigeon smspecif amplif sampl feral pigeon wood pigeon viru harbour sm novel virus identifi character virus belong genu avastroviru astrovirida famili propos novel speci includ genu feral pigeon astroviru wood pigeon astroviru novel virus pigeon picornaviru pigeon picornaviru belong picornavirida famili presum genu sapeloviru novel picornavirus harbour adjac sm call sm suggest increas function sm copi
PLoS One	19165722	2013-03-01	PMC3197180	22043275	control strategi enforc health agenc major type practic influenza outbreak type practic voluntari prevent behavior individu receiv vaccin antivir drug wear face mask type practic effect concurr influenza contain attent paid combin effect articl estim combin effect establish simul model urban area buffalo ny usa three control strategi investig includ target antivir prophylaxi tap workplaceschool closur commun travel restrict combin three control strategi simul regard individu prevent behavior effect compar simul outcom weaker control strategi suffic influenza epidem individu voluntarili adopt prevent behavior render weaker strategi effect expect prevent behavior individu save medic resourc control strategi avoid unnecessari socioeconom interrupt add human behavior dimens simul control strategi offer insight diseas contain health polici maker recommend review current control strategi comprehend prevent behavior pattern local popul make decis influenza contain
PLoS Pathog	23874060	2002-08-07	PMC3197620	22028657	chikungunya viru chikv reemerg alphaviru caus diseas indian ocean region outbreak addit fever rash arthriti sever case chikv infect observ infant challeng notion innat immun respons infant immatur defect demonstr human infant neonat mice gener robust type interferon ifn respons chikv infect contribut insuffici complet control infect character mechan type ifn control chikv infect evalu role isg defin central player host respons neonat mice lack isg profoundli suscept chikv infect surprisingli ubel mice lack isg enzym unabl form isg conjug displai increas lethal chikv infect point nonclass role isg differ viral load observ wildtyp wt isg mice dramat increas proinflammatori cytokin chemokin observ isg mice suggest innat immun respons chikv contribut lethal studi insight control chikv infect establish model isg function immunomodulatori molecul blunt patholog level innat effector molecul host respons viral infect
PLoS Pathog	12167619	2013-11-04	PMC3197621	22028656	sever acut respiratori syndrom viru sarscov lack envelop gene rsarscov attenu vivo identifi factor contribut rsarscov attenu gene express cell infect sarscov gene compar twentyf stress respons gene preferenti upregul infect absenc gene addit gene involv signal transduct transcript cell metabol immunoregul inflamm apoptosi cell cycl differenti differenti regul cell infect rsarscov gene administr protein tran reduc stress respons cell infect rsarscov respiratori syncyti viru treat drug tunicamycin thapsigargin elicit cell stress mechan addit sarscov protein downregul signal pathwai inositolrequir enzym ir unfold protein respons pkrlike er kinas perk activ transcript factor atf pathwai reduc cell apoptosi activ ir pathwai restor cell homeostasi apoptosi induc measur protect host limit viru product dissemin express proinflammatori cytokin reduc rsarscoveinfect cell compar rsarscovinfect cell suggest increas stress respons reduct inflamm absenc gene contribut attenu rsarscov
PLoS One	24191027	2010-06-16	PMC3198457	22039434	the ideal clinic diagnost system deliv rapid sensit specif reproduc minim requir special laboratori facil skill technician describ integr diagnost platform filmarrai fulli autom detect identif multipl organ singl sampl hour unprocess biologicclin sampl subject nucleic acid purif revers transcript highord nest multiplex polymeras chain reaction amplicon melt curv analysi biochem reaction enclos dispos pouch minim pcr contamin risk filmarrai potenti detect greater nucleic acid target time featur system wellsuit molecular detect infecti agent valid filmarrai technolog achiev develop panel assai capabl identifi common viral bacteri respiratori pathogen initi test system cultur organ clinic nasal aspir children demonstr analyt clinic sensit specif compar exist diagnost platform demonstr autom identif pathogen correspond target amplicon accomplish analysi dna melt curv amplicon
BMC Med	20554960	2006-06-14	PMC3198886	21968214	while growth urban worldwid improv live migrant hinterland rais health risk popul densiti concentr poverti transmiss infecti diseas will megac region evolv social infect breed ground rapid transmiss diseas critic spatial entiti protect promot popul health address question pearl river delta region prd base data chines sourc experi york greater london tokyo pari grappl challeng protect popul health provid popul access health care servic respect lesson compar experi prd notabl cover entir popul health care servic target special program highest risk diseas respect prd growth rate sheer scale uniqu megac region face challeng will requir solut
Evid Based Complement Alternat Med	16775348	2016-01-19	PMC3199055	22028733	introduct posttraumat stress disord ptsd accompani poor gener psycholog statu gp studi investig effect chines herbal formula gp earthquak survivor ptsd method random doubleblind placebocontrol trial compar chines herbal formula xiaotanjieyufang xtjyf placebo sichuan earthquak survivor ptsd patient random xtjyf placebo group baselinetoendpoint score chang three global indic symptom checklistrevis sclr rate respons scl global sever gsi primari endpoint subanalysi scl factor sleep qualiti score secondari endpoint discuss compar placebo xtjyf group improv three scl global indic patient xtjyf group report improv placebo group xtjyf group perform better control scl factor somat obsessivecompuls behavior depress anxieti hostil sleep qualiti score xtjyf produc seriou advers event find xtjyf effect safe treatment option improv gp patient ptsd
Vet Res	26787699	2016-01-07	PMC3199250	21982125	in order understand mechan neuroinvas highli pathogen avian influenza viru hpaiv central nervou system cn chicken specif pathogen free chicken inocul hn hpaiv blood cerebrospin fluid csf nasal caviti brain tissu sampl dai postinocul dpi infect control chicken viral antigen topograph distribut presenc influenza viru receptor brain role olfactori rout viru cn invas studi immunohistochemistri techniqu viral rna load csf blood quantifi quantit realtim revers transcriptionpolymeras chain reaction viral antigen observ distribut cn show bilater symmetr distribut nuclei diencephalon mesencephalon rhombencephalon viral rna detect blood csf dpi indic viru cross bloodcsfbarri earli infect earli dissemin favour presenc sia gal sia gal receptor brain vascular endotheli cell sia gal receptor ependym choroid plexu cell viral antigen observ olfactori sensori neuron olfactori bulb weak stain suggest viru pathwai enter brain sequenc viru appear topograph distribut hn hpaiv indic viral entri occur haematogen rout earli gener spread csf
BMC Emerg Med	29769974	2016-08-25	PMC3199257	21982119	background emerg depart globe follow triag system order cope overcrowd intent triag improv emerg care priorit case term clinic urgenc discuss emerg depart triag medic care lead advers consequ delai provid care compromis privaci confidenti poor physicianpati commun fail provid care altogeth decid life save save consequ challeng ethic qualiti emerg care articl ethic analysi routin emerg depart triag principl biomed ethic respect autonomi benefic nonmalefic justic provid start point help identifi ethic challeng emerg depart triag offer comprehens ethic view address ethic issu emerg depart triag comprehens ethic view care ethic perspect offer addit insight summari integr the analysi principl biomed ethic care ethic perspect triag propos integr clinic ethic base framework emerg depart triag plan comprehens ethic perspect incorpor principlesbas careori approach
Ir Vet J	27933788	2005-04-01	PMC3199273	21967764	anim health ireland produc clear guidelin control bovin viral diarrhoea bvd infect irish cattl herd cours develop guidelin clear framework region andor nation bvd control requir increas uptak bvd control farm level reduc preval diseas paper assess econom impact bvd epidemiolog aspect diseas control model bvd control intern experi bvd control programm technic knowledg test technolog exist erad bvd countri embark control diseas identif prompt elimin pi cattl will form basi control programm trade anim curtail pregnant pregnant carri pi foetus pose threat intern experi indic systemat coordin programm success voluntari programm good initi progress ultim fail farm commun bui propos programm support failur bui programm creat demand bvd control farmer inform stem econom loss improv product will primari motiv individu farm level
Virol J	15815038	2015-07-28	PMC3199808	21794150	background airborn virus remain major public health issu worldwid detect quantif airborn virus essenti order provid public health risk assess find studi optim simpl low cost method sampl airborn virus low melt agaros lma plate convent microbi air sampl devic develop lma plate permit direct nucleic acid extract captur virus preliminari elut step molecular detect quantif airborn virus perform realtim quantit rtpcr qrtpcr techniqu method test adenovirus adv norovirus nov gii repres dna rna virus method test outdoor experi detect quantifi human adenovirus hadv airborn environ wastewat treatment plant conclus great advantag lma nucleic acid extract perform directli lma plate elut nucleic acid total free inhibitori substanc coupl qpcr procedur complet three hour
Virol J	31214460	2014-12-31	PMC3200163	21967756	background base previou studi observ relev studi hypothesi antivir activ quercetin rhamnosid qr flavonoid relat abil antioxid method investig effect qr cytopath effect cpe cpe reduct assai product dna fragment reactiv oxygen speci ro induc pedv infect studi dna fragment assai flow cytometri cours studi discov qr extrem potent compound pedv addit qr pedvinfect vero cell directli reduc format visibl cytopath cpe qr induc dna fragment ro increas infect pedv decreas nacetyllcystein nac increas ro decreas qr antivir activ antioxid nac pyrrolidin dithiocarbam pdtc vitamin deriv trolox notic conclus conclud inhibit pedv product qr simpli gener action antioxid highli specif antioxid nac pdtc trolox inact pedv infect
PLoS One	25552712	2009-08-05	PMC3200317	22039436	sever arenavirus viral hemorrhag fever sever diseas casefat rate hospit individu rang limit prophylaxi treatment option medic countermeasur need virus classifi nation institut allergi infecti diseas niaid top prioriti biodefens categori pathogen recombin consensu interferon alpha cifn licens protein broad clinic appeal cifn great therapeut util biodefens applic hinder short vivo halflif mode frequenc administr costli product address limit describ def replicationdefici adenoviru vector drive express cifn pre postexposur prophylaxi acut arenavir infect model hamster intranas administr def prior challeng pichind viru picv highli effect protect anim mortal prevent viral replic liverassoci diseas protect observ singl dose def week prior picv challeng def efficaci administ treatment postviru exposur protect def attribut express cifn dose control empti vector adenoviru protect hamster lethal picv challeng effect countermeasur highli stabl easili administ elicit long last protect immun need arena viral infect def technolog potenti address issu serv broadspectrum antivir enhanc host defens number viral pathogen
PLoS Pathog	19656889	2011-03-23	PMC3203186	22046136	sever virus encod factor promot host mrna degrad silenc gene express unclear cellular mrna turnov pathwai engag assist process kaposi sarcomaassoci herpesviru phenotyp enact host shutoff factor sox soxinduc mrna turnov twostep process mrna cleav intern sox degrad cellular exonucleas xrn sox bypass regulatori step deadenyl decap requir xrn activ sox recruit translat mrna cosedi translat initi complex deplet polysom cleav mrna intermedi accumul fraction indic recognit occur earli stage translat exampl viral protein command cellular mrna turnov pathwai destroi host mrna suggest xrn pois deplet messag undergo translat mammalian cell
PLoS Pathog	21430047	2006-03-14	PMC3203193	22046132	coronavirus cov human anim pathogen induc fatal respiratori gastrointestin neurolog diseas outbreak sever acut respiratori syndrom sar demonstr human vulner coronaviru cov epidem vaccin therapeut human anim cov knowledg host cell protein pivot virushost interact defin broadspectrum antivir target studi system biologi approach emploi genomewid yeasttwo hybrid interact screen identifi immunopilin ppia ppib ppih ppig fkbpa fkbpb interact partner cov nonstructur protein nsp molecul modul calcineurinnfat pathwai plai role immun cell activ overexpress nsp infect live sarscov increas signal calcineurinnfat pathwai enhanc induct interleukin compat latestag immunopathogen longterm cytokin dysregul observ sever sar case convers inhibit cyclophilin cyclosporin cspa block replic cov genera includ sarscov human cove nl felin cov avian infecti bronchiti viru nonimmunosuppress deriv cspa serv broadrang cov inhibitor applic emerg cov ubiquit pathogen human livestock
Proc Biol Sci	16537610	2012-11-01	PMC3203494	21525058	influenza spread human popul multiplewav outbreak success reinfect individu short time interv explicitli report pandem rapid reinfect role reinfect drive multiplewav outbreak remain understood investig issu focu twowav influenza ahn epidem occur remot island tristan cunha dai island experienc attack experienc attack formul mathemat model invok varieti antigen immunolog reinfect mechan maximumlikelihood analysi confront model predict report incid time seri demonstr mechan retain host delai defici humor immun respons primari influenza infect reinfect strain initi second epidem wave mechan support previou empir studi combin genet ecolog advoc better understand account heterogen human immun respons essenti analysi multiplewav influenza outbreak pandem plan
Viruses	23077141	2018-01-11	PMC3205387	22069521	we develop felin model lentivir crossspeci transmiss puma lentiviru plv fivpco infect domest cat diseas infect plv protect cat cd tcell declin caus subsequ infect virul felin immunodefici viru fiv previou studi implic innat immun andor cellular restrict mechan fiv diseas attenu plvinfect cat studi evalu viral infect cytokin mrna transcript tissu reservoir month post infect quantit tissu provir load viral mrna load rel transcript il ilp ifn tissu cat expos fiv plv virus analyz paramet multivari statist approach distribut intens fiv infect ifn transcript differ singl coinfect cat character higher fiv provir load ifn express coinfect cat tissu variabl fiv mrna load ifn constrain coinfect versu singli infect cat tissu singleinfectedcoinfect ratio fiv mrna load compar fiv provir load indic activ viral transcript inhibit coinfect indic previou plv infect increas activ tissu innat immun constrain abil fiv product infect tissu reservoir infect month independ fiv provir load support model innat immun andor modul target cell suscept plai kei role plvinduc protect fiv diseas
Viruses	29322882	2013-10-16	PMC3205390	22069524	frog viru fv best character member famili iridovirida fv studi provid insight replic famili member serv model viral transcript genom replic virusmedi hostshutoff broad outlin fv replic elucid precis role viral protein remain unknown current studi knock kd mediat antisens morpholino oligonucleotid asmo small interf rna sirna knock ko replac target gene select marker homolog recombin ectop viral gene express recombin viral protein enabl research systemat ascertain replic virulencerel gene function addit applic molecular tool ecolog studi provid novel wai field biologist identifi potenti pathogen quantifi infect trace evolut ecolog viral speci review summar current studi fv iridovirus infect ectotherm describ gener principl ascertain fv serv model famili studi util ranavirus megalocytivirus confirm extend understand iridoviru replic collect futur effort will elucid molecular event viral replic intrins extrins factor contribut diseas outbreak role host immun system protect diseas
Vet Med Int	24498542	2014-12-01	PMC3206505	22135772	newli emerg infecti diseas neid increas rapidli present alarm challeng global health argu effect manag global health basic strategi includ three essenti tactic form action directli focus natur institut coordin disciplinari integr approach health manag level action illustr exampl livestock sector asia clear exampl three tactic form place develop countri food secur threat vietnam develop comprehens strategi final ecosystem health approach global health manag advoc approach move tradit singl disciplinari approach stronger guidanc need direct ecohealth applic manag global health
PLoS One	25343382	2006-05-01	PMC3206854	22073191	recent advanc highthroughput technolog gener gene protein sequenc data unpreced rate scale enabl entir omicsbas approach analysi complex biolog process amount complex data singl experi produc serious challeng research limit bioinformat expertis handl analyz interpret data understood biolog context unmet tool allow nonbioinformat user interpret larg data set develop method nnalign gener applic biolog problem quantit peptid data method effici identifi underli sequenc pattern simultan align peptid sequenc identifi motif associ quantit readout provid webbas implement nnalign allow nonexpert endus submit data option adjust method paramet return receiv train method includ visual represent identifi motif subsequ predict method appli unknown proteinspeptid appli method data set includ peptid microarrayderiv set data point nnalign onlin httpwwwcbsdtudkservicesnnalign
PLoS One	16827414	2019-05-28	PMC3206940	22073294	background coronavirus cov classifi alphacoronaviru group betacoronaviru group gammacoronaviru group base divers protein sequenc clike proteas clpro catalyz proteolyt process polyprotein viral replic potenti target anticoronavir infect methodologyprincip find profil substrat specif clpro human cov nl group human cov oc group sever acut respiratori syndrom coronaviru sarscov group infecti bronchiti viru ibv group measur activ substrat librari of variant singl substitut posit correl structur properti side chain volum hydrophob secondari structur propens substitut residu clpro prefer gln posit leu posit basic residu posit small hydrophob residu posit small residu p posit despit clpro group cov share similar substrat specif differ substrat specif observ posit ibv clpro prefer ppro sarscov clpro prefer pval combin favor residu posit identifi superact substrat sequenc varlqsgf cleav effici clpro rel activ vprlqsgf cleav ibv clpro rel activ conclusionssignific comprehens substrat specif clpro group cov profil studi provid insight ration design broadspectrum peptidomimet inhibitor target proteas
BMC Res Notes	31138703	2010-04-09	PMC3208482	22011414	background develop dna resequenc microarrai includ mitochondri dna mtdna sequenc mutat detect failur microarrai identifi base compar refer sequenc design ncall studi reexamin ncall distribut mtdna sampl sequenc affymetrix mitochip base hypothesi ncall repres insert delet indel mtdna find analys patient mtdna sampl mitochip ncall proprietari gseq softwar reduc freewar onlin algorithm resqmi sprofil util sprofil decreas ncall homoplasm heteroplasm mutat level compar gseq softwar resqmi produc chang mutat load produc longer ncell stretch reason analysi resqmi attempt convent dna sequenc longer ncall stretch sprofil reveal insert point mutat analysi singlebas ncall mtdna sampl point mutat conclus studi analys ncall produc gseq softwar mitochipv narrow focu longer stretch ncall reveal sprofil convent sequenc identifi uniqu insert point mutat shorter ncall harbour point mutat absenc delet ncall suggest probe confirm bind ncall studi support content gseq capabl assign base conjunct sprofil
BMC Infect Dis	20382757	2018-08-10	PMC3210101	22023788	background tuberculosi tb remain health problem roma popul serbia studi highlight increas awar tb reduc associ stigma reduc incid tb enabl earlier diagnosi effect treatment studi investig knowledg belief transmiss symptom treatment tb attitud patient tb roma popul belgrad method focusgroup method consid appropri investig knowledg belief tb total roma peopl ag year particip three focusgroup discuss particip knew tb pulmonari diseas contagi saliva commonli mention mode transmiss individu thought albeit hesitantli tb transmit shake hand infect individu factor contribut tb particip mention bad live condit low qualiti lack food stress particip quot chest pain cough haemoptysi loss appetit loss weight weak sweat basic symptom tb particip believ effect treatment includ rest prescrib medicin inhal fresh air eat strong food bacon pork approach consid antibiot addit particip mention folk medicin rel friend lesser extent televis main sourc tb particip appreci person contact doctor sourc conclus conclud particip awar serious tb mode transmiss misconcept find confid doctor express roma peopl
Mar Drugs	30097535	2012-10-31	PMC3210601	22072992	four tetromycin deriv tetromycin tetromycin isol streptomyc axinella polt cultiv mediterranean spong axinella polypoid structur assign extens d nmr spectroscopi hresim analysi compound test antiparasit activ leishmania major trypanosoma brucei proteas inhibit cystein proteas falcipain rhodesain cathepsin cathepsin viral proteas sarscov mpro plpro compound antiparasit activ brucei timedepend inhibit cathepsin llike proteas ki valu low micromolar rang
PLoS One	23115293	2003-08-01	PMC3210785	22087287	n previou studi canin coronaviru type ii ccovii activ extrins intrins apoptot pathwai canin fibrosarcoma cell cell investig role sirtuin forkhead box foxo famili experiment model nortern blot western blot analysi demonstr mitochondri sirt sirt protein express increas post infect pi onward nuclear sirt express increas pi decreas pi reach level control pi sirtuin interact withand regul activ foxo famili protein observ foxoa foxo express increas stabli pi onward addit ccovii induc remark increas express tnfrelat apoptosisinduc ligand trail observ slight upregul faslfa pi decreas protein infect viru infect increas bax transloc mitochondria decreas bcl express cytosol timedepend manner data foxo transcript factor mediat proapoptot effect ccovii activ extrins apoptosi pathwai sirtuin famili member sirt sirt involv intrins apoptot pathwai propos trail mediat cell death induc ccovii vitro infect
BMC Immunol	12885985	2006-12-01	PMC3212807	22011168	background balanc function proantiinflammatori mediat complex innat respons investig varieti experiment inflammatori set annexina anxa mediat endogen antiinflamm afford regul leukocyt traffick activ context role lung patholog scarc investig despit highli express lung cell appli bleomycin lung fibrosi model anxa null mice dai timecours monitor potenti impact mediat control inflammatori fibrot phase analys wildtyp mice reveal strict spatial tempor regul anxa gene upregul epitheli cell infiltr granulocyt dai augment protein level alveolar macrophag dai absenc anxa caus increas degre inflamm dai ii index fibrosi assess deposit hydroxyprolin lung dai alter anxa null mice parallel augment tgf ifn tnf gener compar wildtyp mice final treatment wild type anim anxa peptidomimet prophylact dai therapeut dai onward amelior sign inflamm fibrosi conclus collect data reveal pathophysiolog relev endogen anxa lung inflamm importantli fibrosi open insight pharmacolog treatment lung fibrosi
Virol J	17145913	2008-06-30	PMC3212826	22029605	human enteroviru ev infect hand foot mouth diseas children year infect occasion induc sever neurolog complic vaccin drug clinic control ev epidem studi treatment lycorin reduc viral cytopath cpe rhabdomyosarcoma cell inhibit viru replic analysi inhibitori lycorin viral protein synthesi suggest lycorin block elong viral polyprotein translat lycorin treatment mice challeng lethal dose ev reduct mortal clinic score patholog chang muscl mice achiev inhibit viral replic mice infect moder dose ev lycorin treatment protect paralysi lycorin potenti drug candid clinic treatment evinfect patient
Virol J	18587411	2012-05-23	PMC3212842	22032619	background three year suspect poultri farm provinc china diagnos avian infecti bronchiti ib survei final ibv strain confirm dwarf embryo test rtpcr assai viru recoveri trial isol caus bird di distress nephriti accord clinic record base epidemiolog analysi field isol nephropathogen ib vaccin farm china yl strain vaccin evalu antibodi titer challeng test immunoprotect test indic practic applic vaccin base field strain fine facilit control nephropathogen ib conclus studi aim set guid safeguard nephropathogen ibvcaus diseas china
BMC Med Genet	22623799	2008-04-30	PMC3213239	22013876	background antisens oligom induc exon skip aim reduc sever duchenn muscular dystrophi redirect splice prerna process caus mutat bypass shorter partial function becker muscular dystrophylik dystrophin isoform produc normal exon gener target restor dystrophin read frame appreci subset dystrophin mutat intraexon potenti compromis oligom effici necessit personalis oligom design patient antisens oligom easili personalis remain unclear patient polymorph antisens oligom target sequenc will requir costli process produc valid patient specif compound method report preclin test panel splice switch antisens oligom design excis exon dystrophin transcript normal dystroph patient cell patient cell harbour singl base insert exon li target sequenc oligom effect remov exon anticip mutat compromis oligom bind effici despit mismatch oligom design optimis excis exon normal dystrophin mrna remov mutat exon effici mutationspecif oligom conclus rais possibl mismatch ao therapeut applic case negat necess produc patientspecif compound
BMC Bioinformatics	18448543	2012-10-10	PMC3213686	21679460	background develop extend opensourc loopmedi isotherm amplif lamp signatur design program call lava lamp assai versatil analysi lava creat respons limit exist lamp signatur program lava identifi combin primer region basic lamp signatur combin primer region lamp signatur loop primer lamp signatur identifi primer conserv target organ sequenc primer combin optim base length melt temperatur space primer site compar lamp signatur candid staphylococcu aureu creat lava primerexplor includ signatur sampl target strain mycobacterium tuberculosi conclus design demonstr softwar identifi signatur candid appropri lamp assai softwar download httplavadnagooglecodecom
PLoS One	23055554	2018-05-25	PMC3214059	22096568	antibodi repertoir librari construct convention harvest mrna immun cell examin germlin rearrang immunoglobulin ig variabl region gene sourc antibodi repertoir immun phagedisplai scfv librari prepar splenocyt genom dna templat addit novel frameshift pcr fspcr step introduc rescu codon enhanc divers complementaritydetermin region cdr germlin scfv librari initi character hapten antigen phenyloxazolon phox sequenc analysi phoxselect scfv indic cdr consist novel conserv motif order illustr divers cdr increas fspcr step second scfv librari construct singl scfv clone lgc templat despit show bind characterist phox scfv clone lgcderiv antibodi librari lower nonspecif bind parent lgc clone determin germlin librari repres endogen immun statu specif scfv clone nucleocapsid protein sarsassoci coronaviru scov nave immun germlin scfv librari librari yield specif antin scfv exhibit bind characterist recombin protein immun librari larger number specif antin scfv clone ident nucleotid sequenc conclus highli diversifi antibodi librari effici construct germlin rearrang immunoglobulin variabl gene sourc antibodi repertoir fspcr diversifi cdr
PLoS One	29802199	2018-03-01	PMC3214079	22096610	background vaccin develop malaria complex diseas remain challeng scientif commun elucid genom proteom transcriptom of complex pathogen basi ration vaccin design identifi proteomewid scale novel target antigen recogn cell antibodi expos individu current algorithm effect identifi target antigen genom sequenc data challeng cell target pathogen plasmodium protein express convent platform problemat cellfre vitro transcript translat ivtt strategi prove success report novel approach proteomewid scale identif antigen target cell respons ivtt product princip find conduct seri vitro vivo experi ivtt protein unpurifi absorb carboxyl polybead affin purifi nickel resin magnet bead vitro studi human cmv ebv influenza viru protein antigenspecif cytokin product elispot cytometr bead arrai assai cell stimul purifi unpurifi ivtt antigen vitro vivo studi mice immun plasmodium yoelii circumsporozoit dna vaccin ivtt protein boost antigenspecif cytokin product purifi ivtt antigen nickel resin method ivtt antigen purif prove optim human murin system conclus work proof concept potenti highthroughput approach identifi cell target complex parasit viral bacteri pathogen genom sequenc data ration vaccin develop emerg reemerg diseas pose threat public health
Clin Dev Immunol	29278789	2012-03-20	PMC3216312	22110538	follow hn pandem ongo sporad aviantohuman transmiss hn virus emphasi better understand determin pathogenesi sever influenza infect current literatur focus viral genet impact host immun novel risk factor sever infect hn pandem understand host genet determin suscept sever respiratori ill current lack better defin role genet variabl influenza infect identifi kei polymorph impair host immun respons correl protect will better identifi atrisk popul target therapeut intervent vaccin paper will summar immunogenet factor associ suscept sever phn hn infect will identifi genet pathwai polymorph high relev futur studi
Int J Hypertens	22356166	2002-06-15	PMC3216391	22121476	the reninangiotensin system ra critic regul hypertens action vasoact peptid ang ii gener action angiotensinconvert enzym ac mediat increas blood pressur discoveri ac metabolis ang ii vasodilatori ang dimens tradit ra result huge interest ac decad potenti therapeut lower blood pressur elev excess ang ii studi focus ac help reveal action ang vasodil antifibrot antiprolif effect investig focus ac reveal varieti role catalyt viral receptor amino acid transport paper focus ac biolog role pai attent regul ac express light entranc human recombin ac clinic trial discuss potenti ac therapeut highlight pertin question remain unansw ac
PLoS One	12021344	2015-08-28	PMC3217956	22110607	object test incid common cold colleg student china associ ventil rate crowded dormitori method phase studi crosssect studi student live dorm room build respond questionnair incid durat common cold previou month phase ii air temperatur rel humid concentr measur hour dorm room build summer winter outto indoor air flow rate night calcul base measur concentr phase colleg student report incid common cold previou month report infect last week student person dorm room time incid common cold time year durat week compar student person room phase ii measur dorm room outto indoor air flow rate chines standard ls person heat season doserespons relationship outto indoor air flow rate person dorm room proport occup annual common cold infect time ventil rate lsperson dorm build associ report common cold time compar lsperson conclus crowd dormitori low outto indoor airflow rate associ respiratori infect colleg student
Genome Biol	26320212	2006-12-07	PMC3218861	21477297	we optim probe design copi number variat cnv snp genotyp plasmodium falciparum genom demonstr variabl length isotherm probe superior static length probe sampl prepar hybrid condit mitig effect host dna contamin field sampl microarrai workflow present identifi cnv snp accuraci singl hybrid field sampl human dna contamin
PLoS Genet	17156499	2001-09-01	PMC3219607	22125497	knowledg distribut mutat fit effect dmfe essenti evolutionari model year properti dmfe carefulli describ microorgan case singl environ studi explor environment variat dmfe environment effect relev evolut multihost parasit emerg pathogen character dmfe collect twenti singlenucleotid substitut mutant tobacco etch potyviru tev set host environ host speci natur infect tev belong famili solanacea three partial suscept host belong three plant famili viru genotypebyhost speci interact sustain differ genet varianc fit pleiotrop mutat host second dmfe markedli solanacea nonsolanacea host exposur tev genotyp nonsolanacea host led larg reduct viral fit varianc remain constant skew increas tail solanacea host distribut contain excess deleteri mutat nonsolanacea fraction benefici mutat larger result suggest tev easili broaden host rang improv fit host knowledg dmfe natur host allow make predict properti altern host
Virol J	11483763	2012-04-11	PMC3219666	21951835	background felin coronaviru compris pathogen biotyp consist felin infecti periton viru fipv felin enter coronaviru fecv divid serotyp examin preval korean cat infect felin coronaviru fcov type ii fecal sampl cat pet feral fourteen cat fcovposit includ infect type fcov type ii fcov type ii coinfect low seropreval fcov identifi chronic cat healthi cat conclus preval fcov infect high comparison countri higher preval type fcov korean felin preval fcov antigen antibodi korean cat expect gradual increas rise number strai companion cat
PLoS Pathog	22494341	2017-10-01	PMC3219706	22114553	sinc case fever thrombocytopenia leukopenia syndrom ftl emerg henan provinc china patient report tick bite suggest infect contribut ftl ticktransmit microbi pathogen test pcrrtpcr andor indirect immunofluoresc assai ifa sampl collect test posit human granulocyt anaplasmosi hga suggest pathogen involv unbias metagenom approach screen survei microb associ ftl blastx analysi deduc protein sequenc reveal novel bunyaviru ident tehran viru access hq sera ftl patient phylogenet analysi close uukuniemi viru phleboviru genu viru distinct candid viru examin associ ftl sampl collect henan provinc rtpcr viral cultur seroepidemiolog survei undertaken rtpcr acutephas serum sampl contain viral rna patient pair acut convalesc sera serolog evid infect seroconvers exhibit fold increas antibodi titer viru viru isol patient acutephas serum sampl name henan fever viru hnf viru wholegenom sequenc confirm viru novel bunyaviru genet similar bunyavirus close uukuniemi viru maximum ident segment maximum queri coverag releas genbank sequenc sftsv ident ident novel bunyaviru hnf viru correl ftl
PLoS Pathog	28901902	2016-01-06	PMC3219726	22114563	follow infect central nervou system cn immun system face challeng elimin pathogen caus damag neuron limit capac renew thought neuron protect direct attack cytotox lymphocyt ctl express major histocompat class mhc molecul steadi state current knowledg specif neuronctl interact base studi artifici induc mhc express neuron load exogen peptid appli ctl clone line differenti cultur remain uncov modal interact infect neuron antivir cd cell cours natur diseas model neuroinflamm caus neurotrop borna diseas viru bdv virusspecif ctl demonstr main immun effector trigger diseas test pathogen properti brainisol cd cell pure neuron cultur infect bdv observ bdv infect cortic neuron trigger regul mhc molecul render suscept recognit antivir ctl freshli isol brain acut infect rat realtim imag analyz spatiotempor relationship neuron ctl brainisol ctl exhibit reduc mobil establish stabl contact bdvinfect neuron antigen mhcdepend manner interact induc rapid morpholog chang neuron kill impair electr activ earli sign neuron apoptosi detect hour initi contact infect neuron recogn effici brainisol antivir cd cell uncov unusu modal ctlinduc neuron damag
Ir Vet J	26739058	2005-07-13	PMC3220626	22018053	calfhood diseas major impact econom viabil cattl oper three review seri develop focus calf health birth wean paper the three seri review diseas prevent manag refer pneumonia focus prewean calf pneumonia wean suckler calv consid kei risk factor time wean wean suckler calf combin addit stressor includ chang nutrit environment chang transport pain husbandri procedur castrat dehorn reduct cumul effect multipl stressor time wean vaccin programm precondit reduc subsequ morbid mortal feedlot studi calv hous individu calv hous outdoor shelter associ decreas risk diseas pose greater manag challeng success group hous calv special emphasi equal ag group keep group stabl form manag pneumonia calv reliant sound understand aetiolog relev risk factor effect approach diagnosi treatment earli sign pneumonia includ increas respiratori rate fever depress singl factor determin success therapi calv pneumonia earli onset treatment subsequ adequ durat treatment efficaci econom viabil vaccin respiratori diseas calv remain unclear
PLoS One	16014971	2012-09-16	PMC3222642	22132172	background major influenza transmiss occur home school workplac frequent touch commun item situat transmiss fomit unclear data exist surviv viru commonli touch surfac measur viabil time hn influenza strain appli varieti materi commonli household workplac methodolog princip find influenza apuertorico pr acambridgeaho pandem hn virus inocul wide rang surfac work environ sampl set time incub stabilis temperatur humid viru genom measur rtpcr plaqu assai pr fluoresc focu format pandem hn assess surviv viabl viru conclusionssignific genom viru detect surfac applic drop copi number except unseal wood surfac contrast viru viabil drop rapidli live viru recov surfac test hour applic nonpor materi hour fallen level detect surfac conclud influenza transmiss fomit occur long period surfac contamin reinocul occur situat involv high probabl influenza transmiss data hierarchi prioriti surfac decontamin multisurfac environ hospit
J Med Case Reports	22894960	2019-06-01	PMC3223529	22018019	introduct media sensation hn outbreak influenc decision process clinic diagnosi case present report case patient present coexist hn viru legionella infect yearold caucasian man yearold caucasian woman case sign symptom includ vomit progress respiratori diseas lead respiratori failur refractori hypoxemia leukopenia lymphopenia thrombocytopenia elev level creatin kinas hepat aminotransferas consist critic ill hn viru infect infecti disord mimic hn viral infect legionnair diseas swine flu hn pandem occur autumn itali legionnair diseas highli suspect peak incid occur earli fall suspicion legionella infect base clinic histori xrai abnorm fundament success resolut conclus case report patient hn screen legionella current common practic sign symptom infect similar
Pan Afr Med J	31160479	2017-04-03	PMC3224071	22187606	as subsaharan africa inhabit live numer public health challeng public health initi unit state presid emerg plan aid relief presid malaria initi success reduc mortal prioriti diseas compet train public health workforc oper multidiseas surveil respons system build sustain success address public health problem subsaharan africa appear weather global econom downturn remark increas middl class demand stronger public health system protect commun epidem intellig servic ei program center diseas control prevent cdc backbon public health surveil respons year exist ei adapt internation creat field epidemiolog train program fetp countri cdc rockefel foundat collabor uganda zimbabw ministri health local univers creat year public health school wall phswow base fetp model fetp model adapt creat field epidemiolog laboratori train program feltp kenya conduct joint competencybas train field epidemiologist public health laboratori scientist provid master degre particip complet feltp model implement addit countri subsaharan africa feltp phswow cover peopl subsaharan africa enrol public health profession describ process develop feltp cover countri subsaharan africa strategi develop local train public health workforc oper multidiseas surveil respons system
BMC Res Notes	28373566	2003-07-01	PMC3224397	21955389	background outbreak respiratori ill caus influenza hn viru occur worldwid patient requir intens care unit icu admiss noninvas ventil niv patient controversi aerosol dispers contamin environ healthcar cowork method describ respiratori profil mortal rate benefit niv patient confirm diagnosi influenza ahn admit icu year total case influenza hn confirm hospit realtim rtpcr patient admit icu patient ag rang year median acut respiratori failur arf patient median acut physiolog chronic health evalu ii score rang patient develop arf need niv need invas mv admiss success rate niv higher describ hospit mortal rate influenza hn arriv brazil diseas endem alert countri popul awar symptom healthcar system treatment allow patient properli treat influenza hn healthcar worker protect measur avoid contamin conclus studi high success low mortal rate noninvas ventil patient influenza hn
Adv Prev Med	12819288	2014-04-02	PMC3226423	22162813	health care facil ventil design greatli diseas transmiss aerosol desir control infect hospit time reduc carbon footprint motiv unconvent solut build design associ control measur paper consid indoor sourc type infecti aerosol pathogen viabil infect behavior respons environment condit aerosol dispers heat mass transfer deposit respiratori tract infect mechan discuss emphasi experiment model approach kei build design paramet describ includ type ventil system mix displac natur hybrid air exchang rate temperatur rel humid air flow distribut structur occup engin disinfect air filtrat uv radiat architectur program sourc activ manag health care facil paper describ major find suggest futur method ventil design health care facil prevent airborn infect risk
PLoS One	24696472	2018-10-15	PMC3226564	22140457	aberr activ caspas emerg major contributor pathogenes neurodegen disord alzheim huntington diseas commerci assai measur caspas activ commonli veid peptid substrat method suit assess caspas activ presenc confound proteas activ encount cell tissu sampl report develop method overcom limit protein substrat lamin highli specif caspas cleavag amino acid neoepitop antibodi cleav lamin develop electrochemiluminescencebas elisa assai suitabl detect quantifi caspas activ highli apoptot cell extract method sensit veidbas assai adapt highcont imag platform highthroughput screen method screen character caspas inhibitor compound intervent decreas intracellular caspas activ applic neurodegen disord
Clin Dev Immunol	30322911	2009-03-01	PMC3227431	22162720	the human zona pellucida glycoprotein hzp virtu critic role fertil propos promis candid antigen develop contracept vaccin direct imper map minim motif cell epitop bce avoid zpspecif oophoritogen cell epitop tce zpbase immunogen studi base map marmoset bonnet monkei zp mstzp bmzp predict epitop hzp confirm minim motif epitop hzp defin serum recombin hzpa hzpb biosynthet peptid strategi defin minim motif qplwll hzp mqvtdd hzp eenw hzp snswf egp hzp antigen peptid hzp hzp specif antibodi respons peptid evalu produc hightit antibodi immun anim capabl react zp human oocyt rhzpb protein rhzp rhzp rhzp epitop peptid fuse truncat gst protein
PLoS One	19258537	2005-08-15	PMC3227585	22164200	member tolllik receptor tlr gene famili occupi kei role mammalian innat immun system function sentri detect invad pathogen provok host innat immun respons util custom nextgener sequenc approach allelespecif genotyp assai detect valid biallel variant bovin tlr gene includ nonsynonym singl nucleotid polymorph snp put nonsens snp bayesian haplotyp reconstruct median join network reveal haplotyp share bo tauru tauru bo tauru indicu breed locu special beef dairi breed differenti despit averag polymorph densiti marker bp collect tagsnp tag insertiondelet mutat indel suffici predict variat variabl site bo subspeci hybrid tagsnp tagindel predict captur variat variabl site tauru polyphen sift analys amino acid aa replac encod bovin tlr snp indic aa substitut expect impact protein function classic newli develop test divers provid strong support balanc select oper tlr tlr purifi select act tlr investig persist continu linkag disequilibrium adjac variabl site support presenc select act tlr tlr casecontrol studi emploi valid variant bovin tlr gene recogn bacteri ligand reveal snp elicit small effect suscept mycobacterium avium spp paratuberculosi infect dairi cattl studi will broadli impact domest cattl provid foundat explor avenu bovin translat genom potenti markerassist vaccin
PLoS One	16103198	2018-11-01	PMC3227592	22140483	despit effect combin antiretrovir treatment cart hiv evid indic residu infect persist cell type intensif cart decreas residu viral load immun activ cart restrict synthesi infecti viru curtail hiv transcript translat integr unintegr viral genom infect cell treat patient full viral suppress lowlevel viremia treat individu develop minor hiv associ neurocognit deficit hand residu viru immun activ therapeut agent need curtail hiv transcript residu viru studi luteolin dietari supplement profoundli reduc hiv infect report cell primari lymphocyt hivinhibit luteolin independ viral entri fact wildtyp vsvpseudotyp hiv infect inhibit luteolin unabl inhibit viral revers transcript luteolin antivir activ latent hiv reactiv model effect ablat cladeb tatdriven ltr transactiv report assai tat express subcellular local conclud luteolin confer antihiv activ tat function level biosafeti profil abil cross bloodbrain barrier luteolin serv base flavonoid develop potent antihiv deriv complement cart
PLoS One	30252528	2014-05-20	PMC3227604	22140516	the worldwid spread hn avian influenza increas report resist current drug high prioriti develop antiinfluenza drug uniqu function assist virus bind cellular surfac kei step subsequ penetr infect cell hemagglutinin ha main target drug design influenza viru develop potent ha inhibitor zinc fragment databas search find optim compound core hop techniqu result neo compound subsequ molecular dock studi molecular dynam simul neo assum favor conform bind pocket ha stronger bind interact receptor neo promis candid develop power drug treat influenza find report provid insight stimul strategi area
PLoS One	24847143	2007-09-01	PMC3227611	22140523	bat harbor highli pathogen zoonot virus includ rabi marburg henipavirus overt clinic symptom anim suspect bat evolv effect mechan suppress viral replic investig interferon ifn respons induct secret signal epitheliallik cell relev abund african fruit bat speci eidolon helvum helvum immort cell line gener potenti induc react ifn confirm biolog assai adapt applic bat cell cultur enabl comparison landmark ifn properti common mammalian cell line helvum cell fulli capabl react viral artifici ifn stimuli helvum cell highest ifn mrna induct highli product ifn protein secret evid effici ifn stimul gene induct alphaviru infect model onyongnyong viru exhibit strong ifn induct evad ifn respons translat transcript shutoff alphaviru infect novel ifncompet cell line will allow compar zoonot batborn virus order model mechan viral mainten emerg bat reservoir
PLoS One	17767687	2007-02-01	PMC3227662	22140536	the infect virus neighbor cell consid benefici term evas host antiviru defens system pathwai viral infect door viru transmiss cellcel fusion form syncytium product progeni virion mediat virion viru diffus gener design celltocel transmiss influenza virus believ transmit cellfre viru infect cell uninfect cell demonstr influenza viru util celltocel transmiss pathwai apic membran handov virion surfac infect cell adjac host cell live cell imag techniqu recombin influenza viru neuraminidas gene replac green fluoresc protein gene spread infect cell adjac cell form infect cell cluster type viru spread requir ha activ proteas treatment celltocel transmiss block amantadin inhibit acidif endosom requir uncoat influenza viru particl endosom indic function hemagglutinin endosom acidif ion channel essenti celltocel influenza viru transmiss celltocel transmiss influenza viru progeni virion remain associ surfac infect cell bud progeni virion pass adjac uninfect cell evid celltocel transmiss occur influenza viru lead caution local infect proce treat neuraminidas inhibitor
Interdiscip Perspect Infect Dis	17255311	2011-07-12	PMC3228346	22162687	by definit zoonot pathogen strict hostspeci specialist infect human nonhuman reservoir speci major zoonot pathogen infect amplifi multipl vertebr speci natur quantit impact distribut abund pathogen diseas risk zoonot pathogen emerg domin respons public health scientist search singl reservoir ignor speci influenc transmiss focu singl primari reservoir host speci delai biolog understand public health intervent speci amplifi regul pathogen overlook investig evolutionari ecolog strategi newli discov emerg pathogen commun potenti actual host speci will fruit biolog understand public health
PLoS One	21749228	2016-07-01	PMC3229576	22164298	sever acut respiratori coronaviru sarscov emerg roughli case worldwid mortal anim reservoir sarscov precursor exist likelihood futur outbreak human popul high sarscov papainlik proteas plp attract target pharmaceut develop essenti viru replic conserv human coronavirus yeastbas assai establish plp activ reli abil plp induc pronounc slowgrowth phenotyp express cerevisia induct slowgrowth phenotyp place hour time cours provid basi conduct screen small molecul restor growth inhibit function plp chemic suppressor slowgrowth phenotyp identifi member nih divers set librari nsc potent inhibit sarscov replic cell cultur toxic effect cell inhibit sarscov replic influenza viru replic nsc plp proteas deubiquitinas antiinterferon activ investig compound alter activ suppressor nsc demonstr abil inhibit plp proteas activ cellbas assai identif inhibitor demonstr strong function connect plpbase yeast assai inhibitori compound sarscov biologi data nsc novel mechan inhibit sarscov replic involv unknown activ plp altern direct cellular target modifi bypass plp function yeast mammalian cell
PLoS One	27373336	2006-10-18	PMC3229585	22164286	object purpos studi examin chang health statu china adult popul year rapid econom growth medic system improv method data third fourth chines nation health servic survei cover resid resid ag year analyz chines respond report diseas smoke decreas men women regular exercis improv stratifi analys reveal subpopul dispar rate ratio presenc chronic diseas greater increas women elderli han nation unmarri widow illiter rural region east china group conclus chines adult wors health statu in term presenc chronic diseas china reform health care will face complex challeng come year deterior health statu chines adult
